0001628280-24-008053.txt : 20240229 0001628280-24-008053.hdr.sgml : 20240229 20240229170748 ACCESSION NUMBER: 0001628280-24-008053 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 124 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Evolv Technologies Holdings, Inc. CENTRAL INDEX KEY: 0001805385 STANDARD INDUSTRIAL CLASSIFICATION: COMPUTER PERIPHERAL EQUIPMENT, NEC [3577] ORGANIZATION NAME: 06 Technology IRS NUMBER: 844473840 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39417 FILM NUMBER: 24704968 BUSINESS ADDRESS: STREET 1: 12141 WICKCHESTER LN., SUITE 325 CITY: HOUSTON STATE: TX ZIP: 77079 BUSINESS PHONE: 212-653-0153 MAIL ADDRESS: STREET 1: 12141 WICKCHESTER LN., SUITE 325 CITY: HOUSTON STATE: TX ZIP: 77079 FORMER COMPANY: FORMER CONFORMED NAME: NewHold Investment Corp. DATE OF NAME CHANGE: 20200303 10-K 1 nhic-20231231.htm 10-K nhic-20231231
00018053852023FYfalseP1YP1YP1YP1YP1YP1YP1YP1YP1YP1Y26600018053852023-01-012023-12-310001805385us-gaap:CommonClassAMember2023-01-012023-12-310001805385nhic:WarrantsToPurchaseOneShareOfClassCommonStockMember2023-01-012023-12-3100018053852023-06-30iso4217:USD00018053852024-02-28xbrli:shares00018053852023-12-3100018053852022-12-31iso4217:USDxbrli:shares0001805385us-gaap:RelatedPartyMember2023-12-310001805385us-gaap:RelatedPartyMember2022-12-310001805385us-gaap:ProductMember2023-01-012023-12-310001805385us-gaap:ProductMember2022-01-012022-12-310001805385us-gaap:SubscriptionAndCirculationMember2023-01-012023-12-310001805385us-gaap:SubscriptionAndCirculationMember2022-01-012022-12-310001805385us-gaap:ServiceMember2023-01-012023-12-310001805385us-gaap:ServiceMember2022-01-012022-12-310001805385nhic:LicenseFeeAndOtherRevenueMember2023-01-012023-12-310001805385nhic:LicenseFeeAndOtherRevenueMember2022-01-012022-12-3100018053852022-01-012022-12-310001805385us-gaap:RelatedPartyMember2023-01-012023-12-310001805385us-gaap:RelatedPartyMember2022-01-012022-12-310001805385us-gaap:CommonStockMember2021-12-310001805385us-gaap:AdditionalPaidInCapitalMember2021-12-310001805385us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001805385us-gaap:RetainedEarningsMember2021-12-3100018053852021-12-310001805385us-gaap:CommonStockMember2022-01-012022-12-310001805385us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001805385us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001805385us-gaap:RetainedEarningsMember2022-01-012022-12-310001805385us-gaap:CommonStockMember2022-12-310001805385us-gaap:AdditionalPaidInCapitalMember2022-12-310001805385us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001805385us-gaap:RetainedEarningsMember2022-12-310001805385us-gaap:CommonStockMember2023-01-012023-12-310001805385us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310001805385us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310001805385us-gaap:RetainedEarningsMember2023-01-012023-12-310001805385us-gaap:CommonStockMember2023-12-310001805385us-gaap:AdditionalPaidInCapitalMember2023-12-310001805385us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001805385us-gaap:RetainedEarningsMember2023-12-310001805385srt:RestatementAdjustmentMembernhic:LicenseFeeAndOtherRevenueMember2022-01-012022-12-310001805385us-gaap:CustomerConcentrationRiskMembernhic:MotorolaSolutionsIncMemberus-gaap:SalesRevenueNetMember2023-01-012023-12-31xbrli:pure0001805385us-gaap:CustomerConcentrationRiskMembernhic:MotorolaSolutionsIncMemberus-gaap:SalesRevenueNetMember2022-01-012022-12-310001805385us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembernhic:CustomerAMember2022-01-012022-12-310001805385us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembernhic:CustomerBMember2023-01-012023-12-310001805385us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembernhic:CustomerOneMember2023-01-012023-12-310001805385us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembernhic:CustomerOneMember2022-01-012022-12-310001805385us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembernhic:CustomerAMember2023-01-012023-12-310001805385us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembernhic:CustomerBMember2022-01-012022-12-310001805385us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembernhic:MotorolaSolutionsIncMember2022-01-012022-12-310001805385us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembernhic:CustomerBMember2022-01-012022-12-310001805385us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembernhic:CustomerOneMember2023-01-012023-12-310001805385us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembernhic:CustomerOneMember2022-01-012022-12-310001805385us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembernhic:MotorolaSolutionsIncMember2023-01-012023-12-310001805385us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembernhic:CustomerBMember2023-01-012023-12-310001805385nhic:PlanOfMergerWithNhicAndMergerSubMembernhic:TriggeringEventOneMemberus-gaap:CommonClassAMembersrt:ScenarioForecastMember2026-03-082026-03-080001805385nhic:PlanOfMergerWithNhicAndMergerSubMembernhic:TriggeringEventOneMemberus-gaap:CommonClassAMembersrt:MinimumMembersrt:ScenarioForecastMember2026-03-080001805385nhic:TriggeringEventOneMembersrt:ScenarioForecastMember2026-03-082026-03-08utr:D0001805385nhic:PlanOfMergerWithNhicAndMergerSubMembernhic:TriggeringEventTwoMemberus-gaap:CommonClassAMembersrt:ScenarioForecastMember2026-03-082026-03-080001805385nhic:PlanOfMergerWithNhicAndMergerSubMembernhic:TriggeringEventTwoMemberus-gaap:CommonClassAMembersrt:MinimumMembersrt:ScenarioForecastMember2026-03-080001805385nhic:TriggeringEventTwoMembersrt:ScenarioForecastMember2026-03-082026-03-080001805385nhic:TriggeringEventThreeMembernhic:PlanOfMergerWithNhicAndMergerSubMemberus-gaap:CommonClassAMembersrt:ScenarioForecastMember2026-03-082026-03-080001805385nhic:TriggeringEventThreeMembernhic:PlanOfMergerWithNhicAndMergerSubMemberus-gaap:CommonClassAMembersrt:MinimumMembersrt:ScenarioForecastMember2026-03-080001805385nhic:TriggeringEventThreeMembersrt:ScenarioForecastMember2026-03-082026-03-080001805385nhic:PlanOfMergerWithNhicAndMergerSubMember2023-12-310001805385nhic:NhicSubIncMember2023-12-310001805385us-gaap:CommonClassBMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2023-01-012023-12-310001805385srt:MaximumMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2023-01-012023-12-310001805385us-gaap:ShareBasedCompensationAwardTrancheTwoMembersrt:MinimumMember2023-12-310001805385us-gaap:ShareBasedCompensationAwardTrancheTwoMember2023-01-012023-12-310001805385us-gaap:CommonClassBMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2023-01-012023-12-310001805385us-gaap:ShareBasedCompensationAwardTrancheThreeMember2023-01-012023-12-310001805385us-gaap:ShareBasedCompensationAwardTrancheThreeMembersrt:MinimumMember2023-12-310001805385us-gaap:CommonClassBMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2023-01-012023-12-310001805385nhic:GiveEvolvLlcMember2023-01-012023-12-3100018053852021-07-160001805385nhic:EdgeUnitsMember2023-01-012023-12-310001805385nhic:EdgeUnitsMember2022-01-012022-12-310001805385us-gaap:ComputerEquipmentMember2023-12-310001805385nhic:LabEquipmentMember2023-12-310001805385us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-12-310001805385us-gaap:FurnitureAndFixturesMember2023-12-310001805385srt:MaximumMemberus-gaap:LeaseholdImprovementsMember2023-12-310001805385us-gaap:MachineryAndEquipmentMembersrt:MinimumMember2023-12-310001805385us-gaap:MachineryAndEquipmentMembersrt:MaximumMember2023-12-310001805385us-gaap:SoftwareDevelopmentMember2023-12-310001805385us-gaap:MachineryAndEquipmentMember2023-12-31nhic:segment0001805385nhic:LeasedEquipmentMember2023-12-310001805385us-gaap:EmployeeStockOptionMember2023-01-012023-12-310001805385us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-310001805385us-gaap:EmployeeStockOptionMember2021-01-012021-01-310001805385nhic:BusinessDevelopmentAgreementWithFinbackMember2021-01-310001805385nhic:SubscriptionAgreementsMember2023-01-012023-12-310001805385us-gaap:USTreasuryBillSecuritiesMember2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBillSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBillSecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBillSecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryBillSecuritiesMember2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMember2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membernhic:ContingentEarnOutLiabilityMember2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:ContingentEarnOutLiabilityMemberus-gaap:FairValueInputsLevel2Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:ContingentEarnOutLiabilityMemberus-gaap:FairValueInputsLevel3Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:ContingentEarnOutLiabilityMember2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membernhic:ContingentlyIssuableCommonStockLiabilityMember2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membernhic:ContingentlyIssuableCommonStockLiabilityMember2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:ContingentlyIssuableCommonStockLiabilityMemberus-gaap:FairValueInputsLevel3Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:ContingentlyIssuableCommonStockLiabilityMember2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membernhic:PublicWarrantLiabilityMember2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:PublicWarrantLiabilityMemberus-gaap:FairValueInputsLevel2Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:PublicWarrantLiabilityMemberus-gaap:FairValueInputsLevel3Member2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:PublicWarrantLiabilityMember2023-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMember2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membernhic:LongTermDebtIncludingCurrentPortionMember2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:LongTermDebtIncludingCurrentPortionMemberus-gaap:FairValueInputsLevel2Member2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:LongTermDebtIncludingCurrentPortionMemberus-gaap:FairValueInputsLevel3Member2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:LongTermDebtIncludingCurrentPortionMember2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membernhic:ContingentEarnOutLiabilityMember2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:ContingentEarnOutLiabilityMemberus-gaap:FairValueInputsLevel2Member2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:ContingentEarnOutLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:ContingentEarnOutLiabilityMember2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membernhic:ContingentlyIssuableCommonStockLiabilityMember2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membernhic:ContingentlyIssuableCommonStockLiabilityMember2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:ContingentlyIssuableCommonStockLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:ContingentlyIssuableCommonStockLiabilityMember2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membernhic:PublicWarrantLiabilityMember2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:PublicWarrantLiabilityMemberus-gaap:FairValueInputsLevel2Member2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:PublicWarrantLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-12-310001805385us-gaap:FairValueMeasurementsRecurringMembernhic:PublicWarrantLiabilityMember2022-12-310001805385nhic:ContingentEarnOutLiabilityMember2023-01-012023-12-310001805385nhic:ContingentEarnOutLiabilityMemberus-gaap:MeasurementInputPriceVolatilityMember2023-01-012023-12-310001805385nhic:ContingentEarnOutLiabilityMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2023-01-012023-12-310001805385nhic:ContingentEarnOutLiabilityMemberus-gaap:MeasurementInputControlPremiumMember2023-01-012023-12-310001805385nhic:ContingentEarnOutLiabilityMemberus-gaap:MeasurementInputExpectedTermMember2023-01-012023-12-310001805385nhic:ContingentEarnOutLiabilityMember2021-12-310001805385nhic:ContingentEarnOutLiabilityMember2022-01-012022-12-310001805385nhic:ContingentEarnOutLiabilityMember2022-12-310001805385nhic:ContingentEarnOutLiabilityMember2023-12-310001805385nhic:ContingentlyIssuableCommonStockLiabilityMember2021-07-152021-07-150001805385nhic:ContingentlyIssuableCommonStockLiabilityMember2021-07-162021-07-160001805385nhic:ContingentlyIssuableCommonStockLiabilityMember2023-01-012023-12-310001805385nhic:ContingentlyIssuableCommonStockLiabilityMemberus-gaap:MeasurementInputPriceVolatilityMember2023-01-012023-12-310001805385us-gaap:MeasurementInputRiskFreeInterestRateMembernhic:ContingentlyIssuableCommonStockLiabilityMember2023-01-012023-12-310001805385nhic:ContingentlyIssuableCommonStockLiabilityMemberus-gaap:MeasurementInputControlPremiumMember2023-01-012023-12-310001805385us-gaap:MeasurementInputExpectedTermMembernhic:ContingentlyIssuableCommonStockLiabilityMember2023-01-012023-12-310001805385nhic:ContingentlyIssuableCommonStockLiabilityMember2021-12-310001805385nhic:ContingentlyIssuableCommonStockLiabilityMember2022-01-012022-12-310001805385nhic:ContingentlyIssuableCommonStockLiabilityMember2022-12-310001805385nhic:ContingentlyIssuableCommonStockLiabilityMember2023-12-310001805385nhic:PublicWarrantLiabilityMember2021-12-310001805385nhic:PublicWarrantLiabilityMember2022-01-012022-12-310001805385nhic:PublicWarrantLiabilityMember2022-12-310001805385nhic:PublicWarrantLiabilityMember2023-01-012023-12-310001805385nhic:PublicWarrantLiabilityMember2023-12-3100018053852024-01-01us-gaap:ProductMember2023-12-3100018053852025-01-01us-gaap:ProductMember2023-12-3100018053852026-01-01us-gaap:ProductMember2023-12-310001805385us-gaap:ProductMember2023-12-3100018053852024-01-01us-gaap:SubscriptionAndCirculationMember2023-12-310001805385us-gaap:SubscriptionAndCirculationMember2025-01-012023-12-310001805385us-gaap:SubscriptionAndCirculationMember2026-01-012023-12-310001805385us-gaap:SubscriptionAndCirculationMember2023-12-3100018053852024-01-01us-gaap:ServiceMember2023-12-310001805385us-gaap:ServiceMember2025-01-012023-12-310001805385us-gaap:ServiceMember2026-01-012023-12-310001805385us-gaap:ServiceMember2023-12-3100018053852024-01-01nhic:LicenseFeeAndOtherRevenueMember2023-12-310001805385nhic:LicenseFeeAndOtherRevenueMember2025-01-012023-12-3100018053852026-01-01nhic:LicenseFeeAndOtherRevenueMember2023-12-310001805385nhic:LicenseFeeAndOtherRevenueMember2023-12-3100018053852024-01-012023-12-3100018053852025-01-012023-12-3100018053852026-01-012023-12-310001805385nhic:LeasedEquipmentMember2023-01-012023-12-310001805385nhic:LeasedEquipmentMember2022-01-012022-12-310001805385nhic:SaaSMaintenanceAndOtherMember2023-01-012023-12-310001805385nhic:SaaSMaintenanceAndOtherMember2022-01-012022-12-310001805385nhic:LicenseFeeMember2023-01-012023-12-310001805385nhic:LicenseFeeMember2022-01-012022-12-310001805385nhic:ProfessionalServicesAndOtherRevenueMember2023-01-012023-12-310001805385nhic:ProfessionalServicesAndOtherRevenueMember2022-01-012022-12-310001805385country:US2023-01-012023-12-310001805385country:US2022-01-012022-12-310001805385us-gaap:NonUsMember2023-01-012023-12-310001805385us-gaap:NonUsMember2022-01-012022-12-310001805385nhic:GiveEvolvLlcMember2023-01-012023-12-31nhic:unit0001805385nhic:GiveEvolvLlcMember2022-01-012022-12-3100018053852021-05-0100018053852021-05-012021-05-01nhic:space0001805385nhic:ComputerAndTelecomEquipmentMember2023-12-310001805385nhic:ComputerAndTelecomEquipmentMember2022-12-310001805385us-gaap:EquipmentMember2023-12-310001805385us-gaap:EquipmentMember2022-12-310001805385us-gaap:FurnitureAndFixturesMember2022-12-310001805385us-gaap:LeaseholdsAndLeaseholdImprovementsMember2023-12-310001805385us-gaap:LeaseholdsAndLeaseholdImprovementsMember2022-12-310001805385nhic:LeasedEquipmentMember2022-12-310001805385us-gaap:SoftwareDevelopmentMember2022-12-310001805385nhic:SalesDemoEquipmentMember2023-12-310001805385nhic:SalesDemoEquipmentMember2022-12-310001805385nhic:EquipmentHeldForLeaseMember2023-12-310001805385nhic:EquipmentHeldForLeaseMember2022-12-310001805385us-gaap:ConstructionInProgressMember2023-12-310001805385us-gaap:ConstructionInProgressMember2022-12-310001805385us-gaap:SoftwareDevelopmentMember2023-01-012023-12-310001805385us-gaap:SoftwareDevelopmentMember2022-01-012022-12-310001805385nhic:LeasedEquipmentMember2023-01-012023-12-310001805385nhic:LeasedEquipmentMember2022-01-012022-12-310001805385nhic:TermLoansPayableMember2023-12-310001805385nhic:TermLoansPayableMember2022-12-310001805385nhic:A2022SVBTermLoanMember2023-12-310001805385nhic:A2022SVBTermLoanMember2023-01-012023-12-310001805385nhic:A2022SVBTermLoanTwoMember2023-12-310001805385nhic:A2022SVBTermLoanTwoMember2023-01-012023-12-310001805385us-gaap:PrimeRateMembersrt:MaximumMembernhic:A2022SVBTermLoanMember2023-12-310001805385srt:MaximumMembernhic:A2022SVBTermLoanMember2023-12-310001805385nhic:A2022SVBTermLoanMember2023-12-210001805385nhic:A2022SVBTermLoanMember2023-03-312023-03-310001805385nhic:A2022SVBTermLoanMember2023-03-310001805385nhic:WarrantsIssuedAtJanuaryTwoThousandTwentyOneMember2023-12-310001805385nhic:WarrantsIssuedAtJulyTwoThousandTwentyOneMember2023-12-310001805385nhic:WarrantsIssuedAtJanuaryTwoThousandTwentyOneMember2022-12-310001805385nhic:WarrantsIssuedAtJulyTwoThousandTwentyOneMember2022-12-31nhic:Vote0001805385nhic:ShareBasedAwardsExcludingEmployeeStockPurchasePlanMember2023-12-310001805385nhic:ShareBasedAwardsExcludingEmployeeStockPurchasePlanMember2022-12-310001805385us-gaap:EmployeeStockMember2023-12-310001805385us-gaap:EmployeeStockMember2022-12-310001805385nhic:TwoThousandAndTwentyOneEquityIncentivePlanMember2023-12-310001805385nhic:TwoThousandAndTwentyOneEquityIncentivePlanMember2023-01-012023-12-310001805385srt:MaximumMembernhic:TwoThousandAndTwentyOneEquityIncentivePlanMember2023-01-012023-12-310001805385us-gaap:RestrictedStockUnitsRSUMember2021-12-310001805385us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001805385us-gaap:RestrictedStockUnitsRSUMember2022-12-310001805385us-gaap:RestrictedStockUnitsRSUMember2023-12-310001805385us-gaap:PerformanceSharesMember2021-12-310001805385us-gaap:PerformanceSharesMember2022-01-012022-12-310001805385us-gaap:PerformanceSharesMember2022-12-310001805385us-gaap:PerformanceSharesMember2023-01-012023-12-310001805385us-gaap:PerformanceSharesMember2023-12-310001805385us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:PerformanceSharesMember2023-01-012023-12-310001805385us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:PerformanceSharesMember2023-01-012023-12-310001805385nhic:TwentyTwentyOneEmployeeStockPurchasePlanMember2021-07-160001805385nhic:TwentyTwentyOneEmployeeStockPurchasePlanMember2021-07-012021-07-310001805385nhic:TwentyTwentyOneEmployeeStockPurchasePlanMember2023-12-310001805385us-gaap:MeasurementInputRiskFreeInterestRateMembernhic:BusinessDevelopmentAgreementWithFinbackMember2023-12-310001805385us-gaap:MeasurementInputExpectedTermMembernhic:BusinessDevelopmentAgreementWithFinbackMember2023-12-310001805385us-gaap:MeasurementInputPriceVolatilityMembernhic:BusinessDevelopmentAgreementWithFinbackMember2023-12-310001805385nhic:BusinessDevelopmentAgreementWithFinbackMemberus-gaap:MeasurementInputExpectedDividendRateMember2023-12-310001805385nhic:BusinessDevelopmentAgreementWithFinbackMember2023-12-310001805385nhic:FinbackCommonStockWarrants2021Member2021-01-310001805385nhic:BusinessDevelopmentAgreementWithFinbackMember2023-01-012023-12-310001805385us-gaap:SellingAndMarketingExpenseMembernhic:BusinessDevelopmentAgreementWithFinbackMember2023-01-012023-12-310001805385us-gaap:SellingAndMarketingExpenseMembernhic:BusinessDevelopmentAgreementWithFinbackMember2022-01-012022-12-310001805385us-gaap:CostOfSalesMember2023-01-012023-12-310001805385us-gaap:CostOfSalesMember2022-01-012022-12-310001805385us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-12-310001805385us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-12-310001805385us-gaap:SellingAndMarketingExpenseMember2023-01-012023-12-310001805385us-gaap:SellingAndMarketingExpenseMember2022-01-012022-12-310001805385us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-12-310001805385us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-12-310001805385us-gaap:EmployeeStockOptionMember2023-01-012023-12-310001805385us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001805385nhic:EarnOutSharesMember2023-01-012023-12-310001805385nhic:EarnOutSharesMember2022-01-012022-12-310001805385us-gaap:WarrantMember2023-01-012023-12-310001805385us-gaap:WarrantMember2022-01-012022-12-310001805385nhic:RestrictedStockUnitsAndPhantomShareUnitsMember2023-01-012023-12-310001805385nhic:RestrictedStockUnitsAndPhantomShareUnitsMember2022-01-012022-12-310001805385nhic:UnvestedStockOptionsAndRestrictedStockUnitsMember2023-12-310001805385nhic:UnvestedStockOptionsAndRestrictedStockUnitsMember2023-01-012023-12-310001805385us-gaap:DomesticCountryMember2023-12-310001805385us-gaap:DomesticCountryMember2022-12-310001805385us-gaap:StateAndLocalJurisdictionMember2023-12-310001805385us-gaap:StateAndLocalJurisdictionMember2022-12-310001805385us-gaap:ForeignCountryMember2023-12-310001805385us-gaap:ForeignCountryMember2022-12-310001805385us-gaap:DomesticCountryMemberus-gaap:ResearchMember2023-12-310001805385us-gaap:StateAndLocalJurisdictionMemberus-gaap:ResearchMember2023-12-310001805385us-gaap:DomesticCountryMemberus-gaap:ResearchMember2022-12-310001805385us-gaap:StateAndLocalJurisdictionMemberus-gaap:ResearchMember2022-12-310001805385us-gaap:EmployeeStockOptionMember2023-01-012023-12-310001805385us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001805385us-gaap:WarrantMembernhic:WarrantsIssuedAtJulyTwoThousandTwentyOneMember2023-01-012023-12-310001805385us-gaap:WarrantMembernhic:WarrantsIssuedAtJulyTwoThousandTwentyOneMember2022-01-012022-12-310001805385us-gaap:WarrantMembernhic:WarrantsIssuedAtJanuaryTwoThousandTwentyOneMember2023-01-012023-12-310001805385us-gaap:WarrantMembernhic:WarrantsIssuedAtJanuaryTwoThousandTwentyOneMember2022-01-012022-12-310001805385us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-310001805385us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001805385us-gaap:PerformanceSharesMember2023-01-012023-12-310001805385us-gaap:PerformanceSharesMember2022-01-012022-12-310001805385nhic:EarnOutSharesMember2023-01-012023-12-310001805385nhic:EarnOutSharesMember2022-01-012022-12-310001805385nhic:FounderSharesMember2023-01-012023-12-310001805385nhic:FounderSharesMember2022-01-012022-12-310001805385nhic:DistributionAgreementWithMotorolaMemberMember2020-12-31nhic:item0001805385nhic:DistributionAgreementWithMotorolaMemberMemberus-gaap:RelatedPartyMember2023-01-012023-12-310001805385nhic:DistributionAgreementWithMotorolaMemberMemberus-gaap:RelatedPartyMember2022-01-012022-12-310001805385nhic:DistributionAgreementWithMotorolaMemberMemberus-gaap:RelatedPartyMember2023-12-310001805385nhic:DistributionAgreementWithMotorolaMemberMemberus-gaap:RelatedPartyMember2022-12-310001805385nhic:ResellerAgreementMemberus-gaap:RelatedPartyMember2023-01-012023-12-310001805385nhic:ResellerAgreementMemberus-gaap:RelatedPartyMember2022-01-012022-12-310001805385nhic:ResellerAgreementMemberus-gaap:RelatedPartyMember2023-12-310001805385nhic:ResellerAgreementMemberus-gaap:RelatedPartyMember2022-12-3100018053852023-10-012023-12-310001805385nhic:AnilChitkaraMember2023-01-012023-12-310001805385nhic:AnilChitkaraMember2023-10-012023-12-310001805385nhic:AnilChitkaraMember2023-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2023
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from   to
Commission file number: 001-39417
EVOLV TECHNOLOGIES HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
Delaware84-4473840
(State of Other Jurisdiction of Incorporation or Organization)(I.R.S. Employer Identification No.)
500 Totten Pond Road, 4th Floor, Waltham, Massachusetts
02451
(Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone number, including area code: (781) 374-8100
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange
on Which Registered
Class A common stock, par value $0.0001 per share
Warrants to purchase one share of Class A common stock
EVLV
EVLVW
 The Nasdaq Stock Market
The Nasdaq Stock Market
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes o No x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes o No x
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer x
Accelerated filer o
Non-accelerated filer o
Smaller reporting company x
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. x
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. o
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
The aggregate market value of the registrant's common stock held by non-affiliates of the registrant as of June 30, 2023, based on the closing price of $6.00 per share as reported on The Nasdaq Stock Market LLC, was approximately $722.8 million.
As of February 28, 2024, the registrant had 152,182,633 shares of Class A common stock, par value $0.0001 per share, outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Certain portions of the information required to be furnished pursuant to Part III of this Annual Report on Form 10-K will be set forth in, and incorporated by reference from, the registrant’s definitive proxy statement for the annual meeting of stockholders which will be filed with the Securities and Exchange Commission no later than 120 days after the end of the fiscal year ended December 31, 2023.


TABLE OF CONTENTS
Page
2

Forward-Looking Statements
This Annual Report on Form 10-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this Annual Report on Form 10-K, other than statements of historical fact, including, without limitation, statements regarding our results of operations and financial position, business strategy, plans and prospects, our relationship with significant manufacturers and suppliers, our ability to obtain new customers and retain existing customers, existing and prospective products, research and development costs, the potential benefits of our transition to a pure subscription model, timing and likelihood of success, macroeconomic and market trends, the government regulations that we are subject to, and plans and objectives of management for future operations and results, are forward-looking statements. The words “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “forecasts,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions are intended to identify forward-looking statements though not all forward-looking statement use these word or expressions.
The forward-looking statements in this Annual Report on Form 10-K are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, without limitation the important factors discussed in Part I, Item 1A, “Risk Factors” in this Annual Report on Form 10-K, as any such factors may be updated from time to time in its other filings with the Securities and Exchange Commission (the “SEC”). The forward-looking statements in this Annual Report on Form 10-K are based upon information available to us as of the date of this Annual Report on Form 10-K, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.
You should read this Annual Report on Form 10-K and the documents that we reference in this Annual Report on Form 10-K and have filed as exhibits to this Annual Report on Form 10-K with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. These forward-looking statements speak only as of the date of this Annual Report on Form 10-K. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this Annual Report on Form 10-K, whether as a result of any new information, future events or otherwise.

3

Summary Risk Factors
Our business is subject to numerous risks and uncertainties, including those described in Part I, Item 1A. “Risk Factors” in this Annual Report on Form 10-K. You should carefully consider these risks and uncertainties when investing in our common stock. The principal risks and uncertainties affecting our business include the following:
We have a history of losses and may not achieve or maintain profitability in the future.
Our operating results may fluctuate for a variety of reasons, including our failure to close large volume opportunity customer sales.
Our reliance on reseller partners to generate a growing portion of our revenue.
We depend on a third-party contract manufacturer for substantially all of our manufacturing and distribution needs. If our principal third-party manufacturer, or any of our limited or sole source suppliers, experiences any delay, disruption, or quality control problems in their operations, we could lose market share and our brand may suffer.
Increases in component costs, long lead times, supply shortages, and supply changes could disrupt our supply chain and have an adverse effect on our business, financial condition, and operating results.
We recognize a substantial portion of our revenue ratably over the term of our agreements with customers and, as a result, downturns or upturns in sales may not be immediately reflected in our operating results.
The AI-based weapons detection for security screening market is new and evolving and may not grow as expected or may develop more slowly or differently than we expect. Additionally, the security screening industry in which we operate requires us to continue to develop new products and innovations to meet constantly evolving customer demands and which could adversely affect market adoption of our products.
Our business model is predicated, in part, on building a customer base that will generate a recurring stream of revenues through the sale of our products and services. If that recurring stream of revenues does not develop as expected, including due to the inability of the customer to implement our products or if our business model changes as the industry evolves, our operating results may be adversely affected.
The failure of our products to detect threats could result in injury or loss of life, which could harm our brand, reputation, and results of operations.
The loss of designation of our Evolv Express® system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act could result in adverse reputational and financial consequences.
If we do not successfully anticipate market needs and enhance our existing products or develop new products that meet those needs on a timely basis, we may not be able to compete effectively and our ability to generate revenues will suffer.
If our customers are unable to implement our products successfully, or if we fail to effectively assist our customers in installing our products and provide effective ongoing support and training, customer perceptions of our products may be impaired, or our reputation and brand may suffer.
Any failure to obtain, maintain, protect, or enforce our intellectual property rights, including as related to machine learning, artificial intelligence, and automated decision making, could impair our competitive position and ability to generate revenues and cause us to lose valuable assets.
We may experience significant delays in the design, production and launch of our security screening solutions, and we may be unable to successfully commercialize products on our planned timelines.
Our products and services may be affected from time to time by design and manufacturing defects.
4

If we are unable to compete successfully with new entrants and other potential competitors, our sales and profitability could be adversely affected.
Because our products collect and store visitor and related information and images, we could be subject to domestic and international privacy and cyber security concerns, laws and regulations.
Our failure to meet our customers’ price expectations would adversely affect our business and results of operations.
We are subject to government regulation and other legal obligations, including those related to privacy, data protection, information security, and product marketing. From time to time, we receive government regulatory inquiries and requests for information relating to our marketing practices, such as the current investigations by the FTC and the SEC. There can be no assurance whether there will be further information requests or potential enforcement or litigation, which is necessarily uncertain.
We have identified material weaknesses in our internal control over financial reporting and our internal control over financial reporting was not effective as of December 31, 2023.
5

PART I
ITEM 1. BUSINESS
Company Overview
Evolv Technologies Holdings, Inc. (“we,” “us,” “our,” the “Company” and “Evolv”) is a leader in Artificial Intelligence (“AI”)-based weapons detection for security screening. Our mission is to make the world a safer and more enjoyable place to live, work, learn, and play. We are democratizing security by making it seamless for facility operators to address the chronic epidemic of escalating gun violence, mass shootings and terrorist attacks in a cost-effective manner while improving the visitor experience.
Unlike traditional walk-through metal detectors, our touchless security screening solutions use AI software, software-as-a-service (“SaaS”) cloud services, and advanced sensors to reliably detect weapons that could be a threat to a crowd of visitors while significantly reducing nuisance alarms from harmless personal items. This means that most visitors can walk through our solution without stopping, without removing personal items from their pockets or bags, and without having to form a single file line. Our products significantly reduce the number of false positive alarms, allowing security staff to focus their attention on high probability threats.
Our innovative technology not only enhances security but makes screening up to ten times faster, which is capable of delivering up to a 70% lower total cost than traditional alternatives. Our products deliver a largely touchless screening experience — a capability that has become an increasingly important consumer demand as well as unique analytic insights about security screening performance and visitor flows. Our products, which are offered to our customers primarily under a multi-year subscription pricing model, deliver both excellent value to our customers and predictable revenue streams for us.
We are focused on delivering value in the spaces in and around the physical threshold of venues and facilities. We believe that digitally transforming the visitor experience at the entry point to venues and facilities will be a critically important innovation in physical security. We believe that our solutions will not only make venues and facilities safer and more enjoyable, but also more efficient, more informed about their visitors’ needs, and ultimately more profitable.
Our touchless security screening systems have screened over one billion visitors since 2019 worldwide since our inception. We believe that we have screened more visitors through advanced AI-based detection systems in the United States than any organization, other than the United States Transportation Security Administration (“TSA”). Our customers include many iconic venues across a wide variety of industries, including major sports stadiums and arenas, notable performing arts and entertainment venues, major tourist destinations and cultural attractions, hospitals, large industrial workplaces, schools, and prominent houses of worship. We offer our products for lease or purchase and utilize a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities.
Our Industry
We believe that most people associate security screening with airports, courthouses, and prisons. These facilities represent a small fraction of the total number of gathering spaces where mass shootings, terrorist attacks, and other forms of armed violence might occur, but they have historically had a disproportionate impact on the design and implementation of security screening technology. These specialized facilities are typically required by law to meet specific screening regulations using products built to meet technical standards designed for these environments. Many of these standards and regulations were designed in the pre-digital era of the last century.
Regulated facilities like airports and prisons usually have a local monopoly on the services they provide and therefore have historically been incentivized to emphasize technical regulatory compliance at the expense of the visitor experience. Security technology providers have historically focused on serving this regulated market and, as a result, developed solutions to meet the regulatory requirements without regard to the visitor experience. This limited functionality has unfortunately led many unregulated facilities either to avoid security screening altogether or to employ outdated technology rather than risk creating a prison-like visitor experience for their valued customers and employees. We believe that forcing venues to choose between better security and an enjoyable visitor experience is unacceptable. We believe the solution is to deliver technology that provides both.
6

Security screening at most venues and facilities has historically been designed around metal detectors that require visitors to enter in single-file lines after submitting their bags and pocket contents to manual inspection. This process is usually supported by multiple security guards who perform manual bag inspections, hand wand scans, and hands-on body ‘pat downs’ to resolve the large numbers of alarms, frequently false positives, generated by the metal detectors. This cumbersome process has numerous shortcomings such as nuisance alarm fatigue, ambiguous alarms, frequent human error, frustrating delays, invasive contact, high labor costs, inattentive and transient security staff, and lack of data insights.
The historical emphasis on technical detection performance using outdated standards tested in isolation has drawn attention away from performance of the screening process as a holistic system. Legacy screening technologies effectively detect metal, but they also generate numerous false alarms for harmless items. To bring down the false alarm rate, security teams proactively divert personal items away from the metal detectors into manual bag check processes that are vulnerable to human error and relatively easy for a determined attacker to defeat. The result is a slow, frustrating process that fails to deliver the security it promises. The root causes are outdated technical standards, old analog technology, and the inability of humans to fully compensate for these deficiencies.
Our touchless security screening technology overcomes the limitations of legacy security screening methods and processes. We define touchless security screening as a screening process that reliably detects weapons and other threats in a way that allows most people to enter venues and facilities while walking at a normal pace together with their party, without requiring manual bag or body inspections. Touchless security screening provides a range of benefits including reliable precision, automated and targeted, high throughput, non-invasive and reduced visitor anxiety, improved security staff experience, reduced and cost-effective physical footprint, continuous improvement, and analytic insights.
Our Market Opportunity
We believe that the current macro trends in firearms ownership and mass shootings suggest that the need for effective security screening processes has never been greater and will continue to grow for the foreseeable future.
In the United States, there are over 460 million privately-owned guns in circulation. According to the Gun Violence Archive, in 2023 there were over 650 mass shootings in the United States.
Based on our experience with customers, we believe that visitors are and will remain uncomfortable with traditional high-touch security screening processes. We believe that visitors and security staff alike will continue to prefer a touchless security screening process in the future.
We believe that many venues and facilities have reluctantly chosen to operate without security screening because of the inherent shortcomings of old screening methods like walk through metal detectors. Due to these macro trends, we believe that venues and facilities that already conduct security screening will feel increasingly compelled to consider alternatives. Further, we believe that venues and facilities that have previously chosen not to implement security screening due to concerns about cost, effectiveness, and/or visitor experience impact will feel increasingly compelled to introduce our modern security screening for the first time.
We believe our market opportunity has both a security screening opportunity as well as an adjacent market expansion opportunity as follows:
Security Screening Opportunity
We estimate that our primary market opportunity is for weapon screening at venues and facilities in the following segments:
educational institutions including schools,
hospitals & health care facilities,
professional sports venues,
industrial warehouses,
distribution facilities,
7

large workplaces,
arts & entertainment venues,
government offices,
hospitality facilities, and
houses of worship.
Using a variety of published industry reports and government data, we estimate that the above facilities together comprise nearly 400,000 sites and approximately 700,000 individual thresholds where our security screening products could potentially be deployed. We estimate that this market represents over $20 billion in potential weapon screening system sales annually.
Most venues and facilities in our target segments do not fall under government regulations that mandate the adoption of security screening systems that conform to specific standards. We estimate that these unregulated facilities represent over 90% of the total worldwide market opportunity for security screening technology and represent the best opportunity for rapid adoption of our innovative weapon screening products.
Our Growth Strategy
The key elements of our growth strategy within our target market include the following:
Develop Initial Customer Successes in Specific Target Metropolitan Areas
Decision-makers at our prospective customers are often professionally connected to decision-makers at other prospective customers in different vertical industries within a specific target metropolitan area. We have established a successful pattern of targeting and winning lighthouse customers in specific vertical industries and then leveraging that success to solicit referrals at other venues and facilities across that metropolitan area in other vertical industries. We have developed a playbook for executing this pattern through orchestration of our direct sales resources and reseller partners in a manner that we believe will continue to scale as we develop the available markets.
Expand and Activate Our Reseller Strategy
We have a global distribution network consisting of dozens of value-added resellers. This includes market leaders such as Motorola Solutions, STANLEY Securitas, and Johnson Controls, as well as smaller regional resellers. STANLEY Security, which was acquired by Securitas, and Motorola Solutions were also early investors in the Company. We intend to continue to develop our distribution network by adding further geographic coverage and sales capacity based upon demand. We plan to continue to cultivate field level collaboration between our direct sales team and our resellers to develop the ability of the resellers to find, develop, close, and/or support customers independently.
Concentrate Sales and Marketing Effort in Specific Target Accounts in Specific Vertical Industries
Through our experience to date, we have developed a proprietary list of target vertical industries, developed a list of target accounts within those industries, and identified target decision-makers in our target accounts. We believe that our target account list represents the best immediate growth opportunities for our business. Over time we plan to adjust our target account list to reflect current market conditions and the capabilities of our products. We plan to continue to execute advertising, content marketing, lead generation, and sales development activities to our target account list to create qualified sales opportunities.
Promote Awareness by Gathering and Leveraging Our Customer Community
Our business model presents significant opportunities to bring incremental value to existing customers over time. We intend to realize this value by seeking referrals from existing customers and partners to other prospective qualified customers, selling additional capacity to existing customers, and selling new add-on
8

products and services to existing customers. We are continuing to develop and expand our customer success function within the global revenue organization to focus on helping customers successfully deploy our products and cultivate referrals, expansion, and upsell opportunities. We are also investing in programs to help our customers connect with each other to share best practices on a regional and vertical industry basis. Our buyers are naturally collaborative on security best practices due to their vested interest in collective deterrence and the likelihood that any security event will have a negative collective impact at the metropolitan, regional, or industry level.
Extend Our Value Proposition with Additional Products and Digital Capabilities
Our customers turn to our solutions first and foremost for increased security at the thresholds of the entrances of their venues. In addition to increased security posture, we believe our solutions also provide for an enhanced visitor experience, lower overall security costs, enhanced employee retention and unprecedented insights into visitor and security data through our Evolv Insights solution. Our customers often look to us to provide additional applications and services that extend the security perimeter beyond the threshold of their venues. To that end, we believe there is an opportunity to introduce new applications and services that solve adjacent security challenges being faced by our customers. As we adapt to customer demands, we may introduce new applications and services to the market via our own internal product development, partnering with third parties, or through acquisitions.
Competition
We have experienced, and expect to continue to experience, competition from a number of companies, including other vendors of security screening systems. A variety of security screening technologies compete with our proprietary technologies, including, but not limited to legacy walk-through metal detectors, handheld metal detector wands, and passive or active weapon screening systems based on magnetic field sensing, millimeter wave or terahertz imaging technology.
We believe that we are well-positioned to compete in our industry based on these core competencies and on the following competitive strengths:
Unmatched Detection Effectiveness Based on Artificial Intelligence Software
Based on feedback from our customers, we believe that real-world screening operations using our products detect more actual weapon threats with fewer nuisance alarms than similar screening operations based on conventional walk-through metal detectors. Our solutions use digital processing and artificial intelligence to differentiate between real weapon threats and harmless items like cell phones and keys. The Evolv Cortex AI® software platform provides the digital brain of our solutions. Unlike analog alternatives, our solutions classify threats based on classification models that improve over time as we process more real-world data. Evolv Cortex AI also makes it possible to integrate new kinds of sensors and data sources and integrate our solutions with other platforms and applications.
Large and Growing Data Set
The vast amounts of data collected by our products during each screening process constitute a large and diverse repository of digital machine learning training data for weapons and common non-threat items. This proprietary data set is essential in training our software to accurately classify a broad set of threats and non-threats under a wide variety of real-world conditions. We expect that this data set will continue to grow as our products are deployed in more venues and facilities. As the data set grows, we expect that our detection capabilities will continue to improve. In turn, we expect our customers to benefit from these improvements through regular software updates under our subscription business model. In a world where data is an increasingly decisive competitive advantage, we believe we are well positioned to deliver value to our customers in ways that competitors may be unable to match.
Differentiated and Proprietary Technology Platform
We have invested significant resources in developing proprietary and patented technologies across artificial intelligence software, cloud services, and advanced sensors to accelerate the widespread adoption of
9

touchless security screening. These technologies serve as the foundation of our products. We have also designed our platform with application programming interfaces (“APIs”) that allow integration and interoperability with complementary third-party security solutions such as brandished gun detection, biometric authentication, video management software, threat intelligence, messaging, and mass-notification systems.
High Screening Throughput
Our unique detection methodology results in fewer nuisance alarms and allows visitors to walk through in unstructured flows, without emptying their pockets and without surrendering their bags for manual inspection. The overall result is screening that is up to ten times faster than old screening processes. The result is a visitor experience that is more like walking through a department store shoplifting prevention system than an intrusive airport security checkpoint.
Significant Cost Savings
Because our technology generates fewer nuisance alarms and scans visitors so quickly, far fewer security guards and equipment is required. We believe the total scanning costs are up to 70% lower with our products, allowing venues to reduce overall operational costs and making security screening financially feasible at more venues and events.
Digital Access and Analytic Insights
Evolv Insights® provides our customers self-serve access, insights regarding visitor flow and arrival curves, location specific performance, system detection performance and alarm statistics, and comparisons across multiple business dimensions.
Using Evolv Insights, organizations use the powerful dashboards and metrics provided to inform their security decisions, operationalize the way their security and venue operations teams make staffing and traffic flow decisions to avoid overcrowding, rebalance security and operational resources, and improve the overall experience for their guests.
Key Strategic Partners
We have signed strategic partnership agreements with Motorola Solutions, STANLEY Securitas, and Johnson Controls. Each of these strategic partners has a globally recognized brand, a large distribution network, systems integration and support capabilities, and customer networks full of potential prospects for our touchless security screening solutions. Both Motorola Solutions and Stanley Security were early investors in the Company. We believe that these strategic partners will provide us with significant leverage and reach that will allow us to rapidly scale our business and guide customers to success.
Distribution Capabilities
We have developed a distribution network consisting of dozens of value-added resellers. Our resellers, who have extensive experience in physical security technologies and processes, provide marketing, sales, systems integration, and local support services for customers across an array of vertical markets and regions. They also bring an existing base of customers into which we can drive awareness of and ultimately sell our touchless security screening products. Whenever possible we seek to form relationships with the leading resellers in each region in order to secure access to the most valuable existing customer relationships and the best talent pool available in each region.
Visionary and Experienced Management Team and Advisors
Our management team and board of directors blend a range of skills and backgrounds from technology, cybersecurity, materials science, artificial intelligence, military, and law enforcement. Our advisors are renowned industry leaders with experience at the United States Secret Service, the Federal Bureau of Investigation (“FBI”), the U.S. military, the TSA, the United States Department of Homeland Security (the "DHS"), the United States intelligence community, and United States Congress. Our engineering and digital
10

products teams are led by accomplished and visionary technologists and scientists who have many years of experience in relevant fields. Our commercialization efforts are managed by individuals with prior successes in building and scaling both direct and indirect, reseller-driven global sales organizations.
Self-Reinforcing Adoption Cycle
We believe that as we acquire more customers and deploy more of our products, we gather more digital data that helps us improve the detection accuracy and performance of our systems and provide deeper analytic insights to our customers. As the accuracy and analytic insight of our systems increases, we believe more prospective customers will be attracted to our products and more engaged prospects will choose to purchase our products. We anticipate that this cycle will continue to operate in the future, creating ongoing competitive advantages for us and our reseller partners.
Our Products
Since our founding in 2013, we have developed an extensive portfolio of proprietary technologies that form the foundation of our integrated security screening products, which are comprised of artificial intelligence software, cloud services, and advanced sensors.
Evolv Express
Our flagship product is Evolv Express, a touchless security screening system designed to quickly detect firearms, improvised explosive devices, and large tactical knives in unstructured people flows. Evolv Express currently supports a maximum screening throughput of approximately 4,000 people per hour. Evolv Express became commercially available in October 2019. The number of Evolv Express solutions deployed across our customer base grew from 2,267 at December 31, 2022 to 4,505 at December 31, 2023. We believe that the number of Evolv Express solutions deployed is closely correlated to our revenues.

Evolv Insights Analytics Application
We collect a significant amount of anonymous data from every visitor that passes through one of our Evolv Express solutions. This data allows us to generate analytics that appear in our Evolv Insights application. Evolv Insights provides self-serve access, insights regarding visitor flow and arrival curves, location specific performance, system detection performance and alarm statistics, and comparisons across multiple business dimensions. Using Evolv Insights, organizations use the powerful dashboards and metrics provided to inform their security decisions, operationalize the way their security and venue operations teams make staffing and traffic flow decisions to avoid overcrowding, rebalance security and operational resources, and improve the overall experience for their guests.
Sales Models
We sell our solutions under two primary sales models. We offer a pure subscription agreement that bundles our AI-software, cloud services, and advanced sensor equipment. The SaaS agreement generally provides customers access to our solution for a defined time, usually with a multi-year term, annual pre-payment installments, and no right of cancellation for convenience. For end-user customers that prefer to purchase our hardware outright, we offer our distributor licensing model based on a distributor licensing agreement (the "Distribution and License Agreement") we entered into with Columbia Electrical Contractors, Inc. ("Columbia Tech") in March of 2023. Columbia Tech, a wholly-owned subsidiary of Coghlin Companies, currently serves as our primary contract manufacturer. Under this arrangement, we have granted a license of our intellectual property to Columbia Tech, which contracts directly with certain of our resellers to fulfill sales demand where the end-user customer prefers to purchase the hardware equipment. Columbia Tech pays us a hardware license fee for each system it manufactures and sells under this agreement. In these instances, we still contract directly with the reseller to provide a multi-year security-as-a-service subscription to the end-users. Under the distributor licensing model, the title to the related hardware equipment is transferred to the end-user customer by Columbia Tech. We also directly offer short-term rental agreements for our solutions and allow certain reseller partners to offer rental terms to customers under certain conditions.
We also have historically sold our systems under a purchase subscription model, where customers purchase the hardware from us, and we provide a multi-year security-as-a-service subscription. However, except in limited circumstances, we do not plan to offer this sales model in future periods.
11

Our Customers
Our customers include many iconic venues across a wide variety of industries including education, healthcare, professional sports, notable performing arts and entertainment venues, major tourist destinations and cultural attractions, large industrial workplaces, and houses of worship.
The majority of our customer agreements include non-cancelable multi-year commitments. Two customers each accounted for more than 10% of our total revenue for both the year ended December 31, 2023 and the year ended December 31, 2022.
Research and Development
We believe that the touchless security screening market is poised for rapid technological advancements across software, cloud services, and sensors. We invest significant resources into ongoing research and development programs because we believe our ability to maintain and extend our market position depends, in part, on breakthrough technologies that offer a unique value proposition for our customers and differentiation versus our competitors. Our research and development team, which is responsible for both the development of new products and improvements to our existing product portfolio, consists of talented and dedicated engineers, technicians, scientists, and professionals with experience from a wide variety of the world’s leading physical security, cybersecurity, and software technology organizations. Our primary areas of focus in research and development include, but are not limited to:
Enhanced system usability, operator ergonomics, form factor options, and mobility to drive further efficiencies and opportunities in a variety of operating environments;
Continued improvement of the detection algorithm performance, including assessing the ability to detect new threats;
Additional system sensors and fusion with a variety of other data inputs to expand venue insights, analytics applications, and operational performance;
New applications that digitally transform operations in and adjacent to the arrival experience at venues and facilities; and
Integrations into venue security infrastructure and operating systems.
Sales and Marketing
We sell our security screening products through both our own direct sales force and through a global distribution network consisting of dozens of reseller partners. Our partners sell our products to our joint customers, for whom they may also perform installation, systems integration, and local support and maintenance services, with backup services provided by our internal support teams. Many partners offer third-party physical security products including cameras, access control systems, and video monitoring systems in their respective territories and regions, which provides an opportunity to cross-sell our touchless security screening products to a broad, existing customer base that has purchased these other products. To augment the reach of our distribution network, we also intend to increase our direct sales efforts focused primarily on serving major accounts and expanding our footprint.
Our marketing strategies are focused on supporting sales growth by (1) driving awareness; (2) developing comprehensive sales and marketing content, tools, and campaigns for each stage of the sales process; (3) scaling those campaigns via our global distribution network, and (4) building our sales pipeline through demand generation efforts. We drive awareness for the Company, our security screening products, and our customers’ successes through public relations and communications efforts that span mainstream, business, social media and trade press across the security sector generally and in key verticals such as education, healthcare, professional sports as well as tourist sites, performing arts and entertainment, theme parks, industrial workplaces, and municipal governments. Our internal marketing team develops content in multiple formats and delivery methods to facilitate marketing campaigns and sales enablement.
12

Manufacturing and Suppliers
Our physical products are manufactured by our primary third-party contract manufacturer, Columbia Tech, based in the United States with international quality certifications, such as ISO 9001:2015. We also utilize other third-party manufacturers for the production of certain components. We design our products and processes and internally manufacture the initial engineering prototypes. Our internal manufacturing and supply chain teams work collaboratively with both our internal engineering department and Columbia Tech to scale up the prototypes for commercialization through a phase gate product launch process. There have been significant efforts made over the last several years with Columbia Tech to scale up our production. Columbia Tech also provides a variety of services including sourcing off-the-shelf components, manufacturing custom components/assemblies, final product assembly and integration, end of line testing and quality assurance per our specifications, material and finished goods inventory, and direct global shipping to our customers.
We initially manage the supply chain for key components and materials, and then, in some cases, set up supply agreements in conjunction with Columbia Tech to enable stable supply and redundancy where applicable. Component purchasing is managed by Columbia Tech's sourcing team under a vendor list approved by us to leverage the buying power of their global scale. All of our products are built to our specifications, work instructions, and testing protocols. Inventory levels are managed with our manufacturing partners to ensure an adequate supply is on hand to meet business forecasts.
Intellectual Property
Our ability to drive innovation in the security screening market depends in part upon our ability to protect our core technology and intellectual property. We attempt to protect our intellectual property rights, both in the United States and abroad, through a combination of patent, trademark, copyright, and trade secret laws, as well as nondisclosure and invention assignment agreements with our consultants and employees and through non-disclosure agreements with our vendors and business partners. However, our contractual provisions may not always be effective at preventing unauthorized parties from obtaining our intellectual property and proprietary technology.
Unpatented research, development, know-how, and engineering skills make an important contribution to our business, but we pursue patent protection when we believe it is possible and consistent with our overall strategy for safeguarding intellectual property. We intend to pursue additional intellectual property protection to the extent we believe it would advance our business objectives and maintain our competitive position. Notwithstanding these efforts, there can be no assurance that we will adequately protect our intellectual property or that it will provide any competitive advantage. Intellectual property laws, procedures, and restrictions provide only limited protection and any of our intellectual property or proprietary rights may be challenged, invalidated, circumvented, infringed, misappropriated, or otherwise violated. Further, the laws of certain countries may not protect intellectual property or proprietary rights to the same extent as the laws of the U.S., and, therefore, in certain jurisdictions, we may be unable to protect our intellectual property and proprietary technology.
As of December 31, 2023, we own or co-own eight issued United States patents, 24 issued foreign patents and have 24 pending or allowed patent applications. In addition, we have five registered United States trademarks, five pending United States trademark applications, 36 registered foreign trademarks and nine pending foreign trademark applications. Our patents and patent applications are directed to, among other things, security screening, threat detection and discrimination, imaging systems, and related technologies. In addition to patents owned or co-owned by us, we have in-licensed 95 patents, including but not limited to metamaterials, RF imaging, compressive sensing, and signal processing, for security related applications.
While most of the intellectual property we use is developed and owned by us, we also use a combination of proprietary, open-source and third-party licensed software in connection with our products and services. Although we believe these licenses are sufficient for the operation of our business, these licenses typically limit our use of the third- parties’ intellectual property to specific uses and for specific time periods.
From time to time, we have faced, and we expect to face in the future, allegations by third parties, including our competitors, that we have infringed their trademarks, copyrights, patents, and other intellectual property rights or challenging the validity or enforceability of our intellectual property rights. We are not presently a party to any such legal proceedings that, in the opinion of our management, would individually or taken together have a material adverse effect on our business, financial condition, results of operations or cash flows.
13

Human Capital
Our employees are critical to our success. As of December 31, 2023, we employed 293 people, substantially all of whom are full-time employees. We also engage numerous consultants and contractors to supplement our permanent workforce. A majority of our employees are engaged in research and development and selling functions. We consider our relationship with our employees to be in good standing. None of our employees are subject to a collective bargaining agreement or represented by a labor union.
Diversity and Inclusion. We value the diversity of our employees and are committed to providing an engaging and inclusive atmosphere for all employees that promotes productivity and encourages creativity and innovation. We strive to maintain a highly skilled and diverse workforce where employees are hired, retained, compensated, and promoted based on their performance and contribution to the Company.
Employee Development and Retention. The attraction, development, and retention of our employees is a key focus for our Company. We offer training programs to enhance the knowledge, skills, and advancement opportunities for our employees. We focus on maintaining a solid pipeline of talent throughout our organization and we are continually developing the capabilities and skills needed for the future of our business.
Work Environment. We believe that maintaining a work environment that recognizes effort and teamwork, values mutual respect and open communication, and demonstrates care and concern for our employees is essential to an engaged and productive workforce. In furtherance of this objective, we provide a regular Code of Business Conduct training for our employees to identify and prevent misconduct and report situations that violate our policies and/or negatively impact our work environment. We investigate and take prompt action to correct conduct that is inconsistent with our Code of Business Conduct and other policies.
Competitive Pay and Benefits. We strive to provide pay and comprehensive benefits that help meet the varying needs of our employees. Our total rewards package includes market-competitive pay, equity compensation, unlimited time off, tuition reimbursement, 401(k) match, and other comprehensive and competitive benefits.
Government Regulations
We are subject to various laws, regulations, and permitting requirements of federal, state, and local authorities, related to health and safety, anti-corruption, and export controls. We believe that we are in material compliance with all such laws, regulations, and permitting requirements.
Anti-Corruption Export and Trade Matters
We are subject to anti-corruption laws and regulations imposed by governments around the world with jurisdiction over our operations, including the U.S. Foreign Corrupt Practices Act (the "FCPA") and the U.K. Bribery Act 2010 (the "Bribery Act"), as well as the laws of the countries where we do business. We are also subject to various trade restrictions, including trade and economic sanctions and export controls, imposed by governments around the world with jurisdiction over our operations. For example, in accordance with trade sanctions administered by the U.S. Treasury Department, Office of Foreign Assets Control (“OFAC”) and the U.S. Department of State, we are prohibited from engaging in transactions involving certain persons and certain designated countries or territories, including Cuba, Iran, Syria, North Korea, the Crimea Region of Ukraine, the so-called Donetsk People’s Republic, and the so-called Luhansk People’s Republic, unless authorized by OFAC or otherwise exempt from the regulations. In recent years, the United States government has a renewed focus on export control matters. For example, the Export Control Reform Act of 2018 and regulatory guidance thereunder have imposed additional controls and may result in the imposition of further additional controls, on the export of certain “emerging and foundational technologies.” Our current and future products may be subject to these heightened regulations, which could increase our compliance costs.
See Part I, Item 1A, “Risk Factors — Failure to comply with applicable anti-corruption legislation, export controls, economic sanctions, and other governmental laws and regulations could result in fines, criminal penalties and materially adversely affect our business, financial condition and results of operations” for additional information about the environmental, health and safety laws, and regulations that apply to our business.
Corporate Background
14

On July 16, 2021, we consummated the business combination (the “Merger”) contemplated by the Agreement and Plan of Merger, as amended on March 5, 2021 (the “Merger Agreement”), with NHIC Sub Inc. (“Merger Sub”), a wholly-owned subsidiary of NHIC, which is our legal predecessor, and Evolv Technologies, Inc. dba Evolv Technology, Inc. (“Legacy Evolv”). Pursuant to the Merger Agreement, Merger Sub was merged with and into Legacy Evolv, with Legacy Evolv surviving the Merger as a wholly owned subsidiary of the Company. Upon the closing of the Merger, we changed our name to Evolv Technologies Holdings, Inc.
Additional Information
Our Internet address is https://evolvtechnology.com. At our Investor Relations website https://ir.evolvtechnology.com, we make available free of charge a variety of information for investors, including our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports, as soon as reasonably practicable after we electronically file that material with or furnish it to the SEC. Our SEC filings are available to the public over the Internet at the SEC's website at http://www.sec.gov. The information found on our website is not part of this or any other report we file with, or furnish to, the SEC. We use our Investor Relations website as a means of disclosing material information. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, and public conference calls and webcasts.
15

ITEM 1A. RISK FACTORS
Our business involves significant risks and uncertainties, some of which are described below. You should carefully consider the risks and uncertainties described below, together with all of the other information in this Annual Report on Form 10-K. The realization of any of these risks and uncertainties could have a material adverse effect on our reputation, business, financial condition, results of operations, growth, and future prospects as well as our ability to accomplish our strategic objectives. In that event, the market price of our common stock could decline and you could lose part or all of your investment.
Risks Related to Our Business
We have a history of losses. We have not been profitable historically and may not achieve or maintain profitability in the future.
We have a history of losses. Our ability to forecast our future operating results is subject to a number of uncertainties, including our ability to plan for and model future growth. We have encountered and will continue to encounter risks and uncertainties frequently experienced by growing companies in rapidly evolving industries. If our assumptions regarding these uncertainties, which we use to plan our business, are incorrect or change in reaction to changes in our markets, or if we do not address these risks successfully, our operating and financial results could differ materially from expectations, our business could suffer, and the trading price of our stock may decline.
We have incurred net losses of $106.3 million and $86.4 million for the years ended December 31, 2023 and 2022, respectively. As of December 31, 2023, we had an accumulated deficit of $298.5 million.
We are not certain whether or when we will obtain a high enough volume of sales of our products to sustain or increase our growth or achieve or maintain profitability in the future. We expect our costs to increase in future periods, which could negatively affect our future operating results if our revenue does not increase. In particular, we expect to continue to expend substantial financial and other resources on:
research and development related to our products, including investments in expanding our research and development team;
sales and marketing, including a significant expansion of our sales organization, both direct and through reseller partners;
continued expansion of our business into new and adjacent vertical markets and the launch of new product offerings; and
general administration expenses, including legal and accounting expenses related to being a public company and transitioning to large accelerated filer status.
These investments may not result in increased revenue or growth in our business. If we are unable to increase our revenue at a rate sufficient to offset the expected increase in our costs, our business, financial position, and results of operations will be harmed, and we may not be able to achieve or maintain profitability over the long term. Additionally, we may encounter unforeseen operating expenses, difficulties, complications, delays, and other unknown factors that may result in losses in future periods. If our revenue growth does not meet our expectations in future periods, our financial performance may be harmed, and we may not be able to achieve or maintain profitability in the future.
Our operating results may fluctuate for a variety of reasons, including our failure to close large volume opportunity customer sales.
A meaningful portion of our revenue is generated by product sales to new customers and sales of additional products to existing customers. The timing of certain large volume opportunities can impact our results from quarter to quarter. In addition, the sales cycle can last several months from initial engagement to contract negotiation and execution, culminating in delivery of our products to our customers, and this sales cycle can be even longer, less predictable and more resource-intensive for both larger volume sales as well as sales to customers in certain market segments. Customers may also require additional internal approvals or seek to pilot our products for a longer trial period before deciding to purchase our solutions. As a result, the timing of individual sales can be difficult to predict. In some cases, sales have occurred in a
16

quarter subsequent to when anticipated, or have not occurred at all, which can significantly impact our quarterly financial results and make it more difficult to meet market expectations. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies — Revenue Recognition.”
In addition to the sales cycle-related fluctuations noted above, our financial results, including our billings and deferred revenue, may continue to vary from period to period as a result of numerous factors, many of which are outside of our control and may be difficult to predict, including:
our ability to attract and retain new customers;
our ability to sell additional Evolv Express systems to existing customers;
unforeseen changes or delays in our supply chain or third-party manufacturing partners;
our ability to expand into adjacent and complementary markets;
changes in customer or reseller partner requirements or market needs;
changes in the growth rate of the next-generation touchless security screening market;
the timing and success of new product introductions by us or our competitors, or any other change in the competitive landscape of the next-generation touchless security screening market, including consolidation among our customers or competitors or significant price competition;
a disruption in, or termination of, any of our relationships with reseller partners;
our ability to successfully expand our business globally;
reductions in customer retention rates, especially at subscription term expiration;
changes in our pricing policies or those of our competitors;
changes in financial markets or macroeconomic conditions, including, for example, due to the effects of recessionary trends, slow economic growth, or political elections in the United States and abroad, inflation and high interest rates, fuel prices, international currency fluctuations, corruption, political instability, continuing social concerns and divisions in the United States and abroad, acts of war, including the conflicts in Europe and the Middle East , and acts of terrorism, both domestic and international;
future accounting pronouncements or changes in our accounting policies or practices;
the amount and timing of our operating costs, including cost of goods sold;
the impact of any pandemic, epidemic, or future outbreak of disease or similar public health concern, such as COVID-19 (including the emergence of any new variants of COVID-19) on our existing and new customers, partners, employees, and supply chain; and
increases or decreases in our revenue and expenses caused by fluctuations in foreign currency exchange rates.
Any of the above factors, individually or in the aggregate, may result in significant fluctuations in our financial and other operating results from period to period. These fluctuations could result in our failure to meet our operating plan or the expectations of investors or analysts for any period. If we fail to meet such expectations for these or other reasons, the trading price of our common stock could fall substantially, and we could face costly lawsuits, including securities class action suits.
17

We rely on reseller partners to generate a growing portion of our revenue, both in the United States and in emerging international markets which are generally slower to develop. If we fail to maintain successful relationships with our reseller partners, or if our partners fail to perform, our ability to market, sell and distribute our products will be limited, and our business, financial position and results of operations will be harmed.
In addition to our direct sales force, we rely on our reseller partners to sell our products. We expect to continue to focus on generating sales to new and existing customers through our reseller partners as a part of our growth strategy. We provide our reseller partners with specific training and programs to assist them in selling and supporting our products, but there can be no assurance that these steps will be effective. In addition, our reseller partners may be unsuccessful in marketing, selling, and supporting our products.
If we are unable to develop and maintain effective sales incentive programs for our third-party reseller partners, we may not be able to incentivize these partners to sell our products to customers and, in particular, to high profile public and private venues and institutions. Our agreements with our reseller partners are generally non-exclusive and these partners may also market, sell and support products that are competitive with us and may devote more resources to the marketing, sales and support of such competitive products. These partners may have incentives to promote our competitors’ products to the detriment of ours or may cease selling our products altogether. Our reseller partners may cease or de-emphasize the marketing of our products with limited or no notice and with little or no penalty. Our agreements with our reseller partners may generally be terminated for any reason by either party with advance notice prior to each annual renewal date. It cannot be certain that we will retain these reseller partners or that we will be able to secure additional or replacement reseller partners. The loss of one or more of our significant reseller partners or a decline in the number or size of orders from them could harm our operating results. In addition, any new reseller partner requires extensive training and may take several months or more to achieve productivity. Our reseller partner sales structure could subject us to lawsuits, potential liability and reputational harm if, for example, any of our reseller partners misrepresent the functionality of our products, subscriptions or services to customers, or violate laws or our corporate policies.
If we fail to effectively manage our existing resellers, or if our reseller partners are unsuccessful in fulfilling the orders for our products, or if we are unable to enter into arrangements with, and retain a sufficient number of, high quality reseller partners in each of the regions in which it sells products and keep them motivated to sell our products, our ability to sell our products and operating results will be harmed. The termination of our relationship with any significant reseller partner may also adversely impact our sales and operating results.
We may not be successful in our distributor licensing agreement with our third-party manufacturer.
As part of our overall strategy to move away from purchase subscription contracts, we entered into a distributor licensing agreement with Columbia Tech in March 2023. Under this arrangement, we have granted a license of our intellectual property to Columbia Tech, who contracts directly with certain of our resellers to fulfill the sales demand where the end-user customer requires the contract to be in form of a hardware purchase, instead of leasing our hardware. Columbia Tech pays us a hardware license fee for each Evolv Express system it manufactures and sells under this agreement. In these instances, we still contract directly with the reseller to provide a multi-year security-as-a-service subscription to the end-users. Columbia Tech is an independent entity subject to its own unique operational and financial risks which are out of our control. Further, Columbia Tech does not regularly act in the capacity of a distributor for the products it manufactures. If Columbia Tech fails to perform as required under the distributor licensing agreement, this could impair the reputation of our company and our products, our relationships with resellers, our ability to earn revenue from SaaS subscription contracts, and our ability to receive license fees from it under the distributor licensing agreement, any of which could, in turn, adversely impact our business, financial position, and results of operations.
Increases in component costs, long lead times, supply shortages, and supply changes could disrupt our supply chain and have an adverse effect on our business, financial condition, and operating results.
We acquire certain of our materials, which are critical to the ongoing operation and future growth of our business, from several third parties, both foreign and domestic. Generally, our third-party contract manufacturers contract directly with component suppliers, and we rely on our contract manufacturers to manage their supply chains. Our contract manufacturers have experienced, and may in the future experience, supply chain disruptions as a result of COVID-19 or other similar health crises as well as global economic impacts or other changes in macroeconomic trends. In the event our contract manufacturers are unable to adequately manage their supply chain or our relationships with our contract manufacturers terminate, we could experience delays, which could negatively impact our business, customer relationships, and margins. We also source some materials and components directly from suppliers. While most components and
18

materials for our products are available from multiple suppliers, certain of those items are only available from limited or sole sources. Should any of these suppliers become unavailable or inadequate, or impose terms unacceptable to us, such as increased pricing terms, we could be required to spend a significant amount of time and expense to develop alternate sources of supply, and may not be successful in doing so on terms acceptable to it, or at all. As a result, the loss of a limited or sole source supplier could adversely affect our manufacturing capacity, and relationships with our customers, as well as our results of operations and financial condition.
We depend on our primary third-party contract manufacturer for the production of our touchless security screening systems. While there are several potential contract manufacturers for most of these products, all our systems are currently manufactured, assembled, tested, and packaged by Columbia Tech. In most cases, we rely on this manufacturer to procure components and, in some cases, provide manufacturing engineering work. Although we are seeking to expand and diversify our contract manufacturer relationships, our current reliance on one contract manufacturer involves several risks, including:
unexpected increases in manufacturing and repair costs;
inability to control the quality and reliability of finished systems;
inability to control delivery schedules;
potential liability for expenses incurred by the third-party contract manufacturer in reliance on our forecasts that later prove to be inaccurate;
potential lack of adequate capacity to manufacture all components or parts of the products we require;
potential labor unrest or unavailability affecting the ability of the third-party manufacturers to produce our systems; and
the occurrence of unforeseen force majeure events affecting the third-party manufacturer.
We also use a third-party contract manufacturer located in Massachusetts as a second source for the production of a key sensor component used in our touchless security screening systems. If our third-party contract manufacturers experience a delay, disruption, or quality control problems in its operations or if the third-party contract manufacturers do not renew or terminate our agreement with them, our operations could be significantly disrupted and our product shipments could be delayed. Qualifying new manufacturers and commencing volume production is expensive and time consuming. Ensuring that a contract manufacturer is qualified to manufacture our products or components to our standards is time consuming. In addition, there is no assurance that contract manufacturers can scale their production of our products or components at the volumes and in the quality that we require. If contract manufacturers are unable to do these things, we may have to move production for the products or components to a new or existing third-party manufacturer, which would take significant effort and our business, results of operations and financial condition could be materially adversely affected.
As we contemplate moving manufacturing into different jurisdictions, we may be subject to additional and significant challenges in ensuring that quality, processes, and costs, among other issues, are consistent with our expectations. For example, while we expect our third-party contract manufacturers to be responsible for penalties assessed on us because of excessive failures of the products or warranty claims, there is no assurance that we will be able to collect such reimbursements from these manufacturers, which causes us to take on additional risk for potential failures of our products.
In addition, because we currently use third-party contract manufacturers to produce our touchless security screening systems and certain key components, increases in the prices charged may have an adverse effect on our results of operations, as we may be unable to find contract manufacturers who can supply us at a lower price. As a result, the loss of a limited or sole source supplier could adversely affect our relationships with our customers and our results of operations and financial condition.
19

Our business operations are vulnerable to disruption due to natural or other disasters, including climate-related events, strikes, and other events beyond our control.
A major earthquake, fire, tsunami, hurricane, cyclone, or other disaster, such as a major flood, seasonal storms, drought, extreme temperatures, nuclear event, or terrorist attack affecting our facilities or the areas in which we are located, or affecting those of our customers or third-party manufacturers or suppliers, could significantly disrupt our or their operations and delay or prevent product shipment or installation during the time required to repair, reinforce, rebuild or replace our or their damaged manufacturing facilities. These delays could be lengthy and costly. Climate change may contribute to increased frequency or intensity of certain of these events, including increasing frequency and severity of storms, floods, drought, water scarcity, heat waves, wildfires and resultant air quality impacts and power shutoffs associated with these types of events, or a significant power outage as well as contribute to chronic changes in the physical environment (such as changes to ambient temperature and precipitation patterns or sea-level rise) that may impair the operating conditions of these facilities, or otherwise adversely impact our operations. If our third-party contract manufacturers', suppliers’, or customers’ facilities are negatively impacted by such a disaster, production, shipment, and installation of our products could be delayed, which can impact the period in which it recognizes the revenue related to that product sale. Additionally, customers may delay purchases of our products until operations return to normal. Even if we can respond quickly to a disaster, the continued effects of the disaster could create uncertainty in our business operations.
Climate-related events, including the increasing frequency of extreme weather events and their impact on critical infrastructure in the United States and elsewhere, have the potential to disrupt businesses in general and may cause us to experience higher attrition, losses, and additional costs to maintain and resume operations. Transitional climate change risks that result from a shift to a low-carbon economy may also subject us to increased regulations, reporting requirements, standards, or expectations regarding the environmental impacts of our business and untimely or inaccurate disclosure could adversely affect our reputation, business, or financial performance.
In addition, concerns about terrorism, the effects of a terrorist attack, political turmoil, strikes or other labor unrest, war, including in Europe and the Middle East, and the related geopolitical impacts, or the outbreak of epidemic diseases (such as the COVID-19 pandemic) could have a negative effect on the operations of our facilities and those of our contract manufacturers, suppliers and customers, resulting in delays or other challenges in the deployment of our products and services, among others, and thereby negatively impact our sales.
We recognize a substantial portion of our revenue ratably over the term of our agreements with customers and, as a result, downturns or upturns in sales may not be immediately reflected in our operating results.
We recognize a substantial portion of our revenue ratably over the terms of our agreements with customers, which generally occurs over a four-year period. As a result, a substantial portion of the revenue that we report in each period will be derived from the recognition of deferred revenue relating to agreements entered into during previous periods. Consequently, a decline in new sales or renewals in any one period may not be immediately reflected in our revenue results for that period. This decline, however, will negatively affect our revenue in future periods. Accordingly, the effect of significant downturns in sales and market acceptance of our products, and potential changes in our rate of renewals may not be fully reflected in our results of operations until future periods. Our model also makes it difficult to rapidly increase our revenue through additional sales in any period, as revenue from new customers generally will be recognized over the term of the applicable agreement.
We also intend to increase our investment in research and development, sales and marketing, and general and administrative functions and other areas to grow our business. These costs are generally expensed as incurred (with the exception of sales commissions), as compared to our revenue, a substantial portion of which is recognized ratably in future periods. We are likely to recognize the costs associated with these increased investments earlier than some of the anticipated benefits and the return on these investments may be lower, or may develop more slowly, than we expect, which could adversely affect our operating results.
The AI-based weapons detection for security screening market is new and evolving and may not grow as expected or may develop more slowly or differently than we expect. If the market does not grow as we expect, or if we cannot expand our solutions to meet the demands of this market, our revenue may decline, fail to grow or fail to grow at an accelerated rate, and we may incur operating losses.
We believe our future success will depend in large part on the growth, if any, in the market for AI-based weapons detection for security screening solutions. This market is new and evolving, and as such, it is difficult to predict important
20

market trends, including our potential growth, if any. To date, enterprise and corporate security budgets have allocated a majority of dollars to conventional security solutions, such as lower priced walk-through metal detectors. Organizations that use these security products may be satisfied with them or slow to adapt to technical advances and, as a result, these organizations may not adopt our solutions in addition to, or in lieu of, security products they currently use.
Further, sophisticated attackers are skilled at adapting to new technologies and developing new methods of breaching organizations’ security systems, and changes in the nature of security threats could result in a shift in budgets away from products such as ours. In addition, while recent high visibility attacks at publicly and privately-owned venues and schools have increased market awareness of mass shootings, terrorist, or other attacks, if such attacks were to decline, or enterprises or governments perceived that the general level of attacks has declined, our ability to attract new customers and expand our sales to existing customers could be materially and adversely affected. If products such as ours are not viewed by organizations as necessary, or if customers do not recognize the benefit of our products as a critical element of an effective security strategy, our revenue may not grow as quickly as expected, or may decline, and the trading price of our stock could suffer.
In addition, it is difficult to predict customer adoption and retention rates, customer demand for our products, the size and growth rate of the market for AI-based weapons detection for security screening, the entry of competitive products, or the success of existing competitive products. Any expansion in our market depends on a number of factors, including the cost, performance, and perceived value associated with our products and those of our competitors. If these products do not achieve widespread adoption or there is a reduction in demand for products in our market caused by a lack of customer acceptance, technological challenges, regulatory restrictions, competing technologies or products, decreases in corporate spending, weakening economic conditions or otherwise, it could result in reduced customer orders, early terminations, reduced customer retention rates or decreased revenue, any of which would adversely affect our business operations and financial results. You should consider our business and prospects in light of the risks and difficulties it may encounter in this new and evolving market.
We use machine learning, artificial intelligence, and automated decision making in our development process and in our AI-based weapon detection products. Machine learning, artificial intelligence and automated decision making technologies may not be accurate and we may not be able to protect our intellectual property rights related to products or services created with machine learning, artificial intelligence and automated decision making.
We use machine learning, artificial intelligence, and automated decision making technologies, including propriety artificial intelligence and machine learning algorithms, in the development and operation of our AI-based weapons detection products for security screening. There are significant risks involved in developing, maintaining, and deploying machine learning and artificial intelligence technologies and there can be no assurance that the usage of such technologies will always enhance our products or services or be beneficial to our business, including our efficiency or profitability. In particular, if these artificial intelligence or machine learning models are incorrectly designed or implemented; trained or reliant on incomplete, inadequate, inaccurate, biased or otherwise poor quality data or on data to which we do have sufficient rights; and/or are adversely impacted by unforeseen defects, technical challenges, cyber security threats or material performance issues, the performance of our products, services, and business, as well as our reputation and the reputations of our customers, could suffer or we could incur liability through the violation of laws or contracts to which we are a party or civil claims. Further, our ability to continue to develop or use such technologies may be dependent on access to specific third-party software and infrastructure, such as processing hardware or third-party artificial intelligence models, and we cannot control the availability or pricing of such third party software and infrastructure, especially in a highly competitive environment. In addition, market acceptance and consumer perceptions of artificial intelligence and machine learning technologies are uncertain.
A number of aspects of intellectual property protection in the field of artificial intelligence and machine learning are currently under development, and there is uncertainty and ongoing litigation in different jurisdictions as to the degree and extent of protection warranted for artificial intelligence and machine learning systems and relevant system input and outputs. If we fail to obtain protection for the intellectual property rights concerning our artificial intelligence and machine learning technologies, or later have our intellectual property rights invalidated or otherwise diminished, our competitors may be able to take advantage of our research and development efforts to develop competing products.
21

If we are unable to acquire new customers, our future revenues and operating results will be harmed. Likewise, potential customer turnover in the future, or costs we incur to retain our existing customers, could materially and adversely affect our financial performance.
Our success depends on our ability to acquire new customers in new and existing vertical markets, and in new and existing geographic markets. If we are unable to attract a sufficient number of new customers and retain our existing customers, we may be unable to generate revenue growth at desired rates. The physical security solutions market is competitive, and many of our competitors have significantly greater financial, personnel, and other resources than we do and may be able to devote greater resources to their efforts to develop solutions and attract customers. As a result, it may be difficult for us to add new customers to our customer base. Competition in the marketplace may also lead us to win fewer new customers or result in us providing discounts and other commercial incentives to win new customers or retain our existing customers. Additional factors that impact our ability to acquire new customers and retain existing customers include the perceived need for AI-based weapons detection for security solutions, the size of our prospective customers’ security budgets, the availability of government funding, the utility and efficacy of our existing and new products or product enhancements, whether proven or perceived, and general economic conditions. These factors may have a meaningful negative impact on our future revenues and operating results.
While our immediate focus is on the United States market, our long-term success in part depends on our ability to acquire new customers outside the United States. The United States has significantly more privately owned firearms than any other country. If customers in other countries do not perceive the threat of firearms and weapons to be significant enough to justify the purchase of our products, we will be unable to establish a meaningful business outside the United States. If we are unable to attract a sufficient number of new customers outside the United States, we may be unable to generate future revenue growth at desired rates in the long term.
If we are unable to sell additional products to our customers and maintain and grow our customer retention rates, our future revenue and operating results will be harmed.
Our future success depends, in part, on our ability to expand the deployment of our products with existing customers by selling them additional Evolv Express systems. This may require increasingly sophisticated and costly sales efforts and may not result in additional sales. In addition, the rate at which our customers purchase additional products depends on a number of factors, including the perceived need for additional touchless security screening solutions as well as general economic conditions. If our efforts to sell additional products to our customers are not successful, our business may suffer.
If our products fail or are perceived to fail to detect threats such as a firearm or other potential weapon or explosive device, or if our products contain undetected errors or defects, these failures or errors could result in injury or loss of life, which could harm our brand and reputation and have an adverse effect on our business and results of operations.
If our products fail or are perceived to fail to detect and prevent attacks or if our products fail to identify and respond to new and increasingly complex and unpredictable methods of attacks, our business and reputation may suffer. There is no guarantee that our products will detect and prevent all attacks, especially in light of the rapidly changing security landscape to which it must respond, as well as unique factors that may be present in our customers’ operating environments. Additionally, our products may falsely detect items that do not actually represent threats. These false positives may impair the perceived reliability of our products and may therefore adversely impact market acceptance of our products, which could, in turn, result in negative publicity, loss of customers and sales, and increased costs to remedy any problem.
Our products, which are complex, may also contain undetected errors or defects when first introduced or as new versions are released. We have experienced these errors or defects in the past in connection with new products and product upgrades. We expect that these errors or defects will be found from time to time in the future in new or enhanced products after commercial release. Defects may result in increased vulnerability to attacks, cause our products to fail to detect security threats, or temporarily interrupt our products’ ability to screen visitors in a customer’s location. Any errors, defects, disruptions in service or other performance problems with our products may damage our customers’ business and could harm our reputation. If our products fail to detect security threats for any reason, including failures due to customer personnel or security processes, it may result in significant costs, the attention of our key personnel could be diverted, our customers may delay or withhold payment to us or elect not to renew or cause other significant customer relations problems to arise.
22

We may also be subject to liability claims for damages related to errors or defects in our products. For example, if our products fail to detect weapons or explosive devices that are subsequently used by terrorists, criminals, or unbalanced individuals to cause casualties at a high profile, public venue, we could incur financial damages and our reputation could also be significantly harmed. A material liability claim or other occurrence that harms our reputation or decreases market acceptance of our products may harm our business and operating results. Although we have limitation of liability provisions in our terms and conditions of sale, they may not fully or effectively protect us from claims as a result of federal, state, or local laws or ordinances, or unfavorable judicial decisions in the United States or other countries. The sale and support of our products also entails the risk of product liability claims. We maintain insurance to protect against certain claims associated with the use of our products, but our insurance coverage may not adequately cover any claim asserted against us. In addition, even claims that ultimately are unsuccessful could result in our expenditure of funds in litigation, divert or distract management’s time and other resources, and harm our business and reputation.
The loss of designation of our Evolv Express system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act could result in adverse reputational and financial consequences.
Our Evolv Express system has been awarded the DHS SAFETY Act Designation as a Qualified Anti-Terrorism Technology. Technologies that are awarded the SAFETY Act Designation have undergone rigorous use and review to meet and/or exceed the DHS' performance standards that include examination of test results for weapons detection, operational use and effectiveness, manufacturing and quality assurance practices, and customer feedback.
Any amendments or interpretive guidance related to the SAFETY Act may affect our ability to retain our SAFETY Act Designation, may increase the costs of compliance, and/or may negatively impact our ability to attract new customers. Because we view our SAFETY Act Designation as a differentiating factor among our industry peers, if laws and regulations change relating to the SAFETY Act or if we fail to comply with the SAFETY Act's requirements, our business, financial condition, results of operations, and stock price could be materially and adversely affected.

If we do not successfully anticipate market needs and enhance our existing products or develop new products that meet those needs on a timely basis, we may not be able to compete effectively and our ability to generate revenues will suffer.
Our customers face evolving security risks that require them to adapt to increasingly complex infrastructures that incorporate a variety of security solutions. We face significant challenges in ensuring that our products effectively identify and respond to these security risks without disrupting the performance of our customers’ infrastructures. As a result, we must continually modify and improve our products in response to changes in our customers’ infrastructures.
We cannot guarantee that we will be able to anticipate future market needs and opportunities or be able to develop product enhancements or new products to meet such needs or opportunities in a timely manner, if at all. Even if we are able to anticipate, develop and commercially introduce enhancements and new products, there can be no assurance that enhancements or new products will achieve widespread market acceptance.
New products, as well as enhancements to our existing products, could fail to attain sufficient market acceptance for many reasons, including:
delays in releasing new products or product enhancements;
failure to accurately predict market demand and to supply products that meet this demand in a timely fashion;
inability to protect against new types of attacks or techniques used by terrorists or other threat sources;
defects in our products, errors or failures of our products;
negative publicity or perceptions about the performance or effectiveness of our products;
introduction or anticipated introduction of competing products by our competitors;
installation, configuration, sensitivity setting, or usage errors by our customers; and
easing or changing of regulatory requirements at the federal, state, and/or local levels related to security or other aspects of our business.
23

If we fail to anticipate market requirements or fail to develop and introduce product enhancements or new products to meet those needs in a timely manner, it could cause us to lose existing customers and prevent us from gaining new customers, which would significantly harm our business, financial condition, and results of operations.
While we continue to invest significant resources in research and development to enable our products to continue to address the security risks that our customers face, the introduction of products embodying new technologies could also render our existing products or services obsolete or less attractive to customers. If we spend significant time and effort on research and development and are unable to generate an adequate return on our investment, our business and results of operations may be materially and adversely affected.
Our business model is predicated, in part, on building a customer base that will generate a recurring stream of revenues through the sale of our subscription contracts. If that recurring stream of revenues does not develop as expected, or if our business model changes as the industry evolves, our operating results may be adversely affected.
Our business model is dependent, in part, on our ability to maintain and increase subscriptions for our proprietary products as they generate recurring revenues. Existing and future customers of our products may not purchase our subscriptions for our proprietary products at the same rate at which customers currently purchase those subscriptions. If our current and future customers purchase a lower volume of our subscriptions for our proprietary products, our recurring revenue stream relative to our total revenues would be reduced and our operating results would be adversely affected.
A portion of our revenue is generated by sales to government entities and such sales are subject to a number of challenges and risks.
Approximately 4% of our revenue was generated by sales to government entities during each of the years ended December 31, 2023 and December 31, 2022, respectively. Selling to government entities can be highly competitive, expensive, and time-consuming, and often requires significant upfront time investment and expense without any assurance of winning a sales contract. Government demand and payment for our solutions may also be impacted by changes in fiscal or contracting policies, changes in government programs or applicable requirements, the adoption of new laws or regulations or changes to existing laws or regulations, public sector budgetary cycles and funding authorizations, with funding reductions or delays adversely affecting public sector demand for our solutions. Accordingly, increasing sales of our products to government entities may be more challenging than selling to commercial organizations, especially given extensive certification, compliance, clearance, and security requirements. Government agencies may have statutory, contractual, or other legal rights to terminate contracts with us or reseller partners. Further, in the course of providing our solutions to government entities, our employees and those of our reseller partners may be exposed to sensitive government information. Any failure by us or our reseller partners to safeguard and maintain the confidentiality of such information could subject us to liability and reputational harm, which could materially and adversely affect our results of operations and financial performance. Governments routinely investigate and audit government contractors’ administrative processes, and any unfavorable audit may cause the government to shift away from our solutions and may result in a reduction of revenue, fines or civil or criminal liability if the audit uncovers improper or illegal activities, which could adversely impact our results or operations.
Downturns in general economic and market conditions and reductions in spending may reduce demand for our products and services and may impact third parties on which we rely, which could harm our revenue, results of operations, and cash flows, and could make it difficult to predict revenue for a particular period.
Our revenue depends significantly on general economic conditions and the level of concern regarding physical security, which impacts the public’s willingness to attend live events or otherwise gather in numbers. Economic weakness, customer financial difficulties and constrained spending on security measures may result in decreased revenue and earnings. Further worsening, broadening or protracted extension of an economic downturn could have a material negative impact on our business, revenue, results of operations, and cash flows. In addition, concerns regarding continued budgetary challenges in the United States and Europe, high interest rates in the United States and around the world, an inflationary environment, recessionary pressures, geopolitical turmoil (including in Europe and the Middle East) and terrorism in many parts of the world, and the effects of climate change have and may continue to put pressure on global economic conditions and level of concern regarding physical security. If we do not succeed in convincing customers that our products should be an integral part of their overall approach to security and that a fixed portion of their annual security budgets should be allocated to our products, general reductions in security spending by our customers are likely to have a disproportionate impact on our business, results of operations, and financial condition. General economic weakness may also lead to longer collection cycles for payments due from our customers, an increase in customer bad debt, restructuring initiatives and
24

associated expenses and impairment of investments. Furthermore, the continued weakness and uncertainty in worldwide credit markets, including the sovereign debt situation in certain countries in the European Union ("the "EU") may adversely impact the ability of our customers to adequately fund their expected capital expenditures, which could lead to delays or cancellations of planned purchases of our products.
We also face risks from financial difficulties or other uncertainties experienced by our suppliers, reseller partners, or other third parties on which we rely. If our partners and suppliers are negatively impacted by declining economic conditions or circumstances arising from military conflicts, and such third parties are unable to supply us with required materials or components or otherwise assist us in operating our business, our business could be harmed. In addition, military conflicts, including those in Europe and the Middle East, have and could continue to disrupt or otherwise adversely impact our operations and those of third parties upon which we rely. Related sanctions, export controls, and other actions have and may in the future be initiated by nations including the United States, the EU, China, or Russia (such as potential cyberattacks, disruption of energy flows, and others), which could adversely affect our business and/or our supply chain.
Uncertainty about future economic conditions and market volatility also makes it difficult to forecast operating results and to make decisions about future investments. Future or continued economic weakness for us or our customers, failure of our customers and markets to recover from such weakness, customer financial difficulties, and reductions in spending on security systems could have a material adverse effect on demand for our products, and consequently on our business, financial condition, and results of operations.
Our brand, reputation, and ability to attract, retain, and serve our customers are dependent in part upon the reliable performance of our products, infrastructure, and employees.
Our brand, reputation, and ability to attract, retain, and serve our customers are dependent in part upon the reliable performance of, and the ability of our existing customers and new customers to access and use, our solutions, including real-time analytics and intelligence. We have experienced, and may in the future experience, disruptions, outages, and other performance problems due to a variety of factors, including infrastructure changes, equipment failure, human or software errors, capacity constraints, and fraud or cybersecurity attacks. In some instances, we may not be able to identify the cause or causes of these performance problems within an acceptable period of time.
Interruptions in our systems or the third-party systems on which we rely, whether due to system failures, computer viruses, physical or electronic break-ins, or other factors, could affect the security or availability of our products, network infrastructure, cloud infrastructure, and website.
Problems with the reliability or security of our systems could harm our reputation. Damage to our reputation and the cost of remedying these problems could negatively affect our business, financial condition, and operating results. Additionally, our third-party hosting suppliers have no obligations to renew their agreements with us on commercially reasonable terms or at all, and certain of the agreements governing these relationships may be terminated by either party at any time. If we are unable to maintain, renew, or expand our agreements with these providers on commercially reasonable terms, we may experience costs or downtime as we transition our operations.
Any disruptions or other performance problems with our products could harm our reputation and business and may damage our customers’ businesses. Interruptions in our service delivery might reduce our revenue, cause us to issue credits to customers, subject us to potential liability, and cause customers not to renew their subscription purchases of our products.
If we do not effectively expand, train, and retain qualified sales and marketing personnel, we may be unable to acquire new customers or sell additional products to successfully pursue our growth strategy.
We depend significantly on our sales force to attract new customers and expand sales to existing customers. As a result, our ability to grow our revenue depends in part on our success in recruiting, training, and retaining sufficient numbers of sales personnel to support our growth, particularly in the United States and, to a more limited extent, internationally. The number of our sales and marketing personnel increased from 97 as of December 31, 2022 to 139 as of December 31, 2023. We expect to continue to expand our sales and marketing personnel and face a number of challenges in achieving our hiring and integration goals. There is intense competition for individuals with sales training and experience. In addition, the training and integration of a large number of sales and marketing personnel in a short time requires the allocation of significant internal resources. We invest significant time and resources in training new sales force
25

personnel to understand our products, platform, and our growth strategy. Based on our past experience, it takes approximately six to 12 months before a new sales force member operates at target performance levels, depending on their role. However, we may be unable to achieve or maintain our target performance levels with large numbers of new sales personnel as quickly as we have done in the past. Our failure to hire a sufficient number of qualified sales force members and train them to operate at target performance levels may materially and adversely impact our projected growth rate.
If we are not able to maintain and enhance our brand or reputation as an industry leader, our business and operating results may be adversely affected.
We believe that maintaining and enhancing our reputation as the leader in next-generation AI-based weapons detection for security screening is critical to our relationship with our existing end-user customers and reseller partners and our ability to attract new customers and reseller partners. The successful promotion of our brand will depend on multiple factors, including our marketing efforts, our ability to continue to deliver a superior customer experience and develop high-quality features for our products, and our ability to successfully differentiate our products from those of our competitors. Our brand promotion activities may not be successful or yield increased revenue. Additionally, the performance of our reseller partners may affect our brand and reputation if customers do not have a positive experience with our products as implemented by our reseller partners or with the implementation generally. The promotion of our brand requires us to make substantial expenditures, and we anticipate that the expenditures will increase as our market becomes more competitive, as we expand into new geographies and vertical markets and as more sales are generated through our reseller partners. To the extent that these activities yield increased revenue, such increase in revenue may not offset the corresponding increase in expenses we incur. If we do not successfully maintain and enhance our brand and reputation, our business and operating results may be adversely affected.
If our customers are unable to implement our products successfully, or if we fail to effectively assist our customers in installing our products and provide effective ongoing support and training, customer perceptions of our products may be impaired, or our reputation and brand may suffer.
Our products are deployed in a wide variety of indoor and outdoor environments, including large venues with multiple entry points. Some of our customers have experienced difficulties implementing our products in the past and may experience implementation difficulties in the future. If our customers are unable to implement our products successfully, customer perceptions of our products may be impaired, or our reputation and brand may suffer.
Any failure by our customers to appropriately implement our products or any failure of our products to effectively integrate and operate within our customers’ operating environments could result in customer dissatisfaction, impact the perceived reliability of our products, result in negative press coverage, negatively affect our reputation, and harm our financial results.
Successful deployment and operation of our products depend on the knowledge and skill of the customer security personnel or implementation contractors charged with setting up, configuring, monitoring, and troubleshooting the equipment in their own environment. Many of our customers experience relatively high turnover in their security personnel, creating opportunities for knowledge and skill gaps that can result, and have resulted, in configuration, sensitivity setting, or operational errors that allow prohibited threats into customer facilities. In these situations, customers can perceive, and have perceived, that our products have failed to perform as designed until and unless we have been able to demonstrate otherwise. There can be no assurance that we or our implementation partners will successfully isolate and identify failures due to customer error in the future, and this could result in customer dissatisfaction, impact the perceived reliability of our products, result in negative press coverage, negatively affect our reputation, and harm our financial results.
Our customers depend in large part on customer support delivered by us to resolve issues relating to the use of our products. However, even with our support, our customers are ultimately responsible for effectively using our products and ensuring that their staff is properly trained in the use of our products. The failure of our customers to correctly use our products, or our failure to effectively assist customers in installing our products and provide effective ongoing support and training, may result in an increase in the vulnerability of our customers’ facilities and visitors to security threats. We are also in the process of expanding our customer success and support organizations, including the engagement and training of third-party contractors. It can take significant time and resources to recruit, hire and train qualified technical support and service employees and contractors. We may not be able to keep up with demand, particularly if the sales of our products exceed our internal forecasts. To the extent that we are unsuccessful in hiring, training, and retaining adequate support resources, our ability to provide adequate and timely support to our customers may be negatively impacted, and our
26

customers’ satisfaction with our products may be adversely affected. Additionally, in unusual circumstances, if we needed to rely on our sales engineers to provide post-sales support while growing our service organization, our sales productivity may be negatively impacted. Accordingly, any failure by us to provide satisfactory maintenance and technical support services could have a material and adverse effect on our business and results of operations.
We are dependent on the continued services and performance of our senior management and other key employees, as well as on our ability to successfully hire, train, manage, and retain qualified personnel, especially those in sales and marketing and research and development.
Our future performance depends on the continued services and contributions of our senior management, particularly Peter George, our President and Chief Executive Officer, and other key employees to execute on our business plan and to identify and pursue new opportunities and product innovations. We do not maintain key man insurance for any of our executive officers or key employees. From time to time, there may be changes in our senior management team resulting from the termination or departure of our executive officers and key employees. Our senior management and key employees are generally employed on an at-will basis, which means that they could terminate their employment with us at any time. The loss of the services of our senior management, particularly Mr. George and our founders, or other key employees for any reason could significantly delay or prevent our development or the achievement of our strategic objectives and harm our business, financial condition, and results of operations.
Our ability to successfully pursue our growth strategy will also depend on our ability to attract, motivate, and retain our personnel, especially those in sales and marketing and research and development. We face escalating compensation demands from new and prospective employees, as well as intense competition for these employees from numerous technology, software, and other companies, especially in certain geographic areas in which we operate, and we cannot ensure that we will be able to attract, motivate and/or retain additional qualified employees in the future. If we are unable to attract new employees and retain our current employees, we may not be able to adequately develop and maintain new products, or market our existing products at the same levels as our competitors, which may lead us to lose customers and market share. Our failure to attract and retain personnel, especially those in sales and marketing, research and development, and engineering positions, could have an adverse effect on our ability to execute our business objectives. Even if we are able to identify and recruit a sufficient number of new hires, these new hires will require significant training before they achieve full productivity and they may not become productive as quickly as we would like, or at all. Any of these factors may adversely impact our ability to compete and cause our revenue to decrease and our operating results to suffer.
We incorporate technology and components from third parties into our products, and our inability to obtain or maintain rights to the technology could harm our business.
We incorporate technology and components from third parties into our products. We cannot be certain that our suppliers and licensors are not infringing the intellectual property rights of third parties or that the suppliers and licensors have sufficient rights to the technology in all jurisdictions in which it may sell our products. We may not be able to rely on indemnification obligations of third parties if some of our agreements with our suppliers and licensors may be terminated for convenience by them. If we are unable to obtain or maintain rights to any of this technology because of intellectual property infringement claims brought by third parties against our suppliers and licensors or against us, or if we are unable to continue to obtain such technology or enter into new agreements on commercially reasonable terms, our ability to develop and sell products, subscriptions, and services containing such technology could be severely limited, and our business could be harmed. Disputes with suppliers and licensors over uses or terms could result in the payment of additional royalties or penalties by us, cancellation or non-renewal of the underlying license or litigation. In the event that we cannot renew and/or expand existing licenses, we may be required to discontinue or limit our use of the operations, products, or offerings that include or incorporate the licensed intellectual property. Any such discontinuation or limitation could have a material and adverse impact on our business, financial condition, and results of operation. Additionally, if we are unable to obtain necessary technology and components from third parties, including certain sole suppliers, we may be forced to acquire or develop alternative technology or components, which may require significant time, cost, and effort and may be of lower quality or performance standards. This would limit or delay our ability to offer new or competitive products and increase our costs of production. If alternative technology or components cannot be obtained or developed, we may not be able to offer certain functionality as part of our products, subscriptions, and services. As a result, our margins, market share and results of operations could be significantly harmed.
27

Our use of “open source” software could subject our proprietary software to general release, negatively affect our ability to offer our products and subject us to possible litigation.
We have used “open source” software in connection with the development and deployment of our software products, and we expect to continue to use open source software in the future. Open source software is licensed by its authors or other third parties under open source licenses, which in some instances may subject us to certain unfavorable conditions, including requirements that we offer our products that incorporate the open source software for no cost, that we make publicly available all or part of the source code for any modifications or derivative works we create based upon, incorporating or using the open source software, or that we license such modifications or derivative works under the terms of the particular open source license.
Companies that incorporate open source software into their products have, from time to time, faced claims challenging the use of open source software and compliance with open source license terms. As a result, we could be subject to suits by parties claiming ownership of what we believe to be open source software or claiming noncompliance with open source licensing terms. While we monitor our use of open source software and try to ensure that none is used in a manner that would require us to disclose our proprietary source code or that would otherwise breach the terms of an open source agreement, we cannot guarantee that we will be successful, that all open source software is reviewed prior to use in our products, that our developers have not incorporated open source software into our products that we are unaware of or that they will not do so in the future.
Furthermore, there are an increasing number of open source software license types, almost none of which have been interpreted by U.S. or foreign courts, resulting in a dearth of guidance regarding the proper legal interpretation of such licenses. As a result, there is a risk that open source software licenses could be construed in a manner that imposes unanticipated conditions or restrictions on our ability to market or provide our products and services. If we are held to have breached or failed to fully comply with all the terms and conditions of an open source software license, we could face infringement claims or other liability, or be required to seek costly licenses from third parties to continue providing our offerings on terms that are not economically feasible, if at all, to re-engineer all or a portion of our products, to discontinue or delay the provision of our offerings if re-engineering could not be accomplished on a timely basis or to make generally available, in source code form, our proprietary code. Further, in addition to risks related to license requirements, use of certain open source software carries greater technical and legal risks than does the use of third-party commercial software. For example, open source software is generally provided without any support or warranties or other contractual protections regarding infringement or the quality of the code, including the existence of security vulnerabilities. To the extent that our products depend upon the successful operation of open source software, any undetected errors or defects in open source software that we use could prevent the deployment or impair the functionality of our systems and injure our reputation. In addition, the public availability of such software may make it easier for others to compromise our products. Any of the foregoing risks could materially and adversely affect our business, financial condition, and results of operations.
We may acquire or invest in other companies or technologies in the future, which could divert management’s attention, fail to meet our expectations, result in additional dilution to our stockholders, increase expenses, disrupt our operations, or otherwise harm our operating results.
We may in the future acquire or invest in businesses, products, or technologies that we believe could complement or expand our platform, enhance our technical capabilities, or otherwise offer growth opportunities. The pursuit of potential acquisitions may divert the attention of management and cause us to incur various expenses related to identifying, investigating, and pursuing suitable acquisitions, whether or not they are consummated. Even if they are consummated, we may not be able to fully realize the anticipated benefits of any future acquisitions or anticipated benefits may not transpire.
There are inherent risks in integrating and managing acquisitions. If we acquire additional businesses, we may not be able to assimilate or integrate the acquired personnel, operations, products, services, and technologies successfully or effectively manage the combined business following the acquisition and our management may be distracted from operating our business. We also may not achieve the anticipated benefits from the acquired business due to a number of factors, including, without limitation:
unanticipated costs or liabilities associated with the acquisition;
incurrence of acquisition-related costs, which would be recognized as a current period expense;
inability to generate sufficient revenue to offset acquisition or investment costs;
28

inability to maintain relationships with customers and partners of the acquired business;
difficulty of incorporating acquired technology and rights into our platform and of maintaining quality and security standards consistent with our brand;
delays in customer purchases due to uncertainty related to any acquisition;
the potential loss of key employees;
use of resources that are needed in other parts of our business and diversion of management and employee resources;
inability to recognize acquired deferred revenue in accordance with our revenue recognition policies; and
use of substantial portions of our available cash and equity or the incurrence of debt to consummate the acquisition.
Acquisitions also increase the risk of unforeseen legal liability, including potential shareholder suits or potential violations of applicable law or industry rules and regulations, arising from prior or ongoing acts or omissions by the acquired businesses that are not discovered by due diligence during the acquisition process or new regulatory restrictions at the federal, state, or local levels. Generally, if an acquired business fails to meet our expectations, our operating results, business, and financial condition may suffer. Acquisitions could also result in dilutive issuances of equity securities or the incurrence of debt, which could adversely affect our business, results of operations and financial condition.
In addition, a significant portion of the purchase price of companies we acquire may be allocated to goodwill and other intangible assets, which must be assessed for impairment at least annually. If our acquisitions do not ultimately yield expected returns, we may be required to take charges to our operating results based on our impairment assessment process, which could harm our results of operations.
Our intellectual property rights are valuable and any inability to protect our proprietary technology and intellectual property rights could substantially harm our business and operating results.
Our future success and competitive position depend in part on our ability to protect our intellectual property and proprietary technologies. To safeguard these rights, we rely on a combination of patent, trademark, copyright, and trade secret laws and contractual protections in the United States and other jurisdictions, all of which provide only limited protection and may not now or in the future provide us with a competitive advantage. We maintain a program of identifying technology appropriate for patent protection. Our practice is to require employees and consultants to execute non-disclosure and proprietary rights agreements upon commencement of employment or consulting arrangements. These agreements acknowledge our exclusive ownership of all intellectual property developed by the individuals during their work for us and require that all proprietary information disclosed will remain confidential. Such agreements may not be enforceable in full or in part in all jurisdictions and any breach could have a negative effect on our business and our remedy for such breach may be limited.
We own or co-own eight issued U.S. patents and 24 issued foreign patents and have 24 pending or allowed patent applications relating to our products. It cannot be certain that any patents will issue from any patent applications, that patents that issue from such applications will give us the protection that we seek or that any such patents will not be challenged, invalidated, or circumvented. Any patents that may issue in the future from our pending or future patent applications may not provide sufficiently broad protection and may not be enforceable in actions against alleged infringers. We have registered the Evolv Technology®, Evolv Express, Evolv Insights, Evolv Cortex AI, and Evolv Edge® names and logos in the United States and certain other countries. We also have registrations and/or pending applications for additional marks in the United States and other countries; however, we cannot be certain that any future trademark registrations will be issued for pending or future applications or that any registered trademarks will be enforceable or provide adequate protection of our proprietary rights. We also license software from third parties for integration into our products, including open source software and other software available on commercially reasonable terms. We cannot be certain that such third parties will maintain such software or continue to make it available. If we are unable to maintain sufficient intellectual property protection for our proprietary technologies or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors and other third parties could develop and commercialize technologies similar or identical to ours, and our ability to successfully commercialize our technologies may be impaired.
29

While we take steps to protect our intellectual property, the steps we take may be inadequate to prevent infringement, misappropriation, or other violations of our intellectual property rights. We will not be able to protect our intellectual property if we are unable to enforce our rights or if we do not detect unauthorized use of our intellectual property. Any of our patents or other intellectual property rights may be challenged by others or invalidated through administrative process or litigation. Furthermore, legal standards relating to the validity, enforceability, and scope of protection of intellectual property rights are uncertain. Some license provisions protecting against unauthorized use, copying, transfer, and disclosure of our offerings may be unenforceable under the laws of certain jurisdictions and foreign countries. In addition, the laws of some countries do not protect proprietary rights to the same extent as the laws of the United States, and mechanisms for enforcement of intellectual property rights in some foreign countries may be inadequate. Changes in the law or adverse court rulings may also negatively affect our ability to prevent others from using our technology. To the extent we expand our international activities, our exposure to unauthorized copying and use of our technology and proprietary information may increase.
We may be required to spend significant resources to monitor and protect our intellectual property rights. From time to time, legal action by us may be necessary to enforce our patents and other intellectual property rights, to protect our trade secrets, to determine the validity and scope of the intellectual property rights of others or to defend against claims of infringement or invalidity. Such litigation could result in substantial costs and diversion of resources and could negatively affect our business, operating results, and financial condition. Furthermore, our efforts to enforce our intellectual property rights may be met with defenses, counterclaims, and countersuits attacking the validity and enforceability of our intellectual property rights. Our inability to protect our proprietary technology against unauthorized copying or use, as well as any costly litigation, could delay further sales or the implementation of our products and offerings, impair the functionality of our products and offerings, delay introductions of new features or enhancements, result in our substituting inferior or more costly technologies into our products and offerings, or injure our reputation.
Assertions by third parties of infringement or other violations by us of their intellectual property rights, whether or not correct, could result in significant costs and harm to our business and operating results.
Third parties may in the future assert claims of infringement, misappropriation, or other violations of intellectual property rights against us. They may also assert such claims against our customers or reseller partners, whom we typically indemnify against claims that our products infringe, misappropriate, or otherwise violate the intellectual property rights of third parties. If we do infringe a third party’s rights and are unable to provide a sufficient workaround, we may need to negotiate with holders of those rights to obtain a license to those rights or otherwise settle any infringement claim as a party that makes a claim of infringement against us may obtain an injunction preventing us from shipping products containing the allegedly infringing technology. As the number of products and competitors in our market increase and overlaps occur, claims of infringement, misappropriation, and other violations of intellectual property rights may increase. Any claim of infringement, misappropriation, or other violation of intellectual property rights by a third party, even those without merit, could cause us to incur substantial costs defending against the claim and could distract our management from our business.
Future assertions of patent rights by third parties, and any resulting litigation, may involve patent holding companies or other adverse patent owners who have no relevant product revenues and against whom our own patents may therefore provide little or no deterrence or protection. There can be no assurance that we will not be found to infringe or otherwise violate any third-party intellectual property rights or to have done so in the past.
An adverse outcome of a dispute may require us to:
pay substantial damages, including treble damages, if we are found to have willfully infringed a third party’s patents or copyrights;
make substantial payments for legal fees, settlement payments or other costs or damages;
cease selling, making, licensing, or using products that are alleged to infringe or misappropriate the intellectual property of others;
expend additional development resources to attempt to redesign our products or otherwise develop non-infringing technology, which may not be successful;
enter into potentially unfavorable royalty or license agreements to obtain the right to use necessary technologies or intellectual property rights;
30

take legal action or initiate administrative proceedings to challenge the validity and scope of the third-party rights or to defend against any allegations of infringement; and
indemnify our partners and other third parties.
In addition, royalty or licensing agreements, if required or desirable, may be unavailable on terms acceptable to us, or at all, and may require significant royalty payments and other expenditures. Some licenses may also be non-exclusive, and therefore our competitors may have access to the same technology licensed to us. Any of the foregoing events could seriously harm our business, financial condition, and results of operations.
Even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and harm our business and operating results. Moreover, there could be public announcements of the results of hearings, motions, or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our ordinary shares. We expect that the occurrence of infringement claims is likely to grow as the market for our products and solutions grows. Accordingly, our exposure to damages resulting from infringement claims could increase and this could further exhaust our financial and management resources.
Confidentiality arrangements with employees and others may not adequately prevent disclosure of trade secrets and other proprietary information.
We have devoted substantial resources to the development of our technology, business operations, and business plans. In order to protect our trade secrets and proprietary information, we rely in significant part on confidentiality arrangements with our employees, licensees, independent contractors, advisors, suppliers, reseller partners, and customers. However, we cannot guarantee that we have entered into such agreements with each party that may have or has had access to our trade secrets or proprietary technology and processes. Further, despite these efforts, these arrangements may not be effective to prevent disclosure of confidential information, including trade secrets, and may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. Unauthorized parties may also attempt to copy or reverse engineer certain aspects of our technologies that we consider proprietary. In addition, if others independently develop equivalent knowledge, methods, and know-how, we would not be able to assert trade secret rights against such parties. Monitoring unauthorized uses and disclosures is difficult, and we do not know whether the steps we have taken to protect our proprietary information will be effective.
Moreover, policing unauthorized use of our technologies, trade secrets and intellectual property and enforcing a claim that a party illegally disclosed or misappropriated a trade secret are difficult, expensive, time-consuming, and the outcome is unpredictable. In addition, effective trade secret protection may not be available in every country in which our products are available or where we have employees or independent contractors as some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be disclosed to or independently developed by a competitor or other third party, our competitive position would be materially and adversely harmed. The loss of trade secret protection could make it easier for third parties to compete with our products by copying functionality. In addition, any changes in, or unexpected interpretations of, the trade secret and employment laws in any country in which we operate may compromise our ability to enforce our trade secret and intellectual property rights. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain trade secret protection could adversely affect our competitive business position.
Our products and services may be affected from time to time by design and manufacturing defects that could adversely affect our business and result in harm to our reputation.
Our touchless security screening systems are complex and may contain undetected defects or errors when first introduced or as enhancements are released that, despite testing, are not discovered until after a product has been used. This could result in delayed market acceptance of those products or claims from resellers, customers, or others, which may result in litigation, increased end user warranty, support and repair or replacement costs, damage to our reputation and business, or significant costs and diversion of support and engineering personnel to correct the defect or error. We have been in the past and may from time to time become subject to warranty or product liability claims related to product quality issues that could lead us to incur significant expenses.
31

We attempt to include provisions in our agreements with customers that are designed to limit our exposure to potential liability for damages arising from defects or errors in our products. However, it is possible that these limitations may not be effective as a result of unfavorable judicial decisions or applicable laws in existence or enacted in the future.
The sale and support of our products entails the risk of product liability claims. Any product liability claim brought against us, regardless of its merit, could result in material expense, diversion of management time and attention, damage to our business and reputation and brand, and cause us to fail to retain existing customers or to fail to attract new customers.
If the general level of physical threats/attacks declines, or is perceived by our current or potential customers to have declined, our business could be harmed.
Our business is substantially dependent on enterprises and governments recognizing that mass shootings, terrorist attacks and similar security threats are not necessarily effectively prevented by conventional security products such as walk-through metal detectors. High visibility attacks on prominent enterprises and governments have increased market awareness of the problem of security threats and help to provide an impetus for enterprises and governments to devote resources to protecting against security threats, such as testing our products, purchasing them and broadly deploying them within their organizations. If security threats were to decline, or enterprises or governments perceived that the general level of security threats has declined, our ability to attract new customers and expand sales of our products to existing customers could be materially and adversely affected. A reduction in the security threat landscape could increase our sales cycles and harm our business, results of operations, and financial condition.
If we are unable to compete effectively with new entrants and other potential competitors, our sales and profitability could be adversely affected.
The sales prices for our products and services may decline for a variety of reasons, including competitive pricing pressures, discounts, a change in our mix of products and services, anticipation of the introduction of new products or promotional programs. Competition continues to increase in the market segments in which we participate, and we expect competition to further increase in the future, thereby leading to increased pricing pressures. Larger competitors with more diverse product and service offerings may reduce the price of products that compete with theirs or may bundle them with other products and services. Additionally, currency fluctuations in certain countries and regions may negatively impact prices that partners and customers are willing to pay in those countries and regions. We cannot be certain that we will be successful in developing and introducing new products with enhanced functionality on a timely basis, or that our new product offerings, if introduced, will enable it to maintain our prices and gross profits at levels that will allow us to maintain positive gross margins and achieve profitability.
Because our products collect and store visitor and related information and images, domestic and international privacy and cybersecurity concerns, and other laws and regulations, could result in additional costs and liabilities to us or inhibit sales of our products.
In the ordinary course of our business, we and our third-party vendors collect and store personal information about individuals such as our customers and employees, as well as our proprietary business information and intellectual property and that of our customers and employees. Additionally, we rely on third parties and their security procedures for the secure storage, processing, maintenance, and transmission of information that is critical to our operations. We and our third-party vendors may be affected by cyber-attacks and other means of gaining unauthorized access to our products, systems, and data. Our reliance on ever-evolving technology systems introduces ever more complex security risks that are difficult to predict and defend against. An increasing number of companies, including those with significant online operations, have recently disclosed breaches of their security, some of which involved sophisticated tactics and techniques allegedly attributable to criminal enterprises or nation-state actors.
Cybersecurity threats as well as the tools (including artificial intelligence) used to breach security safeguards, circumvent security controls, evade detection, and remove forensic evidence, are also constantly evolving and may originate from remote areas increasing the difficulty of detecting and successfully defending against them. For instance, cyber criminals or insiders may target us or third parties with which we have business relationships to obtain data, or in a manner that disrupts our operations or compromises our products or the systems into which our products are integrated.
Remote and hybrid working arrangements also increase cybersecurity risks due to the challenges associated with managing remote computing assets and security vulnerabilities that are present in many non-corporate and home networks.
32

As such, we and our third-party vendors may be subject to boycotts, spam, spyware, ransomware, phishing and social engineering, viruses, worms, malware, DDOS attacks, password attacks, impersonation of employees or officers, and other threats.
Cybersecurity incidents directed at us or our third-party vendors can range from errors on the part of our personnel to uncoordinated individual attempts to gain unauthorized access to information technology systems to sophisticated and targeted measures known as advanced persistent threats. Specifically, a cyber incident could be caused by disasters, insiders (through inadvertence or with malicious intent), or malicious third parties (including nation-states or nation-state supported actors) using sophisticated, targeted methods to circumvent firewalls, encryption, and other security defenses, including hacking, fraud, trickery, or other forms of deception. And it is possible that our security controls over personal information and other practices we follow may not prevent the unauthorized access to, or the unintended release of, personal information. In addition, we do not know whether our current practices will be deemed sufficient under applicable laws or whether new regulatory requirements might make our current practices insufficient. Despite measures designed to prevent, detect, address, and mitigate cybersecurity incidents, such measures will require updates and improvements, and we cannot guarantee that such measures will be adequate to detect, prevent or mitigate cyber incidents. Such incidents may occur to us or our third-party providers and, depending on their nature and scope, could potentially result in the misappropriation, destruction, corruption or unavailability of critical data and confidential or proprietary information (our own or that of third parties, including personal information of our customers and employees) and the disruption of business operations. If there is a breach of our computer systems and we know or suspect that certain personal information has been accessed, or used inappropriately, we may need to inform the affected individual and may be subject to significant fines and penalties. In the event of a breach, we could face government scrutiny or consumer class actions. Furthermore, there can be no assurance that our cybersecurity risk management program and processes, including our policies, controls, or procedures, will be fully implemented, complied with or effective in protecting our systems and information.
We and our third-party vendors have experienced and expect to continue to experience cyber-attacks, such as through phishing scams and ransomware. Although none of these actual or attempted cyber-attacks has had a material adverse impact on our operations or financial condition, we cannot guarantee that any such incidents will not have such an impact in the future. For example, we are at risk for interruptions, outages and breaches of: operational systems, including business, financial, accounting, product development, data processing or production processes, owned by us or our third-party vendors or suppliers; facility security systems, owned by us or our third-party vendors or suppliers; in-product technology owned by us or our third-party vendors or suppliers; the integrated software in our solutions; or customer or other data that we process or our third-party vendors or suppliers process on our behalf. Such cyber incidents could materially disrupt operational systems; result in loss of intellectual property, trade secrets or other proprietary or competitively sensitive information; compromise certain information of customers, employees, suppliers, or others; jeopardize the security of our facilities; or affect the performance of in-product technology and the integrated software in our solutions.
Due to concerns about data security and integrity, a growing number of legislative and regulatory bodies have adopted breach notification and other requirements in the event that information subject to such laws is accessed by unauthorized persons and additional regulations regarding the use, access, accuracy, and security of such data are possible. For example, in the United States, we are subject to laws in all states and numerous territories that require notification. In addition, the SEC has recently adopted rules on the Cybersecurity Risk Management, Strategy, Governance, and Incident Disclosure by Public Companies that enhances and standardizes disclosures for public companies with regards to their cybersecurity risk strategy, management, and governance. Complying with such numerous and complex regulations in the event of unauthorized access would be expensive and difficult, and failure to comply with these regulations could subject us to regulatory scrutiny and additional liability.
In addition to potential noncompliance, any actual or alleged security breaches or alleged violations of federal or state laws or regulations relating to privacy and data security could result in mandated user notifications, litigation (including class actions), government investigations, regulatory action, significant fines, and expenditures; divert management’s attention from operations; deterring people from using our platform; damage our brand and reputation; and a materially adversely affect our business, results of operations, and financial condition. Defending against claims or litigation based on any security breach or incident, regardless of their merit, will be costly and may cause reputation harm. In addition, we may incur significant costs for remediation that may include liability for stolen assets or information, repair of system damage, and compensation to customers, employees, and business partners. The successful assertion of one or more large claims against us that exceed available insurance coverage, denial of coverage as to any specific claim, or any change or cessation in our insurance policies and coverages, including premium increases or the imposition of large
33

deductible requirements, could have a material adverse effect on our business, results of operations, and financial condition.
We are subject to governmental regulation and other legal obligations, particularly related to privacy, data protection, information security, and product marketing and our actual or perceived failure to comply with such obligations could harm our business.
We, our reseller partners, and our customers are subject to a number of domestic and international laws and regulations that apply to cloud services and the internet generally. These laws, rules, and regulations address a range of issues including data privacy and cyber security, breach notification and restrictions or technological requirements regarding the collection, use, storage, protection, disclosure, retention, transfer, or other processing of data. The regulatory framework for online services, data privacy and cyber security issues worldwide can vary substantially from jurisdiction to jurisdiction, is rapidly evolving and is likely to remain uncertain for the foreseeable future. Many federal, state, local, and foreign government bodies and agencies have adopted or are considering adopting laws, rules and regulations regarding the collection, use, storage, disclosure and other processing of information, web browsing and geolocation data collection, data analytics, facial recognition, cyber security, and breach response and notification procedures. Furthermore, new laws and regulations that apply to our business are being introduced at every level of government in the United States, as well as internationally. As we seek to expand our business, we are, and may increasingly become subject to various laws, regulations, and standards, and may be subject to contractual obligations relating to data privacy and security in the jurisdictions in which we operate.
For example, in the United States, there are numerous federal and state data privacy and security laws, rules, and regulations governing the collection, use, disclosure, retention, security, transfer, storage, and other processing of personal information, including federal and state data privacy laws, data breach notification laws, and consumer protection laws. The U.S. Federal Trade Commission ("FTC") and many state attorneys general are interpreting federal and state consumer protection laws to impose standards for the online collection, use, dissemination, and security of data. Such standards require us to publish statements that describe how we handle personal data and choices individuals may have about the way we handle their personal data. If such information that we publish is considered untrue or inaccurate, we may be subject to government claims of unfair or deceptive trade practices, which could lead to significant liabilities and consequences. Moreover, according to the FTC, violating consumers’ privacy rights or failing to take appropriate steps to keep consumers’ personal data secure may constitute unfair acts or practices in or affecting commerce in violation of Section 5(a) of the Federal Trade Commission Act. State consumer protection laws provide similar causes of action for unfair or deceptive practices.
There are also laws and regulations governing the collection and use of biometric information, such as fingerprints and face prints. For example, the Illinois' Biometric Information Privacy Act (“BIPA”) applies to the collection and use of “biometric identifiers” and “biometric information” which include finger and face prints. Several class action lawsuits have been brought under BIPA, as the statute is broad and still being interpreted by the courts.
In addition, many state legislatures have adopted legislation that regulates how businesses operate, including measures relating to privacy, data security, and data breaches. Such legislation includes the California Consumer Privacy Act ("CCPA"), as amended by the California Privacy Rights Act (“CPRA”), which grants privacy rights to California consumers and imposes obligations on companies that process their personal information. Among other things, the CCPA gives California consumers rights related to their personal information, including the right to access, correct and delete their personal information, opt out of certain processing of their personal information, including possibly restricting the use of certain cookies and similar technologies for advertising purposes. The CCPA prohibits discrimination against individuals who exercise their privacy rights and provides for civil penalties for violations enforceable by the California Attorney General as well as a private right of action for certain data breaches that result in the loss of personal information. This private right of action is expected to increase the likelihood of, and risks associated with, data breach litigation. Additionally, the CPRA, which substantially amends the CCPA, went into effect on January 1, 2023 and restricts use of certain categories of sensitive personal information that we handle; further restricts the use of cross-context behavioral advertising techniques on which our products may rely in the future; establishes restrictions on the retention of personal information; expands the types of data breaches subject to the private right of action; and establishes the California Privacy Protection Agency to implement and enforce the new law, as well as impose administrative fines. Additionally, comprehensive privacy statutes that share similarities with the CCPA have been enacted in Virginia (effective January 1, 2023), Colorado (effective July 1, 2023), Connecticut (effective July 1, 2023), and Utah (effective December 31, 2023) and other states and federal legislation has also been enacted and/or proposed, reflecting a trend toward more stringent data privacy legislation in the United States.
34

This legislation may add additional complexity, variation in requirements, restrictions, and potential legal risk, require additional investment in resources to compliance programs, could impact strategies and availability of previously useful data, and could result in increased compliance costs and/or changes in business practices and policies.
In addition, some laws may require us to notify governmental authorities and/or affected individuals of data breaches involving certain personal information or other unauthorized or inadvertent access to or disclosure of such information. We may need to notify governmental authorities and affected individuals with respect to such incidents. For example, laws in all 50 U.S. states may require businesses to provide notice to consumers whose personal information has been disclosed as a result of a data breach. These laws are not consistent, and compliance in the event of a widespread data breach may be difficult and costly. We also may be contractually required to notify consumers or other counterparties of a security breach. Regardless of our contractual protections, any actual or perceived security breach or breach of our contractual obligations could harm our reputation and brand, expose us to potential liability or require us to expend significant resources on data security and in responding to any such actual or perceived breach.
Internationally, virtually every jurisdiction in which we operate and has customers and/or have prospective customers to which we market has established its own data security and privacy legal frameworks with which we, our reseller partners or our customers must comply.
For example, in Europe and the United Kingdom ("UK"), we are subject to the European Union General Data Protection Regulation (the “EU GDPR”) and to the United Kingdom General Data Protection Regulation and Data Protection Act 2018 (collectively, the “UK GDPR”) (the EU GDPR and UK GDPR together referred to as the “GDPR”). The GDPR imposes comprehensive data privacy compliance obligations in relation to our collection, processing, sharing, disclosure, transfer, and other use of data relating to an identifiable living individual or “personal data,” including a principal of accountability and the obligation to demonstrate compliance through policies, procedures, training, and audit. Non-compliance with the EU GDPR and UK GDPR can trigger steep fines of up to the greater of (i) 4% of total worldwide annual turnover and (ii) €20 million. Separate EU and UK laws and regulations (and national implementations thereof) govern the protection of consumers and of electronic communications and these are also evolving. For instance, the current European laws that cover the use of cookies and similar technology and marketing online or by electronic means are under reform. A draft of the new ePrivacy Regulation extends the strict opt-in marketing rules with limited exceptions to business-to-business communications, alters rules on third-party cookies, web beacons and similar technology and significantly increases penalties. We cannot yet determine the impact such future laws, regulations, and standards may have on our business. Such laws and regulations are often subject to differing interpretations and may be inconsistent among jurisdictions. Compliance with the EU GDPR and UK GDPR, and other such laws, may incur substantial expense and we may be required to make significant changes in our business operations and product and services development, all of which may adversely affect our revenues and our business.
We are also subject to EU and UK rules with respect to cross-border transfers of personal data out of the European Economic Area (the "EEA") and the UK, respectively. Recent legal developments in Europe have created complexity and uncertainty regarding transfers of personal data from the EEA and the UK to the United States. Transfers must be assessed on a case-by-case basis and reliance on the standard contractual clauses (a standard form of contract approved by the European Commission as an adequate personal data transfer mechanism,) alone may not necessarily be sufficient in all circumstances. European court and regulatory decisions take a restrictive approach to international data transfers. The UK regulator has adopted a similar approach to data export outside of the UK and, on March 21, 2022, the international data transfer agreement and the international data transfer addendum to the European Commission’s standard contractual clauses for international data transfers came into force. The UK regulator also recommends, consistent with the European Commission approach, a transfer risk assessment is undertaken. Use of such standard contractual clauses must now be assessed on a case-by-case basis taking into account the legal regime applicable in the destination country, in particular applicable surveillance laws and rights of individuals and additional measures and/or contractual provisions may need to be put in place, however, the nature of these additional measures is currently uncertain. As the enforcement landscape further develops, and supervisory authorities issue further guidance on international data transfers, we could suffer additional costs, complaints and/or regulatory investigations or fines; we may have to stop using certain tools and vendors and make other operational changes and/or it could otherwise affect the manner in which we provide our services, and could adversely affect our business, operations, and financial condition.
Further, many federal, state, and foreign government bodies and agencies have introduced, and are currently considering, additional laws and regulations, including related to the development and integration of artificial intelligence (“AI”), machine learning, and additional emerging data technologies while mitigating or controlling for bias and discrimination in the context of AI and machine learning. For example, in the United States, an executive order was issued
35

in October 2023 on the Safe, Secure and Trustworthy Development and Use of AI, emphasizing the need for transparency, accountability and fairness in the development and use of AI. The order seeks to balance innovation with addressing risks associated with AI by providing eight guiding principles and priorities, such as ensuring that consumers are protected from fraud, discrimination and privacy risks related to AI. Legislation has also been promulgated on the state level. For example, the California Privacy Protection Agency is currently in the process of finalizing regulations under the CCPA regarding the use of automated decision making. In addition, in Europe the European Commission proposed a regulation seeking to establish a comprehensive, risk-based governance framework for AI in the EU market, the EU AI Act, which was politically agreed to in December 2023. It is intended to apply to companies that develop, use and/or provide AI in the EU and includes requirements around transparency, conformity assessments and monitoring, risk assessments, human oversight, security and accuracy and introduces significant fines for noncompliance. There are also specific rules on the use of automated decision making under the GDPR that provide the data subject the right not to be subject to a decision based solely on automated processing, including profiling, which produces legal effects concerning him or her or similarly significantly affects him or her. Additionally, the existence of automated decision making must be disclosed to the data subject with a meaningful explanation of the logic used in such decision making in certain circumstances and safeguards must be implemented to safeguard individual rights, including the right to obtain human intervention and to contest any decision. If passed, we will likely incur additional expenses and costs associated with complying with such laws, as well as face heightened potential liability if we are unable to comply with these laws. While we minimize any physical bias in our product’s identification of threats because the product’s AI does not process or analyze an individual's physical characteristics, we may not be able to identify such issues in advance, or if identified, we may not be able to identify mechanisms for effectively mitigating such issues.
We strive to comply with all applicable laws, policies, legal obligations, and industry codes of conduct relating to privacy and data protection to the extent possible. Because the interpretation and application of privacy and data protection laws are still uncertain, it is possible that these laws may be interpreted and applied in a manner that is inconsistent from one jurisdiction to another or with our existing practices or the features of our products and may conflict with other rules or regulations, making enforcement, and thus compliance requirements, ambiguous, uncertain, and potentially inconsistent. Any significant change to applicable laws, regulations or industry practices, or how each is interpreted, regarding the use or disclosure of personal information, or regarding the manner in which the express or implied consent of customers for the use and disclosure of personal information is obtained, could require us to modify our products and features, possibly in a material manner and subject to increased compliance costs, which may limit our ability to develop new products and features that make use of the personal information that our customers voluntarily share. Any failure or perceived failure by us to comply with our privacy policies, privacy-related obligations to customers or other third parties, or our privacy-related legal obligations, or any compromise of security that results in the unauthorized access to or unintended release of personally identifiable information or other customer data, may result in governmental enforcement actions, litigation, or public statements against us by consumer advocacy groups or others. Any of these events could cause us to incur significant costs in investigating and defending such claims and, if found liable, pay significant damages. Further, these proceedings and any subsequent adverse outcomes may cause our customers to lose trust in us, which could have an adverse effect on our reputation and business.
We may also be subject to claims of liability or responsibility for the actions of third parties with whom we interact or upon whom it relies in relation to various products, including but not limited to vendors and business partners. If so, in addition to the possibility of fines, lawsuits and other claims, we could be required to fundamentally change our business activities and practices or modify our products, which could have an adverse effect on our business. Any inability to adequately address privacy and/or data concerns, even if unfounded, or comply with applicable privacy or data protection laws, regulations, and policies, could result in additional cost and liability to us, damage our reputation, inhibit sales and adversely affect our business.
The costs of compliance with, and other burdens imposed by, the laws, rules, regulations, and policies that are applicable to the businesses of our customers may limit the use and adoption of, and reduce the overall demand for, our software. Even the perception of privacy or discrimination concerns, whether or not valid, may harm our reputation, inhibit adoption of our products by current and future customers, or adversely impact our ability to attract and retain workforce talent. Our failure to comply with applicable laws and regulations, or to protect such data, could result in enforcement action against us, including fines, imprisonment of company officials and public censure, claims for damages by customers and other affected individuals, damage to our reputation and loss of goodwill (both in relation to existing customers and prospective customers), any of which could have a material adverse effect on our operations, financial performance and business. We may also have costs associated with engaging with stakeholders, including investors, insurance providers, and other capital providers, on such issues.
36

The marketing and sale of our products are also subject to extensive regulation by various federal agencies, including the FTC and Customer Product Safety commission, as well as various other federal, state, provincial, local, and international regulatory authorities in the countries in which our products are distributed or sold and industry codes of conduct. From time to time, we receive government regulatory inquiries and requests for information relating to our marketing practices and our approach is to be cooperative and educate them about our company and products. For example, the FTC has requested information about certain aspects of our marketing practices. We are complying with the FTC's requests and have been cooperating with them to answer their questions and educate them about our mission. Furthermore, in February 2024, we received a subpoena from the SEC, Division of Enforcement, requesting that we produce certain documents and information, much of which is similar to the documents and information previously requested by the FTC. We are cooperating and intend to continue to cooperate with the SEC's investigation. The Company is cooperating with the FTC and SEC with respect to the investigations, and there can be no assurance whether there will be further information requests or potential enforcement or litigation, which is necessarily uncertain. We can offer no assurances as to the outcome of these investigations or their potential effect, if any, on us or our results of operations. Any inability to adequately address the FTC’s or SEC's concerns, even if unfounded, or comply with applicable laws, regulations, and policies, could result in enforcement actions or significant penalties or claims, which could, in turn, divert financial and management resources, damage our reputation, inhibit sales, and otherwise adversely affect our business. In addition to the possibility of fines, injunctive relief, lawsuits and other claims, we could be required to fundamentally change our business operations, marketing activities, and practices. Responding to these or other investigations alone can be costly and time-consuming.
Regulations related to “conflict minerals” may force us to incur additional expenses, may result in damage to our business reputation and may materially and adversely impact our ability to conduct our business.
As a public company, we are subject to the requirements under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”) that require us to exercise diligence, disclose and report whether or not our devices contain conflict minerals. These requirements could adversely affect the sourcing, availability and pricing of the materials used in the manufacture of components used in our devices. In addition, we will incur additional costs to comply with the disclosure requirements, including costs related to conducting diligence procedures to determine the sources of conflict minerals that may be used or necessary to the production of our devices and, if applicable, potential changes to devices, processes or sources of supply as a consequence of such verification activities. It is also possible that we may face reputational harm if we determine that certain of our devices contain minerals which are not determined to be conflict-free or if we are unable to alter our devices, processes, or sources of supply to avoid such materials.
Our operating results may be harmed if we are required to collect sales and use or other related taxes for our products in jurisdictions where it has not historically done so.
Taxing jurisdictions, including state, local, and foreign taxing authorities, have differing rules and regulations governing sales and use or other taxes, and these rules and regulations are subject to varying interpretations that may change over time. In particular, significant judgment is required in evaluating our tax positions and our worldwide provision for taxes. While we believe that we are in material compliance with our obligations under applicable taxing regimes, one or more states, localities, or countries may seek to impose additional sales or other tax collection obligations on us, including for past sales by us or our reseller partners. It is possible that we could face sales tax audits and that such audits could result in tax-related liabilities for which it has not accrued. A successful assertion that it should be collecting additional sales or other taxes on our products in jurisdictions where it has not historically done so and do not accrue for sales taxes could result in substantial tax liabilities for past sales, discourage customers from purchasing our products or otherwise harm our business and operating results.
In addition, our tax obligations and effective tax rates could be adversely affected by changes in the relevant tax, accounting and other laws, regulations, principles and interpretations (such as the recent United States Inflation Reduction Act which, among other changes, introduced a 15% corporate minimum tax on certain United States corporations and a 1% excise tax on certain stock redemptions by United States corporations), including those relating to income tax nexus, jurisdictional mix of profits at varying statutory tax rates, by changes in foreign currency exchange rates, or by changes in the valuation of our deferred tax assets and liabilities. Although we believe our tax estimates are reasonable, the final determination of any tax audits or litigation could be materially different from our historical tax provisions and accruals, which could have a material adverse effect on our operating results or cash flows in the period or periods for which a determination is made. For example, in 2021 we established a new wholly owned subsidiary of Evolv Technologies Holdings, Inc., Give Evolv LLC, a Delaware limited liability company, to (1) promote our core mission in locations that might not otherwise be able to afford our weapons detection security screening systems and related products and services,
37

(2) make public venues and institutions safer for all patrons, students, visitors, and other attendees, and (3) carry out charitable efforts consistent with the foregoing mission, for which historical tax data does not exist.
Our ability to utilize net operating loss carryforwards as well as research and development tax credit carryforwards to offset future taxable income may be subject to certain limitations and we could be subject to tax audits or examinations that could result in a loss of our net operating loss carryforwards as well as research and development credits and/or cash tax exposures.
As of December 31, 2023 and 2022, we had gross federal net operating losses of $20.1 million and $20.1 million that are subject to expire at various dates beginning in 2033, and federal net operating losses of $142.4 million and $124.3 million, which have no expiration date and can be used to offset up to 80% of future taxable income in any one tax period, respectively. We also had gross state net operating loss carryforwards of $142.4 million and $103.8 million for the years ended December 31, 2023 and 2022, respectively, which may be available to offset future state taxable income and which begin to expire in 2033. Additionally, we had no gross UK net operating loss carryforwards as of December 31, 2023 and gross UK net operating loss carryforwards of approximately $2.3 million that will not expire as of December 31, 2022. As of December 31, 2023, we had gross U.S. federal and state research and development and other tax credit carryforwards of $2.5 million and $1.6 million, respectively, which may be available to offset future tax liabilities and the majority of which begin to expire in 2033 and 2030, respectively. As of December 31, 2022, we had gross U.S. federal and state research and development and other tax credit carryforwards of $2.5 million and $1.6 million, respectively, which may be available to offset future tax liabilities and the majority of which begin to expire in 2033 and 2029, respectively.
These net operating loss and tax credit carryforwards could expire unused and be unavailable to offset our future income tax liabilities. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended, or the Code, and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50% change, by value, in our equity ownership over a three-year period, the corporation’s ability to use our pre-change net operating loss carryforwards and other pre-change tax attributes to offset our post-change income may be limited. We have not determined if we have experienced Section 382 ownership changes as of December 31, 2023 and if a portion of our net operating loss and tax credit carryforwards is subject to an annual limitation under Section 382. In addition, we may experience ownership changes in the future as a result of subsequent shifts in our stock ownership, some of which may be outside of our control, but that would not be material to the consolidated financial statements for the year ended December 31, 2023. If we determine that an ownership change has occurred and our ability to use our historical net operating loss and tax credit carryforwards is materially limited, it would harm our future operating results by effectively increasing our future tax obligations.
Our cash and cash equivalents could be adversely affected if the financial institutions at which we hold our cash and cash equivalents fail.
We maintain the majority of our cash and cash equivalents in accounts with major U.S. and multi-national financial institutions, and our deposits at certain of these institutions exceed insured limits. Market conditions can impact the viability of these institutions. In the event of a future failure or closure of any of the financial institutions where we maintain our cash and cash equivalents, there can be no assurance that we would be able to access uninsured funds in a timely manner or at all, and there is no guarantee that the Federal Reserve Board, the U.S. Treasury Department and the Federal Deposit Insurance Corporation will provide access to uninsured funds in a timely fashion or at all. Any inability to access or delay in accessing these funds could adversely affect our ability to finance our operations, which, in turn, could adversely affect our business, results of operations, financial position, and liquidity.
We may require additional capital to support business growth, and this capital might not be available on acceptable terms, if at all.
We intend to continue to make investments to support our business growth and may require additional funds to respond to business challenges, including the need to develop new features or enhance our products, improve our operating infrastructure, or acquire complementary businesses and technologies. Accordingly, we may need to engage in equity or debt financings to secure additional funds. If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences, and privileges superior to those of holders of our common stock. Any debt financing that we may secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain additional financing on terms favorable to it,
38

if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to it when we require it, our ability to continue to support our business growth and to respond to business challenges could be significantly impaired, and our business may be adversely affected.
We have identified material weaknesses in our internal control over financial reporting and our internal control over financial reporting was not effective as of December 31, 2023. We may identify additional material weaknesses in the future or otherwise fail to maintain effective internal control over financial reporting, which may result in a material misstatement of our consolidated financial statements or cause us to fail to meet our periodic reporting obligations.
As described in Part II, Item 9A – Controls and Procedures, of this Annual Report on Form 10-K, we have identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.
We did not design and maintain an effective control environment commensurate with our financial reporting requirements. Specifically, we lacked a sufficient complement of personnel with an appropriate level of internal controls and accounting knowledge, training and experience commensurate with our financial reporting requirements. Additionally, the limited personnel resulted in our inability to consistently establish appropriate authorities and responsibilities in pursuit of our financial reporting objectives, as demonstrated by, among other things, insufficient segregation of duties in our finance and accounting functions. In addition, we did not design and maintain effective controls in response to the risks of material misstatement, as changes to existing controls or the implementation of new controls were not sufficient to respond to changes to the risks of material misstatement to financial reporting. These material weaknesses contributed to the following additional material weaknesses:
We did not design and maintain effective controls over the period-end financial reporting process to achieve complete, accurate, and timely financial accounting, reporting and disclosures, including the classification of various accounts in the financial statements and the presentation and disclosure of items in the consolidated statements of cash flows.
We did not design and maintain processes and controls to analyze, account for and disclose non-routine, unusual or complex transactions. Specifically, we did not design and maintain controls to timely analyze and account for debt modifications and extinguishments, convertible notes, warrant instruments, non-routine complex revenue transactions including the leasing of products and transfer of inventory for leased assets into property plant and equipment, merger transactions, and the accounting and valuation of earn out liabilities.
We did not design and maintain formal accounting policies, procedures, and controls to achieve complete, accurate, and timely financial accounting, reporting and disclosures, including segregation of duties, controls to validate reliability of system-generated information used in the controls, controls over the preparation and review of account reconciliations and journal entries, and controls over recording of revenue, receivables, and deferred revenue transactions, completeness and accuracy of accounts payable and accrued liabilities, commissions, equity and share-based compensation, fixed assets, inventory, payroll, income taxes, and cash and investments.
These material weaknesses resulted in audit adjustments and certain immaterial misstatements in the Evolv financial statements to prepaid and other current assets, accounts payable and accrued liabilities, long-term and short-term debt, convertible notes, contingent earn-out liabilities, change in fair value of contingent earn-out liability, equity, commission assets, contract assets, revenue, deferred revenue, accounts receivable, inventory, property plant and equipment, cost of sales and various expense line items and related financial statement disclosures as of and for the years ended December 31, 2019, 2020 and 2021. The material weaknesses related to accounting for warrant instruments, the classification of various accounts in the consolidated financial statements and the presentation and disclosure of items in the consolidated statements of cash flows also resulted in the revision of the Company's previously issued 2020 annual financial statements, 2021 quarterly and annual financial statements, and quarterly financial statements for the three months ended March 31, 2022, as well as the restatement of the Company’s financial statements as of and for the three and six months ended June 30, 2023. Additionally, these material weaknesses could result in a misstatement of substantially all of
39

our accounts or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.
In addition to the foregoing, we did not design and maintain effective controls over information technology (“IT”) general controls for information systems that are relevant to the preparation of our consolidated financial statements, specifically, with respect to: (i) program change management controls for financial systems to ensure that IT program and data changes affecting financial IT applications and underlying accounting records are identified, tested, authorized, and implemented appropriately; (ii) user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs, and data to appropriate company personnel; (iii) computer operations controls to ensure that critical batch jobs are monitored and data backups are authorized and monitored, and (iv) testing and approval controls for program development to ensure that new software development is aligned with business and IT requirements. These IT deficiencies did not result in a misstatement to the consolidated financial statements, however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would not be prevented or detected. Accordingly, management has determined these deficiencies in the aggregate constitute a material weakness.
We have continued implementation of a plan to remediate these material weaknesses. These remediation measures are ongoing and include hiring additional accounting, internal audit, and IT personnel to bolster our reporting, technical accounting, and IT capabilities. We are in the process of designing and implementing controls to formalize roles and review responsibilities to align with our team’s skills and experience and designing and implementing controls over segregation of duties. We added, and continue to add, finance personnel, including a Chief Financial Officer and a Chief Accounting Officer, to strengthen our internal accounting team, to provide oversight, structure and reporting lines, and to provide additional review over our disclosures. We have performed a financial statement risk assessment in order to identify material financial statement line items for which key controls are needed in order to ensure complete and accurate financial reporting, and have engaged outside consultants to assist with the design and implementation of control activities resulting from the risk assessment. We have designed and implemented additional review and training procedures within our accounting and finance functions to enhance knowledge and understanding of internal control over financial reporting. During each of the three months ended June 30, September 30, and December 31, 2023, we implemented controls related to, among other items, (i) the period-end financial reporting process and the classification of various accounts in our consolidated financial statements, including the presentation and disclosure of items in the consolidated statements of cash flows, (ii) timely identification and accounting for non-routine, unusual, or complex transactions, including controls over the preparation and review of accounting memoranda addressing these matters, (iii) revenue recognition, including non-routine complex revenue transactions that may also include the leasing of products, the recording of revenue transactions in the appropriate period, (iv) the completeness and accuracy of accounts payable and accrued liabilities, and (v) completeness, accuracy, valuation, and classification of each equivalent and marketable securities. Additionally, we are in the process of designing and implementing controls related to the preparation and review of journal entries and account reconciliations to ensure proper segregation of duties. We are in the process of designing and maintaining formal accounting policies, procedures, and controls to achieve complete, accurate, and timely financial accounting, reporting, and disclosures. We are in the process of designing and implementing information technology general controls, including controls over program change management, the review and update of user access rights and privileges, controls over batch jobs and data backups, and program development approvals and testing. In April 2022, we went live on a new Enterprise Resource Planning ("ERP") system and have implemented, and continue to implement, IT general controls related to the new system.
While we are undertaking efforts to remediate these material weaknesses, the material weaknesses will not be considered remediated until our remediation plan has been fully implemented, the applicable controls operate for a sufficient period of time, and we have concluded, through testing, that the newly implemented and enhanced controls are operating effectively. As disclosed in Part II, Item 9A – Controls and Procedures, of this Annual Report on Form 10-K, our management has concluded that our internal control over financial reporting was not effective as of December 31, 2023, and our independent registered public accounting firm rendered an adverse opinion on our internal control over financial reporting, as a result of the material weaknesses described above. At this time, we cannot predict the success of our remediation efforts or the outcome of our assessment of such efforts. We can give no assurance that our efforts will remediate these material weaknesses in our internal control over financial reporting, or that additional material weaknesses will not be identified in the future. The effectiveness of our internal control over financial reporting is subject to various
40

inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events, the possibility of human error and the risk of fraud. If we are unable to remediate the material weaknesses, our ability to record, process, and report financial information accurately, and to prepare the consolidated financial statements within the time periods specified by the rules and regulations of the SEC, could continue to be adversely affected which, in turn, may adversely affect our reputation and business and the trading price of our common stock. In addition, any such failures could result in litigation or regulatory actions by the SEC or other regulatory authorities, which could further result in loss of investor confidence, a decline in the price of our common stock, delisting of our securities, harm to our reputation and financial condition and/or diversion of financial and management resources from the operation of our business.
Failure to comply with applicable anti-corruption legislation, export controls, economic sanctions and other governmental laws and regulations could result in fines and criminal penalties and materially adversely affect our business, financial condition, and results of operations.
We are required to comply with anti-corruption and anti-bribery laws in the jurisdictions in which we operate, including the FCPA in the United States, the Bribery Act, and other similar laws in other countries in which we do business. The FCPA prohibits us or any third party acting on our behalf from corruptly promising, authorizing, making, offering, or providing anything of value to foreign officials for the purposes of obtaining or retaining business or securing any improper business advantage. The FCPA further requires us to keep and maintain books and records that accurately reflect transactions and dispositions of assets and to maintain a system of internal accounting controls. The Bribery Act also prohibits “commercial” bribery not involving foreign officials, facilitation payments, and the receipt of bribes, while providing a defense to a charge of failure to prevent bribery to companies that demonstrate they had in place adequate procedures to prevent bribery. We may deal with both governments and state-owned business enterprises, the employees of which are considered foreign officials for purposes of the FCPA. Some of the international locations in which we will operate have developing legal systems and may have higher levels of corruption than more developed nations. As a result of doing business in foreign countries, including through reseller partners and agents, we will be exposed to a risk of violating anti-corruption laws.
We are also required to comply with applicable export controls and economic and trade sanctions laws and regulations, such as those administered and enforced by OFAC, the U.S. Department of State, and the U.S. Department of Commerce. Our global operations expose us to the risk of violating or being accused of violating these laws.
Although we have adopted policies and procedures reasonably designed to promote compliance with such laws, there can be no assurance that such policies or procedures will work effectively at all times or protect us against liability under these or other laws for actions taken by our employees, reseller partners, and other third parties who are acting on our behalf with respect to our business. If we are not in compliance with anti-corruption laws and other laws governing the conduct of business with government entities and/or officials (including local laws) or export controls and economic and trade sanction laws and regulations, we may be subject to criminal and civil penalties and other remedial measures, which could harm our business, financial condition, results of operations, cash flows, and prospects. In addition, investigations of any actual or alleged violations of such laws or policies related to us could harm our business, financial condition, results of operations, cash flows, and prospects.
41

Risks Related to Our Common Stock and Warrants
The market price of our common stock and warrants has been highly and may continue to be highly volatile, and you may lose some or all of your investment.
The trading price of our common stock as well as warrants has been highly volatile since their initial listing on the NASDAQ and may continue to fluctuate widely in response to a variety of factors, including the following:
actual or anticipated fluctuations in our financial condition and results of operations;
the financial projections we may provide to the public, any changes in these projections or our failure to meet these projections;
failure of securities analysts to initiate or maintain coverage of our company, changes in financial estimates or ratings by any securities analysts who follow our company, or our failure to meet these estimates or the expectations of investors;
changes in financial markets or macroeconomic conditions, including, for example, due to the effects of recession or slow economic growth in the United States and abroad, high inflation and interest rates, bank failures, fuel prices, international currency fluctuations, corruption, political instability, acts of war, including the conflicts in Europe and the Middle East, and acts of terrorism;
changes in market valuations of similar companies;
the impact of a pandemic (such as COVID-19 or variants thereof), epidemic or a similar future outbreak of disease or public health concern on our business;
competition in our industry, our ability to grow and manage growth profitability, and retain our key employees;
lawsuits threatened or filed against us;
anticipated or actual changes in laws, or regulations or government policies applicable to our business;
increases in compliance or enforcement inquiries and government inquiries or investigations (such as the ongoing SEC and FTC matters);
risks related to the organic and inorganic growth of our business and the timing of expected business milestones;
short sales, hedging, and other derivative transactions involving our common stock; and
the other factors described in this "Risk Factors" section of this Annual Report on Form 10-K.
Furthermore, short sellers or those that directly or indirectly assist short sellers may attempt to engage in manipulative activity intended to drive down the market price of a target company's stock. We believe we have in the past been the subject of negative public attacks by certain non-governmental entities purporting to be objective media outlets, and while we reviewed the allegations published in their associated reports and believe them to be unsubstantiated and false, we may in the future become subject to similar attacks, which may lead to increased volatility in the price of our common stock.
In addition, the stock market has experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. These fluctuations have often been unrelated or disproportionate to the operating performance of those companies.
42

Volatility in our share price could subject us to securities class action litigation.
In the past, securities class action litigation has often been brought against a company following a decline in the market price of its securities or the completion of a merger. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and a diversion of management’s attention and resources, which could harm our business, financial condition, and results of operations.
Certain of our warrants are accounted for as liabilities and the changes in value of such warrants could have a material effect on our financial results.
On April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the SEC together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Statement”). Specifically, the SEC Statement focused on certain settlement terms and provisions related to certain tender offers following a business combination, which terms are similar to those contained in the warrant agreement governing our public warrants.
We evaluated the accounting treatment of our public warrants and determined to classify such warrants as derivative liabilities measured at fair value, with changes in fair value each period reported in earnings. Due to the recurring fair value measurement, we recognize non-cash gains or losses on our public warrants each reporting period. The amount of such gains or losses could be material.
Our accounting treatment of the public warrants is based on our current interpretation of the SEC Statement and other related guidance and may change in light of any further interpretive guidance or new guidance, as may be applicable.
Certain of our earn-out shares and founder shares are accounted for as liabilities and the changes in value of such shares could have a material effect on our financial results.
We evaluated the accounting treatment of (i) our earn-out shares and (ii) 4,312,500 shares of NHIC Class B common stock owned by certain NHIC shareholders which were converted into shares of the Company's stock in connection with the Merger, (the "Founder Shares") and determined to classify such shares as liabilities measured at fair value, with changes in fair value each period reported in earnings. Due to the recurring fair value measurement, we recognize non-cash gains or losses on our earn-out and founder shares each reporting period. The amount of such gains or losses could be material.
Because we do not intend to pay any cash dividends for the foreseeable future, capital appreciation, if any, would be your sole source of gain.
We currently intend to retain any future earnings for the development, operation and expansion of our business and do not intend to declare or pay any cash dividends for the foreseeable future. As a result, capital appreciation, if any, of our common stock would be your sole source of gain on an investment in such shares for the foreseeable future.
Future sales, or the perception of future sales, of common stock by our existing security holders in the public market may cause the market price of our securities to decline.
Future sales of a substantial number of our common stock into the public market, particularly sales by our directors and executive officers or by holders of Founder Shares, or the perception that these sales might occur, could cause the market price of our common stock to decline. The shares held by our directors and executive officers, as well as the Founder Shares that vested at the closing of the Merger may be freely resold in the public market, except that any shares held by our affiliates, as defined in Rule 144 under the Securities Act would only be able to be sold in compliance with Rule 144. Certain of the Founder Shares are also subject to certain performance-based vesting provisions where 25% of the Founder Shares will vest on or before July 16, 2026 if the closing share price of the common stock equals or exceeds $12.50 over any 20 trading days within a 30-day trading period and the remaining 25% will vest on or before July 16, 2026 if the closing share price of the common stock equals or exceeds $15.00 over any 20 trading days within any 30-day trading period. In addition, as of December 31, 2023, we had stock options, restricted stock units (“RSUs”), and performance stock units ("PSUs") outstanding that, if fully exercised or vested, would result in the issuance of 33,751,207 shares of our common stock. All of the shares of our common stock issuable upon the exercise of stock options, and the shares reserved for future issuance under our plans, are registered for public resale under the Securities Act. Accordingly,
43

these shares can be freely sold in the public market upon issuance subject to applicable vesting requirements, compliance by affiliates with Rule 144, and other restrictions provided under the terms of the applicable plan and/or the award agreements entered into with participants and any such sales could adversely affect the market price of our common stock. We are unable to predict the timing or effect of such sales on the market price of our common stock.
We are no longer an "emerging growth company" or a "smaller reporting company" and the reduced reporting requirements applicable to emerging growth companies and smaller reporting companies will no longer apply to us.
As of December 31, 2023, we lost our status as an "emerging growth company" as defined in the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act") and a “smaller reporting company” as defined under the Exchange Act. As a result, we are no longer entitled to rely on exemptions from certain disclosure and compliance requirements that are applicable to emerging growth companies, including, but not limited to:
the requirement to have our independent registered public accounting firm audit our internal controls over financial reporting under Section 404(b) of the Sarbanes-Oxley Act;
the requirement that we adopt new or revised accounting standards when they are applicable to public companies, instead of delaying their adoption until they are applicable to private companies; and
the requirement that we hold a non-binding advisory vote on executive compensation and obtain stockholder approval of any golden parachute payments not previously approved.
Additionally, although we are permitted to continue to provide scaled disclosures permitted for a smaller reporting company through our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, beginning with our first quarterly report on Form 10-Q for the quarter ending March 31, 2024, we will no longer be permitted to rely on exemptions from those requirements that are applicable to smaller reporting companies, including, but not limited to, the requirement that we provide full and more detailed disclosures regarding executive compensation. We expect that the loss of emerging growth company status and smaller reporting company status and compliance with these additional requirements may place a burden on our financial and management resources and increase our accounting, legal, and financial compliance costs associated with corporate governance requirements applicable to us as a public company, including under the rules and regulations of the SEC, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Customer Protection Act of 2010, the Securities Act, and the Exchange Act, as well as the Nasdaq rules, and make some activities more time consuming. We also expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to incur substantial costs to maintain the same or similar coverage. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified individuals to serve on our board of directors, our board committees or as executive officers. Furthermore, if our additional disclosures in future SEC filings are perceived as insufficient or inadequate by investors or regulatory authorities, the market price of our stock could decline and we could be subject to actions by stockholders or regulatory authorities.
44

General Risk Factors
Increasing attention to, and evolving expectations for, environmental, social, and governance (“ESG”) initiatives could increase our costs, harm our reputation, or otherwise adversely impact our business.
Companies across industries are facing increasing scrutiny from a variety of stakeholders related to their ESG practices. Expectations regarding voluntary ESG initiatives and disclosures may result in increased costs (including but not limited to increased costs related to compliance, stakeholder engagement, contracting, and insurance), changes in demand for certain offerings, enhanced compliance or disclosure obligations, or other adverse impacts to our business, financial condition, or results of operations. While we may at times engage in voluntary initiatives (such as voluntary disclosures, certifications, or goals, among others) to improve the ESG profile of our company and/or offerings or to respond to stakeholder demands, such initiatives may be costly and may not have the desired effect. Expectations around companies’ management of ESG matters continue to evolve rapidly, in many instances due to factors that are out of our control. We may experience pressure to make commitments relating to ESG matters that affect us; however, we may not agree that particular initiatives will be appropriate for our business, and we may not be able to implement such initiatives because of potential costs or technical or operational obstacles, which may adversely impact our reputation or stakeholder relations. If we do not, or are perceived by stakeholders to not, take sufficient action to respond to ESG matters, we may be subject to investor or regulator engagement on our ESG initiatives and disclosures, even if such initiatives are currently voluntary.
Certain market participants, including major institutional investors and capital providers, use third-party benchmarks and scores to assess companies’ ESG profiles in making investment or voting decisions. Unfavorable ESG ratings could lead to increased negative investor sentiment towards us, which could negatively impact our share price as well as our access to and cost of capital. To the extent ESG matters negatively impact our reputation, it may also impede our ability to compete as effectively to attract and retain employees or customers, which may adversely impact our operations. In addition, we expect there will likely be increasing levels of regulation, disclosure-related and otherwise, with respect to ESG matters. For example, the SEC has proposed requirements to disclose a variety of climate-related information, in addition to other rules, which could require us to incur significant costs for monitoring and compliance. This and other regulations will likely lead to increased costs as well as scrutiny that could heighten all of the risks identified in this risk factor. Additionally, many of our customers and suppliers may be subject to similar expectations, which may augment or create additional risks, including risks that may not be known to us.
If we cannot maintain our company culture as we grow, we could lose the innovation, teamwork, passion, and focus on execution that we believe contributes to our success and our business may be harmed.
We believe that a critical component to our success has been our mission-driven company culture based on our shared commitment to make the world a safer place to live, work, learn, and play, which we believe fosters innovation, teamwork, passion for customers and focus on execution, and facilitates critical knowledge transfer, knowledge sharing, and professional growth. We have invested substantial time and resources in building our team within this company culture. Any failure to preserve our culture could negatively affect our ability to retain and recruit personnel and to effectively focus on and pursue our corporate objectives. As we grow and develop our public company infrastructure and processes, we may find it difficult to maintain these important aspects of our company culture. If we fail to maintain our company culture, our business may be adversely impacted.
Our reported financial results may be adversely affected by changes in accounting principles generally accepted in the United States.
U.S. Generally Accepted Accounting Principles ("GAAP") are subject to interpretation by the Financial Accounting Standards Board (FASB), the SEC, and various bodies formed to promulgate and interpret appropriate accounting principles. A change in these principles or interpretations could have a significant effect on our reported results of operations and could affect the reporting of transactions already completed before the announcement of such change.
If securities or industry analysts do not publish research or reports about us, or publish negative reports, our stock price and trading volume could decline.
The trading market for our common stock will depend, in part, on the research and reports that securities or industry analysts publish about us. We do not have any control over these analysts reports. If our financial performance fails to meet analyst estimates or one or more of the analysts who cover us downgrade our common stock, change their opinion, or reduce their target stock price on us, our stock price would likely decline. If one or more of these analysts cease
45

coverage of our company or fail to regularly publish reports about us, we could lose visibility in the financial markets, which could cause our stock price or trading volume to decline.
ITEM 1B. UNRESOLVED STAFF COMMENTS
None.
ITEM 1C. CYBERSECURITY
Cybersecurity Risk Management and Strategy
We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems and information.
We design and assess our program based on the National Institute of Standards and Technology Cybersecurity Framework ("NIST CSF") and SOC 2 trust principles on security. This does not imply that we meet any particular technical standards, specifications, or requirements, only that we use these frameworks as a guide to help us identify, assess, and manage cybersecurity risks relevant to our business.
Our cybersecurity risk management program is integrated into our overall enterprise risk management program, and shares common methodologies, reporting channels and governance processes that apply across the enterprise risk management program to other legal, compliance, strategic, operational, and financial risk areas.
Key elements of our cybersecurity risk management program include:
risk assessments designed to help identify material cybersecurity risks to our critical systems, information, products, services, and our broader enterprise IT environment;
a security team principally responsible for managing (1) our cybersecurity risk assessment processes, (2) our security controls, and (3) our response to cybersecurity incidents;
the use of external service providers, where appropriate, to assess, test or otherwise assist with aspects of our security controls;
cybersecurity awareness training of our employees, incident response personnel, and senior management;
a cybersecurity incident response plan that includes procedures for responding to cybersecurity incidents; and
a third-party risk management process for service providers that includes a diligence and contracting process depending on our assessment of each provider's respective criticality and risk profile.
We have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents, that have materially affected us, including our operations, business strategy, results of operations, or financial condition. We face certain ongoing risks from cybersecurity threats that, if realized, are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or financial condition. See “Risk Factors – Because our products collect and store visitor and related information and images, domestic and international privacy and cybersecurity concerns, and other laws and regulations, could result in additional costs and liabilities to us or inhibit sales of our products.”
Cybersecurity Governance
Our Board considers cybersecurity risk as part of its risk oversight function and has delegated to the Audit Committee ("Committee") oversight of cybersecurity and other information technology risks. The Committee oversees management’s implementation of our cybersecurity risk management program.
The Committee receives periodic reports from management on our cybersecurity risks. In addition, management updates the Committee, as necessary, regarding any material cybersecurity incidents, as well as any incidents with lesser impact potential.
46

The Committee reports to the full Board regarding its activities, including those related to cybersecurity.
Our management team, including our Vice President of Cybersecurity and Information Technology, is responsible for assessing and managing our material risks from cybersecurity threats. The management team has primary responsibility for our overall cybersecurity risk management program and supervises both our internal cybersecurity personnel and our retained external cybersecurity consultants. Our Vice President of Cybersecurity and IT has served in that position since 2022, and has extensive experience assessing and managing cybersecurity programs and technology risk. Prior to joining Evolv, our Vice President of Cybersecurity and IT was the Leader of Global Information Security for New Balance.
Our management team supervises efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources, including external consultants engaged by us; and alerts and reports produced by security tools deployed in the IT environment.
ITEM 2. PROPERTIES
Our corporate headquarters is located in an approximately 49,100 square foot facility that we sublease in Waltham, Massachusetts. Our sublease of this facility expires on October 31, 2024, subject to an option to extend through October 31, 2027 with written notice. Our executive offices are located at 500 Totten Pond Road, 4th Floor, Waltham, MA 02451 under the foregoing sublease. We believe that our office space is adequate for our current needs and, should we need additional space, we believe we will be able to obtain additional space on commercially reasonable terms.
ITEM 3. LEGAL PROCEEDINGS
We are from time to time subject to various claims, lawsuits, and other legal and administrative proceedings arising in the ordinary course of business. We are not currently engaged in any litigation of a material nature or criminal proceedings.
From time to time, we receive government regulatory inquiries and requests for information relating to our marketing practices and our approach is to be cooperative and educate them about our company and products. For example, the FTC has requested information about certain aspects of our marketing practices. We are complying with the FTC's requests and have been cooperating with them to answer their questions and educate them about our mission. Furthermore, in February 2024, we received a subpoena from the SEC, Division of Enforcement, requesting that we produce certain documents and information, much of which is similar to the documents and information previously requested by the FTC. We are cooperating with the FTC and SEC with respect to the investigations, and there can be no assurance whether there will be further information requests or potential enforcement or litigation, which is necessarily uncertain as of the filing of this Form 10-K. See Part I, Item IA, "Risk Factors - We are subject to governmental regulation and other legal obligations, particularly related to privacy, data protection, information security, and product marketing and our actual or perceived failure to comply with such obligations could harm our business" for additional information.
See also Note 19 (Commitments and Contingencies) to our consolidated financial statements for the year ended December 31, 2023 for additional information.
ITEM 4. MINE SAFETY DISCLOSURES
None.
INFORMATION ABOUT OUR DIRECTORS & EXECUTIVE OFFICERS
For information regarding our directors and executive officers, see Part III, Item 10, “Directors, Executive Officer and Corporate Governance.”
47

PART II
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
Shares of our Common Stock and warrants began trading on Nasdaq under the symbol “EVLV” and “EVLVW,” respectively, on July 16, 2021. Prior to that time, there was no established public trading market for our common stock or warrants.
Holders of Records
As of February 28, 2024, there were 152,182,633 issued and outstanding shares of our common stock by approximately 60 stockholders of record. The number of record holders was determined from the records of our transfer agent and does not include beneficial owners of shares of common stock whose shares are held in the names of various security brokers, dealers, and registered clearing agencies.
Dividend Policy
We have never declared or paid any cash dividends on our capital stock. We currently intend to retain all available funds and future earnings, if any, for the operation and expansion of our business and do not anticipate declaring or paying any dividends in the foreseeable future. Any future determination related to our dividend policy will be made at the discretion of our board of directors after considering our financial condition, results of operations, capital requirements, business prospects and other factors the board of directors deems relevant, and subject to the restrictions contained in any financing instruments. The terms of our existing term loan agreement preclude us from paying cash dividends without consent. Our ability to declare dividends may also be limited by restrictive covenants pursuant to any other future debt financing agreements.
Recent Sales of Unregistered Equity Securities
None.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
None.
ITEM 6. [RESERVED]
48

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements based upon current plans, expectations and beliefs involving risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under “Risk Factors” and in other parts of this Annual Report on Form 10-K. Our results of operations for the year ended December 31, 2021, including a discussion of the year ended December 31, 2022 compared to the year ended December 31, 2021, has been reported previously in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 24, 2023, under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
As used in this Annual Report on Form 10-K, unless otherwise indicated or the context otherwise requires, references to “we,” “us,” “our,” the “Company” and “Evolv” refer to the consolidated operations of Evolv Technologies Holdings, Inc. and its subsidiaries. References to “NHIC” refer to the company prior to the consummation of the Merger and references to “Legacy Evolv” refer to Evolv Technologies, Inc. dba Evolv Technology, Inc. prior to the consummation of the Merger.
Business Overview
We are a leader in AI-based weapons detection for security screening. Unlike conventional walk-through metal detectors, our products use advanced sensors, artificial intelligence software, and cloud services to reliably detect guns, improvised explosives, and large knives while ignoring harmless items like phones and keys. This not only enhances security at venues and facilities but also improves the visitor experience by making screening up to ten times faster than alternatives at up to 70% lower total cost.
Our products have screened over one billion visitors worldwide since our inception. We believe that we have screened more people through advanced systems than any organization other than the TSA. Our customers include many iconic venues across a wide variety of industries including major sports stadiums and arenas, notable performing arts and entertainment venues, major tourist destinations and cultural attractions, hospitals, large industrial workplaces, schools, and prominent houses of worship. We offer our products for purchase and primarily under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities.
Since our inception, we have incurred significant operating losses. Our ability to generate revenue and achieve cost improvements sufficient to achieve profitability will depend on the successful further development and commercialization of our products. We generated revenue of $80.4 million and $55.2 million for the years ended December 31, 2023 and 2022, respectively. We generated a net loss of $106.3 million and $86.4 million for the years ended December 31, 2023 and 2022, respectively. We expect to continue to incur operating losses as we focus on growing and establishing recurring commercial sales of our products, including growing our sales and marketing teams, scaling our manufacturing operations, and continuing research and development efforts to develop new products and further enhance our existing products.
Because of the numerous risks and uncertainties associated with product development and commercialization, we are unable to accurately predict the timing or amount of increased expenses or when, or if, we will be able to achieve or maintain profitability. Until such time, if ever, as we can generate substantial revenue sufficient to achieve profitability, we expect to finance our operations through cash generated from operations, and if necessary, debt financings. However, we may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we are unable to raise capital or enter into such agreements as, and when, needed, we may have to significantly delay, scale back or discontinue the further development and commercialization efforts of one or more of our products, or may be forced to reduce or terminate our operations. See “Liquidity and Capital Resources.”
Key Factors Affecting Our Operating Results
We believe that our performance and future success depend on many factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and in the "Risk Factors" section of this Annual Report on Form 10-K.
49

General Economic and Market Conditions
We expect that our results of operations, including our revenue and cost of revenue, may fluctuate or continue to fluctuate based on, among other things, the impact of rising inflation and interest rates on business spending; supply chain issues and the impacts on our manufacturing capabilities; public health emergencies; geopolitical conflicts and war, including the conflicts in Europe and the Middle East; and recessionary trends. See the risk factor titled “Downturns in general economic and market conditions and reductions in spending may reduce demand for our products and services and may impact third parties on which we rely, which could harm our revenue, results of operations, and cash flows, and could make it difficult to predict revenue for a particular period” in Item 1A. Risk Factors of this Annual Report on Form 10-K. While these factors continue to evolve, we plan to remain flexible and optimize our business as appropriate and allocate resources, as necessary.
Adoption of our Security Screening Products
We believe the world will continue to focus on the safety and security of people in the places where they gather. Many of these locations, such as professional sports venues, educational institutions, and healthcare facilities, are moving toward a more frictionless security screening experience. We are well-positioned to take advantage of this opportunity due to our proprietary technologies and distribution capabilities. Our products are designed to empower venues and facilities to realize the full benefits of touchless security screening, including a rapid visitor throughput and minimal security staff to screened visitor physical contact. We expect that our results of operations, including revenue, will fluctuate for the foreseeable future as venues and facilities continue to shift away from conventional security screening processes towards touchless security screening or consider security screening processes for the first time. The degree to which potential and current customers recognize these benefits and invest in our products will affect our financial results.
Sales Mix, Pricing, Product Cost and Margins
Historically, we offered our products under either a "pure subscription" sales model, where the customer leases our hardware, or a purchase subscription model, where the customer purchases the hardware from us. In both models, we provide a multi-year security-as-a-service subscription. During 2023, we gradually transitioned away from the purchase subscription model. Accordingly, product revenue as a percentage of total revenue decreased sequentially in each quarter of 2023. Going forward, we only plan to offer the purchase subscription model under limited circumstances. We introduced a new sales model in March 2023, when we entered into the Distribution and License Agreement. Under this arrangement, we have granted a limited, non-exclusive license under our intellectual property rights to Columbia Tech, and Columbia Tech manufactures hardware systems and contracts directly with certain of our resellers to fulfill sales demand where the end-user customer requires the contract to be in form of a hardware purchase. Columbia Tech pays us a hardware license fee for each system manufactured and sold under this agreement. In these instances, we still contract directly with the reseller to provide a multi-year security-as-a-service subscription to the end-users. We expect substantially all of our sales in future periods to be made under either the pure subscription model or the distributor licensing model, which would result in an increase in the percentage of revenue recognized over time and a decrease in the percentage of revenue recognized at a point in time.
Going forward, we expect our products to be adopted in a variety of vertical industry markets and geographic regions, primarily within the United States. Pricing may vary by region or vertical market due to market-specific dynamics. As a result, our financial performance depends, in part, on the mix of sales, bookings, and business in different markets during a given period. In addition, we are subject to price competition, and our ability to compete in key markets will depend on the success of our investments in new technologies and cost improvements as well as our ability to efficiently and reliably introduce cost-effective touchless security screening products to our customers.
Continued Investment and Innovation
We are a leader in AI-based weapons detection for security screening, offering transformative technologies that enable higher throughput, a more frictionless visitor experience, and substantial cost savings through our product innovations. Our performance is significantly dependent on the investment we make in our research and development efforts and on our ability to be at the forefront of the security screening industry. It is essential that we continually identify and respond to rapidly evolving customer requirements, develop, and introduce innovative new products, enhance existing products and generate customer demand for our products. We believe that investment in our security screening products will contribute to long-term revenue growth, but it may adversely affect our near-term profitability.
50

Components of Results of Operations
Revenue
We derive revenue from (1) subscription arrangements generally accounted for as operating leases, including SaaS and maintenance, (2) the sale of products, (3) SaaS and maintenance related to products sold to customers either by Evolv or by Columbia Tech pursuant to the Distribution and License Agreement, (4) license fees related to the Distribution and License Agreement, and (5) professional services, including installation, training, and event support. Maintenance consists of preventative maintenance, technical support, bug fixes, and when-and-if available threat updates. Our arrangements are generally noncancelable and nonrefundable after shipment to the customer. Revenue is recognized net of sales tax.
Product Revenue
We derive a portion of our revenue from the sale of our Evolv Express equipment and related add-on accessories to customers. Revenue is recognized when control of the product has transferred to the customer, which follows the terms of each contract. We expect product revenue to continue declining as a percentage of our overall revenue as we continue focusing our go-to-market strategy on pure subscription contracts and contracts under our distributor licensing model.
Subscription Revenue
Subscription revenue consists of revenue derived from leasing Evolv Express and Evolv Edge units to our customers. Lease terms are typically four years and customers generally pay either a quarterly or annual fixed payment for the lease, SaaS, and maintenance elements over the contractual lease term. Equipment leases are generally classified as operating leases and recognized ratably over the duration of the lease. There are no contingent lease payments as a part of these arrangements.
Lease arrangements generally include both lease and non-lease components. The non-lease components relate to (1) distinct services, including professional services, SaaS, and maintenance, and (2) any add-on accessories. Professional services are included in license fees and other revenue as described below, and add-on accessories are included in product revenue as described above. Because the equipment lease, SaaS, and maintenance components of a subscription arrangement are recognized as revenue over the same time period and in the same pattern, the equipment lease and SaaS/maintenance performance obligations are classified as a single category of subscription revenue in our consolidated statements of operations and comprehensive loss.
Service Revenue
Service revenue consists of subscription-based SaaS and maintenance revenue related to products sold to customers. Customers generally pay either a quarterly or annual fixed payment for SaaS and maintenance. SaaS and maintenance revenue is recognized ratably over the period of the arrangement, which is typically four years.
License Fee and Other Revenue
License fee and other revenue includes license fee revenue from the Distribution and License Agreement, revenue from professional services, and other one-time revenue. License fee revenue is recognized upon the shipment of product from our primary third-party manufacturer to the reseller. Revenue for professional services is recognized upon transfer of control of these services, which are normally rendered over a short duration. Revenue for professional services and other one-time revenue, which had previously been included in service revenue, has been reclassified for prior periods to License fee and other revenue on the consolidated statements of operations and comprehensive loss.
Cost of Revenue
We recognize cost of revenue in the same manner that the related revenue is recognized.
Cost of Product Revenue
Cost of product revenue consists primarily of costs paid to our third-party manufacturer and other suppliers, labor costs (including stock-based compensation), and shipping costs.
51

Cost of Subscription Revenue
Cost of subscription revenue consists primarily of depreciation expense related to leased units, an allocated portion of internal-use software amortization expense, shipping costs, and maintenance costs related to leased units. Maintenance costs consist primarily of labor (including stock-based compensation), spare parts, shipping costs, field service repair costs, equipment, and supplies.
Cost of Service Revenue
Cost of services revenue consists of maintenance costs related to units purchased by customers and an allocated portion of internal-use software amortization expense. Maintenance costs consist primarily of labor (including stock-based compensation), spare parts, shipping costs, field service repair costs, equipment, and supplies.
Cost of License Fee and Other Revenue
Cost of license fees and other revenue consists primarily of internal and third-party costs related to professional services, such as installation, training, and event support.
Gross Profit and Gross Margin
Our gross profit is calculated based on the difference between our revenues and cost of revenues. Gross margin is the percentage obtained by dividing gross profit by our revenue. Our gross profit and gross margin are, or may be, influenced by a number of factors, including:
Market conditions that may impact our pricing;
Product mix changes between established products and new products;
Mix of sales between our pure subscription, purchase subscription, and distributor licensing sales models;
Our cost structure for manufacturing operations, including contract manufacturers, relative to volume, and our product support obligations;
Our ability to maintain our costs on the components that go into the manufacture of our products; and
Write-offs of inventory.
We expect our gross margins to fluctuate over time, depending on the factors described above.
Research and Development
Our research and development expenses represent costs incurred to support activities that advance the development of innovative security screening technologies, new product platforms, as well as activities that enhance the capabilities of our existing product platforms. Our research and development expenses consist primarily of salaries and bonuses, employee benefits, stock-based compensation, prototypes, design expenses, and consulting and contractor costs. We expect research and development costs will increase for the year ending December 31, 2024 compared to the year ended December 31, 2023 primarily due to incremental investments in headcount and programs we are making to support our new product development efforts.
Sales and Marketing
Sales and marketing expenses consist primarily of personnel-related expenses associated with our sales and marketing, customer success, business development, and strategy functions, as well as costs related to trade shows and events, and stock-based compensation. We expect our sales and marketing costs will increase for the year ending December 31, 2024 compared to the year ended December 31, 2023 primarily due to an expected increase in customer facing headcount to support higher sales volume.
52

General and Administrative
General and administrative expenses consist primarily of personnel-related expenses associated with our executive, finance, investor relations, legal, information technology, and human resources functions, as well as professional fees for legal, audit, accounting and other consulting services, stock-based compensation, and sales tax contingencies. We expect our general and administrative expenses will remain relatively consistent for the year ending December 31, 2024 compared to the year ended December 31, 2023 as we look to leverage previous investments made in people and processes.
Loss From Impairment of Property and Equipment
Loss from impairment of property and equipment relates to (i) leased Evolv Edge units and Evolv Express prototype units that are removed from service and retired as we transition our domestic customers to our most current Evolv Express units and (ii) damaged or destroyed leased units.
Interest Expense
Interest expense includes cash interest paid on long-term debt and amortization of deferred financing fees and costs.
Interest Income
Interest income relates to interest earned on money market funds and treasury bills, and interest earned on our lease receivables for our Evolv Express units recognized as sales-type leases.
Loss on Extinguishment of Debt
In December 2022, the Company entered into a loan and security agreement (the "2022 SVB Credit Agreement") with Silicon Valley Bank ("SVB") in order to finance purchases of hardware to be leased to customers. On March 10, 2023, SVB was closed by California state regulators and the FDIC was appointed as receiver. In light of the foregoing, the Company terminated the 2022 SVB Credit Agreement on March 31, 2023. As a result of the termination of the SVB Credit Agreement, the Company incurred a loss on extinguishment of debt.
Change in Fair Value of Contingent Earn-out Liability
In connection with the Merger and pursuant to the Merger Agreement, certain of Legacy Evolv’s initial shareholders are entitled to receive additional shares of our common stock upon us achieving certain milestones. The earn-out arrangement with the Legacy Evolv shareholders is accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as a component of other income (expense), net in the consolidated statements of operations and comprehensive loss.
Change in Fair Value of Contingently Issuable Common Stock Liability
Prior to the Merger, certain NHIC stockholders owned 4,312,500 shares of NHIC Class B common stock, referred to as Founder Shares. Upon the closing of the Merger, NHIC Class A and Class B common stock became the Company's common stock. 1,897,500 Founder Shares vested at the closing of the Merger, 1,897,500 Founder Shares are contingently issuable and shall vest upon the Company achieving certain milestones, and 517,500 Founder Shares were contributed to Give Evolv LLC. The 1,897,500 outstanding contingently issuable common shares are accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as a component of other income (expense), net in the consolidated statements of operations and comprehensive loss.
Change in Fair Value of Public Warrant Liability
In connection with the closing of the Merger, the Company assumed warrants to purchase 14,325,000 shares of common stock (the “Public Warrants”) at an exercise price of $11.50. The Public Warrants are currently exercisable and expire in July 2026. We assessed the features of these warrants and determined that they qualify for classification as a liability. Accordingly, we recorded the warrants at fair value upon the closing of the Merger as a component of other income (expense), net in the consolidated statements of operations and comprehensive loss with the offset to additional paid-in capital.
53

Income Taxes
Our income tax provision consists of an estimate for federal, state, and foreign income taxes based on enacted rates in the jurisdictions in which we operate, as adjusted for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities and changes in tax law. We have historically incurred net operating losses and maintain a full valuation allowance against our deferred tax assets.
Reclassification
During the year ended December 31, 2023, the Company began classifying revenue from professional services, which includes installation, training, and event support, as well as one-time revenue within license fee and other revenue on the consolidated statements of operations and comprehensive loss, whereas the revenue for these services has previously been included in service revenue. Correspondingly, the Company began classifying costs associated with professional services within cost of license fee and other revenue, whereas these costs were previously included in cost of service revenue. These reclassifications were made to align the presentation of professional services with the Company's internal reporting and analysis.

54

Results of Operations
Comparison of the Years Ended December 31, 2023 and 2022
The following table summarizes our results of operations for the years ended December 31, 2023 and 2022 (in thousands):
Year Ended December 31,
20232022$ Change% Change
Revenue:
Product revenue$21,977 $31,985 $(10,008)(31) %
Subscription revenue37,247 17,569 19,678 112 
Service revenue16,141 4,331 11,810 273 
License fee and other revenue5,053 1,310 3,743 286 
Total revenue80,418 55,195 25,223 46 
Cost of revenue:
Cost of product revenue26,667 41,575 (14,908)(36)
Cost of subscription revenue14,991 7,469 7,522 101 
Cost of service revenue3,982 2,200 1,782 81 
Cost of license fee and other revenue949 2,222 (1,273)(57)
Total cost of revenue46,589 53,466 (6,877)(13)
Gross profit33,829 1,729 32,100 1,857 
Operating expenses:
Research and development24,455 18,771 5,684 30 
Sales and marketing55,223 46,639 8,584 18 
General and administrative42,091 37,719 4,372 12 
Loss from impairment of property and equipment322 1,161 (839)(72)
Total operating expenses122,091 104,290 17,801 17 
Loss from operations(88,262)(102,561)14,299 14 
Other income (expense), net:
Interest expense(654)(712)58 
Interest income6,227 3,165 3,062 97 
Other expense, net(84)(64)(20)(31)
Loss on extinguishment of debt(626)— (626)*
Change in fair value of contingent earn-out liability(14,901)6,988 (21,889)(313)
Change in fair value of contingently issuable common stock liability(3,138)1,872 (5,010)(268)
Change in fair value of public warrant liability(4,765)4,906 (9,671)(197)
Total other income (expense), net(17,941)16,155 (34,096)(211)
Loss before income taxes(106,203)(86,406)(19,797)(23) %
Provision for income taxes(51)— (51)*
Net loss$(106,254)$(86,406)$(19,848)(23) %
*N/A – Not meaningful
55

Revenue, Cost of Revenue and Gross Profit
We believe there are several key trends that are continuing to drive increased adoption of our solutions and growth in our sales, including (i) escalating gun violence, which has created stronger demand for security screening solutions for customers and prospects in our key vertical markets, (ii) customer acquisition activities which led to the addition of 280 new customers during the year ended December 31, 2023 and 295 new customers during the year ended December 31, 2022, compared to 84 new customer during the year ended December 31, 2021, (iii) the expansion of our existing customers' initial Evolv Express deployments to other venues and locations, and (iv) growing momentum with our reseller partners which helps us extend our reach in certain geographies or vertical markets.
Product Revenue
Year Ended December 31,
20232022$ Change% Change
Product revenue$21,977$31,985$(10,008)(31) %
Cost of product revenue$26,667$41,575$(14,908)(36) %
Gross profit - Product revenue$(4,690)$(9,590)$4,90051 %
Gross profit margin - Product revenue(21) %(30) %N/A9 %
The decreases in product revenue and cost of product revenue and the increase in gross profit for the year ended December 31, 2023 compared to the year ended December 31, 2022 are primarily due to a gradual transition to pure subscription sales and sales under our distributor licensing model. Cost of product revenue for the year ended December 31, 2023 includes $1.9 million of costs, primarily cancellation fees associated with firm inventory purchase commitments, related to the planned transition of our manufacturing operations to the next generation of the Evolv Express system in 2024.
Subscription Revenue
Year Ended December 31,
20232022$ Change% Change
Subscription revenue$37,247$17,569$19,678112 %
Cost of subscription revenue$14,991$7,469$7,522101 %
Gross profit - Subscription revenue$22,256$10,100$12,156120 %
Gross profit margin - Subscription revenue60 %57 %N/A2 %
The increases in subscription revenue, cost of subscription revenue and subscription gross profit are primarily due to growth in our customer base for the year ended December 31, 2023, compared to the year ended December 31, 2022, which was due to a gradual transition to our pure subscription contract model and a higher number of active Evolv Express units deployed under our pure subscription model. Subscription gross profit margin increased slightly as the result of our ability to leverage our fixed costs over a higher revenue base.
Service Revenue
Year Ended December 31,
20232022$ Change% Change
Service revenue$16,141$4,331$11,810273 %
Cost of service revenue$3,982$2,200$1,78281 %
Gross profit - Service revenue$12,159$2,131$10,028471 %
Gross profit margin - Service revenue75 %49 %N/A26 %
The increase in service revenue and gross profit is primarily due to an increased number of active revenue-generating purchase subscription units, as well as active revenue-generating units purchased by customers directly from
56

Columbia Tech, for the year ended December 31, 2023 compared to the year ended December 31, 2022. Service gross profit margin increased primarily as the result of our ability to leverage our fixed costs over a higher revenue base.
License fee and other revenue
Year Ended December 31,
20232022$ Change% Change
License fee and other revenue$5,053$1,310$3,743286 %
Cost of license fee and other revenue$949$2,222$(1,273)(57) %
Gross profit - License fee and other revenue$4,104$(912)$5,016550 %
Gross profit margin - License fee and other revenue81 %(70) %N/A151 %
The increase in license fee and other revenue, gross profit, and gross profit margin was primarily driven by $3.0 million of license fees earned during the year ended December 31, 2023 under the Distribution and License Agreement which was executed in March 2023, compared to no license fees earned during the year ended December 31, 2022. Professional services, consisting primarily of installation, training, and event support, increased to $1.9 million for the year ended December 31, 2023 compared to $1.0 million for the year ended December 31, 2022, primarily as the result of a higher number of new Express systems deployed during the year ended December 31, 2023 compared to the prior year.
Research and Development Expenses


Year Ended December 31,
20232022$ Change% Change
Personnel related (including stock-based compensation)$16,692$14,568$2,12415  %
Materials and prototypes2,4326521,780 273 
Professional fees3,9962,8061,190 42 
Other1,335745590 79 
$24,455$18,771$5,684 30  %
The increase in personnel related expenses for the year ended December 31, 2023 compared to the year ended December 31, 2022 was due to higher payroll and stock-based compensation expense, which was primarily attributable to increased headcount in connection with new hires in our research and development function. Stock compensation expense was $4.3 million for the year ended December 31, 2023, compared to $4.0 million for the year ended December 31, 2022. Additionally, we experienced an increase in materials and prototype costs due to an increase in design and engineering costs in connection with the development of the next generation of our Evolv Express system. The year-over-year increase in professional fees was primarily due to consulting costs incurred for product development and engineering. The increase in other expense was primarily due to an increase in IT and software subscription costs.
57

Sales and Marketing Expenses
Year Ended December 31,
20232022$ Change% Change
Personnel related (including stock-based compensation)$40,592 $31,591 $9,001 28  %
Advertising and direct marketing3,575 5,457 -1,882(34)
Travel and entertainment5,015 3,327 1,68851 
Professional fees2,231 1,446 78554 
Other3,810 4,818 -1,008(21)
$55,223 $46,639 $8,584 18  %
The increase in personnel related expenses for the year ended December 31, 2023 compared to the year ended December 31, 2022 was due to an increase in payroll costs and commissions resulting primarily from new hires in our sales and marketing functions during the year ended December 31, 2023 to support increased sales volume. Stock compensation expense was $9.4 million for the year ended December 31, 2023, compared to $10.0 million for the year ended December 31, 2022. The decrease in advertising and direct marketing expense was primarily attributable to lower spending at trade shows. The increase in travel and entertainment expense was due to an increase in travel costs for in-person sales personnel meetings and events. Professional fees increased primarily due to an increase in marketing consulting costs. Other expense decreased primarily due to $1.0 million of certain-one-time expenses incurred during the year ended December 31, 2022, including a $0.4 million one-time payment to former employees.
General and Administrative Expenses
Year Ended December 31,
20232022$ Change% Change
Personnel related (including stock-based compensation)$23,145 $17,369 $5,776 33  %
Professional fees6,712 8,715 (2,003)(23)
Insurance costs3,424 4,514 (1,090)(24)
Other8,810 7,121 1,689 24 
$42,091 $37,719 $4,372 12  %
The increase in personnel related expenses was due to an increase in payroll costs and stock-based compensation as a result of expanding our administrative team during the year ended December 31, 2023. Stock compensation expense was $9.9 million for the year ended December 31, 2023, compared to $7.6 million for the year ended December 31, 2022. The decrease in professional fees was primarily related to a decrease in outsourced accounting consultancy and audit fees. The decrease in insurance costs was primarily related to a decrease in director and officer insurance premiums. The increase in other expenses was primarily attributable to a $1.0 million increase in IT and software subscription costs, a $0.4 million increase in property taxes, and a $0.3 million increase in the change in the allowance of expected credit losses.
Loss From Impairment of Property and Equipment
Loss from impairment of property and equipment was $0.3 million for the year ended December 31, 2023, compared to $1.2 million for the year ended December 31, 2022, primarily related to the removal of Evolv Edge units and Evolv Express prototypes from service, resulting in an impairment of the remaining economic value of such units.
Interest Expense and Loss on Extinguishment of Debt
Interest expense remained flat on a year-over-year basis at $0.7 million for the years ended December 31, 2023 and 2022. In March 2023, the Company fully repaid all borrowings and accrued interest under the 2022 SVB Credit Agreement and terminated the 2022 SVB Credit Agreement. In accordance with the terms of the 2022 SVB Credit Agreement, the Company was required to pay a prepayment premium equal to 1.0% of the principal balance on the date of
58

repayment. The Company incurred a loss on debt extinguishment of $0.6 million, consisting of the prepayment penalty of $0.3 million and the write off of $0.3 million of unamortized debt issuance costs.
Interest Income
Interest income of $6.2 million and $3.2 million for the years ended December 31, 2023 and December 31, 2022, respectively, related primarily to interest earned on money market funds, and for the year ended December 31, 2023, accretion of discounts on treasury bills.
Change in Fair Value of Contingent Earn-out Liability
The change in fair value of the contingent earn-out liability was $(14.9) million and $7.0 million for the years ended December 31, 2023 and 2022, respectively, resulting from quarterly mark-to-market adjustments.
Change in Fair Value of Contingently Issuable Common Stock Liability
The change in the fair value of the contingently issuable common stock liability was $(3.1) million and $1.9 million for the years ended December 31, 2023 and 2022, respectively, resulting from quarterly mark-to-market adjustments.
Change in Fair Value of Public Warrant Liability
The change in the fair value of the public warrant liability was $(4.8) million and $4.9 million for the years ended December 31, 2023 and 2022, respectively, resulting from quarterly mark-to-market adjustments.
Income Taxes

Our effective tax rate (“ETR”) on income before taxes for each of the years ended December 31, 2023 and December 31, 2022 was 0%. For December 31, 2023, the ETR was primarily impacted by the full valuation allowance maintained on the Company’s net deferred tax assets and non-deductible fair value adjustments. For the year ended December 31, 2022, the ETR was primarily impacted by the full valuation allowance maintained on the Company’s net deferred tax assets and non-taxable fair value adjustments. We have provided a valuation allowance for all of our net deferred tax assets as a result of our historical net losses in the jurisdictions in which we operate. We continue to assess all positive and negative evidence, including our future taxable income by jurisdiction based on our recent historical operating results, the expected timing of reversal of temporary differences, various tax planning strategies that we may be able to enact in future periods, the impact of potential operating changes on our business and our forecasted results from operations in future periods based on available information at the end of each reporting period. To the extent that we are able to reach the conclusion that deferred tax assets are realizable based on any combination of the above factors in any given tax jurisdiction, a reversal of all or some related portion of our existing valuation allowances may occur.
Liquidity and Capital Resources
Our primary requirements for liquidity and capital are working capital, inventory management, capital expenditures, and general corporate needs. We expect these needs to continue as we develop and grow our business. As of December 31, 2023, we had $118.5 million in cash, cash equivalents, and marketable securities. We incurred a net loss of $106.3 million and $86.4 million for the years ended December 31, 2023 and 2022, respectively. We incurred cash outflows from operating activities of $9.8 million and $74.7 million during the years ended December 31, 2023 and 2022, respectively.
We maintain substantially all of our cash, cash equivalents, and marketable securities in accounts with U.S. and multi-national financial institutions and our cash deposits at these institutions exceed Federal Deposit Insurance Corporation insured limits. The Company does not believe it is exposed to any unusual credit risk or deposit concentration risk beyond the ordinary credit risk associated with commercial banking relationships.
59

We expect our cash, cash equivalents, and marketable securities, together with cash we expect to generate from future operations, will be sufficient to fund our operating expenses and capital expenditure requirements for a period of at least twelve months from the date of this Annual Report on Form 10-K. However, because we are in the growth stage of our business and operate in an emerging field of technology, we expect to continue to invest in research and development and expand our sales and marketing team. We may require additional capital to respond to the expected growth in the demand for equipment purchases to support our "leased equipment" offering, technological advancements, competitive dynamics or technologies, customer demands, business opportunities, challenges, acquisitions, or unforeseen circumstances and in either the short-term or long-term may determine to engage in debt financings or enter into credit facilities for other reasons. If we are unable to obtain adequate financing or financing on terms satisfactory to us, when we require it, our ability to continue to grow or support our business and to respond to business challenges could be significantly limited. In particular, global events such as public health emergencies, including the COVID-19 pandemic and its variants, international political turmoil, including in Europe and the Middle East, and related international sanctions, supply chain disruptions, and prolonged inflation and rising interest rates have resulted in, and may continue to result in, significant disruption of global financial markets, reducing our ability to access capital. If we are unable to raise additional funds when or on the terms desired, our business, financial condition and results of operations could be adversely affected.
Financing Arrangements
In December 2020, we entered into a $10.0 million credit agreement with JPMorgan Chase Bank, N.A. (“JPM Credit Agreement”) with a maturity date of December 3, 2024, and a revolving line of credit of up to $10.0 million with a maturity date of December 3, 2022. Under the terms of the JPM Credit Agreement, we received proceeds of $10.0 million. We fully repaid all borrowings under the JPM Credit Agreement and terminated the JPM Credit Agreement in November 2022.
In December 2022, we entered into the 2022 SVB Credit Agreement in order to finance purchases of hardware to be leased to customers. The 2022 SVB Credit Agreement provided for an initial term loan advance of $30.0 million, which was approximately equivalent to the value of all hardware purchases made to support leasing transactions with our customers through December 21, 2022 (the "SVB Closing Date"), with the opportunity to obtain, within 18 months after the SVB Closing Date, additional term loan advances, subject to the satisfaction of certain conditions, in an aggregate principal amount equal to $20.0 million, (subject to an increase of an additional $25.0 million upon the satisfaction of certain conditions and approval from SVB). The interest rate applicable to the SVB Term Loans was the greater of (a) the Wall Street Journal Prime Rate plus 1.0% or (b) 7.25% per annum. Interest and principal under the SVB Credit Agreement was payable monthly.
On March 31, 2023, following the collapse of SVB, the Company fully repaid all borrowings and accrued interest under the 2022 SVB Credit Agreement and terminated the 2022 SVB Credit Agreement. The Company has no debt outstanding as of December 31, 2023.
Material Cash Requirements for Known Contractual and Other Obligations
The following is a description of commitments for capital expenditures and other known and reasonably likely cash requirements as of December 31, 2023. We anticipate fulfilling such commitments with our existing cash and cash equivalents, as well as cash and cash equivalents obtained through operations and, if necessary, proceeds from long-term debt. Cash, cash equivalents, and marketable securities amounted to $118.5 million as of December 31, 2023.
We are party to a lease agreement for office space for the period from May 1, 2021 through October 31, 2024, with the option to extend through October 31, 2027 with written notice. During the year ended December 31, 2023, we amended the lease agreement to add additional square footage within the same building. The amendment did not impact the term of the lease. We are required to maintain a minimum cash balance of $0.3 million as a security deposit on the leased space which is classified as restricted cash, current on the consolidated balance sheet as of December 31, 2023. Total future minimum lease payments under this noncancelable operating lease amount to $1.4 million. See Note 6 to our consolidated financial statements for the year ended December 31, 2023.
60

Cash Flows
The following table sets forth a summary of cash flows for the periods presented:
Year Ended
December 31,
20232022
Net cash used in operating activities$(9,801)$(74,728)
Net cash used in investing activities(123,113)(23,881)
Net cash provided by (used in) financing activities(29,664)20,510 
Effect of exchange rate changes on cash and cash equivalents(43)(10)
Net increase (decrease) in cash, cash equivalents and restricted cash$(162,621)$(78,109)
Operating Activities
Year Ended
December 31,
20232022
Net loss$(106,254)$(86,406)
Non-cash expense59,754 17,331 
Changes in operating assets and liabilities36,699 (5,653)
Net cash used in operating activities$(9,801)$(74,728)
Net loss increased to $106.3 million for the year ended December 31, 2023 from $86.4 million for the year ended December 31, 2022 as a result of the factors described in "Results of Operations" above.
Non-cash expenses for the year ended December 31, 2023 were primarily attributable to $24.2 million of stock-based compensation expense, $9.9 million of depreciation and amortization, $1.6 million of write-off of inventory, and $22.8 million of an aggregate change in fair value of the earn-out liability, contingently issuable common stock warrant liability, and public warrant liability. Non-cash expenses for the year ended December 31, 2022 were primarily attributable to $22.5 million of stock-based compensation expense, $5.5 million of depreciation and amortization, $1.6 million of write-off of inventory, and $1.2 million of loss from impairment of property and equipment, offset by $13.8 million of an aggregate change in fair value of the earn-out liability, contingently issuable common stock warrant liability, and public warrant liability.
Changes in operating assets and liabilities for the year ended December 31, 2023 are primarily related to the following:
$35.5 million increase in deferred revenue to a higher volume of sales;
$8.9 million decrease in accounts receivable primarily due to the Company's transition away from the purchase model, under which upfront billings to customers are generally higher; and
$3.7 million increase in accrued expenses and other current liabilities, related to accrued consulting and professional fees and an accrual for purchase order cancellation fees, offset by
$6.0 million decrease in accounts payable (excluding the non-cash portion related to capital expenditures incurred but not yet paid) due primarily to the timing of vendor payments;
$2.6 million increase in prepaid expense and other current assets due to an increase in vendor deposits; and
$2.4 million increase in commission assets due to a higher volume of sales.
Changes in operating assets and liabilities for the year ended December 31, 2022 are primarily related to the following:

$26.9 million increase in deferred revenue due to a higher volume of sales;
$7.7 million increase in accounts payable primarily due to amounts payable to the Company's contract manufacturer; offset by
$25.6 million increase in accounts receivable primarily due to higher sales and the timing of billings to customers;
61

$8.5 million increase in inventory primarily due to increased production of units to meet customer demand;
$3.7 million increase in commission assets due to a higher volume of sales; and
$3.2 million increase in prepaid expenses and other current assets primarily due to deposits paid to the Company's contract manufacturer.
Investing Activities
During the year ended December 31, 2023, cash used in investing activities was $123.1 million, consisting of $69.1 million for the purchase of property and equipment, primarily related to the purchase of Evolv Express units to be leased to customers, $3.5 million for the development of internal-use software and software embedded in products to be sold or leased, and a net $50.7 million outflow related to purchases and redemptions of marketable securities.
During the year ended December 31, 2022, cash used in investing activities was $23.9 million, consisting of $21.5 million for the purchase of property and equipment, primarily related to the purchase of Express units to be leased to customers, and $2.7 million for the development of internal-use software, offset by $0.3 million of proceeds from the sale of property and equipment.
Financing Activities
During the year ended December 31, 2023, cash used in financing activities was $29.7 million, consisting of $1.9 million of proceeds under the 2022 SVB Credit Agreement and $0.7 million of proceeds from the exercise of stock options, offset by $31.9 million related to the full repayment of amounts owed under the 2022 SVB Credit Agreement and a $0.3 million payment of debt issuance costs and a prepayment penalty.
During the year ended December 31, 2022, cash provided by financing activities was $20.5 million, consisting of $29.7 million of proceeds from long-term debt, net of issuance costs, and $0.8 million of proceeds from the exercise of stock options, offset by $10.0 million of debt repayments.
Recent Accounting Pronouncements
A description of recently issued accounting pronouncements that may potentially impact our financial position, results of operations or cash flows is disclosed in Note 2 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K.
Emerging Growth Company Status
Upon the completion of the Merger, we qualified as an "emerging growth company" as defined in the JOBS Act. Effective December 31, 2023, we exited our EGC status and became a "large accelerated filer" as defined in Rule 12b-2 of the Exchange Act. As a result, we may no longer take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards available to EGCs, and we must comply with all financial reporting and compliance requirements applicable to a "large accelerated filer". The effect of the loss of EGC status and the impact of the adoption of new accounting pronouncements is discussed further in Note 2 to our consolidated financial statements in this Annual Report on Form 10-K.
Critical Accounting Policies and Estimates
Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses, and the disclosure of contingent assets and liabilities in our consolidated financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.
While our significant accounting policies are described in more detail in Note 2 to our consolidated financial statements, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated financial statements.
62

Marketable Securities
Marketable securities are reported at fair value and, at December 31, 2023, are comprised solely of zero coupon U.S. treasury bills with maturities of less than one year that are classified as available-for-sale debt securities. The Company considers an available-for-sale debt security to be impaired if the fair value of the investment is less than its amortized cost basis. The entire difference between the amortized cost basis and the fair value of the Company’s available-for-sale debt securities is recognized on the consolidated statements of operations as an impairment if, (i) the fair value of the security is below its amortized cost and (ii) the Company intends to sell or is more likely than not required to sell the security before recovery of its amortized cost basis. If neither criterion is met, the Company evaluates whether the decline in fair value is due to credit losses or other factors. In making this assessment, the Company considers the changes to the rating of the security by third-party rating agencies, and adverse conditions specific to the security, among other factors. If the Company’s assessment indicates that a credit loss exists, the credit loss is measured based on the Company’s best estimate of the cash flows expected to be collected. When developing its estimate of cash flows expected to be collected, the Company considers all available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable forecasts.
Revenue Recognition
We derive revenue from (1) subscription arrangements generally accounted for as operating leases, including SaaS and maintenance, (2) the sale of products, (3) SaaS and maintenance related to products sold to customers either by Evolv or by Columbia Tech pursuant to the Distribution and License Agreement, (4) license fees under the Distribution and License Agreement, and (5) professional services, including installation, training, and event support. Maintenance consists of preventative maintenance, technical support, bug fixes, and when-and-if available threat updates. Our arrangements are generally noncancelable and nonrefundable after ownership passes to the customer. Revenue is recognized net of sales tax.
Product Revenue
We derive a portion of our revenue from the sale of our Evolv Express equipment and related add-on accessories to customers. Revenue is recognized when control of the product has transferred to the customer, which follows the terms of each contract.
Subscription Revenue
Subscription revenue is comprised of revenue derived from leasing Evolv Express and Evolv Edge units to our customers. Lease terms are typically four years and customers generally pay either a quarterly or annual fixed payment for the lease, SaaS, and maintenance elements over the contractual lease term. Equipment leases are generally classified as operating leases and recognized ratably over the duration of the lease. There are no contingent lease payments as a part of these arrangements.
Lease arrangements generally include both lease and non-lease components. The non-lease components relate to (1) distinct services, including professional services, SaaS, and maintenance, and (2) any add-on accessories. Professional services are included in license fees and other revenue as described below, and add-on accessories are included in product revenue as described above. Because the equipment lease, SaaS, and maintenance components of a subscription arrangement are recognized as revenue over the same time period and in the same pattern, the equipment lease and SaaS/maintenance performance obligations are classified as a single category of subscription revenue in our consolidated statements of operations and comprehensive loss.
Service Revenue
Service revenue consists of subscription-based SaaS and maintenance revenue related to products sold to a customer. Customers generally pay either a quarterly or annual fixed payment for SaaS and maintenance. SaaS and maintenance revenue is recognized ratably over the period of the arrangement, which is typically four years.
License Fee and Other Revenue
License fee and other revenue includes license fee revenue from the Distribution and License Agreement, revenue from professional services, and other one-time revenue. License fee revenue is recognized upon the shipment of product
63

from our third-party manufacturer to the reseller. Revenue for professional services is recognized upon transfer of control of these services, which are normally rendered over a short duration.
Revenue from Reseller Partners
A portion of our revenue is generated by sales in conjunction with our reseller partners. When we transact with a reseller partner, our contractual arrangement is with the reseller partner and not with the end-use customer. Whether we transact with a reseller partner and receive the order from a reseller partner or directly from an end-use customer, our revenue recognition policy and resulting pattern of revenue recognition is the same.
Standalone Selling Price
We allocate the transaction price to each distinct performance obligation based on the standalone selling price (“SSP”) of each product or service. Our contracts may include multiple performance obligations when customers purchase a combination of products and services. When our customer arrangements have multiple performance obligations that contain a lease as well as distinct services that are delivered simultaneously, we allocate the arrangement consideration between the lease deliverables and non-lease deliverables based on the relative estimated SSP of each distinct performance obligation. For multiple performance obligation arrangements that do not contain a lease, we allocate the contract’s transaction price to each performance obligation on a relative SSP basis.
Stock-Based Compensation
We measure stock-based option awards granted to employees, consultants and directors based on their fair value on the date of grant using the Black-Scholes option-pricing model. Compensation expense for those awards is recognized, net of estimated forfeitures, over the requisite service period, which is generally the vesting period of the respective award.
Prior to the closing of the Merger, the fair value of each stock option grant was estimated on the date of grant using the Black-Scholes option-pricing model, which uses the following inputs: (1) the fair value per share of the common stock issuable upon exercise of the option, (2) the expected term of the option, (3) expected volatility of the price of the common stock, (4) the risk-free interest rate, and (5) the expected dividend yield.
After the closing of the Merger, we determine the fair value of each share of common stock underlying stock-based awards based on the closing price of our common stock as reported by Nasdaq on the date of grant.
The Black-Scholes option-pricing model uses as inputs the fair value of our common shares and assumptions we make for the volatility of our common shares, the expected term of our stock options, the risk-free interest rate for a period that approximates the expected term of our stock options, and our expected dividend yield. As a result of being a private company prior to the Merger, the Company currently lacks sufficient company-specific historical and implied volatility information to solely utilize its own data for purposes of establishing the volatility assumption for use in the Black-Scholes model. Therefore, we estimate our expected share volatility based on a mix of company-specific historical volatility and historical volatility of a publicly traded set of peer companies. We expect to continue to do so until such time as we have adequate historical data regarding the volatility of our own traded share price.
Valuation of Contingent Earn-out Liability
The estimated fair value of the contingent earn-out shares is determined using a Monte Carlo simulation that simulated the future path of the Company’s stock price over the earn-out period. The significant assumptions utilized in the calculation are based on the achievement of certain stock price milestones including volatility, risk-free rate of return, likelihood of a change in control, and expected remaining term. For potential common stock issuances related to a stock price milestones, the fair value was determined based on our expectations of achieving such a milestone and the simulated estimated stock price on the expected date of achievement.
We believe our assumptions are reasonable based on available information, our experience, knowledge, and judgments. These estimates can be affected by factors that are difficult to predict including future (1) EVLV closing price per share on the Nasdaq, (2) estimated stock price volatility over the earn-out period, and (3) risk free rates. Changes in assumptions and estimates used in our analysis, or future results that vary from assumptions used in the analysis, could affect the fair value of the contingent earn-out and could result in material changes in future periods.
64

Valuation of Contingently Issuable Common Stock Liability
The estimated fair value of the contingently issuable common shares was determined using a Monte Carlo simulation that simulated the future path of the Company’s stock price over the vesting period. The significant assumptions utilized in the calculation are based on the achievement of certain stock price milestones including volatility, risk-free rate of return, likelihood of a change in control, and expected remaining term.
We believe our assumptions are reasonable based on available information, our experience, knowledge, and judgments. These estimates can be affected by factors that are difficult to predict including future (1) EVLV closing price per share on the Nasdaq, (2) estimated stock price volatility over the contingently issuable common shares period, and (3) risk free rates. Changes in assumptions and estimates used in our analysis, or future results that vary from assumptions used in the analysis, could affect the fair value of the contingently issuable common stock and could result in material changes in future periods.
Valuation of Public Warrant Liability
In connection with the closing of the Merger, we assumed the Public Warrants to purchase shares of common stock, which were classified as a liability, as the Public Warrants do not meet the criteria to be indexed to our common stock. Accordingly, we recorded the Public Warrants at fair value upon the closing of the Merger with a corresponding adjustment to additional paid-in capital. After the initial measurement, the fair value of the Public Warrants is subsequently remeasured quarterly based on the listed market price on the Nasdaq of such Public Warrants.
Valuation of Inventory
Inventory is valued at the lower of cost or net realizable value. Cost is computed using the weighted average method. We regularly review inventory quantities on-hand for excess and obsolete inventory and, when circumstances indicate, record charges to write down inventories to their estimated net realizable value, after evaluating historical sales, future demand, our estimates of forecasted net revenue, market conditions and expected product life cycles. A significant change in the timing or level of demand for our products as compared to forecasted amounts may result in recording additional write-offs. Such charges are classified as cost of product revenue in the statements of operations and comprehensive loss. Any write-down of inventory to net realizable value creates a new cost basis.
Capitalized Software
Software development costs consist of certain consulting costs and compensation expenses for employees who devote time to the development of our internal-use software and software embedded in products to be sold or leased, as well as certain upgrades and enhancements that are expected to result in enhanced functionality. We amortize these development costs over the estimated useful life of four years. We determined that a four year life is appropriate for our capitalized software based on our best estimate of the useful life of the software after considering factors such as continuous developments in the technology, obsolescence, and anticipated life of the service offering before significant upgrades. Management evaluates the useful lives of these assets on a quarterly basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets.
We determine the amount of software costs to be capitalized based on the amount of time spent by our developers and consultants on projects in the application stage of development. There is judgment in estimating the time allocated to a particular project in the application stage. A significant change in the time spent on each project could have a material impact on the amount capitalized and related amortization expense in subsequent periods.
Leases
To determine the residual value estimates and useful life of equipment that we lease to our customers, we are required to make judgments about future events that are subject to risks and uncertainties outside of their control, such as inventory levels of new equipment, changing consumer preferences, new technology and mandatory regulations. We have disciplines related to the management and maintenance of our leased equipment designed to manage the risk associated with the residual values of our revenue generating equipment. We periodically review and adjust, as appropriate, the estimated residual values and useful lives of existing revenue generating equipment for the purposes of classifying transactions as operating or sales-type leases and recording depreciation expense. Based on the results of our analysis, we
65

may adjust the estimated residual values and useful lives of individual assets of our revenue generating equipment each year.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS
Our operations are primarily within the United States, and we transact primarily in United States dollars. Therefore, we do not have any material foreign currency exposure. We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in interest rates and to a lesser extent, inflation risk. The following analysis provides quantitative information regarding these risks.
Interest Rate Risk
Our exposure to market risk for changes in interest rates relate to our cash, cash equivalents and marketable securities balances. We had cash, cash equivalents, and marketable securities totaling $118.5 million as of December 31, 2023. Cash equivalents are invested primarily in money market funds. Marketable securities are invested in U.S. treasury bills. Our investment policy is focused on the preservation of capital and supporting our liquidity needs. Under the policy, we invest in highly rated securities, issued by the U.S. government or liquid money market funds. We do not invest in financial instruments for trading or speculative purposes, nor do we use leveraged financial instruments. We utilize external investment managers who adhere to the guidelines of our investment policy. Based upon a sensitivity analysis, a hypothetical 100 basis point increase in interest rates would have increased our interest income by $1.3 million for the year ended December 31, 2023, and a 100 basis point decrease in interest rates would have decreased our interest income by $1.3 million for the year ended December 31, 2023.
Inflation Risk
Our results of operations and financial condition are presented based on historical cost. While it is difficult to accurately measure the impact of inflation due to the imprecise nature of the estimates required, we do not believe the effects of inflation have had a material impact on our results of operations and financial condition. Nonetheless, if our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs. We cannot assure that our results of operations and financial condition will not be materially impacted by inflation in the future.
66

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
EVOLV TECHNOLOGIES HOLDINGS, INC.
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
67

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of Evolv Technologies Holdings, Inc.

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Evolv Technologies Holdings, Inc. and its subsidiaries (the “Company”) as of December 31, 2023 and 2022, and the related consolidated statements of operations and comprehensive loss, of stockholders' equity (deficit) and of cash flows for the years then ended, including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for the years then ended December 31, 2023 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company did not maintain, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO because material weaknesses in internal control over financial reporting existed as of that date related the Company not designing and maintaining (i) an effective control environment commensurate with its financial reporting requirements, (ii) effective controls in response to the risks of material misstatement to financial reporting, (iii) effective controls over the period-end financial reporting process, (iv) effective controls to analyze, account for and disclose non-routine, unusual or complex transactions, (v) formal accounting policies, procedures and controls to achieve complete, accurate and timely financial accounting, reporting and disclosures, including segregation of duties and controls over the preparation and review of account reconciliations and journal entries, and (vi) effective controls over information technology general controls for information systems that are relevant to the preparation of the consolidated financial statements, including program change management, user access, computer operations, and program development.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. The material weaknesses referred to above are described in Management’s Annual Report on Internal Control Over Financial Reporting appearing under Item 9A. We considered these material weaknesses in determining the nature, timing, and extent of audit tests applied in our audit of the 2023 consolidated financial statements, and our opinion regarding the effectiveness of the Company’s internal control over financial reporting does not affect our opinion on those consolidated financial statements.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in management's report referred to above. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

68

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Consolidated Financial Statements - Impact of Control Environment, Risk Assessment, and Control Activities Related to Financial Reporting

The completeness and accuracy of the consolidated financial statements, including the financial condition, results of operations and cash flows, is dependent on, in part, (i) maintaining a sufficient complement of personnel with an appropriate level of internal controls and accounting knowledge, training and experience commensurate with the Company’s financial reporting requirements, (ii) designing and maintaining controls in response to the risks of material misstatement to financial reporting, (iii) designing and maintaining effective controls over the period-end financial reporting process, (iv) designing and maintaining controls to analyze, account for and disclose non-routine, unusual or complex transactions, (v) designing and maintaining formal accounting policies, procedures, and controls to achieve complete, accurate, and timely financial accounting, reporting and disclosures, including segregation of duties and controls over the preparation and review of account reconciliations and journal entries, and (vi) designing and maintaining effective controls over information technology general controls for information systems that are relevant to the preparation of the consolidated financial statements, including program change management, user access, computer operations, and program development.
The principal considerations for our determination that performing procedures relating to the consolidated financial statements – impact of control environment, risk assessment, and control activities related to financial reporting is a critical audit matter are a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating audit evidence related to business processes that affect substantially all financial statement account balances and disclosures. As described in the “Opinions on the Financial Statements and Internal Control over Financial Reporting” section, material weaknesses were identified related to this matter.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included, among others, evaluating and determining the nature and extent of audit procedures performed and evidence obtained that are responsive to the material weaknesses identified. These procedures also included (i) evaluating whether segregation of duties was maintained over the preparation and review of account reconciliations and recording of journal entries, (ii) testing the completeness and accuracy of period-end financial reporting, including the classification and presentation of accounts and disclosures; (iii) testing the accounting and disclosures for non-routine, unusual or complex transactions; and (iv) manually testing the completeness and accuracy of system reports or other information generated by the Company’s information systems.

69

/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 29, 2024
We have served as the Company’s auditor since 2015.
70

EVOLV TECHNOLOGIES HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
December 31,
20232022
Assets  
Current assets:  
Cash and cash equivalents$67,162 $229,783 
Restricted cash275  
Marketable securities51,289  
Accounts receivable, net *22,611 31,920 
Inventory9,507 10,257 
Current portion of contract assets3,707 2,852 
Current portion of commission asset4,339 3,384 
Prepaid expenses and other current assets16,954 14,388 
Total current assets175,844 292,584 
Restricted cash, noncurrent 275 
Contract assets, noncurrent451 1,386 
Commission asset, noncurrent7,107 5,655 
Property and equipment, net112,921 44,707 
Operating lease right-of-use assets1,195 1,673 
Other assets1,202 1,835 
Total assets$298,720 $348,115 
Liabilities and Stockholders’ Equity  
Current liabilities:  
Accounts payable$17,400 $18,194 
Accrued expenses and other current liabilities15,578 11,545 
Current portion of deferred revenue47,677 18,273 
Current portion of long-term debt 10,000 
Current portion of operating lease liabilities1,391 1,114 
Total current liabilities82,046 59,126 
Deferred revenue, noncurrent23,813 17,695 
Long-term debt, noncurrent 19,683 
Operating lease liabilities, noncurrent 892 
Contingent earn-out liability29,119 14,218 
Contingently issuable common stock liability6,530 3,392 
Public warrant liability10,889 6,124 
Total liabilities152,397 121,130 
Commitments and contingencies (Note 19)
Stockholders’ equity:  
Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2023 and December 31, 2022; no shares issued and outstanding at December 31, 2023 and December 31, 2022
  
Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2023 and December 31, 2022, 151,310,080 and 145,204,974 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively
15 15 
Additional paid-in capital444,825 419,190 
Accumulated other comprehensive loss(53)(10)
Accumulated deficit(298,464)(192,210)
Stockholders’ equity146,323 226,985 
Total liabilities and stockholders’ equity$298,720 $348,115 
*Includes related party accounts receivable, net of $1.7 million and $14.6 million as of December 31, 2023 and December 31, 2022, respectively.
The accompanying notes are an integral part of these consolidated financial statements.
71

EVOLV TECHNOLOGIES HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In thousands, except share and per share amounts)
December 31,
20232022
Revenue:
Product revenue$21,977 $31,985 
Subscription revenue37,247 17,569 
Service revenue16,141 4,331 
License fee and other revenue5,053 1,310 
Total revenue *80,418 55,195 
Cost of revenue:
Cost of product revenue26,667 41,575 
Cost of subscription revenue14,991 7,469 
Cost of service revenue3,982 2,200 
Cost of license fee and other revenue949 2,222 
Total cost of revenue46,589 53,466 
Gross profit33,829 1,729 
Operating expenses:
Research and development24,455 18,771 
Sales and marketing55,223 46,639 
General and administrative42,091 37,719 
Loss from impairment of property and equipment322 1,161 
Total operating expenses122,091 104,290 
Loss from operations(88,262)(102,561)
Other income (expense), net:
Interest expense(654)(712)
Interest income6,227 3,165 
Other expense, net(84)(64)
Loss on extinguishment of debt(626) 
Change in fair value of contingent earn-out liability(14,901)6,988 
Change in fair value of contingently issuable common stock liability(3,138)1,872 
Change in fair value of public warrant liability(4,765)4,906 
Total other income (expense), net(17,941)16,155 
Loss before income taxes(106,203)(86,406)
Provision for income taxes(51) 
Net loss$(106,254)$(86,406)
Weighted average common shares outstanding – basic and diluted149,168,105 143,858,668 
Net loss per share - basic and diluted$(0.71)$(0.60)
Net loss$(106,254)$(86,406)
Other comprehensive loss
Cumulative translation adjustment(43)(10)
Total other comprehensive loss(43)(10)
Total comprehensive loss$(106,297)$(86,416)
*Includes related party revenue of $11.3 million and $13.5 million for the years ended December 31, 2023 and 2022, respectively.
The accompanying notes are an integral part of these consolidated financial statements.
72

EVOLV TECHNOLOGIES HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)
(In thousands, except share amounts)

Common StockAdditional
Paid-in
Capital
Accumulated Other Comprehensive Income (Loss)Accumulated
Deficit
Total
Stockholders’
Equity
SharesAmount
Balances at December 31, 2021142,745,021 $14 $396,064 $ $(105,804)$290,274 
Issuance of common stock upon exercise of stock options1,894,179 1 827 — — 828 
Issuance of common stock upon vesting of restricted stock units565,774 — — — — — 
Stock-based compensation cost— — 22,299 — — 22,299 
Cumulative translation adjustment— — — (10)— (10)
Net loss— — — — (86,406)(86,406)
Balances at December 31, 2022145,204,974 15 419,190 (10)(192,210)226,985 
Issuance of common stock upon exercise of stock options1,735,978  668 — — 668 
Issuance of common stock upon vesting of restricted stock units3,265,155 — — — — — 
Issuance of common stock upon exercise of warrants1,103,973 — 464 — — 464 
Stock-based compensation cost— — 24,503 — — 24,503 
Cumulative translation adjustment— — — (43)— (43)
Net loss— — — — (106,254)(106,254)
Balances at December 31, 2023151,310,080 $15 $444,825 $(53)$(298,464)$146,323 
The accompanying notes are an integral part of these consolidated financial statements.
73

EVOLV TECHNOLOGIES HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
Year Ended December 31,
20232022
Cash flows from operating activities:
Net loss$(106,254)$(86,406)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization9,932 5,465 
Write-off of inventory and change in inventory reserve1,612 1,582 
Adjustment to property and equipment for sales type leases (625)
Loss from impairment of property and equipment322 1,161 
Stock-based compensation24,151 22,498 
Non-cash interest expense22 55 
Accretion of discount on marketable securities(575) 
Non-cash lease expense478 811 
Change in allowance for expected credit losses382 150 
Loss on extinguishment of debt626  
Change in fair value of earn-out liability14,901 (6,988)
Change in fair value of contingently issuable common stock3,138 (1,872)
Change in fair value of public warrant liability4,765 (4,906)
Changes in operating assets and liabilities
Accounts receivable8,927 (25,593)
Inventory(644)(8,495)
Commission assets(2,407)(3,675)
Contract assets80 639 
Other assets633 (419)
Prepaid expenses and other current assets(2,566)(3,174)
Accounts payable(5,963)7,661 
Deferred revenue35,522 26,887 
Accrued expenses and other current liabilities3,732 1,462 
Operating lease liability(615)(946)
Net cash used in operating activities(9,801)(74,728)
Cash flows from investing activities:
Development of internal-use software(3,535)(2,720)
Purchases of property and equipment(69,134)(21,473)
Proceeds from sale of property and equipment270 312 
Purchases of marketable securities(89,898) 
Proceeds from maturities of marketable securities39,184  
Net cash used in investing activities(123,113)(23,881)
Cash flows from financing activities:
Proceeds from exercise of stock options668 827 
Proceeds from long-term debt1,876 29,683 
Repayment of principal on long-term debt(31,876)(10,000)
Payment of debt issuance costs and prepayment penalty(332) 
Net cash provided by (used in) financing activities(29,664)20,510 
Effect of exchange rate changes on cash and cash equivalents(43)(10)
Net increase (decrease) in cash, cash equivalents and restricted cash(162,621)(78,109)
Cash, cash equivalents and restricted cash
74

Cash, cash equivalents and restricted cash at beginning of period230,058 308,167 
Cash, cash equivalents and restricted cash at end of period$67,437 $230,058 
Supplemental disclosure of cash flow information
Cash paid for interest$710 $581 
Supplemental disclosure of non-cash activities
Transfer of property and equipment to inventory$218 $ 
Capital expenditures incurred but not yet paid13,322 7,552 
Capitalization of stock compensation516 205 
Finback exercise price464  
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents$67,162 $229,783 
Restricted cash275  
Restricted cash, noncurrent 275 
Total cash, cash equivalents and restricted cash shown in the statements of cash flows$67,437 $230,058 
The accompanying notes are an integral part of these consolidated financial statements.
75

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. Nature of the Business and Basis of Presentation
Evolv Technologies Holdings, Inc. (the “Company”), a Delaware corporation, is a global leader in AI-based weapons detection for security screening. The Company’s mission is to make the world a safer and more enjoyable place to work, learn, and play. The Company is democratizing security by making it seamless for gathering spaces to address the chronic epidemic of escalating gun violence, mass shootings and terrorist attacks in a cost-effective manner while improving the visitor experience. The Company is headquartered in Waltham, Massachusetts.
As used in this Annual Report on Form 10-K, unless otherwise indicated or the context otherwise requires, references to “we,” “us,” “our,” the “Company” and “Evolv” refer to the consolidated operations of Evolv Technologies Holdings, Inc. and its wholly owned subsidiaries, which include Evolv Technologies, Inc., Evolv Technologies UK Ltd. and Give Evolv LLC.
Risks and uncertainties
There is significant uncertainty in the current macroeconomic environment due to inflationary pressures globally, conflicts in Europe and the Middle East, and foreign currency volatility and their impacts on the Company’s business. If economic conditions were to worsen, the Company’s results of operations, financial condition, and cash flows from operations may be materially and adversely impacted.
Basis of presentation
The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”).
Merger
On July 16, 2021, we consummated the business combination (the “Merger”), contemplated by the Agreement and Plan of Merger, dated March 5, 2021, with NHIC Sub Inc. (“Merger Sub”), a wholly-owned subsidiary of NewHold Investment Corp. (“NHIC”), a special purpose acquisition company, which is our legal predecessor, and Evolv Technologies, Inc. dba Evolv Technology, Inc. (“Legacy Evolv”), as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 by and among NHIC, Merger Sub and Legacy Evolv (the “Amendment” and as amended, the “Merger Agreement”). Pursuant to the Merger Agreement, Merger Sub was merged with and into Legacy Evolv, with Legacy Evolv surviving the Merger as a wholly-owned subsidiary of NHIC. Upon the closing of the Merger, NHIC changed its name to Evolv Technologies Holdings, Inc. Evolv Technologies Holdings, Inc. became the successor entity to NHIC pursuant to Rule 12g-3(a) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
Reclassifications
During the year ended December 31, 2023, the Company began classifying revenue from professional services, which includes installation, training, and event support, as well as other one-time revenue, within license fee and other revenue on the consolidated statements of operations and comprehensive loss, whereas the revenue for these services has previously been included in service revenue. Correspondingly, the Company began classifying costs associated with professional services within cost of license fee and other revenue, whereas these costs were previously included in cost of service revenue. These reclassifications were made to align the presentation of professional services with the Company's internal reporting and analysis. The reclassifications did not impact total revenue or total cost of revenue for any period. Prior year amounts included in this Annual Report on Form 10-K have been reclassified to conform to the current presentation.
76

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the year ended December 31, 2022, the reclassifications resulted in an increase in license fee and other revenue of $1.3 million and a corresponding decrease in service revenue, as well as in increase in cost of license fee and other revenue of $2.2 million and a corresponding decrease in cost of service revenue.
2. Summary of Significant Accounting Policies
Use of Estimates
The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to calculating the standalone selling price for revenue recognition, the valuation of inventory, the expensing and capitalization of costs associated with internal-use software, stock-based awards, the valuation of the contingent earn-out liability, the valuation of the contingently issuable common stock, and the valuation of the public warrant liability. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts, and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.
Risk of Concentrations of Credit, Significant Customers and Significant Suppliers
Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash equivalents, restricted cash, marketable securities, and accounts receivable, net. We maintain substantially all of our cash and cash equivalents with U.S. and multi-national financial institutions, and our deposits are generally in excess of federally insured limits. The Company maintains its cash, cash equivalents, restricted cash, and marketable securities with financial institutions that management believes to be of high credit quality. The Company has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.
Significant customers are those which represent more than 10% of the Company’s total revenue or accounts receivable, net balance at each respective balance sheet date. The following table presents customers that represent 10% or more of the Company’s total revenue for the years ended December 31, 2023 and December 31, 2022. Each customer shown is a reseller partner of the Company.
Year Ended December 31, 2023Year Ended December 31, 2022
Motorola Solutions, Inc.12.0  %20.9  %
Customer A*10.1  %
Customer B10.4  %*
22.4  %31.0  %
* Less than 10%
77

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table presents customers that represent 10% or more of the Company’s accounts receivable, net. Each customer shown is a reseller partner of the Company.
December 31,
20232022
Motorola Solutions, Inc.*39.0  %
Customer B*16.0  %
55.0  %
* Less than 10%
The Company relies on one primary third-party contract manufacturer, Columbia Tech, for the production of our touchless security screening systems. Columbia Tech provides a variety of services including sourcing off-the-shelf components, manufacturing custom components/assemblies, final product assembly and integration, end of line testing and quality assurance per our specifications, material and finished goods inventory, and direct shipping to our customers. We also use a different third-party manufacturer as a second source for the production of a key sensor component used in our systems. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers to satisfactorily deliver its products to its customers on time, if at all, which could have a material adverse effect on the Company’s operating results, financial condition and cash flows and damage its customer relationships.
Cash, Cash Equivalents, and Restricted Cash
The Company considers all short-term, highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Restricted cash relates to a letter of credit on the Company’s office lease in Waltham, Massachusetts, all of which is included in restricted cash, current on the consolidated balance sheet as of December 31, 2023. As the letter of credit is reduced, restricted cash is reclassified to cash and cash equivalents.
Marketable Securities
Marketable securities are reported at fair value and, at December 31, 2023, are comprised solely of zero coupon U.S. treasury bills with maturities of less than one year that are classified as available-for-sale debt securities. The Company considers an available-for-sale debt security to be impaired if the fair value of the investment is less than its amortized cost basis. The entire difference between the amortized cost basis and the fair value of the Company’s available-for-sale debt securities is recognized on the consolidated statements of operations as an impairment if, (i) the fair value of the security is below its amortized cost and (ii) the Company intends to sell or is more likely than not required to sell the security before recovery of its amortized cost basis. If neither criterion is met, the Company evaluates whether the decline in fair value is due to credit losses or other factors. In making this assessment, the Company considers the changes to the rating of the security by third-party rating agencies, and adverse conditions specific to the security, among other factors. If the Company’s assessment indicates that a credit loss exists, the credit loss is measured based on the Company’s best estimate of the cash flows expected to be collected. When developing its estimate of cash flows expected to be collected, the Company considers all available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable forecasts.
Unrealized gains and losses, net of tax, on marketable securities, if any, are recognized in accumulated other comprehensive income (loss) in the accompanying consolidated balance sheets. Realized net gains and losses on marketable securities, if any, are reflected in interest income in the accompanying consolidated statements of operations and comprehensive loss.
Fair Value Measurements of Financial Instruments
Certain assets and liabilities of the Company are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement
78

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:
Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.
Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.
The Company’s cash equivalents, restricted cash, marketable securities, derivative liability, contingent earn-out liability, contingently issuable common stock liability and its common stock warrant liability are carried at fair value, determined according to the fair value hierarchy described above (see Note 4). The carrying values of the Company’s accounts receivable, net, accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities. The carrying value of the Company’s long-term debt approximates its fair value (a Level 2 measurement) at each balance sheet date due to its variable interest rate, which approximates a market interest rate.
Assets that are measured at fair value on a nonrecurring basis primarily relate to property and equipment. We do not periodically adjust carrying value to fair value for property and equipment. Rather, the carrying value of the asset is reduced to its fair value when we determine that impairment has occurred.
Contingent Earn-out
In connection with the Merger and pursuant to the Merger Agreement, certain of the Legacy Evolv’s shareholders and Legacy Evolv Service Providers are entitled to receive additional shares of the Company’s common stock (the “Earn-Out Shares”) upon the Company achieving certain milestones:
Triggering Event I – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $12.50 per share for any 20 trading days within any 30 trading day period.
Triggering Event II – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $15.00 per share for any 20 trading days within any 30 trading day period.
Triggering Event III – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $17.50 per share for any 20 trading days within any 30 trading day period.
In accordance with ASC 815 – Derivatives and Hedging, the earn-out arrangement with the Legacy Evolv shareholders is accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as a change in fair value of contingent earn-out liability in other income (expense), net in the consolidated statements of operations and comprehensive loss. When the Triggering Events have been achieved and the Earn-Out Shares are issued, the Company will reclassify the corresponding amount from a liability to additional paid-in-capital and common stock at par value of $0.0001 per share.
The estimated fair value of the contingent earn-out shares was determined using a Monte Carlo simulation that simulated the future path of the Company’s stock price over the earn-out period. The significant assumptions utilized in the calculation are based on the achievement of certain stock price milestones including projected stock price, volatility, drift rate, percentage of change in control and expected term.
79

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The contingent earn-out liability is categorized as a Level 3 fair value measurement (see Note 4) because the Company estimates projections during the earn-out period utilizing unobservable inputs, including various potential pay-out scenarios. Contingent earn-out payments involve certain assumptions requiring significant judgment and actual results may differ from assumed and estimated amounts.
The Earn-Out Shares issued to employees, officers, directors, and non-employees are based on achievement of certain target share price contingencies and for the employees and officers, subject to continued employment, (the “Earn-Out Service Providers”) represents share-based compensation and is included in additional paid-in capital on the Company’s balance sheet. Corresponding stock-based compensation expense is recorded in the consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. As a condition to being issued Earn-Out Shares, the Earn-Out Service Providers must still be providing services to the Company on the date of the issuance of the shares. If the relationship with the service provider is terminated prior to the issuance of the Earn-Out Shares, the shares will be redistributed to the remaining participants in the Earn-Out Shares.
Contingently Issuable Common Stock
Prior to the Merger, NewHold Industrial Technology Holdings, LLC, the sponsor of the NHIC special purpose acquisition company owned 4,312,500 shares of NHIC Class B common stock (the “Founder Shares). Upon the closing of the Merger, NHIC Class A and Class B common stock became the Company’s common stock. The Founder Shares outstanding were subject to certain share-performance-based vesting provisions as follows:
Vesting Provision I – 1,897,500 shares of the Company’s common stock shall vest and no longer be subject to forfeiture as of the Merger;
Vesting Provision II – if within five years following the closing of the Merger, the last reported sale price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period, then 948,750 shares of the Company’s common stock shall vest and no longer be subject to forfeiture and
Vesting Provision III – if within five years following the closing of the Merger, the last reported sale price of the Company’s common stock equals or exceeds $15.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period, then 948,750 shares of the Company’s common stock) shall vest and no longer be subject to forfeiture.
The remaining 517,500 Founder Shares were contributed to Give Evolv LLC.
If Vesting Provision II and/or Vesting Provision III are not satisfied, the corresponding number of shares specified shall be forfeited and no longer issued and outstanding. If there is a Change of Control event prior to Vesting Provision II and/or Vesting Provision III are satisfied, the Founder shares are no longer subject to forfeiture and shall vest immediately upon the occurrence of a Change of Control event.
In accordance with ASC 815 – Derivatives and Hedging, the contingently issuable common stock is accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as change in fair value of contingently issuable common stock liability in other income (expense), net in the consolidated statements of operations and comprehensive loss. When the Vesting Provisions have been achieved and the contingently issuable common shares are issued, the Company will reclassify the corresponding amount from a liability to additional paid-in-capital and common stock at par value of $0.0001 per share.
The estimated fair value of the contingently issuable common shares was determined using a Monte Carlo simulation that simulated the future path of the Company’s stock price over the earn-out period. The assumptions utilized in the calculation are based on the achievement of certain stock price milestones including expected stock price volatility, risk-free rate of return, likelihood of change in control, and remaining term.
80

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The contingently issuable common shares are categorized as a Level 3 fair value measurement (see Note 4) because the Company estimates projections during the earn-out period utilizing unobservable inputs, including various potential pay-out scenarios. Contingently issuable shares involve certain assumptions requiring significant judgment and actual results may differ from assumed and estimated amounts.
Public Warrant Liability
In connection with the closing of the Merger, the Company assumed warrants for the purchase of 14,325,000 shares of common stock at an exercise price of $11.50 (the “Public Warrants”). The Public Warrants are classified as a liability pursuant to ASC 815 – Derivatives and Hedging as the equity derivative scope exception was not met and are measured at fair value, with the changes in fair value reported in earnings as a component of other income (expense), net in the consolidated statements of operations and comprehensive loss with the offset to additional paid in capital.
Leases as a Lessee
The Company accounts for leases in accordance with ASC 842, Leases. At contract inception, the Company determines if an arrangement is or contains a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If determined to be or contain a lease, the lease is assessed for classification as either an operating or finance lease at the lease commencement date, defined as the date on which the leased asset is made available for use by the Company (when the Company is the lessee). Where the Company is the lessee, for each lease with a term greater than twelve months, the Company records a right-of-use asset and lease liability.
A right-of-use asset represents the economic benefit conveyed to the Company by the right to use the underlying asset over the lease term. A lease liability represents the obligation to make lease payments arising from the use of the asset over the lease term. Lease liabilities are measured at lease commencement and calculated as the present value of the future lease payments in the contract using the rate implicit in the contract, when available. If an implicit rate is not readily determinable, the Company uses an incremental borrowing rate measured as the rate at which the Company could borrow, on a fully collateralized basis, a commensurate loan in the same currency over a period consistent with the lease term at the commencement date. Right-of-use assets are measured as the amount of the initial lease liability plus initial direct costs and prepaid lease payments, less lease incentives granted by the lessor. The lease term is measured as the noncancelable period in the contract, adjusted for any options to extend or terminate when it is reasonably certain the Company will extend the lease term via such options based on an assessment of economic factors present as of the lease commencement date. The Company elected the practical expedient to not recognize leases with a lease term of twelve months or less.
Components of a lease are split into three categories: lease components, non-lease components, and non-components. The fixed and in-substance fixed contract consideration (including any consideration related to non-components) are allocated, based on the respective relative fair values, to the lease components and non-lease components. The Company has elected the practical expedient to account for lease and non-lease components together as a single lease component for all underlying assets and allocate all of the contract consideration to the lease component only.
The Company’s operating leases are presented in the consolidated balance sheet as operating lease right-of-use assets, classified as noncurrent assets, and operating lease liabilities, classified as current and noncurrent liabilities. Operating lease expense is recognized on a straight-line basis over the lease term. Variable costs associated with a lease, such as maintenance and utilities, are not included in the measurement of the lease liabilities and right-of-use assets but rather are expensed when the events determining the amount of variable consideration to be paid have occurred.
Inventory
Inventory is stated at the lower of cost or net realizable value with cost being determined using the weighted average method. The Company regularly reviews inventory quantities on-hand for excess and obsolete inventory and, when circumstances indicate, records charges to write down inventories to their estimated net realizable value, after evaluating historical sales, future demand, market conditions and expected product life cycles. Such charges are classified as product cost of revenues in the consolidated statement of operations and comprehensive loss. Any write-down of inventory to net realizable value creates a new cost basis. The Company recorded $1.6 million and $1.6 million in inventory write-offs and change in inventory reserves during the years ended December 31, 2023 and 2022, respectively. Inventory write-offs primarily relate to Edge units and prior generation Express units, as the Company is no longer selling these products, as well as other inventory that was determined to be obsolete or unsellable.
81

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expense are recognized using the straight-line method over the estimated useful life of each asset, as follows:
Estimated Useful Life
Computers and telecommunications equipment3 years
Lab equipment5 years
Software4 years
Furniture and fixtures5 years
Leasehold improvements
Shorter of useful life of 7 years or remaining lease term

Leased equipment
4-7 years
Internal-use software4 years
Estimated useful lives are periodically assessed to determine if changes are appropriate. Leasehold improvements are depreciated using the straight-line method over the lesser of the lease term or its estimated economic useful life. Lease terms are used based upon the initial lease agreement and do not consider potential renewals or extensions until such time that the renewals or extensions are contracted. Maintenance and repairs are charged to expense as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation are eliminated from the consolidated balance sheet and any resulting gains or losses are included in the consolidated statements of operations and comprehensive loss in the period of disposal. Costs for capital assets not yet placed into service are capitalized as construction-in-progress and depreciated once placed into service.
The Company’s leases for leased equipment generally are 48 months. The Company’s subscription contracts are generally classified as operating leases because title does not transfer and they do not meet any of the other criteria per Accounting Standards Codification 842 – Leases (“ASC 842”).
The Company evaluates property and equipment for obsolescence and impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset group for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset group to its carrying value. An impairment loss would be recognized in loss from operations and comprehensive loss when estimated undiscounted future cash flows expected to result from the use of an asset group are less than its carrying amount. The impairment loss is based on the excess of the carrying value of the impaired asset group over its fair value, determined based on discounted cash flows. The Company recorded impairment losses of $0.3 million and $1.2 million during the years ended December 31, 2023 and 2022, respectively. These impairment losses related primarily to Edge and Express prototype units that were taken out of service and retired.
The Company capitalizes certain software development costs, including consulting costs and compensation expenses for employees who devote time to the development projects, beginning upon completion of the preliminary project stage (in relation to internal-use software) or upon establishment of technological feasibility (in relation to software embedded in products to be sold or leased), and through the date the software is ready for its intended use. The Company records software development costs in property and equipment, net. Costs incurred in the preliminary stages of development activities and post implementation are expensed in the period incurred and are recorded in research and development expense in the consolidated statements of operations and comprehensive loss. The Company also capitalizes
82

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality.
Once the project is available for general release, capitalization ceases, and the asset can begin amortization. Capitalized software costs are amortized on a straight-line basis over their estimated useful life, which is generally four years, and are recorded in cost of subscription revenue and cost of service revenue in the consolidated statements of operations and comprehensive loss.
Debt Issuance Costs
The Company capitalizes certain legal, accounting, and other third-party fees that are directly associated with the issuance of debt as debt issuance costs. Debt issuance costs are recorded as a direct reduction of the carrying amount of the associated debt on the consolidated balance sheet and amortized as interest expense on the consolidated statement of operations and comprehensive loss using the effective interest method.
Segment Information
The Company determined that it has one operating segment after considering the Company’s organizational structure and the information regularly reviewed and evaluated by the Company’s chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. The Company has determined that its CODM is its President and Chief Executive Officer. The CODM reviews the financial information on a consolidated basis for purposes of evaluating financial performance and allocating resources. On the basis of these factors, the Company determined that it operates and manages its business as one operating segment, that develops, manufactures, markets and sells security screening products and specific services, and accordingly has one reportable segment for financial reporting purposes.
Revenue Recognition
The Company recognizes revenue in accordance with Accounting Standards Codification 606 – Revenue from Contracts with Customers (“ASC 606”). Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In order to achieve this core principle, the Company applies the following five steps when recording revenue: (1) identify the contract, or contracts, with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when, or as, performance obligations are satisfied.
We derive revenue from (1) subscription arrangements generally accounted for as operating leases, including SaaS and maintenance, (2) the sale of products, (3) SaaS and maintenance related to products sold to customers either by Evolv or by Columbia Tech pursuant to the Distribution and License Agreement (as defined below), (4) license fees related to the Distribution and License Agreement (as defined below), and (5) professional services, including installation, training, and event support. Maintenance consists of preventative maintenance, technical support, bug fixes, and when-and-if available threat updates. Our arrangements are generally noncancelable and nonrefundable after ownership passes to the customer. Revenue is recognized net of sales tax.
Distribution and License Agreement
In March 2023, the Company entered into a distributor licensing agreement (the "Distribution and License Agreement") with Columbia Electrical Contractors, Inc. ("Columbia Tech"). Columbia Tech, a wholly-owned subsidiary of Coghlin Companies, which serves as the Company's primary contract manufacturer. Under this arrangement, the Company has granted a license of its intellectual property to Columbia Tech, which contracts directly with certain of the Company's resellers to fulfill sales demand where the end-user customer prefers to purchase the hardware equipment as opposed to lease the equipment. Columbia Tech pays the Company a hardware license fee for each system it manufactures and sells under the agreement. In these instances, the Company still contracts directly with the reseller to provide a multi-year SaaS and maintenance subscription to the end-users.
83

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Company has assessed whether it operates as the principal or as an agent in relation to the sale of product made by Columbia Tech to the Company's resellers pursuant to the Distribution and License Agreement. The Company considered various factors, including but not limited to, inventory risk, discretion in establishing pricing, and which entity is primarily responsible for fulfillment. Based on an evaluation of the facts and circumstances, the Company concluded that Columbia Tech is the principal in the arrangement. The Company therefore does not recognize revenue in relation to sales of product pursuant to the Distribution and License Agreement, but does recognize revenue in relation to license fees received from Columbia Tech and the SaaS and maintenance subscription contracts, each as further described below.
Product Revenue
The Company derives revenue from the sale of its Evolv Express equipment and related add-on accessories to customers. Revenue is recognized when control of the product has transferred to the customer. Transfer of control occurs when the Company has transferred title and risk of loss and has a present right to payment for the equipment, which follows the terms of each customer contract. Products are predominantly sold with distinct services, which are described in the services section below.
Subscription Revenue - Leases as Lessor
In addition to selling our products directly to customers, we also derive revenue from leasing our equipment, which we classify as subscription revenue. Lease terms are typically four years, generally do not include unilateral options by either the Company or our customer to extend, terminate or to purchase the underlying asset, and customers generally pay either a quarterly or annual fixed payment for the lease, SaaS, and maintenance elements over the contractual lease term. There are no variable lease payments as a part of these arrangements.
The accounting provisions we use to classify transactions as sales-type are: (i) whether the lease transfers ownership of the equipment by the end of the lease term, (ii) whether the lease grants the customer an option to purchase the equipment and the customer is reasonably certain to do so, (iii) whether the lease term is for the major part of the economic life of the underlying equipment, (iv) whether the present value of the lease payments, and any residual value guaranteed by the customer that is not already reflected in the lease payments, is equal to or greater than substantially all of the fair market value of the equipment at the commencement of the lease, and (v) whether the equipment is specific to the customer and of such a specialized nature that it is expected to have no alternative use to the Company at the end of the lease term. Leasing arrangements meeting any of these conditions are accounted for as sales-type leases and revenue attributable to the lease component is recognized in a manner consistent with product revenue and the related equipment is derecognized with the associated expense presented as a cost of revenue. Leasing arrangements that do not meet the criteria for classification as a sales-type lease will be accounted for as a direct-financing lease if the following two conditions are met: (i) the present value of the lease payments, and any residual value guaranteed by the customer that is not already reflected in the lease payments and any other third party unrelated to the Company, is equal to or greater than substantially all of the fair market value of the equipment at the commencement of the lease, and (ii) it is probable that the Company will collect the lease payments and amounts necessary to satisfy a residual value guarantee. Leasing arrangements that do not meet any of the sales-type lease or direct-financing lease classification criteria are accounted for as operating leases and revenue is recognized straight-line over the term of the lease. Historically, nearly all of the Company's equipment leases have been classified as operating leases.
The Company considers the economic life of most of our products to be seven years. The Company believes seven years is representative of the period during which the equipment is expected to be economically usable by one or more users, with normal service, for the purpose for which it is intended. The unguaranteed residual value is estimated to be the value at the end of the lease term based on the anticipated fair market value of the units. The Company mitigates residual value risk of our leased equipment by performing regular management and maintenance, as necessary.
Generally, lease arrangements include both lease and non-lease components. The lease component relates to the customer’s right-to-use the equipment over the lease term. The non-lease components relate to (1) distinct services, such as SaaS and maintenance, (2) any add-on accessories, and (3) professional services, including installation, training, and event. Professional services are included in license fees and other revenue, as described below, and add-on accessories are included in product revenue. Because the equipment, SaaS, and maintenance components of a subscription arrangement are recognized as revenue over the same time period and in the same pattern, the Company elected the practical expedient to aggregate non-lease components with the associated lease component and account for the combined component as an
84

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
operating lease for all underlying asset classes. In the evaluation of whether the lease component (equipment) or the non-lease components associated with the lease component (SaaS and maintenance) is the predominant component, the Company determined that the lease component is predominant as we believe the customer would ascribe more value to the use of the security equipment than that of the SaaS and maintenance services. Therefore, the Company accounts for the combined lease component under ASC 842. The equipment lease and SaaS/maintenance performance obligations are classified as a single category of subscription revenue in the consolidated statements of operations and comprehensive loss. The professional services represent distinct services provided to customers. These activities are considered separate performance obligations to the customer and therefore are considered non-lease components. As professional services are generally performed prior to lease commencement, the timing and pattern of transfer for these services differ from that of the lease component and are not eligible to be combined.
We exclude from variable payments all lessor costs that are explicitly required to be paid directly by a lessee on behalf of the lessor to a third party.
Professional services are generally billed to the lessee as part of the lease contract billing, according to various contractual terms. Professional services costs incurred by the Company are accounted for as a fulfillment cost and are included in the cost of license fees and other revenue in the consolidated statements of operations and comprehensive loss.
Service Revenue
Service revenue consists of subscription-based SaaS and maintenance revenue related to products sold to a customer by either the Company or by Columbia Tech pursuant to the Distribution and License Agreement. Customers generally pay either a quarterly or annual fixed payment for SaaS and maintenance. SaaS and maintenance revenue is recognized ratably over the period of the arrangement, which is typically 4 years.
License Fee and Other Revenue
License fee and other revenue includes license fee revenue from the Distribution and License Agreement, revenue from professional services, and other one-time revenue. License fee revenue is recognized upon the shipment of product from our third-party manufacturer to the reseller. Revenue for professional services is recognized upon transfer of control of these services, which are normally rendered over a short duration.
Revenue from Reseller Partners
A portion of the Company’s revenue is also generated by sales to its reseller partners. When the Company transacts with a reseller partner, its contractual arrangement is with the reseller partner and not with the end-use customer. In these transactions, the reseller partner is considered the customer; the Company has discretion over the pricing to the reseller partner and maintains overall control of the inventory and sales process to the reseller partner. Right of return does not generally exist. Whether the Company transacts with a reseller partner and receives the order from a reseller partner or directly from an end-use customer, its revenue recognition policy and resulting pattern of revenue recognition is the same.
Transaction Price
The transaction price is the amount of consideration that the Company expects to be entitled for providing goods and services under a contract, which includes fixed amounts, and on rare occasions, variable consideration. The Company may also provide discounts to customers which reduce the transaction price. On infrequent occasions, the Company may offer customers the option to purchase additional goods and services at a fixed price. In these circumstances, the Company assesses whether these offers constitute a material right, and if so, the Company would account for the material right as a separate performance obligation. The Company does not normally provide for rights of returns to customers on product sales and, therefore, does not record a provision for returns. Amounts paid or payable to customers, including those related to sponsorship arrangements, are recognized as a reduction of the transaction price, and therefore, of revenue unless the payment is in exchange for a distinct good or service.
85

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Performance Obligations
A performance obligation is a promise in a contract to transfer a distinct product or service to a customer that is both capable of being distinct, whereby the customer can benefit from the product or service either on its own or together with other resources that are readily available, and is distinct in the context of the contract, whereby the transfer of the product or service is separately identifiable from other promises in the contract.
Equipment is sold or leased with embedded software, which is considered a single performance obligation. Maintenance, which includes preventative maintenance, future updates, security threat updates, and minor bug fixes on a when-and-if available basis, is considered a single performance obligation. SaaS, which includes data-driven security information and analytics insights, is also considered a performance obligation. Professional services, including installation, training, and event support, are considered separate performance obligations and are included within license fee and other revenue. Any add-on accessories are also considered separate performance obligations and are included in product revenue.
Payment terms
Payment terms for customer orders are typically 30 days after the shipment or installation of the product. Generally, the Company’s contracts do not contain a significant financing component.
Multiple Performance Obligations within an Arrangement
The Company’s contracts may include multiple performance obligations when customers purchase a combination of products and services. When the Company’s customer arrangements have multiple performance obligations that contain an equipment lease for the customer’s use as well as distinct services that are delivered simultaneously, the Company allocates the arrangement consideration between the lease deliverables and non-lease deliverables based on the relative estimated SSP of each distinct performance obligation. For multiple performance obligation arrangements that do not contain a lease, the Company allocates the contract’s transaction price to each performance obligation on a relative SSP basis. The Company determines SSP based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, the Company estimates the SSP taking into account available information such as market conditions, internally approved pricing guidelines, and observable pricing data such as standard cost metrics related to the performance obligation.
Stock-Based Compensation
The Company measures all stock-based awards granted to employees, officers, directors and non-employees based on their fair value on the date of the grant and recognizes compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. The vesting period for stock options is generally four years and the vesting period for restricted stock units is generally three years. The Company classifies stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. The Company issues stock-based awards with service-based vesting conditions and records the expense for these awards using the straight-line method. Forfeitures are accounted for as they occur.
In January 2021, the Company granted warrants (the "Finback Common Stock Warrants") exercisable for 2,552,913 shares of common stock at an exercise price of $0.42 per share to Finback Evolv OBH, LLC ("Finback"), a consulting group affiliated with one of the Company's shareholders. The Finback Common Stock Warrants vest upon meeting certain sales criteria as defined in a business development agreement (the "Finback BDA") which has a term of three years. The Finback Common Stock Warrants expire in January 2031. The Finback Common Stock Warrants are accounted for under ASC 718 Compensation - Stock Compensation as the warrants vest upon certain performance conditions being met.
Prior to the closing of the Merger, there was not a public market for the shares of the Company’s common stock. The Company’s determination of the fair value of stock options on the date of grant utilized the Black-Scholes option-pricing model and was impacted by its common stock price, as determined by the Board of Directors with input from the Company’s management, as well as changes in assumptions regarding a number of subjective variables. These variables
86

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
included, but were not limited to, the expected term that options remained outstanding, the expected common stock price volatility over the term of the option awards, risk-free interest rates, and expected dividends. The Company valued its common stock taking into consideration its most recently available valuation of common stock performed by third parties as well as additional factors since the date of the most recent contemporaneous valuation through the date of grant. After the closing of the Merger, the Company determines the fair value of each share of common stock underlying stock-based awards based on the closing price of the Company’s common stock as reported by Nasdaq on the date of grant.
Pursuant to the Merger Agreement, the Company will issue 15,000,000 earn-out shares of the Company’s common stock to Legacy Evolv shareholders and Legacy Evolv Service Providers including employees, officers, directors, and non-employees based on the achievement of certain target share price contingencies and subject to continued employment. The company classifies the share-based compensation arrangement with Legacy Evolv Service Providers as equity on its balance sheet and corresponding stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. As of December 31, 2023, of the total 15,000,000 earn-out shares of the Company’s common stock, 2,115,304 earn-out shares can be earned by the Legacy Evolv Service Providers and are subject to the stock-based compensation guidance. As a condition for Earn-Out Shares being issued to Earn-Out Service Providers, the service provider must be providing services to the Company on the date of the issuance of the shares. If the relationship with the service provider is terminated prior to the issuance of the Earn-Out Shares, the shares will be redistributed to the remaining participants in the Earn-Out Shares.
Income Taxes
The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company’s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes.
The Company assesses the likelihood that its deferred tax assets will be recovered from future sources of income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. The potential for recovery of deferred tax assets is evaluated by analyzing past operating results, estimating the future taxable profits expected and considering prudent and feasible tax planning strategies.
The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.
The Company evaluates at the end of each reporting period whether some or all the undistributed earnings of its foreign subsidiaries are permanently reinvested. The Company would recognize deferred income tax liabilities to the extent that management asserts that undistributed earnings of its foreign subsidiaries are not permanently reinvested and will not be permanently reinvested in the future. For the year ended December 31, 2023, the Company had less than $0.1 million in foreign earnings. For the year ended December 31, 2022, the Company had no foreign earnings in any foreign jurisdictions. The Company will continue to evaluate its position in the future based on its future strategy and cash needs.
Net Loss per Share Attributable to Common Stockholders
Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net loss attributable to common stockholders is computed by adjusting net loss attributable to common stockholders for the impact
87

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
to the extent a denominator adjustment is required. Diluted net loss per share attributable to common stockholders is computed by dividing the diluted net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period, including the dilutive effect of potential dilutive common shares as determined under the treasury stock method. For purposes of this calculation, outstanding stock options, convertible preferred stock, convertible notes, warrants to purchase common stock, and warrants to purchase preferred stock are considered potential dilutive common shares.
In periods in which the Company reported a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December 31, 2023 and 2022.
Recently Adopted Accounting Pronouncements
Becoming a Large Accelerated Filer
Prior to December 31, 2023, the Company qualified as an "emerging growth company", as defined in the Jumpstart our Business Startups Act of 2012, and elected not to “opt out” of the extended transition related to complying with new or revised accounting standards.
The Company became a large accelerated filer and ceased to qualify as an emerging growth company as of December 31, 2023. The adoption dates discussed below for recently adopted accounting pronouncements reflect the updated transition periods required as a result of becoming a "large accelerated filer" (as defined under Rule 12b-2 of the Exchange Act) as of December 31, 2023. The Company will be required to adopt all future new or revised accounting pronouncements in accordance with applicable public company timelines specified in those accounting pronouncements.
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326) (“ASU 2016-13”). The new standard adjusts the accounting for assets held at amortized cost basis, including marketable securities accounted for as available for sale, and trade receivables. The standard eliminates the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For public entities except smaller reporting companies, the guidance is effective for annual reporting periods beginning after December 15, 2019 and for interim periods within those fiscal years. In November 2019, the FASB issued ASU No. 2019-10, which deferred the effective date for non-public entities and smaller reporting companies to annual reporting periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is allowed. The Company adopted this guidance effective January 1, 2023, and the adoption of this guidance did not have a material impact on its consolidated financial statements and related disclosures.
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The amendments in ASU 2021-08 are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption of the amendments is permitted, including adoption in an interim period. The Company adopted this guidance effective January 1, 2023, and the adoption of this guidance did not have an impact on its consolidated financial statements and related disclosures.
Recently Issued Accounting Pronouncements
In July 2023, the FASB issued Accounting Standards Update ASU 2023-03, “Presentation of Financial Statement (Topic 205), Income Statement - Reporting Comprehensive Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation - Stock Compensation (Topic 718),” to amend various U.S. Securities Exchange Commission ("SEC") paragraphs in the Accounting Standards Codification to reflect the issuance of SEC Staff Accounting Bulletin No. 120, among other things. The ASU does not provide any new guidance so there is no transition or
88

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
effective date associated with it. The Company is currently assessing the impact of adopting ASU 2023-03 on the consolidated financial statements and related disclosures.
In October 2023, the FASB issued ASU 2023-06, “Disclosure Improvements – Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative,” related to disclosure or presentation requirements for various subtopics in the FASB’s Accounting Standards Codification (“Codification”). The amendments in the update are intended to align the requirements in the Codification with the SEC regulations and facilitate the application of GAAP for all entities. The effective date for each amendment is the date on which the SEC removal of the related disclosure requirement from Regulation S-X or Regulation S-K becomes effective, or if the SEC has not removed the requirements by June 30, 2027, this amendment will be removed from the Codification and will not become effective for any entity. Early adoption is prohibited. The Company does not expect this update to have a material impact on the consolidated financial statements and related disclosures.
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The updated accounting guidance requires enhanced reportable segment disclosures, primarily related to significant segment expenses which are regularly provided to the chief operating decision maker. The guidance is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required and early adoption is permitted. The Company is currently evaluating the impact of this standard on the disclosures within the consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." ASU 2023-09 is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. A public entity should apply the amendments in ASU 2023-09 prospectively to all annual periods beginning after December 15, 2024. The Company is currently evaluating the impact of this standard on the disclosures within the consolidated financial statements.
3. Marketable Securities
Marketable securities as of December 31, 2023 consisted of the following:
December 31, 2023
Amortized CostUnrealized Gain/(Loss)Fair Value
U.S. Treasury bills$51,289 $ $51,289 
Total marketable securities$51,289 $ $51,289 
Marketable securities at December 31, 2023 are comprised solely of zero coupon U.S. treasury bills with maturities of less than one year that are classified as available-for-sale debt securities. The Company did not record any unrealized gains or losses on available-for-sale securities for the year ended December 31, 2023. The accretion of discounts on marketable securities is included in interest income on the consolidated statements of operations and comprehensive income. The Company did not have any marketable securities as of December 31, 2022.
89

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
4. Fair Value Measurements
The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):
Fair Value Measurements at December 31, 2023
Level 1Level 2Level 3Total
Assets:
Money market funds$57,829 $ $ $57,829 
Treasury bills 51,289  51,289 
$57,829 $51,289 $ $109,118 
Liabilities:
Contingent earn-out liability$ $ $29,119 $29,119 
Contingently issuable common stock liability  6,530 6,530 
Public Warrant liability10,889   10,889 
$10,889 $ $35,649 $46,538 
Fair Value Measurements at December 31, 2022
Level 1Level 2Level 3Total
Assets:
Money market funds$149,971 $ $ $149,971 
$149,971 $ $ $149,971 
Liabilities:
Long-term debt including current portion$ $29,683 $ $29,683 
Contingent earn-out liability  14,218 14,218 
Contingently issuable common stock liability  3,392 3,392 
Public Warrant liability6,124   6,124 
$6,124 $29,683 $17,610 $53,417 
Money market funds are included in cash and cash equivalents on the consolidated balance sheets. As of December 31, 2023, all outstanding treasury bills, which totaled $51.3 million, had maturities greater than 3 months and are reflected as marketable securities. The fair value of the treasury bills, which are classified as Level 2 securities, is calculated by a third-party pricing service and is based on estimates obtained from various sources.
The Company may also value its non-financial assets and liabilities, including items such as inventories and property and equipment, at fair value on a non-recurring basis if it is determined that impairment has occurred. Such fair value measurements use significant unobservable inputs and are classified as Level 3.
The carrying amounts of cash and cash equivalents, accounts receivable, restricted cash, accounts payable, accrued liabilities, and other accrued expenses approximate fair value because of their short maturity.
During each of the years ended December 31, 2023 and 2022, there were no transfers between Level 1, Level 2, and Level 3.
Valuation of Contingent Earn-out
Pursuant to the Merger Agreement, the Legacy Evolv stockholders, immediately prior to the Merger, were entitled to receive additional shares of the Company’s common stock upon the Company achieving certain milestones as described in Note 2. The Company’s contingent earn-out shares were recorded at fair value as contingent earn-out liability upon the
90

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
closing of the Merger and are remeasured at each reporting period. As of December 31, 2023, no milestones have been achieved.
The fair value of the contingent earn-out is calculated using a Monte Carlo analysis in order to simulate the future path of the Company’s stock price over the earn-out period. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value. The significant assumptions used in the Monte Carlo model as of December 31, 2023 were as follows: 90% expected stock price volatility, a risk-free rate of return of 4.2%, a 25% likelihood of change in control, and a remaining term of 2.2 years.
The following table provides a rollforward of the contingent earn-out liability (in thousands):
Balance at December 31, 2021$21,206 
Change in fair value(6,988)
Balance at December 31, 2022$14,218 
Change in fair value14,901 
Balance at December 31, 2023$29,119 
Valuation of Contingently Issuable Common Stock
Prior to the Merger, certain NHIC shareholders owned 4,312,500 Founder Shares. Of these shares, 1,897,500 shares vested at the closing of the Merger, 517,500 shares were transferred back to NHIC and then contributed to Give Evolv LLC and the remaining 1,897,500 outstanding shares will vest upon the Company achieving certain milestones (see Note 2). The Company’s contingently issuable common stock was recorded at fair value as contingent shares on the closing of the Merger and will be remeasured at each reporting period. As of December 31, 2023, no milestones have been achieved.
The fair value of the contingently issued common shares is determined using a Monte Carlo analysis in order to simulate the future path of the Company’s stock price over the vesting period. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value. The significant assumptions used in the Monte Carlo model as of December 31, 2023 were as follows: 90% expected stock price volatility, a risk-free rate of return of 4.1%, a 25% likelihood of change in control, and a remaining term of 2.5 years.
The following table provides a rollforward of the contingently issuable common shares (in thousands):
Balance at December 31, 2021$5,264 
Change in fair value(1,872)
Balance at December 31, 2022$3,392 
Change in fair value3,138 
Balance at December 31, 2023$6,530 
Valuation of Public Warrant Liability
Upon the closing of the Merger, the Company assumed the Public Warrants to purchase shares of the Company’s common stock. The Public Warrants are publicly traded and the initial fair value of the public warrants were based on the closing price as reported by Nasdaq on the date of the Merger and remeasured at each reporting period.
91

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table provides a rollforward of the public warrant liability (in thousands):
Balance at December 31, 2021$11,030 
Change in fair value(4,906)
Balance at December 31, 2022$6,124 
Change in fair value4,765 
Balance at December 31, 2023$10,889 
5. Revenue Recognition
Remaining Performance Obligations
The following table includes estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially satisfied) as of December 31, 2023.

Less than 1 year1 - 2 yearsMore than 2 yearsTotal
Product revenue$997 $ $ $997 
Subscription revenue56,819 52,188 63,265 172,272 
Service revenue21,255 20,948 24,898 67,101 
License fee and other revenue143   143 
Total revenue$79,214 $73,136 $88,163 $240,513 
The amount of minimum future leases is based on expected income recognition. As of December 31, 2023, future minimum payments on noncancelable leases are as follows (in thousands):

Year Ending December 31:
2024$56,819 
202552,188 
202641,088 
202721,118 
Thereafter1,059 
$172,272 
Contract Balances from Contracts with Customers
Contract assets arise from unbilled amounts in customer arrangements when revenue recognized exceeds the amount billed to the customer and the Company’s right to payment is conditional and not only subject to the passage of time. As of December 31, 2023 and December 31, 2022, the Company had $3.7 million and $2.9 million in current portion of contract assets and $0.5 million and $1.4 million in contract assets, noncurrent on the consolidated balance sheets, respectively.
Contract liabilities represent the Company’s obligation to transfer goods or services to a customer for which it has received consideration (or the amount is due) from the customer. The Company has a contract liability related to service revenue, which consists of amounts that have been invoiced but that have not been recognized as revenue. Amounts expected to be recognized as revenue within 12 months of the balance sheet date are classified as current deferred revenue and amounts expected to be recognized as revenue beyond 12 months of the balance sheet date are classified as deferred revenue, noncurrent. The Company recognized revenue of $19.1 million during the year ended December 31, 2023 that was included in the 2022 deferred revenue balance. The Company recognized revenue of $6.6 million during the year ended December 31, 2022 that was included in the 2021 deferred revenue balance.
92

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The following table provides a rollforward of deferred revenue (in thousands):
Balance at December 31, 2021$9,074 
Revenue recognized in relation to the beginning of the year contract liability balance(6,632)
Revenue deferred33,526 
Balance at December 31, 2022$35,968 
Revenue recognized in relation to the beginning of the year contract liability balance(19,104)
Revenue deferred54,626 
Balance at December 31, 2023$71,490 
The following table presents the Company’s components of lease revenue (in thousands):
Twelve Months Ended
December 31,
20232022
Revenue from sales-type leases$ $1,123 
Interest income on lease receivables197 224 
Lease income - operating leases37,247 17,569 
Total lease revenue$37,444 $18,916 
The revenue from sales-type leases is related to the Evolv Express units where the lease term is for the major part of the economic life of the underlying equipment and is classified as product revenue in the consolidated statements of operations and comprehensive loss. The interest income on lease receivables is classified under interest income in the consolidated statements of operations and comprehensive loss. The lease income from operating leases is related to the leased equipment under subscription arrangements and is classified as subscription revenue in the consolidated statements of operations and comprehensive loss. Revenue related to leases entered into with related parties were $0.9 million and $0.6 million during the years ended December 31, 2023 and 2022, respectively.
Disaggregated Revenue
The following table presents the Company’s revenue by revenue stream (in thousands). Certain prior period amounts have been reclassified to conform to current period presentation:

Twelve Months Ended
December 31,
20232022
Product revenue$21,977 $31,985 
Leased equipment37,247 17,569 
Service revenue16,141 4,331 
License fees2,963  
Professional services and other revenue2,090 1,310 
Total revenue$80,418 $55,195 

93

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table presents the Company's revenue by geographical region based on customer location (in thousands):

Twelve Months Ended
December 31,
20232022
United States$78,556 $53,815 
Foreign1,862 1,380 
Total revenue$80,418 $55,195 
Commissions
The Company incurs and pays commissions on product sales. The Company applies the practical expedient for contracts less than one year in duration to expense the commission costs in the period in which they were incurred. Commissions on product sales and services are expensed in the period in which the related revenue is recognized. Commissions on subscription arrangements and maintenance are expensed ratably over the life of the contract. The Company had a deferred asset related to commissions of $11.4 million and $9.0 million as of December 31, 2023 and December 31, 2022, respectively. During the years ended December 31, 2023 and 2022, the Company recognized commission expense of $5.6 million and $4.1 million, respectively.
Give Evolv LLC
Upon the closing of the Merger, the NHIC Founders transferred 517,500 shares of its common stock to Evolv NewHold Benefit LLC (“ENHB”), which represented the initial contribution to be used to pay for the donation of Evolv’s Express units to public venues and institutions, primarily schools in locations that might not otherwise be able to afford weapon detection security screening systems and related products and services. In September 2021, ENHB was renamed to Give Evolv LLC (“Give Evolv”). Give Evolv is deemed an entity under common control and a consolidating entity as it is under the same management as the Company. As such, the shares held by Give Evolv are not considered outstanding or issued.
For such arrangements, Give Evolv generally purchases the related products and services from Evolv through an intercompany transaction using the available donated proceeds from the transfer of common stock upon the closing of the Merger. Evolv will be responsible for the delivery of the units, in addition to providing related services, such as installation, training, and maintenance. Consideration transferred to Evolv for the related products and services may be in the form of common stock or cash. Shares of common stock may be sold to generate funds for the purposes of paying for the donated goods and services. The sales transactions between Evolv and Give Evolv eliminate in consolidation.
During the year ended December 31, 2023, the Company donated five Evolv Express units to schools resulting in $0.2 million in general and administrative expenses in the Company's consolidated statements of operations and comprehensive loss. During the year ended December 31, 2022, the Company donated six Evolv Express units to schools, resulting in $0.2 million in general and administrative expenses in the Company's consolidated statements of operations and comprehensive loss.
6. Leases
Company Headquarters (Waltham, MA)
In April 2021, the Company entered into a sublease agreement for office and storage space for its corporate headquarters located at 500 Totten Pond Road in Waltham, MA. The Company entered into an amendment to the sublease agreement in August 2023 in order to lease additional space within the building. The sublease expires on October 31, 2024. The Company is required to maintain a minimum cash balance of $0.3 million as a security deposit on the space which is classified as restricted cash, current on the consolidated balance sheets. The Company pays for its proportionate share of building operating expenses and taxes that are treated as variable costs and excluded from the measurement of the lease. The sublease grants the Company an option to extend the term for an additional three years at the fair market rent by giving
94

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
the landlord nine months written notice. The Company was not reasonably certain to exercise the option to extend the lease and therefore the extension term was excluded from the measurement of the lease.
Storage Facilities
The Company additionally leases three storage spaces on a month-to-month basis that are classified as short-term leases.
Operating lease cost recognized during the years ended December 31, 2023 and December 31, 2022 was $1.2 million and $1.0 million, respectively. Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2023 and December 31, 2022 was $1.4 million and $1.1 million, respectively.
The weighted-average remaining lease term and discount rate were as follows:

December 31,
20232022
Weighted average remaining lease term0.8 years1.8 years
Weighted average discount rate7.75 %6.95 %
Future annual lease payments under non-cancelable operating leases as of December 31, 2023 were as follows (in thousands):

Year Ended December 31:
2024$1,432 
2025 
Total future lease payments1,432 
Less: imputed interest(41)
Present value of operating lease liability $1,391 
7. Accounts Receivable
Allowance for Expected Credit Losses
Changes in the allowance for expected credit losses were as follows (in thousands):
Allowance for Expected Credit Losses
December 31, 2021$(50)
Provisions(150)
Write-offs, net of recoveries
December 31, 2022$(200)
Provisions(410)
Write-offs, net of recoveries28
December 31, 2023$(582)
95

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
8. Inventory
Inventory consisted of the following (in thousands):
December 31,
20232022
Raw materials$1,869 $2,334 
Finished goods7,638 7,923 
Total$9,507 $10,257 
9. Prepaid expenses and other current assets
Prepaid expenses and other current assets consisted of the following (in thousands):
December 31,
20232022
Prepaid deposits$12,177 $9,666 
Prepaid subscriptions1,868 897 
Current portion of net investment in sales-type leases367 337 
Prepaid insurance1,208 2,374 
Other1,334 1,114 
Total$16,954 $14,388 
10. Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
December 31,
20232022
Computers and telecom equipment$1,331 $599 
Lab equipment1,171 871 
Furniture and fixtures111 111 
Leasehold improvements566 542 
Leased equipment80,206 35,983 
Capitalized software8,629 4,150 
Sales demo equipment2,758 2,340 
Equipment held for lease1
32,910 7,826 
Construction in progress2,493 71 
130,175 52,493 
Less: Accumulated depreciation and amortization(17,254)(7,786)
$112,921 $44,707 
(1) Represents equipment that has not yet been deployed to a customer and, accordingly, is not being depreciated.
As of December 31, 2023 and 2022, the net book value of capitalized software was $7.0 million and $3.5 million, respectively. These amounts include $0.7 million and approximately $0.2 million of capitalized stock compensation costs, respectively. Depreciation expense and amortization expense related to property and equipment was $9.9 million and $5.5
96

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
million for the years ended December 31, 2023 and 2022, respectively, which included amortization expense of capitalized software of $1.0 million and $0.6 million for the years ended December 31, 2023 and 2022, respectively.
Leased equipment and the related accumulated depreciation were as follows:
December 31,
20232022
Leased equipment$80,206 $35,983 
Accumulated depreciation(13,283)(5,802)
Leased equipment, net$66,923 $30,181 
Depreciation expense related to leased units was $8.0 million and $4.3 million during the years ended December 31, 2023 and 2022, respectively. Depreciable lives are generally 7 years, consistent with the Company’s planned and historical usage of the equipment subject to operating leases.
Loss from impairment of property and equipment was $0.3 million and $1.2 million during the years ended December 31, 2023 and 2022, respectively. This primarily related to the removal of Evolv Edge units and Evolv Express prototypes from service, resulting in an impairment of the remaining economic value of such units.
11. Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
December 31,
20232022
Accrued employee compensation and benefits expense$7,780 $7,225 
Accrued professional services and consulting1,579 722 
Accrued sales tax1,643 1,680 
Purchase order cancellation fees1,188  
Other3,388 1,918 
$15,578 $11,545 
12. Long-term Debt
The components of the Company’s long-term debt consisted of the following (in thousands):
December 31,
20232022
Term loans payable$ $30,000 
Less: Unamortized discount (317)
 29,683 
Less: Current portion of long-term debt (10,000)
Long-term debt, net of discount$ $19,683 
Silicon Valley Bank Term Loan Agreement
In December 2022, the Company entered into a loan and security agreement (the "2022 SVB Credit Agreement") with Silicon Valley Bank ("SVB") in order to finance purchases of hardware to be leased to customers. The 2022 SVB Credit Agreement provided for an initial term loan advance of $30.0 million, which was approximately equivalent to the value of all hardware purchases made to support leasing transactions with the Company's customers through December 21,
97

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2022 (the "SVB Closing Date"), with the opportunity to obtain, within 18 months after the SVB Closing Date, additional term loan advances, subject to the satisfaction of certain conditions, in an aggregate principal amount equal to $20.0 million (subject to an increase of an additional $25.0 million upon the satisfaction of certain conditions and approval from SVB). The interest rate applicable to the SVB term loans was the greater of (a) the Wall Street Journal Prime Rate plus 1.0% or (b) 7.25% per annum. Interest and principal under the 2022 SVB Credit Agreement was payable monthly.
On March 10, 2023, SVB was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Corporation ("FDIC") as receiver. The FDIC created a successor bridge bank, Silicon Valley Bridge Bank, N.A. ("SVBB"), and all deposits of SVB were transferred to SVBB under a systemic risk exception approved by the Federal Reserve Board, the U.S. Treasury Department, and the FDIC. On March 12, 2023, the Federal Reserve Board, the U.S. Treasury Department, and the FDIC announced in a joint statement that all SVB deposits, including both insured and uninsured amounts, would be available in full to account holders. SVB was acquired by First Citizens Bank on March 27, 2023.
In light of the foregoing, on March 28, 2023, upon the recommendation of the Company’s newly-formed Investment Committee of the Board of Directors, the Company (i) gave notice of its desire and intent to terminate the commitments under the 2022 SVB Credit Agreement and (ii) transferred its excess cash out of First Citizens Bank (the “Transfer”). The Transfer resulted in an event of default under the 2022 SVB Credit Agreement. Upon the occurrence of such event of default, First Citizens Bank could have, but was not required to, declare all obligations under the 2022 SVB Credit Agreement immediately due and payable. First Citizens Bank did not make such declaration following such event of default.
On March 31, 2023, the Company fully repaid all borrowings and accrued interest under the 2022 SVB Credit Agreement and terminated the 2022 SVB Credit Agreement. In accordance with the terms of the 2022 SVB Credit Agreement, the Company was required to pay a prepayment premium equal to 1.0% of the principal balance on the date of repayment. The Company incurred a loss on debt extinguishment of $0.6 million, consisting of the prepayment penalty of $0.3 million and the write-off of $0.3 million of unamortized debt issuance costs.
13. Warrants
As of December 31, 2023 and 2022, warrants to purchase the following classes of common stock outstanding consisted of the following:
December 31, 2023
Warrant DescriptionIssuance DateContractual
Term
(in years)
Underlying Equity
Instrument
Balance Sheet
Classification
Shares Issuable
Upon Exercise
of Warrant
Weighted
Average
Exercise Price
Finback Common Stock Warrants (see Note 15)January 13, 202110Common stockEquity1,317,327 $0.42 
Public Warrants (see Note 2)July 16, 20215Common stockLiability14,324,893 $11.50 
15,642,220 
December 31, 2022
Warrant DescriptionIssuance DateContractual
Term
(in years)
Underlying Equity
Instrument
Balance Sheet
Classification
Shares Issuable
Upon Exercise
of Warrant
Weighted
Average
Exercise Price
Finback Common Stock Warrants (see Note 15)January 13, 202110Common stockEquity2,421,200 $0.42 
Public Warrants (see Note 2)July 16, 20215Common stockLiability14,324,994 $11.50 
16,746,194 
98

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
14. Common Stock
Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the board of directors, subject to the preferential dividend rights of Preferred Stock. As of December 31, 2023 and 2022, no cash dividends had been declared or paid.
As of December 31, 2023 and 2022, the Company had reserved 80,298,297 and 79,795,376 shares, respectively, of common stock for the exercise of outstanding stock options, vesting of outstanding restricted stock units and performance stock units, vesting of contingent earn-out shares, vesting of contingently issuable common stock, granting of awards under the Company’s 2021 Equity Incentive Plan (see Note 15), and the exercise of outstanding warrants (see Note 13). In addition, as of December 31, 2023 and 2022, the Company had 6,315,248 and 4,863,198 shares, respectively, of common stock available to be issued under the 2021 Employee Stock Purchase Plan (see Note 15).
15. Stock-Based Compensation
2021 Equity Incentive Plan
The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) provides for the Company to grant incentive stock options or nonqualified stock options, restricted stock awards, restricted stock units, performance stock units, and other stock-based awards to employees, officers, directors, and non-employees of the Company. A total of 21,177,295 shares of common stock were initially authorized under the 2021 Plan, subject to annual evergreen increases of up to 5% of total common shares outstanding as of the end of the prior year. As of December 31, 2023, 14,007,370 shares were available for future grant under the 2021 Plan. Shares, units, and options that are expired, forfeited, canceled, or otherwise terminated without having been fully exercised will be available for future grant under the 2021 Plan. In addition, shares of common stock that are tendered to the Company by a participant to exercise an award are added to the number of shares of common stock available for future grants.
The 2021 Plan is administered by the Board of Directors or, at the discretion of the Board of Directors, by a committee of the Board of Directors. The exercise prices, vesting, and other restrictions are determined at the discretion of the Board of Directors, or its committee if so delegated, except that the exercise price per share of stock options may not be less than 100% of the fair market value of a share of common stock on the date of grant and the term of the stock option may not be greater than ten years. Stock options granted to employees, officers, members of the Board of Directors and non-employees vesting terms are determined on an individual basis on the date of grant. Prior to the closing of the Merger, the Company’s Board of Directors valued the Company’s common stock, taking into consideration its most recently available valuation of common stock performed by third parties as well as additional factors which may have changed since the date of the most recent contemporaneous valuation through the date of grant. After the closing of the Merger, the fair value of each share of common stock underlying stock-based awards is based on the closing price of our common stock as reported by Nasdaq on the date of grant.
Stock Options
The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted during the years ended December 31, 2023 and 2022:
Year Ended December 31,
20232022
Risk-free interest rate4.2 %1.6 %
Expected term (in years)6.16.1
Expected volatility87.5 %75.0 %
Expected dividend yield0.0 %0.0 %
99

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following tables summarize the Company’s stock option activity under the 2021 Equity Incentive Plan (in thousands, except for share and per share data):
Number of
Shares
Weighted
Average
Exercise Price
Weighted
Average
Remaining
Contractual Term (in years)
Aggregate
Intrinsic Value
Outstanding as of December 31, 2021
20,769,130$0.39 
Granted2,262,9253.49 
Exercised(1,896,975)0.43 
Forfeited(710,707)0.42 
Expired(27,549)0.42 
Outstanding as of December 31, 2022
20,396,824$0.73 
Granted2,840,4213.12 
Exercised(1,735,978)0.38 
Forfeited(1,164,932)1.72 
Expired(11,807)0.42 
Outstanding as of December 31, 2023
20,324,528$1.04 6.0$74,768 
Vested and expected to vest as of December 31, 2023
20,324,528$1.04 6.0$74,768 
Options exercisable as of December 31, 2023
16,114,401$0.67 5.4$65,339 
The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for those options that had exercise prices lower than the fair value of the Company’s common stock.
The weighted average grant date fair value of stock options granted was $2.35 and $2.32 during the years ended December 31, 2023 and 2022, respectively. The aggregate intrinsic value of the stock options exercised was $8.7 million and $4.4 million during the years ended December 31, 2023 and 2022, respectively.
Restricted Stock Units
The following table summarizes the Company’s restricted stock units activity under its existing restricted stock unit plan:
Number of
Shares
Grant Date Fair
Value
Outstanding as of December 31, 2021
1,951,924$6.76 
Granted7,613,4723.26 
Vested(565,774)6.72 
Forfeited(1,497,677)5.15 
Outstanding as of December 31, 2022
7,501,945$3.54 
Granted9,477,0143.48 
Vested(2,833,155)3.55 
Forfeited(1,099,125)3.54 
Outstanding as of December 31, 2023
13,046,679$3.49 
100

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
During the years ended December 31, 2023 and 2022, the aggregate grant-date fair value of restricted stock units issued under the 2021 Plan was $33.0 million and $24.9 million, respectively. RSUs generally vest ratably over a three year period subject to the grantee's continued service through the applicable vesting date. During the year ended December 31, 2023 and 2022, the total fair value of shares vested was $10.1 million and $3.8 million, respectively.
Performance Stock Units
The following table summarizes the Company's performance stock units activity under its existing performance stock units plan:
Number of
Shares
Grant Date Fair
Value
Outstanding as of December 31, 2021
 $ 
Granted947,000 2.65 
Vested  
Forfeited(83,000)2.65 
Outstanding as of December 31, 2022
864,000 $2.65 
Granted  
Vested(432,000)2.65 
Forfeited(52,000)2.67 
Outstanding as of December 31, 2023
380,000 $2.64 
Based upon the terms of the award agreements and achievement of the performance goal, 50% of the applicable performance stock units vested on January 1, 2023 and 50% on January 1, 2024, subject to the grantee’s continued service through the applicable vesting date.
2021 Employee Stock Purchase Plan
In July 2021, the Company’s Board of Directors adopted the 2021 Employee Stock Purchase Plan (“2021 ESPP”), which was subsequently approved by the Company’s stockholders and became effective on July 16, 2021. The 2021 ESPP authorizes the initial issuance of up to 3,435,748 shares of the Company’s common stock to eligible employees of the Company or, as designated by the Company’s Board of Directors, employees of a related company. The 2021 ESPP provides that the number of shares reserved and available for issuance under the 2021 ESPP will automatically increase each January 1, beginning on January 1, 2022 and ending on (and including) January 1, 2032, by an amount equal to the lesser of (i) 1% of the outstanding number of shares of common stock on the immediately preceding December 31 and (ii) such smaller number of shares as determined by the Company’s Board of Directors. As of December 31, 2023, 6,315,248 shares of the Company’s common stock were available for future issuance. The Company’s Board of Directors may from time to time grant or provide for the grant to eligible employees of options to purchase common stock under the 2021 ESPP during a specific offering period. As of December 31, 2023, no offerings have been approved.
Finback Common Stock Warrants
The Company utilized a Black-Scholes pricing model to determine the grant-date fair value of the Finback Common Stock Warrants. The assumptions used are presented in the following table:
Warrants - Black Scholes
Risk-free interest rate0.4 %
Expected term (in years)3.0
Expected volatility23.9 %
Expected dividend yield %
101

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In January 2021, the Company granted warrants (the "Finback Common Stock Warrants") to purchase 2,552,913 shares of the Company's Class A common stock at an exercise price of $0.42 per share to Finback Evolv OBH, LLC ("Finback"), a consulting group affiliated with one of the Company's stockholders. The Finback Common Stock Warrants vest upon meeting certain sales criteria as defined in a business development agreement (the "Finback BDA"), which has a term of 3 years. The Finback BDA expired on January 1, 2023, subject to a 1-year "tail period" expiring on January 1, 2024. During the tail period, the Finback Common Stock Warrants will continue to vest related to any sale consummated by the Company for which it is determined Finback provided services prior to January 1, 2023 in furtherance of the sale. The Finback Common Stock Warrants expire in January 2031. The Finback Common Stock Warrants are accounted for under ASC 718 Compensation – Stock Compensation as the warrants vest upon certain performance conditions being met. On the date of issuance, the Finback Common Stock Warrants were valued at $19.5 million.
Upon the closing of the Merger, vested Finback Common Stock Warrants automatically converted into 131,713 shares of the Company’s common stock. As of December 31, 2023, 117,423 Finback Common Stock Warrants were exercisable at a total aggregate intrinsic value of $0.5 million. The remaining 1,199,904 Finback Common Stock Warrants are unvested and have a total unrecognized grant date fair value of $9.1 million. As of December 31, 2023, 1,103,873 of the Finback common stock warrants were exercised. The Company recognizes compensation expense for the Finback Common Stock Warrants when the warrants become vested based on meeting the specified sales criteria. During the years ended December 31, 2023 and 2022, the Company recorded $3.1 million and $4.5 million, respectively, of stock-based compensation expense within sales and marketing expense related to the Finback Common Stock Warrants.
Stock-Based Compensation
Stock-based compensation expense was classified in the consolidated statements of operations and comprehensive loss as follows (in thousands):
Year Ended December 31,
20232022
Cost of revenue$583$829
Research and development4,2844,009
Sales and marketing9,38710,038
General and administrative9,8977,622
Total stock-based compensation expense$24,151$22,498
Stock-based compensation expense by award type recognized in the consolidated statements of operations and comprehensive loss was as follows (in thousands):
Year Ended December 31,
20232022
Stock options $2,925$1,594
Earn-out shares2,0736,499
Warrants 3,1474,523
RSUs and PSUs16,0069,882
Total stock-based compensation expense $24,151$22,498
Total unrecognized compensation expense related to stock options and restricted stock units as of December 31, 2023, was $40.8 million, which is expected to be recognized over a weighted average period of 2.1 years. Total unrecognized compensation expense related to earn-out shares associated with the share-based compensation arrangement as of December 31, 2023, was $0.2 million, which is expected to be recognized over a weighted average period of 0.5 years.
102

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
16. Income Taxes
The components of the Company’s loss before income tax expense are as follows (in thousands):
Year Ended December 31,
20232022
United States$(106,261)$(85,760)
Foreign58 (646)
Loss before income tax provision$(106,203)$(86,406)
Income tax expense is comprised of the following (in thousands):
Year Ended December 31,
20232022
Current:
Federal$$
State27
Foreign24
Total current income tax expense$51$
Deferred:
Federal$$
State
Foreign
Total deferred income tax expense$$
Total income tax expense$51$
103

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The effective tax rate differs from the U.S. federal statutory rate primarily due to the full valuation allowance maintained on the Company’s net deferred tax assets and non-deductible fair value adjustments for the years ended December 31, 2023 and 2022. A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:
Year Ended December 31,
20232022
Federal statutory income tax rate21.0 %21.0 %
State income taxes, net of federal benefit3.4 3.5 
Federal and state research and development tax credits (1.2)
Change in fair value of contingent earn-out liability and contingently issuable common stock liability(4.5)3.4 
Change in valuation allowance(16.9)(23.6)
Change in uncertain tax positions(0.4) 
Change in tax rate0.8 (0.1)
Stock-based compensation(0.6)(0.2)
Non-deductible compensation(2.4)(2.6)
Permanent differences(0.1)(0.2)
Other(0.3) 
Effective income tax rate0.0 %0.0 %
Net deferred tax assets consisted of the following (in thousands):
December 31,
20232022
Deferred tax assets:  
Net operating loss carryforwards$41,541$36,518
Research and development tax credit carryforwards3,8023,836
Capitalized research and development costs13,0439,965
Accrued expenses7,2306,660
Deferred revenue18,2068,884
Lease liability351490
Other1,305106
Total deferred tax assets85,47866,459
Valuation allowance(82,558)(64,570)
Total deferred tax assets, net of valuation allowance2,9201,889
Deferred tax liabilities:  
Depreciation and amortization(2,601)(1,464)
Right of use lease asset(302)(409)
Other(17)(16)
Total deferred tax liabilities(2,920)(1,889)
Net deferred tax assets$$
As of December 31, 2023 and December 31, 2022, the Company had gross federal net operating losses of $20.1 million and $20.1 million that are subject to expire at various dates beginning in 2033, and federal net operating losses of $142.4 million and $124.3 million, which have no expiration date and can be used to offset up to 80% of future taxable income in any one tax period, respectively. The Company also had gross state net operating loss carryforwards of $142.4
104

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
million and $103.8 million for the years ended December 31, 2023 and 2022, respectively, which may be available to offset future state taxable income and which begin to expire in 2033. Additionally, the Company had no UK net operating loss carryforwards as of December 31, 2023 and gross UK net operating loss carryforwards of approximately $2.3 million that will not expire as of December 31, 2022. As of December 31, 2023, the Company had gross U.S. federal and state research and development and other tax credit carryforwards of $2.5 million and $1.6 million, respectively, which may be available to offset future tax liabilities and the majority of which begin to expire in 2033 and 2030, respectively. As of December 31, 2022, the Company had gross U.S. federal and state research and development and other tax credit carryforwards of $2.5 million and $1.6 million, respectively, which may be available to offset future tax liabilities and the majority of which begin to expire in 2033 and 2029, respectively.
Utilization of the U.S. federal and state net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Sections 382 and 383 of the Internal Revenue Code of 1986, and corresponding provisions of state law, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income or tax liabilities. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards would be subject to an annual limitation under Section 382, which is determined by first multiplying the value of the Company’s stock at the time of the ownership change by the applicable long-term tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization.
The Company considered the significant negative evidence of its history of cumulative net operating losses incurred since inception, as well as other positive and negative evidence bearing upon its ability to realize the deferred tax assets, and has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets as of December 31, 2023 and 2022. If or when recognized, the tax benefits related to any reversal of the valuation allowance on deferred tax assets as of December 31, 2023, will be accounted for as follows: approximately $80.0 million will be recognized as a reduction of income tax expense and $2.5 million will be recorded as an increase in equity. The Company reevaluates the positive and negative evidence at each reporting period.
Changes in the valuation allowance for deferred tax assets related primarily to the increase in net operating loss carryforwards and capitalized R&D costs and were as follows (in thousands):
December 31,
20232022
Valuation allowance as of beginning of year$64,570$43,966
Additions charged to provision for income taxes17,98820,320
Additions charged to equity332
Currency translation and other(48)
Valuation allowance as of end of year$82,558$64,570
The Company accounts for income tax uncertainties in accordance with ASC 740 Income Taxes, which prescribes a recognition threshold and measurement criteria for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Benefits from tax positions should be recognized in the financial statements only when it is more likely than not that the tax position will be sustained upon examination by the appropriate taxing authority that would have full knowledge of all relevant information. A tax position that meets the more likely than not recognition threshold is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Tax positions that previously failed to meet the more likely than not recognition threshold should be recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more likely than not recognition threshold should be derecognized in the first subsequent
105

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
financial reporting period in which that threshold is no longer met. ASC 740 also provides guidance on the accounting for and disclosure of liabilities for uncertain tax positions, interest and penalties. The Company’s policy is to record interest and penalties related to income taxes as part of its income tax provision.
The following table summarizes the activity related to the Company’s uncertain tax positions (excluding interest and penalties and related tax attributes) (in thousands):
December 31,
20232022
Balance at beginning of fiscal year$$
Gross increases related to prior year tax positions407
Foreign exchange and others21
Balance at end of fiscal year$428$
The Company’s liability for uncertain tax positions as of December 31, 2023, includes $0.4 million related to amounts that, if recognized, would affect the effective tax rate (excluding related interest and penalties).
The Company files income tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal, state, and non-US jurisdictions, where applicable. The Company is open to future tax examinations in the US under statute from 2020 to the present; however, carryforward attributes that were generated prior to 2020 may still be adjusted upon examination by federal, state, or local tax authorities if they either have been or will be used in a future period. The Company is also open for future tax examinations under statute from 2021 to the present in the UK. The Company has not received notice of examination in any jurisdictions for any tax year open under statute.
17. Net Loss per Share
Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):
Year Ended December 31,
20232022
Numerator:  
Net income (loss) attributable to common stockholders – basic and diluted$(106,254)$(86,406)
  
Denominator:  
Weighted average common shares outstanding - basic and diluted149,168,105143,858,668
Net loss per share attributable to common stockholders – basic and diluted$(0.71)$(0.60)
106

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:
Year Ended December 31,
20232022
Options issued and outstanding20,324,528 20,396,824 
Public Warrants to purchase common stock14,324,893 14,324,994 
Warrants to purchase common stock (Finback)**1,317,327 2,421,200 
Unvested restricted stock units13,046,679 7,501,945 
Unvested performance stock units380,000 864,000 
Earn-out shares*15,000,000 15,000,000 
Contingently issuable common stock*1,897,500 1,897,500 
66,290,927 62,406,463 
*Issuance of Earn-out shares and Contingently issuable common stock is contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period.
**Includes 117,423 vested warrants and 1,199,904 unvested warrants as of December 31, 2023.
18. Related Party Transactions
Business Development Agreement with Finback
In January 2021, the Company granted the Finback Common Stock Warrants subject to the terms of the Finback BDA, as discussed in Note 15.
In connection with the Merger and pursuant to the Merger Agreement, in addition to earn-out shares allocated to Finback based on its common stock ownership percentage as of the Merger date, Finback is entitled to receive a proportional share of earn-out shares based upon its remaining unvested warrants as of the Merger Date.
Original Equipment Manufacturer Partnership Agreement with Motorola Solutions, Inc.
In December 2020, the Company entered into an original equipment manufacturer partnership agreement with Motorola Solutions, Inc. ("Motorola"), an investor in the Company. The partnership agreement has since been amended and restated. Motorola sells Motorola-branded premium products based on the Evolv Express platform through their worldwide network of over 2,000 resellers and integration partners, and has integrated the Evolv Express platform with Motorola products. During the years ended December 31, 2023 and 2022, revenue from Motorola’s distributor services was $9.6 million and $11.6 million, respectively. As of December 31, 2023 and 2022, accounts receivable related to Motorola’s distributor services were $1.2 million and $12.5 million, respectively.
Reseller Agreement with Stanley Black & Decker
In June 2020, the Company entered into a reseller agreement with Stanley Black & Decker, an investor in the Company. Stanley Black & Decker's electronic security business was acquired by Securitas AB ("Securitas") in 2023. Securitas, directly or through its affiliates, resells the Company's products. During the years ended December 31, 2023 and 2022, revenue from Stanley Black & Decker’s reseller services was $1.7 million and $1.9 million, respectively. As of December 31, 2023 and 2022, accounts receivable related to Stanley Black & Decker’s reseller services were $0.6 million and $2.2 million, respectively.
107

EVOLV TECHNOLOGIES HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
19. Commitments and Contingencies
Indemnification Agreements
In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its Board of Directors and certain of its executive officers and employees that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their role, status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not currently aware of any indemnification claims and has not accrued any liabilities related to such obligations in its consolidated financial statements as of December 31, 2023 or 2022.
Legal Proceedings
The Company is not a party to any litigation of a material nature and does not have contingency reserves established for any litigation liabilities. At each reporting date, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company expenses the costs related to such legal proceedings as incurred.
In the ordinary course of business, the Company is subject to regulatory and governmental examinations, information gathering requests, inquiries, and investigations. The FTC has previously requested information about certain aspects of the Company's marketing practices. The Company is cooperating with the investigation and has provided documentation and information responsive to the FTC inquiry. We currently do not expect this investigation to have a material effect on our results of operations, financial condition or liquidity, either individually or in the aggregate.
Further, in February 2024, we received a subpoena from the SEC, Division of Enforcement, requesting that we produce certain documents and information, much of which is similar to the documents and information previously requested by the FTC. We are cooperating and intend to continue to cooperate with the SEC's investigation.
We can offer no assurances as to the outcome of these investigations or their potential effect, if any, on us or our results of operations. There can be no assurance whether there will be further information requests or potential enforcement action or litigation, which is necessarily uncertain.
20. Benefit Plans
The Company established a defined contribution savings plan under Section 401(k) of the Code. This plan covers all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pre-tax basis. The Company made $0.3 million matching contributions to the plan during the year ended December 31, 2023. The Company did not make any matching contributions to the plan during the year ended December 31, 2022.
108


ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
ITEM 9A. CONTROLS AND PROCEDURES
Limitations on effectiveness of controls and procedures
We maintain disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of our controls and procedures relative to their costs.
Evaluation of disclosure controls and procedures
Our management, with the participation of our principal executive officer and principal financial officer, evaluated, as of the end of the period covered by this Annual Report on Form 10-K, the effectiveness of our disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of December 31, 2023 due to the material weaknesses in our internal control over financial reporting as described below.
Management’s Annual Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as that term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). Our management, including our principal executive officer and principal financial officer, conducted an assessment as of December 31, 2023 of the effectiveness of our internal control over financial reporting based on the criteria set forth in Internal Control–Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this assessment, management concluded that, as of December 31, 2023, our internal control over financial reporting was not effective due to the material weaknesses described below.
We identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.
We did not design and maintain an effective control environment commensurate with our financial reporting requirements. Specifically, we lacked a sufficient complement of personnel with an appropriate level of internal controls and accounting knowledge, training and experience commensurate with our financial reporting requirements. Additionally, the limited personnel resulted in our inability to consistently establish appropriate authorities and responsibilities in pursuit of our financial reporting objectives, as demonstrated by, among other things, insufficient segregation of duties in our finance and accounting functions. In addition, we did not design and maintain effective controls in response to the risks of material misstatement as changes to existing controls or the implementation of new controls were not sufficient to respond to changes to the risks of material misstatement to financial reporting. These material weaknesses contributed to the following additional material weaknesses:
We did not design and maintain effective controls over the period-end financial reporting process to achieve complete, accurate, and timely financial accounting, reporting and disclosures, including the classification of various accounts in the financial statements and the presentation and disclosure of items in the consolidated statements of cash flows.
109


We did not design and maintain processes and controls to analyze, account for and disclose non-routine, unusual or complex transactions. Specifically, we did not design and maintain controls to timely analyze and account for debt modifications and extinguishments, convertible notes, warrant instruments, non-routine complex revenue transactions including the leasing of products and transfer of inventory for leased assets into property plant and equipment, merger transactions, and the accounting and valuation of earn out liabilities.
We did not design and maintain formal accounting policies, procedures, and controls to achieve complete, accurate, and timely financial accounting, reporting and disclosures, including segregation of duties, controls to validate reliability of system-generated information used in the controls, controls over the preparation and review of account reconciliations and journal entries, and controls over recording of revenue, receivables, and deferred revenue transactions, completeness and accuracy of accounts payable and accrued liabilities, commissions, equity and share-based compensation, fixed assets, inventory, payroll, income taxes, and cash and investments.
These material weaknesses resulted in audit adjustments and certain immaterial misstatements in the Evolv financial statements to prepaid and other current assets, accounts payable and accrued liabilities, long-term and short-term debt, convertible notes, contingent earn-out liabilities, change in fair value of contingent earn-out liability, equity, commission assets, contract assets, revenue, deferred revenue, accounts receivable, inventory, property plant and equipment, cost of sales and various expense line items and related financial statement disclosures as of and for the years ended December 31, 2019, 2020 and 2021. The material weaknesses related to accounting for warrant instruments, the classification of various accounts in the consolidated financial statements and the presentation and disclosure of items in the consolidated statements of cash flows also resulted in the revision of the Company's previously issued 2020 annual financial statements, 2021 quarterly and annual financial statements, and quarterly financial statements for the three months ended March 31, 2022, as well as the restatement of the Company’s financial statements as of and for the three and six months ended June 30, 2023. Additionally, these material weaknesses could result in a misstatement of substantially all of our accounts or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.
In addition to the foregoing, we did not design and maintain effective controls over information technology (“IT”) general controls for information systems that are relevant to the preparation of our consolidated financial statements, specifically, with respect to: (i) program change management controls for financial systems to ensure that IT program and data changes affecting financial IT applications and underlying accounting records are identified, tested, authorized, and implemented appropriately; (ii) user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs, and data to appropriate company personnel; (iii) computer operations controls to ensure that critical batch jobs are monitored and data backups are authorized and monitored, and (iv) testing and approval controls for program development to ensure that new software development is aligned with business and IT requirements. These IT deficiencies did not result in a misstatement to the consolidated financial statements, however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would not be prevented or detected. Accordingly, management has determined these deficiencies in the aggregate constitute a material weakness.
Our independent registered public accounting firm, PricewaterhouseCoopers LLP, has issued an audit report with respect to the effectiveness of our internal control over financial reporting as of December 31, 2023, which appears in Part II, Item 8 of this Annual Report on Form 10-K.
Remediation Plan for the Material Weaknesses
We continue to be focused on designing and implementing effective internal controls to improve our internal control over financial reporting and remediate the material weaknesses. Our efforts include a number of actions:
We have hired additional accounting, internal audit, and IT personnel to bolster our reporting, technical accounting, internal control, and IT capabilities. Additionally, we are in the process of designing and implementing controls to formalize roles and review responsibilities to align with our team’s skills and experience and designing and implementing controls over segregation of duties.
110


We added, and continue to add, finance personnel to the organization, including in fiscal 2022 a new Chief Financial Officer and a Chief Accounting Officer, to strengthen our internal accounting team, to provide oversight, structure and reporting lines, and to provide additional review over our accounting and financial reporting.
We have performed, and will continue to perform, a financial statement risk assessment in order to identify material financial statement line items for which key controls are needed in order to ensure complete and accurate financial reporting. Additionally, we have engaged outside consultants to assist with the design and implementation of control activities resulting from the aforementioned risk assessment.
We have designed and implemented additional review and training procedures within Evolv's accounting and finance functions to enhance knowledge and understanding of internal control over financial reporting.
During each of the three months ended June 30, 2023, September 30, 2023, and December 31, 2023, we implemented controls related to, among other items, (i) the period-end financial reporting process and classification of various accounts in our consolidated financial statements, including the presentation and disclosure of items in the consolidated statements of cash flows, (ii) timely identification and accounting for non-routine, unusual and complex transactions, including controls over the preparation and review of accounting memoranda addressing these matters, (iii) revenue recognition, including non-routine complex revenue transactions that may also include the leasing of products and the recording of revenue transactions in the appropriate period, (iv) completeness and accuracy of accounts payable and accrued liabilities, and (v) completeness, accuracy, valuation, and classification of cash equivalents and marketable securities.
Additionally, we are in the process of designing and implementing controls related to:
the preparation and review of journal entries and account reconciliations to ensure proper segregation of duties;
formal accounting policies, procedures and controls to achieve complete, accurate and timely financial accounting, reporting and disclosures; and
information technology general controls, including controls over program change management, the review and update of user access rights and privileges, controls over batch jobs and data backups, and program development approvals and testing. To this end, we implemented a new Enterprise Resource Planning ("ERP") system in April 2022 and have implemented, and continue to implement, IT general controls related to the new system.
The process of designing and maintaining effective internal control over financial reporting is a continuous effort that requires management to anticipate and react to changes in our business, economic, and regulatory environments and to expend significant resources. As we continue to evaluate our internal control over financial reporting, we may take additional actions to remediate the material weaknesses or modify the remediation actions described above.
While we continue to devote significant time and attention to these remediation efforts, the material weaknesses will not be considered remediated until management completes the design and implementation of the actions described above and the controls operate for a sufficient period of time, and management has concluded, through testing, that these controls are effective.
Changes in Internal Control over Financial Reporting
Other than with respect to the remediation efforts described in the Remediation Plan for the Material Weaknesses section above, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
111


ITEM 9B. OTHER INFORMATION
During the quarter ended December 31, 2023, the following “officer” (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
On December 15, 2023, Anil Chitkara, Chief Growth Officer and Founder, adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 200,000 shares of the Company’s common stock until September 6, 2024.
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
None.
112


PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

Certain information concerning Evolv’s current executive officers as of February 29, 2024 follows. There are no family relationships between any of our executive officers.

NameAgePosition
Executive Officers:
Peter George65President and Chief Executive Officer
Mark Donohue50Chief Financial Officer
Jay Muelhoefer52Chief Commercial Officer
Anil Chitkara56Chief Growth Officer and Founder
Michael Ellenbogen59Chief Innovation Officer, Founder, and Director
Non-Employee Directors:
Neil Glat56Chairman of the Board
Kevin Charlton58Director
David Mounts Gonzales60Director
Rajan Naik51Director
Merline Saintil47Director
Kimberly Sheehy59Director
Mark Sullivan69Director
Bilal Zuberi47Director
Executive Officers
Peter G. George. Peter G. George has served as our President and Chief Executive Officer and director since July 2021. Prior to that, Mr. George served as Chief Executive Officer and President of Legacy Evolv since January 2020. Prior to assuming the role of Chief Executive Officer at Legacy Evolv, Mr. George served as Chief Commercial Officer of Legacy Evolv from February 2019 to December 2019. Prior to joining Legacy Evolv, Mr. George served as President, Chief Executive Officer, and Chairman of Fidelis Cybersecurity, a company focused on threat and data breach detection, from March 2008 to August 2019. Mr. George also served as the Chief Executive Officer of Empow Cybersecurity, a company offering intelligent, Al and natural language processing solutions to reduce false positives during threat detection, from March 2018 to November 2018. Mr. George serves on the Board of Directors of Corero Network Security PLC (LON: CNS), including its Compensation Committee, since January 2019. Mr. George received a Bachelor of Arts degree in History from the College of the Holy Cross in 1981.
Mark Donohue. Mark Donohue has been our Chief Financial Officer since June 2022. Prior to joining the Company, Mr. Donohue, served as Chief Financial Officer of Vestmark, Inc. (“Vestmark”), a provider of SaaS-based portfolio management and trading tools for financial advisors and institutions where he oversaw Vestmark’s Financial Planning, Corporate Development, Accounting, and Investor Relation departments, from August 2018 to May 2022. Prior to his time at Vestmark, Mr. Donohue served at Rapid7, Inc. (“Rapid7”) (NASDAQ: RPD), a provider of security analytics and automation, in several senior roles including Vice President of Finance, Corporate Development, and Treasury & Investor Relations, from February 2016 to August 2018. Before his time at Rapid7, Mr. Donohue held multiple Director level positions at Cisco Systems (NASDAQ: CSCO) in which he was involved in strategy, finance, and business operations and Starent Networks, Corp., in which he was involved in investor relations and treasury roles, and held senior roles at International Data Corporation, Ferris Baker Watts Inc., Teradyne, Inc. (NASDAQ: TER), and Quantum Corporation (NASDAQ: QMCO). He earned a BS in Business Administration & Finance from the University of New Hampshire, and received both his MBA and MS in Finance from Boston College’s Wallace E. Carroll Graduate School of Management.
Jay Muelhoefer. Jay Muelhoefer has been our Chief Commercial Officer since October 2023. Prior to that, Mr. Muelhoefer served as Chief Marketing Officer for Kinaxis (TSX: KXS), a leading SaaS-based supply chain management applications provider focused on planning and execution for digital transformation, sustainability, and resiliency using Al
113


and advanced analytics, from 2018 to 2023. Prior to joining Kin axis, Mr. Muelhoefer served as Chief Marketing Officer at lntralinks (NYSE: IL), a global provider of enterprise SaaS solutions for secure content sharing, collaboration, and work lifecycle management. Before that, he spent two years at IBM (NYSE: IBM) where he served as Global Executive Director and led global go-to market efforts for Software Defined Data Center initiatives spanning analytics, big data, high performance computing, and cloud technologies. Earlier in his career, Mr. Muelhoefer held various executive leadership roles spanning sales, channel, marketing, strategy and general management at Platform Computing (acquired by IBM), PTC (NYSE: PTC) and Booz Allen Hamilton (NYSE:BAH). Mr. Muelhoefer earned an MBA from Harvard Business School and holds both a Master's Degree and Bachelor's Degree in Mechanical Engineering from the Massachusetts Institute of Technology.
Anil R. Chitkara. Anil R. Chitkara has been our Chief Growth Officer since April 2022, and previously served as Head of Corporate Development since July 2021. Prior to that, Mr. Chitkara co-founded Legacy Evolv with Michael Philip Ellenbogen in July 2013, serving in a variety of roles focused on building the business. Before co-founding Legacy Evolv, Mr. Chitkara was the Senior Vice President, Market Development for Oco, Inc., a business analytics software provider that was subsequently acquired by Deloitte, from January 2007 to June 2011. Prior to joining Oco, Inc., Mr. Chitkara was the Vice President of Parametric Technology Corporation, a company currently offering a variety of augmented reality, industrial IoT, PLM and CAD solutions, from May 2001 to January 2007. Mr. Chitkara received a Bachelor of Science degree in Business Administration from Boston University in 1989 and a Master of Business Administration degree from the Tuck School of Business at Dartmouth College in 1994.
Michael Philip Ellenbogen. Michael Philip Ellenbogen has been our Chief Innovation Officer and a director since July 2021. Prior to that, Mr. Ellenbogen co-founded Legacy Evolv with Anil R. Chitkara in July 2013 and served as Legacy Evolv’s Head of Advanced Technology since January 2020. Prior to that, Mr. Ellenbogen served as the Legacy Evolv’s Chief Executive Officer from August 2013 to January 2020. Prior to co-founding Evolv, Mr. Ellenbogen was the founder, President and Chief Executive Officer of Reveal Imaging Technologies, an X-ray imaging systems company focusing on automated explosives detection, from 2002 to 2010. Prior to joining Reveal, Mr. Ellenbogen was the Vice President of Research & Development and Business Development of PerkinElmer Detection Systems, a provider of X-ray-based security technologies, from 1994 to 2002. During his 25-plus year career in the security industry, Mr. Ellenbogen has proven his expertise in product and business development, as well as stakeholder value creation. In addition, Mr. Ellenbogen is an inventor with over 20 awarded patents. Mr. Ellenbogen received a Bachelor of Arts degree in Physics from Colgate University in 1986.
Non-Employee Directors
Neil Glat. Neil Glat has been a director on our Board since July 2021 and Chairman of our Board since November 2023. He was appointed in December 2021 as Co-President, Americas for SPORTFIVE, a global sports, entertainment, and marketing agency and operated in that role until February 2024. From September 2019 to Present, Mr. Glat has been the Managing Member of NG Strategies, LLC and has been serving on advisory boards and providing strategic advice to sports, media, and technology businesses. From April 2012 through August 2019, Mr. Glat served as President of the New York Jets, and, from September 2019 to March 2020, he was a Senior Advisor to the New York Jets. Prior to that, Mr. Glat was a senior executive at the National Football League for 15 years, where he oversaw corporate development and strategy, and has previous experience in management consulting at McKinsey & Company and investment banking at Dillon, Read & Co. Mr. Glat is currently a Senior Advisor for Arctos Sports Partners, a private equity platform focused on the professional sports industry. He also is on the Board of ASM Global, a privately-held company which is the world’s largest stadium, arena, convention center, and venue management company and which was formed by the merger of SMG and AEG Facilities. Mr. Glat previously served on the board of NewHold Investment Corp. I, a publicly-traded SPAC, from July 2020 to July 2021. In addition, Mr. Glat serves on many philanthropic boards. Mr. Glat has extensive operating and strategic experience in sports, entertainment, media, and hospitality. During his more than 25 years in combined tenures at the New York Jets, the National Football League, SPORTFIVE, and professional service firms, Mr. Glat has consistently focused on, among other things, driving revenue growth, increasing consumer engagement, identifying new businesses, encouraging innovation, developing forward-looking strategies, and executing strategic transactions and deals. Mr. Glat earned a Bachelor of Sciences in Economics from The Wharton School at the University of Pennsylvania and a JD from Harvard Law School. We believe that Mr. Glat is qualified to serve on Evolv’s Board based on his experience in sports (in particular with professional sports franchises) and related industries and the leadership roles he has had.
Kevin Charlton. Kevin Charlton has been a director on our Board since July 2021 and also serves as Chairman of Give Evolv LLC. He previously served as the Chief Executive Officer of NewHold Investment Company, the special purpose acquisition corporation that merged with Evolv in 2021. Mr. Charlton has been the Co-Chairman of NewHold
114


Enterprises LLC since 2017 and has spent more than 20 years in private equity. Prior to NewHold, Mr. Charlton was with JPMorgan (NYSE: JPM), Investcorp, and Macquarie (ASX: MQG). Mr. Charlton has served on more than 25 Boards of Directors in all relevant roles, and in almost all cases as Chairman or Lead Director on behalf of the majority owner. Prior to his career in private equity, Mr. Charlton was with McKinsey and Company in New York and NASA Headquarters in Washington, DC. Mr. Charlton currently serves as Chairman of American AllWaste LLC since May 2018; and serves on the Boards of Macro Energy LLC, a high efficiency lighting company and F&S Tools, a high-end tooling manufacturer. In addition, from January 2014 through October 2019, Mr. Charlton served in various roles for Hennessy Capital Acquisition Corp I, II, and III, including as President, Chief Operating Officer, and Vice Chairman. Mr. Charlton received his Bachelor’s degree in Aerospace Engineering cum laude from Princeton University in 1988, his Master of Science in Aerospace Engineering with Distinction from the University of Michigan in 1990, and his Master of Business Administration with Honors from the Kellogg School at Northwestern University in 1995. We believe that Mr. Charlton is qualified to serve on Evolv’s Board based on his broad private equity and public company experience.
David Mounts Gonzales. David Mounts Gonzales has been a director on our Board since November 2023. He retired from Inmar Intelligence, Inc. (“Inmar”) in April 2022 and completed 6 months of transition, leaving Inmar in October 2022. He joined Inmar as Chief Executive Officer in April 2010 and assumed the additional role of Chairman in February 2014. During his tenure he transformed Inmar from a small business service company to a market leading data platform and software business for nearly 20,000 retail and healthcare companies. Mr. Mounts Gonzales is currently a managing partner at Aero X Ventures, a venture fund focused on Advanced Air Mobility. Prior to joining Inmar, Mr. Mounts Gonzales served as Executive Vice President of Supply Chain for Domino’s Pizza, Inc. (“Domino’s”) from October 2007 to April 2010. He also served as Domino’s Chief Financial Officer from 2005 to 2007. Mr. Mounts Gonzales was part of the leadership team that transformed Domino's product taste, e-commerce, and supply chain. Prior to Domino’s, Mr. Mounts Gonzales held several positions of increasing seniority during his 23-year tenure at UPS, which he joined in July 1983. Mr. Mounts Gonzales holds an MBA from The Wharton School, University of Pennsylvania, and a Bachelor of Science from University of Nevada, Las Vegas. Mr. Mounts Gonzales previously served on the boards of Papa Murphy’s Holdings, Inc. from 2014 to 2019 and Inmar Intelligence, Inc. from 2010 to 2022. He was past Chairman of the Wharton Alumni Executive Board and currently serves on the Wharton Graduate Executive Board, the Elliott Aviation Board, and is an Advisor to Corridor Capital. He previously served on the Board of Visitors for the Wake Forest University School of Business, and is a founding member of the Advisory Board for Wake Forest Innovation Quarter. The Company believes that Mr. Mounts Gonzales is qualified to serve on the Board based on his broad experience and the executive leadership roles he has held.
Rajan Naik. Rajan Naik, Ph.D., has been a director on our Board since November 2023. He has served as senior vice president, Strategy & Ventures, for Motorola Solutions, Inc. (NYSE: MSI) since 2016. He is responsible for the corporate strategy organization, mergers and acquisitions, venture capital portfolio and competitive and market intelligence. Prior to joining Motorola, Dr. Naik was senior vice president and chief strategy officer at Advanced Micro Devices and before that was a partner in the technology practice at McKinsey & Company. Dr. Naik has served on the board of directors for CSG Systems International Inc. (Nasdaq: CSG) since August 2018. He earned a bachelor's degree in engineering from Cornell University and a doctorate in engineering from the Massachusetts Institute of Technology. The Company believes Dr. Naik is qualified to serve on the Board based on his broad experience in strategy and technology as well as extensive M&A experience having led over 30 acquisitions in the safety and security industry.
Merline Saintil. Merline Saintil has been a director on our Board since July 2021. Ms. Saintil has served as a technology and business executive at Fortune 500 and privately-held companies, including Intuit, Yahoo, PayPal, Adobe, Joyent, and Sun Microsystems. From 2019 to 2020, she was the Chief Operating Officer, R&D-IT of Change Healthcare Inc. Prior to that, Ms. Saintil held the position of Head of Operations, Product & Technology with Intuit Inc. from November 2014 until August 2018. Ms. Saintil has served on the Boards of Directors of TD Synnex Corp. (NYSE: SNX) since 2021, Rocket Lab USA, Inc. (NASDAQ: RKLB) since 2021, Symbotic Inc. (NASDAQ: SYM) since 2021, GitLab Inc. (NASDAQ: GTLB) since 2020, Lightspeed Commerce Inc. (NYSE: LSPD) from 2020 to 2022, ShotSpotter Inc. (NASDAQ: SSTI) from 2019 to 2021, Banner Corporation (NASDAQ: BANR) from 2017 to 2022, and Alkami Technology, Inc. (NASDAQ: ALKT) from 2010 to 2022. She is a member of the Audit Committee at TD Synnex. She is the Chair of the Compensation Committee at Rocket Lab and member of the Compensation Committee at Gitlab. She is the Chair of the Nominating and Corporate Governance Committee at Symbotic. Ms. Saintil has received numerous accolades during her career, most recently being named Women lnc.'s 2019 Most Influential Corporate Board Director. In prior years, she was ranked one of the Most Powerful Women Engineers in the World by Business Insider magazine, she was recognized as a Women of Influence 2017 by Silicon Valley Business Journal and she has earned a Lifetime Achievement Award from Girls in Tech. She is certified in Cybersecurity Oversight by the National Association of Corporate Directors and the Carnegie Mellon Software Engineering Institute. Ms. Saintil earned a Bachelor of Science degree in Computer
115


Science from Florida A&M University in 1998 and a Master of Science degree in Software Engineering Management from Carnegie Mellon University in 2005, and has completed Stanford Directors' College and Harvard Business School's executive education program. We believe Ms. Saintil is qualified to serve on Evolv's Board based on her broad corporate background and service on the boards of directors of technology public companies. Our Board of Directors do not believe that Ms. Saintil's outside boards (5 in total, including Evolv's Board) or other commitments limit her ability to devote sufficient time and attention to her duties as a director of the Company. Ms. Saintil has demonstrated that she has effectively balanced her responsibilities of serving on the Board of Directors.
Kimberly Sheehy. Kimberly Sheehy has been a director on our Board since July 2021. From March 2019 to May 2020, she was the Chief Financial Officer of ResMan LLC, a privately-owned software company providing software solutions to multi-family residential property managers. Previously, from April 2018 to March 2019, she served as Chief Financial Officer of Lori's Gifts, Inc., a privately-owned retail company serving hospitals throughout the United States. From November 2015 to October 2017, Ms. Sheehy served as the Chief Financial Officer of StackPath, LLC, an edge computing platform provider, and from November 2012 to October 2015, Ms. Sheehy served as Chief Financial & Administrative Officer of CyrusOne Inc. (NASDAQ: CONE), a public high-growth real estate investment trust specializing in engineering, building and managing data center properties. She has also held various senior roles at Cincinnati Bell Inc. Ms. Sheehy serves on the Board of Directors of Shift Technologies Inc. (Nasdaq: SFT) and the Board of Directors and as the Chair of the Audit Committee and member of the Compensation Committee and Nominating and Corporate Governance Committee of CVB Financial Corp (NASDAQ: CVBF). In addition, Ms. Sheehy has been a Certified Public Accountant since 1990. Ms. Sheehy earned a Bachelor of Science degree in accounting from the University of Cincinnati in 1989. We believe that Ms. Sheehy is qualified to serve on Evolv's board based on her extensive executive, managerial, accounting and public company experience.
Mark Sullivan. Mark Sullivan has been a director on our Board since July 2021. Since January 2018, Mr. Sullivan has been the owner of Mark Sullivan Consulting in St. Petersburg Beach, Florida. Prior to that, Mr. Sullivan was a Principal at Global Security and Innovative Strategies from February 2013 to December 2017. Before entering the private sector, Mr. Sullivan was a federal agent for 35 years, 30 years as a special agent with the U.S. Secret Service, serving in a variety of leadership roles. He was appointed Director of the Secret Service by the President in May 2006 and served in that position until February 2013. Mr. Sullivan served on the Board of Directors of Command Security Corporation (now known as Prosegur Compania de Seguridad SA (BME:PSG)), a full-service security solutions company, from July 2013 to January 2019. Mr. Sullivan received his Bachelor of Science degree in Criminal Justice from St. Anselm College in 1977. We believe Mr. Sullivan is qualified to serve on Evolv’s Board based on his experience working in security services, both in the public and private sectors.
Bilal Zuberi. Bilal Zuberi has been a director on our Board since July 2021. Since May 2013, Mr. Zuberi has been a partner at Lux Capital, a firm that invests in technology start-ups. At Lux Capital, Mr. Zuberi has led Lux’s investments in Applied Intuition, OpenSpace, Saildrone, Nozomi Networks, DesktopMetal (NYSE: DM), Zededa, Ironclad, Aurora Solar, Fiddler, Commure, Copia Automation, Cloaked, Kinetic Automation, Happiest Baby, Lumafield, Paradigm Inc, and Tendo. Prior to joining Lux Capital, Mr. Zuberi was a principal at General Catalyst Partners from October 2008 to May 2013, where he led the firm’s investments in deep tech, including energy, robotics, medtech, and hardware and software systems. Before becoming an investor, he co-founded GEO2 Technologies in January 2004. Earlier in his career, Mr. Zuberi was a management consultant at The Boston Consulting Group from September 2003 to May 2004, where he advised management teams in complex business and strategy issues. Mr. Zuberi is a member of the Advisory Board of the Lemelson Foundation and has served on the boards of multiple private companies, including serving as a member of certain of such companies’ audit and compensation committees. Mr. Zuberi has also served as a member of Desktop Metal Inc.’s (NYSE: DM) Board of Directors and Audit Committee since December 2020. Mr. Zuberi received a Bachelor of Science degree in Chemistry from The College of Wooster in 1998 and a Ph.D. in Physical Chemistry (with a focus in materials and analytical chemistry) from the Massachusetts Institute of Technology in 2003. We believe Mr. Zuberi is qualified to serve on Evolv’s Board based on his experience working with physical infrastructure and technology companies.
Code of Business Conduct and Ethics
We have a written Code of Business Conduct and Ethics that applies to our directors, officers, and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. We have posted a current copy of the Code of Business Conduct and Ethics on our website, www.evovltechnology.com, in the “Investor Relations” section under “Governance.” In addition, we intend to post on our
116


website all disclosures that are required by law or the rules of Nasdaq concerning any amendments to, or waivers from, any provision of the Code of Business Conduct and Ethics. We granted no waivers in fiscal 2023.
The remaining information required by this item will appear in our definitive proxy statement to be filed with the SEC within 120 days after December 31, 2023, which information is incorporated herein by reference.
ITEM 11. EXECUTIVE COMPENSATION AND DIRECTOR COMPENSATION
The information required by this item will appear in our definitive proxy statement to be filed with the SEC within 120 days after December 31, 2023, which information is incorporated herein by reference.
117


ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Securities Authorized For Issuance under Equity Compensation Plans (As of December 31, 2023)
Plan category:Number of Securities to
be Issued Upon Exercise
of Outstanding Options,
Warrants, and Rights
Weighted-Average
Exercise Price of
Outstanding Options,
Warrants, and Rights (6)
Number of Securities
Available for Future
Issuance Under Equity
Compensation Plans
(excludes securities
reflected in first column) (2)
Equity compensation plans approved by security holders(1)33,751,207 $1.04 20,322,618 
Restricted Stock Units(3)13,046,679 N/A14,007,370 
Performance Stock Units(4)380,000 N/A14,007,370 
Options to Purchase Common Stock(5)20,324,528 $1.04 14,007,370 
Equity compensation plans not approved by security holders— N/AN/A
(1)Consists of the Evolv Technologies Holdings, Inc. 2021 Incentive Award Plan (“2021 Plan”), Evolv Technologies Holdings, Inc. 2021 Employee Stock Purchase Plan (“ESPP”), and the Evolv Technologies, Inc. 2013 Employee, Director, and Consultant Equity Incentive Plan (“2013 Plan”).
(2)The 2021 Plan provides for an annual increase to the number of shares available for issuance thereunder on the first day of each calendar year beginning on January 1, 2022 and ending on and including January 1, 2032, equal to the lesser of (A) 5% of the shares of Common Stock outstanding as of the last day of the immediately preceding fiscal year and (B) such lesser number of shares as determined by our board of directors. The ESPP provides for an annual increase to the number of shares available for issuance thereunder on the first day of each calendar year beginning on January 1, 2022 and ending on and including January 1, 2032, equal to the lesser of (A) 1% of the shares of Common Stock outstanding as of the last day of the immediately preceding fiscal year and (B) such lesser number of shares as determined by our board of directors. No additional awards will be granted under the 2013 Plan and, as a result, no shares remain available for issuance for new awards under the 2013 Plan.
(3)Consists of 77,270 outstanding restricted stock units under the 2013 Plan and 12,969,409 outstanding restricted stock units under the 2021 Plan.
(4)Consists of 380,000 outstanding performance stock units under the 2021 Plan.
(5)Consists of 15,749,244 outstanding options to purchase shares of common stock under the 2013 Plan and 4,575,284 outstanding options to purchase shares of common stock under the 2021 Plan.
(6)As of December 31, 2023, the weighted-average exercise price of outstanding options under the 2013 Plan was $0.39, and the weighted-average exercise price of outstanding options under the 2021 Plan was $3.29.
The remaining information required by this item will appear in our definitive proxy statement to be filed with the SEC within 120 days after December 31, 2023, which information is incorporated herein by reference.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required by this item will appear in our definitive proxy statement to be filed with the SEC within 120 days after December 31, 2023, which information is incorporated herein by reference.
ITEM 14. PRINCIPAL ACCOUNTANT’S FEES AND SERVICES
The information required by this item will appear in our definitive proxy statement to be filed with the SEC within 120 days after December 31, 2023, which information is incorporated herein by reference.
118


PART IV
Item 15. Exhibits and Financial Statement Schedules
(a)(1) Financial Statements.
The following documents are included in Item 8, Financial Statements and Supplementary Data, attached hereto and are filed as part of this Annual Report on Form 10-K.
(a)(2) Financial Statement Schedules.
All financial statement schedules for the Company have been included in the consolidated financial statements or the related footnotes, or are either inapplicable or not required.
(a)(3) Exhibits.
The following is a list of exhibits filed as part of this Annual Report on Form 10-K.
EXHIBIT INDEX
Incorporated by Reference
Exhibit
No.
 Description Form File Number Exhibit Filing Date Filed/Furnished
Herewith
2.1Form 8-K001-394172.1March 8, 2021
2.2Form 8-K001-394172.2July 22, 2021
3.1Form 10-Q001-394173.1November 15, 2021
3.2Form 8-K001-394173.1January 31, 2024
4.1Form S-4/A333-2550174.4June 9, 2021
4.2Form S-1/A333-2332994.3July 27, 2020
4.3Form S-1/A333-2332994.4July 27, 2020
4.4Form 10-K001-394174.4March 28, 2022
10.1Form 8-K001-3941710.1March 8, 2021
10.2Form 8-K001-3941710.2March 8, 2021
119


10.3Form 8-K001-3941710.4March 8, 2021
10.4#Form S-4/A333-25501710.10June 9, 2021
10.5#Form S-4/A333-25501710.11June 9, 2021
10.6#Form S-4/A333-25501710.12June 9, 2021
10.7#Form 8-K001-3941710.1May 19, 2022
10.8#Form S-8333-25996199.1September 21, 2021
10.9#Form S-8333-25996199.2September 21, 2021
10.10#Form 10-K001-3941710.9March 24, 2023
10.11#Form 10-Q001-3941710.1November 15, 2021
10.12#Form 10-Q001-3941710.1November 9, 2022
10.13#Form S-8333-25996199.3September 21, 2021
10.14#Form 8-K001-3941710.1March 2, 2023
10.15#Form 8-K001-3941710.1October 31, 2022
10.16#Form 10-Q001-3941710.1November 9, 2023
21.1*
23.1*
31.1*
31.2*
32.1**
32.2**
97#*
120


101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document*
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.SCHInline XBRL Taxonomy Extension Schema Document.*
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LABInline XBRL Taxonomy Extension Labels Linkbase Document.*
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.*
104Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)*
*    Filed herewith.
**    Furnished herewith.
#    Management contract or compensatory plan, contract or arrangement.
Item 16. Form 10-K Summary
None.
121


SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
EVOLV TECHNOLOGIES HOLDINGS, INC.
Date: February 29, 2024
By:/s/ Mark Donohue
Mark Donohue
Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer
122


Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.
SignatureTitleDate
/s/ Peter GeorgePresident, Chief Executive Officer and Director (Principal Executive Officer) February 29, 2024
Peter George
/s/ Mark DonohueChief Financial Officer (Principal Financial Officer and Principal Accounting Officer)February 29, 2024
Mark Donohue
/s/ Neil GlatChairman of the BoardFebruary 29, 2024
Neil Glat
/s/ Kevin CharltonDirectorFebruary 29, 2024
Kevin Charlton
/s/ Michael EllenbogenDirectorFebruary 29, 2024
Michael Ellenbogen
/s/ David Mounts GonzalesDirectorFebruary 29, 2024
David Mounts Gonzales
/s/ Rajan NaikDirectorFebruary 29, 2024
Rajan Naik
/s/ Merline SaintilDirectorFebruary 29, 2024
Merline Saintil
/s/ Kimberly SheehyDirectorFebruary 29, 2024
Kimberly Sheehy
/s/ Mark SullivanDirectorFebruary 29, 2024
Mark Sullivan
/s/ Bilal ZuberiDirectorFebruary 29, 2024
Bilal Zuberi
123
EX-21.1 2 evlv-20231231xexx211.htm EX-21.1 Document

Exhibit 21.1
LIST OF SUBSIDIARIES
The following is a list of the direct and indirect subsidiaries of Evolv Technologies Holdings, Inc., that is current as of December 31, 2023:
SubsidiariesJurisdiction
Evolv Technologies, Inc.United States
Evolv Technology UK Ltd.United Kingdom
Give Evolv LLCUnited States

EX-23.1 3 evlv-20231231xexx231.htm EX-23.1 Document

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-258748) and Form S-8 (No. 333-259691) of Evolv Technologies Holdings, Inc. of our report dated February 29, 2024 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 29, 2024

EX-31.1 4 evlv-20231231xexx311.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION
I, Peter George, certify that:
1.I have reviewed this annual report on Form 10-K of Evolv Technologies Holdings, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: February 29, 2024
By:/s/ Peter George
Name:Peter George
Title:
Chief Executive Officer (principal executive officer)

EX-31.2 5 evlv-20231231xexx312.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION
I, Mark Donohue, certify that:
1.I have reviewed this annual report on Form 10-K of Evolv Technologies Holdings, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: February 29, 2024
By:/s/ Mark Donohue
Name:Mark Donohue
Title:
Chief Financial Officer (principal financial officer)

EX-32.1 6 evlv-20231231xexx321.htm EX-32.1 Document

Exhibit 32.1
Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the annual report of Evolv Technologies Holdings, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, the undersigned, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:
(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: February 29, 2024
By:/s/ Peter George
Name:Peter George
Title:
Chief Executive Officer
(principal executive officer)

EX-32.2 7 evlv-20231231xexx322.htm EX-32.2 Document

Exhibit 32.2
Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the annual report of Evolv Technologies Holdings, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, the undersigned, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:
(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: February 29, 2024
By:/s/ Mark Donohue
Name:Mark Donohue
Title:Chief Financial Officer
(principal financial officer)

EX-97 8 policyforrecoveryoferroneo.htm EX-97 Document

Exhibit 97


EVOLV TECHNOLOGIES HOLDINGS, INC.
POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION
Evolv Technologies Holdings, Inc. (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of October 2, 2023 (the “Effective Date”). Capitalized terms used in this Policy but not otherwise defined herein are defined in Section 11.
1.Persons Subject to Policy
This Policy shall apply to current and former Officers of the Company. Each Officer shall be required to sign an acknowledgment pursuant to which such Officer will agree to be bound by the terms of, and comply with, this Policy; however, any Officer’s failure to sign any such acknowledgment shall not negate the application of this Policy to the Officer.
2.Compensation Subject to Policy
This Policy shall apply to Incentive-Based Compensation received on or after the Effective Date. For purposes of this Policy, the date on which Incentive-Based Compensation is “received” shall be determined under the Applicable Rules, which generally provide that Incentive-Based Compensation is “received” in the Company’s fiscal period during which the relevant Financial Reporting Measure is attained or satisfied, without regard to whether the grant, vesting or payment of the Incentive-Based Compensation occurs after the end of that period.
3.Recovery of Compensation
In the event that the Company is required to prepare a Restatement, the Company shall recover, reasonably promptly, the portion of any Incentive-Based Compensation that is Erroneously Awarded Compensation, unless the Committee has determined that recovery would be Impracticable. Recovery shall be required in accordance with the preceding sentence regardless of whether the applicable Officer engaged in misconduct or otherwise caused or contributed to the requirement for the Restatement and regardless of whether or when restated financial statements are filed by the Company. For clarity, the recovery of Erroneously Awarded Compensation under this Policy will not give rise to any person’s right to voluntarily terminate employment for “good reason,” or due to a “constructive termination” (or any similar term of like effect) under any plan, program or policy of or agreement with the Company or any of its affiliates.
4.Manner of Recovery; Limitation on Duplicative Recovery
The Committee shall, in its sole discretion, determine the manner of recovery of any Erroneously Awarded Compensation, which may include, without limitation, reduction or cancellation by the Company or an affiliate of the Company of Incentive-Based Compensation,
1


Erroneously Awarded Compensation or solely time-vesting equity awards, reimbursement or repayment by any person subject to this Policy of the Erroneously Awarded Compensation, and, to the extent permitted by law, an offset of the Erroneously Awarded Compensation against other compensation payable by the Company or an affiliate of the Company to such person. Notwithstanding the foregoing, unless otherwise prohibited by the Applicable Rules, to the extent this Policy provides for recovery of Erroneously Awarded Compensation already recovered by the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 or Other Recovery Arrangements, the amount of Erroneously Awarded Compensation already recovered by the Company from the recipient of such Erroneously Awarded Compensation may be credited to the amount of Erroneously Awarded Compensation required to be recovered pursuant to this Policy from such person.
5.Administration
This Policy shall be administered, interpreted and construed by the Committee, which is authorized to make all determinations necessary, appropriate or advisable for such purpose. The Board of Directors of the Company (the “Board”) may re-vest in itself the authority to administer, interpret and construe this Policy in accordance with applicable law, and in such event references herein to the “Committee” shall be deemed to be references to the Board. Subject to any permitted review by the applicable national securities exchange or association pursuant to the Applicable Rules, all determinations and decisions made by the Committee pursuant to the provisions of this Policy shall be final, conclusive and binding on all persons, including the Company and its affiliates, equity holders and employees. The Committee may delegate administrative duties with respect to this Policy to one or more directors or employees of the Company, as permitted under applicable law, including any Applicable Rules.
6.Interpretation
This Policy shall be interpreted and applied in a manner that is consistent with the requirements of the Applicable Rules, and to the extent this Policy is inconsistent with such Applicable Rules, it shall be deemed amended to the minimum extent necessary to ensure compliance therewith.
7.No Indemnification; No Liability
The Company shall not indemnify or insure any person against the loss of any Erroneously Awarded Compensation pursuant to this Policy, nor shall the Company directly or indirectly pay or reimburse any person for any premiums for third-party insurance policies that such person may elect to purchase to fund such person’s potential obligations under this Policy. None of the Company, an affiliate of the Company or any member of the Committee or the Board shall have any liability to any person as a result of actions taken under this Policy.
8.Application; Enforceability
Except as otherwise determined by the Committee or the Board, the adoption of this Policy does not limit, and is intended to apply in addition to, any other clawback, recoupment, forfeiture or similar policies or provisions of the Company or its affiliates, including any such policies or

2



provisions of such effect contained in any employment agreement, bonus plan, incentive plan, equity-based plan or award agreement thereunder or similar plan, program or agreement of the Company or an affiliate or required under applicable law (the “Other Recovery Arrangements”). The remedy specified in this Policy shall not be exclusive and shall be in addition to every other right or remedy at law or in equity that may be available to the Company or an affiliate of the Company.
9.Severability
The provisions in this Policy are intended to be applied to the fullest extent of the law; provided, however, to the extent that any provision of this Policy is found to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law.
10.Amendment and Termination
The Board or the Committee may amend, modify or terminate this Policy in whole or in part at any time and from time to time in its sole discretion. This Policy will terminate automatically when the Company does not have a class of securities listed on a national securities exchange or association.
11.Definitions
Applicable Rules” means Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder, the listing rules of the national securities exchange or association on which the Company’s securities are listed, and any applicable rules, standards or other guidance adopted by the Securities and Exchange Commission or any national securities exchange or association on which the Company’s securities are listed.
Committee” means the committee of the Board responsible for executive compensation decisions comprised solely of independent directors (as determined under the Applicable Rules), or in the absence of such a committee, a majority of the independent directors serving on the Board.
Erroneously Awarded Compensation” means the amount of Incentive-Based Compensation received by a current or former Officer that exceeds the amount of Incentive-Based Compensation that would have been received by such current or former Officer based on a restated Financial Reporting Measure, as determined on a pre-tax basis in accordance with the Applicable Rules.
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
Financial Reporting Measure” means any measure determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures derived wholly or in part from such measures, including GAAP, IFRS and non- GAAP/IFRS financial measures, as well as stock or share price and total equity holder return.
“GAAP” means United States generally accepted accounting principles.

3



IFRS” means international financial reporting standards as adopted by the International Accounting Standards Board.
Impracticable” means (a) the direct costs paid to third parties to assist in enforcing recovery would exceed the Erroneously Awarded Compensation; provided that the Company has
(i) made reasonable attempts to recover the Erroneously Awarded Compensation, (ii) documented such attempt(s), and (iii) provided such documentation to the relevant listing exchange or association, (b) to the extent permitted by the Applicable Rules, the recovery would violate the Company’s home country laws pursuant to an opinion of home country counsel; provided that the Company has (i) obtained an opinion of home country counsel, acceptable to the relevant listing exchange or association, that recovery would result in such violation, and (ii) provided such opinion to the relevant listing exchange or association, or (c) recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and the regulations thereunder.
Incentive-Based Compensation” means, with respect to a Restatement, any compensation that is granted, earned, or vested based wholly or in part upon the attainment of one or more Financial Reporting Measures and received by a person: (a) after such person began service as an Officer; (b) who served as an Officer at any time during the performance period for that compensation; (c) while the Company has a class of its securities listed on a national securities exchange or association; and (d) during the applicable Three-Year Period.
Officer” means each person who serves as an executive officer of the Company, as defined in Rule 10D-1(d) under the Exchange Act.
Restatement” means an accounting restatement to correct the Company’s material noncompliance with any financial reporting requirement under securities laws, including restatements that correct an error in previously issued financial statements (a) that is material to the previously issued financial statements or (b) that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.
Three-Year Period” means, with respect to a Restatement, the three completed fiscal years immediately preceding the date that the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare such Restatement, or, if earlier, the date on which a court, regulator or other legally authorized body directs the Company to prepare such Restatement. The “Three-Year Period” also includes any transition period (that results from a change in the Company’s fiscal year) within or immediately following the three completed fiscal years identified in the preceding sentence. However, a transition period between the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months shall be deemed a completed fiscal year.
4


ACKNOWLEDGMENT AND CONSENT TO
POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION

The undersigned has received a copy of the Policy for Recovery of Erroneously Awarded Compensation (the “Policy”) adopted by Evolv Technologies Holdings, Inc. (the “Company”).
The undersigned acknowledges and agrees to the terms of the Policy and agrees that compensation received by the undersigned may be subject to reduction, cancellation, forfeiture and/or recoupment to the extent necessary to comply with the Policy, notwithstanding any other agreement to the contrary. The undersigned further acknowledges and agrees that the undersigned is not entitled to indemnification in connection with any enforcement of the Policy and expressly waives any rights to such indemnification under the Company’s organizational documents or otherwise.


_______________________
Date
_________________________________________________
_
Signature
_________________________________________________
Name
_________________________________________________
Title
5
EX-101.SCH 9 nhic-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Nature of the Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Accounts Receivable link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Prepaid expenses and other current assets link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Long-term Debt link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Net Loss per Share link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Benefit Plans link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Accounts Receivable (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Prepaid expenses and other current assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Long-term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Net Loss per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Nature of the Business and Basis of Presentation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Significant Accounting Policies - Risk of Concentrations of Credit, Significant Customers and Significant Suppliers (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Summary of Significant Accounting Policies - Contingent Earn-out (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Summary of Significant Accounting Policies - Contingently Issuable Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Summary of Significant Accounting Policies - Public Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Summary of Significant Accounting Policies - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Summary of Significant Accounting Policies - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Summary of Significant Accounting Policies - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value On Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Fair Value Measurements - Contingent Earn-Out and Contingently Issuable Common Shares (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Fair Value Measurements - Warrant Liability (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Revenue Recognition - Schedule of Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Revenue Recognition - Schedule of Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Revenue Recognition - Schedule of Minimum Future Payments on Noncancelable Leases (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Revenue Recognition - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Revenue Recognition - Summary of Rollforward of Deferred Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Revenue Recognition - Schedule of Components of Lease Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Revenue Recognition - Summary of Company's Revenue by Revenue Stream (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Revenue Recognition - Revenue by Geographical Location (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Leases - Schedule of Weighted-Average Remaining Lease Term and Discount Rate (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Leases - Schedule of Future Annual Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Leases - Schedule of Future Annual Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Inventory - Summary of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Prepaid expenses and other current assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - Property and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - Property and Equipment, Net - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - Property and Equipment, Net - Leased Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - Long-term Debt - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - Long-term Debt - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954521 - Disclosure - Long-term Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954522 - Disclosure - Warrants - Preferred Stock and Common Stock Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 9954523 - Disclosure - Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 9954524 - Disclosure - Stock-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954525 - Disclosure - Stock-Based Compensation - Grant Date Fair Value of Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 9954526 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954527 - Disclosure - Stock-Based Compensation - Restricted Stock Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954528 - Disclosure - Stock-Based Compensation - Performance Stock Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954529 - Disclosure - Stock-Based Compensation - Company Utilized Black-Scholes Pricing Model (Details) link:presentationLink link:calculationLink link:definitionLink 9954530 - Disclosure - Stock-Based Compensation - Stock Based Compensation Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 9954531 - Disclosure - Stock-Based Compensation - Stock Based Compensation Expenses by Award Type (Details) link:presentationLink link:calculationLink link:definitionLink 9954532 - Disclosure - Income Taxes - Components of Loss Before Income Tax Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954533 - Disclosure - Income Taxes - Components of Income Tax Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954534 - Disclosure - Income Taxes - Effective Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 9954535 - Disclosure - Income Taxes - Net Deferred Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954536 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954537 - Disclosure - Income Taxes - Valuation Allowance for Deferred Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954538 - Disclosure - Income Taxes - Uncertain Tax Positions (Details) link:presentationLink link:calculationLink link:definitionLink 9954539 - Disclosure - Net Loss per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954540 - Disclosure - Net Loss per Share - Antidilutive Effect (Details) link:presentationLink link:calculationLink link:definitionLink 9954541 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 9954542 - Disclosure - Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 nhic-20231231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 nhic-20231231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 nhic-20231231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Accounts Receivable Accounts and Nontrade Receivable [Text Block] Schedule of accrued liabilities Schedule of Accrued Liabilities [Table Text Block] Research and development Research and Development Expense Changes in operating assets and liabilities Increase (Decrease) in Operating Capital [Abstract] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Revenue arrangement period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Income Tax Uncertainties Income Tax Uncertainties, Policy [Policy Text Block] Stock-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Contingent Earn-out Contingent Earn-out Policy [Policy Text Block] The disclosure of accounting policy for Contingent Earn-out. Expected volatility Measurement Input, Price Volatility [Member] Insider Trading Policies and Procedures [Line Items] Options exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Long-term debt including current portion Long-Term Debt Including Current Portion [Member] Long-Term Debt Including Current Portion Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Error Corrections and Prior Period Adjustments Restatement [Line Items] Error Corrections and Prior Period Adjustments Restatement [Line Items] Write-off of inventory and change in inventory reserve Inventory Write-down Sales demo equipment Sales demo equipment Represents the information about Sales Demo Equipment member. Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Issuance of common stock upon vesting of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Shares vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number Liabilities of fair value Financial Liabilities Fair Value Disclosure Computers and telecom equipment Computers and telecom equipment Represents the information about Computer and telecom Equipment member. Customer [Axis] Customer [Axis] Current liabilities: Liabilities, Current [Abstract] Federal Deferred Federal Income Tax Expense (Benefit) Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2023 and December 31, 2022; no shares issued and outstanding at December 31, 2023 and December 31, 2022 Preferred Stock, Value, Issued Net loss per share - diluted (in dollars per share) Earnings Per Share, Diluted Loss from impairment of property and equipment Impairment of property and equipment Impairment, Long-Lived Asset, Held-for-Use Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Prepaid Expense and Other Assets, Current [Abstract] Prepaid Expense and Other Assets, Current [Abstract] Components of the Company's loss before income tax expense Components of Income Tax Expense (Benefit), Continuing Operations [Abstract] Net operating losses with no expiry Operating Loss Carryforwards, With No Expiry Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws with no expiration date. Trading Symbol Trading Symbol Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate Effective Income Tax Rate Reconciliation, Percent [Abstract] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Leased equipment Machinery and Equipment [Member] Cost of revenue: Cost of Revenue [Abstract] Lessor, operating lease, payments to be received Lessor, Operating Lease, Payment to be Received Employee Stock Employee Stock [Member] Marketable Securities Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Change in tax rate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Number of votes per common share Common Stock, Number of Votes For Each Share Represents the number of votes per common shares. Schedule of Uncertain Tax Positions Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Balance at beginning of period Balance at end of period Contract with Customer, Liability Schedule of basic and diluted net loss per share attributable to common stockholders Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Executive Category: Executive Category [Axis] 2027 Lessor, Operating Lease, Payment to be Received, Year Four Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Level 1 Fair Value, Inputs, Level 1 [Member] Total deferred tax assets, net of valuation allowance Deferred Tax Assets, Net of Valuation Allowance Marketable securities Marketable Securities, Current Schedule of property and equipment, net Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Financial Instruments [Domain] Financial Instruments [Domain] Weighted Average Exercise Price Weighted average exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Warrants Warrants and Rights Note Disclosure [Text Block] The entire disclosure related to warrants and rights. Current portion of net investment in sales-type leases Sales-Type Lease, Net Investment in Lease, after Allowance for Credit Loss, Current Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Entity Small Business Entity Small Business Local Phone Number Local Phone Number Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table] Accounts Receivable Accounts Receivable [Member] Measurement Frequency [Axis] Measurement Frequency [Axis] Unvested restricted stock units Restricted Stock Units Restricted Stock Units (RSUs) [Member] Summary of restricted stock unit activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Depreciation Depreciation Marketable Securities Marketable Securities [Table Text Block] Term loans payable Term loans payable Represents information pertaining to term loans payable. Federal and state research and development tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Number of warrants exercised (in shares) Number of Warrants Exercised Number warrants exercised during the period. Accrued sales tax Accrued Income Taxes, Current Total revenue Revenue Revenues Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Schedule of potential common shares excluded from the computation of diluted net loss per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accrued expenses and other current liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Research and development Research and Development Expense [Member] Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract] Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures Antidilutive securities excluded from the computation of diluted net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Expected dividend yield Dividends, Common Stock Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag General and administrative General and Administrative Expense [Member] Leased equipment Property, Plant and Equipment, Gross Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Related Party Transactions Related Party Transactions Disclosure [Text Block] Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Schedule of Income Tax Expense Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Prepaid subscriptions Prepaid Expense, Current Current portion of operating lease liabilities Operating Lease, Liability, Current Annual increase of total common shares outstanding Annual Increase Of Total Common Shares Outstanding As A Percentage Of Common Shares Outstand As Of The End Of Prior Year Annual Increase Of Total Common Shares Outstanding As A Percentage Of Common Shares Outstand As Of The End Of Prior Year Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Revenue deferred Contract With Customer, Liability, Additions Contract With Customer, Liability, Additions Public Warrant liability Public Warrant Liability. Reports to public warrant liability. 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Summary of components of the Company's loss before income tax expense Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Interest income Investment Income, Interest Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Gross profit Gross Profit Current portion of deferred revenue Contract with Customer, Liability, Current Schedule of fair value weighted-average assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Security Exchange Name Security Exchange Name Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Vesting percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Stock options Options issued and outstanding Employee Stock Option [Member] Maximum Maximum [Member] Document Type Document Type Tabular List, Table Tabular List [Table Text Block] Contingent earn-out liability Contingent Earn-Out Liability Represents the information pertaining to Contingent earn-out liability. Inventory Inventory, Policy [Policy Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Federal Current Federal Tax Expense (Benefit) Basis of presentation Basis of Accounting, Policy [Policy Text Block] Business Acquisition [Axis] Business Acquisition [Axis] 2021 Equity Incentive Plan 2021 Equity Incentive Plan Represents the information pertaining to two thousand and twenty one equity incentive plan. Customer Concentration Risk Customer Concentration Risk [Member] Restricted cash, noncurrent Restricted Cash, Noncurrent State Deferred State and Local Income Tax Expense (Benefit) Variable Rate [Axis] Variable Rate [Axis] 2024 Lessor, Operating Lease, Payment to be Received, Year One Inventory [Line Items] Inventory [Line Items] Prepaid deposits Deposits Assets, Current Raw materials Inventory, Raw Materials, Net of Reserves Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Title of 12(b) Security Title of 12(b) Security Related Party [Domain] Related Party, Type [Domain] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Anil Chitkara [Member] Anil Chitkara Earn-out shares Earn Out Shares Represents the information pertaining to to earn-out shares. Outstanding, beginning balance (in dollars per share) Outstanding, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Purchases of marketable securities Payments to Acquire Marketable Securities Number of resellers and integration partners Number of Resellers And Integration Partners Represents number of resellers and integration partners are sold motorola products through company integrated platform. Statistical Measurement [Axis] Statistical Measurement [Axis] Capitalization of stock compensation Share-Based Payment Arrangement, Amount Capitalized Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Common Stock Common Stock Disclosure [Text Block] The entire disclosure of common stock Lessor, lease term Lessor, Operating Lease, Term of Contract Product revenue Product [Member] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Give Evolv LLC Give Evolv LLC Represents information pertaining to Give Evolv LLC. Aggregate intrinsic value of warrants exercisable Aggregate Intrinsic Value of Warrants Exercisable Represents the information pertaining to aggregate intrinsic value of warrants exercisable. Business Acquisition, Contingent Consideration [Line Items] Business Acquisition, Contingent Consideration [Line Items] Summary of net deferred tax assets Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Operating lease payments Operating Lease, Payments Schedule of stock-based compensation expense Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Common stock, outstanding (in shares) Common Stock, Shares, Outstanding Deferred asset related to commissions Capitalized Contract Cost, Gross Revenue arrangement period Service Revenue, Arrangement Period Service Revenue, Arrangement Period PEO PEO [Member] Schedule of minimum future payments on noncancelable leases Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block] Risk of Concentrations of Credit, Significant Customers and Significant Suppliers Concentration Risk, Credit Risk, Policy [Policy Text Block] Auditor Location Auditor Location Contract assets, noncurrent Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent Shares outstanding (in shares) Shares, Outstanding Debt instrument, increase Debt Instrument, Increase (Decrease), Net Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Contingent consideration term Contingent Consideration Term Contingent Consideration Term Customer Customer Represents information pertaining to Customer A. Debt Instrument [Axis] Debt Instrument [Axis] July 16, 2021 July 16, 2021 Represents information pertaining to warrants issued at july two thousand twenty one. Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Measurement Input Type [Domain] Measurement Input Type [Domain] Total liabilities Liabilities Total current income tax expense Current Income Tax Expense (Benefit) 2022 SVB Term Loan 2022 SVB Term Loan [Member] 2022 SVB Term Loan Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Number of shares remained available for future grant (in shares) Common Stock, Capital Shares Reserved for Future Issuance Measurement Frequency [Domain] Measurement Frequency [Domain] Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] 2026 Lessor, Operating Lease, Payment to be Received, Year Three Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Related Party Transaction [Domain] Related Party Transaction [Domain] Service revenue SaaS, Maintenance and Other [Member] SaaS and Maintenance Services Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Marketable Securities Marketable Securities, Policy [Policy Text Block] Sales and marketing Selling and Marketing Expense General and administrative General and Administrative Expense Prepayment premium Debt Instrument, Interest Rate, Prepayment Premium Debt Instrument, Interest Rate, Prepayment Premium Reseller Agreement Reseller Agreement [Member] Reseller Agreement Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] State Current State and Local Tax Expense (Benefit) Segment Information Segment Reporting, Policy [Policy Text Block] Total current assets Assets, Current Schedule of customers that represent 10% or more of the Company's total revenue and accounts receivable Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Supplemental disclosure of cash flow information Supplemental Cash Flow Information [Abstract] Net Loss per Share Attributable to Common Stockholders Earnings Per Share, Policy [Policy Text Block] Business development agreement term Business Development Agreement Term. Business development agreement term. Concentration risk, percentage (less than) Concentration Risk, Percentage Balance at beginning Balance at ending Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Current: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Number of storage spaces Lessee, Operating Lease, Number Of Storage Spaces Lessee, Operating Lease, Number Of Storage Spaces State income taxes, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Prepaid insurance Prepaid Insurance 2021 Employee Stock Purchase Plan 2021 Employee Stock Purchase Plan Twenty Twenty One Employee Stock Purchase Plan [Member] Accrued employee compensation and benefits expense Accrued Employee Compensation And Benefits Expense Current Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Class of Stock [Axis] Class of Stock [Axis] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Class of warrant or right, unissued (in shares) Class of Warrant or Right, Unissued Depreciation and amortization Depreciation, Depletion and Amortization Furniture and fixtures Furniture and Fixtures [Member] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Schedule of estimated useful life of property and equipment Schedule of Property, Plant And Equipment, Estimated Useful Life [Table Text Block] The entire disclosure about schedule of property, plant and equipment, estimated useful life. Accrued professional services and consulting Accrued Professional Service And Consulting Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional service and consulting, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Additions charged to equity Valuation Allowance Deferred Tax Asset Additions To Equity Valuation Allowance Deferred Tax Asset Additions To Equity Unrealized Gain/(Loss) Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain (Loss), before Tax Valuation allowance Valuation allowance as of beginning of year Valuation allowance as of end of year Deferred Tax Assets, Valuation Allowance Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Revenue recognized in relation to the beginning of the year contract liability balance Revenue recognized in relation to the beginning of the year contract liability balance Contract with Customer, Liability, Revenue Recognized Cumulative translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Contingent Earnout, Triggering Event [Axis] Contingent Earnout, Triggering Event [Axis] Contingent Earnout, Triggering Event Customer A Customer A [Member] Represents information pertaining to Customer A. Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Preferred stock, issued (in shares) Preferred Stock, Shares Issued Entity Emerging Growth Company Entity Emerging Growth Company Total deferred tax assets Deferred Tax Assets, Gross Schedule of components of lease revenue Operating Lease, Lease Income [Table Text Block] Contingent earn-out liability Reverse Recapitalization, Contingent Consideration, Liability, Noncurrent Reverse Recapitalization, Contingent Consideration, Liability, Noncurrent 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Title Trading Arrangement, Individual Title Common Stock Common Stock [Member] Individual: Individual [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Income Statement Location [Domain] Income Statement Location [Domain] Schedule of common stock warrant liability Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Benefit Plans Benefit Plans Benefit Plans Disclosure Minimum Minimum [Member] Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Property and equipment, net Leased equipment, net Leased equipment, net Property, Plant and Equipment, Net Change in allowance for expected credit losses Accounts Receivable, Allowance For Credit Loss, Expense (Reversal) Net Of Writeoff And Recovery Accounts Receivable, Allowance For Credit Loss, Expense (Reversal) Net Of Writeoff And Recovery Total other comprehensive loss Other Comprehensive Income (Loss), Net of Tax Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Proceeds from long-term debt Proceeds from Issuance of Long-Term Debt Operating lease liability Increase (Decrease) in Operating Lease Liability Other Deferred Tax Assets, Other License fees License Fee [Member] License Fee Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Plan of merger with NHIC and Merger Sub Plan of merger with NHIC and Merger Sub Represents the information pertaining to Plan of merger with NHIC and Merger Sub. Number of Evolv Express units donated Number of Units Donated Number of Units Donated Accumulated Deficit Retained Earnings [Member] Current portion of long-term debt Less: Current portion of long-term debt Long-Term Debt, Current Maturities Non-cash lease expense Noncash Lease Expense Noncash Lease Expense Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Other income (expense), net: Nonoperating Income (Expense) [Abstract] Net loss per share - basic (in dollars per share) Earnings Per Share, Basic Professional services and other revenue Professional Services and Other Revenue [Member] Professional Services and Other Revenue Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Accounting Policies [Abstract] Accounting Policies [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Contractual Term (in years) Warrants and Rights Outstanding, Term Net deferred tax assets Deferred Tax Assets, Net Aggregate intrinsic value of the stock options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Number of shares purchased from issuance of warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Finback Common Stock Warrants 2021 Finback Common Stock Warrants 2021 [Member] Represents information pertaining to Finback Common Stock Warrants. Issuance of common stock upon exercise of warrants (in shares) Stock Issued During Period, Share, Issuance Of Common Stock For Net Settlement Of Common Stock Upon Exercise Of Warrants Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Weighted Average Remaining Contractual Term (in years) Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term Abstract No definition available. Triggering Event One Triggering Event One Represents the information pertaining to Triggering Event I. Accounts payable Increase (Decrease) in Accounts Payable Measurement input Derivative Liability, Measurement Input Contingently issuable common stock Unvested Founder Shares Represents the information pertaining to founder shares . NHIC Sub Inc NHIC Sub Inc This member stands for NHIC Sub Inc. Entity Public Float Entity Public Float Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Term loans payable Long-Term Debt, Gross Liability Class [Axis] Liability Class [Axis] All Trading Arrangements All Trading Arrangements [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Cash, Cash Equivalents, and Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Compensation Amount Outstanding Recovery Compensation Amount Schedule of performance obligations Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] Provisions Accounts Receivable, Credit Loss Expense (Reversal) Contingent consideration, measurement input Contingent Consideration, Liability, Measurement Input Value of input used to measure contingent consideration liability. Cancelled (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Right of use lease asset Deferred Tax Liabilities, Leasing Arrangements Total deferred income tax expense Deferred Income Tax Expense (Benefit) Proceeds from exercise of stock options Proceeds from Stock Options Exercised Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Document Financial Statement Error Correction [Flag] Document Financial Statement Error Correction [Flag] Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract] Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract] Beginning balance Ending balance Accounts Receivable, Allowance for Credit Loss Share price (in dollars per share) Share Price Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Change in fair value of contingently issuable common stock liability Change in fair value of contingently issuable common stock Increase (Decrease) in Fair Value of Contingently Issuable Common Stock Liability The amount of increase (decrease) in fair value of contingently issuable common stock liability. Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Document Period End Date Document Period End Date Adoption Date Trading Arrangement Adoption Date Reduction of income tax expense Valuation Allowance, Deferred Tax Asset, Decrease For Reversal Charged To Income Tax Expenses (Benefit), Amount Amount of decrease in the valuation allowance for tax benefits related to any reversal of the valuation allowance on net operating losses deferred tax assets charged income tax expenses. Summary of changes in allowance for expected credit losses Accounts Receivable, Allowance for Credit Loss [Table Text Block] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Provision for income taxes Provision for income taxes Total income tax expense Income Tax Expense (Benefit) Foreign Non-US [Member] Write-offs, net of recoveries Accounts Receivable, Allowance for Credit Loss, Writeoff Vesting [Axis] Vesting [Axis] Fair Value Measurements Fair Value Disclosures [Text Block] Number of operating segment Number of Operating Segments Cash, cash equivalents and restricted cash Cash and Cash Equivalents [Abstract] Unamortized debt issuance cost Deferred Debt Issuance Cost, Writeoff Inventory Inventory Disclosure [Text Block] Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Change in fair value of contingent earn-out liability and contingently issuable common stock liability Effective Income Tax Rate Reconciliation, Change in Fair Value of Contingent Earn Out Liability And Common Stock Liability, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Change in fair value of contingent earn-out liability and contingently issuable common stock liability. 2025 Lessor, Operating Lease, Payment to be Received, Year Two Money market funds Money Market Funds [Member] Schedule of performance shares Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block] Tax credit carryforwards Tax Credit Carryforward, Amount Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Non-deductible compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Share-Based Awards Excluding Employee Stock Purchase Plan Share-Based Awards Excluding Employee Stock Purchase Plan [Member] Share-Based Awards Excluding Employee Stock Purchase Plan Measurement Input, Control Premium Measurement Input, Control Premium [Member] Estimated Useful Life Depreciable lives Property, Plant and Equipment, Useful Life Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Internal-use software Software Development [Member] Summary of changes in the valuation allowance for deferred tax assets Summary of Valuation Allowance [Table Text Block] RSUs and PSUs Restricted Stock Units And Phantom Share Units [Member] Restricted Stock Units And Phantom Share Units Summary of rollforward of deferred revenue Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Revenue Recognition Revenue from Contract with Customer [Text Block] Grant date fair value of restricted stock Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Aggregate Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Aggregate Grant Date Fair Value Additional Paid-in Capital Additional Paid-in Capital [Member] Document Annual Report Document Annual Report Revision of Prior Period [Axis] Revision of Prior Period [Axis] Cover [Abstract] Cover [Abstract] Lab equipment Lab equipment Represents information pertaining to lab equipment. United States UNITED STATES Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Fair Value, Recurring Fair Value, Recurring [Member] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Total future lease payments Lessee, Operating Lease, Liability, to be Paid Total revenue Revenue, Remaining Performance Obligation, Amount Benefit Plans Compensation and Employee Benefit Plans [Text Block] Total operating expenses Operating Expenses Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Subscription revenue Subscription and Circulation [Member] Lease renewal term Lessee, Operating Lease, Renewal Term Equity Component [Domain] Equity Component [Domain] State and Local Jurisdiction State and Local Jurisdiction [Member] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Other Deferred Tax Liabilities, Other Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Loss from operations Operating Income (Loss) Operating Lease Income Comprehensive Income Extensible List Not Disclosed Flag Operating Lease Income Comprehensive Income Extensible List Not Disclosed Flag Operating Lease Income Comprehensive Income Extensible List Not Disclosed Flag Total deferred tax liabilities Deferred Tax Liabilities, Gross Consolidated Entities [Domain] Consolidated Entities [Domain] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax [Abstract] Scenario [Domain] Scenario [Domain] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Purchases of property and equipment Payments To Acquire Property, Plant, And Equipment, Net Payments To Acquire Property, Plant, And Equipment, Net Earn-out shares are subject to the share-based compensation (in shares) Earn Out Shares Subject To Share Based Compensation Number of earn out shares subject to share based compensation. Share-based Payment Arrangement, Tranche One Share-Based Payment Arrangement, Tranche One [Member] Consolidated Entities [Axis] Consolidated Entities [Axis] Variable Rate [Domain] Variable Rate [Domain] Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Pay vs Performance Disclosure [Line Items] Entity Voluntary Filers Entity Voluntary Filers Purchase order cancellation fees Purchase Order Cancellation Fees Current Purchase Order Cancellation Fees Current Statistical Measurement [Domain] Statistical Measurement [Domain] Change in fair value of contingent earn-out liability Change in fair value of earn-out liability Increase (Decrease) in Fair Value of Contingent Earnout Liability The amount of increase (decrease) in fair value of contingent earnout liability Underlying Security Market Price Change Underlying Security Market Price Change, Percent Number of consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Long-term Debt Debt Disclosure [Text Block] Thereafter Lessor, Operating Lease, Payment to be Received, after Year Four Lessor, Operating Lease, Payment to be Received, after Year Four Liabilities and Stockholders’ Equity Statement of Stockholders' Equity [Abstract] Investments, Debt and Equity Securities [Abstract] Term of payments after the shipment or delivery of the product Term Of Payments After The Shipment Or Delivery Of The Product Represents the term of payments after the shipment or delivery of the product. Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Outstanding shares expected to vest (in shares) Share Outstanding Expected To Vest Upon Certain Milestone Share Outstanding Expected To Vest Upon Certain Milestone MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Unvested performance stock units Performance Shares [Member] Accounts payable Accounts Payable, Current Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Computers and telecommunications equipment Computer Equipment [Member] Restatement Determination Date: Restatement Determination Date [Axis] Total other income (expense), net Nonoperating Income (Expense) Federal statutory income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Commitments and contingencies (Note 19) Commitments and Contingencies Geographical [Axis] Geographical [Axis] Term of stock option Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Income Taxes Income Tax Disclosure [Text Block] Commission asset, noncurrent Commission Asset, Noncurrent The carrying value as of balance sheet date of commission assets due after one year or the normal operating cycle, if longer. Deferred revenue Increase (Decrease) in Contract with Customer, Liability Concentration Risk [Line Items] Concentration Risk [Line Items] Leases as a Lessee Lessee, Leases [Policy Text Block] Revenue Recognition Revenue [Policy Text Block] Intrinsic value of warrants unvested Intrinsic Value of Warrants Unvested Represents the information pertaining to intrinsic value of warrants unvested. Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Transfer of property and equipment to inventory Transfers Of Inventory To Property And Equipment Represents the transfers of inventory to property and equipment in noncash investing or financing activities. Quarterly Financial Data [Abstract] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] PEO Total Compensation Amount PEO Total Compensation Amount Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Outstanding at beginning (in shares) Outstanding as ending (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Issuance of common stock upon exercise of stock options Stock Issued During Period, Value, Stock Options Exercised License fee and other revenue License Fee And Other Revenue [Member] License Fee And Other Revenue Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Weighted average grant date fair value of options granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Net loss Net loss Net loss Net Income (Loss) Total current liabilities Liabilities, Current Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Leases Lessee, Operating Leases [Text Block] Balance at the beginning (in shares) Balance at the end (in shares) Shares, Issued Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Issuance of common stock upon exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Shares issuable upon exercise of warrant (in shares) Class of Warrant or Right Number of Securities, Exercisable Number of securities into which the class of warrant or right that may be exercisable. Common Class B Common Class B [Member] Name Measure Name Name Forgone Recovery, Individual Name Gross increases related to prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Underlying Securities Award Underlying Securities Amount Accounts receivable Increase (Decrease) in Accounts Receivable Forecast Forecast [Member] Warrants Warrant [Member] Operating lease liabilities, noncurrent Operating Lease, Liability, Noncurrent Class of Warrant or Right [Table] Class of Warrant or Right [Table] Debt instrument, term Debt Instrument, Term Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Percent of increase of outstanding number of common stock Percent Of Increase Of Outstanding Number Of Common Stock Percent Of Increase Of Outstanding Number Of Common Stock Income Statement Location [Axis] Income Statement Location [Axis] Audit Information [Abstract] Audit Information [Abstract] Required notice period before renewal Lessee, Operating Lease, Renewal Term, Required Notice Period Lessee, Operating Lease, Renewal Term, Required Notice Period Schedule of future annual lease payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Payables and Accruals [Abstract] Payables and Accruals [Abstract] Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Schedule of weighted-average remaining lease term and discount rate Lease, Cost [Table Text Block] Inventory Increase (Decrease) in Inventories Current portion of contract assets Contract with Customer, Asset, after Allowance for Credit Loss, Current Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Plan Name [Domain] Plan Name [Domain] Payment of debt issuance costs and prepayment penalty Payment for Debt Extinguishment or Debt Prepayment Cost Interest expense Interest Expense Capital expenditures incurred but not yet paid Capital Expenditures Incurred but Not yet Paid Loss on extinguishment of debt Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Number of shares of common stock may be issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Trading Arrangement: Trading Arrangement [Axis] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Use of Estimates Use of Estimates, Policy [Policy Text Block] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current [Text Block] The entire disclosure of prepaid expenses and other current assets. Entity File Number Entity File Number Change in fair value of public warrant liability Change in fair value of public warrant liability Fair Value Adjustment Of Public Warrant Liability The amount of change in fair value of public warrant liability. Less: Unamortized discount Debt Instrument, Unamortized Discount Auditor Firm ID Auditor Firm ID Equipment held for lease Equipment Held For Lease [Member] Equipment Held For Lease Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Entity Shell Company Entity Shell Company Revision of Prior Period, Adjustment Revision of Prior Period, Adjustment [Member] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Change in uncertain tax positions Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Restatement Determination Date Restatement Determination Date Lease revenue (less than) Total lease revenue Revenue Not from Contract with Customer Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash shown in the statements of cash flows Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Asset Class [Axis] Asset Class [Axis] Expected term (in years) Measurement Input, Expected Term [Member] Operating lease cost Operating Lease, Cost Common stock, issued (in shares) Common Stock, Shares, Issued Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Long-term debt Long-Term Debt Total assets measured at fair value Assets, Fair Value Disclosure Common Class A Common Class A [Member] Weighted average period expected of recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Total comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Triggering Event Three Triggering Event Three Represents the information pertaining to Triggering Event III. Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Domestic Tax Authority Domestic Tax Authority [Member] Total fair value of shares vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued Liabilities and Other Liabilities Triggering Event Two Triggering Event Two Represents the information pertaining to Triggering Event II. Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Net operating losses with expiry Operating Loss Carryforwards Deferred revenue Deferred Tax Assets, Deferred Income Income Statement [Abstract] Income Statement [Abstract] Issuance of common stock in connection with the consummation of the PIPE Investment (in shares) Stock Issued During Period, Shares, New Issues Contract assets Increase (Decrease) in Contract with Customer, Asset Warrants and Rights Note Disclosure [Abstract] Warrants and Rights Note Disclosure [Abstract] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Accrued expenses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Other Other Assets, Current Currency translation and other Valuation Allowance, Deferred Tax Asset, Increase, Currency Translation And Other, Amount Amount of increase in the valuation allowance by additions charged to Currency translation and other for a specified deferred tax asset. Inventory Total Inventory, Net Amortized commissions Capitalized Contract Cost, Amortization Financial Instrument [Axis] Financial Instrument [Axis] 2022 Additional SVB Term Loan 2022 SVB Term Loan Two [Member] 2022 SVB Term Loan Two Total Shareholder Return Amount Total Shareholder Return Amount Reconciliation of cash, cash equivalents and restricted cash: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Threshold percentage Threshold Percentage Of Fair Market Value Of A Share Of Common Stock On The Date Of Grant Threshold percentage of fair market value of a share of common stock on the date of grant in the calculation of exercise price of stock options. Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Foreign Deferred Foreign Income Tax Expense (Benefit) Supplemental disclosure of non-cash activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Prepayment premium Debt Instrument, Prepayment Premium Debt Instrument, Prepayment Premium Revenue Recognition and Deferred Revenue [Abstract] Accumulated deficit Retained Earnings (Accumulated Deficit) Face amount of debt Debt Instrument, Face Amount Fair value of shares Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares Current assets: Assets, Current [Abstract] Leases [Abstract] Finback BDA Business Development Agreement with Finback [Member] Represents the information pertaining to Business Development Agreement with Finback. Deferred tax assets: Components of Deferred Tax Assets [Abstract] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Warrants to purchase one share of Class A common stock Warrants to purchase one share of Class A common stock Represents information pertaining to warrants to purchase common stock. Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Earn-out shares issuable upon achieving certain milestones (in shares) Earn Out Shares Issuable Upon Achieving Certain Milestones Number of earn out shares issuable upon achievement of certain milestones. Customer B Customer B [Member] Customer B Asset Class [Domain] Asset Class [Domain] Subscription Agreements Subscription Agreements Represents the information pertaining to Subscription Agreements. Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Class of Stock [Domain] Class of Stock [Domain] U.S. Treasury bills Treasury bills US Treasury Bill Securities [Member] Customer [Domain] Customer [Domain] Net income (loss) attributable to common stockholders - basic Net Income (Loss) Available to Common Stockholders, Basic Summary of inventory Schedule of Inventory, Current [Table Text Block] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Present value of operating lease liability Operating Lease, Liability Service revenue Service [Member] Nature of the Business and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Vesting [Domain] Vesting [Domain] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] All Executive Categories All Executive Categories [Member] Deferred revenue, noncurrent Contract with Customer, Liability, Noncurrent Plan Name [Axis] Plan Name [Axis] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Number of reportable segment Number of Reportable Segments Earnings Per Share [Abstract] Earnings Per Share [Abstract] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2023 and December 31, 2022, 151,310,080 and 145,204,974 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] All Individuals All Individuals [Member] Other expense, net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Summary of reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Balance at beginning of fiscal year Balance at end of fiscal year Unrecognized Tax Benefits Income Tax Authority [Axis] Income Tax Authority [Axis] Public Warrant Liability Warrant Liability [Policy Text Block] Disclosure of accounting policy pertaining to warrant liability. PEO Name PEO Name Expected dividend yield Measurement Input, Expected Dividend Rate [Member] Debt Issuance Costs Debt, Policy [Policy Text Block] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Restricted cash Restricted Cash, Current Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding Additions charged to provision for income taxes Valuation Allowance, Deferred Tax Asset, Increase Charged To Provision For Income Taxes, Amount Amount of increase in the valuation allowance by additions charged to provision for income taxes for a specified deferred tax asset. Schedule of prepaid expenses and other current assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Marketable Securities [Line Items] Marketable Securities [Line Items] Contingently Issuable Common Stock Contingently Issuable Common Stock Policy [Policy Text Block] The disclosure of accounting policy for Contingently Issuable Common Stock. Other Other Accrued Liabilities, Current Warrants January 13, 2021 Warrants Issued At January Two Thousand Twenty One [Member] Warrants Issued At January Two Thousand Twenty One Schedule of leased equipment and the related accumulated depreciation Schedule Of Property Plant And Equipment Related Lease [Table Text Block] Tabular disclosure represents about leased equipment related accumulated depreciation. Development of internal-use software Payments to Develop Software Interest rate Debt Instrument, Interest Rate, Stated Percentage Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Stockholders’ equity Balance at the beginning Balance at the end Equity, Attributable to Parent Liability for uncertain tax positions Unrecognized Tax Benefits that Would Impact Effective Tax Rate Leasehold improvements Leaseholds and Leasehold Improvements [Member] Schedule of fair value measurements of common stock warrants granted Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Revision of Prior Period [Domain] Revision of Prior Period [Domain] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Fair Value Measurements of Financial Instruments Fair Value Measurement, Policy [Policy Text Block] Level 2 Fair Value, Inputs, Level 2 [Member] Foreign exchange and others Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Current portion of commission asset Commission Asset, Current The carrying value as of balance sheet date of commission assets due within one year or the normal operating cycle, if longer. Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Number of trading days Debt Instrument, Convertible, Threshold Trading Days Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Outstanding at beginning (in dollars per share) Outstanding at ending (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Revenue from External Customers by Geographic Areas Revenue from External Customers by Geographic Areas [Table Text Block] Foreign Tax Authority Foreign Tax Authority [Member] City Area Code City Area Code Net Loss per share Earnings Per Share [Text Block] Product and Service [Axis] Product and Service [Axis] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Marketable Securities [Table] Marketable Securities [Table] Lease term Lessee, Operating Lease, Term of Contract Inventory [Domain] Inventory [Domain] Software Software and Software Development Costs [Member] Commission assets Increase (Decrease) in Commission Assets The increase (decrease) during the reporting period of all commission assets associated with underlying transactions that are classified as operating activities. Receivables [Abstract] Summary of stock option activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Exercise Price Award Exercise Price Security deposit Lessee, Operating Lease, Security Deposit Lessee, Operating Lease, Security Deposit Summary of warrants to purchase the classes of Preferred Stock and Common Stock outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Cash dividends declared or paid Dividends, Common Stock, Cash Edge Units Edge Units [Member] Edge Units [Member] Contingent Earnout, Triggering Event [Domain] Contingent Earnout, Triggering Event [Domain] Contingent Earnout, Triggering Event [Domain] Schedule of allocation of share based compensation expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Accretion of discount on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Total liabilities and stockholders’ equity Liabilities and Equity Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Foreign Current Foreign Tax Expense (Benefit) Net income (loss) attributable to common stockholders - diluted Net Income (Loss) Available to Common Stockholders, Diluted Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Related Party Related Party [Member] Inventory, Current [Table] Inventory, Current [Table] Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Lease liability Deferred Tax Asset, Leasing Arrangements Deferred Tax Asset, Leasing Arrangements Termination Date Trading Arrangement Termination Date Adjustment to property and equipment for sales type leases Adjustment To Property And Equipment For Sale Type Leases Amount of adjustment to property, plant and equipment for sale type leases. Proceeds from maturities of marketable securities Proceeds from Sale and Maturity of Marketable Securities Common stock, shares authorized (in shares) Common Stock, Shares Authorized Capitalized software amortization Capitalized Computer Software, Amortization Fair Value Debt Securities, Available-for-Sale Accrued Expenses and Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Document Information [Table] Document Information [Table] Non-cash interest expense Noncash Interest Expense Amount of interest expense that result in no cash flow. Unvested Stock Options and Restricted Stock Units Unvested Stock Options and Restricted Stock Units Represents the information pertaining to unvested stock options and unvested restricted stock units. Revenue from sales-type leases Sales-type Lease, Revenue Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Measurement Input Type [Axis] Measurement Input Type [Axis] Award Timing Disclosures [Line Items] Additional paid-in capital Additional Paid in Capital Inventory [Axis] Inventory [Axis] Capitalized research and development costs Deferred Tax Assets, Tax Credit Carryforwards, Capitalized Research and Development Costs Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capitalized research and development costs. Document Information [Line Items] Document Information [Line Items] Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Abstract No definition available. Share-based Payment Arrangement, Tranche Three Share-Based Payment Arrangement, Tranche Three [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Income Taxes Income Tax, Policy [Policy Text Block] Prepaid expenses and other current assets Total Prepaid Expense and Other Assets, Current Insider Trading Arrangements [Line Items] Related Party [Axis] Related Party, Type [Axis] Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Entity Registrant Name Entity Registrant Name Remaining number of founder shares Remaining Founder Shares Outstanding The remaining number of founder shares outstanding. Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Other assets Increase (Decrease) in Other Operating Assets Public warrant liability Warrants and Rights Outstanding Adjustment to Compensation, Amount Adjustment to Compensation Amount Share-based Payment Arrangement, Tranche Two Share-Based Payment Arrangement, Tranche Two [Member] Cost of revenue Cost of Sales [Member] Deferred tax liabilities: Components of Deferred Tax Liabilities [Abstract] Auditor Name Auditor Name Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Less: Accumulated depreciation and amortization Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Schedule of financial assets and liabilities measured at fair value on a recurring basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Options exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Repayment of principal on long-term debt Repayments of Long-Term Debt Entity Central Index Key Entity Central Index Key Liabilities: Liabilities, Fair Value Disclosure [Abstract] Stock compensation expense Total stock-based compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Finished goods Inventory, Finished Goods, Net of Reserves Permanent differences Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Income Tax Authority [Domain] Income Tax Authority [Domain] Revenue Benchmark Revenue Benchmark [Member] Name Trading Arrangement, Individual Name Summary of company's revenue by revenue stream Disaggregation of Revenue [Table Text Block] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Entity [Domain] Entity [Domain] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Increase in equity Valuation Allowance, Deferred Tax Asset, Decrease For Reversal Charged To Equity, Amount Amount of decrease in the valuation allowance for tax benefits related to any reversal of the valuation allowance on net operating losses deferred tax assets for a specified deferred tax asset charged to Equity. Legal Entity [Axis] Legal Entity [Axis] Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Assets: Assets, Fair Value Disclosure [Abstract] Merger Business Combinations Policy [Policy Text Block] Long-term debt, noncurrent Long-term debt, net of discount Long-Term Debt, Excluding Current Maturities Leasehold improvements Leasehold Improvements [Member] Sales and marketing Selling and Marketing Expense [Member] Weighted average common shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Operating expenses: Operating Expenses [Abstract] Company Selected Measure Amount Company Selected Measure Amount Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Lab equipment Equipment [Member] Stock-based compensation cost APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Construction in progress Construction in Progress [Member] Contingently issuable common stock liability Reverse Recapitalization, Contingent Consideration, Equity, Noncurrent Reverse Recapitalization, Contingent Consideration, Equity, Noncurrent Prime Rate Prime Rate [Member] Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Non-PEO NEO Non-PEO NEO [Member] Adjustment to Compensation: Adjustment to Compensation [Axis] Motorola Solutions, Inc. Motorola Solutions, Inc. [Member] Represents information pertaining to Customer. Movement in Deferred Revenue [Roll Forward] Movement In Contract With Customer, Liability [Roll Forward] Movement In Contract With Customer, Liability Distribution Agreement With Motorola Member Distribution Agreement With Motorola Member [Member] Distribution Agreement With Motorola Member Research and development tax credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards, Research Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Debt Instrument [Line Items] Debt Instrument [Line Items] Scenario [Axis] Scenario [Axis] Weighted average common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Interest income on lease receivables Sales-type Lease, Interest Income Depreciation and amortization Deferred Tax Liabilities, Property, Plant and Equipment Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Contingently issuable common stock liability Contingently Issuable Common Stock Liability Represents the information pertaining to contingently issuable common stock liability. Revenue: Revenues [Abstract] Leased equipment Leased Equipment [Member] Leased Equipment Total cost of revenue Cost of Revenue Lease income - operating leases Operating Lease, Lease Income Related Party Transaction [Axis] Related Party Transaction [Axis] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement [Line Items] Statement [Line Items] Concentration Risk [Table] Concentration Risk [Table] Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Issuance of common stock upon exercise of warrants Finback exercise price Stock Issued During Period, Value, Issuance Of Common Stock For Net Settlement Of Common Stock Upon Exercise Of Warrants Value of stock issued for net settlement of common stock and preferred stock warrants upon settlement of the Merger. Summary of components of long-term debt Schedule of Debt [Table Text Block] Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] EX-101.PRE 13 nhic-20231231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 14 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Feb. 28, 2024
Jun. 30, 2023
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-39417    
Entity Registrant Name EVOLV TECHNOLOGIES HOLDINGS, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 84-4473840    
Entity Address, Address Line One 500 Totten Pond Road    
Entity Address, Address Line Two 4th Floor    
Entity Address, City or Town Waltham    
Entity Address, State or Province MA    
Entity Address, Postal Zip Code 02451    
City Area Code (781)    
Local Phone Number 374-8100    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 722.8
Entity Common Stock, Shares Outstanding   152,182,633  
Documents Incorporated by Reference Certain portions of the information required to be furnished pursuant to Part III of this Annual Report on Form 10-K will be set forth in, and incorporated by reference from, the registrant’s definitive proxy statement for the annual meeting of stockholders which will be filed with the Securities and Exchange Commission no later than 120 days after the end of the fiscal year ended December 31, 2023.    
Entity Central Index Key 0001805385    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag false    
Common Class A      
Document Information [Line Items]      
Title of 12(b) Security Class A common stock, par value $0.0001 per share    
Trading Symbol EVLV    
Security Exchange Name NASDAQ    
Warrants to purchase one share of Class A common stock      
Document Information [Line Items]      
Title of 12(b) Security Warrants to purchase one share of Class A common stock    
Trading Symbol EVLVW    
Security Exchange Name NASDAQ    
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Audit Information
12 Months Ended
Dec. 31, 2023
Audit Information [Abstract]  
Auditor Name PricewaterhouseCoopers LLP
Auditor Location Boston, Massachusetts
Auditor Firm ID 238
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 67,162 $ 229,783
Restricted cash 275 0
Marketable securities 51,289 0
Accounts receivable, net [1] 22,611 31,920
Inventory 9,507 10,257
Current portion of contract assets 3,707 2,852
Current portion of commission asset 4,339 3,384
Prepaid expenses and other current assets 16,954 14,388
Total current assets 175,844 292,584
Restricted cash, noncurrent 0 275
Contract assets, noncurrent 451 1,386
Commission asset, noncurrent 7,107 5,655
Property and equipment, net 112,921 44,707
Operating lease right-of-use assets 1,195 1,673
Other assets 1,202 1,835
Total assets 298,720 348,115
Current liabilities:    
Accounts payable 17,400 18,194
Accrued expenses and other current liabilities 15,578 11,545
Current portion of deferred revenue 47,677 18,273
Current portion of long-term debt 0 10,000
Current portion of operating lease liabilities 1,391 1,114
Total current liabilities 82,046 59,126
Deferred revenue, noncurrent 23,813 17,695
Long-term debt, noncurrent 0 19,683
Operating lease liabilities, noncurrent 0 892
Contingent earn-out liability 29,119 14,218
Contingently issuable common stock liability 6,530 3,392
Public warrant liability 10,889 6,124
Total liabilities 152,397 121,130
Commitments and contingencies (Note 19)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2023 and December 31, 2022; no shares issued and outstanding at December 31, 2023 and December 31, 2022 0 0
Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2023 and December 31, 2022, 151,310,080 and 145,204,974 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively 15 15
Additional paid-in capital 444,825 419,190
Accumulated other comprehensive loss (53) (10)
Accumulated deficit (298,464) (192,210)
Stockholders’ equity 146,323 226,985
Total liabilities and stockholders’ equity $ 298,720 $ 348,115
[1] Includes related party accounts receivable, net of $1.7 million and $14.6 million as of December 31, 2023 and December 31, 2022, respectively.
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 100,000,000 100,000,000
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 1,100,000,000 1,100,000,000
Common stock, issued (in shares) 151,310,080 145,204,974
Common stock, outstanding (in shares) 151,310,080 145,204,974
Accounts receivable, net [1] $ 22,611 $ 31,920
Related Party    
Accounts receivable, net $ 1,700 $ 14,600
[1] Includes related party accounts receivable, net of $1.7 million and $14.6 million as of December 31, 2023 and December 31, 2022, respectively.
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue:    
Total revenue [1] $ 80,418 $ 55,195
Cost of revenue:    
Total cost of revenue 46,589 53,466
Gross profit 33,829 1,729
Operating expenses:    
Research and development 24,455 18,771
Sales and marketing 55,223 46,639
General and administrative 42,091 37,719
Loss from impairment of property and equipment 322 1,161
Total operating expenses 122,091 104,290
Loss from operations (88,262) (102,561)
Other income (expense), net:    
Interest expense (654) (712)
Interest income 6,227 3,165
Other expense, net (84) (64)
Loss on extinguishment of debt (626) 0
Change in fair value of contingent earn-out liability (14,901) 6,988
Change in fair value of contingently issuable common stock liability (3,138) 1,872
Change in fair value of public warrant liability (4,765) 4,906
Total other income (expense), net (17,941) 16,155
Loss before income taxes (106,203) (86,406)
Provision for income taxes (51) 0
Net loss $ (106,254) $ (86,406)
Weighted average common shares outstanding - basic (in shares) 149,168,105 143,858,668
Weighted average common shares outstanding - diluted (in shares) 149,168,105 143,858,668
Net loss per share - basic (in dollars per share) $ (0.71) $ (0.60)
Net loss per share - diluted (in dollars per share) $ (0.71) $ (0.60)
Net loss $ (106,254) $ (86,406)
Other comprehensive loss    
Cumulative translation adjustment (43) (10)
Total other comprehensive loss (43) (10)
Total comprehensive loss (106,297) (86,416)
Product revenue    
Revenue:    
Total revenue 21,977 31,985
Cost of revenue:    
Total cost of revenue 26,667 41,575
Subscription revenue    
Revenue:    
Total revenue 37,247 17,569
Cost of revenue:    
Total cost of revenue 14,991 7,469
Service revenue    
Revenue:    
Total revenue 16,141 4,331
Cost of revenue:    
Total cost of revenue 3,982 2,200
License fee and other revenue    
Revenue:    
Total revenue 5,053 1,310
Cost of revenue:    
Total cost of revenue $ 949 $ 2,222
[1] Includes related party revenue of $11.3 million and $13.5 million for the years ended December 31, 2023 and 2022, respectively.
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue [1] $ 80,418 $ 55,195
Related Party    
Revenue $ 11,300 $ 13,500
[1] Includes related party revenue of $11.3 million and $13.5 million for the years ended December 31, 2023 and 2022, respectively.
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2021   142,745,021      
Balance at the beginning at Dec. 31, 2021 $ 290,274 $ 14 $ 396,064 $ 0 $ (105,804)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 1,896,975 1,894,179      
Issuance of common stock upon exercise of stock options $ 828 $ 1 827    
Issuance of common stock upon vesting of restricted stock units (in shares)   565,774      
Issuance of common stock upon exercise of warrants 0        
Stock-based compensation cost 22,299   22,299    
Cumulative translation adjustment (10)     (10)  
Net loss (86,406)       (86,406)
Balance at the end (in shares) at Dec. 31, 2022   145,204,974      
Balance at the end at Dec. 31, 2022 $ 226,985 $ 15 419,190 (10) (192,210)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 1,735,978 1,735,978      
Issuance of common stock upon exercise of stock options $ 668 $ 0 668    
Issuance of common stock upon vesting of restricted stock units (in shares)   3,265,155      
Issuance of common stock upon exercise of warrants (in shares)   1,103,973      
Issuance of common stock upon exercise of warrants 464   464    
Stock-based compensation cost 24,503   24,503    
Cumulative translation adjustment (43)     (43)  
Net loss (106,254)       (106,254)
Balance at the end (in shares) at Dec. 31, 2023   151,310,080      
Balance at the end at Dec. 31, 2023 $ 146,323 $ 15 $ 444,825 $ (53) $ (298,464)
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net loss $ (106,254) $ (86,406)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 9,932 5,465
Write-off of inventory and change in inventory reserve 1,612 1,582
Adjustment to property and equipment for sales type leases 0 (625)
Loss from impairment of property and equipment 322 1,161
Stock-based compensation 24,151 22,498
Non-cash interest expense 22 55
Accretion of discount on marketable securities (575) 0
Non-cash lease expense 478 811
Change in allowance for expected credit losses 382 150
Loss on extinguishment of debt 626 0
Change in fair value of earn-out liability 14,901 (6,988)
Change in fair value of contingently issuable common stock 3,138 (1,872)
Change in fair value of public warrant liability 4,765 (4,906)
Changes in operating assets and liabilities    
Accounts receivable 8,927 (25,593)
Inventory (644) (8,495)
Commission assets (2,407) (3,675)
Contract assets 80 639
Other assets 633 (419)
Prepaid expenses and other current assets (2,566) (3,174)
Accounts payable (5,963) 7,661
Deferred revenue 35,522 26,887
Accrued expenses and other current liabilities 3,732 1,462
Operating lease liability (615) (946)
Net cash used in operating activities (9,801) (74,728)
Cash flows from investing activities:    
Development of internal-use software (3,535) (2,720)
Purchases of property and equipment (69,134) (21,473)
Proceeds from sale of property and equipment 270 312
Purchases of marketable securities (89,898) 0
Proceeds from maturities of marketable securities 39,184 0
Net cash used in investing activities (123,113) (23,881)
Cash flows from financing activities:    
Proceeds from exercise of stock options 668 827
Proceeds from long-term debt 1,876 29,683
Repayment of principal on long-term debt (31,876) (10,000)
Payment of debt issuance costs and prepayment penalty (332) 0
Net cash provided by (used in) financing activities (29,664) 20,510
Effect of exchange rate changes on cash and cash equivalents (43) (10)
Net increase (decrease) in cash, cash equivalents and restricted cash (162,621) (78,109)
Cash, cash equivalents and restricted cash    
Cash, cash equivalents and restricted cash at beginning of period 230,058 308,167
Cash, cash equivalents and restricted cash at end of period 67,437 230,058
Supplemental disclosure of cash flow information    
Cash paid for interest 710 581
Supplemental disclosure of non-cash activities    
Transfer of property and equipment to inventory 218 0
Capital expenditures incurred but not yet paid 13,322 7,552
Capitalization of stock compensation 516 205
Finback exercise price 464 0
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 67,162 229,783
Restricted cash 275 0
Restricted cash, noncurrent 0 275
Total cash, cash equivalents and restricted cash shown in the statements of cash flows $ 67,437 $ 230,058
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
Nature of the Business and Basis of Presentation
12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of the Business and Basis of Presentation Nature of the Business and Basis of Presentation
Evolv Technologies Holdings, Inc. (the “Company”), a Delaware corporation, is a global leader in AI-based weapons detection for security screening. The Company’s mission is to make the world a safer and more enjoyable place to work, learn, and play. The Company is democratizing security by making it seamless for gathering spaces to address the chronic epidemic of escalating gun violence, mass shootings and terrorist attacks in a cost-effective manner while improving the visitor experience. The Company is headquartered in Waltham, Massachusetts.
As used in this Annual Report on Form 10-K, unless otherwise indicated or the context otherwise requires, references to “we,” “us,” “our,” the “Company” and “Evolv” refer to the consolidated operations of Evolv Technologies Holdings, Inc. and its wholly owned subsidiaries, which include Evolv Technologies, Inc., Evolv Technologies UK Ltd. and Give Evolv LLC.
Risks and uncertainties
There is significant uncertainty in the current macroeconomic environment due to inflationary pressures globally, conflicts in Europe and the Middle East, and foreign currency volatility and their impacts on the Company’s business. If economic conditions were to worsen, the Company’s results of operations, financial condition, and cash flows from operations may be materially and adversely impacted.
Basis of presentation
The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”).
Merger
On July 16, 2021, we consummated the business combination (the “Merger”), contemplated by the Agreement and Plan of Merger, dated March 5, 2021, with NHIC Sub Inc. (“Merger Sub”), a wholly-owned subsidiary of NewHold Investment Corp. (“NHIC”), a special purpose acquisition company, which is our legal predecessor, and Evolv Technologies, Inc. dba Evolv Technology, Inc. (“Legacy Evolv”), as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 by and among NHIC, Merger Sub and Legacy Evolv (the “Amendment” and as amended, the “Merger Agreement”). Pursuant to the Merger Agreement, Merger Sub was merged with and into Legacy Evolv, with Legacy Evolv surviving the Merger as a wholly-owned subsidiary of NHIC. Upon the closing of the Merger, NHIC changed its name to Evolv Technologies Holdings, Inc. Evolv Technologies Holdings, Inc. became the successor entity to NHIC pursuant to Rule 12g-3(a) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
Reclassifications
During the year ended December 31, 2023, the Company began classifying revenue from professional services, which includes installation, training, and event support, as well as other one-time revenue, within license fee and other revenue on the consolidated statements of operations and comprehensive loss, whereas the revenue for these services has previously been included in service revenue. Correspondingly, the Company began classifying costs associated with professional services within cost of license fee and other revenue, whereas these costs were previously included in cost of service revenue. These reclassifications were made to align the presentation of professional services with the Company's internal reporting and analysis. The reclassifications did not impact total revenue or total cost of revenue for any period. Prior year amounts included in this Annual Report on Form 10-K have been reclassified to conform to the current presentation.
For the year ended December 31, 2022, the reclassifications resulted in an increase in license fee and other revenue of $1.3 million and a corresponding decrease in service revenue, as well as in increase in cost of license fee and other revenue of $2.2 million and a corresponding decrease in cost of service revenue.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Use of Estimates
The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to calculating the standalone selling price for revenue recognition, the valuation of inventory, the expensing and capitalization of costs associated with internal-use software, stock-based awards, the valuation of the contingent earn-out liability, the valuation of the contingently issuable common stock, and the valuation of the public warrant liability. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts, and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.
Risk of Concentrations of Credit, Significant Customers and Significant Suppliers
Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash equivalents, restricted cash, marketable securities, and accounts receivable, net. We maintain substantially all of our cash and cash equivalents with U.S. and multi-national financial institutions, and our deposits are generally in excess of federally insured limits. The Company maintains its cash, cash equivalents, restricted cash, and marketable securities with financial institutions that management believes to be of high credit quality. The Company has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.
Significant customers are those which represent more than 10% of the Company’s total revenue or accounts receivable, net balance at each respective balance sheet date. The following table presents customers that represent 10% or more of the Company’s total revenue for the years ended December 31, 2023 and December 31, 2022. Each customer shown is a reseller partner of the Company.
Year Ended December 31, 2023Year Ended December 31, 2022
Motorola Solutions, Inc.12.0  %20.9  %
Customer A*10.1  %
Customer B10.4  %*
22.4  %31.0  %
* Less than 10%
The following table presents customers that represent 10% or more of the Company’s accounts receivable, net. Each customer shown is a reseller partner of the Company.
December 31,
20232022
Motorola Solutions, Inc.*39.0  %
Customer B*16.0  %
55.0  %
* Less than 10%
The Company relies on one primary third-party contract manufacturer, Columbia Tech, for the production of our touchless security screening systems. Columbia Tech provides a variety of services including sourcing off-the-shelf components, manufacturing custom components/assemblies, final product assembly and integration, end of line testing and quality assurance per our specifications, material and finished goods inventory, and direct shipping to our customers. We also use a different third-party manufacturer as a second source for the production of a key sensor component used in our systems. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers to satisfactorily deliver its products to its customers on time, if at all, which could have a material adverse effect on the Company’s operating results, financial condition and cash flows and damage its customer relationships.
Cash, Cash Equivalents, and Restricted Cash
The Company considers all short-term, highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Restricted cash relates to a letter of credit on the Company’s office lease in Waltham, Massachusetts, all of which is included in restricted cash, current on the consolidated balance sheet as of December 31, 2023. As the letter of credit is reduced, restricted cash is reclassified to cash and cash equivalents.
Marketable Securities
Marketable securities are reported at fair value and, at December 31, 2023, are comprised solely of zero coupon U.S. treasury bills with maturities of less than one year that are classified as available-for-sale debt securities. The Company considers an available-for-sale debt security to be impaired if the fair value of the investment is less than its amortized cost basis. The entire difference between the amortized cost basis and the fair value of the Company’s available-for-sale debt securities is recognized on the consolidated statements of operations as an impairment if, (i) the fair value of the security is below its amortized cost and (ii) the Company intends to sell or is more likely than not required to sell the security before recovery of its amortized cost basis. If neither criterion is met, the Company evaluates whether the decline in fair value is due to credit losses or other factors. In making this assessment, the Company considers the changes to the rating of the security by third-party rating agencies, and adverse conditions specific to the security, among other factors. If the Company’s assessment indicates that a credit loss exists, the credit loss is measured based on the Company’s best estimate of the cash flows expected to be collected. When developing its estimate of cash flows expected to be collected, the Company considers all available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable forecasts.
Unrealized gains and losses, net of tax, on marketable securities, if any, are recognized in accumulated other comprehensive income (loss) in the accompanying consolidated balance sheets. Realized net gains and losses on marketable securities, if any, are reflected in interest income in the accompanying consolidated statements of operations and comprehensive loss.
Fair Value Measurements of Financial Instruments
Certain assets and liabilities of the Company are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement
date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:
Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.
Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.
The Company’s cash equivalents, restricted cash, marketable securities, derivative liability, contingent earn-out liability, contingently issuable common stock liability and its common stock warrant liability are carried at fair value, determined according to the fair value hierarchy described above (see Note 4). The carrying values of the Company’s accounts receivable, net, accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities. The carrying value of the Company’s long-term debt approximates its fair value (a Level 2 measurement) at each balance sheet date due to its variable interest rate, which approximates a market interest rate.
Assets that are measured at fair value on a nonrecurring basis primarily relate to property and equipment. We do not periodically adjust carrying value to fair value for property and equipment. Rather, the carrying value of the asset is reduced to its fair value when we determine that impairment has occurred.
Contingent Earn-out
In connection with the Merger and pursuant to the Merger Agreement, certain of the Legacy Evolv’s shareholders and Legacy Evolv Service Providers are entitled to receive additional shares of the Company’s common stock (the “Earn-Out Shares”) upon the Company achieving certain milestones:
Triggering Event I – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $12.50 per share for any 20 trading days within any 30 trading day period.
Triggering Event II – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $15.00 per share for any 20 trading days within any 30 trading day period.
Triggering Event III – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $17.50 per share for any 20 trading days within any 30 trading day period.
In accordance with ASC 815 – Derivatives and Hedging, the earn-out arrangement with the Legacy Evolv shareholders is accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as a change in fair value of contingent earn-out liability in other income (expense), net in the consolidated statements of operations and comprehensive loss. When the Triggering Events have been achieved and the Earn-Out Shares are issued, the Company will reclassify the corresponding amount from a liability to additional paid-in-capital and common stock at par value of $0.0001 per share.
The estimated fair value of the contingent earn-out shares was determined using a Monte Carlo simulation that simulated the future path of the Company’s stock price over the earn-out period. The significant assumptions utilized in the calculation are based on the achievement of certain stock price milestones including projected stock price, volatility, drift rate, percentage of change in control and expected term.
The contingent earn-out liability is categorized as a Level 3 fair value measurement (see Note 4) because the Company estimates projections during the earn-out period utilizing unobservable inputs, including various potential pay-out scenarios. Contingent earn-out payments involve certain assumptions requiring significant judgment and actual results may differ from assumed and estimated amounts.
The Earn-Out Shares issued to employees, officers, directors, and non-employees are based on achievement of certain target share price contingencies and for the employees and officers, subject to continued employment, (the “Earn-Out Service Providers”) represents share-based compensation and is included in additional paid-in capital on the Company’s balance sheet. Corresponding stock-based compensation expense is recorded in the consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. As a condition to being issued Earn-Out Shares, the Earn-Out Service Providers must still be providing services to the Company on the date of the issuance of the shares. If the relationship with the service provider is terminated prior to the issuance of the Earn-Out Shares, the shares will be redistributed to the remaining participants in the Earn-Out Shares.
Contingently Issuable Common Stock
Prior to the Merger, NewHold Industrial Technology Holdings, LLC, the sponsor of the NHIC special purpose acquisition company owned 4,312,500 shares of NHIC Class B common stock (the “Founder Shares). Upon the closing of the Merger, NHIC Class A and Class B common stock became the Company’s common stock. The Founder Shares outstanding were subject to certain share-performance-based vesting provisions as follows:
Vesting Provision I – 1,897,500 shares of the Company’s common stock shall vest and no longer be subject to forfeiture as of the Merger;
Vesting Provision II – if within five years following the closing of the Merger, the last reported sale price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period, then 948,750 shares of the Company’s common stock shall vest and no longer be subject to forfeiture and
Vesting Provision III – if within five years following the closing of the Merger, the last reported sale price of the Company’s common stock equals or exceeds $15.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period, then 948,750 shares of the Company’s common stock) shall vest and no longer be subject to forfeiture.
The remaining 517,500 Founder Shares were contributed to Give Evolv LLC.
If Vesting Provision II and/or Vesting Provision III are not satisfied, the corresponding number of shares specified shall be forfeited and no longer issued and outstanding. If there is a Change of Control event prior to Vesting Provision II and/or Vesting Provision III are satisfied, the Founder shares are no longer subject to forfeiture and shall vest immediately upon the occurrence of a Change of Control event.
In accordance with ASC 815 – Derivatives and Hedging, the contingently issuable common stock is accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as change in fair value of contingently issuable common stock liability in other income (expense), net in the consolidated statements of operations and comprehensive loss. When the Vesting Provisions have been achieved and the contingently issuable common shares are issued, the Company will reclassify the corresponding amount from a liability to additional paid-in-capital and common stock at par value of $0.0001 per share.
The estimated fair value of the contingently issuable common shares was determined using a Monte Carlo simulation that simulated the future path of the Company’s stock price over the earn-out period. The assumptions utilized in the calculation are based on the achievement of certain stock price milestones including expected stock price volatility, risk-free rate of return, likelihood of change in control, and remaining term.
The contingently issuable common shares are categorized as a Level 3 fair value measurement (see Note 4) because the Company estimates projections during the earn-out period utilizing unobservable inputs, including various potential pay-out scenarios. Contingently issuable shares involve certain assumptions requiring significant judgment and actual results may differ from assumed and estimated amounts.
Public Warrant Liability
In connection with the closing of the Merger, the Company assumed warrants for the purchase of 14,325,000 shares of common stock at an exercise price of $11.50 (the “Public Warrants”). The Public Warrants are classified as a liability pursuant to ASC 815 – Derivatives and Hedging as the equity derivative scope exception was not met and are measured at fair value, with the changes in fair value reported in earnings as a component of other income (expense), net in the consolidated statements of operations and comprehensive loss with the offset to additional paid in capital.
Leases as a Lessee
The Company accounts for leases in accordance with ASC 842, Leases. At contract inception, the Company determines if an arrangement is or contains a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If determined to be or contain a lease, the lease is assessed for classification as either an operating or finance lease at the lease commencement date, defined as the date on which the leased asset is made available for use by the Company (when the Company is the lessee). Where the Company is the lessee, for each lease with a term greater than twelve months, the Company records a right-of-use asset and lease liability.
A right-of-use asset represents the economic benefit conveyed to the Company by the right to use the underlying asset over the lease term. A lease liability represents the obligation to make lease payments arising from the use of the asset over the lease term. Lease liabilities are measured at lease commencement and calculated as the present value of the future lease payments in the contract using the rate implicit in the contract, when available. If an implicit rate is not readily determinable, the Company uses an incremental borrowing rate measured as the rate at which the Company could borrow, on a fully collateralized basis, a commensurate loan in the same currency over a period consistent with the lease term at the commencement date. Right-of-use assets are measured as the amount of the initial lease liability plus initial direct costs and prepaid lease payments, less lease incentives granted by the lessor. The lease term is measured as the noncancelable period in the contract, adjusted for any options to extend or terminate when it is reasonably certain the Company will extend the lease term via such options based on an assessment of economic factors present as of the lease commencement date. The Company elected the practical expedient to not recognize leases with a lease term of twelve months or less.
Components of a lease are split into three categories: lease components, non-lease components, and non-components. The fixed and in-substance fixed contract consideration (including any consideration related to non-components) are allocated, based on the respective relative fair values, to the lease components and non-lease components. The Company has elected the practical expedient to account for lease and non-lease components together as a single lease component for all underlying assets and allocate all of the contract consideration to the lease component only.
The Company’s operating leases are presented in the consolidated balance sheet as operating lease right-of-use assets, classified as noncurrent assets, and operating lease liabilities, classified as current and noncurrent liabilities. Operating lease expense is recognized on a straight-line basis over the lease term. Variable costs associated with a lease, such as maintenance and utilities, are not included in the measurement of the lease liabilities and right-of-use assets but rather are expensed when the events determining the amount of variable consideration to be paid have occurred.
Inventory
Inventory is stated at the lower of cost or net realizable value with cost being determined using the weighted average method. The Company regularly reviews inventory quantities on-hand for excess and obsolete inventory and, when circumstances indicate, records charges to write down inventories to their estimated net realizable value, after evaluating historical sales, future demand, market conditions and expected product life cycles. Such charges are classified as product cost of revenues in the consolidated statement of operations and comprehensive loss. Any write-down of inventory to net realizable value creates a new cost basis. The Company recorded $1.6 million and $1.6 million in inventory write-offs and change in inventory reserves during the years ended December 31, 2023 and 2022, respectively. Inventory write-offs primarily relate to Edge units and prior generation Express units, as the Company is no longer selling these products, as well as other inventory that was determined to be obsolete or unsellable.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expense are recognized using the straight-line method over the estimated useful life of each asset, as follows:
Estimated Useful Life
Computers and telecommunications equipment3 years
Lab equipment5 years
Software4 years
Furniture and fixtures5 years
Leasehold improvements
Shorter of useful life of 7 years or remaining lease term

Leased equipment
4-7 years
Internal-use software4 years
Estimated useful lives are periodically assessed to determine if changes are appropriate. Leasehold improvements are depreciated using the straight-line method over the lesser of the lease term or its estimated economic useful life. Lease terms are used based upon the initial lease agreement and do not consider potential renewals or extensions until such time that the renewals or extensions are contracted. Maintenance and repairs are charged to expense as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation are eliminated from the consolidated balance sheet and any resulting gains or losses are included in the consolidated statements of operations and comprehensive loss in the period of disposal. Costs for capital assets not yet placed into service are capitalized as construction-in-progress and depreciated once placed into service.
The Company’s leases for leased equipment generally are 48 months. The Company’s subscription contracts are generally classified as operating leases because title does not transfer and they do not meet any of the other criteria per Accounting Standards Codification 842 – Leases (“ASC 842”).
The Company evaluates property and equipment for obsolescence and impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset group for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset group to its carrying value. An impairment loss would be recognized in loss from operations and comprehensive loss when estimated undiscounted future cash flows expected to result from the use of an asset group are less than its carrying amount. The impairment loss is based on the excess of the carrying value of the impaired asset group over its fair value, determined based on discounted cash flows. The Company recorded impairment losses of $0.3 million and $1.2 million during the years ended December 31, 2023 and 2022, respectively. These impairment losses related primarily to Edge and Express prototype units that were taken out of service and retired.
The Company capitalizes certain software development costs, including consulting costs and compensation expenses for employees who devote time to the development projects, beginning upon completion of the preliminary project stage (in relation to internal-use software) or upon establishment of technological feasibility (in relation to software embedded in products to be sold or leased), and through the date the software is ready for its intended use. The Company records software development costs in property and equipment, net. Costs incurred in the preliminary stages of development activities and post implementation are expensed in the period incurred and are recorded in research and development expense in the consolidated statements of operations and comprehensive loss. The Company also capitalizes
costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality.
Once the project is available for general release, capitalization ceases, and the asset can begin amortization. Capitalized software costs are amortized on a straight-line basis over their estimated useful life, which is generally four years, and are recorded in cost of subscription revenue and cost of service revenue in the consolidated statements of operations and comprehensive loss.
Debt Issuance Costs
The Company capitalizes certain legal, accounting, and other third-party fees that are directly associated with the issuance of debt as debt issuance costs. Debt issuance costs are recorded as a direct reduction of the carrying amount of the associated debt on the consolidated balance sheet and amortized as interest expense on the consolidated statement of operations and comprehensive loss using the effective interest method.
Segment Information
The Company determined that it has one operating segment after considering the Company’s organizational structure and the information regularly reviewed and evaluated by the Company’s chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. The Company has determined that its CODM is its President and Chief Executive Officer. The CODM reviews the financial information on a consolidated basis for purposes of evaluating financial performance and allocating resources. On the basis of these factors, the Company determined that it operates and manages its business as one operating segment, that develops, manufactures, markets and sells security screening products and specific services, and accordingly has one reportable segment for financial reporting purposes.
Revenue Recognition
The Company recognizes revenue in accordance with Accounting Standards Codification 606 – Revenue from Contracts with Customers (“ASC 606”). Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In order to achieve this core principle, the Company applies the following five steps when recording revenue: (1) identify the contract, or contracts, with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when, or as, performance obligations are satisfied.
We derive revenue from (1) subscription arrangements generally accounted for as operating leases, including SaaS and maintenance, (2) the sale of products, (3) SaaS and maintenance related to products sold to customers either by Evolv or by Columbia Tech pursuant to the Distribution and License Agreement (as defined below), (4) license fees related to the Distribution and License Agreement (as defined below), and (5) professional services, including installation, training, and event support. Maintenance consists of preventative maintenance, technical support, bug fixes, and when-and-if available threat updates. Our arrangements are generally noncancelable and nonrefundable after ownership passes to the customer. Revenue is recognized net of sales tax.
Distribution and License Agreement
In March 2023, the Company entered into a distributor licensing agreement (the "Distribution and License Agreement") with Columbia Electrical Contractors, Inc. ("Columbia Tech"). Columbia Tech, a wholly-owned subsidiary of Coghlin Companies, which serves as the Company's primary contract manufacturer. Under this arrangement, the Company has granted a license of its intellectual property to Columbia Tech, which contracts directly with certain of the Company's resellers to fulfill sales demand where the end-user customer prefers to purchase the hardware equipment as opposed to lease the equipment. Columbia Tech pays the Company a hardware license fee for each system it manufactures and sells under the agreement. In these instances, the Company still contracts directly with the reseller to provide a multi-year SaaS and maintenance subscription to the end-users.
The Company has assessed whether it operates as the principal or as an agent in relation to the sale of product made by Columbia Tech to the Company's resellers pursuant to the Distribution and License Agreement. The Company considered various factors, including but not limited to, inventory risk, discretion in establishing pricing, and which entity is primarily responsible for fulfillment. Based on an evaluation of the facts and circumstances, the Company concluded that Columbia Tech is the principal in the arrangement. The Company therefore does not recognize revenue in relation to sales of product pursuant to the Distribution and License Agreement, but does recognize revenue in relation to license fees received from Columbia Tech and the SaaS and maintenance subscription contracts, each as further described below.
Product Revenue
The Company derives revenue from the sale of its Evolv Express equipment and related add-on accessories to customers. Revenue is recognized when control of the product has transferred to the customer. Transfer of control occurs when the Company has transferred title and risk of loss and has a present right to payment for the equipment, which follows the terms of each customer contract. Products are predominantly sold with distinct services, which are described in the services section below.
Subscription Revenue - Leases as Lessor
In addition to selling our products directly to customers, we also derive revenue from leasing our equipment, which we classify as subscription revenue. Lease terms are typically four years, generally do not include unilateral options by either the Company or our customer to extend, terminate or to purchase the underlying asset, and customers generally pay either a quarterly or annual fixed payment for the lease, SaaS, and maintenance elements over the contractual lease term. There are no variable lease payments as a part of these arrangements.
The accounting provisions we use to classify transactions as sales-type are: (i) whether the lease transfers ownership of the equipment by the end of the lease term, (ii) whether the lease grants the customer an option to purchase the equipment and the customer is reasonably certain to do so, (iii) whether the lease term is for the major part of the economic life of the underlying equipment, (iv) whether the present value of the lease payments, and any residual value guaranteed by the customer that is not already reflected in the lease payments, is equal to or greater than substantially all of the fair market value of the equipment at the commencement of the lease, and (v) whether the equipment is specific to the customer and of such a specialized nature that it is expected to have no alternative use to the Company at the end of the lease term. Leasing arrangements meeting any of these conditions are accounted for as sales-type leases and revenue attributable to the lease component is recognized in a manner consistent with product revenue and the related equipment is derecognized with the associated expense presented as a cost of revenue. Leasing arrangements that do not meet the criteria for classification as a sales-type lease will be accounted for as a direct-financing lease if the following two conditions are met: (i) the present value of the lease payments, and any residual value guaranteed by the customer that is not already reflected in the lease payments and any other third party unrelated to the Company, is equal to or greater than substantially all of the fair market value of the equipment at the commencement of the lease, and (ii) it is probable that the Company will collect the lease payments and amounts necessary to satisfy a residual value guarantee. Leasing arrangements that do not meet any of the sales-type lease or direct-financing lease classification criteria are accounted for as operating leases and revenue is recognized straight-line over the term of the lease. Historically, nearly all of the Company's equipment leases have been classified as operating leases.
The Company considers the economic life of most of our products to be seven years. The Company believes seven years is representative of the period during which the equipment is expected to be economically usable by one or more users, with normal service, for the purpose for which it is intended. The unguaranteed residual value is estimated to be the value at the end of the lease term based on the anticipated fair market value of the units. The Company mitigates residual value risk of our leased equipment by performing regular management and maintenance, as necessary.
Generally, lease arrangements include both lease and non-lease components. The lease component relates to the customer’s right-to-use the equipment over the lease term. The non-lease components relate to (1) distinct services, such as SaaS and maintenance, (2) any add-on accessories, and (3) professional services, including installation, training, and event. Professional services are included in license fees and other revenue, as described below, and add-on accessories are included in product revenue. Because the equipment, SaaS, and maintenance components of a subscription arrangement are recognized as revenue over the same time period and in the same pattern, the Company elected the practical expedient to aggregate non-lease components with the associated lease component and account for the combined component as an
operating lease for all underlying asset classes. In the evaluation of whether the lease component (equipment) or the non-lease components associated with the lease component (SaaS and maintenance) is the predominant component, the Company determined that the lease component is predominant as we believe the customer would ascribe more value to the use of the security equipment than that of the SaaS and maintenance services. Therefore, the Company accounts for the combined lease component under ASC 842. The equipment lease and SaaS/maintenance performance obligations are classified as a single category of subscription revenue in the consolidated statements of operations and comprehensive loss. The professional services represent distinct services provided to customers. These activities are considered separate performance obligations to the customer and therefore are considered non-lease components. As professional services are generally performed prior to lease commencement, the timing and pattern of transfer for these services differ from that of the lease component and are not eligible to be combined.
We exclude from variable payments all lessor costs that are explicitly required to be paid directly by a lessee on behalf of the lessor to a third party.
Professional services are generally billed to the lessee as part of the lease contract billing, according to various contractual terms. Professional services costs incurred by the Company are accounted for as a fulfillment cost and are included in the cost of license fees and other revenue in the consolidated statements of operations and comprehensive loss.
Service Revenue
Service revenue consists of subscription-based SaaS and maintenance revenue related to products sold to a customer by either the Company or by Columbia Tech pursuant to the Distribution and License Agreement. Customers generally pay either a quarterly or annual fixed payment for SaaS and maintenance. SaaS and maintenance revenue is recognized ratably over the period of the arrangement, which is typically 4 years.
License Fee and Other Revenue
License fee and other revenue includes license fee revenue from the Distribution and License Agreement, revenue from professional services, and other one-time revenue. License fee revenue is recognized upon the shipment of product from our third-party manufacturer to the reseller. Revenue for professional services is recognized upon transfer of control of these services, which are normally rendered over a short duration.
Revenue from Reseller Partners
A portion of the Company’s revenue is also generated by sales to its reseller partners. When the Company transacts with a reseller partner, its contractual arrangement is with the reseller partner and not with the end-use customer. In these transactions, the reseller partner is considered the customer; the Company has discretion over the pricing to the reseller partner and maintains overall control of the inventory and sales process to the reseller partner. Right of return does not generally exist. Whether the Company transacts with a reseller partner and receives the order from a reseller partner or directly from an end-use customer, its revenue recognition policy and resulting pattern of revenue recognition is the same.
Transaction Price
The transaction price is the amount of consideration that the Company expects to be entitled for providing goods and services under a contract, which includes fixed amounts, and on rare occasions, variable consideration. The Company may also provide discounts to customers which reduce the transaction price. On infrequent occasions, the Company may offer customers the option to purchase additional goods and services at a fixed price. In these circumstances, the Company assesses whether these offers constitute a material right, and if so, the Company would account for the material right as a separate performance obligation. The Company does not normally provide for rights of returns to customers on product sales and, therefore, does not record a provision for returns. Amounts paid or payable to customers, including those related to sponsorship arrangements, are recognized as a reduction of the transaction price, and therefore, of revenue unless the payment is in exchange for a distinct good or service.
Performance Obligations
A performance obligation is a promise in a contract to transfer a distinct product or service to a customer that is both capable of being distinct, whereby the customer can benefit from the product or service either on its own or together with other resources that are readily available, and is distinct in the context of the contract, whereby the transfer of the product or service is separately identifiable from other promises in the contract.
Equipment is sold or leased with embedded software, which is considered a single performance obligation. Maintenance, which includes preventative maintenance, future updates, security threat updates, and minor bug fixes on a when-and-if available basis, is considered a single performance obligation. SaaS, which includes data-driven security information and analytics insights, is also considered a performance obligation. Professional services, including installation, training, and event support, are considered separate performance obligations and are included within license fee and other revenue. Any add-on accessories are also considered separate performance obligations and are included in product revenue.
Payment terms
Payment terms for customer orders are typically 30 days after the shipment or installation of the product. Generally, the Company’s contracts do not contain a significant financing component.
Multiple Performance Obligations within an Arrangement
The Company’s contracts may include multiple performance obligations when customers purchase a combination of products and services. When the Company’s customer arrangements have multiple performance obligations that contain an equipment lease for the customer’s use as well as distinct services that are delivered simultaneously, the Company allocates the arrangement consideration between the lease deliverables and non-lease deliverables based on the relative estimated SSP of each distinct performance obligation. For multiple performance obligation arrangements that do not contain a lease, the Company allocates the contract’s transaction price to each performance obligation on a relative SSP basis. The Company determines SSP based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, the Company estimates the SSP taking into account available information such as market conditions, internally approved pricing guidelines, and observable pricing data such as standard cost metrics related to the performance obligation.
Stock-Based Compensation
The Company measures all stock-based awards granted to employees, officers, directors and non-employees based on their fair value on the date of the grant and recognizes compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. The vesting period for stock options is generally four years and the vesting period for restricted stock units is generally three years. The Company classifies stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. The Company issues stock-based awards with service-based vesting conditions and records the expense for these awards using the straight-line method. Forfeitures are accounted for as they occur.
In January 2021, the Company granted warrants (the "Finback Common Stock Warrants") exercisable for 2,552,913 shares of common stock at an exercise price of $0.42 per share to Finback Evolv OBH, LLC ("Finback"), a consulting group affiliated with one of the Company's shareholders. The Finback Common Stock Warrants vest upon meeting certain sales criteria as defined in a business development agreement (the "Finback BDA") which has a term of three years. The Finback Common Stock Warrants expire in January 2031. The Finback Common Stock Warrants are accounted for under ASC 718 Compensation - Stock Compensation as the warrants vest upon certain performance conditions being met.
Prior to the closing of the Merger, there was not a public market for the shares of the Company’s common stock. The Company’s determination of the fair value of stock options on the date of grant utilized the Black-Scholes option-pricing model and was impacted by its common stock price, as determined by the Board of Directors with input from the Company’s management, as well as changes in assumptions regarding a number of subjective variables. These variables
included, but were not limited to, the expected term that options remained outstanding, the expected common stock price volatility over the term of the option awards, risk-free interest rates, and expected dividends. The Company valued its common stock taking into consideration its most recently available valuation of common stock performed by third parties as well as additional factors since the date of the most recent contemporaneous valuation through the date of grant. After the closing of the Merger, the Company determines the fair value of each share of common stock underlying stock-based awards based on the closing price of the Company’s common stock as reported by Nasdaq on the date of grant.
Pursuant to the Merger Agreement, the Company will issue 15,000,000 earn-out shares of the Company’s common stock to Legacy Evolv shareholders and Legacy Evolv Service Providers including employees, officers, directors, and non-employees based on the achievement of certain target share price contingencies and subject to continued employment. The company classifies the share-based compensation arrangement with Legacy Evolv Service Providers as equity on its balance sheet and corresponding stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. As of December 31, 2023, of the total 15,000,000 earn-out shares of the Company’s common stock, 2,115,304 earn-out shares can be earned by the Legacy Evolv Service Providers and are subject to the stock-based compensation guidance. As a condition for Earn-Out Shares being issued to Earn-Out Service Providers, the service provider must be providing services to the Company on the date of the issuance of the shares. If the relationship with the service provider is terminated prior to the issuance of the Earn-Out Shares, the shares will be redistributed to the remaining participants in the Earn-Out Shares.
Income Taxes
The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company’s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes.
The Company assesses the likelihood that its deferred tax assets will be recovered from future sources of income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. The potential for recovery of deferred tax assets is evaluated by analyzing past operating results, estimating the future taxable profits expected and considering prudent and feasible tax planning strategies.
The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.
The Company evaluates at the end of each reporting period whether some or all the undistributed earnings of its foreign subsidiaries are permanently reinvested. The Company would recognize deferred income tax liabilities to the extent that management asserts that undistributed earnings of its foreign subsidiaries are not permanently reinvested and will not be permanently reinvested in the future. For the year ended December 31, 2023, the Company had less than $0.1 million in foreign earnings. For the year ended December 31, 2022, the Company had no foreign earnings in any foreign jurisdictions. The Company will continue to evaluate its position in the future based on its future strategy and cash needs.
Net Loss per Share Attributable to Common Stockholders
Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net loss attributable to common stockholders is computed by adjusting net loss attributable to common stockholders for the impact
to the extent a denominator adjustment is required. Diluted net loss per share attributable to common stockholders is computed by dividing the diluted net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period, including the dilutive effect of potential dilutive common shares as determined under the treasury stock method. For purposes of this calculation, outstanding stock options, convertible preferred stock, convertible notes, warrants to purchase common stock, and warrants to purchase preferred stock are considered potential dilutive common shares.
In periods in which the Company reported a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December 31, 2023 and 2022.
Recently Adopted Accounting Pronouncements
Becoming a Large Accelerated Filer
Prior to December 31, 2023, the Company qualified as an "emerging growth company", as defined in the Jumpstart our Business Startups Act of 2012, and elected not to “opt out” of the extended transition related to complying with new or revised accounting standards.
The Company became a large accelerated filer and ceased to qualify as an emerging growth company as of December 31, 2023. The adoption dates discussed below for recently adopted accounting pronouncements reflect the updated transition periods required as a result of becoming a "large accelerated filer" (as defined under Rule 12b-2 of the Exchange Act) as of December 31, 2023. The Company will be required to adopt all future new or revised accounting pronouncements in accordance with applicable public company timelines specified in those accounting pronouncements.
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326) (“ASU 2016-13”). The new standard adjusts the accounting for assets held at amortized cost basis, including marketable securities accounted for as available for sale, and trade receivables. The standard eliminates the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For public entities except smaller reporting companies, the guidance is effective for annual reporting periods beginning after December 15, 2019 and for interim periods within those fiscal years. In November 2019, the FASB issued ASU No. 2019-10, which deferred the effective date for non-public entities and smaller reporting companies to annual reporting periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is allowed. The Company adopted this guidance effective January 1, 2023, and the adoption of this guidance did not have a material impact on its consolidated financial statements and related disclosures.
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The amendments in ASU 2021-08 are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption of the amendments is permitted, including adoption in an interim period. The Company adopted this guidance effective January 1, 2023, and the adoption of this guidance did not have an impact on its consolidated financial statements and related disclosures.
Recently Issued Accounting Pronouncements
In July 2023, the FASB issued Accounting Standards Update ASU 2023-03, “Presentation of Financial Statement (Topic 205), Income Statement - Reporting Comprehensive Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation - Stock Compensation (Topic 718),” to amend various U.S. Securities Exchange Commission ("SEC") paragraphs in the Accounting Standards Codification to reflect the issuance of SEC Staff Accounting Bulletin No. 120, among other things. The ASU does not provide any new guidance so there is no transition or
effective date associated with it. The Company is currently assessing the impact of adopting ASU 2023-03 on the consolidated financial statements and related disclosures.
In October 2023, the FASB issued ASU 2023-06, “Disclosure Improvements – Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative,” related to disclosure or presentation requirements for various subtopics in the FASB’s Accounting Standards Codification (“Codification”). The amendments in the update are intended to align the requirements in the Codification with the SEC regulations and facilitate the application of GAAP for all entities. The effective date for each amendment is the date on which the SEC removal of the related disclosure requirement from Regulation S-X or Regulation S-K becomes effective, or if the SEC has not removed the requirements by June 30, 2027, this amendment will be removed from the Codification and will not become effective for any entity. Early adoption is prohibited. The Company does not expect this update to have a material impact on the consolidated financial statements and related disclosures.
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The updated accounting guidance requires enhanced reportable segment disclosures, primarily related to significant segment expenses which are regularly provided to the chief operating decision maker. The guidance is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required and early adoption is permitted. The Company is currently evaluating the impact of this standard on the disclosures within the consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." ASU 2023-09 is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. A public entity should apply the amendments in ASU 2023-09 prospectively to all annual periods beginning after December 15, 2024. The Company is currently evaluating the impact of this standard on the disclosures within the consolidated financial statements.
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
Marketable Securities
12 Months Ended
Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities Marketable Securities
Marketable securities as of December 31, 2023 consisted of the following:
December 31, 2023
Amortized CostUnrealized Gain/(Loss)Fair Value
U.S. Treasury bills$51,289 $— $51,289 
Total marketable securities$51,289 $— $51,289 
Marketable securities at December 31, 2023 are comprised solely of zero coupon U.S. treasury bills with maturities of less than one year that are classified as available-for-sale debt securities. The Company did not record any unrealized gains or losses on available-for-sale securities for the year ended December 31, 2023. The accretion of discounts on marketable securities is included in interest income on the consolidated statements of operations and comprehensive income. The Company did not have any marketable securities as of December 31, 2022.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value Measurements
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):
Fair Value Measurements at December 31, 2023
Level 1Level 2Level 3Total
Assets:
Money market funds$57,829 $— $— $57,829 
Treasury bills— 51,289 — 51,289 
$57,829 $51,289 $— $109,118 
Liabilities:
Contingent earn-out liability$— $— $29,119 $29,119 
Contingently issuable common stock liability— — 6,530 6,530 
Public Warrant liability10,889 — — 10,889 
$10,889 $— $35,649 $46,538 
Fair Value Measurements at December 31, 2022
Level 1Level 2Level 3Total
Assets:
Money market funds$149,971 $— $— $149,971 
$149,971 $— $— $149,971 
Liabilities:
Long-term debt including current portion$— $29,683 $— $29,683 
Contingent earn-out liability— — 14,218 14,218 
Contingently issuable common stock liability— — 3,392 3,392 
Public Warrant liability6,124 — — 6,124 
$6,124 $29,683 $17,610 $53,417 
Money market funds are included in cash and cash equivalents on the consolidated balance sheets. As of December 31, 2023, all outstanding treasury bills, which totaled $51.3 million, had maturities greater than 3 months and are reflected as marketable securities. The fair value of the treasury bills, which are classified as Level 2 securities, is calculated by a third-party pricing service and is based on estimates obtained from various sources.
The Company may also value its non-financial assets and liabilities, including items such as inventories and property and equipment, at fair value on a non-recurring basis if it is determined that impairment has occurred. Such fair value measurements use significant unobservable inputs and are classified as Level 3.
The carrying amounts of cash and cash equivalents, accounts receivable, restricted cash, accounts payable, accrued liabilities, and other accrued expenses approximate fair value because of their short maturity.
During each of the years ended December 31, 2023 and 2022, there were no transfers between Level 1, Level 2, and Level 3.
Valuation of Contingent Earn-out
Pursuant to the Merger Agreement, the Legacy Evolv stockholders, immediately prior to the Merger, were entitled to receive additional shares of the Company’s common stock upon the Company achieving certain milestones as described in Note 2. The Company’s contingent earn-out shares were recorded at fair value as contingent earn-out liability upon the
closing of the Merger and are remeasured at each reporting period. As of December 31, 2023, no milestones have been achieved.
The fair value of the contingent earn-out is calculated using a Monte Carlo analysis in order to simulate the future path of the Company’s stock price over the earn-out period. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value. The significant assumptions used in the Monte Carlo model as of December 31, 2023 were as follows: 90% expected stock price volatility, a risk-free rate of return of 4.2%, a 25% likelihood of change in control, and a remaining term of 2.2 years.
The following table provides a rollforward of the contingent earn-out liability (in thousands):
Balance at December 31, 2021$21,206 
Change in fair value(6,988)
Balance at December 31, 2022$14,218 
Change in fair value14,901 
Balance at December 31, 2023$29,119 
Valuation of Contingently Issuable Common Stock
Prior to the Merger, certain NHIC shareholders owned 4,312,500 Founder Shares. Of these shares, 1,897,500 shares vested at the closing of the Merger, 517,500 shares were transferred back to NHIC and then contributed to Give Evolv LLC and the remaining 1,897,500 outstanding shares will vest upon the Company achieving certain milestones (see Note 2). The Company’s contingently issuable common stock was recorded at fair value as contingent shares on the closing of the Merger and will be remeasured at each reporting period. As of December 31, 2023, no milestones have been achieved.
The fair value of the contingently issued common shares is determined using a Monte Carlo analysis in order to simulate the future path of the Company’s stock price over the vesting period. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value. The significant assumptions used in the Monte Carlo model as of December 31, 2023 were as follows: 90% expected stock price volatility, a risk-free rate of return of 4.1%, a 25% likelihood of change in control, and a remaining term of 2.5 years.
The following table provides a rollforward of the contingently issuable common shares (in thousands):
Balance at December 31, 2021$5,264 
Change in fair value(1,872)
Balance at December 31, 2022$3,392 
Change in fair value3,138 
Balance at December 31, 2023$6,530 
Valuation of Public Warrant Liability
Upon the closing of the Merger, the Company assumed the Public Warrants to purchase shares of the Company’s common stock. The Public Warrants are publicly traded and the initial fair value of the public warrants were based on the closing price as reported by Nasdaq on the date of the Merger and remeasured at each reporting period.
The following table provides a rollforward of the public warrant liability (in thousands):
Balance at December 31, 2021$11,030 
Change in fair value(4,906)
Balance at December 31, 2022$6,124 
Change in fair value4,765 
Balance at December 31, 2023$10,889 
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue Recognition
12 Months Ended
Dec. 31, 2023
Revenue Recognition and Deferred Revenue [Abstract]  
Revenue Recognition Revenue Recognition
Remaining Performance Obligations
The following table includes estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially satisfied) as of December 31, 2023.

Less than 1 year1 - 2 yearsMore than 2 yearsTotal
Product revenue$997 $— $— $997 
Subscription revenue56,819 52,188 63,265 172,272 
Service revenue21,255 20,948 24,898 67,101 
License fee and other revenue143 — — 143 
Total revenue$79,214 $73,136 $88,163 $240,513 
The amount of minimum future leases is based on expected income recognition. As of December 31, 2023, future minimum payments on noncancelable leases are as follows (in thousands):

Year Ending December 31:
2024$56,819 
202552,188 
202641,088 
202721,118 
Thereafter1,059 
$172,272 
Contract Balances from Contracts with Customers
Contract assets arise from unbilled amounts in customer arrangements when revenue recognized exceeds the amount billed to the customer and the Company’s right to payment is conditional and not only subject to the passage of time. As of December 31, 2023 and December 31, 2022, the Company had $3.7 million and $2.9 million in current portion of contract assets and $0.5 million and $1.4 million in contract assets, noncurrent on the consolidated balance sheets, respectively.
Contract liabilities represent the Company’s obligation to transfer goods or services to a customer for which it has received consideration (or the amount is due) from the customer. The Company has a contract liability related to service revenue, which consists of amounts that have been invoiced but that have not been recognized as revenue. Amounts expected to be recognized as revenue within 12 months of the balance sheet date are classified as current deferred revenue and amounts expected to be recognized as revenue beyond 12 months of the balance sheet date are classified as deferred revenue, noncurrent. The Company recognized revenue of $19.1 million during the year ended December 31, 2023 that was included in the 2022 deferred revenue balance. The Company recognized revenue of $6.6 million during the year ended December 31, 2022 that was included in the 2021 deferred revenue balance.
The following table provides a rollforward of deferred revenue (in thousands):
Balance at December 31, 2021$9,074 
Revenue recognized in relation to the beginning of the year contract liability balance(6,632)
Revenue deferred33,526 
Balance at December 31, 2022$35,968 
Revenue recognized in relation to the beginning of the year contract liability balance(19,104)
Revenue deferred54,626 
Balance at December 31, 2023$71,490 
The following table presents the Company’s components of lease revenue (in thousands):
Twelve Months Ended
December 31,
20232022
Revenue from sales-type leases$— $1,123 
Interest income on lease receivables197 224 
Lease income - operating leases37,247 17,569 
Total lease revenue$37,444 $18,916 
The revenue from sales-type leases is related to the Evolv Express units where the lease term is for the major part of the economic life of the underlying equipment and is classified as product revenue in the consolidated statements of operations and comprehensive loss. The interest income on lease receivables is classified under interest income in the consolidated statements of operations and comprehensive loss. The lease income from operating leases is related to the leased equipment under subscription arrangements and is classified as subscription revenue in the consolidated statements of operations and comprehensive loss. Revenue related to leases entered into with related parties were $0.9 million and $0.6 million during the years ended December 31, 2023 and 2022, respectively.
Disaggregated Revenue
The following table presents the Company’s revenue by revenue stream (in thousands). Certain prior period amounts have been reclassified to conform to current period presentation:

Twelve Months Ended
December 31,
20232022
Product revenue$21,977 $31,985 
Leased equipment37,247 17,569 
Service revenue16,141 4,331 
License fees2,963 — 
Professional services and other revenue2,090 1,310 
Total revenue$80,418 $55,195 
The following table presents the Company's revenue by geographical region based on customer location (in thousands):

Twelve Months Ended
December 31,
20232022
United States$78,556 $53,815 
Foreign1,862 1,380 
Total revenue$80,418 $55,195 
Commissions
The Company incurs and pays commissions on product sales. The Company applies the practical expedient for contracts less than one year in duration to expense the commission costs in the period in which they were incurred. Commissions on product sales and services are expensed in the period in which the related revenue is recognized. Commissions on subscription arrangements and maintenance are expensed ratably over the life of the contract. The Company had a deferred asset related to commissions of $11.4 million and $9.0 million as of December 31, 2023 and December 31, 2022, respectively. During the years ended December 31, 2023 and 2022, the Company recognized commission expense of $5.6 million and $4.1 million, respectively.
Give Evolv LLC
Upon the closing of the Merger, the NHIC Founders transferred 517,500 shares of its common stock to Evolv NewHold Benefit LLC (“ENHB”), which represented the initial contribution to be used to pay for the donation of Evolv’s Express units to public venues and institutions, primarily schools in locations that might not otherwise be able to afford weapon detection security screening systems and related products and services. In September 2021, ENHB was renamed to Give Evolv LLC (“Give Evolv”). Give Evolv is deemed an entity under common control and a consolidating entity as it is under the same management as the Company. As such, the shares held by Give Evolv are not considered outstanding or issued.
For such arrangements, Give Evolv generally purchases the related products and services from Evolv through an intercompany transaction using the available donated proceeds from the transfer of common stock upon the closing of the Merger. Evolv will be responsible for the delivery of the units, in addition to providing related services, such as installation, training, and maintenance. Consideration transferred to Evolv for the related products and services may be in the form of common stock or cash. Shares of common stock may be sold to generate funds for the purposes of paying for the donated goods and services. The sales transactions between Evolv and Give Evolv eliminate in consolidation.
During the year ended December 31, 2023, the Company donated five Evolv Express units to schools resulting in $0.2 million in general and administrative expenses in the Company's consolidated statements of operations and comprehensive loss. During the year ended December 31, 2022, the Company donated six Evolv Express units to schools, resulting in $0.2 million in general and administrative expenses in the Company's consolidated statements of operations and comprehensive loss.
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Leases Leases
Company Headquarters (Waltham, MA)
In April 2021, the Company entered into a sublease agreement for office and storage space for its corporate headquarters located at 500 Totten Pond Road in Waltham, MA. The Company entered into an amendment to the sublease agreement in August 2023 in order to lease additional space within the building. The sublease expires on October 31, 2024. The Company is required to maintain a minimum cash balance of $0.3 million as a security deposit on the space which is classified as restricted cash, current on the consolidated balance sheets. The Company pays for its proportionate share of building operating expenses and taxes that are treated as variable costs and excluded from the measurement of the lease. The sublease grants the Company an option to extend the term for an additional three years at the fair market rent by giving
the landlord nine months written notice. The Company was not reasonably certain to exercise the option to extend the lease and therefore the extension term was excluded from the measurement of the lease.
Storage Facilities
The Company additionally leases three storage spaces on a month-to-month basis that are classified as short-term leases.
Operating lease cost recognized during the years ended December 31, 2023 and December 31, 2022 was $1.2 million and $1.0 million, respectively. Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2023 and December 31, 2022 was $1.4 million and $1.1 million, respectively.
The weighted-average remaining lease term and discount rate were as follows:

December 31,
20232022
Weighted average remaining lease term0.8 years1.8 years
Weighted average discount rate7.75 %6.95 %
Future annual lease payments under non-cancelable operating leases as of December 31, 2023 were as follows (in thousands):

Year Ended December 31:
2024$1,432 
2025— 
Total future lease payments1,432 
Less: imputed interest(41)
Present value of operating lease liability $1,391 
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
Accounts Receivable
12 Months Ended
Dec. 31, 2023
Receivables [Abstract]  
Accounts Receivable Accounts Receivable
Allowance for Expected Credit Losses
Changes in the allowance for expected credit losses were as follows (in thousands):
Allowance for Expected Credit Losses
December 31, 2021$(50)
Provisions(150)
Write-offs, net of recoveries
December 31, 2022$(200)
Provisions(410)
Write-offs, net of recoveries28
December 31, 2023$(582)
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
Inventory
12 Months Ended
Dec. 31, 2023
Inventory Disclosure [Abstract]  
Inventory Inventory
Inventory consisted of the following (in thousands):
December 31,
20232022
Raw materials$1,869 $2,334 
Finished goods7,638 7,923 
Total$9,507 $10,257 
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Prepaid expenses and other current assets
12 Months Ended
Dec. 31, 2023
Prepaid Expense and Other Assets, Current [Abstract]  
Prepaid expenses and other current assets Prepaid expenses and other current assets
Prepaid expenses and other current assets consisted of the following (in thousands):
December 31,
20232022
Prepaid deposits$12,177 $9,666 
Prepaid subscriptions1,868 897 
Current portion of net investment in sales-type leases367 337 
Prepaid insurance1,208 2,374 
Other1,334 1,114 
Total$16,954 $14,388 
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
Property and Equipment, Net
12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
Property and Equipment, Net Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
December 31,
20232022
Computers and telecom equipment$1,331 $599 
Lab equipment1,171 871 
Furniture and fixtures111 111 
Leasehold improvements566 542 
Leased equipment80,206 35,983 
Capitalized software8,629 4,150 
Sales demo equipment2,758 2,340 
Equipment held for lease1
32,910 7,826 
Construction in progress2,493 71 
130,175 52,493 
Less: Accumulated depreciation and amortization(17,254)(7,786)
$112,921 $44,707 
(1) Represents equipment that has not yet been deployed to a customer and, accordingly, is not being depreciated.
As of December 31, 2023 and 2022, the net book value of capitalized software was $7.0 million and $3.5 million, respectively. These amounts include $0.7 million and approximately $0.2 million of capitalized stock compensation costs, respectively. Depreciation expense and amortization expense related to property and equipment was $9.9 million and $5.5
million for the years ended December 31, 2023 and 2022, respectively, which included amortization expense of capitalized software of $1.0 million and $0.6 million for the years ended December 31, 2023 and 2022, respectively.
Leased equipment and the related accumulated depreciation were as follows:
December 31,
20232022
Leased equipment$80,206 $35,983 
Accumulated depreciation(13,283)(5,802)
Leased equipment, net$66,923 $30,181 
Depreciation expense related to leased units was $8.0 million and $4.3 million during the years ended December 31, 2023 and 2022, respectively. Depreciable lives are generally 7 years, consistent with the Company’s planned and historical usage of the equipment subject to operating leases.
Loss from impairment of property and equipment was $0.3 million and $1.2 million during the years ended December 31, 2023 and 2022, respectively. This primarily related to the removal of Evolv Edge units and Evolv Express prototypes from service, resulting in an impairment of the remaining economic value of such units.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
Accrued Expenses and Other Current Liabilities
12 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
December 31,
20232022
Accrued employee compensation and benefits expense$7,780 $7,225 
Accrued professional services and consulting1,579 722 
Accrued sales tax1,643 1,680 
Purchase order cancellation fees1,188 — 
Other3,388 1,918 
$15,578 $11,545 
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
Long-term Debt
12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Long-term Debt Long-term Debt
The components of the Company’s long-term debt consisted of the following (in thousands):
December 31,
20232022
Term loans payable$— $30,000 
Less: Unamortized discount— (317)
— 29,683 
Less: Current portion of long-term debt— (10,000)
Long-term debt, net of discount$— $19,683 
Silicon Valley Bank Term Loan Agreement
In December 2022, the Company entered into a loan and security agreement (the "2022 SVB Credit Agreement") with Silicon Valley Bank ("SVB") in order to finance purchases of hardware to be leased to customers. The 2022 SVB Credit Agreement provided for an initial term loan advance of $30.0 million, which was approximately equivalent to the value of all hardware purchases made to support leasing transactions with the Company's customers through December 21,
2022 (the "SVB Closing Date"), with the opportunity to obtain, within 18 months after the SVB Closing Date, additional term loan advances, subject to the satisfaction of certain conditions, in an aggregate principal amount equal to $20.0 million (subject to an increase of an additional $25.0 million upon the satisfaction of certain conditions and approval from SVB). The interest rate applicable to the SVB term loans was the greater of (a) the Wall Street Journal Prime Rate plus 1.0% or (b) 7.25% per annum. Interest and principal under the 2022 SVB Credit Agreement was payable monthly.
On March 10, 2023, SVB was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Corporation ("FDIC") as receiver. The FDIC created a successor bridge bank, Silicon Valley Bridge Bank, N.A. ("SVBB"), and all deposits of SVB were transferred to SVBB under a systemic risk exception approved by the Federal Reserve Board, the U.S. Treasury Department, and the FDIC. On March 12, 2023, the Federal Reserve Board, the U.S. Treasury Department, and the FDIC announced in a joint statement that all SVB deposits, including both insured and uninsured amounts, would be available in full to account holders. SVB was acquired by First Citizens Bank on March 27, 2023.
In light of the foregoing, on March 28, 2023, upon the recommendation of the Company’s newly-formed Investment Committee of the Board of Directors, the Company (i) gave notice of its desire and intent to terminate the commitments under the 2022 SVB Credit Agreement and (ii) transferred its excess cash out of First Citizens Bank (the “Transfer”). The Transfer resulted in an event of default under the 2022 SVB Credit Agreement. Upon the occurrence of such event of default, First Citizens Bank could have, but was not required to, declare all obligations under the 2022 SVB Credit Agreement immediately due and payable. First Citizens Bank did not make such declaration following such event of default.
On March 31, 2023, the Company fully repaid all borrowings and accrued interest under the 2022 SVB Credit Agreement and terminated the 2022 SVB Credit Agreement. In accordance with the terms of the 2022 SVB Credit Agreement, the Company was required to pay a prepayment premium equal to 1.0% of the principal balance on the date of repayment. The Company incurred a loss on debt extinguishment of $0.6 million, consisting of the prepayment penalty of $0.3 million and the write-off of $0.3 million of unamortized debt issuance costs.
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Warrants
12 Months Ended
Dec. 31, 2023
Warrants and Rights Note Disclosure [Abstract]  
Warrants Warrants
As of December 31, 2023 and 2022, warrants to purchase the following classes of common stock outstanding consisted of the following:
December 31, 2023
Warrant DescriptionIssuance DateContractual
Term
(in years)
Underlying Equity
Instrument
Balance Sheet
Classification
Shares Issuable
Upon Exercise
of Warrant
Weighted
Average
Exercise Price
Finback Common Stock Warrants (see Note 15)January 13, 202110Common stockEquity1,317,327 $0.42 
Public Warrants (see Note 2)July 16, 20215Common stockLiability14,324,893 $11.50 
15,642,220 
December 31, 2022
Warrant DescriptionIssuance DateContractual
Term
(in years)
Underlying Equity
Instrument
Balance Sheet
Classification
Shares Issuable
Upon Exercise
of Warrant
Weighted
Average
Exercise Price
Finback Common Stock Warrants (see Note 15)January 13, 202110Common stockEquity2,421,200 $0.42 
Public Warrants (see Note 2)July 16, 20215Common stockLiability14,324,994 $11.50 
16,746,194 
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock
12 Months Ended
Dec. 31, 2023
Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]  
Common Stock Common Stock
Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the board of directors, subject to the preferential dividend rights of Preferred Stock. As of December 31, 2023 and 2022, no cash dividends had been declared or paid.
As of December 31, 2023 and 2022, the Company had reserved 80,298,297 and 79,795,376 shares, respectively, of common stock for the exercise of outstanding stock options, vesting of outstanding restricted stock units and performance stock units, vesting of contingent earn-out shares, vesting of contingently issuable common stock, granting of awards under the Company’s 2021 Equity Incentive Plan (see Note 15), and the exercise of outstanding warrants (see Note 13). In addition, as of December 31, 2023 and 2022, the Company had 6,315,248 and 4,863,198 shares, respectively, of common stock available to be issued under the 2021 Employee Stock Purchase Plan (see Note 15).
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
2021 Equity Incentive Plan
The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) provides for the Company to grant incentive stock options or nonqualified stock options, restricted stock awards, restricted stock units, performance stock units, and other stock-based awards to employees, officers, directors, and non-employees of the Company. A total of 21,177,295 shares of common stock were initially authorized under the 2021 Plan, subject to annual evergreen increases of up to 5% of total common shares outstanding as of the end of the prior year. As of December 31, 2023, 14,007,370 shares were available for future grant under the 2021 Plan. Shares, units, and options that are expired, forfeited, canceled, or otherwise terminated without having been fully exercised will be available for future grant under the 2021 Plan. In addition, shares of common stock that are tendered to the Company by a participant to exercise an award are added to the number of shares of common stock available for future grants.
The 2021 Plan is administered by the Board of Directors or, at the discretion of the Board of Directors, by a committee of the Board of Directors. The exercise prices, vesting, and other restrictions are determined at the discretion of the Board of Directors, or its committee if so delegated, except that the exercise price per share of stock options may not be less than 100% of the fair market value of a share of common stock on the date of grant and the term of the stock option may not be greater than ten years. Stock options granted to employees, officers, members of the Board of Directors and non-employees vesting terms are determined on an individual basis on the date of grant. Prior to the closing of the Merger, the Company’s Board of Directors valued the Company’s common stock, taking into consideration its most recently available valuation of common stock performed by third parties as well as additional factors which may have changed since the date of the most recent contemporaneous valuation through the date of grant. After the closing of the Merger, the fair value of each share of common stock underlying stock-based awards is based on the closing price of our common stock as reported by Nasdaq on the date of grant.
Stock Options
The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted during the years ended December 31, 2023 and 2022:
Year Ended December 31,
20232022
Risk-free interest rate4.2 %1.6 %
Expected term (in years)6.16.1
Expected volatility87.5 %75.0 %
Expected dividend yield0.0 %0.0 %
The following tables summarize the Company’s stock option activity under the 2021 Equity Incentive Plan (in thousands, except for share and per share data):
Number of
Shares
Weighted
Average
Exercise Price
Weighted
Average
Remaining
Contractual Term (in years)
Aggregate
Intrinsic Value
Outstanding as of December 31, 2021
20,769,130$0.39 
Granted2,262,9253.49 
Exercised(1,896,975)0.43 
Forfeited(710,707)0.42 
Expired(27,549)0.42 
Outstanding as of December 31, 2022
20,396,824$0.73 
Granted2,840,4213.12 
Exercised(1,735,978)0.38 
Forfeited(1,164,932)1.72 
Expired(11,807)0.42 
Outstanding as of December 31, 2023
20,324,528$1.04 6.0$74,768 
Vested and expected to vest as of December 31, 2023
20,324,528$1.04 6.0$74,768 
Options exercisable as of December 31, 2023
16,114,401$0.67 5.4$65,339 
The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for those options that had exercise prices lower than the fair value of the Company’s common stock.
The weighted average grant date fair value of stock options granted was $2.35 and $2.32 during the years ended December 31, 2023 and 2022, respectively. The aggregate intrinsic value of the stock options exercised was $8.7 million and $4.4 million during the years ended December 31, 2023 and 2022, respectively.
Restricted Stock Units
The following table summarizes the Company’s restricted stock units activity under its existing restricted stock unit plan:
Number of
Shares
Grant Date Fair
Value
Outstanding as of December 31, 2021
1,951,924$6.76 
Granted7,613,4723.26 
Vested(565,774)6.72 
Forfeited(1,497,677)5.15 
Outstanding as of December 31, 2022
7,501,945$3.54 
Granted9,477,0143.48 
Vested(2,833,155)3.55 
Forfeited(1,099,125)3.54 
Outstanding as of December 31, 2023
13,046,679$3.49 
During the years ended December 31, 2023 and 2022, the aggregate grant-date fair value of restricted stock units issued under the 2021 Plan was $33.0 million and $24.9 million, respectively. RSUs generally vest ratably over a three year period subject to the grantee's continued service through the applicable vesting date. During the year ended December 31, 2023 and 2022, the total fair value of shares vested was $10.1 million and $3.8 million, respectively.
Performance Stock Units
The following table summarizes the Company's performance stock units activity under its existing performance stock units plan:
Number of
Shares
Grant Date Fair
Value
Outstanding as of December 31, 2021
— $— 
Granted947,000 2.65 
Vested— — 
Forfeited(83,000)2.65 
Outstanding as of December 31, 2022
864,000 $2.65 
Granted— — 
Vested(432,000)2.65 
Forfeited(52,000)2.67 
Outstanding as of December 31, 2023
380,000 $2.64 
Based upon the terms of the award agreements and achievement of the performance goal, 50% of the applicable performance stock units vested on January 1, 2023 and 50% on January 1, 2024, subject to the grantee’s continued service through the applicable vesting date.
2021 Employee Stock Purchase Plan
In July 2021, the Company’s Board of Directors adopted the 2021 Employee Stock Purchase Plan (“2021 ESPP”), which was subsequently approved by the Company’s stockholders and became effective on July 16, 2021. The 2021 ESPP authorizes the initial issuance of up to 3,435,748 shares of the Company’s common stock to eligible employees of the Company or, as designated by the Company’s Board of Directors, employees of a related company. The 2021 ESPP provides that the number of shares reserved and available for issuance under the 2021 ESPP will automatically increase each January 1, beginning on January 1, 2022 and ending on (and including) January 1, 2032, by an amount equal to the lesser of (i) 1% of the outstanding number of shares of common stock on the immediately preceding December 31 and (ii) such smaller number of shares as determined by the Company’s Board of Directors. As of December 31, 2023, 6,315,248 shares of the Company’s common stock were available for future issuance. The Company’s Board of Directors may from time to time grant or provide for the grant to eligible employees of options to purchase common stock under the 2021 ESPP during a specific offering period. As of December 31, 2023, no offerings have been approved.
Finback Common Stock Warrants
The Company utilized a Black-Scholes pricing model to determine the grant-date fair value of the Finback Common Stock Warrants. The assumptions used are presented in the following table:
Warrants - Black Scholes
Risk-free interest rate0.4 %
Expected term (in years)3.0
Expected volatility23.9 %
Expected dividend yield— %
In January 2021, the Company granted warrants (the "Finback Common Stock Warrants") to purchase 2,552,913 shares of the Company's Class A common stock at an exercise price of $0.42 per share to Finback Evolv OBH, LLC ("Finback"), a consulting group affiliated with one of the Company's stockholders. The Finback Common Stock Warrants vest upon meeting certain sales criteria as defined in a business development agreement (the "Finback BDA"), which has a term of 3 years. The Finback BDA expired on January 1, 2023, subject to a 1-year "tail period" expiring on January 1, 2024. During the tail period, the Finback Common Stock Warrants will continue to vest related to any sale consummated by the Company for which it is determined Finback provided services prior to January 1, 2023 in furtherance of the sale. The Finback Common Stock Warrants expire in January 2031. The Finback Common Stock Warrants are accounted for under ASC 718 Compensation – Stock Compensation as the warrants vest upon certain performance conditions being met. On the date of issuance, the Finback Common Stock Warrants were valued at $19.5 million.
Upon the closing of the Merger, vested Finback Common Stock Warrants automatically converted into 131,713 shares of the Company’s common stock. As of December 31, 2023, 117,423 Finback Common Stock Warrants were exercisable at a total aggregate intrinsic value of $0.5 million. The remaining 1,199,904 Finback Common Stock Warrants are unvested and have a total unrecognized grant date fair value of $9.1 million. As of December 31, 2023, 1,103,873 of the Finback common stock warrants were exercised. The Company recognizes compensation expense for the Finback Common Stock Warrants when the warrants become vested based on meeting the specified sales criteria. During the years ended December 31, 2023 and 2022, the Company recorded $3.1 million and $4.5 million, respectively, of stock-based compensation expense within sales and marketing expense related to the Finback Common Stock Warrants.
Stock-Based Compensation
Stock-based compensation expense was classified in the consolidated statements of operations and comprehensive loss as follows (in thousands):
Year Ended December 31,
20232022
Cost of revenue$583$829
Research and development4,2844,009
Sales and marketing9,38710,038
General and administrative9,8977,622
Total stock-based compensation expense$24,151$22,498
Stock-based compensation expense by award type recognized in the consolidated statements of operations and comprehensive loss was as follows (in thousands):
Year Ended December 31,
20232022
Stock options $2,925$1,594
Earn-out shares2,0736,499
Warrants 3,1474,523
RSUs and PSUs16,0069,882
Total stock-based compensation expense $24,151$22,498
Total unrecognized compensation expense related to stock options and restricted stock units as of December 31, 2023, was $40.8 million, which is expected to be recognized over a weighted average period of 2.1 years. Total unrecognized compensation expense related to earn-out shares associated with the share-based compensation arrangement as of December 31, 2023, was $0.2 million, which is expected to be recognized over a weighted average period of 0.5 years.
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The components of the Company’s loss before income tax expense are as follows (in thousands):
Year Ended December 31,
20232022
United States$(106,261)$(85,760)
Foreign58 (646)
Loss before income tax provision$(106,203)$(86,406)
Income tax expense is comprised of the following (in thousands):
Year Ended December 31,
20232022
Current:
Federal$$
State27
Foreign24
Total current income tax expense$51$
Deferred:
Federal$$
State
Foreign
Total deferred income tax expense$$
Total income tax expense$51$
The effective tax rate differs from the U.S. federal statutory rate primarily due to the full valuation allowance maintained on the Company’s net deferred tax assets and non-deductible fair value adjustments for the years ended December 31, 2023 and 2022. A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:
Year Ended December 31,
20232022
Federal statutory income tax rate21.0 %21.0 %
State income taxes, net of federal benefit3.4 3.5 
Federal and state research and development tax credits— (1.2)
Change in fair value of contingent earn-out liability and contingently issuable common stock liability(4.5)3.4 
Change in valuation allowance(16.9)(23.6)
Change in uncertain tax positions(0.4)— 
Change in tax rate0.8 (0.1)
Stock-based compensation(0.6)(0.2)
Non-deductible compensation(2.4)(2.6)
Permanent differences(0.1)(0.2)
Other(0.3)— 
Effective income tax rate0.0 %0.0 %
Net deferred tax assets consisted of the following (in thousands):
December 31,
20232022
Deferred tax assets:  
Net operating loss carryforwards$41,541$36,518
Research and development tax credit carryforwards3,8023,836
Capitalized research and development costs13,0439,965
Accrued expenses7,2306,660
Deferred revenue18,2068,884
Lease liability351490
Other1,305106
Total deferred tax assets85,47866,459
Valuation allowance(82,558)(64,570)
Total deferred tax assets, net of valuation allowance2,9201,889
Deferred tax liabilities:  
Depreciation and amortization(2,601)(1,464)
Right of use lease asset(302)(409)
Other(17)(16)
Total deferred tax liabilities(2,920)(1,889)
Net deferred tax assets$$
As of December 31, 2023 and December 31, 2022, the Company had gross federal net operating losses of $20.1 million and $20.1 million that are subject to expire at various dates beginning in 2033, and federal net operating losses of $142.4 million and $124.3 million, which have no expiration date and can be used to offset up to 80% of future taxable income in any one tax period, respectively. The Company also had gross state net operating loss carryforwards of $142.4
million and $103.8 million for the years ended December 31, 2023 and 2022, respectively, which may be available to offset future state taxable income and which begin to expire in 2033. Additionally, the Company had no UK net operating loss carryforwards as of December 31, 2023 and gross UK net operating loss carryforwards of approximately $2.3 million that will not expire as of December 31, 2022. As of December 31, 2023, the Company had gross U.S. federal and state research and development and other tax credit carryforwards of $2.5 million and $1.6 million, respectively, which may be available to offset future tax liabilities and the majority of which begin to expire in 2033 and 2030, respectively. As of December 31, 2022, the Company had gross U.S. federal and state research and development and other tax credit carryforwards of $2.5 million and $1.6 million, respectively, which may be available to offset future tax liabilities and the majority of which begin to expire in 2033 and 2029, respectively.
Utilization of the U.S. federal and state net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Sections 382 and 383 of the Internal Revenue Code of 1986, and corresponding provisions of state law, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income or tax liabilities. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards would be subject to an annual limitation under Section 382, which is determined by first multiplying the value of the Company’s stock at the time of the ownership change by the applicable long-term tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization.
The Company considered the significant negative evidence of its history of cumulative net operating losses incurred since inception, as well as other positive and negative evidence bearing upon its ability to realize the deferred tax assets, and has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets as of December 31, 2023 and 2022. If or when recognized, the tax benefits related to any reversal of the valuation allowance on deferred tax assets as of December 31, 2023, will be accounted for as follows: approximately $80.0 million will be recognized as a reduction of income tax expense and $2.5 million will be recorded as an increase in equity. The Company reevaluates the positive and negative evidence at each reporting period.
Changes in the valuation allowance for deferred tax assets related primarily to the increase in net operating loss carryforwards and capitalized R&D costs and were as follows (in thousands):
December 31,
20232022
Valuation allowance as of beginning of year$64,570$43,966
Additions charged to provision for income taxes17,98820,320
Additions charged to equity332
Currency translation and other(48)
Valuation allowance as of end of year$82,558$64,570
The Company accounts for income tax uncertainties in accordance with ASC 740 Income Taxes, which prescribes a recognition threshold and measurement criteria for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Benefits from tax positions should be recognized in the financial statements only when it is more likely than not that the tax position will be sustained upon examination by the appropriate taxing authority that would have full knowledge of all relevant information. A tax position that meets the more likely than not recognition threshold is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Tax positions that previously failed to meet the more likely than not recognition threshold should be recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more likely than not recognition threshold should be derecognized in the first subsequent
financial reporting period in which that threshold is no longer met. ASC 740 also provides guidance on the accounting for and disclosure of liabilities for uncertain tax positions, interest and penalties. The Company’s policy is to record interest and penalties related to income taxes as part of its income tax provision.
The following table summarizes the activity related to the Company’s uncertain tax positions (excluding interest and penalties and related tax attributes) (in thousands):
December 31,
20232022
Balance at beginning of fiscal year$$
Gross increases related to prior year tax positions407
Foreign exchange and others21
Balance at end of fiscal year$428$
The Company’s liability for uncertain tax positions as of December 31, 2023, includes $0.4 million related to amounts that, if recognized, would affect the effective tax rate (excluding related interest and penalties).
The Company files income tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal, state, and non-US jurisdictions, where applicable. The Company is open to future tax examinations in the US under statute from 2020 to the present; however, carryforward attributes that were generated prior to 2020 may still be adjusted upon examination by federal, state, or local tax authorities if they either have been or will be used in a future period. The Company is also open for future tax examinations under statute from 2021 to the present in the UK. The Company has not received notice of examination in any jurisdictions for any tax year open under statute.
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
Net Loss per Share
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Net Loss per share Net Loss per Share
Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):
Year Ended December 31,
20232022
Numerator:  
Net income (loss) attributable to common stockholders – basic and diluted$(106,254)$(86,406)
  
Denominator:  
Weighted average common shares outstanding - basic and diluted149,168,105143,858,668
Net loss per share attributable to common stockholders – basic and diluted$(0.71)$(0.60)
The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:
Year Ended December 31,
20232022
Options issued and outstanding20,324,528 20,396,824 
Public Warrants to purchase common stock14,324,893 14,324,994 
Warrants to purchase common stock (Finback)**1,317,327 2,421,200 
Unvested restricted stock units13,046,679 7,501,945 
Unvested performance stock units380,000 864,000 
Earn-out shares*15,000,000 15,000,000 
Contingently issuable common stock*1,897,500 1,897,500 
66,290,927 62,406,463 
*Issuance of Earn-out shares and Contingently issuable common stock is contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period.
**Includes 117,423 vested warrants and 1,199,904 unvested warrants as of December 31, 2023.
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
Related Party Transactions
12 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
Business Development Agreement with Finback
In January 2021, the Company granted the Finback Common Stock Warrants subject to the terms of the Finback BDA, as discussed in Note 15.
In connection with the Merger and pursuant to the Merger Agreement, in addition to earn-out shares allocated to Finback based on its common stock ownership percentage as of the Merger date, Finback is entitled to receive a proportional share of earn-out shares based upon its remaining unvested warrants as of the Merger Date.
Original Equipment Manufacturer Partnership Agreement with Motorola Solutions, Inc.
In December 2020, the Company entered into an original equipment manufacturer partnership agreement with Motorola Solutions, Inc. ("Motorola"), an investor in the Company. The partnership agreement has since been amended and restated. Motorola sells Motorola-branded premium products based on the Evolv Express platform through their worldwide network of over 2,000 resellers and integration partners, and has integrated the Evolv Express platform with Motorola products. During the years ended December 31, 2023 and 2022, revenue from Motorola’s distributor services was $9.6 million and $11.6 million, respectively. As of December 31, 2023 and 2022, accounts receivable related to Motorola’s distributor services were $1.2 million and $12.5 million, respectively.
Reseller Agreement with Stanley Black & Decker
In June 2020, the Company entered into a reseller agreement with Stanley Black & Decker, an investor in the Company. Stanley Black & Decker's electronic security business was acquired by Securitas AB ("Securitas") in 2023. Securitas, directly or through its affiliates, resells the Company's products. During the years ended December 31, 2023 and 2022, revenue from Stanley Black & Decker’s reseller services was $1.7 million and $1.9 million, respectively. As of December 31, 2023 and 2022, accounts receivable related to Stanley Black & Decker’s reseller services were $0.6 million and $2.2 million, respectively.
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
Commitments and Contingencies
12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Indemnification Agreements
In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its Board of Directors and certain of its executive officers and employees that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their role, status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not currently aware of any indemnification claims and has not accrued any liabilities related to such obligations in its consolidated financial statements as of December 31, 2023 or 2022.
Legal Proceedings
The Company is not a party to any litigation of a material nature and does not have contingency reserves established for any litigation liabilities. At each reporting date, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company expenses the costs related to such legal proceedings as incurred.
In the ordinary course of business, the Company is subject to regulatory and governmental examinations, information gathering requests, inquiries, and investigations. The FTC has previously requested information about certain aspects of the Company's marketing practices. The Company is cooperating with the investigation and has provided documentation and information responsive to the FTC inquiry. We currently do not expect this investigation to have a material effect on our results of operations, financial condition or liquidity, either individually or in the aggregate.
Further, in February 2024, we received a subpoena from the SEC, Division of Enforcement, requesting that we produce certain documents and information, much of which is similar to the documents and information previously requested by the FTC. We are cooperating and intend to continue to cooperate with the SEC's investigation.
We can offer no assurances as to the outcome of these investigations or their potential effect, if any, on us or our results of operations. There can be no assurance whether there will be further information requests or potential enforcement action or litigation, which is necessarily uncertain.
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
Benefit Plans
12 Months Ended
Dec. 31, 2023
Benefit Plans  
Benefit Plans Benefit Plans
The Company established a defined contribution savings plan under Section 401(k) of the Code. This plan covers all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pre-tax basis. The Company made $0.3 million matching contributions to the plan during the year ended December 31, 2023. The Company did not make any matching contributions to the plan during the year ended December 31, 2022.
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure    
Net loss $ (106,254) $ (86,406)
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
Insider Trading Arrangements
3 Months Ended 12 Months Ended
Dec. 31, 2023
shares
Dec. 31, 2023
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Anil Chitkara [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement   On December 15, 2023, Anil Chitkara, Chief Growth Officer and Founder, adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 200,000 shares of the Company’s common stock until September 6, 2024.
Name Anil Chitkara  
Title Chief Growth Officer and Founder  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 15, 2023  
Arrangement Duration 266 days  
Aggregate Available 200,000 200,000
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Basis of presentation
Basis of presentation
The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”).
Merger
Merger
On July 16, 2021, we consummated the business combination (the “Merger”), contemplated by the Agreement and Plan of Merger, dated March 5, 2021, with NHIC Sub Inc. (“Merger Sub”), a wholly-owned subsidiary of NewHold Investment Corp. (“NHIC”), a special purpose acquisition company, which is our legal predecessor, and Evolv Technologies, Inc. dba Evolv Technology, Inc. (“Legacy Evolv”), as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 by and among NHIC, Merger Sub and Legacy Evolv (the “Amendment” and as amended, the “Merger Agreement”). Pursuant to the Merger Agreement, Merger Sub was merged with and into Legacy Evolv, with Legacy Evolv surviving the Merger as a wholly-owned subsidiary of NHIC. Upon the closing of the Merger, NHIC changed its name to Evolv Technologies Holdings, Inc. Evolv Technologies Holdings, Inc. became the successor entity to NHIC pursuant to Rule 12g-3(a) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
Reclassifications
Reclassifications
During the year ended December 31, 2023, the Company began classifying revenue from professional services, which includes installation, training, and event support, as well as other one-time revenue, within license fee and other revenue on the consolidated statements of operations and comprehensive loss, whereas the revenue for these services has previously been included in service revenue. Correspondingly, the Company began classifying costs associated with professional services within cost of license fee and other revenue, whereas these costs were previously included in cost of service revenue. These reclassifications were made to align the presentation of professional services with the Company's internal reporting and analysis. The reclassifications did not impact total revenue or total cost of revenue for any period. Prior year amounts included in this Annual Report on Form 10-K have been reclassified to conform to the current presentation.
Use of Estimates
Use of Estimates
The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to calculating the standalone selling price for revenue recognition, the valuation of inventory, the expensing and capitalization of costs associated with internal-use software, stock-based awards, the valuation of the contingent earn-out liability, the valuation of the contingently issuable common stock, and the valuation of the public warrant liability. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts, and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.
Risk of Concentrations of Credit, Significant Customers and Significant Suppliers
Risk of Concentrations of Credit, Significant Customers and Significant Suppliers
Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash equivalents, restricted cash, marketable securities, and accounts receivable, net. We maintain substantially all of our cash and cash equivalents with U.S. and multi-national financial institutions, and our deposits are generally in excess of federally insured limits. The Company maintains its cash, cash equivalents, restricted cash, and marketable securities with financial institutions that management believes to be of high credit quality. The Company has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.
Significant customers are those which represent more than 10% of the Company’s total revenue or accounts receivable, net balance at each respective balance sheet date. The following table presents customers that represent 10% or more of the Company’s total revenue for the years ended December 31, 2023 and December 31, 2022. Each customer shown is a reseller partner of the Company.
Year Ended December 31, 2023Year Ended December 31, 2022
Motorola Solutions, Inc.12.0  %20.9  %
Customer A*10.1  %
Customer B10.4  %*
22.4  %31.0  %
* Less than 10%
The following table presents customers that represent 10% or more of the Company’s accounts receivable, net. Each customer shown is a reseller partner of the Company.
December 31,
20232022
Motorola Solutions, Inc.*39.0  %
Customer B*16.0  %
55.0  %
* Less than 10%
The Company relies on one primary third-party contract manufacturer, Columbia Tech, for the production of our touchless security screening systems. Columbia Tech provides a variety of services including sourcing off-the-shelf components, manufacturing custom components/assemblies, final product assembly and integration, end of line testing and quality assurance per our specifications, material and finished goods inventory, and direct shipping to our customers. We also use a different third-party manufacturer as a second source for the production of a key sensor component used in our systems. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers to satisfactorily deliver its products to its customers on time, if at all, which could have a material adverse effect on the Company’s operating results, financial condition and cash flows and damage its customer relationships.
Cash, Cash Equivalents, and Restricted Cash
Cash, Cash Equivalents, and Restricted Cash
The Company considers all short-term, highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Restricted cash relates to a letter of credit on the Company’s office lease in Waltham, Massachusetts, all of which is included in restricted cash, current on the consolidated balance sheet as of December 31, 2023. As the letter of credit is reduced, restricted cash is reclassified to cash and cash equivalents.
Marketable Securities
Marketable Securities
Marketable securities are reported at fair value and, at December 31, 2023, are comprised solely of zero coupon U.S. treasury bills with maturities of less than one year that are classified as available-for-sale debt securities. The Company considers an available-for-sale debt security to be impaired if the fair value of the investment is less than its amortized cost basis. The entire difference between the amortized cost basis and the fair value of the Company’s available-for-sale debt securities is recognized on the consolidated statements of operations as an impairment if, (i) the fair value of the security is below its amortized cost and (ii) the Company intends to sell or is more likely than not required to sell the security before recovery of its amortized cost basis. If neither criterion is met, the Company evaluates whether the decline in fair value is due to credit losses or other factors. In making this assessment, the Company considers the changes to the rating of the security by third-party rating agencies, and adverse conditions specific to the security, among other factors. If the Company’s assessment indicates that a credit loss exists, the credit loss is measured based on the Company’s best estimate of the cash flows expected to be collected. When developing its estimate of cash flows expected to be collected, the Company considers all available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable forecasts.
Unrealized gains and losses, net of tax, on marketable securities, if any, are recognized in accumulated other comprehensive income (loss) in the accompanying consolidated balance sheets. Realized net gains and losses on marketable securities, if any, are reflected in interest income in the accompanying consolidated statements of operations and comprehensive loss.
Fair Value Measurements of Financial Instruments
Fair Value Measurements of Financial Instruments
Certain assets and liabilities of the Company are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement
date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:
Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.
Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.
The Company’s cash equivalents, restricted cash, marketable securities, derivative liability, contingent earn-out liability, contingently issuable common stock liability and its common stock warrant liability are carried at fair value, determined according to the fair value hierarchy described above (see Note 4). The carrying values of the Company’s accounts receivable, net, accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities. The carrying value of the Company’s long-term debt approximates its fair value (a Level 2 measurement) at each balance sheet date due to its variable interest rate, which approximates a market interest rate.
Assets that are measured at fair value on a nonrecurring basis primarily relate to property and equipment. We do not periodically adjust carrying value to fair value for property and equipment. Rather, the carrying value of the asset is reduced to its fair value when we determine that impairment has occurred.
Contingent Earn-out
Contingent Earn-out
In connection with the Merger and pursuant to the Merger Agreement, certain of the Legacy Evolv’s shareholders and Legacy Evolv Service Providers are entitled to receive additional shares of the Company’s common stock (the “Earn-Out Shares”) upon the Company achieving certain milestones:
Triggering Event I – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $12.50 per share for any 20 trading days within any 30 trading day period.
Triggering Event II – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $15.00 per share for any 20 trading days within any 30 trading day period.
Triggering Event III – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $17.50 per share for any 20 trading days within any 30 trading day period.
In accordance with ASC 815 – Derivatives and Hedging, the earn-out arrangement with the Legacy Evolv shareholders is accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as a change in fair value of contingent earn-out liability in other income (expense), net in the consolidated statements of operations and comprehensive loss. When the Triggering Events have been achieved and the Earn-Out Shares are issued, the Company will reclassify the corresponding amount from a liability to additional paid-in-capital and common stock at par value of $0.0001 per share.
The estimated fair value of the contingent earn-out shares was determined using a Monte Carlo simulation that simulated the future path of the Company’s stock price over the earn-out period. The significant assumptions utilized in the calculation are based on the achievement of certain stock price milestones including projected stock price, volatility, drift rate, percentage of change in control and expected term.
The contingent earn-out liability is categorized as a Level 3 fair value measurement (see Note 4) because the Company estimates projections during the earn-out period utilizing unobservable inputs, including various potential pay-out scenarios. Contingent earn-out payments involve certain assumptions requiring significant judgment and actual results may differ from assumed and estimated amounts.
The Earn-Out Shares issued to employees, officers, directors, and non-employees are based on achievement of certain target share price contingencies and for the employees and officers, subject to continued employment, (the “Earn-Out Service Providers”) represents share-based compensation and is included in additional paid-in capital on the Company’s balance sheet. Corresponding stock-based compensation expense is recorded in the consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. As a condition to being issued Earn-Out Shares, the Earn-Out Service Providers must still be providing services to the Company on the date of the issuance of the shares. If the relationship with the service provider is terminated prior to the issuance of the Earn-Out Shares, the shares will be redistributed to the remaining participants in the Earn-Out Shares.
Contingently Issuable Common Stock
Contingently Issuable Common Stock
Prior to the Merger, NewHold Industrial Technology Holdings, LLC, the sponsor of the NHIC special purpose acquisition company owned 4,312,500 shares of NHIC Class B common stock (the “Founder Shares). Upon the closing of the Merger, NHIC Class A and Class B common stock became the Company’s common stock. The Founder Shares outstanding were subject to certain share-performance-based vesting provisions as follows:
Vesting Provision I – 1,897,500 shares of the Company’s common stock shall vest and no longer be subject to forfeiture as of the Merger;
Vesting Provision II – if within five years following the closing of the Merger, the last reported sale price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period, then 948,750 shares of the Company’s common stock shall vest and no longer be subject to forfeiture and
Vesting Provision III – if within five years following the closing of the Merger, the last reported sale price of the Company’s common stock equals or exceeds $15.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period, then 948,750 shares of the Company’s common stock) shall vest and no longer be subject to forfeiture.
The remaining 517,500 Founder Shares were contributed to Give Evolv LLC.
If Vesting Provision II and/or Vesting Provision III are not satisfied, the corresponding number of shares specified shall be forfeited and no longer issued and outstanding. If there is a Change of Control event prior to Vesting Provision II and/or Vesting Provision III are satisfied, the Founder shares are no longer subject to forfeiture and shall vest immediately upon the occurrence of a Change of Control event.
In accordance with ASC 815 – Derivatives and Hedging, the contingently issuable common stock is accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as change in fair value of contingently issuable common stock liability in other income (expense), net in the consolidated statements of operations and comprehensive loss. When the Vesting Provisions have been achieved and the contingently issuable common shares are issued, the Company will reclassify the corresponding amount from a liability to additional paid-in-capital and common stock at par value of $0.0001 per share.
The estimated fair value of the contingently issuable common shares was determined using a Monte Carlo simulation that simulated the future path of the Company’s stock price over the earn-out period. The assumptions utilized in the calculation are based on the achievement of certain stock price milestones including expected stock price volatility, risk-free rate of return, likelihood of change in control, and remaining term.
The contingently issuable common shares are categorized as a Level 3 fair value measurement (see Note 4) because the Company estimates projections during the earn-out period utilizing unobservable inputs, including various potential pay-out scenarios. Contingently issuable shares involve certain assumptions requiring significant judgment and actual results may differ from assumed and estimated amounts.
Public Warrant Liability
Public Warrant Liability
In connection with the closing of the Merger, the Company assumed warrants for the purchase of 14,325,000 shares of common stock at an exercise price of $11.50 (the “Public Warrants”). The Public Warrants are classified as a liability pursuant to ASC 815 – Derivatives and Hedging as the equity derivative scope exception was not met and are measured at fair value, with the changes in fair value reported in earnings as a component of other income (expense), net in the consolidated statements of operations and comprehensive loss with the offset to additional paid in capital.
Leases as a Lessee
Leases as a Lessee
The Company accounts for leases in accordance with ASC 842, Leases. At contract inception, the Company determines if an arrangement is or contains a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If determined to be or contain a lease, the lease is assessed for classification as either an operating or finance lease at the lease commencement date, defined as the date on which the leased asset is made available for use by the Company (when the Company is the lessee). Where the Company is the lessee, for each lease with a term greater than twelve months, the Company records a right-of-use asset and lease liability.
A right-of-use asset represents the economic benefit conveyed to the Company by the right to use the underlying asset over the lease term. A lease liability represents the obligation to make lease payments arising from the use of the asset over the lease term. Lease liabilities are measured at lease commencement and calculated as the present value of the future lease payments in the contract using the rate implicit in the contract, when available. If an implicit rate is not readily determinable, the Company uses an incremental borrowing rate measured as the rate at which the Company could borrow, on a fully collateralized basis, a commensurate loan in the same currency over a period consistent with the lease term at the commencement date. Right-of-use assets are measured as the amount of the initial lease liability plus initial direct costs and prepaid lease payments, less lease incentives granted by the lessor. The lease term is measured as the noncancelable period in the contract, adjusted for any options to extend or terminate when it is reasonably certain the Company will extend the lease term via such options based on an assessment of economic factors present as of the lease commencement date. The Company elected the practical expedient to not recognize leases with a lease term of twelve months or less.
Components of a lease are split into three categories: lease components, non-lease components, and non-components. The fixed and in-substance fixed contract consideration (including any consideration related to non-components) are allocated, based on the respective relative fair values, to the lease components and non-lease components. The Company has elected the practical expedient to account for lease and non-lease components together as a single lease component for all underlying assets and allocate all of the contract consideration to the lease component only.
The Company’s operating leases are presented in the consolidated balance sheet as operating lease right-of-use assets, classified as noncurrent assets, and operating lease liabilities, classified as current and noncurrent liabilities. Operating lease expense is recognized on a straight-line basis over the lease term. Variable costs associated with a lease, such as maintenance and utilities, are not included in the measurement of the lease liabilities and right-of-use assets but rather are expensed when the events determining the amount of variable consideration to be paid have occurred.
Inventory
Inventory
Inventory is stated at the lower of cost or net realizable value with cost being determined using the weighted average method. The Company regularly reviews inventory quantities on-hand for excess and obsolete inventory and, when circumstances indicate, records charges to write down inventories to their estimated net realizable value, after evaluating historical sales, future demand, market conditions and expected product life cycles. Such charges are classified as product cost of revenues in the consolidated statement of operations and comprehensive loss. Any write-down of inventory to net realizable value creates a new cost basis. The Company recorded $1.6 million and $1.6 million in inventory write-offs and change in inventory reserves during the years ended December 31, 2023 and 2022, respectively. Inventory write-offs primarily relate to Edge units and prior generation Express units, as the Company is no longer selling these products, as well as other inventory that was determined to be obsolete or unsellable.
Property and Equipment
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expense are recognized using the straight-line method over the estimated useful life of each asset, as follows:
Estimated Useful Life
Computers and telecommunications equipment3 years
Lab equipment5 years
Software4 years
Furniture and fixtures5 years
Leasehold improvements
Shorter of useful life of 7 years or remaining lease term

Leased equipment
4-7 years
Internal-use software4 years
Estimated useful lives are periodically assessed to determine if changes are appropriate. Leasehold improvements are depreciated using the straight-line method over the lesser of the lease term or its estimated economic useful life. Lease terms are used based upon the initial lease agreement and do not consider potential renewals or extensions until such time that the renewals or extensions are contracted. Maintenance and repairs are charged to expense as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation are eliminated from the consolidated balance sheet and any resulting gains or losses are included in the consolidated statements of operations and comprehensive loss in the period of disposal. Costs for capital assets not yet placed into service are capitalized as construction-in-progress and depreciated once placed into service.
The Company’s leases for leased equipment generally are 48 months. The Company’s subscription contracts are generally classified as operating leases because title does not transfer and they do not meet any of the other criteria per Accounting Standards Codification 842 – Leases (“ASC 842”).
The Company evaluates property and equipment for obsolescence and impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset group for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset group to its carrying value. An impairment loss would be recognized in loss from operations and comprehensive loss when estimated undiscounted future cash flows expected to result from the use of an asset group are less than its carrying amount. The impairment loss is based on the excess of the carrying value of the impaired asset group over its fair value, determined based on discounted cash flows. The Company recorded impairment losses of $0.3 million and $1.2 million during the years ended December 31, 2023 and 2022, respectively. These impairment losses related primarily to Edge and Express prototype units that were taken out of service and retired.
The Company capitalizes certain software development costs, including consulting costs and compensation expenses for employees who devote time to the development projects, beginning upon completion of the preliminary project stage (in relation to internal-use software) or upon establishment of technological feasibility (in relation to software embedded in products to be sold or leased), and through the date the software is ready for its intended use. The Company records software development costs in property and equipment, net. Costs incurred in the preliminary stages of development activities and post implementation are expensed in the period incurred and are recorded in research and development expense in the consolidated statements of operations and comprehensive loss. The Company also capitalizes
costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality.
Once the project is available for general release, capitalization ceases, and the asset can begin amortization. Capitalized software costs are amortized on a straight-line basis over their estimated useful life, which is generally four years, and are recorded in cost of subscription revenue and cost of service revenue in the consolidated statements of operations and comprehensive loss.
Debt Issuance Costs
Debt Issuance Costs
The Company capitalizes certain legal, accounting, and other third-party fees that are directly associated with the issuance of debt as debt issuance costs. Debt issuance costs are recorded as a direct reduction of the carrying amount of the associated debt on the consolidated balance sheet and amortized as interest expense on the consolidated statement of operations and comprehensive loss using the effective interest method.
Segment Information
Segment Information
The Company determined that it has one operating segment after considering the Company’s organizational structure and the information regularly reviewed and evaluated by the Company’s chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. The Company has determined that its CODM is its President and Chief Executive Officer. The CODM reviews the financial information on a consolidated basis for purposes of evaluating financial performance and allocating resources. On the basis of these factors, the Company determined that it operates and manages its business as one operating segment, that develops, manufactures, markets and sells security screening products and specific services, and accordingly has one reportable segment for financial reporting purposes.
Revenue Recognition
Revenue Recognition
The Company recognizes revenue in accordance with Accounting Standards Codification 606 – Revenue from Contracts with Customers (“ASC 606”). Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In order to achieve this core principle, the Company applies the following five steps when recording revenue: (1) identify the contract, or contracts, with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when, or as, performance obligations are satisfied.
We derive revenue from (1) subscription arrangements generally accounted for as operating leases, including SaaS and maintenance, (2) the sale of products, (3) SaaS and maintenance related to products sold to customers either by Evolv or by Columbia Tech pursuant to the Distribution and License Agreement (as defined below), (4) license fees related to the Distribution and License Agreement (as defined below), and (5) professional services, including installation, training, and event support. Maintenance consists of preventative maintenance, technical support, bug fixes, and when-and-if available threat updates. Our arrangements are generally noncancelable and nonrefundable after ownership passes to the customer. Revenue is recognized net of sales tax.
Distribution and License Agreement
In March 2023, the Company entered into a distributor licensing agreement (the "Distribution and License Agreement") with Columbia Electrical Contractors, Inc. ("Columbia Tech"). Columbia Tech, a wholly-owned subsidiary of Coghlin Companies, which serves as the Company's primary contract manufacturer. Under this arrangement, the Company has granted a license of its intellectual property to Columbia Tech, which contracts directly with certain of the Company's resellers to fulfill sales demand where the end-user customer prefers to purchase the hardware equipment as opposed to lease the equipment. Columbia Tech pays the Company a hardware license fee for each system it manufactures and sells under the agreement. In these instances, the Company still contracts directly with the reseller to provide a multi-year SaaS and maintenance subscription to the end-users.
The Company has assessed whether it operates as the principal or as an agent in relation to the sale of product made by Columbia Tech to the Company's resellers pursuant to the Distribution and License Agreement. The Company considered various factors, including but not limited to, inventory risk, discretion in establishing pricing, and which entity is primarily responsible for fulfillment. Based on an evaluation of the facts and circumstances, the Company concluded that Columbia Tech is the principal in the arrangement. The Company therefore does not recognize revenue in relation to sales of product pursuant to the Distribution and License Agreement, but does recognize revenue in relation to license fees received from Columbia Tech and the SaaS and maintenance subscription contracts, each as further described below.
Product Revenue
The Company derives revenue from the sale of its Evolv Express equipment and related add-on accessories to customers. Revenue is recognized when control of the product has transferred to the customer. Transfer of control occurs when the Company has transferred title and risk of loss and has a present right to payment for the equipment, which follows the terms of each customer contract. Products are predominantly sold with distinct services, which are described in the services section below.
Subscription Revenue - Leases as Lessor
In addition to selling our products directly to customers, we also derive revenue from leasing our equipment, which we classify as subscription revenue. Lease terms are typically four years, generally do not include unilateral options by either the Company or our customer to extend, terminate or to purchase the underlying asset, and customers generally pay either a quarterly or annual fixed payment for the lease, SaaS, and maintenance elements over the contractual lease term. There are no variable lease payments as a part of these arrangements.
The accounting provisions we use to classify transactions as sales-type are: (i) whether the lease transfers ownership of the equipment by the end of the lease term, (ii) whether the lease grants the customer an option to purchase the equipment and the customer is reasonably certain to do so, (iii) whether the lease term is for the major part of the economic life of the underlying equipment, (iv) whether the present value of the lease payments, and any residual value guaranteed by the customer that is not already reflected in the lease payments, is equal to or greater than substantially all of the fair market value of the equipment at the commencement of the lease, and (v) whether the equipment is specific to the customer and of such a specialized nature that it is expected to have no alternative use to the Company at the end of the lease term. Leasing arrangements meeting any of these conditions are accounted for as sales-type leases and revenue attributable to the lease component is recognized in a manner consistent with product revenue and the related equipment is derecognized with the associated expense presented as a cost of revenue. Leasing arrangements that do not meet the criteria for classification as a sales-type lease will be accounted for as a direct-financing lease if the following two conditions are met: (i) the present value of the lease payments, and any residual value guaranteed by the customer that is not already reflected in the lease payments and any other third party unrelated to the Company, is equal to or greater than substantially all of the fair market value of the equipment at the commencement of the lease, and (ii) it is probable that the Company will collect the lease payments and amounts necessary to satisfy a residual value guarantee. Leasing arrangements that do not meet any of the sales-type lease or direct-financing lease classification criteria are accounted for as operating leases and revenue is recognized straight-line over the term of the lease. Historically, nearly all of the Company's equipment leases have been classified as operating leases.
The Company considers the economic life of most of our products to be seven years. The Company believes seven years is representative of the period during which the equipment is expected to be economically usable by one or more users, with normal service, for the purpose for which it is intended. The unguaranteed residual value is estimated to be the value at the end of the lease term based on the anticipated fair market value of the units. The Company mitigates residual value risk of our leased equipment by performing regular management and maintenance, as necessary.
Generally, lease arrangements include both lease and non-lease components. The lease component relates to the customer’s right-to-use the equipment over the lease term. The non-lease components relate to (1) distinct services, such as SaaS and maintenance, (2) any add-on accessories, and (3) professional services, including installation, training, and event. Professional services are included in license fees and other revenue, as described below, and add-on accessories are included in product revenue. Because the equipment, SaaS, and maintenance components of a subscription arrangement are recognized as revenue over the same time period and in the same pattern, the Company elected the practical expedient to aggregate non-lease components with the associated lease component and account for the combined component as an
operating lease for all underlying asset classes. In the evaluation of whether the lease component (equipment) or the non-lease components associated with the lease component (SaaS and maintenance) is the predominant component, the Company determined that the lease component is predominant as we believe the customer would ascribe more value to the use of the security equipment than that of the SaaS and maintenance services. Therefore, the Company accounts for the combined lease component under ASC 842. The equipment lease and SaaS/maintenance performance obligations are classified as a single category of subscription revenue in the consolidated statements of operations and comprehensive loss. The professional services represent distinct services provided to customers. These activities are considered separate performance obligations to the customer and therefore are considered non-lease components. As professional services are generally performed prior to lease commencement, the timing and pattern of transfer for these services differ from that of the lease component and are not eligible to be combined.
We exclude from variable payments all lessor costs that are explicitly required to be paid directly by a lessee on behalf of the lessor to a third party.
Professional services are generally billed to the lessee as part of the lease contract billing, according to various contractual terms. Professional services costs incurred by the Company are accounted for as a fulfillment cost and are included in the cost of license fees and other revenue in the consolidated statements of operations and comprehensive loss.
Service Revenue
Service revenue consists of subscription-based SaaS and maintenance revenue related to products sold to a customer by either the Company or by Columbia Tech pursuant to the Distribution and License Agreement. Customers generally pay either a quarterly or annual fixed payment for SaaS and maintenance. SaaS and maintenance revenue is recognized ratably over the period of the arrangement, which is typically 4 years.
License Fee and Other Revenue
License fee and other revenue includes license fee revenue from the Distribution and License Agreement, revenue from professional services, and other one-time revenue. License fee revenue is recognized upon the shipment of product from our third-party manufacturer to the reseller. Revenue for professional services is recognized upon transfer of control of these services, which are normally rendered over a short duration.
Revenue from Reseller Partners
A portion of the Company’s revenue is also generated by sales to its reseller partners. When the Company transacts with a reseller partner, its contractual arrangement is with the reseller partner and not with the end-use customer. In these transactions, the reseller partner is considered the customer; the Company has discretion over the pricing to the reseller partner and maintains overall control of the inventory and sales process to the reseller partner. Right of return does not generally exist. Whether the Company transacts with a reseller partner and receives the order from a reseller partner or directly from an end-use customer, its revenue recognition policy and resulting pattern of revenue recognition is the same.
Transaction Price
The transaction price is the amount of consideration that the Company expects to be entitled for providing goods and services under a contract, which includes fixed amounts, and on rare occasions, variable consideration. The Company may also provide discounts to customers which reduce the transaction price. On infrequent occasions, the Company may offer customers the option to purchase additional goods and services at a fixed price. In these circumstances, the Company assesses whether these offers constitute a material right, and if so, the Company would account for the material right as a separate performance obligation. The Company does not normally provide for rights of returns to customers on product sales and, therefore, does not record a provision for returns. Amounts paid or payable to customers, including those related to sponsorship arrangements, are recognized as a reduction of the transaction price, and therefore, of revenue unless the payment is in exchange for a distinct good or service.
Performance Obligations
A performance obligation is a promise in a contract to transfer a distinct product or service to a customer that is both capable of being distinct, whereby the customer can benefit from the product or service either on its own or together with other resources that are readily available, and is distinct in the context of the contract, whereby the transfer of the product or service is separately identifiable from other promises in the contract.
Equipment is sold or leased with embedded software, which is considered a single performance obligation. Maintenance, which includes preventative maintenance, future updates, security threat updates, and minor bug fixes on a when-and-if available basis, is considered a single performance obligation. SaaS, which includes data-driven security information and analytics insights, is also considered a performance obligation. Professional services, including installation, training, and event support, are considered separate performance obligations and are included within license fee and other revenue. Any add-on accessories are also considered separate performance obligations and are included in product revenue.
Payment terms
Payment terms for customer orders are typically 30 days after the shipment or installation of the product. Generally, the Company’s contracts do not contain a significant financing component.
Multiple Performance Obligations within an Arrangement
The Company’s contracts may include multiple performance obligations when customers purchase a combination of products and services. When the Company’s customer arrangements have multiple performance obligations that contain an equipment lease for the customer’s use as well as distinct services that are delivered simultaneously, the Company allocates the arrangement consideration between the lease deliverables and non-lease deliverables based on the relative estimated SSP of each distinct performance obligation. For multiple performance obligation arrangements that do not contain a lease, the Company allocates the contract’s transaction price to each performance obligation on a relative SSP basis. The Company determines SSP based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, the Company estimates the SSP taking into account available information such as market conditions, internally approved pricing guidelines, and observable pricing data such as standard cost metrics related to the performance obligation.
Stock-Based Compensation
Stock-Based Compensation
The Company measures all stock-based awards granted to employees, officers, directors and non-employees based on their fair value on the date of the grant and recognizes compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. The vesting period for stock options is generally four years and the vesting period for restricted stock units is generally three years. The Company classifies stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. The Company issues stock-based awards with service-based vesting conditions and records the expense for these awards using the straight-line method. Forfeitures are accounted for as they occur.
In January 2021, the Company granted warrants (the "Finback Common Stock Warrants") exercisable for 2,552,913 shares of common stock at an exercise price of $0.42 per share to Finback Evolv OBH, LLC ("Finback"), a consulting group affiliated with one of the Company's shareholders. The Finback Common Stock Warrants vest upon meeting certain sales criteria as defined in a business development agreement (the "Finback BDA") which has a term of three years. The Finback Common Stock Warrants expire in January 2031. The Finback Common Stock Warrants are accounted for under ASC 718 Compensation - Stock Compensation as the warrants vest upon certain performance conditions being met.
Prior to the closing of the Merger, there was not a public market for the shares of the Company’s common stock. The Company’s determination of the fair value of stock options on the date of grant utilized the Black-Scholes option-pricing model and was impacted by its common stock price, as determined by the Board of Directors with input from the Company’s management, as well as changes in assumptions regarding a number of subjective variables. These variables
included, but were not limited to, the expected term that options remained outstanding, the expected common stock price volatility over the term of the option awards, risk-free interest rates, and expected dividends. The Company valued its common stock taking into consideration its most recently available valuation of common stock performed by third parties as well as additional factors since the date of the most recent contemporaneous valuation through the date of grant. After the closing of the Merger, the Company determines the fair value of each share of common stock underlying stock-based awards based on the closing price of the Company’s common stock as reported by Nasdaq on the date of grant.
Pursuant to the Merger Agreement, the Company will issue 15,000,000 earn-out shares of the Company’s common stock to Legacy Evolv shareholders and Legacy Evolv Service Providers including employees, officers, directors, and non-employees based on the achievement of certain target share price contingencies and subject to continued employment. The company classifies the share-based compensation arrangement with Legacy Evolv Service Providers as equity on its balance sheet and corresponding stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. As of December 31, 2023, of the total 15,000,000 earn-out shares of the Company’s common stock, 2,115,304 earn-out shares can be earned by the Legacy Evolv Service Providers and are subject to the stock-based compensation guidance. As a condition for Earn-Out Shares being issued to Earn-Out Service Providers, the service provider must be providing services to the Company on the date of the issuance of the shares. If the relationship with the service provider is terminated prior to the issuance of the Earn-Out Shares, the shares will be redistributed to the remaining participants in the Earn-Out Shares.
Income Taxes
Income Taxes
The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company’s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes.
The Company assesses the likelihood that its deferred tax assets will be recovered from future sources of income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. The potential for recovery of deferred tax assets is evaluated by analyzing past operating results, estimating the future taxable profits expected and considering prudent and feasible tax planning strategies.
The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.
The Company evaluates at the end of each reporting period whether some or all the undistributed earnings of its foreign subsidiaries are permanently reinvested. The Company would recognize deferred income tax liabilities to the extent that management asserts that undistributed earnings of its foreign subsidiaries are not permanently reinvested and will not be permanently reinvested in the future. For the year ended December 31, 2023, the Company had less than $0.1 million in foreign earnings. For the year ended December 31, 2022, the Company had no foreign earnings in any foreign jurisdictions. The Company will continue to evaluate its position in the future based on its future strategy and cash needs.
Net Loss per Share Attributable to Common Stockholders
Net Loss per Share Attributable to Common Stockholders
Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net loss attributable to common stockholders is computed by adjusting net loss attributable to common stockholders for the impact
to the extent a denominator adjustment is required. Diluted net loss per share attributable to common stockholders is computed by dividing the diluted net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period, including the dilutive effect of potential dilutive common shares as determined under the treasury stock method. For purposes of this calculation, outstanding stock options, convertible preferred stock, convertible notes, warrants to purchase common stock, and warrants to purchase preferred stock are considered potential dilutive common shares.
In periods in which the Company reported a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December 31, 2023 and 2022.
Recently Issued Accounting Pronouncements
Recently Adopted Accounting Pronouncements
Becoming a Large Accelerated Filer
Prior to December 31, 2023, the Company qualified as an "emerging growth company", as defined in the Jumpstart our Business Startups Act of 2012, and elected not to “opt out” of the extended transition related to complying with new or revised accounting standards.
The Company became a large accelerated filer and ceased to qualify as an emerging growth company as of December 31, 2023. The adoption dates discussed below for recently adopted accounting pronouncements reflect the updated transition periods required as a result of becoming a "large accelerated filer" (as defined under Rule 12b-2 of the Exchange Act) as of December 31, 2023. The Company will be required to adopt all future new or revised accounting pronouncements in accordance with applicable public company timelines specified in those accounting pronouncements.
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326) (“ASU 2016-13”). The new standard adjusts the accounting for assets held at amortized cost basis, including marketable securities accounted for as available for sale, and trade receivables. The standard eliminates the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For public entities except smaller reporting companies, the guidance is effective for annual reporting periods beginning after December 15, 2019 and for interim periods within those fiscal years. In November 2019, the FASB issued ASU No. 2019-10, which deferred the effective date for non-public entities and smaller reporting companies to annual reporting periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is allowed. The Company adopted this guidance effective January 1, 2023, and the adoption of this guidance did not have a material impact on its consolidated financial statements and related disclosures.
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The amendments in ASU 2021-08 are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption of the amendments is permitted, including adoption in an interim period. The Company adopted this guidance effective January 1, 2023, and the adoption of this guidance did not have an impact on its consolidated financial statements and related disclosures.
Recently Issued Accounting Pronouncements
In July 2023, the FASB issued Accounting Standards Update ASU 2023-03, “Presentation of Financial Statement (Topic 205), Income Statement - Reporting Comprehensive Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation - Stock Compensation (Topic 718),” to amend various U.S. Securities Exchange Commission ("SEC") paragraphs in the Accounting Standards Codification to reflect the issuance of SEC Staff Accounting Bulletin No. 120, among other things. The ASU does not provide any new guidance so there is no transition or
effective date associated with it. The Company is currently assessing the impact of adopting ASU 2023-03 on the consolidated financial statements and related disclosures.
In October 2023, the FASB issued ASU 2023-06, “Disclosure Improvements – Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative,” related to disclosure or presentation requirements for various subtopics in the FASB’s Accounting Standards Codification (“Codification”). The amendments in the update are intended to align the requirements in the Codification with the SEC regulations and facilitate the application of GAAP for all entities. The effective date for each amendment is the date on which the SEC removal of the related disclosure requirement from Regulation S-X or Regulation S-K becomes effective, or if the SEC has not removed the requirements by June 30, 2027, this amendment will be removed from the Codification and will not become effective for any entity. Early adoption is prohibited. The Company does not expect this update to have a material impact on the consolidated financial statements and related disclosures.
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The updated accounting guidance requires enhanced reportable segment disclosures, primarily related to significant segment expenses which are regularly provided to the chief operating decision maker. The guidance is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required and early adoption is permitted. The Company is currently evaluating the impact of this standard on the disclosures within the consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." ASU 2023-09 is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. A public entity should apply the amendments in ASU 2023-09 prospectively to all annual periods beginning after December 15, 2024. The Company is currently evaluating the impact of this standard on the disclosures within the consolidated financial statements.
Income Tax Uncertainties
The Company accounts for income tax uncertainties in accordance with ASC 740 Income Taxes, which prescribes a recognition threshold and measurement criteria for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Benefits from tax positions should be recognized in the financial statements only when it is more likely than not that the tax position will be sustained upon examination by the appropriate taxing authority that would have full knowledge of all relevant information. A tax position that meets the more likely than not recognition threshold is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Tax positions that previously failed to meet the more likely than not recognition threshold should be recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more likely than not recognition threshold should be derecognized in the first subsequent
financial reporting period in which that threshold is no longer met. ASC 740 also provides guidance on the accounting for and disclosure of liabilities for uncertain tax positions, interest and penalties. The Company’s policy is to record interest and penalties related to income taxes as part of its income tax provision.
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of customers that represent 10% or more of the Company's total revenue and accounts receivable
Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash equivalents, restricted cash, marketable securities, and accounts receivable, net. We maintain substantially all of our cash and cash equivalents with U.S. and multi-national financial institutions, and our deposits are generally in excess of federally insured limits. The Company maintains its cash, cash equivalents, restricted cash, and marketable securities with financial institutions that management believes to be of high credit quality. The Company has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.
Significant customers are those which represent more than 10% of the Company’s total revenue or accounts receivable, net balance at each respective balance sheet date. The following table presents customers that represent 10% or more of the Company’s total revenue for the years ended December 31, 2023 and December 31, 2022. Each customer shown is a reseller partner of the Company.
Year Ended December 31, 2023Year Ended December 31, 2022
Motorola Solutions, Inc.12.0  %20.9  %
Customer A*10.1  %
Customer B10.4  %*
22.4  %31.0  %
* Less than 10%
The following table presents customers that represent 10% or more of the Company’s accounts receivable, net. Each customer shown is a reseller partner of the Company.
December 31,
20232022
Motorola Solutions, Inc.*39.0  %
Customer B*16.0  %
55.0  %
* Less than 10%
Schedule of estimated useful life of property and equipment Depreciation and amortization expense are recognized using the straight-line method over the estimated useful life of each asset, as follows:
Estimated Useful Life
Computers and telecommunications equipment3 years
Lab equipment5 years
Software4 years
Furniture and fixtures5 years
Leasehold improvements
Shorter of useful life of 7 years or remaining lease term

Leased equipment
4-7 years
Internal-use software4 years
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Marketable Securities (Tables)
12 Months Ended
Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities
Marketable securities as of December 31, 2023 consisted of the following:
December 31, 2023
Amortized CostUnrealized Gain/(Loss)Fair Value
U.S. Treasury bills$51,289 $— $51,289 
Total marketable securities$51,289 $— $51,289 
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities measured at fair value on a recurring basis
The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):
Fair Value Measurements at December 31, 2023
Level 1Level 2Level 3Total
Assets:
Money market funds$57,829 $— $— $57,829 
Treasury bills— 51,289 — 51,289 
$57,829 $51,289 $— $109,118 
Liabilities:
Contingent earn-out liability$— $— $29,119 $29,119 
Contingently issuable common stock liability— — 6,530 6,530 
Public Warrant liability10,889 — — 10,889 
$10,889 $— $35,649 $46,538 
Fair Value Measurements at December 31, 2022
Level 1Level 2Level 3Total
Assets:
Money market funds$149,971 $— $— $149,971 
$149,971 $— $— $149,971 
Liabilities:
Long-term debt including current portion$— $29,683 $— $29,683 
Contingent earn-out liability— — 14,218 14,218 
Contingently issuable common stock liability— — 3,392 3,392 
Public Warrant liability6,124 — — 6,124 
$6,124 $29,683 $17,610 $53,417 
Schedule of common stock warrant liability
The following table provides a rollforward of the contingent earn-out liability (in thousands):
Balance at December 31, 2021$21,206 
Change in fair value(6,988)
Balance at December 31, 2022$14,218 
Change in fair value14,901 
Balance at December 31, 2023$29,119 
The following table provides a rollforward of the contingently issuable common shares (in thousands):
Balance at December 31, 2021$5,264 
Change in fair value(1,872)
Balance at December 31, 2022$3,392 
Change in fair value3,138 
Balance at December 31, 2023$6,530 
The following table provides a rollforward of the public warrant liability (in thousands):
Balance at December 31, 2021$11,030 
Change in fair value(4,906)
Balance at December 31, 2022$6,124 
Change in fair value4,765 
Balance at December 31, 2023$10,889 
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue Recognition (Tables)
12 Months Ended
Dec. 31, 2023
Revenue Recognition and Deferred Revenue [Abstract]  
Schedule of performance obligations
The following table includes estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially satisfied) as of December 31, 2023.

Less than 1 year1 - 2 yearsMore than 2 yearsTotal
Product revenue$997 $— $— $997 
Subscription revenue56,819 52,188 63,265 172,272 
Service revenue21,255 20,948 24,898 67,101 
License fee and other revenue143 — — 143 
Total revenue$79,214 $73,136 $88,163 $240,513 
Schedule of minimum future payments on noncancelable leases
The amount of minimum future leases is based on expected income recognition. As of December 31, 2023, future minimum payments on noncancelable leases are as follows (in thousands):

Year Ending December 31:
2024$56,819 
202552,188 
202641,088 
202721,118 
Thereafter1,059 
$172,272 
Summary of rollforward of deferred revenue
The following table provides a rollforward of deferred revenue (in thousands):
Balance at December 31, 2021$9,074 
Revenue recognized in relation to the beginning of the year contract liability balance(6,632)
Revenue deferred33,526 
Balance at December 31, 2022$35,968 
Revenue recognized in relation to the beginning of the year contract liability balance(19,104)
Revenue deferred54,626 
Balance at December 31, 2023$71,490 
Schedule of components of lease revenue
The following table presents the Company’s components of lease revenue (in thousands):
Twelve Months Ended
December 31,
20232022
Revenue from sales-type leases$— $1,123 
Interest income on lease receivables197 224 
Lease income - operating leases37,247 17,569 
Total lease revenue$37,444 $18,916 
Summary of company's revenue by revenue stream
The following table presents the Company’s revenue by revenue stream (in thousands). Certain prior period amounts have been reclassified to conform to current period presentation:

Twelve Months Ended
December 31,
20232022
Product revenue$21,977 $31,985 
Leased equipment37,247 17,569 
Service revenue16,141 4,331 
License fees2,963 — 
Professional services and other revenue2,090 1,310 
Total revenue$80,418 $55,195 
Revenue from External Customers by Geographic Areas
The following table presents the Company's revenue by geographical region based on customer location (in thousands):

Twelve Months Ended
December 31,
20232022
United States$78,556 $53,815 
Foreign1,862 1,380 
Total revenue$80,418 $55,195 
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases (Tables)
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Schedule of weighted-average remaining lease term and discount rate
The weighted-average remaining lease term and discount rate were as follows:

December 31,
20232022
Weighted average remaining lease term0.8 years1.8 years
Weighted average discount rate7.75 %6.95 %
Schedule of future annual lease payments
Future annual lease payments under non-cancelable operating leases as of December 31, 2023 were as follows (in thousands):

Year Ended December 31:
2024$1,432 
2025— 
Total future lease payments1,432 
Less: imputed interest(41)
Present value of operating lease liability $1,391 
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
Accounts Receivable (Tables)
12 Months Ended
Dec. 31, 2023
Receivables [Abstract]  
Summary of changes in allowance for expected credit losses
Changes in the allowance for expected credit losses were as follows (in thousands):
Allowance for Expected Credit Losses
December 31, 2021$(50)
Provisions(150)
Write-offs, net of recoveries
December 31, 2022$(200)
Provisions(410)
Write-offs, net of recoveries28
December 31, 2023$(582)
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
Inventory (Tables)
12 Months Ended
Dec. 31, 2023
Inventory Disclosure [Abstract]  
Summary of inventory
Inventory consisted of the following (in thousands):
December 31,
20232022
Raw materials$1,869 $2,334 
Finished goods7,638 7,923 
Total$9,507 $10,257 
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Prepaid expenses and other current assets (Tables)
12 Months Ended
Dec. 31, 2023
Prepaid Expense and Other Assets, Current [Abstract]  
Schedule of prepaid expenses and other current assets
Prepaid expenses and other current assets consisted of the following (in thousands):
December 31,
20232022
Prepaid deposits$12,177 $9,666 
Prepaid subscriptions1,868 897 
Current portion of net investment in sales-type leases367 337 
Prepaid insurance1,208 2,374 
Other1,334 1,114 
Total$16,954 $14,388 
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
Property and Equipment, Net (Tables)
12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment, net
Property and equipment, net consisted of the following (in thousands):
December 31,
20232022
Computers and telecom equipment$1,331 $599 
Lab equipment1,171 871 
Furniture and fixtures111 111 
Leasehold improvements566 542 
Leased equipment80,206 35,983 
Capitalized software8,629 4,150 
Sales demo equipment2,758 2,340 
Equipment held for lease1
32,910 7,826 
Construction in progress2,493 71 
130,175 52,493 
Less: Accumulated depreciation and amortization(17,254)(7,786)
$112,921 $44,707 
(1) Represents equipment that has not yet been deployed to a customer and, accordingly, is not being depreciated.
Schedule of leased equipment and the related accumulated depreciation
Leased equipment and the related accumulated depreciation were as follows:
December 31,
20232022
Leased equipment$80,206 $35,983 
Accumulated depreciation(13,283)(5,802)
Leased equipment, net$66,923 $30,181 
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
Accrued Expenses and Other Current Liabilities (Tables)
12 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
Schedule of accrued liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
December 31,
20232022
Accrued employee compensation and benefits expense$7,780 $7,225 
Accrued professional services and consulting1,579 722 
Accrued sales tax1,643 1,680 
Purchase order cancellation fees1,188 — 
Other3,388 1,918 
$15,578 $11,545 
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
Long-term Debt (Tables)
12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Summary of components of long-term debt
The components of the Company’s long-term debt consisted of the following (in thousands):
December 31,
20232022
Term loans payable$— $30,000 
Less: Unamortized discount— (317)
— 29,683 
Less: Current portion of long-term debt— (10,000)
Long-term debt, net of discount$— $19,683 
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
Warrants (Tables)
12 Months Ended
Dec. 31, 2023
Warrants and Rights Note Disclosure [Abstract]  
Summary of warrants to purchase the classes of Preferred Stock and Common Stock outstanding
As of December 31, 2023 and 2022, warrants to purchase the following classes of common stock outstanding consisted of the following:
December 31, 2023
Warrant DescriptionIssuance DateContractual
Term
(in years)
Underlying Equity
Instrument
Balance Sheet
Classification
Shares Issuable
Upon Exercise
of Warrant
Weighted
Average
Exercise Price
Finback Common Stock Warrants (see Note 15)January 13, 202110Common stockEquity1,317,327 $0.42 
Public Warrants (see Note 2)July 16, 20215Common stockLiability14,324,893 $11.50 
15,642,220 
December 31, 2022
Warrant DescriptionIssuance DateContractual
Term
(in years)
Underlying Equity
Instrument
Balance Sheet
Classification
Shares Issuable
Upon Exercise
of Warrant
Weighted
Average
Exercise Price
Finback Common Stock Warrants (see Note 15)January 13, 202110Common stockEquity2,421,200 $0.42 
Public Warrants (see Note 2)July 16, 20215Common stockLiability14,324,994 $11.50 
16,746,194 
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of fair value weighted-average assumptions
The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted during the years ended December 31, 2023 and 2022:
Year Ended December 31,
20232022
Risk-free interest rate4.2 %1.6 %
Expected term (in years)6.16.1
Expected volatility87.5 %75.0 %
Expected dividend yield0.0 %0.0 %
Summary of stock option activity
The following tables summarize the Company’s stock option activity under the 2021 Equity Incentive Plan (in thousands, except for share and per share data):
Number of
Shares
Weighted
Average
Exercise Price
Weighted
Average
Remaining
Contractual Term (in years)
Aggregate
Intrinsic Value
Outstanding as of December 31, 2021
20,769,130$0.39 
Granted2,262,9253.49 
Exercised(1,896,975)0.43 
Forfeited(710,707)0.42 
Expired(27,549)0.42 
Outstanding as of December 31, 2022
20,396,824$0.73 
Granted2,840,4213.12 
Exercised(1,735,978)0.38 
Forfeited(1,164,932)1.72 
Expired(11,807)0.42 
Outstanding as of December 31, 2023
20,324,528$1.04 6.0$74,768 
Vested and expected to vest as of December 31, 2023
20,324,528$1.04 6.0$74,768 
Options exercisable as of December 31, 2023
16,114,401$0.67 5.4$65,339 
Summary of restricted stock unit activity
The following table summarizes the Company’s restricted stock units activity under its existing restricted stock unit plan:
Number of
Shares
Grant Date Fair
Value
Outstanding as of December 31, 2021
1,951,924$6.76 
Granted7,613,4723.26 
Vested(565,774)6.72 
Forfeited(1,497,677)5.15 
Outstanding as of December 31, 2022
7,501,945$3.54 
Granted9,477,0143.48 
Vested(2,833,155)3.55 
Forfeited(1,099,125)3.54 
Outstanding as of December 31, 2023
13,046,679$3.49 
Schedule of performance shares
The following table summarizes the Company's performance stock units activity under its existing performance stock units plan:
Number of
Shares
Grant Date Fair
Value
Outstanding as of December 31, 2021
— $— 
Granted947,000 2.65 
Vested— — 
Forfeited(83,000)2.65 
Outstanding as of December 31, 2022
864,000 $2.65 
Granted— — 
Vested(432,000)2.65 
Forfeited(52,000)2.67 
Outstanding as of December 31, 2023
380,000 $2.64 
Schedule of fair value measurements of common stock warrants granted
The Company utilized a Black-Scholes pricing model to determine the grant-date fair value of the Finback Common Stock Warrants. The assumptions used are presented in the following table:
Warrants - Black Scholes
Risk-free interest rate0.4 %
Expected term (in years)3.0
Expected volatility23.9 %
Expected dividend yield— %
Schedule of allocation of share based compensation expense
Stock-based compensation expense was classified in the consolidated statements of operations and comprehensive loss as follows (in thousands):
Year Ended December 31,
20232022
Cost of revenue$583$829
Research and development4,2844,009
Sales and marketing9,38710,038
General and administrative9,8977,622
Total stock-based compensation expense$24,151$22,498
Schedule of stock-based compensation expense
Stock-based compensation expense by award type recognized in the consolidated statements of operations and comprehensive loss was as follows (in thousands):
Year Ended December 31,
20232022
Stock options $2,925$1,594
Earn-out shares2,0736,499
Warrants 3,1474,523
RSUs and PSUs16,0069,882
Total stock-based compensation expense $24,151$22,498
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Summary of components of the Company's loss before income tax expense
The components of the Company’s loss before income tax expense are as follows (in thousands):
Year Ended December 31,
20232022
United States$(106,261)$(85,760)
Foreign58 (646)
Loss before income tax provision$(106,203)$(86,406)
Schedule of Income Tax Expense
Income tax expense is comprised of the following (in thousands):
Year Ended December 31,
20232022
Current:
Federal$$
State27
Foreign24
Total current income tax expense$51$
Deferred:
Federal$$
State
Foreign
Total deferred income tax expense$$
Total income tax expense$51$
Summary of reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:
Year Ended December 31,
20232022
Federal statutory income tax rate21.0 %21.0 %
State income taxes, net of federal benefit3.4 3.5 
Federal and state research and development tax credits— (1.2)
Change in fair value of contingent earn-out liability and contingently issuable common stock liability(4.5)3.4 
Change in valuation allowance(16.9)(23.6)
Change in uncertain tax positions(0.4)— 
Change in tax rate0.8 (0.1)
Stock-based compensation(0.6)(0.2)
Non-deductible compensation(2.4)(2.6)
Permanent differences(0.1)(0.2)
Other(0.3)— 
Effective income tax rate0.0 %0.0 %
Summary of net deferred tax assets
Net deferred tax assets consisted of the following (in thousands):
December 31,
20232022
Deferred tax assets:  
Net operating loss carryforwards$41,541$36,518
Research and development tax credit carryforwards3,8023,836
Capitalized research and development costs13,0439,965
Accrued expenses7,2306,660
Deferred revenue18,2068,884
Lease liability351490
Other1,305106
Total deferred tax assets85,47866,459
Valuation allowance(82,558)(64,570)
Total deferred tax assets, net of valuation allowance2,9201,889
Deferred tax liabilities:  
Depreciation and amortization(2,601)(1,464)
Right of use lease asset(302)(409)
Other(17)(16)
Total deferred tax liabilities(2,920)(1,889)
Net deferred tax assets$$
Summary of changes in the valuation allowance for deferred tax assets
Changes in the valuation allowance for deferred tax assets related primarily to the increase in net operating loss carryforwards and capitalized R&D costs and were as follows (in thousands):
December 31,
20232022
Valuation allowance as of beginning of year$64,570$43,966
Additions charged to provision for income taxes17,98820,320
Additions charged to equity332
Currency translation and other(48)
Valuation allowance as of end of year$82,558$64,570
Schedule of Uncertain Tax Positions
The following table summarizes the activity related to the Company’s uncertain tax positions (excluding interest and penalties and related tax attributes) (in thousands):
December 31,
20232022
Balance at beginning of fiscal year$$
Gross increases related to prior year tax positions407
Foreign exchange and others21
Balance at end of fiscal year$428$
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
Net Loss per Share (Tables)
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Schedule of basic and diluted net loss per share attributable to common stockholders
Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):
Year Ended December 31,
20232022
Numerator:  
Net income (loss) attributable to common stockholders – basic and diluted$(106,254)$(86,406)
  
Denominator:  
Weighted average common shares outstanding - basic and diluted149,168,105143,858,668
Net loss per share attributable to common stockholders – basic and diluted$(0.71)$(0.60)
Schedule of potential common shares excluded from the computation of diluted net loss per share
The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:
Year Ended December 31,
20232022
Options issued and outstanding20,324,528 20,396,824 
Public Warrants to purchase common stock14,324,893 14,324,994 
Warrants to purchase common stock (Finback)**1,317,327 2,421,200 
Unvested restricted stock units13,046,679 7,501,945 
Unvested performance stock units380,000 864,000 
Earn-out shares*15,000,000 15,000,000 
Contingently issuable common stock*1,897,500 1,897,500 
66,290,927 62,406,463 
*Issuance of Earn-out shares and Contingently issuable common stock is contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period.
**Includes 117,423 vested warrants and 1,199,904 unvested warrants as of December 31, 2023.
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
Nature of the Business and Basis of Presentation - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Revenue [1] $ 80,418 $ 55,195
Total cost of revenue 46,589 53,466
License fee and other revenue    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Revenue 5,053 1,310
Total cost of revenue $ 949 2,222
License fee and other revenue | Revision of Prior Period, Adjustment    
Error Corrections and Prior Period Adjustments Restatement [Line Items]    
Revenue   1,300
Total cost of revenue   $ 2,200
[1] Includes related party revenue of $11.3 million and $13.5 million for the years ended December 31, 2023 and 2022, respectively.
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
Significant Accounting Policies - Risk of Concentrations of Credit, Significant Customers and Significant Suppliers (Details) - Customer Concentration Risk
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue Benchmark | Customer    
Concentration Risk [Line Items]    
Concentration risk, percentage (less than) 22.40% 31.00%
Revenue Benchmark | Motorola Solutions, Inc.    
Concentration Risk [Line Items]    
Concentration risk, percentage (less than) 12.00% 20.90%
Revenue Benchmark | Customer A    
Concentration Risk [Line Items]    
Concentration risk, percentage (less than) 10.00% 10.10%
Revenue Benchmark | Customer B    
Concentration Risk [Line Items]    
Concentration risk, percentage (less than) 10.40% 10.00%
Accounts Receivable | Customer    
Concentration Risk [Line Items]    
Concentration risk, percentage (less than) 55.00%
Accounts Receivable | Motorola Solutions, Inc.    
Concentration Risk [Line Items]    
Concentration risk, percentage (less than) 10.00% 39.00%
Accounts Receivable | Customer B    
Concentration Risk [Line Items]    
Concentration risk, percentage (less than) 10.00% 16.00%
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Contingent Earn-out (Details)
Mar. 08, 2026
d
$ / shares
shares
Dec. 31, 2023
$ / shares
Dec. 31, 2022
$ / shares
Business Acquisition, Contingent Consideration [Line Items]      
Common stock, par value (in dollars per share)   $ 0.0001 $ 0.0001
Triggering Event One | Forecast      
Business Acquisition, Contingent Consideration [Line Items]      
Number of trading days | d 20    
Number of consecutive trading days | d 30    
Triggering Event Two | Forecast      
Business Acquisition, Contingent Consideration [Line Items]      
Number of trading days | d 20    
Number of consecutive trading days | d 30    
Triggering Event Three | Forecast      
Business Acquisition, Contingent Consideration [Line Items]      
Number of trading days 20    
Number of consecutive trading days 30    
Plan of merger with NHIC and Merger Sub      
Business Acquisition, Contingent Consideration [Line Items]      
Common stock, par value (in dollars per share)   $ 0.0001  
Plan of merger with NHIC and Merger Sub | Common Class A | Triggering Event One | Forecast      
Business Acquisition, Contingent Consideration [Line Items]      
Earn-out shares issuable upon achieving certain milestones (in shares) | shares 5,000,000    
Plan of merger with NHIC and Merger Sub | Common Class A | Triggering Event Two | Forecast      
Business Acquisition, Contingent Consideration [Line Items]      
Earn-out shares issuable upon achieving certain milestones (in shares) | shares 5,000,000    
Plan of merger with NHIC and Merger Sub | Common Class A | Triggering Event Three | Forecast      
Business Acquisition, Contingent Consideration [Line Items]      
Earn-out shares issuable upon achieving certain milestones (in shares) | shares 5,000,000    
Plan of merger with NHIC and Merger Sub | Common Class A | Minimum | Triggering Event One | Forecast      
Business Acquisition, Contingent Consideration [Line Items]      
Share price (in dollars per share) $ 12.50    
Plan of merger with NHIC and Merger Sub | Common Class A | Minimum | Triggering Event Two | Forecast      
Business Acquisition, Contingent Consideration [Line Items]      
Share price (in dollars per share) 15.00    
Plan of merger with NHIC and Merger Sub | Common Class A | Minimum | Triggering Event Three | Forecast      
Business Acquisition, Contingent Consideration [Line Items]      
Share price (in dollars per share) $ 17.50    
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Contingently Issuable Common Stock (Details)
12 Months Ended
Dec. 31, 2023
d
$ / shares
shares
Dec. 31, 2022
$ / shares
Business Acquisition, Contingent Consideration [Line Items]    
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001
Unvested restricted stock units    
Business Acquisition, Contingent Consideration [Line Items]    
Vesting period 3 years  
Share-based Payment Arrangement, Tranche Two    
Business Acquisition, Contingent Consideration [Line Items]    
Number of trading days | d 20  
Number of consecutive trading days | d 30  
Share-based Payment Arrangement, Tranche Two | Maximum    
Business Acquisition, Contingent Consideration [Line Items]    
Vesting period 5 years  
Share-based Payment Arrangement, Tranche Two | Minimum    
Business Acquisition, Contingent Consideration [Line Items]    
Share price (in dollars per share) | $ / shares $ 12.50  
Share-based Payment Arrangement, Tranche Three    
Business Acquisition, Contingent Consideration [Line Items]    
Vesting period 5 years  
Number of trading days | d 20  
Number of consecutive trading days | d 30  
Share-based Payment Arrangement, Tranche Three | Minimum    
Business Acquisition, Contingent Consideration [Line Items]    
Share price (in dollars per share) | $ / shares $ 15.00  
Common Class B | Share-based Payment Arrangement, Tranche One    
Business Acquisition, Contingent Consideration [Line Items]    
Shares vested (in shares) 1,897,500  
Common Class B | Share-based Payment Arrangement, Tranche Two    
Business Acquisition, Contingent Consideration [Line Items]    
Shares vested (in shares) 948,750  
Common Class B | Share-based Payment Arrangement, Tranche Three    
Business Acquisition, Contingent Consideration [Line Items]    
Shares vested (in shares) 948,750  
Stock options    
Business Acquisition, Contingent Consideration [Line Items]    
Vesting period 4 years  
Give Evolv LLC    
Business Acquisition, Contingent Consideration [Line Items]    
Remaining number of founder shares 517,500  
NHIC Sub Inc    
Business Acquisition, Contingent Consideration [Line Items]    
Shares outstanding (in shares) 4,312,500  
Common stock, par value (in dollars per share) | $ / shares $ 0.0001  
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Public Warrants (Details) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Jul. 16, 2021
Accounting Policies [Abstract]      
Number of shares purchased from issuance of warrants (in shares) 15,642,220 16,746,194 14,325,000
Weighted Average Exercise Price     $ 11.50
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Inventory (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Inventory [Line Items]    
Write-off of inventory and change in inventory reserve $ 1,612 $ 1,582
Edge Units    
Inventory [Line Items]    
Write-off of inventory and change in inventory reserve $ 1,600 $ 1,600
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Property and Equipment (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Estimated Useful Life 7 years  
Impairment of property and equipment $ 322 $ 1,161
Computers and telecommunications equipment    
Property, Plant and Equipment [Line Items]    
Estimated Useful Life 3 years  
Lab equipment    
Property, Plant and Equipment [Line Items]    
Estimated Useful Life 5 years  
Software    
Property, Plant and Equipment [Line Items]    
Estimated Useful Life 4 years  
Furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Estimated Useful Life 5 years  
Leasehold improvements | Maximum    
Property, Plant and Equipment [Line Items]    
Estimated Useful Life 7 years  
Leased equipment    
Property, Plant and Equipment [Line Items]    
Lease term 48 months  
Leased equipment | Minimum    
Property, Plant and Equipment [Line Items]    
Estimated Useful Life 4 years  
Leased equipment | Maximum    
Property, Plant and Equipment [Line Items]    
Estimated Useful Life 7 years  
Internal-use software    
Property, Plant and Equipment [Line Items]    
Estimated Useful Life 4 years  
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Segment Information (Details)
12 Months Ended
Dec. 31, 2023
segment
Accounting Policies [Abstract]  
Number of operating segment 1
Number of reportable segment 1
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Revenue Recognition (Details)
12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Line Items]  
Lessor, lease term 4 years
Depreciable lives 7 years
Revenue arrangement period 4 years
Term of payments after the shipment or delivery of the product 30 days
Leased equipment  
Property, Plant and Equipment [Line Items]  
Depreciable lives 7 years
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Stock-Based Compensation (Details) - $ / shares
1 Months Ended 12 Months Ended
Jan. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Jul. 16, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares)   2,840,421 2,262,925  
Weighted Average Exercise Price       $ 11.50
Stock options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Granted (in shares) 2,552,913      
Business development agreement term 3 years      
Restricted Stock Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period   3 years    
Subscription Agreements        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Earn-out shares issuable upon achieving certain milestones (in shares)   15,000,000    
Earn-out shares are subject to the share-based compensation (in shares)   2,115,304    
Finback BDA        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted Average Exercise Price $ 0.42      
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Accounting Policies [Abstract]    
Foreign $ 58 $ (646)
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
Marketable Securities (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
Marketable Securities [Line Items]  
Amortized Cost $ 51,289
Unrealized Gain/(Loss) 0
Fair Value 51,289
U.S. Treasury bills  
Marketable Securities [Line Items]  
Amortized Cost 51,289
Unrealized Gain/(Loss) 0
Fair Value $ 51,289
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value On Recurring Basis (Details) - Fair Value, Recurring - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Assets:    
Total assets measured at fair value $ 109,118 $ 149,971
Liabilities:    
Liabilities of fair value 46,538 53,417
Treasury bills    
Assets:    
Total assets measured at fair value 51,289  
Long-term debt including current portion    
Liabilities:    
Liabilities of fair value   29,683
Contingent earn-out liability    
Liabilities:    
Liabilities of fair value 29,119 14,218
Contingently issuable common stock liability    
Liabilities:    
Liabilities of fair value 6,530 3,392
Public Warrant liability    
Liabilities:    
Liabilities of fair value 10,889 6,124
Money market funds    
Assets:    
Total assets measured at fair value 57,829 149,971
Level 1    
Assets:    
Total assets measured at fair value 57,829 149,971
Liabilities:    
Liabilities of fair value 10,889 6,124
Level 1 | Treasury bills    
Assets:    
Total assets measured at fair value 0  
Level 1 | Long-term debt including current portion    
Liabilities:    
Liabilities of fair value   0
Level 1 | Contingent earn-out liability    
Liabilities:    
Liabilities of fair value 0 0
Level 1 | Contingently issuable common stock liability    
Liabilities:    
Liabilities of fair value 0 0
Level 1 | Public Warrant liability    
Liabilities:    
Liabilities of fair value 10,889 6,124
Level 1 | Money market funds    
Assets:    
Total assets measured at fair value 57,829 149,971
Level 2    
Assets:    
Total assets measured at fair value 51,289 0
Liabilities:    
Liabilities of fair value 0 29,683
Level 2 | Money market funds    
Assets:    
Total assets measured at fair value 0 0
Level 2 | Treasury bills    
Assets:    
Total assets measured at fair value 51,289  
Level 2 | Long-term debt including current portion    
Liabilities:    
Liabilities of fair value   29,683
Level 2 | Contingent earn-out liability    
Liabilities:    
Liabilities of fair value 0 0
Level 2 | Contingently issuable common stock liability    
Liabilities:    
Liabilities of fair value 0 0
Level 2 | Public Warrant liability    
Liabilities:    
Liabilities of fair value 0 0
Level 3    
Assets:    
Total assets measured at fair value 0 0
Liabilities:    
Liabilities of fair value 35,649 17,610
Level 3 | Money market funds    
Assets:    
Total assets measured at fair value 0 0
Level 3 | Treasury bills    
Assets:    
Total assets measured at fair value 0  
Level 3 | Long-term debt including current portion    
Liabilities:    
Liabilities of fair value   0
Level 3 | Contingent earn-out liability    
Liabilities:    
Liabilities of fair value 29,119 14,218
Level 3 | Contingently issuable common stock liability    
Liabilities:    
Liabilities of fair value 6,530 3,392
Level 3 | Public Warrant liability    
Liabilities:    
Liabilities of fair value $ 0 $ 0
XML 73 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value Measurements - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Jul. 16, 2021
Jul. 15, 2021
Dec. 31, 2023
Dec. 31, 2022
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]        
Marketable securities     $ 51,289 $ 0
Contingent earn-out liability        
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]        
Expected dividend yield     $ 0  
Contingent earn-out liability | Expected volatility        
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]        
Contingent consideration, measurement input     90.00%  
Contingent earn-out liability | Risk-free interest rate        
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]        
Contingent consideration, measurement input     4.20%  
Contingent earn-out liability | Measurement Input, Control Premium        
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]        
Contingent consideration, measurement input     25.00%  
Contingent earn-out liability | Expected term (in years)        
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]        
Contingent consideration term     2 years 2 months 12 days  
Contingently issuable common stock liability        
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]        
Expected dividend yield     $ 0  
Issuance of common stock in connection with the consummation of the PIPE Investment (in shares) 517,500 4,312,500    
Shares vested (in shares)   1,897,500    
Outstanding shares expected to vest (in shares)     1,897,500  
Contingently issuable common stock liability | Expected volatility        
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]        
Contingent consideration, measurement input     90.00%  
Contingently issuable common stock liability | Risk-free interest rate        
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]        
Contingent consideration, measurement input     4.10%  
Contingently issuable common stock liability | Measurement Input, Control Premium        
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]        
Contingent consideration, measurement input     25.00%  
Contingently issuable common stock liability | Expected term (in years)        
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]        
Contingent consideration term     2 years 6 months  
XML 74 R61.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value Measurements - Contingent Earn-Out and Contingently Issuable Common Shares (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Contingent earn-out liability    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance at beginning $ 14,218 $ 21,206
Change in fair value 14,901 (6,988)
Balance at ending 29,119 14,218
Contingently issuable common stock liability    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance at beginning 3,392 5,264
Change in fair value 3,138 (1,872)
Balance at ending $ 6,530 $ 3,392
XML 75 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
Fair Value Measurements - Warrant Liability (Details) - Public Warrant liability - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance at beginning $ 6,124 $ 11,030
Change in fair value 4,765 (4,906)
Balance at ending $ 10,889 $ 6,124
XML 76 R63.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue Recognition - Schedule of Performance Obligations (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
Disaggregation of Revenue [Line Items]  
Total revenue $ 240,513
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 79,214
Revenue arrangement period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 73,136
Revenue arrangement period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 88,163
Revenue arrangement period
Product revenue  
Disaggregation of Revenue [Line Items]  
Total revenue $ 997
Product revenue | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 997
Revenue arrangement period 1 year
Product revenue | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 0
Revenue arrangement period 1 year
Product revenue | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 0
Revenue arrangement period
Subscription revenue  
Disaggregation of Revenue [Line Items]  
Total revenue $ 172,272
Subscription revenue | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 56,819
Revenue arrangement period 1 year
Subscription revenue | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 52,188
Revenue arrangement period 1 year
Subscription revenue | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 63,265
Revenue arrangement period
Service revenue  
Disaggregation of Revenue [Line Items]  
Total revenue $ 67,101
Service revenue | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 21,255
Revenue arrangement period 1 year
Service revenue | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 20,948
Revenue arrangement period 1 year
Service revenue | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 24,898
Revenue arrangement period
License fee and other revenue  
Disaggregation of Revenue [Line Items]  
Total revenue $ 143
License fee and other revenue | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 143
Revenue arrangement period 1 year
License fee and other revenue | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 0
Revenue arrangement period 1 year
License fee and other revenue | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01  
Disaggregation of Revenue [Line Items]  
Total revenue $ 0
Revenue arrangement period
XML 77 R64.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue Recognition - Schedule of Minimum Future Payments on Noncancelable Leases (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
Revenue Recognition and Deferred Revenue [Abstract]  
2024 $ 56,819
2025 52,188
2026 41,088
2027 21,118
Thereafter 1,059
Lessor, operating lease, payments to be received $ 172,272
XML 78 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue Recognition - Narrative (Details)
$ in Thousands
12 Months Ended
Jul. 16, 2021
shares
Jul. 15, 2021
shares
Dec. 31, 2023
USD ($)
unit
Dec. 31, 2022
USD ($)
unit
Disaggregation of Revenue [Line Items]        
Current portion of contract assets     $ 3,707 $ 2,852
Contract assets, noncurrent     451 1,386
Revenue recognized in relation to the beginning of the year contract liability balance     19,104 6,632
Lease revenue (less than)     37,444 18,916
Deferred asset related to commissions     11,400 9,000
Amortized commissions     5,600 4,100
General and administrative     42,091 37,719
Contingently issuable common stock liability        
Disaggregation of Revenue [Line Items]        
Issuance of common stock in connection with the consummation of the PIPE Investment (in shares) | shares 517,500 4,312,500    
Related Party        
Disaggregation of Revenue [Line Items]        
Lease revenue (less than)     $ 900 $ 600
Give Evolv LLC        
Disaggregation of Revenue [Line Items]        
Number of Evolv Express units donated | unit     5 6
General and administrative     $ 200 $ 200
XML 79 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue Recognition - Summary of Rollforward of Deferred Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Movement in Deferred Revenue [Roll Forward]    
Balance at beginning of period $ 35,968 $ 9,074
Revenue recognized in relation to the beginning of the year contract liability balance (19,104) (6,632)
Revenue deferred 54,626 33,526
Balance at end of period $ 71,490 $ 35,968
XML 80 R67.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue Recognition - Schedule of Components of Lease Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue Recognition and Deferred Revenue [Abstract]    
Revenue from sales-type leases $ 0 $ 1,123
Interest income on lease receivables $ 197 224
Operating Lease Income Comprehensive Income Extensible List Not Disclosed Flag Lease income - operating leases  
Lease income - operating leases $ 37,247 17,569
Total lease revenue $ 37,444 $ 18,916
XML 81 R68.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue Recognition - Summary of Company's Revenue by Revenue Stream (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]    
Total revenue [1] $ 80,418 $ 55,195
Product revenue    
Disaggregation of Revenue [Line Items]    
Total revenue 21,977 31,985
Leased equipment    
Disaggregation of Revenue [Line Items]    
Total revenue 37,247 17,569
Service revenue    
Disaggregation of Revenue [Line Items]    
Total revenue 16,141 4,331
License fees    
Disaggregation of Revenue [Line Items]    
Total revenue 2,963 0
Professional services and other revenue    
Disaggregation of Revenue [Line Items]    
Total revenue $ 2,090 $ 1,310
[1] Includes related party revenue of $11.3 million and $13.5 million for the years ended December 31, 2023 and 2022, respectively.
XML 82 R69.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue Recognition - Revenue by Geographical Location (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]    
Revenue [1] $ 80,418 $ 55,195
United States    
Disaggregation of Revenue [Line Items]    
Revenue 78,556 53,815
Foreign    
Disaggregation of Revenue [Line Items]    
Revenue $ 1,862 $ 1,380
[1] Includes related party revenue of $11.3 million and $13.5 million for the years ended December 31, 2023 and 2022, respectively.
XML 83 R70.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases - Narrative (Details)
$ in Millions
12 Months Ended
May 01, 2021
USD ($)
Dec. 31, 2023
USD ($)
space
Dec. 31, 2022
USD ($)
Leases [Abstract]      
Security deposit $ 0.3    
Lease renewal term 3 years    
Required notice period before renewal 9 months    
Number of storage spaces | space   3  
Operating lease cost   $ 1.2 $ 1.0
Operating lease payments   $ 1.4 $ 1.1
XML 84 R71.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases - Schedule of Weighted-Average Remaining Lease Term and Discount Rate (Details)
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Weighted average remaining lease term 9 months 18 days 1 year 9 months 18 days
Weighted average discount rate 7.75% 6.95%
XML 85 R72.htm IDEA: XBRL DOCUMENT v3.24.0.1
Leases - Schedule of Future Annual Lease Payments (Details)
$ in Thousands
Dec. 31, 2023
USD ($)
Leases [Abstract]  
2024 $ 1,432
2025 0
Total future lease payments 1,432
Less: imputed interest (41)
Present value of operating lease liability $ 1,391
XML 86 R73.htm IDEA: XBRL DOCUMENT v3.24.0.1
Accounts Receivable (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]    
Beginning balance $ (200) $ (50)
Provisions (410) (150)
Write-offs, net of recoveries 28 0
Ending balance $ (582) $ (200)
XML 87 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
Inventory - Summary of Inventory (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw materials $ 1,869 $ 2,334
Finished goods 7,638 7,923
Total $ 9,507 $ 10,257
XML 88 R75.htm IDEA: XBRL DOCUMENT v3.24.0.1
Prepaid expenses and other current assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Prepaid Expense and Other Assets, Current [Abstract]    
Prepaid deposits $ 12,177 $ 9,666
Prepaid subscriptions 1,868 897
Current portion of net investment in sales-type leases 367 337
Prepaid insurance 1,208 2,374
Other 1,334 1,114
Total $ 16,954 $ 14,388
XML 89 R76.htm IDEA: XBRL DOCUMENT v3.24.0.1
Property and Equipment, Net (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Leased equipment $ 130,175 $ 52,493
Less: Accumulated depreciation and amortization (17,254) (7,786)
Leased equipment, net 112,921 44,707
Computers and telecom equipment    
Property, Plant and Equipment [Line Items]    
Leased equipment 1,331 599
Lab equipment    
Property, Plant and Equipment [Line Items]    
Leased equipment 1,171 871
Furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Leased equipment 111 111
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Leased equipment 566 542
Leased equipment    
Property, Plant and Equipment [Line Items]    
Leased equipment 80,206 35,983
Less: Accumulated depreciation and amortization (13,283) (5,802)
Leased equipment, net 66,923 30,181
Internal-use software    
Property, Plant and Equipment [Line Items]    
Leased equipment 8,629 4,150
Leased equipment, net 7,000 3,500
Sales demo equipment    
Property, Plant and Equipment [Line Items]    
Leased equipment 2,758 2,340
Equipment held for lease    
Property, Plant and Equipment [Line Items]    
Leased equipment 32,910 7,826
Construction in progress    
Property, Plant and Equipment [Line Items]    
Leased equipment $ 2,493 $ 71
XML 90 R77.htm IDEA: XBRL DOCUMENT v3.24.0.1
Property and Equipment, Net - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Leased equipment, net $ 112,921 $ 44,707
Depreciation and amortization 9,932 5,465
Capitalized software amortization $ 1,000 600
Depreciable lives 7 years  
Loss from impairment of property and equipment $ 322 1,161
Internal-use software    
Property, Plant and Equipment [Line Items]    
Leased equipment, net 7,000 3,500
Depreciation and amortization $ 700 200
Depreciable lives 4 years  
Leased equipment    
Property, Plant and Equipment [Line Items]    
Leased equipment, net $ 66,923 30,181
Depreciation $ 8,000 $ 4,300
Depreciable lives 7 years  
XML 91 R78.htm IDEA: XBRL DOCUMENT v3.24.0.1
Property and Equipment, Net - Leased Equipment (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Leased equipment $ 130,175 $ 52,493
Accumulated depreciation (17,254) (7,786)
Leased equipment, net 112,921 44,707
Leased equipment    
Property, Plant and Equipment [Line Items]    
Leased equipment 80,206 35,983
Accumulated depreciation (13,283) (5,802)
Leased equipment, net $ 66,923 $ 30,181
XML 92 R79.htm IDEA: XBRL DOCUMENT v3.24.0.1
Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Accrued employee compensation and benefits expense $ 7,780 $ 7,225
Accrued professional services and consulting 1,579 722
Accrued sales tax 1,643 1,680
Purchase order cancellation fees 1,188 0
Other 3,388 1,918
Accrued expenses and other current liabilities $ 15,578 $ 11,545
XML 93 R80.htm IDEA: XBRL DOCUMENT v3.24.0.1
Long-term Debt - Long-Term Debt (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Less: Unamortized discount $ 0 $ (317)
Long-term debt 0 29,683
Less: Current portion of long-term debt 0 (10,000)
Long-term debt, net of discount 0 19,683
Term loans payable    
Debt Instrument [Line Items]    
Term loans payable $ 0 $ 30,000
XML 94 R81.htm IDEA: XBRL DOCUMENT v3.24.0.1
Long-term Debt - Narrative (Details)
$ in Thousands
12 Months Ended
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 21, 2023
Debt Instrument [Line Items]        
Loss on extinguishment of debt   $ 626 $ 0  
2022 SVB Term Loan        
Debt Instrument [Line Items]        
Face amount of debt   $ 30,000    
Debt instrument, term   18 months    
Prepayment premium       0.010
Loss on extinguishment of debt $ 600      
Prepayment premium 300      
Unamortized debt issuance cost $ 300      
2022 SVB Term Loan | Maximum        
Debt Instrument [Line Items]        
Interest rate   7.25%    
2022 SVB Term Loan | Maximum | Prime Rate        
Debt Instrument [Line Items]        
Interest rate   1.00%    
2022 Additional SVB Term Loan        
Debt Instrument [Line Items]        
Face amount of debt   $ 20,000    
Debt instrument, increase   $ 25,000    
XML 95 R82.htm IDEA: XBRL DOCUMENT v3.24.0.1
Warrants - Preferred Stock and Common Stock Outstanding (Details) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Jul. 16, 2021
Class of Warrant or Right [Line Items]      
Number of shares purchased from issuance of warrants (in shares) 15,642,220 16,746,194 14,325,000
Weighted average exercise price (in dollars per share)     $ 11.50
Warrants      
Class of Warrant or Right [Line Items]      
Contractual Term (in years) 10 years 10 years  
Number of shares purchased from issuance of warrants (in shares) 1,317,327 2,421,200  
Weighted average exercise price (in dollars per share) $ 0.42 $ 0.42  
July 16, 2021      
Class of Warrant or Right [Line Items]      
Contractual Term (in years) 5 years 5 years  
Number of shares purchased from issuance of warrants (in shares) 14,324,893 14,324,994  
Weighted average exercise price (in dollars per share) $ 11.50 $ 11.50  
XML 96 R83.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock (Details)
12 Months Ended
Dec. 31, 2023
USD ($)
Vote
shares
Dec. 31, 2022
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of votes per common share | Vote 1  
Cash dividends declared or paid | $ $ 0 $ 0
Share-Based Awards Excluding Employee Stock Purchase Plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares remained available for future grant (in shares) 80,298,297 79,795,376
Employee Stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares remained available for future grant (in shares) 6,315,248 4,863,198
XML 97 R84.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation - Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jul. 31, 2021
Dec. 31, 2023
USD ($)
Vote
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Jul. 16, 2021
$ / shares
shares
Jan. 31, 2021
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Weighted average grant date fair value of options granted (in dollars per share) | $ / shares   $ 2.35 $ 2.32    
Aggregate intrinsic value of the stock options exercised   $ 8,700 $ 4,400    
Number of shares purchased from issuance of warrants (in shares) | shares   15,642,220 16,746,194 14,325,000  
Weighted Average Exercise Price | $ / shares       $ 11.50  
Stock compensation expense   $ 24,151 $ 22,498    
Unrecognized compensation expense   $ 200      
Weighted average period expected of recognition   6 months      
Finback Common Stock Warrants 2021          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares purchased from issuance of warrants (in shares) | shares         131,713
Sales and marketing          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock compensation expense   $ 9,387 10,038    
Finback BDA          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares purchased from issuance of warrants (in shares) | shares         2,552,913
Weighted Average Exercise Price | $ / shares         $ 0.42
Fair value of shares   $ 19,500      
Shares issuable upon exercise of warrant (in shares) | shares   117,423      
Aggregate intrinsic value of warrants exercisable   $ 500      
Class of warrant or right, unissued (in shares) | shares   1,199,904      
Intrinsic value of warrants unvested   $ 9,100      
Number of warrants exercised (in shares) | shares   1,103,873      
Finback BDA | Expected term (in years)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Measurement input | Vote   3.0      
Finback BDA | Sales and marketing          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock compensation expense   $ 3,100 4,500    
Unvested restricted stock units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Grant date fair value of restricted stock   $ 33,000 24,900    
Vesting period   3 years      
Total fair value of shares vested   $ 10,100 $ 3,800    
Unvested performance stock units | Share-based Payment Arrangement, Tranche One          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting percentage   50.00%      
Unvested performance stock units | Share-based Payment Arrangement, Tranche Two          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting percentage   50.00%      
Unvested Stock Options and Restricted Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense   $ 40,800      
Weighted average period expected of recognition   2 years 1 month 6 days      
Maximum | Share-based Payment Arrangement, Tranche Two          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period   5 years      
2021 Equity Incentive Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares of common stock may be issued (in shares) | shares   21,177,295      
Annual increase of total common shares outstanding   5.00%      
Number of shares remained available for future grant (in shares) | shares   14,007,370      
Threshold percentage   100.00%      
2021 Equity Incentive Plan | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Term of stock option   10 years      
2021 Employee Stock Purchase Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares remained available for future grant (in shares) | shares   6,315,248   3,435,748  
Percent of increase of outstanding number of common stock 1.00%        
XML 98 R85.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation - Grant Date Fair Value of Stock Options (Details)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]    
Risk-free interest rate 4.20% 1.60%
Expected term (in years) 6 years 1 month 6 days 6 years 1 month 6 days
Expected volatility 87.50% 75.00%
Expected dividend yield 0.00% 0.00%
XML 99 R86.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation - Stock Options Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Number of Shares    
Outstanding at beginning (in shares) 20,396,824 20,769,130
Granted (in shares) 2,840,421 2,262,925
Exercised (in shares) (1,735,978) (1,896,975)
Forfeited (in shares) (1,164,932) (710,707)
Expired (in shares) (11,807) (27,549)
Outstanding as ending (in shares) 20,324,528 20,396,824
Vested and expected to vest (in shares) 20,324,528  
Options exercisable (in shares) 16,114,401  
Weighted Average Exercise Price    
Outstanding at beginning (in dollars per share) $ 0.73 $ 0.39
Granted (in dollars per share) 3.12 3.49
Exercised (in dollars per share) 0.38 0.43
Forfeited (in dollars per share) 1.72 0.42
Expired (in dollars per share) 0.42 0.42
Outstanding at ending (in dollars per share) 1.04 $ 0.73
Vested and expected to vest (in dollars per share) 1.04  
Options exercisable (in dollars per share) $ 0.67  
Weighted Average Remaining Contractual Term (in years)    
Outstanding 6 years  
Vested and expected to vest 6 years  
Options exercisable 5 years 4 months 24 days  
Aggregate Intrinsic Value    
Outstanding $ 74,768  
Vested and expected to vest 74,768  
Options exercisable $ 65,339  
XML 100 R87.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation - Restricted Stock Units Activity (Details) - Unvested restricted stock units - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Number of Shares      
Outstanding, beginning balance (in shares) 7,501,945 1,951,924  
Granted (in shares) 9,477,014 7,613,472  
Vested (in shares) (2,833,155) (565,774)  
Cancelled (in shares) (1,099,125) (1,497,677)  
Outstanding, ending balance (in shares) 13,046,679 7,501,945  
Grant Date Fair Value      
Outstanding, beginning balance (in dollars per share) $ 3.49 $ 3.54 $ 6.76
Granted (in dollars per share) 3.48 3.26  
Vested (in dollars per share) 3.55 6.72  
Cancelled (in dollars per share) 3.54 5.15  
Outstanding, ending balance (in dollars per share) $ 3.49 $ 3.54 $ 6.76
XML 101 R88.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation - Performance Stock Units Activity (Details) - Unvested performance stock units - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Number of Shares      
Outstanding, beginning balance (in shares) 864,000 0  
Granted (in shares) 0 947,000  
Vested (in shares) (432,000) 0  
Cancelled (in shares) (52,000) (83,000)  
Outstanding, ending balance (in shares) 380,000 864,000  
Grant Date Fair Value      
Outstanding, beginning balance (in dollars per share) $ 2.64 $ 2.65 $ 0
Granted (in dollars per share) 0 2.65  
Vested (in dollars per share) 2.65 0  
Cancelled (in dollars per share) 2.67 2.65  
Outstanding, ending balance (in dollars per share) $ 2.64 $ 2.65 $ 0
XML 102 R89.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation - Company Utilized Black-Scholes Pricing Model (Details) - Finback BDA
Dec. 31, 2023
Vote
Risk-free interest rate  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Measurement input 0.4
Expected term (in years)  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Measurement input 3.0
Expected volatility  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Measurement input 23.9
Expected dividend yield  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Measurement input 0
XML 103 R90.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation - Stock Based Compensation Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense $ 24,151 $ 22,498
Cost of revenue    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 583 829
Research and development    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 4,284 4,009
Sales and marketing    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 9,387 10,038
General and administrative    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense $ 9,897 $ 7,622
XML 104 R91.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation - Stock Based Compensation Expenses by Award Type (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense $ 24,151 $ 22,498
Stock options    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 2,925 1,594
Earn-out shares    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 2,073 6,499
Warrants    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 3,147 4,523
RSUs and PSUs    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense $ 16,006 $ 9,882
XML 105 R92.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Components of Loss Before Income Tax Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Components of the Company's loss before income tax expense    
United States $ (106,261) $ (85,760)
Foreign 58 (646)
Loss before income taxes (106,203) (86,406)
Provision for income taxes $ 51 $ 0
XML 106 R93.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Components of Income Tax Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Current:    
Federal $ 0 $ 0
State 27 0
Foreign 24 0
Total current income tax expense 51 0
Deferred:    
Federal 0 0
State 0 0
Foreign 0 0
Total deferred income tax expense 0 0
Total income tax expense $ 51 $ 0
XML 107 R94.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Effective Income Tax Rate (Details)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate    
Federal statutory income tax rate 21.00% 21.00%
State income taxes, net of federal benefit 3.40% 3.50%
Federal and state research and development tax credits 0.00% (1.20%)
Change in fair value of contingent earn-out liability and contingently issuable common stock liability (4.50%) 3.40%
Change in valuation allowance (16.90%) (23.60%)
Change in uncertain tax positions (0.40%) 0.00%
Change in tax rate 0.80% (0.10%)
Stock-based compensation (0.60%) (0.20%)
Non-deductible compensation (2.40%) (2.60%)
Permanent differences (0.10%) (0.20%)
Other (0.30%) 0.00%
Effective income tax rate 0.00% 0.00%
XML 108 R95.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Net Deferred Tax Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets:      
Net operating loss carryforwards $ 41,541 $ 36,518  
Research and development tax credit carryforwards 3,802 3,836  
Capitalized research and development costs 13,043 9,965  
Accrued expenses 7,230 6,660  
Deferred revenue 18,206 8,884  
Lease liability 351 490  
Other 1,305 106  
Total deferred tax assets 85,478 66,459  
Valuation allowance (82,558) (64,570) $ (43,966)
Total deferred tax assets, net of valuation allowance 2,920 1,889  
Deferred tax liabilities:      
Depreciation and amortization (2,601) (1,464)  
Right of use lease asset (302) (409)  
Other (17) (16)  
Total deferred tax liabilities (2,920) (1,889)  
Net deferred tax assets $ 0 $ 0  
XML 109 R96.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating Loss Carryforwards [Line Items]    
Reduction of income tax expense $ 80,000  
Increase in equity 2,500  
Liability for uncertain tax positions 400  
Domestic Tax Authority    
Operating Loss Carryforwards [Line Items]    
Net operating losses with expiry 20,100 $ 20,100
Net operating losses with no expiry 142,400 124,300
Domestic Tax Authority | Research Tax Credit Carryforward    
Operating Loss Carryforwards [Line Items]    
Tax credit carryforwards 2,500 2,500
State and Local Jurisdiction    
Operating Loss Carryforwards [Line Items]    
Net operating losses with expiry 142,400 103,800
State and Local Jurisdiction | Research Tax Credit Carryforward    
Operating Loss Carryforwards [Line Items]    
Tax credit carryforwards 1,600 1,600
Foreign Tax Authority    
Operating Loss Carryforwards [Line Items]    
Net operating losses with no expiry $ 0 $ 2,300
XML 110 R97.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Valuation Allowance for Deferred Tax Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Valuation allowance as of beginning of year $ 64,570 $ 43,966
Additions charged to provision for income taxes 17,988 20,320
Additions charged to equity 0 332
Currency translation and other 0 (48)
Valuation allowance as of end of year $ 82,558 $ 64,570
XML 111 R98.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Uncertain Tax Positions (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]    
Balance at beginning of fiscal year $ 0 $ 0
Gross increases related to prior year tax positions 407 0
Foreign exchange and others 21 0
Balance at end of fiscal year $ 428 $ 0
XML 112 R99.htm IDEA: XBRL DOCUMENT v3.24.0.1
Net Loss per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Numerator:    
Net income (loss) attributable to common stockholders - basic $ (106,254) $ (86,406)
Net income (loss) attributable to common stockholders - diluted $ (106,254) $ (86,406)
Denominator:    
Weighted average common shares outstanding - basic (in shares) 149,168,105 143,858,668
Weighted average common shares outstanding - diluted (in shares) 149,168,105 143,858,668
Net loss per share - basic (in dollars per share) $ (0.71) $ (0.60)
Net loss per share - diluted (in dollars per share) $ (0.71) $ (0.60)
XML 113 R100.htm IDEA: XBRL DOCUMENT v3.24.0.1
Net Loss per Share - Antidilutive Effect (Details) - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 66,290,927 62,406,463
Finback BDA    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Shares issuable upon exercise of warrant (in shares) 117,423  
Class of warrant or right, unissued (in shares) 1,199,904  
Options issued and outstanding    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 20,324,528 20,396,824
Warrants | July 16, 2021    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 14,324,893 14,324,994
Warrants | January 13, 2021    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 1,317,327 2,421,200
Unvested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 13,046,679 7,501,945
Unvested performance stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 380,000 864,000
Earn-out shares    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 15,000,000 15,000,000
Contingently issuable common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from the computation of diluted net loss per share (in shares) 1,897,500 1,897,500
XML 114 R101.htm IDEA: XBRL DOCUMENT v3.24.0.1
Related Party Transactions (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2020
item
Related Party Transaction [Line Items]      
Accounts receivable, net [1] $ 22,611 $ 31,920  
Related Party      
Related Party Transaction [Line Items]      
Accounts receivable, net 1,700 14,600  
Distribution Agreement With Motorola Member      
Related Party Transaction [Line Items]      
Number of resellers and integration partners | item     2,000
Distribution Agreement With Motorola Member | Related Party      
Related Party Transaction [Line Items]      
Revenue 9,600 11,600  
Accounts receivable, net 1,200 12,500  
Reseller Agreement | Related Party      
Related Party Transaction [Line Items]      
Revenue 1,700 1,900  
Accounts receivable, net $ 600 $ 2,200  
[1] Includes related party accounts receivable, net of $1.7 million and $14.6 million as of December 31, 2023 and December 31, 2022, respectively.
XML 115 R102.htm IDEA: XBRL DOCUMENT v3.24.0.1
Benefit Plans (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Benefit Plans    
Employer contributions $ 300,000 $ 0
EXCEL 117 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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�,'3G#8^\&>Z+.LUOF8 ZP%"K TP= MD5VP[6BQ/<2+&^+%>\_!MA9I6XR %5TQ!1SNR\U^M><_K0N F5$D+\QJ8#F' M4E[U1JA0RJ8$A(K7R&C[08M 5V]IOCZ\J/B"7S>L?\S>41NZ($WMI+]@=UP( MM <>'K$?OR$EQ+$T!,#-B)RF:=4G(!OJ#CV7K0D;8]+NN,2;.?,X!LU. &#O MW,V^%TC5&CQ!4 ^G"41.4:&S+?BEA6[3;T-@X6Y_F$A;GI2L;5SJ@>:\@>9\ M[ZG_MNFF./A?UMVT"WC]0F^>U'MC)X#RQ 1@H"V.[$D&AJQ&VH[9:V>'9P]) M5J0HGPL#*-+&!A>J+''-U2; M*BDOA_+?%7*AIHIN^PB$ GC9G4\="MV7OU# QW)T:6"C83!LEK7,JV#RU+#0 MC_O+V*1UYI(SP#*>+&'O+H0ICU^:M\WAU6EY9K-=7IY\?08J<' C8TO8ZHYG M\.-0E:=)Y8.1:WN"LY#&R-S>KAB%4147P/>EE*9^0 7-D=[)?U!+ P04 M" #UB%U8%/,5GI8$ "\"P &0 'AL+W=ODC=9*7UG*@!+'FHAS7106=N$&[-?F6N/3J$0W2<"6)AL5T7X[= M>K_@-PXKLV43E\E*O$+2]M-1UD U+"@K7"?E:KGV&=CR=8*&'\+UFMUP8#4K3& MJGKMC QJ+KM_]K"NPR$.T=HA\KR[0)[E.V;9;*+5BFBW&M&4 M&ZOQ*T<_._N$??]%&4,:T.2F8AK(T16K0"B%DYYO"!,EJ3DHK50$HF=$YO.&9\*LU;S>6M=_XA5I%!U MCE.9@1% O4[2+>>L/!)?H M/=)80A_")6(('I#&(B:JD9SL"!$F.0W3C(;!&.V89N.,IFGF4_F!XN_-)3@] M"X>=D0;#/E!WYE"PUH!#YIK M8H%W%EYGK2A)A?+![X 7&%(^>:*K"3>F9;+P539M46TJRW&?X3&,B6"6I&V4 M])0-LC4+5FPX%Z MWMIN;)P?X'7W@@W$M MQ8IB PMG=IZMY @Y>2,CH.0YLGXR0FKXPK5IM2,> MTC#/:1XD6._OOAN'^IU(3W>==Z.MB0IOD:6?&UW&>/MTPU7_MA]-+[J)[&EY M-]=^9'K)4?X"%NB*1RV>5+J;%;L'JQH_G\V5Q6G/FQ6.UZ#= OR^4'A&PO=V]R:W-H M965TPYGA##DSW'#Q7:X %/F1 M)ID<62NE\AO;EN$*4B8[/(<,9Q9TZ3M=.69Q9XZ&1 MS<5XR N5Q!G,!9%%FC+Q-(&$;T86M;:"^WBY4EI@CXS&B@ 6;%WS%LY-XWT:8\5HC2"!4&D*AG]K MF$*2:";4X[^*U*KWU,#][RW[.V,\&O/()$QY\D\@'IG &X%<(\!W3, KP)X MQP#_#,"O +[Q3&F*\<.,*38>"KXA0J]&-OUAG&G0:'ZF M"@&$+XA: 9D4$N>E)"R+R(3)6.J9N0 )F6+FH/XBGY@03)\6>34#Q>)$OD;I MEX<9>77UFER1.".?5[R0R"&'MD(E]59V6"DT+15RSRA$7?*19VHER=LL@NB0 MP$;K:A/=K8E3MY5Q!F&'>/2:N([K-2@T^W6XVZ*.5WO<,WS>&;ZW0G!!IER( M,O1+9\]%C-(YX%]$;J-_\>0QNY0D]R#1\Z 'Y.L'Y")W.)+?FCQ;;NPW;ZQO MD!N9LQ!&5JY/5*S!&O_Y!^TZ;YJ\6]WY6,O4OZZ$)D!S[JUS[JOS 9I_W3:'0"[RAD3Q=1CSK- M$3NH=1I<)JL&)SD]\(]S:G"BH.OJJ[Y)0>KL'E;GY4E%?F(LK6-3/9D7=A=P MUWL1U_A\MF[[W,"Z%-NAD_:J#_J[\J_:^5)^NA#;H9_J'-L*UB#T[7H-5++'$SCE#QUFN+,WFL,4A!+TV!)/(P +5<#H]=*XH&[1R MH'AN6I9'KK !,I\K;&I!Z 4XO^!<;0=Z@[I-'O\/4$L#!!0 ( /6(75A7 M;&$F% 0 +87 9 >&PO=V]R:W-H965TJ#Y[D M8D-K4-;*7^^#HF))B& M[#+C?8'$N??DGNN#=;BCO9"O:@V@T9<\XVHW(6A2M:04]41&^#FR5+( MG&IS*U>AVDB@J4W*LY!$43_,*>/!9&37GN5D)+8Z8QR>)5+;/*?RGRED8C\. M<'!BYO'=!Q$14600:(+"&J^=C"#+"N03!U_EZ!!]DHU(9@46:8E&2F!S+D AE,T)/@>JW0SSR%U 4(36>J]I!C>Z:D%?$! MD@Z*\0TB$8D;"II]>SII*2>N=BNV>-T+>'/8 =\"F@)/UN9G]XK^K3K8U*Y6 MM.*$N%,;FL X,$> KF#8/+C#[@?_=1$U1.80[Q;$>]:]/@"\?^K _WYV<2@ M1PVY^JN)>]Q;W7NNDN=VFXWZ -R&+-'+3H0P9*(;VF_&-3&P[8 M.++@Q:&^FT0=0KJC<'=*L S#3EB,JRBG\GY5>?]JN3X)+:3(*%J(;&N/DAOT MR)-.4^VMZ-=NH2R;;8Y2K6QQ=.'8QJ8LG;U?NM+'@5L"K]\X3FDN_=DDX]JY=KU;)%YK+ MOS9+N-6/O%>[W695GEN&8]PEC;O%UVX'M]N=\E^(0G-(@.WH2P9?<;GM@%?O MG2F@QBX,FL3=ZUU0=VV&<+L; M:E;W-::X_057[[8G-+<=M;[0W ;4+HL0W^(E7FV6+S27?VVS2/LTZIWB MC;])O,U1_3/QAB<34".^E1T,*V0%>ICV5:O5\/G>CES/UJ?X;G88(=;X40A]OBA=4 MH_K)?U!+ P04 " #UB%U8W!N=-^(% "T,@ &0 'AL+W=O\(C2>,/%@UQ2JM"W M-,GD96^IU.K"\V2\I"F1IWQ%,_W+G(N4*/U5+#RY$I3,BD)IXF'?'WHI85EO M,B[VW8K)F.R^!]MJF/]'HISJ7A:%=8M2%E6?I)OE1!;!<+^ MG@*X*H"?%,"#/07"JD!X:(%^5:!?*%.>2J%#1!29C 7?(&&.UC2S48A9E-:G MSS)SW>^4T+\R74Y-[LKKC?@(AF MZ&?D(;DD0M=5?K0@IVYD1.-3% 8%,MP"MI"BPTEX+\G3:XUIS7*##/>BK M7.H]4FJ5O^9,,C, 3K;%U9N2S:@@Q=#XYW=]-+I6-)7_MHE<5M9OK\SXQH5< MD9A>]K0Q2"K6M#?YY:=@Z/_:)B\D+ *"62*'M^J:PD[*V#&B]<3_]3W_6#LK;<5>_8P M2XM^K47?J<47P18+*LQH_K V'>P/W:'^0]HX:4RD:CMY)[#KR4/"(B"8)>2@ M%G)PS)$[@!09$A8!P2R1A[7(0V=O_92G]WI@ZK](2I"9Z;0S\EWJ_CIKT[!D M#;=&#/;M035U5M=5&2"8IW^[+AS[B=$]AU($+"(B"8)>1Y+>3Y,=WN'%)D2%@$!+-$#OQF M!NX#^ET%N\*NZD#1;'FV DKP2J97@9VNYZZ\LU1 -%NJ)E<$SAEUB_,M M!7UNIN=F=AV7H+0(BF;KV42((#RF 0:@B0*4%D'1;*6;@!*X$TJ[![:*V#_ M_T #!Q3-EJ:)'(%SLGV _[7*-#C ^T C Q3-EJD)#8$[-=PF)#,BI51H"T0; MII;HT\?K*2+9#-V4.^_R^U:M( /"%)060=%L59O $8R.ZH"0(6,*2HN@:+;2 M36@)W*GEQ^]7N2OH+.[987>LH&JU96LB2N"FL\2@(0:*9M_2;E(,]H]Z4QLRPDQ!:1$4S5:Z"438'8CJI9=JK81)F9/[ MA*)\52RD+1E=FTX=4Z&(=H^4)53;BKXXA9F4I=[JGKYW:>0*[R:G@5_\>S*% M<#>UL["O$9_PUK*,.SY!>LGS]YSG)EF&[O6Q M.V,&:"58W.GIG1)ZOF44 3X=/'$)=]5=A8*BV4(UP3!T!\/7<8GGDXR[69V? ME *-E% T^Y(TD3(\ZJ-^(6AF!*5%4#1;Z:W'_=S/^[W0)<*=Z42PXQ&@@0^* M9LO4!+[0'?A>R2,.2"CNAG7NNZ!A$8IF7Y0F+(9'?:PP!,V"H+0(BF8KW63! MT+U*^$*7&.[.)4:[&UL MO9I=;]LV%(;_"N$-0PNDD43*^>@< XG;K@':+:C;[F+8!2/1-E%)=$7*3H#] M^)&2(DJQ3-L*K9M85G3.X7O(0SZF.%JS] =?$"+ 0QPE_&JP$&+YUG%XL" Q MYJ=L21+YGQE+8RSDUW3N\&5*<)@;Q9$#7??,B3%-!N-1?N\N'8]8)B*:D+L4 M\"R.9?*;T[E):0Q23AE"4C) M[&IP[;V=^+XRR)_X3LF:UZZ!DG+/V _UY3:\&KBJ120B@5 NL/Q8D0F)(N5) MMN-GZ710Q52&]>LG[Q]R\5+,/>9DPJ*_:2@65X.+ 0C)#&>1^,+6'TDI:*C\ M!2SB^5^P+I]U!R#(N&!Q:2Q;$-.D^,0/92)J!LC?8@!+ _C, ZW&*#2 .5" MBY;ELMYA@<>CE*U!JIZ6WM1%GIO<6JJAB>K&J4CE?ZFT$^-IT7V S<"4SA,Z MHP%.!+@. I8E@B9S<,D<$IA%_/7*$;)X*X@1E4VZ*IL M3?$@^"P#+#AXGX0D;#IPI*Y*''P2=P.- M'M^1X!0@[P1 %R(0@E^! _@"IU),\='2R,G^+F'-H:&UJ.H*E+M&6US?9%S> MX5PF_V=&.57#_*26NZWHC9U57O/.QAI9AI65H MU/(M61$N2"AG0"Y2&JC+7!C($BI:VVMT>&@_6G+6T'Y6:3_K- MO)Q7>3DWCHGOP0>B:R!-EE&PXZR+BI9%\9F354%OE%+ M; CN\&.L>O@Z3;'L:W5] K[*:TDEX.N:M8DV>C^T?RTY:R3BLDK$99_C_M)F M7BPY:^3%FKG1Y.:9T6WWTK;#P7#[VF:V["I-@YQG)KE# MJX$F6ZO!*N'9\M9,BV8\KU?(\ZQ2GBUOS=QHSO/,H)8/&;"4V-_YQTL9X;*V M3'CP=/A\H3@&]WD:_#Q;Y+=("6F5:17^;'EKID/CG]&!<)LV56:9D&X+PONPW]PD_\VX-8(,A!N>6M*J0HA-:70Z6O^B+A75R>#]V- ME>(8. % YH$T@O/0O9#D\JP9SS*Z:-!0B,Q2^H!JV_?@S1SRXSX_!E:CV3K??E[IV MW^H> RV11DMDWMP[K![\/>OA&$B(-!*B'4B8O\QE2]6;KIUMP]9!4-;WIJYT6"(7OI:=X<#?_O6AMFRJS3-=L\IXM;\VC.9KW?//^VQ>BS@JJ<9Y4VT,SEB7A MTT_@]C,XFZ]RAUX+ZIN#=Q6G@PR2\S7) M^;#/4>Y;I3A;WIJYT13G[[$[R '+!!KMOW=)U52G-JYU]CDL[S8\$ M--8<.]A.,_X]MI.%%F75D/82?]US?,^)?9UU0MZJ"D"CNYIQM? JK9L+WU>D M@AJKF6B FY52R!IK,Y0[7S42\-:!:N9'09#Z-:;51*JM M:RQ_7P(3W<(+O?N):[JKM)WP\ZS!.UB#_M:LI!GY(\N6UL 5%1Q)*!?>,KPH M$AOO KY3Z-1!'UDE&R%N[>#3=N$%-B%@0+1EP*;9PQ4P9HE,&K\&3F_N:6CPBFW!=U0VS@(=(J M+>H!;#*H*>];?#?X< (DP< T0"('@N(!T#\6$ R )S5?B_%^5!@C?-,B@Y) M&VW8;,>9Z=!&/N7VMZ^U-*O4X'2^[G\W$B5:TQVG)268:[0D1+1<4[Y#*\$H MH:#0&[1J-Z:/;K"4)DBAEP5H3)EZ9=:>(Q^I"DM0F:]-8I;>)T,2EWT2T0-) M%$!F* Y?HRB(X@GXU>/AT02\. W_W+(9"E,'#X_AOG%SM#0:+8T<7_P WY1W M/Y8;I:4YY#^GW.GYDFD^>_$O5(,)+#QSLQ7(/7CYBV=A&KR;\NHIR8HG(COR M,1Y]C$^QYU_;>@/2GLS^7*&FE:0R=WR+2BEJ1)5J,2=@([KQ2%(^A+^:QC-;E'J0IP.C]'4A"%:"5I 2FQ)TD_-]C])1D14]V?FA2.)O_8Y!_4,7L MD_,%RQWE"C$H#2R8GR;@HL=)3D;NR$H!3"RJI&WA>Y):8,"<>6MM.;ZS,3R0O%#&X,;#"N>P /58S86>N2U+2DI@DG"&!&0C MY]:_F0R,OW7X1F M=\;(*'GF_,5,9NG(\4Q 0"%1A@'KUPHF0*DATF'\;#B= M=DL#W!UOV#]9[5K+,Y8PX?2)I*H8.=<.2B'#2ZH>^/HS-'KZAB_A5-HG6C>^ MGH.2I52\;, Z@I*P^HU?FSSL /SH "!H ,%;0.\ (&P H15:1V9E3;'"\5#P M-1+&6[.9@F./_@5$MP=Z[R$D1N M.YQ$]C:N+[[6VC;16]L[WMC'NKG6O7!+4W?F>RQRPB2BD&E*[VJ@RT[4W:Z> M*%[9AO',E6X_=ECH'P00QD&O9YRKS<1LT/YRQ+\!4$L#!!0 ( /6(75@: M&N7;S00 ,$@ 9 >&PO=V]R:W-H965TS#,S=IYX.E@+^4,M&=/H.4TR-0R66J\NPE#%2Y92=2)6+#-W MYD*F5)M3N0C52C(Z*XS2)"2=3B],*<^"T:"X-I&C@([9VNU:*_B?6?;$/HU.+%(E'%7[3>C.T$ M*,Z5%NG&V'B0\JS\I<^;0.P8X-X> [(Q(*\-NGL,HHU!5! M/2MH75--1P,I MUDC:T0;-'A2Q*:P-&Y[9-$ZU-'>YL=.C:9D^).9HRA<9G_.89AI=QK'(,\VS M!9J(A,><*?0%3:0I'ZE?$,UFZ.9GSEIM?HXX=/Z /B M&?IK*7)EQJI!J(VO]HEAO/'KJO2+[/$+$W0O,KU4Z":;L5D=(#0D*Z9DR_2* M@(C7+#Y!$?Z,2(=$#0Z-WVY. '>B*O!1@1?MP=O&\C.:)#;B]9#^&HUO- M4O5O4_!*[&XSMIWZ%VI%8S8,S-Q63#ZQ8/3[;[C7^:.)N">P6ABZ51BZ$/KH M1FEN)B.;H0?%YGF"[OB<-3&&8?KHA5'95&=CT/"=[$XK=J>@6[?IBG)99-1, ML-7N]&';7#>1+5'[!:I=B)]&D2VZIUU>OX[!N(>K035_>Y6_/=#?L4A7N692 M%2YJN]B*-,TSLRC815?!7H/8QQ:E)[!:&/I5&/HMSLV^SS!X JN%X:P*PYF? MN0G#1/OG)FCX3G;G%;MST*T[^@B7,VA^;!X]@=68XHY[R7=:+.@-N*=(^$*K MAV)'[V _17T YW1_5<.6[V5('$,">C85<[VFLID4:'IT*CVAU8DZ!87;E%#8 MJX;RA58/A5-1V).,.H#3!:JZ#2&%G9+"L)3ZFLN,ZURR(LUS_FR/FS\L0*"C M$^L)K4[;"3+<:[/&O4HR7VCU4#A1AD&QADZ)$5A!%=5^X$,8AC@VI;[0ZH2=,".DQ>HF7J6; M+[1Z*)QT(Z >*G./-).-:]H!X^X92HN]P49B;0@QXH08@074ZZ*VBS?/]BW> M,-C1.6U#H1>,AIF^7M5;7Y0JN'PJDV N^CO7WQAG$ .0Y;OI>A$V,$%E%- M=;Y?I,!@1R>W#95&G$HC9VW6N5>]Y@NM'@JGUPB\A_;V.H=Q()'2A@R+G R+ M8/ETFYF75$:3+[EY7RE@9P7&.;HETX8TBYPTBW";S2FOHLT76CT43K1%\&[: MFTO\ ZPE,.6QS(,=YK!*9.+HD>N4-'/+;NEU=6J#W]9=)]?7;_"%^.RF^Y@ MRN;^/94+GBF4L+F![)STS=M6EOWR\D2+5=%R?A1:B[0X7#(Z8](.,/?G0NCM MB7U ]5\+H_\!4$L#!!0 ( /6(75@ Y%VT10( $L% 9 >&PO=V]R M:W-H965T$ ].,DFL=>Q@3YK=O\>7-A2I+;PD'GOFS)D9'R>]TH^F!D#RU AIEK1& M;&^BR.0U-,R,5 O2GI1*-PRMJ:O(M!I8X8,:$<7C\2)J&)5J>)ZE!P M"5M-3-Y88A2Q.M>J*=MT5S"U^J MC[;DN'1#V:&VI]S&8;H+PR"J)#M>25[RG$DDJSQ7G40N*[)5@N<<#'E+=E#9 M>2"YD^$VN+:^V@ R+LSK)$++QZ%&^2'W.N2.+^2>Q.1>2:P-^2@+*/X&B&PA M0S7QL9IU?!5Q _F(3"=O2#R.I\0$NE=PIT.7IAYW>@'W7#M^K#*#VMZJG^F93DLJ962 ;T'FKY\,5F,/UQA.QO8SJZAIU^Z)@/M1FJUJYFG M?;87@6H 6W@PI^%].DFB_9G\\R'__#_S:VB51I8)N$9@_D\"T&PO=V]R:W-H965T99;M^%/QR7+<(GV>[G0M/); ME(07* U7$C2F$^\RO)B%@5.H)7YP7)N].3A75DH]N,5-,O$"QP@%QM9!,!J> M\ J%<$C$XW$+ZK4VG>+^?(?^I7:>G%DQ@U=*_.2)S2?>F0<)IJP2]EZMO^+6 MH8'#BY4P]1?6C>QHX$%<&:N*K3(Q*+AL1O:\#<2>0CA\12':*D0U[\90S7+. M+)N.M5J#=M*$YB:UJ[4VD>/2WGR^8V0*6PY)GD*8^9M' 9QZJ2 MELL,%DKPF*.!3W"/3R@KI#%6)%N']<,<+>/"?!S[EO@X5#_>VIXUMJ-7;(<1 MW"EI

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

7!/="9SSI_UX$LXM!P=$$00*$V@>-G &*)( M@S",EYQI%4MJQ\/[/?V3R1USF5,)8Q[]8*%:#:V>14)8T'6D'OGV,^3YM#4O MX)$TOV2;V;8\BP1KJ7B<.V,$,4NR*WW-=3AP<)LG'-S'0RAU:1IDL%:/#A"KJ#P3?$J&MD:9OC)C&&]-GB=[VF1+XE*&?\K\"BB;) M>W)/A:!Z#\CU!!1ED;PA5X0E9,JB"'=(#FR%ZVDO.\C9XXSMGF W73+EB5I) M\C$)(2P#; RTB-;=1SMR:XE3NB-.\QUQ';=)GF83L7&>(;KU6_,S[NY5 )/QZ^*T$89HE6-T!7CUF0U MM+ D2! ;L/RW;YH=YT.5:)>$32X$*TG7*J1KU=']&01KP=0.SW_*)5-5RF6$ MMB'HTKCQG88WL#>'@M2N MVR>Q*8-5VM5ZGJO=A6 E[;J%=MW:)._7\1P$X0N"WRR!'4-64"7Y?;*RCFJ) MYY:O#-8Y.-%'YWERH>5*\O0*>7JU\GS#=PD_K\F21.8P!EQ6UJ5:RKF2]/XI MR1*9M,]M"DL2IGVBTS[9V6:TAVVB:KJ[1_5DL[-ME^1;>LHVRJ;XWSM M@VXJ!K$T7:G$'5LG*FM5BMFB\;TS_=[1_!@;XJQ__8O)NNDI%4N62%1H@4BG MT<6(1-:A9@/%4].SS;G"#M#R5.X,9P+O%.A=55%UO$4N#S,2 MD=/&BFU+XS:"+*WI%N_1?*OOE+6"CJ5@%0K-I "%FQF91]/%T/E[A^\,#_IL M#4[)6LI'9WPJ9B1T 2''W#@&:A][7"#GCLB&\:OE)-TK'?!\?6+_X+5;+6NJ M<2'Y RM,.2/7! KD>/+)=?^'PZM;T@@WVDCJQ9L(ZB8:)[T MJO@!(6D#BA3:1>5E+:FB6*GD Y;PMFUOXW'BT5<.$ MJ^*]4?:469S)/J/-@88KN+?]4>PX@MS @Q>/Q=5\C\K6$E;H&H*)+7A_^(JJ M BH*6#*=RYTPL*(&XG2$G=IB3U? M+XUJCR1[_2H:A^_[]/TGLF=JDTYM%GM -QWT6 M#L+)9)0&^W-%_7[CFU%X]HLZ4!-]<':#W?3\0M66"6W3O[$LX6 R(J":B=08 M1M;^4J^EL2/"+TL[Q%$Y!WN^D=*<##&ULA55M3]LP M$/XK5H8FD 9ID[YL71H)J- F,:FBL'V8]L%-KHV%8V?VI85_O[,3HFZ$[DMC M._>\7.Y\3?;:/-H" -E3*96=!P5B-0M#FQ50E4,V3/[7?X0 016\ MHA80>=^-D'>YX,C3Q.@],RZ:V-S"I^K19$XH5Y05&GHK"(?I+5!*EIVS%94[ MKR4PO6$W-=8&V*52-9?,A[ E?Z9:H&6G"T NI#UC)TPH=E_HVG*5VR1$\N-8 MPZS5OFJTHS>T%Y!=L'CX@46#*&8/JP4[/3G[FR:D=+J;FV M:*CLO_JL-12C?@IW%6:VXAG, ^IU"V8'0?K^W7 R^'S$8-P9C(^QIY3OJ,]3 M@YIZE+M-NW0XBJ,DW/5HC3JMT?^TQGU:#6IRH#7H%QIW0N.C0O<:J5DV3>M( MWS-5VS-]^N-7^F_G.NDL3(Y:N 5K9TR458V04W,B4.VP3WWR2OU\-.P7GW;B MTZ/B2]^Y&YC=N MMD)9XM\0;'#AAHQIQE"S05WYJ[_62(/$+PN:W&!< +W?:(TO&S=-NO^"] ]0 M2P,$% @ ]8A=6!Y_+7W$ @ E@< !D !X;"]W;W)K&ULK57?;YLP$/Y73JR:.JDM@22DZA*D_-BT2:L4I>OZ,.W!@2-8 M-3:S'=+]][--0M.49'W8"]CFON^^.W-WPXV0CRI'U/!4,*Y&7JYU>>/[*LFQ M(.I*E,C-ETS(@FBSE2M?E1))ZD %\\-.)_(+0KD7#]W97,9#L=:,HU+"]Q? M[]@_N]A-+$NB<"K8 TUU/O*N/4@Q(VNF%V+S!;?Q]"U?(IAR3]C4ME'H0;)6 M6A1;L%%04%Z_R=,V#WN (#H""+> \!#0.P+H;@%=%VBMS(4U(YK$0RDV(*VU M8;,+EQN'-M%0;F_Q3DOSE1J ;T8WR M<*=\$IYDG&%R!=W@ L).V&T1-'T[/#PAI]LDLNOXNF]/Y 6,F:D2PA,$4V\P ME9A2#=^$4O!S(1@#\R=NB$Q_M>6S=M=K=V>+^T:5),&19ZI7H:S0B]^_"Z+. MQ[9<_">R%YGI-9GIG6*/)[BBG%.^,O7&;#+:HJTI!H["=IXJOC2-:.A7^U&T M&/6?;5Z(ZS?B^B?%S:6HJ&U)K?]TC8WV'?:"0U4M1L$Q65$C*SHIZT%2C9BRM0KESG5^!JKNX9S6DS7,:NIQZ<3\S0J6?$,TT]L6Z)-#^J M H:9H>Q<#&PO=V]R:W-H965T+"ZY,YQ9DNNHY.)99@ *O>24R8F3*56,7518=G@! M3*^LN%[?S3%A3AS9N;F(([Y5E#"8"R2W>8[%ZQU0 M7DX]DR^3?A. MH)0'8V2#E5ZC]6($)I]+^HK+*[>OD9"L5SVNP5I 3 M5GWQ2UV' X#??0,0U(#@O8"P!H36:*7,VIIAA>-(\!()DZW9S,#6QJ*U&\+, M*2Z5T*M$XU3\P'; %!>OZ#-:5B>)^!K]G;Z>@<*$RAN=\+2NK&W2%"$./ M&=]*S%(9N4H+,71N4F]Z5VT:O+'I#)(."OU/*/""L 4^?3\\.(:[VGY3@Z"I M06#YPG_68$9D0KG<"D _;U=2"7W+?K7YJPB[[83FY8UE@1.8./II21 [<.*/ M'_R^]Z7-[7\B._(>-M[#2^SQ I?Z.BD0!-/6DZS@ PLW+6$7^\/^*')WAP[. MDX(P[#9)1\JZC;+N167WA!%]KU.TX;S]DE7X_L&N@WXX/)'6DC0REZY-6J^1 MUKLH[9$K3-L4]<[J,.IY@Q-%YTF^%_0&)Y+<@S=M^NDW+#:$241AK7%>9Z!I M1-6CJD#QPC[S%5>Z:=AAIMLZ").@U]>X^>\^"/)AO%G40!(]%*55(R=0LKZQG5%5D"%Q16K@:J1!>,5 MEJK+EZZH.>##T*TPH4Z:F'!C=AI M(UW)G+%GW?F:CYV!!H(2,JDS8/58PP3*4B=2&'_:G$XWI1;NMK?9/YO:52US M+&#"RI\DE\78B1V4PP*O2GG/-E^@K6>D\V6L%.87;9K8*')0MA*25:U8$52$ M-D_\TOJP(_"&!P1^*_!/%02M(#"%-F2FK"F6.$TXVR"NHU4VW3#>&+6JAE#] M%1\D5Z-$Z60ZXU!CDB-X4>M"@$"8YHC) KB:G7.@$F$A0 IT/@6)22D^H$OT M]#!%YVG MR_VWMZ&:6 MH7T6O2]O1(TS&#MJXPG@:W#2]^^\*N=ZOH1UV'8=@%O:$;=G3#D^C$:BXR3FI]+E@1FS3A M+F(R1 V# M.-YCWW3?L-\J3Z06CT+I1M<16HA\.;V:CJ2U>8"F#.IKA/3+-2%#UP' MJ/$%8W+;T7=*]Q&ULM5I=;]LV%/TKA%8,+9#4(FE]9;:! M-EFQ -T0-.OV,.R!L>E8J"2Z)!6G^_6C9$44+5JV$?HEUL>]A^=>7I&'9"8; MQK^)%:42/.=9(:;>2LKUU6@DYBN:$_&>K6FAWBP9SXE4M_QQ)-:\X$&6>$_[C(\W89NI![^7!E_1Q):L'H]ED M31[I/95?UW=!WAUC8/*H;;X*Z4;T;D&52@/C'VK M;FX74\^O&-&,SF4%0=3/$[VF658A*1[?&U"O;;-R[%Z_H'^J@U?!/!!!KUGV M=[J0JZD7>V!!EZ3,Y!>V^8TV =4$YRP3]5^PV=J&V /S4DB6-\Z*09X6VU_R MW"2BXP#'>QQ0XX".=<"- ZX#W3*KP[HADLPFG&T KZP56G51YZ;V5M&D1=6- M]Y*KMZGRD[,[KBJ"RQ^ % OPZ_^,$'Y$_5F/_\$0_\76^".P(PTX#8-> A]]IFJ+V$!Z$ODMF"W"%&-4 T. M3S.(?1@%D]%3-XR^68#&"6ZM#'[CEM_X #\AKL"'^;S,RXQ(175!51KF*=F. M!:K72,ZX3/^K']CH;QL(.[PN882"\0Y]BUD4Q:&=?M#2#TY*[P4HJ#7'0:]U M"%&"X [)OMEX'/F1G638D@P'25ZS?%U*RD6=3ED-M"P?+HE!P%/KWQ&8$7O4 MQAZ=<1B(7*;!$9B1AKA-0_SJ82#NERC&NP7:-PJ2Q%Z>29&'H:)#;J? MV@N.P(Q(H:_G9/^,Y=B .\J$*S0S%1UY E]=D@V$.6Q&NS5IL8H[1B8_K1_@ MX+P\^U3R(I4EIW4G+=/GZMJNBYRJ!5=H9MA:+T!\S@H=5",GI\(1FID*+4W@ M(6UR1(7V906$O0(=-C+I:>D!C] >*Y8M0)JO.7NB%4=[@0X"G=PKCM#,L+68 M@>$Y"]2ILG&%9J9":QLXJ!F.*]"H/V.'X6Z!6HS&:$^!:LT!7R\ZAB%.[@]' M:&; 6LC Y)REZ53GN$(S%]]:Z*!!]7!4WS<0QKSM(W^W."UF.$CB/0M/I 4( M.B1 7KWT1'WE<0DQZG!K0K#8!2K6/2%T]CB&-3O6#*S0S:JT?T/B<6U"#XN3D M5#A",U.AM0HZ;9_$&G!_\R,.4;);HI8M$ACX>RI4JPHTO$=R_)<4]MJ/?-_? M9=FWPH&_CZ6>\-'PA']/,BK4,)6S ZETNG'A"LT,6LL(%)_S,W(J,%RAF:G0 M @,=V"HYYC-*>J6'HB#>+5"+%1[O*5"LIWT\/.WK?EE1M3!9,@ZRBK-UV]GI M;H8K-#-P+28P/&.1XD&E M=\Y$AN7(-2N$Y.7VN#$M@%H]/ZI,6-?.PU G=\TY% G6B@2?4Y%@IXK$%9J9 M"JU(\.L520/1/?(R3KR:0/I6O=W'4><GLCV;H^VGU@4K*\OEQ1LJ"\,E#OEXS)EYOJM+C][X#9_U!+ P04 " #U MB%U8Q@CTC>4# $0 &0 'AL+W=O/ VT]8BB8/M;EE^_;63 M;#Z:U-NB\M+&SLSQF?%X/)/QCO$?8@,@T:\D3L7$VDB97=FV6&X@(>*299"J M-RO&$R+5D*]MD7$@4:Z4Q+;K.(&=$)I:TW$^M^#3,=O*F*:PX$ALDX3PAVN( MV6YB8>MQXC-=;Z2>L*?CC*SA%N37;,'5R*Y0(II *BA+$8?5Q'J+KV9XJ!5R MB6\4=J+QC+0I=XS]T(.;:&(YFA'$L)0:@JB_>YA!'&LDQ>-G"6I5:VK%YO,C M^OO<>&7,'1$P8_&_-)*;B36T4 0KLHWE9[;[!TJ#!AIOR6*1_Z)=(1L.++3< M"LF24EDQ2&A:_)-?I2,:"C@XH."6"NZ^@G] P2L5O-S0@EENUIQ(,AUSMD-< M2RLT_9#[)M=6UM!4;^.MY.HM57IRNN J(KA\0"2-T+N?6YJI/9(7Z).*H-?H M$^&<:#^CEW.0A,;BE9K]>CM'+Y^_0L\13=&7#=L*I2S&ME1\-*J]+->^+M9V M#ZR-7?21I7(CT+LT@J@-8"M#*FO<1VNN72/B'):7R,,7R'5$\Z]0(N8I++M8_3?!R6.;B0DXGN?\PILOQ];'^\KD9$E3"QU?@7P M>["F+Y[AP'G39_B9P%IN\"LW^";TZ0=0YRQ"4$=7"K+/X@(FS&%T_KF?8NR. M7#RV[YNV=,5\/W3"2JI%Y]2X&%*M$TILFS! A>@#"^Q1G1L4_C.IA9=G0'-5,"+3B+$$T MR0CE^9EF*Y0U,VH5\WUF#SM[XKG[ 33L; G& >[?DU'%?&1D?I-*X"F)7V\% M5!'41] (<\Q=3<0E^)D^<"ZWMBL:-C\^3CDN<9O"%W:31 M(^4-#J4-[-8LW?/FXQ(O;+/=)^MVR+H'N=;7/#9>G\&ZRL#'E1D'DT/8H3?L265=*=\[F![J0@&;*X7C MTH,9PU $F35/#1&[T4LFP-=YBRW0DFU3631BU6S5QK_-F]>]^6O=WN<]:@U3 M?!OX2/B:I@+%L%*0SJ5NIGG1;A<#R;*\8[UC4O6_^>,&2 1<"ZCW*\;DXT O M4'WTF/X/4$L#!!0 ( /6(75C\",(PZ ( %8* 9 >&PO=V]R:W-H M965T'?[SI)L[0-#$3WTL;V/2?G''_$@Q47=W(.H,A#EN9R:,R5 M6IR8IHSGD#%YS!>0X\B4BXPI;(J9*1<"V*0$9:E)+ '-]3@X//I #DN3D^YP7$CGDP%0H2Y.;<2WA MK)) GY!P#O$Q<>P>H19U.N"CE\/I)MS$,)I$:),(+?F6-8,BO M2RPG%PHR^;O+:L7M=G/K/7DB%RR&H8&;3H)8@A&]?V?[ULN[+W1+9A-FC,!O]Q@P?[C&%/ M9!LQA$T,X9OG/-Q9;*%%+7]K2>Y6.5X_?&)_]QMY_;WM[W['_G9H2T&ELZ/, M0S_=.FWK[Q?4VL\.KWG:!Z'O]^FVS(XR/%5#>TNGV?KHZQO75R9F22Y)"E/$ M6<./(@>0:%?04LRM7,KJRK9%DD.!Q06K MH%0K&>,%EFK*U[:H..#4.!74]AQG:A>8E%8\,^^6/)ZQ6E)2PI(C41<%YD\W M0-EV;KG6\XL[LLZE?F''LPJOX1[D0[7D:F9W*BDIH!2$E8A#-K>NW:M%I.V- MP0\"6]$;(QW)BK%'/?F>@[NY(B#USIXISKXK8-O FW(3%BW6.)XQMD6<6VMU/3 Y,9X MJVA(J?_%>\G5*E%^,KY.$EY#BC[L5%T($ B7*?HF<^!H47,.I41?"%X12B11 MJ^>W(#&AX@UZAQ[N;]'YV1MTADB)ON>L%LI7S&RIL+2XG;0(-PV"=P3A%I(+ MY+MOD>=X_HC[XG1W;]_=5LGH,N)U&?&,GG]$;XF?\(JVF3#IP52@7] M%W1&>_B3#G]R$G[%609"=QI,D%)O!N#"X9PTXE_ #=FU$O]'MVTHYN^2+>L>9*K5HD8 M3U5?2'"9J+;;E$0&,'KDIT,.-XH.8(=&1TC#CC1\D=0TKC&<<+"3[P]PAD;N MI1N-$T4=473:@>KW5V;Z:]+V5_JOOXZA1X-SX@9!>,@^8N4&D\/C9/0NERH'O MRVP!!997O 2F>V9<%%CIJIC[LA2 (7F# O'=JV.Y$.>:4H87 G MD*R* HO7:Z!\-?)"[ZWAGLP7RC3XZ;#$"5WS'4M."F"2<(8$S$;> MUW P[IMX&_"3P$INE)%Q,N7\V51N\I$7&$% (5.& >O/$L9 J2'2,OZN.3TW MI %NEM_8OUGOVLL42QAS^HOD:C'R>A[*888KJN[YZCNL_70,7\:IM/]H5<"XC7@-@:K9596Q.L<#H4?(6$ MB=9LIF!S8]':#6%F%A^4T+U$XU1ZR]F\I4 4: )3A5K(-CRZAO,)*$RHO-!= M3P\3='YV@AQP2N)62Z'OM(Z#)N?K<>\KL>,]HPY@>P*Q>$EBH(H;H"/ MWP^/MN&^=N]2$+D41)8OWLNG?=XPJ42EEZ="OV]U +I14,@_3>9JMG8SF]EU M UGB#$:>WE82Q!*\]/.G, F^-%D]$=F6\=@9CP^QI[<@Y0 ],5QPH<@_R%%. M9,8KIIILUUQ=RV7.AF4:#/WEII?=B%8<=EW0EL:VT]@^K-&MSUQ/4Y.N&I\< MT+4;$?637MPLK..$==Z1O'$EA%DSI]&M,) _YHE)TYR M\H%<7B*F+PDM^-"D)T>E[D:$^Y/;=4J[!Y7:\X=RS"0J\2N>4F@2=Y#CHQOQ M1&1;=GO.;N^D)U#OE,9/1+9EO.^,]T\PS_VC)\]N1-RP7?R-:](\47Y@,2=Z M: HSC0NNNGK;B?K:KRN*E_;FG'*E[V%;7.B7$@@3H/MGG*NWBKF,W=LK_0]0 M2P,$% @ ]8A=6+$:5HW0! NR( !D !X;"]W;W)K&ULK9I=;]LV%(;_"J$50PNTD4A_I9EM(+%4+$ R!$G370R[8"S: M)BJ)'DG'Z; ?/U)2)-.161LXN8@E6>5:H2;#2 M>GT1AFJ^8CE59V+-"O/-0LB<:K,KEZ%:2T;3,BC/0A)%PS"GO BFX_+8G9R. MQ49GO&!W$JE-GE/YXXIE8CL)"*?C-5VR!Z8?UW?2[(4-)>4Y M*Q07!9)L,0DN\45"B THS_C&V5;M;"-[*4]"?+<[U^DDB&R/6,;FVB*H^7AF M,Y9EEF3Z\4\-#9HV;>#N]BO]2WGQYF*>J&(SD?W)4[V:!.Z !&B^45KD=;#I0 ^P<"!G5 >>EA=>VE<#'5=#J68HND/=O0[$:I?AEM].*%'2@/ M6IION8G3TQM1+#]I)G,4LR>-/J$_J)34)@^]CYFF/%,?T#O$"_1U)3:*%JD: MA]HT;,/#>=W(K&J$'&@$$W0K"KU2*"E2EKJ T/2XZ39Y[?85\1)OJ3Q#/?P1 MD8CTT.-#C-Z_^]#5,3\F9O.C,/'Q&.+!)$=@2-T;CTB])K>]DM<[R#,9O2Z4 MEAMS:VOTUXTY 5UKEJN_.WIW5='ZW31;L2[4FL[9)# E23'YS(+IK[_@8?1; ME_"0L!@2E@#!G)3TFY3T?71SNRF%3'UD+YH7RPU7JS(S8F&*VY/N2HJ7=VI2 M*MBHA-E'R/-T2(;C\'E7Z[?G1.X9"5"7' $'C8 #KX#E'?;P[0I]M37K1M"B M2S0OXU31(&$Q)"P!@CF)&#:)&((6ER%D2B!A,20L 8(Y*1DU*1EY[XTO!HQH M+C;^BN*%G)J)T9MJT8O,WUY-@6PR 8(Y$I\W$I][)2Y'/6]&_4=DITY=(GLQ MIXKL[Q,^1WDYN^H:W)#]2(!@CO*?&^4_>Z_R3K(U_5&6&D//^:93=B_C5-DA M83$D+*E@F.P^I,\BW-QUCL(X:KU !#P[J8'.C&+_[I_Y6SU52%!: D5S%=]Q M7QA@5->0H5ME]U7VMG2RRI"T!(KFJDQ:E8E7YD)5 T5_'6>6*OB^J8IJ/_T"U]X?F!$0[J/4%I M,2@M@:*YB6G])^Z#3MLQJ/\$I<6@M 2*YB:F];78;VRO"S.59$HC237KS 2H MJ:UI]O&W.X48D<'>U!VTV02*YHK<>E;L]5_>LF2V[B3/&;H_E !0"PM*BT%I M"13-S5)K8_$(MD:!.EI06@Q*2Z!H;F):\XO]3O/G-0K4]M8TC _9G%IB4(\+ M17,E;ETN]MOO.OV\DR4'];R@M 2*YO[@U)IC$H%6)0+I M4V>@M!B4ED#1W,2T'IKX/?21KSW]E)/S@=\81-+QXA.TT02*Y@K=VFCBM]%O M7G[R8BX959V/ C_K9+G?^G$RZ) ;U$-#T2JYPYT?Z7,FE^7J"(7F=MQ6/WPW M1YL5&)?ENH.]XS-\$5?K*%I,M:SCELJER0_*V,(@H[.1F6W+:J5$M:/%NEP* M\"2T%GFYN6(T9=*>8+Y?"*%?=VP#S7J5Z?]02P,$% @ ]8A=6.V1$9V[ M P ,A, !D !X;"]W;W)K&ULO9A=CYLX%(;_ MBD57JU9J S:$)+,)TC:H:JM^C#J[.Q=5+SQPDJ !S-HFF?GWM0U#DAE"DXC. M37H%4$*D=065%W6,(ZH2&VB]BJ3"_:%/%CB86BDHA65:+U0JR M)*^N]*X&L2-0B;8+2"T@QPK<6N >*_!J@4%M5ZD8#B&5-)ARMD%<1RLW?6-@ M&K5*/\GU_WXEN7J;*)T,KBGG-)<"O4&7BCAP#C&ZDBRZ132/T9QEF?IWJ@=? M2RFD>IKD2_0R!$F35+Q2PC^0C<2*#EID8?=\H]E.D#8-W*\+[<5R(8F:6@2X^<>\)NG5 C$%JC&BAA' M9BNA[Y]4*/H@(1,_VBA5OEZ[K][\%Z*@$: M[+W.[*]-T5*YTC5P5801W &/$@&HX(E*6B<:LS2E7(%1F$S2K3EWSG/JU]6G M65B937;9X<&PG=NPX3;LYE9_"6TD.I6GDNC3+.S);(^8WQ#S?U/=\OODV:=9 MV)/9'L]1PW/4^07.62ZY:FE*FJ)_@&=FJ]Z#VJBMV[/;##N5M(W8V.22T:.J_C2.> 03YU'U#SLS.)//I.$S>:;"/WE27IV! M1QXA.28H[%SQF3RPL^U2G4XBJE&[/]"HU5UFI_[40M2K6]B7VSZ[G0X?_Z;B M7AOW!;5/M[ OMWVHVT8?=_:]IU;X7[@-#U?XLY5AM_)<0MO6'3]_[X[;6VUO M/'$?U;1#D9,GW7MW&N=BVO;X^+F:?/R+7KH&H]PO&Y,- GX(TQV3! M3U!+ P04 " #UB%U8G->H67@# #!# &0 'AL+W=OXK:+PDV,X_G>3QC#XL3%_%7%JI M4N6-;=4/*Z \=/2 M$ '[I77KWJQ=XV L/F5PDIUGHJGL.+_7@W?)TG)T1, @5AJ"XM\1UL"81L(X M_FE K79-[=A]?D)_:\@CF1V5L.;LKRQ1Z=(*+9+ GE9,?>"GWZ$A--5X,6?2 M_))3;1O,+1)74O&\<<8(\JRH_^E#(T3'P9\\X^ U#MZ9@_?<"G[CX!NB=62& MUAU5-%H(?B)"6R.:?C#:&&]DDQ5Z&[=*X-L,_52TYGF.:FX5C^_)U1THFC'Y M:F$KQ-86=MS@K&H<[QD:%22=X4"21] !N#:B/SGB);>:.(=Q!?$]_] ME7B.YY./VSMR]>(5^<05$)E2 7(@R/6W0WHMY!!:+V*_U=(W\/XS\%L-])M. MJH2@KEAIDII854E6',B;O&3\$: Y&#:5B%.T)!M&BZ'X1Y?ZWL2\$%A/E:!5)?C) M-1Q<4JH+@?6D"ENIPF^LX?H$Q5M=]PTH"#WB+4)W# CV&61?J0HK^H#Z*7*5 M-14^?,F$7Q5WZ'CST)L'9^7PM6$P#^93/Y@-5\6\)34?)=5/_*$01_V_=_\N M!-:CZCI?[G[G)R=[$\"%U+H46E^N3JOD_O"$;Y;L)O+,=Z?>)#Q+^ '#28BF M\_ LX>U.,YB#.)@>6>+M6A6J[K[:V;8/OS7=Y]G\2O?GILG\ E,W]^^I.&2% M) SV".E*EZ;EW'&%#:QY3/$; X0VP/=[CI=[,] +M%\MT7]0 M2P,$% @ ]8A=6$+\DXW!"P ''D !D !X;"]W;W)K&ULQ9U=;]NZ'<:_"I$=#"W0QGJUXRX)D$3DUF$])VB3]F+8!6,S MME!9\I'DI!GVX4>]Q!0EF;:*I_!-(LOBC[2>/RGRD4B=/R?I]VPI1$Y^K*(X MNSA9YOGZPVB4S99BQ;/39"UB^;7IXGFSP*8W&;DFRS6O'TY5I$R?/%B7WRNN-SN%CFQ8[1Y?F:+\07 MD=^O;U/Y:;2ES,.5B+,PB4DJ'B].KNP/;.P6"+L2N'4"MYU@5Y&\.H'72N Z.Q+X=0+_T 3C M.L&X//?5R2K/=,!S?GF>)L\D+8Z6M&*CE*M,+4]P&!>1]25/Y;>A3)=??LF3 MV??WUU*;.;E)5C)@,UY*_I[\SM.4%[J3-X'(>1AE;\EO9$2R)4]%1L*8W,=A MGKV3.^7VW3+99#R>9^>C7):KH(]F=1FNJS(X.\I@DT])G"\S0N.YF/>DO]F3 MWC$ 1O*$;,^*\WI6KATC\9^;Z)2X]COB6([=5R!S\D#,MLE=TN^ M)KEHGL#J7P\].)SN;.F'@.D!O]H>5[_Z("#; ^2Q.HW[@)I0[C9\W3('=U?X M%J#W#]WPO9*Q&R^$; -S\O!"FL?=\I=R]]4S3^?DW_^22/(Q%ZOL/WVA6^7O M]>=?M/L?LC6?B8L3V;!G(GT2)Y=__8L]MO[6%S9(6("$422,@6!:1'C;B/!, M],MOY;5$RLR?1"JOC60A R$GFH*WWN0HQ]$ MD<5B()@FJ+\5U#<*>K58I&)1R!?&>1K*/LU,:9@O!S?;M5;7J.T>XQAR&BKFGO&.R*L>[?>T@M" 42F,HFBYSP^JPC:>-A?$#E\VF'"C* M\T>J-O3;:S=DQU#_V@P=K"R2%D!I%$IC*)HNMJ/$=H[L#-0%0 4&DA9 :11* M8RB:'AC*,;*-]L.O':.8\QX<$U"_"$JC4!JK:=KHR;4GMKOMP>AJ*S?(-MM! M7W@D)>;QG*QX^EWD8;SHU0WJXD!I 91&H32&HNGJ*FO(]H_=R$,M(R@M@-(H ME,90-#TPE ]EFXVH8>-C,VRPR./.4&SJGDU:8S&[QR^R++<]0H86C:%HNBK* M?++-[M-K!_PZN.J5 >HN06D!E$:A-(:BZ:HJ*\H^.W8C##6PH+0 2J-0&D/1 M],!0GIAM-L5^;4\;ZIY!:0&41J$T5M.:UQW']YWIKJZVHUPTYT 7[2?O+9CQ M0Q6%T@(HC4)IK*8U[U98IYZS0T[EECE[W#+M9KE!-J@_5M.:G2=[ZG><;&BF M%$IC*)JNFS*^'*-_4EV.LZIQ?8@$V:S+SF]=%553>W!+:\YOL,!.M]]K3SS' M;2L,=;"@-(:BZ0HK!\LQ.UC&)R*V%]):\B(&>E6%.E4UK5EM>RHMU(""TAB* MIDNJ;"K';%/=1#S+FI4S24E:7$[?D4U<5.7Z^:2#ZBO4RZII>GV=3J>6UU87 M:E-!:0Q%T]55-I5C?H3IHZ&:;N(GD>7]CRN9L8.5[#Z+-+6[E11J*D%I#$73 M952FDG/HTTWM1G9([81Z34Z/BV1;[MFD_ZY2%>EJB^"I]G;7BVAAA64%D!I%$IC*)HNN#*LG&,;5@[4L(+2 BB-0FD, M1=,#0QE6CMFP^B1XMDDK_<-XOU#,VNB5&.H_.5U7IM."0TTE*(VA:/H< M$.4\N6;G26_!#[SE:V8.GMD!M9N@- JE,11-UUK94JY]Y,;;A1I:4%H I5$H MC:%H>F HW\O=XWL-NN5KA@T6V>D,K=SNT,KM6E]>QR6AT)(Q%$T7I3$]SVQ5 MW=>C6R+A<@Q<=JRK^3J;8NYHKS+8&7?8*7?8.7?827>_PL%RE8/E>L=NEZ&^ M%I060&D42F,HFAX8ROQRS>;7WW?-OVPW";V:0QTPM^N N6YG@E90'Z;=(O6F MW88:ZFVA:+I*RMMRS=[65RF&["C7,Q]ZI8 :5WN*XU:N2V]5@SI94!I#T701 ME9/EFIVLNR3G4:N6U8]>[#:9S/*ET1FD.W\W7/2JSC4H8+2 BB-0FD, M1=,C0SE4WK&G)'I05PM*"Z T"J4Q%$T/#.62>6:7[,!V'FJ,U;1][3S4\(+2 M&(JFB]989\K\R-:VG:^,YS_J]8>*^TZ?E;-1?7F_R^PTYS%84ZBG!:51*(VA M:+KVRM/RCCWOT(,:7U!: *51*(VA:'I@*!O-,_M6/[4.C)DY6.ON]$//ZG@K M 313"J4Q%$T74=EHWH&+9/W\&@M !*HU :0]'T % NG'=L%\Z#NG!0 M6@"E42B-H6CZ\J/*A?,/=N%VW!HS X8*NZ8?>Q:E#S72H+0 2J-0&D/1],!01IIOGD5Y5TR< M+B[5C?>R],H+MF)E#A872 BB-0FD,1=.U5A;9^-@S*\=06PU*"Z T"J4Q%$T/#&6K MC6#C$Q%NQFP99KW*]3Y!9K1'3C;E(@ZLIU/J"TAB*5HD[:KS4 M=2721?GZW4RJLHGSZDVFV[W;5_Q>E2^V;>V_L3\$U8MZ%:9Z;_ GGB[".".1 M>)1(ZW0B1_UI]2K>ZD.>K,M7QSXD>9ZLRLVEX'.1%@?([Q^3)'_]4&2P?2'R MY?\!4$L#!!0 ( /6(75AW=J&PO=V]R:W-H965T M9-'72VGQ!J#J(!+3=]E -M5KW,.W! M)!=BD<29;:#\^UT[(8,J14C;2V([]QR?<^W<.]P*N5(9HH:7(B_5R,FTKFY< M5R49%DQ=B0I+^K(0LF":IG+IJDHB2RVHR-W \R*W8+QTXJ%=F\EX*-8ZYR7. M)*AU43"YFV NMB/'=_8+CWR9:;/@QL.*+?$)]?=J)FGFMBPI+[!47)0@<3%R MQO[-=&#B;< SQZTZ&(-Q,A=B929?TY'C&4&88Z(- Z/7!J>8YX:(9/QN.)UV M2P,\'._9[ZUW\C)G"J2&E^84G[2DKYQP.G[2(EE=3B@1*4Q%09=#,9O?2_@L6:F!6!'N M&9?PS/(U@EB Q<"WRL0IN+A%S7BN/@Q=38(,K9LTFT_JS8,W-O<#>!"ESA3< ME2FFQP0N.6GM!'L[D^ DXRTF5Q#Z'R'P@K!#T/1\>'!"3MAF-[1\X5O9S9C$ M)KLSMJ/;KV$L*:]+M..?X[G2DJ[RKZ[DU=R];F[S>]^HBB4X6Y)O(]RV1*T";V MKKP>'<;FT$UWF!^U84@ M=K5M8&-;MU^M3ZBQU7WH+TW=%1^87'(JFCDNB-+DR %9=YIZHD5EB_5<:"K] M=IA1&ULM5G;$@3=K7-:M$XC MCW>4/?$5(0(\ITG&)Z.5$.M+P^#ABJ287] UR>23!64I%G+(E@9?,X*CPBE- M#&2:KI'B.!M-Q\6]6S8=TXU(XHS<,L W:8K9RS5)Z&XR@J/7&W?Q._*NBHGC-W;%^_1O]6D)=DYIB3&4U^ MQY%834;^"$1D@3>)N*.[?TA%R,GCA33AQ5^PJVS-$0@W7-"T"R:?QM)/3.\%#9_.KV4B(C"CJ7P[."[R>PZ*1^#G.A]R<)7G.Q8OX.R& M"!PG_+,T>;B_ 6>?/H-/P !\A1GA(,[ 0Q8+_D7>E->_5G3#<1;QL2$DW'Q2 M(ZR@79?0T!%H$($?-!,K#KYF$8GV QB29TT6O9*]1MJ(-R2\ !;\ I")+ 6@ MV7!WI(%CU;FWBGC6D7C_;M(Y88 NP'V1.U6*R@BV.D)>XY=\C4,R&\"=&KBC!?XWPYF0U=&# MTSF0!\/883]SO84E:H7YM*.4E9FGB> MD%YN\( ;="&T;;.[C>CG/I4;:K@AK73]+MHCN6A76\)DNP=>]Q]PR^*0*+FA M]Y2R]XJVS[]1;JC52KV:131),.-@+<6]6&SU6IC5NB]I N&5 :+606!>PNQ>KS8YM<[ 18:A7X7U]&PC9.<0BDW>P32C- M;.L(Y$:1H5Z2]X5N(&3W$ N\\ ZRK#"3D-$1R(TT0[TVMR5O(&"O!TD%N,]L M'W CT5"OT9TZ;.G?0/B^*M]FM[>LS([6ZC[Z1KRA7KW[5' @AV 8!RV6$W=, MU"@^TBO^,34']$#H*8'0/H> M0%.]2I[Z:#J>'_'=CII> ?5\N1]6KI*?/HI3\@,V2,M#'62#"+^H"6M#G4JX MZ360HZWCJ^62D246!'R751MG/ [!(TXV:MK:ON7-I?I.T?:9-RT+TKGNM7=BS/;?;4.DG.95$T\0@?1/SUKH\/#Y0DM).>BJIIM%!/8W.P"+T#U;( M=:S6]T)%1CO96\D8K>/GE+!E<2K/04@WF2@/9^N[]W;E_#2]GY?E] M$Z;\.>$'9O(+BX.$+&1(V7O).F'E"7TY$'1=''+/J1 T+2Y7!$>$Y0;R^8)2 M\3K()ZA_)YG^#U!+ P04 " #UB%U8MB>Y(^D# #Q$ &0 'AL+W=O MC#9HA1^Q>-K<,UFR:Y8T M*S#A&26 X>78NH.W<^BK (UXSO">'[T#)65!Z8LJ_)..+4=EA'.<"$6!Y&.' M9SC/%9/,XWM%:M7?5(''[Z_LG[5X*6:!.)[1_+\L%>NQ-;1 BI=HFXL'NO\; M5X("Q9?0G.M?L*^PC@62+1>TJ()E!D5&RB?Z41EQ% ##,P%N%> V _PS 5X5 MX/4-\*L ;;5=2M$^S)% DQ&C>\ 46K*I%VVFCI;R,Z+Z_5$PV9K).#%Y%#1Y MN9E*YU(PHX4<3ASI#KD!#Y@+EB5"MF@4>"*9X.!.]50F?H(/P0Q'705@?=@'? !GR-9/O(%C)Q]7D[J9*'S_N&P0XU7=Z*G^;PS M?/]NBP5F@"[!XUF'2P;?S*!6EUN^00D>6W+YX)CML#5Y_P<,G3]-[ER3;'XE MLA/G_-HYOXM]\FTKN$ DS.#]MSUW/\,(SBAA%MH'$QF'=F>J$/<>U#W+E1Z$D.Y$$!@\\H M8^ 9Y5ML4AU?<[>X)MG\2F0G]D'G<%IR?G>_2&F>(\;!1N[(>EP9AU7UG?AH MN'@#OSFFC*B@N: 84.$@"FO4J=:CDR'LO2/T%%6=-;U35<.F*B/,#9NR.M.[ MM*O=@WRW[^[04[UKDM7:)DPPV5W-C;$[NTO5'TZ4L//8U=@H>AK@&0UH'@U, ML& F^MD=X*7&G X&,)?.!D:MHR>EOB]IKD)U9[F;91AFMM'=\$"LY6^4W.0 MT"T1Y?VHKJWO[7?ZMMJHG\+;67G[/M"4?P9\14PN?!SD>"DIG4$D#W&LO%^7 M!4$W^L:YH$+>7_7K&J,4,P60[4M*Q6M!?:#^EV/R/U!+ P04 " #UB%U8 MGRQ!,[P# #)$ &0 'AL+W=O,<.P0D'OW+P^SH$E8.1VBZI&!UB+'$TX6R'N+96:+IA MQ#3>BGY&];P_2J[>9LI/1H^2)2\W,Z5^L*H7 OT&TTA?0M@*\XU<>^5^,SK1(PAN46^^Q%YCN>W M!#3O[^ZUN,?]W=T.-GX]C;[!\T_@_57D"^"(+='C285+A* =09\O=V*#$YA: MZ@ 1P+=@1>]^<4/G4YLZUP2+KP3V1KF@5B[H0H_^+J20F*8977U$"UAEE*JF M.DN(6<+O,UHMV@]MFI;8H<'61^PV&H6!XS@3>WNH5M/LR"+N#/)""0:U!(-. M"7[GF.JM>X;KX!R)>=-B' P;:L2=T5S(-:RYAIU!V<](I0. /N.,HV=,"FBC/+[F MC7!-L/A*8&_D_86J$Q<_PR?SM NG6-O3]WK>Q'T9.[UH36O MS+KNA.[(+F6^3Q7=SGSJZ%KH2=YO)3\\)M]NUICZGY'PN?N,S_T/*5_+)=%3 MDJ#7WFZU:@@2G-W;]D&-EP-?F5I9H(055)953SU:U^/WI@H]&I^Y=_.RJM[# ME$7^%\S542<0@:6"=&Z'*E'C9=U<=B3;F$IRP:2J2TUS#3@%K@W4^R5C\K6C M/U#_>Q']"U!+ P04 " #UB%U8:\U;#/@" #R"@ &0 'AL+W=OUW%3RH03]8IW(Q7U M9&XX$S!21.=I2M5Z %RN^H[O/+ZX8;.YL2_=Q7H$Z=TP9NCA_1+POQ*&9"-5Q(_HLE9MYW3AV2P)3FW-S(U7>H!!U;O%AR M7?R25;77BV4$AM8A&X=QS/)0=-1HK%3,S(M4R DX,A&,JX/L3 2R8FN),,AN<]UR!)F\J- M*T*#DE"P@] 0XA8)_2\D\(*0W$D#SS%<%%BK#&J500':W@%ZP_3B:*H "!,& M%&A#%'V)7+)K!+)GY$QG-(:^@X= @UJ"$WW^Y'>\KPTTPYIF6*"'.VA>4J;( M'>4YD&N@.E> _W]#KD26&TVH2(K%TI^?$,\%N\_1B=\_$(=<&4CUGVV2PCU( M:M>2VHV5W]3!K(YM!$L(O\2PWY%EY+7:/7>Y)?%QG?BX,?&WAPP//OYKT>^4 M'#!!UD"5/MR6OQ'IC07JU#P['^%Y9P^23FI))^_WO(3H;%@>;C?\M,YZ^CK# MEY)3^\DRZVUY&T'>6)AN3;'[$5YW]R#)]YXN$._];E<8SXYX$+:ZVRWW-VXO M_W6F)VS)$L *KAGP9"N%1J2WENGI!O*#C_#>W\=]Y3]=6'[CY?%*\\/_SKKW MPGAWHX.QW> U53,F-.$PQ1BO=8*?:%4V6.7$R*QH:B;28(M4#.?8E(*R&W!] M*K%SJ":V3ZK;W.@?4$L#!!0 ( /6(75C7_K'&NP, &T1 9 >&PO M=V]R:W-H965T69& MD]P()OK<'0\F;"/3)(<[3L0FRRC_.8.4[::&;>Q/W">K6*H39C!9TQ4L0'Y9 MWW$\,BN4*,D@%PG+"8?EU+BQK^>VIQ)TQ-<$=J*V)JJ4!\8>U<&':&I8BA&D M$$H%0?%O"W-(4X6$/'Z4H$9U3Y587^_1W^OBL9@'*F#.TG^22,93PS=(!$NZ M2>4]V_T-94%#A1>R5.A?LBMC+8.$&R%95B8C@RS)BW_Z5 I12\!"VQ.<,L$Y M3AB<27#+!%<76C#39=U228,)9SO"532BJ8761F=C-4FNMG$A.5Y-,$\&"\G" MQ\L9"A&1.OWY+7),G) MYYAM!,TC,3$EDE2W,L.2T*P@Y)PA9#OD$\ME+,B[/(*H"6!B=56)SK[$F=.) M> OA%7'M"^)8CMM":/[_TYT..FZEN*OQW'.*QY3#Y8.6]8[^Q$="DAO.:;X" MM;[8RQL1%)#,Z3J1-$W^A>B"W&1L@]'?/B(D^2 A$]_;!"[N/VB_OWHO7(LU M#6%JX(,O@&_!"/YX97O6GVWB] 36D&I0237H0@\^,RR="&W10K"P[D,HA&J3 MH, =:5SU)ML&SL >VA-S6Z^M)=I*>,R$)6^([;@OYII5= M)\!S-Z@GL$:M7E6K]\)>]OJ4JB>PAE2C2JK1;_)R@>O57#KTW2,GG\;XSKC= MQWY%V.\D?(\24![&>NLB-'/*UFI3VRAV(CUWEWH":Q0]KHH>O["AQWU*U1-8 M0RK;.K0.UF^R= E<]^O \0='IFZ+LJPSMK9K'8_=27M!4^Q=U/YAX_H(,LE7 MK1P[49Z[4WVA-6MV#C4[+^SKDD!?=B'?LGN;IC^@APX,E>;2",<%Q(A.56#4BO73K!G;UE/:,W2#UV7 M/7QIA_?:MO6%UI3KT+C9G=K;X9W.A)^>C\3'U+T /Q :;X$/&)\E62"Y+"$B&MJQ'JSHO9 MOCB0;*W'XP&ULQ5C1 M;J,X%/T5BQVM9J2V@"$D=!.D).UH1]J1HJ:=>5CM@P,W 14P:SM-NU^_MB$D M)!1--8SZDAC[WL.YQP=TS7A'V2./ 01ZSM*<3XQ8B.+:-'D80T;X%2T@ERMK MRC(BY"7;F+Q@0"*=E*4FMBS/S$B2&\%8SRU8,*9;D28Y+!CBVRPC[&4&*=U- M#-O83]PEFUBH"3,8%V0#2Q /Q8+)*[-&B9(,@*L$?)K@OI+@5 F.+K1DILNZ(8($8T9WB*EHB:8& M6AN=+:M)K M%S3=$1:A^Y<"T,<;$"1)^2>9^["\01\_?$(?4)*C^YAN.%_P#' MCCOH.+7^CL9S7M,_)@PN5UKD!7F1#XA 4\9(O@$UOMB+'2$I()J3(A$D3?Z# MZ )-,[J5T7__)2'1%P$9_Z=-X/+^;OO]U5OBFA^_V9[U M1YLX/8$UI')KJ=PN].">RM(1UX8M!0N/70FE4&T2E+A#C:O>:T\!=NV!/3:? MCFMKB<*N/ZJC&J0'->E!)^GR(:*%HMCJ_\[TMVY/3V"-2KVZ4N^=G>SU*55/ M8 VIAK54PU_DY!+7._:HCP^V^[C44UYU$GYEK#\4K8!B*MM;G5R M)\!;MZPAE2V=>@?K%_DY0JX869KZ)R8N27*V M,#]C9^?,J([M#D_M?![E#K#SBIT/K9'=W1O=+1^XWL"%'+2RZ\Q_\R;UA-:L M]M!3V8/W]G2O;5E?:$VY#HV9W=G,_(RGO;.>6+*RO%-3GX?YHQ$^,;5Y=$K- M@&WTX9U++G)#RO-;/5M_()CJ8_')_$Q].-"GWP-,^=7A*V&;).42%/UGH8 XF J0"YOJ94["_4#>K/*<'_4$L#!!0 ( M /6(75CJ-<@)S@( ,0' 9 >&PO=V]R:W-H965T1 TBT*0LJ!DXN977KNB+-H<3BAE5 U9[ M\$P6N=0+;M*O\ *F(%^K"5G)0S9P/"T("DBE9L#JM8(1%(4F4C)^UYQ.LZ4&[HZW[-]-[BJ7&18P M8L4ODLE\X/0(Z6K'I@?'&H%4VA.I3 MG$JNOA*%D\D#35D)Z 5O0*!K-&)EQ2A0*1";HT#K=(PN+Z[0!2(4O>1L*3#-1-^52J/>R4UK/4.K)SBAQP_0$Z,R M%^B>9I#M$[@JN2;#8)OA,#C+.(;T!H7^5Q1X0=@B:/3O\.",G+ Q/#1\X0F^ M?8=E#L9S3-^_"%1HOV?6;V+]ELIOL'ZWF6GWZK3OI2O K:AP"@-'_>("^ J< MY/,G/_*^M1GQG\CV;.DTMG3.L2>OE$C(T%1B":W7QL)C ]>E:95<^UX41'[? M7>TFT1+7Z\:1UX3MR>LV\KIGY:F2H0H";1-F@='.AMW>@:;CD.NH$[4KBAI% MT5E%CZUWI=V[Z'A_[9T7'NALB>M%'>^$TKA1&I]5.N%L14S55V+_JC4^.K_N MX1$?AQR>KKM3$$O@"],G!$K9DDI;.9K5IA7=F0I\L#Y4+,%\0 MJOY9F"M*[R96A\QMS[ 3R2I3=F=,JB)NAKEJL\!U@/H^9TQN)WJ#IG$G?P!0 M2P,$% @ ]8A=6/EY,. 1 P 0@L !D !X;"]W;W)K&ULK9;;;J,P$(9?Q6*K52OMEE-.S29(3=)J>U&I:MK=:QA.PF?_G&X>Q9[2A[)W' )MLY3PL14+D0]MFXX_3L#"?$"D9Z[HD%([H2:4+@B2&^RC+, M/B:0TLW8:6M4[E;!^ MOW._U\G+9-XPARE-_R:1B,?6P$(1+/ J%<]T\QO*A+K*+Z0IU[]H4\8Z%@I7 M7-"L%$N"+"'%%6_+A:@)W-X)@5<*O$-!YX3 +P5ZY>R"3*IOG LFGR92)X('$M(,T O> D<_T91F.25 !$=T@?8/T=U6 M?C@!Z MZ)$2$7-T1R*(F@:V3*C*RMME-?&,CC,(KY'O_D">X_DM0-/SY9X!QZ\6V==^ M_@F_Z8HQN:;#MJ4IE)UVI2KB(<]Q"&-+5BD'M@8K^/[-[3F_VM+Z(K-&DITJ MR8[)/;B'"!A.VW(LA'TM5/O*.G!&]KH.;HIHT'0KFJZ19BZP@#:60M:KOWJ M(A>RR*$H\C;._A%$USW@/ XYP3FH. ?&LIG! B1CU%HW@Z^LFR\R:V1Y4V5Y M\]FZN3&L: %NBFC0N,[^0' ^5SFESH1C#&GRU XH][/%4RJ-1*:0)I&W)_+. MJ)^H_#K/+*#2T\AJ"FFR[D\>U[CGEZQG(OI'N_!1D;?$'#+:M6XD [;431I' M(5T141SAU6S5"-[J]N=@?J(:1-WE[&V*[O(1LV5".$IA(2V=Z[[8"I#/%Y2*W4"]H&J;@_]02P,$% @ ]8A=6*G: MG341! H X !D !X;"]W;W)K&ULK5?;;N,V M$/T50D5;+["11/F22VT#&R>+W8=M@Z3;/M/2R"8BD2Y)V\G?=TC)\F5ER@7Z M8DL4Y_""KF=!#38#3SS MQ=+8@6@Z7K$%O(#YOGI2^!8U*!DO06@N!5&03X)/]&Y&A]; S?B+PU8?/!,K M92[EJWWYFDV"V#*" E)C(1C^;6 &16&1D,<_-6C0K&D-#Y]WZ)^=>!0S9QIF MLOB;9V8Y"6X"DD'.UH5YEMLO4 MR!%-9:/=+MO7<."#I6AM9UL;(H.2B^F=O MM2,.#.CHC$%2&R2G!H,S!OW:H.^$5LR\QR<8\G^ WEF!DCO 0SCA?XPC@RN:ZVC MM%[COEHC.;,&3<@W*1078,$"'AAG6R8WV?>!$?( U)GWXD29ST6PC- M+C=//'3ZC1/[#J]_!N\94BE27G#F0E/FQ"R!? ]?0I)#!HH51!MFUD:J=\(K MQQITK+*.-=+-GLERQ<3[KYI LP!.KU@*DP"37(/:0##] MY2/9'@I]*C81+_ M_,$3/]>-J&LOTFS)Q,)N",D95V3#BC78S<#,-!R_H!B4**[P*".8J'/,5O/N M].YG%!AT6J_9O <+4O,92S Z>O>H,T)?EZ]03C\06'EFNNN(#ARQ$WCB)L+ M'6%]4%4D5N!QS43:FD1^N!X=A;=G!'18)OUPY-_S=,GP(Y6V!J7<>P>%&"6M.9$!TYK MX-1J.BV[=FC?"5!_*_ ']D.JE;W?#CGTS[%OZP'.Y/2^ Z#^%N#QOS1J-9;W MK/3/J5A&![U^"6KAKD :PW@M3-5 -Z/-->N3NUR[0^QAJKO;-Z86 M7&A20(Z0<7B-M%1U':I>C%RY&\5<&KR?N,&PO=V]R:W-H965T8]_K$X\VE'WG"XP%>*ZKAH^]A1#+:]_G MY0+7B%_1)6[DFSEE-1+RECWY?,DPFK5.=>6'09#Z-2*--QFUSV[99$17HB(- MOF6 K^H:L9=/N**;L0>]UP=WY&DAU -_,EJB)WR/Q=?E+9-W?A]E1FK<<$(; MP/!\[-W ZP+FRJ&U^$;PAN]= P7ED=+OZN;+;.P%*B-K2MS1S6?< 4I4 MO))6O/T%FZUM%GN@7'%!Z\Y99E"39ON/GCLB]AS@,8>P-FO=[P>1;(OW$Y$M3TAJ#!_2, M.1B O^1**_ <,X9GZB&XX1P+#MX76"!2\0_2YNM] =Z_^P#> =* AP5=<=3, M^,@7,AT5U"^[H3]MAPZ/#%W@\@I$\",(@S"RN$]/=P\M[L7I[O#0W9<<]D2& M/9%A&R\Z&J]C34C64,O:M8V3;938'D55^35?HA*//5G&'+,U]B:__@+3X#<; M0Y<,5EPHV %[4<]>Y(H^4>M.]C*&!&F>0$4Y!R5B[$4VM@UB]M6UC9BU$55[ M6T]BF,1R+M?[%)E649K _-"J<&9W)O:XQQX[L=_)B(B5"R#+2+:LM>S%2]E9 M1;N22KFDB/@Y&=LATGV8>1!J7-B,HE2CPIGLF50D/16)DXHI6A*!*O)#UA$[ M1DM)N;!RD!CP8!3$D4:":34Q)2)PDW9247$BPUI;E9GHGZC/J3.1,F,,> MYM )\V^QP,P&;FBK3:WJIA8C?:8+Y_AGHH/!3BT%3GP/5+8GI2OUO=XJ?P)S M529QINT]4XM9FL;)4 /NSNQB4_%E!36LNUB[(/9I"' M26* MMA)T)F^F#N[_?U[$$?#=+Q7!=B$++Z29.GXN&:VX5+1#'G>"#KH5 M78%EV))TBT?*%U13)LB/]H&52U.9#<(TT+N_S0S&J;[/N;,[%_U.PT&WB&O/ M#E0!K=2.U^Y[;659@9MJ;! 9NM5F%0=&\;R%:(,[U0;=LNWHU@=-'3: F0[1 M9J3O?>X,SD6X4VO0+=0_4$L#!!0 ( /6(75C!?N"E M/ 0 -X5 9 >&PO=V]R:W-H965TN*X,($BI/^ 92_6;%14*5 MOA5K5VX$T# /2F*7>-[432A+'7^>/[L5_IQG*F8IW HDLR2AXND28KY=.-AY M?G#'UI$R#UQ_OJ%KN ?U97,K])U;H80L@50RGB(!JX5S@<^7A)B ?,1?#+:R M<8T,E0?.OYJ;ZW#A>"8CB"%0!H+J/X^PA#@V2#J/;R6H4\UI IO7S^CO<_*: MS .5L.3QWRQ4T<*9.2B$%W'Z D-#%X 8]E_AMMB['3L8."3"J>E,$Z M@X2EQ5^Z*X5H!.#IG@!2!I#O _;-,"H#1CG1(K."?V6Z3CE7Z]I"&$;P-69 M5^F3Y_0OB17Q"H(3-,*_(.*144]"RQ\/)Y9T1I6:HQQOM ?OSPT8^=(UNN%2 MHJ56\TFWVI:*4*)_;O1H=*T@D?_V:5= C_NA33N?RPT-8.'H?I4@'L'Q?_X) M3[W?^G@/!-9285RI,+:A^W<09D63\I6NF+S %-TAV.G-1T(?]P+P- !<:TP8-,.C2L$QU( M8UK1F%IIW##ZP&*=/=)UB;(T *';/,W79\,E,\O6V]G3#K-QAYAUZ@.)G5;$ M3JW$KG252<4"LY6ABTQ%7.Q9(RO.:_ML(+ 6Y5E%>7:\W68VI H#@;54.*M4 M.+,N_"?M=7BE1*R5T%^R+5.1V6^8Z"V!LVZ;>KA3SF>=3:D]JI4N]NHOKG=@ MPBFWY%RB-I/&8])MPKYQ9#S:FW?#*> #.@S]A^[TFE(11/F+I8"0J58Q]K*Q MSO7:^AL*K:T,J94AQVO$$GLH)09":RM1^Q]L-1:^J8"@J("@J4(O\=&/?"Q? M&M5.M+8HV.Y1[A55@+2-U4L6T!C]D0DF0Y;;EMYD!_(>):EC.!E<6QD\.6*] M#F1?2B6.889P[8:PW0X=\O' 72O4OQ'WC/-&L[VU6SL=;+U!0- MA=;6I[9%^(B^" ]JC(9":RM16R-L]T:OVHZ[IDCGT2GJ%T:U_XNO/1&Q>Z+W M7 !;IR^;=SO.:Y=G*+0VZ]I1$7R\0B6#.JBAT-I*U Z*6'W)H9ZX1&U:].\+ MMF<(Z9IAMW&"EH!8YP>+$@4\2U5QF%8]K0XO+_(C.[<>7IQ\?J1BS5*)8ECI M4._D5'_A1'&86-PHOLG/XQZX4CS)+R.@(0@S0+]?<:Z>;\P$U9&N_S]02P,$ M% @ ]8A=6!@3&UD1 P HP@ !D !X;"]W;W)K&ULK99M;]HP$,>_BI554R>M34@@I!U$HK!I?5&IZM->3'MADH-8=>S4 M=J!\^]E.2'D(=)OV!F+G[N_?G<^^#)9:&;8\*<>&#G;D4\X*6BA,&M0++,=R'!E[ M:_!$8"DWGI&)9,KYLQEN_!8R!4B.D,5YJ3:=9TCAN/J_5 MO]G8=2Q3+&',Z0^2JFSH1 Y*889+JN[X\CO4\?2,7L*IM+]H6=MZ#DI*J7A> M.VN"G+#J'[_6>=APZ(0''/S:P=]UZ!YP"&J'P 9:D=FP)ECA>"#X$@ECK=7, M@\V-]=;1$&9V\5X)_99H/Q5?LX3G@![P*TATAIXP+;'-[XCJ#<8L :1+!4U@ M!D) :@S12$I0$IU.0&%"Y2?M]W@_0:0WQNXB\T ]ZVZP448-E9;Y+V&O'>4?)2FQ(!+E&18S/5! M4!P5@B^(O<[,$2'5SBISDMKHJP7"#:Y._R**=NCWK7PO\+UV^K"A#_^>'EY* MHE9MI.$>PVZ.]RV"P&]G[#>,_:.,XU+?+RQ9(7T.F*1UF; 4<95!:SGTW\7< MMSCK1NV848,9_6,)@V$]7+S17EE&?J^WN_W[5MLE7C&[&_=]#GI#31O4F\M+ MIJJ;L9EM.NW(-IB=^2O=@:N&^293M>\;72=$%PR%F9;TSONZ,$75$JN!XH7M M*E.N=(^RCYG^B@!A#/3[&>=J/3 +--\E\6]02P,$% @ ]8A=6!RZV60. M P %P@ !D !X;"]W;W)K&ULK59-;]LP#/TK M@E<,+=#5CI,F19<8:-)NZZ% D*[;8=A!L6E;J"QYDIRD^_6C9,=+\[4>=HDE MBGQ\)"4RPZ54SSH',&15<*%'7FY,>>W[.LZAH/I"EB#P))6JH :W*O-UJ8 F MSJC@?A@$?;^@3'C1T,FF*AK*RG F8*J(KHJ"JI1UO+9BQ+#=6X$?# MDF;P".:IG"K<^2U*P@H0FDE!%*0C[Z9S/1E8?:?PC<%2;ZR)C60NY;/=W"OP@.M.2!ZD,+DF=R*!Y#6 CW&TP83K8,;A4<1;B"]( MMW-.PB#L[B$T>;MY>(1.M\UMU^%U#^#-()8B9IQ1=V-EBNE5*,L$^PV)R_ 8 M!*3,Z'-RMXIYE3"1D9M"5L)H,JTK845&XCG%\C=F,S"5PK+\F$G."=[G)57) MSWTEJ!GV]C.T+>):ES2&D8<]0(-:@!>]?]?I!Q_WI>\_@;U*9J]-9N\8>C2F MG.+E)-20.61,N+Q@2E.F8\K)"U"U+_X:=.! ;4=;1,'07VP&=4SC%=/+ENGE M4::?E=0:WT:,757CJU+ J<'"81%+Q:1R7(G!,I;K][6/>>VDO\&K%PRVN._J M'.#>;[GWCW+'JX2-3Q!8Q3D5&:9;)$2:'-1>COT=_V%GB^*NR@&*@Y;BX*T7 M 2RY?UZ!P4Z!>^'5%LM=G6V6_D:/+4!E;O1H$MNW6G>H5MI.MQO7U+?D8YQZ M]9#Z"U./S >J\&)KPB%%R.!B@.55]1BJ-T:6KI//I<&YX)8Y3FY05@'/4RG- M>F,=M/\%HC]02P,$% @ ]8A=6%(= 6,Z P O0H !D !X;"]W;W)K M&ULM99;;],P%(#_BA40VJ1MN;1-L]%68BL()(8F MRN#934X;:XY=;*<=_YYC)\W2*NV&-%X27\[MLX_M,]I(]:!S $,>"R[TV,N- M65WYODYS**B^D"L0.+.0JJ &NVKIZY4"FCFE@OM1$,1^09GP)B,W=J' (VFIC2QJ98R@8*+ZT\=Z(5H*87Q (:H5HGV%_@&%7JW0GY)S4M\HNVL)DR0>\&,/L-!;/_(9:FIR/3(-QB/M>JGM>_K MRG=TP'<8D5LI3*[)1Y%!MFO 1Y"&)MK27$='+4XAO2"]\(Q$0=3K".CFY>K1 MD7!ZS>+VG+W>H<4M"U#42'75M3B5;K];UQ[?*[VB*8P]/)\:U!J\R;LW81R\ M[P)[)6,[F/T&LW_,NLLA)E)98.YPS*530HU1;%X:.N= C"0X5^"9Q6Q.'W+) M,U :DPN/'TN[5J9R-W3N[#VTGIR'01P-^B-_W8;ND$OB?A W8CLX@P9G\%]P M,L9+LY_&%=#@A4 = X@8H/IJ&4Q 2KXZ#B1B_9B*^DK$=T&$#.CRZ<[_< MI0T9H6L\=TMH-JJZN? 5TP:O*B:6V^PC)VP[?=JU-)6_N+4A8?\RC),P&.QM M79=D+QDD<9QT[U[20"6O!U7GX'-8R8NQNB2/8ETV6)?/GC*^?7A*= MI:I:J>H8N7+EQEP:+%Y<,\?Z$I05P/F%E&;;L0Z:BG7R%U!+ P04 " #U MB%U8<06$GR,% T( &@ 'AL+W=O&UL MS5I=;]LV%/TKA 8,+=!&(B7+5F8;2)P4[=!N08.N#\,>&)FVA4BD1U)V"NS' MCY04R;1EIBE8Q"^Q/GB/[CGD%8_(C+>,WXL5(1(\%#D5$V\EY?K<]T6Z(@46 M9VQ-J+JS8+S 4IWRI2_6G.!Y%53D/@J"V"]P1KWIN+IVPZ=C5LH\H^2& U$6 M!>;?+DG.MA,/>H\7/F?+E=07_.EXC9?DEL@OZQNNSOP699X5A(J,4<#)8N)= MP/,92G1 U>*OC&S%SC'05.X8N]L* M2SP=<[8%7+=6:/J@TJ:*5FPRJKOQ5G)U-U-QZG1C[4B6@8?RT>=AE_3!TY&$0@4^, MRI4 UW1.YB: KS)OTT>/Z5\B*^(52<] "-\ %*"P)Z'9]X^+8F\X-41RW5D97J+,>J9G(+E MJ(=EDB1!M$?3FL@/TDQ:FHF5YI]K/:[K+E6,,)T#9:6$5 =JD/>QLN(]=S [ M C.HPZ!S%L%)U'^3AB/-7*&9HNW8,7AJ$V*3T6XEH2!$T0"-]DJIOV42CU#4 M/R5"U/%&5MY?Z_> /^!W\O\&X!Q9L<);1;RI/!]U=,010BB(#A2 M)IVYA'9W^85NB-#9JQPESU)]*"13WUS*7,K^A0M'-K&A]C-,)^Q<)TQ.HU2< MNE57:.9"4F=7D=79O42I-!F9I1)$<3Q,]FJEI^5P$, D&O37"NH,)[(;SK96 M5-;5JC!-R5/%8H=\;K^[0C,%Z)PG0B=1+,BI:W6%9HK6N59D-7@O4BSA00F$ MHR#8F2T:90[;C>(H.#:KH,YT(KOIU'W^5GV^6Y:_[0C/[F-':";?SFRBP6D4 MAE.7Z@K-%*USJ-9WTINYH#;*A]S-6-%'G.M'H-.K%J55UA6:*UEE59%\A?8EZ20ZK M8)0H.W50+D\WK%G[._NO!>'+:EM:J(Q+*NN]S/9JN_5]46WX[EV_A.>S>@.[ M@ZGWTS]AOLRH #E9*,C@;*A><[S>HJY/)%M7N[QW3$I65($ZP;J_H(Q M^7BB']#^H\#T?U!+ P04 " #UB%U8)-8A\7($ #+& &@ 'AL+W=O M&ULM5EM;^(X$/XK5JXZ[4H5B0V%T@6DEN2T ME:ZGJMV7#]5^,,D T28Q9QO82O?CSW;2A$":+97Y4F)[YO',$WLR,QUM&?\I ME@ 2_4J33(R=I92K*]<5X1)2*CIL!9E:F3.>4JF&?.&*%0<:&:4T<8GG]=V4 MQIDS&9FY>SX9L;5,X@SN.1+K-*7\^082MAT[V'F9>(@72ZDGW,EH11?P"/+K MZIZKD5NB1'$*F8A9ACC,Q\XUO@J(IQ6,Q+<8MF+G&6E79HS]U(/;:.QXVB)( M()0:@JJ?#4PA2322LN/? M0I]]2*N\\OZ'\9YY4S,RI@RI+O<2278^?201', MZ3J1#VS[&0J'+C1>R!)A_J)M(>LY*%P+R=)"65F0QEG^2W\51.PHX.XK"J10 M('L*A+RBT"T4NF]5Z!4*O7V3AJ\H7!0*QG4W]]T0YU-))R/.MHAK:86F'PS[ M1EOQ%6?ZH#Q*KE9CI2ZZ.NCCSZ&/KD.0[;.I%#A+81X0V<)G*,,9(.=-^U(3[B1]EQI8)1T?-Y,".EC M/'(WNWP>2G7QD'AUJ:#5@'<2=5$2=='J7NW@-3G:JG[L^;()%E@"J]'6+VGK MG^B^]FWR:1,LL 16XW-0\CFP=5^G.5)_YU+A@;=WI_P&H5Y_7RIH->J=+E^6 M+E^VNNS'0O)XMC:GYGK! 51*)M'W6"[5!U0RSA**[B"= 6]BH17\V'-D$RRP M!%8C=5B2.CS1O1S:Y-,F6& )K,8G]JJ4T6L]IO^L]0E$;(XT>I( %T@EABI) ME+#@U'"[4FQG>N&_AGRHR!E;=SF67ZMH08&V&RQ4Z57%BCIS.\DVMG7!%7&_ M_1"W[W8T@S;1 EMH=:9)Q30YT:TO@&V1:A,ML(56)[6J2'!K@JY(W4"VAD;6 MN@<79GCP-ZM" 5NK%*8%5,TC33?B4QO"4)6RP&K:($MM#JA546 3U428*LU@56TP!9:G=2J+,#M=4%; M$'I3'= D-3R\BZ#V4N"H&'1YT%-H"+V'0N0@4 7M5KW7:YVJU]M\ M5:Y)VG/-)_P#W69ALHY H8[ Y3&26*:T2HW/<.]3K^: M$5K(5WHFU2H;B5IR?Y:&UL MK51=;]HP%/TKEC=-K;21+THGED0JT&E[J(2*NCV;Y(98]4=F.]#^^]E.2&D' MJ _+0^)KWW-\CN-[TYU4C[H&,.B),Z$S7!O33(- %S5PHD>R 6%7*JDX,394 MFT W"DCI09P%<1A. DZHP'GJYY8J3V5K&!6P5$BWG!/U/ ,F=QF.\'[BGFYJ MXR:"/&W(!E9@'IJELE$PL)24@]!4"J2@RO!--)V/7;Y/^$5AIP_&R#E92_GH M@I]EAD,G"!@4QC$0^]G"'!AS1%;&GYX3#ULZX.%XS_[=>[=>UD3#7++?M#1U MAK]B5$)%6F;NY>X']'ZN'%\AF?9OM.MRDS%&1:N-Y#W8*N!4=%_RU)_# 2": MG #$/2!^"SBU0](#$F^T4^9M+8@A>:KD#BF7;=G54-Z2 #-O"TZ"V@/-/'Z))^.V8M_]$]LKI>' Z/L>>W_*& MR6=0J+ _5-%UZTKOJ.6.Y]KSN,ZQS9/0/6FP/33S;]I+1JTN73-XH>E:TQU1&VIO.X/*4H:CZRN,5%?N76!D MXRMF+8VM/S^L;8<$Y1+L>B6EV0=N@Z'GYG\!4$L#!!0 ( /6(75CNY%Q9 M4@, *X5 - >&POM-\(?60])LFS]Z^)D,21!^)9^7&><*&Y/'B_:]%KF_> M>?9^]N'LK'/5>;R\V44N:NB2^$[AZP.$45E,-#K(K;GVW)M\[3'Z?.";= MWY9>=S\W6@WW'"/'#O*&B=%Z'7?,3CLF9K@7.,DM:D7TZRP;#=)<;I(M)+;! M*-.,>4]4#,F8"CY1'%@IS;A8V>8N-$QSD2M/FRPWH0)H*?]8.+ UV "U3L9E MKJK8-H+].ZF[[P#K&ACD0C0&N\0VC 8%U9HI>6LJ5>>J\1GDU>6'56$VU.MT6J:XY^X)>OZW\SQCDBDJVJ9-[A_S++_: M'834:G8/(DEKM_"B;C$S#9>[.GY@N>0"WVP71*&<>Q& ',["$,,@=V((Y@# M\( A85B]!W?>1_[Z/>5O?J$=_0502P,$% @ ]8A=6)>*NQS $P( M L !?3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:(7->=I3W;+T]!;X"O.DQQ0FE( M2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'PHM@B:&(F3[:3IK^_:E'1-S,Z];'@BR,'YD&1]VI64 M#T_6/=Q9^R!^;%.37;0V>;Y[W^ED\49M9?:/W2D#5];6;64.;]U])]LY)9-L MHU2^33M>MQMTME*;UL_L;F*1OX%AWT-:IZ.+SN*_&]^S_5:-=K':N)C8NM,OF^'IU*2T"3;?0N M:PDCM^JB-;:/RI7?!_[ +-E_MQR@4$VY]QHNN%E2X?&AC(I$YV)F]A^&JPC+ M([ \7JSQS?7R9CZ;C%;3B;@#7(\ M6GY&D$,"2WSPBEAUR+?*'%99-JH+!/2).)29AI!1@1DQ NY++9;Z9Y+ MRJ6^-QH^)DTN1G%L"Y-CR%Z7&KN[O)A?I'M0X,!4B:6*"Z=SK3(,1XJ%V2Q7 M4COQ5::%$E^4S*#1RP_4\"C!])@-E0&V6Q5;:.$C]?4HM?28W3*'ZJJW M(^60'K-$?G?ZK*PII1]E]=?_H%'FZ#&K8V:@#7/KGC$098D>LR863NVD3H3Z M 3>!-JR&-0L#G1/P>-:F?)0G>LRB@ G\#J;7SQ7>]+]"[\H/_"VN58X1*4OT MF#4!O^&;=$[6 MQUJ/4H''K(*QW6ZM$!1)O"837!;%D)++F0YK*V@ M]V>RRE#4ZHY2@\<=0< SH/-J"E2-96,+$TESKTQ+ M5-9KCE*!QZR"A7P6CYE8*%=]W,1*3'06I[:<4V)(2@0>LPAF)M,)/!70]1)H M5C$J1^#[5U/>/J6%/K,6R*BF%FGW*5OTF6U!8_8Q)B60/K- &H,O\6Y5EF1_ M84HR3<6LD1-1V($38U)FZ3.;I2$::ZQ*RC%]9L?LP[)&+$HL?6:Q-,1GC8R4 M5_K,7GD)U!K)*+GTN>5"16SU,9'22Y]9+T3$5E8I3C=3AO&9#4-&;;7:]"G# M^,R&J4=M37W2I\SB,YOE$+XU@E$R\9EE9AY+VRJCV(JGS*,SVP8>CKK8TS* M,/XYESR^#_!:(668P5ECF !C4H89G#6&"3$F99H!=Q*,Q!QB3,H[ V[OD)@1 MQJ2\,V#V#H7YO5HH?,$DU]N9#41C]C F9:$!LX5H3&RA 66A ;.%3J0!)E"F MTYK3!Y2%!LP6.I4':(LEW#W!F)2%!LP6.HTY2A*-%U@"RD(!LX5.8U9I78Q) M62@XSQ(\8%8A!L:D+!2\_5+\H5\6\%AA3,I" ;.%2,SZ1B7*0L$94FEM<5TV M>+D=$F-2%@K85VP::_,PZ&-,D@I*&16T OCRS@)$Z5O2M]OE.34P(*V;<$'++H:*!8<8U(""L^Y MK:S>-RD!A6^ZK:RLP+)@U;#/;$@Y:,CMH&/,NB\Q)N6@(;.#7M93V@+&IK5R M#GI M991-3_&I!PTY#[S@G;)-*ZUGWVK8TQ*/D/N'-QIS$_0"3 F M)9\A=P[N-&9Y"6-2\AERY^!.8]ZJK/: 4_(943))V*63VTQ>M_0UE19.)BZSW&> M(Z+D$S'+A\2&N:,"J.N0K]ASCAP3N9E1R#3?/H#R6 M:;QPHGRI[N7Y@_)7J\G[EX^3SU_S-QV&S>UOW/8?W[T!^G M?PQN_PSG]W'7]U.S>%F=M_VT;-J/_>WRV%Y?S,-E93F7L $D5 MU@"MC7)M %X;!=L Q#9*M@&8;11M U#;*-L&X+91N U ;J-T&X#=1O$V +VM MZFT!>EO5VP+TMM6/;8#>5O6V +VMZFT!>EO5VP+TMJJW!>AM56\+T-NJWA:@ MMU6]+4!OIWH[@-Y.]78 O9WJ[0!ZN^IA"4!OIWH[@-Y.]78 O9WJ[0!Z.]7; M ?1VJK<#Z.U4;P?0VZO>'J"W5[T]0&^O>GN WE[U]@"]??6P&Z"W5[T]0&^O M>GN WE[U]@"]O>KM 7I[U=L#] ZJ=P#H'53O - [J-X!H'=0O0- [Z!Z!X#> MH?JS$J!W4+T#0.^@>@> WD'U#@"]@^H= 'I'U3L"](ZJ=P3H'57O"- [JMX1 MH'=4O2- [ZAZ1X#>L=IL M [JMX1H'=4O2- [ZAZ1X#>2?5. +V3ZIT >B?5 M.P'T3JIW NB=5.\$T#NIW@F@=U*]$T#O5&T6!.B=5.\$T#NIW@F@=U:],T#O MK'IG@-Y9]&:!WKC9[ _3.JG<& MZ%U4[P+0NZC>!:!W4;T+0.^B>A> WD7U+@"]B^I= 'H7U;L ]"ZJ=P'H753O M M"[5(=U 'J;KCZN _#;=-6!G0X@N.FJ(SO==QH^3I_[?KP5?:VK@.\4>[I\ MMK]]_W7Y=;&^-U>DV_N,\>DO4$L#!!0 ( /6(75C1-?Q97P( -)N*T"V& #4].;=K=; M+_8"#)P&A7^RW2Y]^SFDK;2IBU9ETKXW08GM\SOX2)^[7'][GHU;'89^=)MH MY_W\*4E)I-F-8V4YVJ'WX:A^2N6[V]8-)9)KJI)E&;T:_]L<:T^:VH?UY&EL?TM9OR3$X>2R MQ^VZV5V%#5'R;L)QY<\!+^>^/AEKN]:L[FOKO]1#V)4<^L3YY]ZX^'R)=WJ< MMMNN,>W4/ [A2.QF:^K6[8SQ0Q^?BEZ=3_;AALWI4UR_ MSOBM_@?[D) ^,D@?.:0/!>E#0_HH('V4D#XJ2!\BI31"$5502!444P4%54%1 M55!8%117!05609%54F25%%DE159)D5529)44625%5DF155)DE119,XJL&476 MC")K1I$UH\B:463-*+)F%%DSBJP91=:<(FM.D36GR)I39,TILN8467.*K#E% MUIPB:TZ155%D5119%45619%54615%%D5159%D5519%44635%5DV155-DU119 M-45639%54V35%%DU159-D;6@R%I09"THLA8460N*K 5%UH(B:T&1M:#(6E!D M+2FREA192XJL)476DB)K29&UI,A:4F0M*;*6%%DKBJP51=:*(FM%D;6BR%I1 M9*THLE8462N*K!5%5I%2:!4IQ5:1_D]&UL4$L! A0#% @ ]8A=6'RD1TLC"0 DCL !@ M ("!#0@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0# M% @ ]8A=6&292W:\ P 2@T !@ ("!\1L 'AL+W=O M,? !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6.VI-V=6 M!@ )2L !@ ("!\2L 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6%]'R K,)P 6(8 !D M ("! $8 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ ]8A=6)XCDR56"P EB !D ("!LWH 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A= M6$7_S1%= @ .P4 !D ("!=HX 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6(%("9[- @ :P8 M !D ("!Z9@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6/US:G'0 @ ,P8 !D M ("!.*8 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ ]8A=6-'!-'MR! L0H !D ("!@L8 'AL+W=O MV[P^<$ #3 M# &0 @($KRP >&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6)[R M\V_ @ 708 !D ("!'-< 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6 "^"(Q<0@ )_< !D M ("!Q> 'AL+W=O&PO M=V]R:W-H965TTH 0!X;"]W;W)K&UL4$L! A0#% @ ]8A=6)ZYUN5H! APT !D ("! MK"L! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ ]8A=6,2([$&4 @ Z04 !D ("!I#D! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6&I0FY$B P P@ !D M ("!"4P! 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ ]8A=6!3S%9Z6! O L !D ("!F5T! M 'AL+W=OP# R#P &0 @(%F8@$ >&PO=V]R:W-H965T&UL4$L! A0#% @ M]8A=6-P;G3?B!0 M#( !D ("!U&H! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6*?10_^S @ M?@@ !D ("!'WH! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6)2X0[W7 @ I @ !D M ("!B80! 'AL+W=OD6/[O<$ O( &0 @(&7AP$ >&PO=V]R:W-H M965T&UL4$L! M A0#% @ ]8A=6'Q_0"1] @ R < !D ("!7H\! 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A= M6$@07VJ7 P OPP !D ("!':(! 'AL+W=O@" !M!P &0 M @('KI0$ >&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6'&T_8.H @ L@8 M !D ("!F:\! 'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T M&UL4$L! A0# M% @ ]8A=6/]G)^$^ P ,@P !D ("!QL8! 'AL+W=O M&PO=V]R:W-H965TH8/>P( !<& 9 " @=;, M 0!X;"]W;W)K&UL4$L! A0#% @ ]8A=6!Y_ M+7W$ @ E@< !D ("!B,\! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6$H@HXDC!0 *2 !D M ("!--@! 'AL+W=O4# $0 &0 @(&.W0$ >&PO M=V]R:W-H965T&UL4$L! A0#% @ ]8A=6.(&DTG\ @ B0@ !D ("! MR>0! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ ]8A=6.V1$9V[ P ,A, !D ("!^^\! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6'=VIS77 M @ ^@< !D ("!E ," 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6)\L03.\ P R1 !D M ("!*Q " 'AL+W=O% ( >&PO=V]R M:W-H965T&UL M4$L! A0#% @ ]8A=6)#"J7NK P 6A$ !D ("!/QL" M 'AL+W=O&PO=V]R:W-H965T3#@$0, $(+ 9 M " @28B @!X;"]W;W)K&UL4$L! A0#% @ M]8A=6*G:G341! H X !D ("!;B4" 'AL+W=O M-@( >&PO=V]R:W-H965T&UL4$L! A0#% @ ]8A=6'$%A)\C!0 -" !H M ("!U#P" 'AL+W=O&UL4$L! A0#% M @ ]8A=6"36(?%R! RQ@ !H ("!+T(" 'AL+W=O&UL M4$L! A0#% @ ]8A=6.[D7%E2 P KA4 T ( !2$D" M 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL4$L! M A0#% @ ]8A=6.U(Q+7D @ \3L !H ( !%%4" 'AL M+U]R96QS+W=O XML 118 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 119 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 121 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 322 446 1 true 112 0 false 10 false false R1.htm 0000001 - Document - Cover Sheet http://www.evolvtechnology.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://www.evolvtechnology.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 0000003 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 3 false false R4.htm 0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 5 false false R6.htm 0000006 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) Sheet http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) Statements 6 false false R7.htm 0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) Statements 7 false false R8.htm 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 0000009 - Disclosure - Nature of the Business and Basis of Presentation Sheet http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentation Nature of the Business and Basis of Presentation Notes 9 false false R10.htm 0000010 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 0000011 - Disclosure - Marketable Securities Sheet http://www.evolvtechnology.com/role/MarketableSecurities Marketable Securities Notes 11 false false R12.htm 0000012 - Disclosure - Fair Value Measurements Sheet http://www.evolvtechnology.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 0000013 - Disclosure - Revenue Recognition Sheet http://www.evolvtechnology.com/role/RevenueRecognition Revenue Recognition Notes 13 false false R14.htm 0000014 - Disclosure - Leases Sheet http://www.evolvtechnology.com/role/Leases Leases Notes 14 false false R15.htm 0000015 - Disclosure - Accounts Receivable Sheet http://www.evolvtechnology.com/role/AccountsReceivable Accounts Receivable Notes 15 false false R16.htm 0000016 - Disclosure - Inventory Sheet http://www.evolvtechnology.com/role/Inventory Inventory Notes 16 false false R17.htm 0000017 - Disclosure - Prepaid expenses and other current assets Sheet http://www.evolvtechnology.com/role/Prepaidexpensesandothercurrentassets Prepaid expenses and other current assets Notes 17 false false R18.htm 0000018 - Disclosure - Property and Equipment, Net Sheet http://www.evolvtechnology.com/role/PropertyandEquipmentNet Property and Equipment, Net Notes 18 false false R19.htm 0000019 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 19 false false R20.htm 0000020 - Disclosure - Long-term Debt Sheet http://www.evolvtechnology.com/role/LongtermDebt Long-term Debt Notes 20 false false R21.htm 0000021 - Disclosure - Warrants Sheet http://www.evolvtechnology.com/role/Warrants Warrants Notes 21 false false R22.htm 0000022 - Disclosure - Common Stock Sheet http://www.evolvtechnology.com/role/CommonStock Common Stock Notes 22 false false R23.htm 0000023 - Disclosure - Stock-Based Compensation Sheet http://www.evolvtechnology.com/role/StockBasedCompensation Stock-Based Compensation Notes 23 false false R24.htm 0000024 - Disclosure - Income Taxes Sheet http://www.evolvtechnology.com/role/IncomeTaxes Income Taxes Notes 24 false false R25.htm 0000025 - Disclosure - Net Loss per Share Sheet http://www.evolvtechnology.com/role/NetLossperShare Net Loss per Share Notes 25 false false R26.htm 0000026 - Disclosure - Related Party Transactions Sheet http://www.evolvtechnology.com/role/RelatedPartyTransactions Related Party Transactions Notes 26 false false R27.htm 0000027 - Disclosure - Commitments and Contingencies Sheet http://www.evolvtechnology.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 27 false false R28.htm 0000028 - Disclosure - Benefit Plans Sheet http://www.evolvtechnology.com/role/BenefitPlans Benefit Plans Notes 28 false false R29.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 29 false false R30.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 30 false false R31.htm 9954471 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPolicies 31 false false R32.htm 9954472 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPolicies 32 false false R33.htm 9954473 - Disclosure - Marketable Securities (Tables) Sheet http://www.evolvtechnology.com/role/MarketableSecuritiesTables Marketable Securities (Tables) Tables http://www.evolvtechnology.com/role/MarketableSecurities 33 false false R34.htm 9954474 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.evolvtechnology.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.evolvtechnology.com/role/FairValueMeasurements 34 false false R35.htm 9954475 - Disclosure - Revenue Recognition (Tables) Sheet http://www.evolvtechnology.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.evolvtechnology.com/role/RevenueRecognition 35 false false R36.htm 9954476 - Disclosure - Leases (Tables) Sheet http://www.evolvtechnology.com/role/LeasesTables Leases (Tables) Tables http://www.evolvtechnology.com/role/Leases 36 false false R37.htm 9954477 - Disclosure - Accounts Receivable (Tables) Sheet http://www.evolvtechnology.com/role/AccountsReceivableTables Accounts Receivable (Tables) Tables http://www.evolvtechnology.com/role/AccountsReceivable 37 false false R38.htm 9954478 - Disclosure - Inventory (Tables) Sheet http://www.evolvtechnology.com/role/InventoryTables Inventory (Tables) Tables http://www.evolvtechnology.com/role/Inventory 38 false false R39.htm 9954479 - Disclosure - Prepaid expenses and other current assets (Tables) Sheet http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsTables Prepaid expenses and other current assets (Tables) Tables http://www.evolvtechnology.com/role/Prepaidexpensesandothercurrentassets 39 false false R40.htm 9954480 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.evolvtechnology.com/role/PropertyandEquipmentNetTables Property and Equipment, Net (Tables) Tables http://www.evolvtechnology.com/role/PropertyandEquipmentNet 40 false false R41.htm 9954481 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilities 41 false false R42.htm 9954482 - Disclosure - Long-term Debt (Tables) Sheet http://www.evolvtechnology.com/role/LongtermDebtTables Long-term Debt (Tables) Tables http://www.evolvtechnology.com/role/LongtermDebt 42 false false R43.htm 9954483 - Disclosure - Warrants (Tables) Sheet http://www.evolvtechnology.com/role/WarrantsTables Warrants (Tables) Tables http://www.evolvtechnology.com/role/Warrants 43 false false R44.htm 9954484 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.evolvtechnology.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.evolvtechnology.com/role/StockBasedCompensation 44 false false R45.htm 9954485 - Disclosure - Income Taxes (Tables) Sheet http://www.evolvtechnology.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.evolvtechnology.com/role/IncomeTaxes 45 false false R46.htm 9954486 - Disclosure - Net Loss per Share (Tables) Sheet http://www.evolvtechnology.com/role/NetLossperShareTables Net Loss per Share (Tables) Tables http://www.evolvtechnology.com/role/NetLossperShare 46 false false R47.htm 9954487 - Disclosure - Nature of the Business and Basis of Presentation - Narrative (Details) Sheet http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentationNarrativeDetails Nature of the Business and Basis of Presentation - Narrative (Details) Details http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentation 47 false false R48.htm 9954488 - Disclosure - Significant Accounting Policies - Risk of Concentrations of Credit, Significant Customers and Significant Suppliers (Details) Sheet http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails Significant Accounting Policies - Risk of Concentrations of Credit, Significant Customers and Significant Suppliers (Details) Details 48 false false R49.htm 9954489 - Disclosure - Summary of Significant Accounting Policies - Contingent Earn-out (Details) Sheet http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails Summary of Significant Accounting Policies - Contingent Earn-out (Details) Details 49 false false R50.htm 9954490 - Disclosure - Summary of Significant Accounting Policies - Contingently Issuable Common Stock (Details) Sheet http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails Summary of Significant Accounting Policies - Contingently Issuable Common Stock (Details) Details 50 false false R51.htm 9954491 - Disclosure - Summary of Significant Accounting Policies - Public Warrants (Details) Sheet http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPublicWarrantsDetails Summary of Significant Accounting Policies - Public Warrants (Details) Details 51 false false R52.htm 9954492 - Disclosure - Summary of Significant Accounting Policies - Inventory (Details) Sheet http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails Summary of Significant Accounting Policies - Inventory (Details) Details 52 false false R53.htm 9954493 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details) Sheet http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails Summary of Significant Accounting Policies - Property and Equipment (Details) Details 53 false false R54.htm 9954494 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details) Sheet http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails Summary of Significant Accounting Policies - Segment Information (Details) Details 54 false false R55.htm 9954495 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details) Sheet http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails Summary of Significant Accounting Policies - Revenue Recognition (Details) Details 55 false false R56.htm 9954496 - Disclosure - Summary of Significant Accounting Policies - Stock-Based Compensation (Details) Sheet http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails Summary of Significant Accounting Policies - Stock-Based Compensation (Details) Details 56 false false R57.htm 9954497 - Disclosure - Summary of Significant Accounting Policies - Income Taxes (Details) Sheet http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails Summary of Significant Accounting Policies - Income Taxes (Details) Details 57 false false R58.htm 9954498 - Disclosure - Marketable Securities (Details) Sheet http://www.evolvtechnology.com/role/MarketableSecuritiesDetails Marketable Securities (Details) Details http://www.evolvtechnology.com/role/MarketableSecuritiesTables 58 false false R59.htm 9954499 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value On Recurring Basis (Details) Sheet http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value On Recurring Basis (Details) Details 59 false false R60.htm 9954500 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 60 false false R61.htm 9954501 - Disclosure - Fair Value Measurements - Contingent Earn-Out and Contingently Issuable Common Shares (Details) Sheet http://www.evolvtechnology.com/role/FairValueMeasurementsContingentEarnOutandContingentlyIssuableCommonSharesDetails Fair Value Measurements - Contingent Earn-Out and Contingently Issuable Common Shares (Details) Details 61 false false R62.htm 9954502 - Disclosure - Fair Value Measurements - Warrant Liability (Details) Sheet http://www.evolvtechnology.com/role/FairValueMeasurementsWarrantLiabilityDetails Fair Value Measurements - Warrant Liability (Details) Details 62 false false R63.htm 9954503 - Disclosure - Revenue Recognition - Schedule of Performance Obligations (Details) Sheet http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails Revenue Recognition - Schedule of Performance Obligations (Details) Details 63 false false R64.htm 9954504 - Disclosure - Revenue Recognition - Schedule of Minimum Future Payments on Noncancelable Leases (Details) Sheet http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails Revenue Recognition - Schedule of Minimum Future Payments on Noncancelable Leases (Details) Details 64 false false R65.htm 9954505 - Disclosure - Revenue Recognition - Narrative (Details) Sheet http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails Revenue Recognition - Narrative (Details) Details 65 false false R66.htm 9954506 - Disclosure - Revenue Recognition - Summary of Rollforward of Deferred Revenue (Details) Sheet http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofRollforwardofDeferredRevenueDetails Revenue Recognition - Summary of Rollforward of Deferred Revenue (Details) Details 66 false false R67.htm 9954507 - Disclosure - Revenue Recognition - Schedule of Components of Lease Revenue (Details) Sheet http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofComponentsofLeaseRevenueDetails Revenue Recognition - Schedule of Components of Lease Revenue (Details) Details 67 false false R68.htm 9954508 - Disclosure - Revenue Recognition - Summary of Company's Revenue by Revenue Stream (Details) Sheet http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofCompanysRevenuebyRevenueStreamDetails Revenue Recognition - Summary of Company's Revenue by Revenue Stream (Details) Details 68 false false R69.htm 9954509 - Disclosure - Revenue Recognition - Revenue by Geographical Location (Details) Sheet http://www.evolvtechnology.com/role/RevenueRecognitionRevenuebyGeographicalLocationDetails Revenue Recognition - Revenue by Geographical Location (Details) Details 69 false false R70.htm 9954510 - Disclosure - Leases - Narrative (Details) Sheet http://www.evolvtechnology.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 70 false false R71.htm 9954511 - Disclosure - Leases - Schedule of Weighted-Average Remaining Lease Term and Discount Rate (Details) Sheet http://www.evolvtechnology.com/role/LeasesScheduleofWeightedAverageRemainingLeaseTermandDiscountRateDetails Leases - Schedule of Weighted-Average Remaining Lease Term and Discount Rate (Details) Details 71 false false R72.htm 9954512 - Disclosure - Leases - Schedule of Future Annual Lease Payments (Details) Sheet http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails Leases - Schedule of Future Annual Lease Payments (Details) Details 72 false false R73.htm 9954513 - Disclosure - Accounts Receivable (Details) Sheet http://www.evolvtechnology.com/role/AccountsReceivableDetails Accounts Receivable (Details) Details http://www.evolvtechnology.com/role/AccountsReceivableTables 73 false false R74.htm 9954514 - Disclosure - Inventory - Summary of Inventory (Details) Sheet http://www.evolvtechnology.com/role/InventorySummaryofInventoryDetails Inventory - Summary of Inventory (Details) Details 74 false false R75.htm 9954515 - Disclosure - Prepaid expenses and other current assets (Details) Sheet http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails Prepaid expenses and other current assets (Details) Details http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsTables 75 false false R76.htm 9954516 - Disclosure - Property and Equipment, Net (Details) Sheet http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails Property and Equipment, Net (Details) Details http://www.evolvtechnology.com/role/PropertyandEquipmentNetTables 76 false false R77.htm 9954517 - Disclosure - Property and Equipment, Net - Narrative (Details) Sheet http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails Property and Equipment, Net - Narrative (Details) Details 77 false false R78.htm 9954518 - Disclosure - Property and Equipment, Net - Leased Equipment (Details) Sheet http://www.evolvtechnology.com/role/PropertyandEquipmentNetLeasedEquipmentDetails Property and Equipment, Net - Leased Equipment (Details) Details 78 false false R79.htm 9954519 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities (Details) Details http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables 79 false false R80.htm 9954520 - Disclosure - Long-term Debt - Long-Term Debt (Details) Sheet http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails Long-term Debt - Long-Term Debt (Details) Details 80 false false R81.htm 9954521 - Disclosure - Long-term Debt - Narrative (Details) Sheet http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails Long-term Debt - Narrative (Details) Details 81 false false R82.htm 9954522 - Disclosure - Warrants - Preferred Stock and Common Stock Outstanding (Details) Sheet http://www.evolvtechnology.com/role/WarrantsPreferredStockandCommonStockOutstandingDetails Warrants - Preferred Stock and Common Stock Outstanding (Details) Details 82 false false R83.htm 9954523 - Disclosure - Common Stock (Details) Sheet http://www.evolvtechnology.com/role/CommonStockDetails Common Stock (Details) Details http://www.evolvtechnology.com/role/CommonStock 83 false false R84.htm 9954524 - Disclosure - Stock-Based Compensation - Narrative (Details) Sheet http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails Stock-Based Compensation - Narrative (Details) Details 84 false false R85.htm 9954525 - Disclosure - Stock-Based Compensation - Grant Date Fair Value of Stock Options (Details) Sheet http://www.evolvtechnology.com/role/StockBasedCompensationGrantDateFairValueofStockOptionsDetails Stock-Based Compensation - Grant Date Fair Value of Stock Options (Details) Details 85 false false R86.htm 9954526 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details) Sheet http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails Stock-Based Compensation - Stock Options Activity (Details) Details 86 false false R87.htm 9954527 - Disclosure - Stock-Based Compensation - Restricted Stock Units Activity (Details) Sheet http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails Stock-Based Compensation - Restricted Stock Units Activity (Details) Details 87 false false R88.htm 9954528 - Disclosure - Stock-Based Compensation - Performance Stock Units Activity (Details) Sheet http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails Stock-Based Compensation - Performance Stock Units Activity (Details) Details 88 false false R89.htm 9954529 - Disclosure - Stock-Based Compensation - Company Utilized Black-Scholes Pricing Model (Details) Sheet http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails Stock-Based Compensation - Company Utilized Black-Scholes Pricing Model (Details) Details 89 false false R90.htm 9954530 - Disclosure - Stock-Based Compensation - Stock Based Compensation Expenses (Details) Sheet http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesDetails Stock-Based Compensation - Stock Based Compensation Expenses (Details) Details 90 false false R91.htm 9954531 - Disclosure - Stock-Based Compensation - Stock Based Compensation Expenses by Award Type (Details) Sheet http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesbyAwardTypeDetails Stock-Based Compensation - Stock Based Compensation Expenses by Award Type (Details) Details 91 false false R92.htm 9954532 - Disclosure - Income Taxes - Components of Loss Before Income Tax Expense (Details) Sheet http://www.evolvtechnology.com/role/IncomeTaxesComponentsofLossBeforeIncomeTaxExpenseDetails Income Taxes - Components of Loss Before Income Tax Expense (Details) Details 92 false false R93.htm 9954533 - Disclosure - Income Taxes - Components of Income Tax Expense (Details) Sheet http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails Income Taxes - Components of Income Tax Expense (Details) Details 93 false false R94.htm 9954534 - Disclosure - Income Taxes - Effective Income Tax Rate (Details) Sheet http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails Income Taxes - Effective Income Tax Rate (Details) Details 94 false false R95.htm 9954535 - Disclosure - Income Taxes - Net Deferred Tax Assets (Details) Sheet http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails Income Taxes - Net Deferred Tax Assets (Details) Details 95 false false R96.htm 9954536 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 96 false false R97.htm 9954537 - Disclosure - Income Taxes - Valuation Allowance for Deferred Tax Assets (Details) Sheet http://www.evolvtechnology.com/role/IncomeTaxesValuationAllowanceforDeferredTaxAssetsDetails Income Taxes - Valuation Allowance for Deferred Tax Assets (Details) Details 97 false false R98.htm 9954538 - Disclosure - Income Taxes - Uncertain Tax Positions (Details) Sheet http://www.evolvtechnology.com/role/IncomeTaxesUncertainTaxPositionsDetails Income Taxes - Uncertain Tax Positions (Details) Details 98 false false R99.htm 9954539 - Disclosure - Net Loss per Share (Details) Sheet http://www.evolvtechnology.com/role/NetLossperShareDetails Net Loss per Share (Details) Details http://www.evolvtechnology.com/role/NetLossperShareTables 99 false false R100.htm 9954540 - Disclosure - Net Loss per Share - Antidilutive Effect (Details) Sheet http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails Net Loss per Share - Antidilutive Effect (Details) Details 100 false false R101.htm 9954541 - Disclosure - Related Party Transactions (Details) Sheet http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.evolvtechnology.com/role/RelatedPartyTransactions 101 false false R102.htm 9954542 - Disclosure - Benefit Plans (Details) Sheet http://www.evolvtechnology.com/role/BenefitPlansDetails Benefit Plans (Details) Details http://www.evolvtechnology.com/role/BenefitPlans 102 false false All Reports Book All Reports nhic-20231231.htm nhic-20231231.xsd nhic-20231231_cal.xml nhic-20231231_def.xml nhic-20231231_lab.xml nhic-20231231_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 124 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "nhic-20231231.htm": { "nsprefix": "nhic", "nsuri": "http://www.evolvtechnology.com/20231231", "dts": { "inline": { "local": [ "nhic-20231231.htm" ] }, "schema": { "local": [ "nhic-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "nhic-20231231_cal.xml" ] }, "definitionLink": { "local": [ "nhic-20231231_def.xml" ] }, "labelLink": { "local": [ "nhic-20231231_lab.xml" ] }, "presentationLink": { "local": [ "nhic-20231231_pre.xml" ] } }, "keyStandard": 382, "keyCustom": 64, "axisStandard": 37, "axisCustom": 1, "memberStandard": 57, "memberCustom": 43, "hidden": { "total": 20, "http://fasb.org/us-gaap/2023": 15, "http://xbrl.sec.gov/dei/2023": 4, "http://xbrl.sec.gov/ecd/2023": 1 }, "contextCount": 322, "entityCount": 1, "segmentCount": 112, "elementCount": 803, "unitCount": 10, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 957, "http://xbrl.sec.gov/dei/2023": 42, "http://xbrl.sec.gov/ecd/2023": 10 }, "report": { "R1": { "role": "http://www.evolvtechnology.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.evolvtechnology.com/role/AuditInformation", "longName": "0000002 - Document - Audit Information", "shortName": "Audit Information", "isDefault": "false", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "2", "firstAnchor": { "contextRef": "c-1", "name": "dei:AuditorName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:AuditorName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "nhic:CommissionAssetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R4": { "role": "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GrossProfit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R6": { "role": "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical", "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical)", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-19", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "link:footnote", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R7": { "role": "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT", "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-21", "name": "us-gaap:SharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:SharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nhic:AdjustmentToPropertyAndEquipmentForSaleTypeLeases", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R9": { "role": "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentation", "longName": "0000009 - Disclosure - Nature of the Business and Basis of Presentation", "shortName": "Nature of the Business and Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPolicies", "longName": "0000010 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.evolvtechnology.com/role/MarketableSecurities", "longName": "0000011 - Disclosure - Marketable Securities", "shortName": "Marketable Securities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.evolvtechnology.com/role/FairValueMeasurements", "longName": "0000012 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.evolvtechnology.com/role/RevenueRecognition", "longName": "0000013 - Disclosure - Revenue Recognition", "shortName": "Revenue Recognition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.evolvtechnology.com/role/Leases", "longName": "0000014 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.evolvtechnology.com/role/AccountsReceivable", "longName": "0000015 - Disclosure - Accounts Receivable", "shortName": "Accounts Receivable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.evolvtechnology.com/role/Inventory", "longName": "0000016 - Disclosure - Inventory", "shortName": "Inventory", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.evolvtechnology.com/role/Prepaidexpensesandothercurrentassets", "longName": "0000017 - Disclosure - Prepaid expenses and other current assets", "shortName": "Prepaid expenses and other current assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "nhic:PrepaidExpenseAndOtherAssetsCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nhic:PrepaidExpenseAndOtherAssetsCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.evolvtechnology.com/role/PropertyandEquipmentNet", "longName": "0000018 - Disclosure - Property and Equipment, Net", "shortName": "Property and Equipment, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilities", "longName": "0000019 - Disclosure - Accrued Expenses and Other Current Liabilities", "shortName": "Accrued Expenses and Other Current Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.evolvtechnology.com/role/LongtermDebt", "longName": "0000020 - Disclosure - Long-term Debt", "shortName": "Long-term Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.evolvtechnology.com/role/Warrants", "longName": "0000021 - Disclosure - Warrants", "shortName": "Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "nhic:WarrantsAndRightsNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nhic:WarrantsAndRightsNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.evolvtechnology.com/role/CommonStock", "longName": "0000022 - Disclosure - Common Stock", "shortName": "Common Stock", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "nhic:CommonStockDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nhic:CommonStockDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.evolvtechnology.com/role/StockBasedCompensation", "longName": "0000023 - Disclosure - Stock-Based Compensation", "shortName": "Stock-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.evolvtechnology.com/role/IncomeTaxes", "longName": "0000024 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.evolvtechnology.com/role/NetLossperShare", "longName": "0000025 - Disclosure - Net Loss per Share", "shortName": "Net Loss per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.evolvtechnology.com/role/RelatedPartyTransactions", "longName": "0000026 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.evolvtechnology.com/role/CommitmentsandContingencies", "longName": "0000027 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.evolvtechnology.com/role/BenefitPlans", "longName": "0000028 - Disclosure - Benefit Plans", "shortName": "Benefit Plans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R29": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": null }, "R30": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "c-319", "name": "ecd:NonRule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-319", "name": "ecd:NonRule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies", "longName": "9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesTables", "longName": "9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskCreditRisk", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskCreditRisk", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.evolvtechnology.com/role/MarketableSecuritiesTables", "longName": "9954473 - Disclosure - Marketable Securities (Tables)", "shortName": "Marketable Securities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:MarketableSecuritiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:MarketableSecuritiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.evolvtechnology.com/role/FairValueMeasurementsTables", "longName": "9954474 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.evolvtechnology.com/role/RevenueRecognitionTables", "longName": "9954475 - Disclosure - Revenue Recognition (Tables)", "shortName": "Revenue Recognition (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.evolvtechnology.com/role/LeasesTables", "longName": "9954476 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.evolvtechnology.com/role/AccountsReceivableTables", "longName": "9954477 - Disclosure - Accounts Receivable (Tables)", "shortName": "Accounts Receivable (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.evolvtechnology.com/role/InventoryTables", "longName": "9954478 - Disclosure - Inventory (Tables)", "shortName": "Inventory (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsTables", "longName": "9954479 - Disclosure - Prepaid expenses and other current assets (Tables)", "shortName": "Prepaid expenses and other current assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.evolvtechnology.com/role/PropertyandEquipmentNetTables", "longName": "9954480 - Disclosure - Property and Equipment, Net (Tables)", "shortName": "Property and Equipment, Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables", "longName": "9954481 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)", "shortName": "Accrued Expenses and Other Current Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.evolvtechnology.com/role/LongtermDebtTables", "longName": "9954482 - Disclosure - Long-term Debt (Tables)", "shortName": "Long-term Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.evolvtechnology.com/role/WarrantsTables", "longName": "9954483 - Disclosure - Warrants (Tables)", "shortName": "Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.evolvtechnology.com/role/StockBasedCompensationTables", "longName": "9954484 - Disclosure - Stock-Based Compensation (Tables)", "shortName": "Stock-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.evolvtechnology.com/role/IncomeTaxesTables", "longName": "9954485 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.evolvtechnology.com/role/NetLossperShareTables", "longName": "9954486 - Disclosure - Net Loss per Share (Tables)", "shortName": "Net Loss per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentationNarrativeDetails", "longName": "9954487 - Disclosure - Nature of the Business and Basis of Presentation - Narrative (Details)", "shortName": "Nature of the Business and Basis of Presentation - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-42", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R48": { "role": "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails", "longName": "9954488 - Disclosure - Significant Accounting Policies - Risk of Concentrations of Credit, Significant Customers and Significant Suppliers (Details)", "shortName": "Significant Accounting Policies - Risk of Concentrations of Credit, Significant Customers and Significant Suppliers (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-47", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskCreditRisk", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-47", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskCreditRisk", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "longName": "9954489 - Disclosure - Summary of Significant Accounting Policies - Contingent Earn-out (Details)", "shortName": "Summary of Significant Accounting Policies - Contingent Earn-out (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-59", "name": "us-gaap:DebtInstrumentConvertibleThresholdTradingDays", "unitRef": "d", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "nhic:ContingentEarnOutPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R50": { "role": "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails", "longName": "9954490 - Disclosure - Summary of Significant Accounting Policies - Contingently Issuable Common Stock (Details)", "shortName": "Summary of Significant Accounting Policies - Contingently Issuable Common Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-71", "name": "us-gaap:DebtInstrumentConvertibleThresholdTradingDays", "unitRef": "d", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "nhic:ContingentlyIssuableCommonStockPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R51": { "role": "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPublicWarrantsDetails", "longName": "9954491 - Disclosure - Summary of Significant Accounting Policies - Public Warrants (Details)", "shortName": "Summary of Significant Accounting Policies - Public Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": null }, "R52": { "role": "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails", "longName": "9954492 - Disclosure - Summary of Significant Accounting Policies - Inventory (Details)", "shortName": "Summary of Significant Accounting Policies - Inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InventoryWriteDown", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-78", "name": "us-gaap:InventoryWriteDown", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "us-gaap:InventoryPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R53": { "role": "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "longName": "9954493 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)", "shortName": "Summary of Significant Accounting Policies - Property and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-80", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R54": { "role": "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails", "longName": "9954494 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)", "shortName": "Summary of Significant Accounting Policies - Segment Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails", "longName": "9954495 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)", "shortName": "Summary of Significant Accounting Policies - Revenue Recognition (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:LessorOperatingLeaseTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:LessorOperatingLeaseTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails", "longName": "9954496 - Disclosure - Summary of Significant Accounting Policies - Stock-Based Compensation (Details)", "shortName": "Summary of Significant Accounting Policies - Stock-Based Compensation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-92", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R57": { "role": "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails", "longName": "9954497 - Disclosure - Summary of Significant Accounting Policies - Income Taxes (Details)", "shortName": "Summary of Significant Accounting Policies - Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": null }, "R58": { "role": "http://www.evolvtechnology.com/role/MarketableSecuritiesDetails", "longName": "9954498 - Disclosure - Marketable Securities (Details)", "shortName": "Marketable Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:MarketableSecuritiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:MarketableSecuritiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails", "longName": "9954499 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value On Recurring Basis (Details)", "shortName": "Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value On Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-107", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-107", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "longName": "9954500 - Disclosure - Fair Value Measurements - Additional Information (Details)", "shortName": "Fair Value Measurements - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:MarketableSecuritiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-144", "name": "us-gaap:DividendsCommonStock", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R61": { "role": "http://www.evolvtechnology.com/role/FairValueMeasurementsContingentEarnOutandContingentlyIssuableCommonSharesDetails", "longName": "9954501 - Disclosure - Fair Value Measurements - Contingent Earn-Out and Contingently Issuable Common Shares (Details)", "shortName": "Fair Value Measurements - Contingent Earn-Out and Contingently Issuable Common Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-151", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-149", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R62": { "role": "http://www.evolvtechnology.com/role/FairValueMeasurementsWarrantLiabilityDetails", "longName": "9954502 - Disclosure - Fair Value Measurements - Warrant Liability (Details)", "shortName": "Fair Value Measurements - Warrant Liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-166", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-164", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R63": { "role": "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails", "longName": "9954503 - Disclosure - Revenue Recognition - Schedule of Performance Obligations (Details)", "shortName": "Revenue Recognition - Schedule of Performance Obligations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:RevenueRemainingPerformanceObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:RevenueRemainingPerformanceObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails", "longName": "9954504 - Disclosure - Revenue Recognition - Schedule of Minimum Future Payments on Noncancelable Leases (Details)", "shortName": "Revenue Recognition - Schedule of Minimum Future Payments on Noncancelable Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails", "longName": "9954505 - Disclosure - Revenue Recognition - Narrative (Details)", "shortName": "Revenue Recognition - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:CapitalizedContractCostGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R66": { "role": "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofRollforwardofDeferredRevenueDetails", "longName": "9954506 - Disclosure - Revenue Recognition - Summary of Rollforward of Deferred Revenue (Details)", "shortName": "Revenue Recognition - Summary of Rollforward of Deferred Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-25", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R67": { "role": "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofComponentsofLeaseRevenueDetails", "longName": "9954507 - Disclosure - Revenue Recognition - Schedule of Components of Lease Revenue (Details)", "shortName": "Revenue Recognition - Schedule of Components of Lease Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SalesTypeLeaseRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SalesTypeLeaseRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofCompanysRevenuebyRevenueStreamDetails", "longName": "9954508 - Disclosure - Revenue Recognition - Summary of Company's Revenue by Revenue Stream (Details)", "shortName": "Revenue Recognition - Summary of Company's Revenue by Revenue Stream (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-188", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R69": { "role": "http://www.evolvtechnology.com/role/RevenueRecognitionRevenuebyGeographicalLocationDetails", "longName": "9954509 - Disclosure - Revenue Recognition - Revenue by Geographical Location (Details)", "shortName": "Revenue Recognition - Revenue by Geographical Location (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-196", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R70": { "role": "http://www.evolvtechnology.com/role/LeasesNarrativeDetails", "longName": "9954510 - Disclosure - Leases - Narrative (Details)", "shortName": "Leases - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-202", "name": "nhic:LesseeOperatingLeaseSecurityDeposit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-202", "name": "nhic:LesseeOperatingLeaseSecurityDeposit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.evolvtechnology.com/role/LeasesScheduleofWeightedAverageRemainingLeaseTermandDiscountRateDetails", "longName": "9954511 - Disclosure - Leases - Schedule of Weighted-Average Remaining Lease Term and Discount Rate (Details)", "shortName": "Leases - Schedule of Weighted-Average Remaining Lease Term and Discount Rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails", "longName": "9954512 - Disclosure - Leases - Schedule of Future Annual Lease Payments (Details)", "shortName": "Leases - Schedule of Future Annual Lease Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.evolvtechnology.com/role/AccountsReceivableDetails", "longName": "9954513 - Disclosure - Accounts Receivable (Details)", "shortName": "Accounts Receivable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-25", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R74": { "role": "http://www.evolvtechnology.com/role/InventorySummaryofInventoryDetails", "longName": "9954514 - Disclosure - Inventory - Summary of Inventory (Details)", "shortName": "Inventory - Summary of Inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails", "longName": "9954515 - Disclosure - Prepaid expenses and other current assets (Details)", "shortName": "Prepaid expenses and other current assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DepositsAssetsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DepositsAssetsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R76": { "role": "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails", "longName": "9954516 - Disclosure - Property and Equipment, Net (Details)", "shortName": "Property and Equipment, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-204", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R77": { "role": "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails", "longName": "9954517 - Disclosure - Property and Equipment, Net - Narrative (Details)", "shortName": "Property and Equipment, Net - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:PropertyPlantAndEquipmentNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CapitalizedComputerSoftwareAmortization1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R78": { "role": "http://www.evolvtechnology.com/role/PropertyandEquipmentNetLeasedEquipmentDetails", "longName": "9954518 - Disclosure - Property and Equipment, Net - Leased Equipment (Details)", "shortName": "Property and Equipment, Net - Leased Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": null }, "R79": { "role": "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails", "longName": "9954519 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)", "shortName": "Accrued Expenses and Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c-6", "name": "nhic:AccruedEmployeeCompensationAndBenefitsExpenseCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "nhic:AccruedEmployeeCompensationAndBenefitsExpenseCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R80": { "role": "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails", "longName": "9954520 - Disclosure - Long-term Debt - Long-Term Debt (Details)", "shortName": "Long-term Debt - Long-Term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R81": { "role": "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails", "longName": "9954521 - Disclosure - Long-term Debt - Narrative (Details)", "shortName": "Long-term Debt - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-225", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R82": { "role": "http://www.evolvtechnology.com/role/WarrantsPreferredStockandCommonStockOutstandingDetails", "longName": "9954522 - Disclosure - Warrants - Preferred Stock and Common Stock Outstanding (Details)", "shortName": "Warrants - Preferred Stock and Common Stock Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-234", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R83": { "role": "http://www.evolvtechnology.com/role/CommonStockDetails", "longName": "9954523 - Disclosure - Common Stock (Details)", "shortName": "Common Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "c-1", "name": "nhic:CommonStockNumberOfVotesForEachShare", "unitRef": "vote", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nhic:CommonStockNumberOfVotesForEachShare", "unitRef": "vote", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R84": { "role": "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "longName": "9954524 - Disclosure - Stock-Based Compensation - Narrative (Details)", "shortName": "Stock-Based Compensation - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R85": { "role": "http://www.evolvtechnology.com/role/StockBasedCompensationGrantDateFairValueofStockOptionsDetails", "longName": "9954525 - Disclosure - Stock-Based Compensation - Grant Date Fair Value of Stock Options (Details)", "shortName": "Stock-Based Compensation - Grant Date Fair Value of Stock Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R86": { "role": "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails", "longName": "9954526 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details)", "shortName": "Stock-Based Compensation - Stock Options Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-25", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R87": { "role": "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails", "longName": "9954527 - Disclosure - Stock-Based Compensation - Restricted Stock Units Activity (Details)", "shortName": "Stock-Based Compensation - Restricted Stock Units Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "c-247", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-245", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R88": { "role": "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "longName": "9954528 - Disclosure - Stock-Based Compensation - Performance Stock Units Activity (Details)", "shortName": "Stock-Based Compensation - Performance Stock Units Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "c-251", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-249", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R89": { "role": "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails", "longName": "9954529 - Disclosure - Stock-Based Compensation - Company Utilized Black-Scholes Pricing Model (Details)", "shortName": "Stock-Based Compensation - Company Utilized Black-Scholes Pricing Model (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "c-259", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "vote", "xsiNil": "false", "lang": "en-US", "decimals": "1", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-259", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "vote", "xsiNil": "false", "lang": "en-US", "decimals": "1", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R90": { "role": "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesDetails", "longName": "9954530 - Disclosure - Stock-Based Compensation - Stock Based Compensation Expenses (Details)", "shortName": "Stock-Based Compensation - Stock Based Compensation Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-268", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R91": { "role": "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesbyAwardTypeDetails", "longName": "9954531 - Disclosure - Stock-Based Compensation - Stock Based Compensation Expenses by Award Type (Details)", "shortName": "Stock-Based Compensation - Stock Based Compensation Expenses by Award Type (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-276", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R92": { "role": "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofLossBeforeIncomeTaxExpenseDetails", "longName": "9954532 - Disclosure - Income Taxes - Components of Loss Before Income Tax Expense (Details)", "shortName": "Income Taxes - Components of Loss Before Income Tax Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R93": { "role": "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails", "longName": "9954533 - Disclosure - Income Taxes - Components of Income Tax Expense (Details)", "shortName": "Income Taxes - Components of Income Tax Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R94": { "role": "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails", "longName": "9954534 - Disclosure - Income Taxes - Effective Income Tax Rate (Details)", "shortName": "Income Taxes - Effective Income Tax Rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R95": { "role": "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails", "longName": "9954535 - Disclosure - Income Taxes - Net Deferred Tax Assets (Details)", "shortName": "Income Taxes - Net Deferred Tax Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R96": { "role": "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails", "longName": "9954536 - Disclosure - Income Taxes - Narrative (Details)", "shortName": "Income Taxes - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "c-1", "name": "nhic:ValuationAllowanceDeferredTaxAssetDecreaseForReversalChargedToIncomeTaxExpensesBenefitAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nhic:ValuationAllowanceDeferredTaxAssetDecreaseForReversalChargedToIncomeTaxExpensesBenefitAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R97": { "role": "http://www.evolvtechnology.com/role/IncomeTaxesValuationAllowanceforDeferredTaxAssetsDetails", "longName": "9954537 - Disclosure - Income Taxes - Valuation Allowance for Deferred Tax Assets (Details)", "shortName": "Income Taxes - Valuation Allowance for Deferred Tax Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfValuationAllowanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nhic:ValuationAllowanceDeferredTaxAssetIncreaseChargedToProvisionForIncomeTaxesAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfValuationAllowanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R98": { "role": "http://www.evolvtechnology.com/role/IncomeTaxesUncertainTaxPositionsDetails", "longName": "9954538 - Disclosure - Income Taxes - Uncertain Tax Positions (Details)", "shortName": "Income Taxes - Uncertain Tax Positions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-25", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R99": { "role": "http://www.evolvtechnology.com/role/NetLossperShareDetails", "longName": "9954539 - Disclosure - Net Loss per Share (Details)", "shortName": "Net Loss per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R100": { "role": "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "longName": "9954540 - Disclosure - Net Loss per Share - Antidilutive Effect (Details)", "shortName": "Net Loss per Share - Antidilutive Effect (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } }, "R101": { "role": "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails", "longName": "9954541 - Disclosure - Related Party Transactions (Details)", "shortName": "Related Party Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-310", "name": "nhic:NumberOfResellersAndIntegrationPartners", "unitRef": "item", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "unique": true } }, "R102": { "role": "http://www.evolvtechnology.com/role/BenefitPlansDetails", "longName": "9954542 - Disclosure - Benefit Plans (Details)", "shortName": "Benefit Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nhic-20231231.htm", "first": true, "unique": true } } }, "tag": { "nhic_A2022SVBTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "A2022SVBTermLoanMember", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2022 SVB Term Loan", "label": "2022 SVB Term Loan [Member]", "documentation": "2022 SVB Term Loan" } } }, "auth_ref": [] }, "nhic_A2022SVBTermLoanTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "A2022SVBTermLoanTwoMember", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2022 Additional SVB Term Loan", "label": "2022 SVB Term Loan Two [Member]", "documentation": "2022 SVB Term Loan Two" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsAndNontradeReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsAndNontradeReceivableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/AccountsReceivable" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable", "label": "Accounts and Nontrade Receivable [Text Block]", "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable." } } }, "auth_ref": [ "r299", "r336" ] }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued Expenses and Other Current Liabilities", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r29", "r838" ] }, "nhic_AccountsReceivableAllowanceForCreditLossExpenseReversalNetOfWriteoffAndRecovery": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "AccountsReceivableAllowanceForCreditLossExpenseReversalNetOfWriteoffAndRecovery", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Change in allowance for expected credit losses", "label": "Accounts Receivable, Allowance For Credit Loss, Expense (Reversal) Net Of Writeoff And Recovery", "documentation": "Accounts Receivable, Allowance For Credit Loss, Expense (Reversal) Net Of Writeoff And Recovery" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/AccountsReceivableTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of changes in allowance for expected credit losses", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r990" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable", "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r782" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r300", "r301" ] }, "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accretion of discount on marketable securities", "label": "Accretion (Amortization) of Discounts and Premiums, Investments", "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r125" ] }, "nhic_AccruedEmployeeCompensationAndBenefitsExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "AccruedEmployeeCompensationAndBenefitsExpenseCurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued employee compensation and benefits expense", "label": "Accrued Employee Compensation And Benefits Expense Current", "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued sales tax", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r97", "r155" ] }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesAndOtherLiabilities", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "totalLabel": "Accrued expenses and other current liabilities", "label": "Accrued Liabilities and Other Liabilities", "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other." } } }, "auth_ref": [] }, "nhic_AccruedProfessionalServiceAndConsultingCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "AccruedProfessionalServiceAndConsultingCurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued professional services and consulting", "label": "Accrued Professional Service And Consulting Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional service and consulting, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetLeasedEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated depreciation and amortization", "negatedTerseLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r60", "r191", "r651" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r38", "r39", "r110", "r199", "r647", "r672", "r676" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r13", "r39", "r530", "r533", "r580", "r667", "r668", "r965", "r966", "r967", "r974", "r975", "r976" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r891" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r102", "r838", "r1068" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r484", "r485", "r486", "r692", "r974", "r975", "r976", "r1043", "r1070" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r897" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r897" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r897" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r897" ] }, "nhic_AdjustmentToPropertyAndEquipmentForSaleTypeLeases": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "AdjustmentToPropertyAndEquipmentForSaleTypeLeases", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Adjustment to property and equipment for sales type leases", "label": "Adjustment To Property And Equipment For Sale Type Leases", "documentation": "Amount of adjustment to property, plant and equipment for sale type leases." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation cost", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r71", "r72", "r446" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "nhic_AggregateIntrinsicValueOfWarrantsExercisable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "AggregateIntrinsicValueOfWarrantsExercisable", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate intrinsic value of warrants exercisable", "label": "Aggregate Intrinsic Value of Warrants Exercisable", "documentation": "Represents the information pertaining to aggregate intrinsic value of warrants exercisable." } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r861", "r873", "r883", "r909" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r864", "r876", "r886", "r912" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r897" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r904" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r868", "r877", "r887", "r904", "r913", "r917", "r925" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r923" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesbyAwardTypeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock compensation expense", "terseLabel": "Total stock-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r478", "r491" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/AccountsReceivableDetails" ], "lang": { "en-us": { "role": { "negatedPeriodStartLabel": "Beginning balance", "negatedPeriodEndLabel": "Ending balance", "label": "Accounts Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r200", "r302", "r341", "r344", "r347", "r1064" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "presentation": [ "http://www.evolvtechnology.com/role/AccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/AccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Write-offs, net of recoveries", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance." } } }, "auth_ref": [ "r346" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "nhic_AnilChitkaraMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "AnilChitkaraMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Anil Chitkara [Member]", "documentation": "Anil Chitkara" } } }, "auth_ref": [] }, "nhic_AnnualIncreaseOfTotalCommonSharesOutstandingAsAPercentageOfCommonSharesOutstandAsOfTheEndOfPriorYear": { "xbrltype": "percentItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "AnnualIncreaseOfTotalCommonSharesOutstandingAsAPercentageOfCommonSharesOutstandAsOfTheEndOfPriorYear", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual increase of total common shares outstanding", "label": "Annual Increase Of Total Common Shares Outstanding As A Percentage Of Common Shares Outstand As Of The End Of Prior Year", "documentation": "Annual Increase Of Total Common Shares Outstanding As A Percentage Of Common Shares Outstand As Of The End Of Prior Year" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities excluded from the computation of diluted net loss per share (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r266" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r48" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r48" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r524" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r153", "r193", "r229", "r274", "r289", "r293", "r335", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r525", "r527", "r551", "r643", "r729", "r838", "r850", "r998", "r999", "r1053" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r186", "r205", "r229", "r335", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r525", "r527", "r551", "r838", "r998", "r999", "r1053" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total assets measured at fair value", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r80" ] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets:", "label": "Assets, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "nhic_AuditInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "AuditInformationAbstract", "lang": { "en-us": { "role": { "label": "Audit Information [Abstract]", "documentation": "Audit Information [Abstract]" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://www.evolvtechnology.com/role/AuditInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Firm ID", "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r855", "r856", "r869" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://www.evolvtechnology.com/role/AuditInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Location", "label": "Auditor Location" } } }, "auth_ref": [ "r855", "r856", "r869" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://www.evolvtechnology.com/role/AuditInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Name", "label": "Auditor Name" } } }, "auth_ref": [ "r855", "r856", "r869" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/MarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r306", "r351", "r642" ] }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtSecurities", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/MarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Debt Securities, Available-for-Sale", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r307", "r351", "r636", "r981" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r920" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r921" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r916" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r916" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r916" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r916" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r916" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r916" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.evolvtechnology.com/role/CommonStockDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesbyAwardTypeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r449", "r450", "r451", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r473", "r474", "r475", "r476", "r477" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r919" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r918" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r917" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r917" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "nhic_BenefitPlansDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "BenefitPlansDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Benefit Plans", "label": "Benefit Plans", "documentation": "Benefit Plans Disclosure" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r523", "r831", "r832" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r78", "r79", "r523", "r831", "r832" ] }, "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionContingentConsiderationLineItems", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]", "label": "Business Acquisition, Contingent Consideration [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Merger", "label": "Business Combinations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy." } } }, "auth_ref": [ "r77" ] }, "nhic_BusinessDevelopmentAgreementTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "BusinessDevelopmentAgreementTerm", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business development agreement term", "label": "Business Development Agreement Term.", "documentation": "Business development agreement term." } } }, "auth_ref": [] }, "nhic_BusinessDevelopmentAgreementWithFinbackMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "BusinessDevelopmentAgreementWithFinbackMember", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finback BDA", "label": "Business Development Agreement with Finback [Member]", "documentation": "Represents the information pertaining to Business Development Agreement with Finback." } } }, "auth_ref": [] }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalExpendituresIncurredButNotYetPaid", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Capital expenditures incurred but not yet paid", "label": "Capital Expenditures Incurred but Not yet Paid", "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred." } } }, "auth_ref": [ "r45", "r46", "r47" ] }, "us-gaap_CapitalizedComputerSoftwareAmortization1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedComputerSoftwareAmortization1", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized software amortization", "label": "Capitalized Computer Software, Amortization", "documentation": "Amount of expense for amortization of capitalized computer software costs." } } }, "auth_ref": [ "r11", "r164" ] }, "us-gaap_CapitalizedContractCostAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedContractCostAmortization", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized commissions", "label": "Capitalized Contract Cost, Amortization", "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer." } } }, "auth_ref": [ "r361" ] }, "us-gaap_CapitalizedContractCostGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedContractCostGross", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred asset related to commissions", "label": "Capitalized Contract Cost, Gross", "documentation": "Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer." } } }, "auth_ref": [ "r992" ] }, "us-gaap_CashAndCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash, cash equivalents and restricted cash", "label": "Cash and Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 }, "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r43", "r189", "r799" ] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Cash, Cash Equivalents, and Restricted Cash", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r44", "r152" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "totalLabel": "Total cash, cash equivalents and restricted cash shown in the statements of cash flows", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r43", "r123", "r226" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash:", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r123" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosure of non-cash activities", "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r895" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.evolvtechnology.com/role/Cover", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r181", "r196", "r197", "r198", "r229", "r255", "r256", "r263", "r265", "r272", "r273", "r335", "r370", "r372", "r373", "r374", "r377", "r378", "r408", "r409", "r410", "r411", "r413", "r551", "r683", "r684", "r685", "r686", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r717", "r738", "r761", "r776", "r777", "r778", "r779", "r780", "r932", "r970", "r978" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/WarrantsPreferredStockandCommonStockOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Axis]", "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r67" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/WarrantsPreferredStockandCommonStockOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Domain]", "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPublicWarrantsDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails", "http://www.evolvtechnology.com/role/WarrantsPreferredStockandCommonStockOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price", "verboseLabel": "Weighted average exercise price (in dollars per share)", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r414" ] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://www.evolvtechnology.com/role/WarrantsPreferredStockandCommonStockOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Line Items]", "label": "Class of Warrant or Right [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPublicWarrantsDetails", "http://www.evolvtechnology.com/role/WarrantsPreferredStockandCommonStockOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares purchased from issuance of warrants (in shares)", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r414" ] }, "nhic_ClassOfWarrantOrRightNumberOfSecuritiesExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesExercisable", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issuable upon exercise of warrant (in shares)", "label": "Class of Warrant or Right Number of Securities, Exercisable", "documentation": "Number of securities into which the class of warrant or right that may be exercisable." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://www.evolvtechnology.com/role/WarrantsPreferredStockandCommonStockOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Table]", "label": "Class of Warrant or Right [Table]", "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r67" ] }, "us-gaap_ClassOfWarrantOrRightUnissued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightUnissued", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of warrant or right, unissued (in shares)", "label": "Class of Warrant or Right, Unissued", "documentation": "The number of warrants or rights which entitle the entity to receive future services in exchange for the unvested, forfeitable warrants or rights." } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r896" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r896" ] }, "nhic_CommissionAssetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "CommissionAssetCurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of commission asset", "label": "Commission Asset, Current", "documentation": "The carrying value as of balance sheet date of commission assets due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "nhic_CommissionAssetNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "CommissionAssetNoncurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commission asset, noncurrent", "label": "Commission Asset, Noncurrent", "documentation": "The carrying value as of balance sheet date of commission assets due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note 19)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r35", "r90", "r644", "r716" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r132", "r364", "r365", "r783", "r994" ] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassAMember", "presentation": [ "http://www.evolvtechnology.com/role/Cover", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Class A", "label": "Common Class A [Member]", "documentation": "Classification of common stock representing ownership interest in a corporation." } } }, "auth_ref": [ "r1070" ] }, "us-gaap_CommonClassBMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassBMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Class B", "label": "Common Class B [Member]", "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation." } } }, "auth_ref": [ "r1070" ] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://www.evolvtechnology.com/role/CommonStockDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares remained available for future grant (in shares)", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r36" ] }, "nhic_CommonStockDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "CommonStockDisclosureTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/CommonStock" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock Disclosure [Text Block]", "documentation": "The entire disclosure of common stock" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r841", "r842", "r843", "r845", "r846", "r847", "r848", "r974", "r975", "r1043", "r1067", "r1070" ] }, "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]", "label": "Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]" } } }, "auth_ref": [] }, "nhic_CommonStockNumberOfVotesForEachShare": { "xbrltype": "integerItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "CommonStockNumberOfVotesForEachShare", "presentation": [ "http://www.evolvtechnology.com/role/CommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of votes per common share", "label": "Common Stock, Number of Votes For Each Share", "documentation": "Represents the number of votes per common shares." } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r101" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r101", "r717" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r101" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r14", "r101", "r717", "r735", "r1070", "r1071" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December\u00a031, 2023 and December\u00a031, 2022, 151,310,080 and 145,204,974 shares issued and outstanding at December\u00a031, 2023 and December\u00a031, 2022, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r101", "r646", "r838" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r901" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r900" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r902" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r899" ] }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/BenefitPlans" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit Plans", "label": "Compensation and Employee Benefit Plans [Text Block]", "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans." } } }, "auth_ref": [ "r137", "r138", "r139", "r140" ] }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfDeferredTaxAssetsAbstract", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets:", "label": "Components of Deferred Tax Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities:", "label": "Components of Deferred Tax Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofLossBeforeIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Components of the Company's loss before income tax expense", "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r40", "r208", "r210", "r218", "r638", "r657" ] }, "nhic_ComputerAndTelecomEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ComputerAndTelecomEquipmentMember", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Computers and telecom equipment", "label": "Computers and telecom equipment", "documentation": "Represents the information about Computer and telecom Equipment member." } } }, "auth_ref": [] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Computers and telecommunications equipment", "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r51", "r53", "r82", "r83", "r298", "r782" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r51", "r53", "r82", "r83", "r298", "r677", "r782" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r51", "r53", "r82", "r83", "r298", "r782", "r943" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Risk of Concentrations of Credit, Significant Customers and Significant Suppliers", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r93", "r170" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Line Items]", "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r782" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk, percentage (less than)", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r51", "r53", "r82", "r83", "r298" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Table]", "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r50", "r51", "r53", "r54", "r82", "r150", "r782" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r51", "r53", "r82", "r83", "r298", "r782" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Axis]", "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r234", "r525", "r526", "r527", "r528", "r589", "r793", "r997", "r1000", "r1001" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Domain]", "label": "Consolidated Entities [Domain]" } } }, "auth_ref": [ "r234", "r525", "r526", "r527", "r528", "r589", "r793", "r997", "r1000", "r1001" ] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Construction in progress", "label": "Construction in Progress [Member]", "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [] }, "nhic_ContingentConsiderationLiabilityMeasurementInput": { "xbrltype": "percentItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ContingentConsiderationLiabilityMeasurementInput", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration, measurement input", "label": "Contingent Consideration, Liability, Measurement Input", "documentation": "Value of input used to measure contingent consideration liability." } } }, "auth_ref": [] }, "nhic_ContingentConsiderationTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ContingentConsiderationTerm", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration term", "label": "Contingent Consideration Term", "documentation": "Contingent Consideration Term" } } }, "auth_ref": [] }, "nhic_ContingentEarnOutLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ContingentEarnOutLiabilityMember", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsContingentEarnOutandContingentlyIssuableCommonSharesDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent earn-out liability", "label": "Contingent Earn-Out Liability", "documentation": "Represents the information pertaining to Contingent earn-out liability." } } }, "auth_ref": [] }, "nhic_ContingentEarnOutPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ContingentEarnOutPolicyPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent Earn-out", "label": "Contingent Earn-out Policy [Policy Text Block]", "documentation": "The disclosure of accounting policy for Contingent Earn-out." } } }, "auth_ref": [] }, "nhic_ContingentEarnoutTriggeringEventAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ContingentEarnoutTriggeringEventAxis", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent Earnout, Triggering Event [Axis]", "label": "Contingent Earnout, Triggering Event [Axis]", "documentation": "Contingent Earnout, Triggering Event" } } }, "auth_ref": [] }, "nhic_ContingentEarnoutTriggeringEventDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ContingentEarnoutTriggeringEventDomain", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent Earnout, Triggering Event [Domain]", "label": "Contingent Earnout, Triggering Event [Domain]", "documentation": "Contingent Earnout, Triggering Event [Domain]" } } }, "auth_ref": [] }, "nhic_ContingentlyIssuableCommonStockLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ContingentlyIssuableCommonStockLiabilityMember", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsContingentEarnOutandContingentlyIssuableCommonSharesDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingently issuable common stock liability", "label": "Contingently Issuable Common Stock Liability", "documentation": "Represents the information pertaining to contingently issuable common stock liability." } } }, "auth_ref": [] }, "nhic_ContingentlyIssuableCommonStockPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ContingentlyIssuableCommonStockPolicyPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Contingently Issuable Common Stock", "label": "Contingently Issuable Common Stock Policy [Policy Text Block]", "documentation": "The disclosure of accounting policy for Contingently Issuable Common Stock." } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of rollforward of deferred revenue", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability." } } }, "auth_ref": [ "r1004" ] }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetNetCurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of contract assets", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current." } } }, "auth_ref": [ "r416", "r418", "r429" ] }, "us-gaap_ContractWithCustomerAssetNetNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetNetNoncurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract assets, noncurrent", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent", "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent." } } }, "auth_ref": [ "r416", "r418", "r429" ] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiability", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofRollforwardofDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "label": "Contract with Customer, Liability", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r416", "r417", "r429" ] }, "nhic_ContractWithCustomerLiabilityAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ContractWithCustomerLiabilityAdditions", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofRollforwardofDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue deferred", "label": "Contract With Customer, Liability, Additions", "documentation": "Contract With Customer, Liability, Additions" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of deferred revenue", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r416", "r417", "r429" ] }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, noncurrent", "label": "Contract with Customer, Liability, Noncurrent", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r416", "r417", "r429" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofRollforwardofDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized in relation to the beginning of the year contract liability balance", "negatedLabel": "Revenue recognized in relation to the beginning of the year contract liability balance", "label": "Contract with Customer, Liability, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r430" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total cost of revenue", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r115", "r229", "r335", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r551", "r998" ] }, "us-gaap_CostOfRevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenueAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenue:", "label": "Cost of Revenue [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenue", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Current Federal Tax Expense (Benefit)", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r949", "r973", "r1041" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Current Foreign Tax Expense (Benefit)", "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r949", "r973" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total current income tax expense", "label": "Current Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r146", "r511", "r517", "r973" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current:", "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State", "label": "Current State and Local Tax Expense (Benefit)", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r949", "r973", "r1041" ] }, "nhic_CustomerAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "CustomerAMember", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer A", "label": "Customer A [Member]", "documentation": "Represents information pertaining to Customer A." } } }, "auth_ref": [] }, "nhic_CustomerBMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "CustomerBMember", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer B", "label": "Customer B [Member]", "documentation": "Customer B" } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r52", "r298" ] }, "nhic_CustomerOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "CustomerOneMember", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer", "label": "Customer", "documentation": "Represents information pertaining to Customer A." } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebt" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r133", "r228", "r379", "r385", "r386", "r387", "r388", "r389", "r390", "r395", "r402", "r403", "r405" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r27", "r96", "r97", "r154", "r157", "r234", "r380", "r381", "r382", "r383", "r384", "r386", "r391", "r392", "r393", "r394", "r396", "r397", "r398", "r399", "r400", "r401", "r561", "r814", "r815", "r816", "r817", "r818", "r971" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term loans payable", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r27", "r157", "r406" ] }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of consecutive trading days", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleThresholdTradingDays", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of trading days", "label": "Debt Instrument, Convertible, Threshold Trading Days", "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Face amount of debt", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r85", "r87", "r380", "r561", "r815", "r816" ] }, "us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentIncreaseDecreaseForPeriodNet", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, increase", "label": "Debt Instrument, Increase (Decrease), Net", "documentation": "Net increase or decrease in the carrying amount of the debt instrument for the period." } } }, "auth_ref": [ "r971" ] }, "nhic_DebtInstrumentInterestRatePrepaymentPremium": { "xbrltype": "pureItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "DebtInstrumentInterestRatePrepaymentPremium", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepayment premium", "label": "Debt Instrument, Interest Rate, Prepayment Premium", "documentation": "Debt Instrument, Interest Rate, Prepayment Premium" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r33", "r381" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails", "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r234", "r380", "r381", "r382", "r383", "r384", "r386", "r391", "r392", "r393", "r394", "r396", "r397", "r398", "r399", "r400", "r401", "r404", "r561", "r814", "r815", "r816", "r817", "r818", "r971" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r34", "r234", "r380", "r381", "r382", "r383", "r384", "r386", "r391", "r392", "r393", "r394", "r396", "r397", "r398", "r399", "r400", "r401", "r561", "r814", "r815", "r816", "r817", "r818", "r971" ] }, "nhic_DebtInstrumentPrepaymentPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "DebtInstrumentPrepaymentPremium", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepayment premium", "label": "Debt Instrument, Prepayment Premium", "documentation": "Debt Instrument, Prepayment Premium" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails", "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r34", "r65", "r66", "r84", "r85", "r87", "r92", "r134", "r135", "r234", "r380", "r381", "r382", "r383", "r384", "r386", "r391", "r392", "r393", "r394", "r396", "r397", "r398", "r399", "r400", "r401", "r404", "r561", "r814", "r815", "r816", "r817", "r818", "r971" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, term", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Unamortized discount", "label": "Debt Instrument, Unamortized Discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r84", "r87", "r1003" ] }, "us-gaap_DebtPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Issuance Costs", "label": "Debt, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt." } } }, "auth_ref": [ "r10" ] }, "us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/MarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Gain/(Loss)", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain (Loss), before Tax", "documentation": "Amount, before tax, of unrealized gain (loss) in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r983", "r984" ] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of prepaid expenses and other current assets", "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]", "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs." } } }, "auth_ref": [] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Deferred Federal Income Tax Expense (Benefit)", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r973", "r1040", "r1041" ] }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredForeignIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Deferred Foreign Income Tax Expense (Benefit)", "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r146", "r973", "r1040" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred income tax expense", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r8", "r146", "r178", "r516", "r517", "r973" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred:", "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total deferred tax liabilities", "label": "Deferred Tax Liabilities, Gross", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r98", "r99", "r156", "r505" ] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State", "label": "Deferred State and Local Income Tax Expense (Benefit)", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r973", "r1040", "r1041" ] }, "nhic_DeferredTaxAssetLeasingArrangements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "DeferredTaxAssetLeasingArrangements", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liability", "label": "Deferred Tax Asset, Leasing Arrangements", "documentation": "Deferred Tax Asset, Leasing Arrangements" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsDeferredIncome", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Deferred Tax Assets, Deferred Income", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income." } } }, "auth_ref": [ "r76", "r1039" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax assets", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r506" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax assets", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r1038" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax assets, net of valuation allowance", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r1038" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net operating loss carryforwards", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r76", "r1039" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Deferred Tax Assets, Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r76", "r1039" ] }, "nhic_DeferredTaxAssetsTaxCreditCarryforwardsCapitalizedResearchAndDevelopmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "DeferredTaxAssetsTaxCreditCarryforwardsCapitalizedResearchAndDevelopmentCosts", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized research and development costs", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Capitalized Research and Development Costs", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capitalized research and development costs." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development tax credit carryforwards", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards." } } }, "auth_ref": [ "r75", "r76", "r1039" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities." } } }, "auth_ref": [ "r76", "r1039" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails", "http://www.evolvtechnology.com/role/IncomeTaxesValuationAllowanceforDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "periodStartLabel": "Valuation allowance as of beginning of year", "periodEndLabel": "Valuation allowance as of end of year", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r507" ] }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesLeasingArrangements", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Right of use lease asset", "label": "Deferred Tax Liabilities, Leasing Arrangements", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements." } } }, "auth_ref": [ "r76", "r1039" ] }, "us-gaap_DeferredTaxLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Deferred Tax Liabilities, Other", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other." } } }, "auth_ref": [ "r76", "r1039" ] }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Depreciation and amortization", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment." } } }, "auth_ref": [ "r76", "r1039" ] }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanContributionsByEmployer", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/BenefitPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employer contributions", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets." } } }, "auth_ref": [ "r432", "r434", "r441", "r827", "r828", "r829", "r830" ] }, "us-gaap_DepositsAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositsAssetsCurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Prepaid deposits", "label": "Deposits Assets, Current", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter." } } }, "auth_ref": [ "r963" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r8", "r59" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r8", "r279" ] }, "us-gaap_DerivativeLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityMeasurementInput", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement input", "label": "Derivative Liability, Measurement Input", "documentation": "Value of input used to measure derivative liability." } } }, "auth_ref": [ "r545" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionRevenuebyGeographicalLocationDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofCompanysRevenuebyRevenueStreamDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r428", "r820", "r821", "r822", "r823", "r824", "r825", "r826" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionRevenuebyGeographicalLocationDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofCompanysRevenuebyRevenueStreamDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r428", "r820", "r821", "r822", "r823", "r824", "r825", "r826" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of company's revenue by revenue stream", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r1005" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r444", "r448", "r480", "r481", "r483", "r834" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "nhic_DistributionAgreementWithMotorolaMemberMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "DistributionAgreementWithMotorolaMemberMember", "presentation": [ "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Distribution Agreement With Motorola Member", "label": "Distribution Agreement With Motorola Member [Member]", "documentation": "Distribution Agreement With Motorola Member" } } }, "auth_ref": [] }, "us-gaap_DividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStock", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Expected dividend yield", "label": "Dividends, Common Stock", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r6", "r136" ] }, "us-gaap_DividendsCommonStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStockCash", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/CommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash dividends declared or paid", "label": "Dividends, Common Stock, Cash", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r136" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Annual Report", "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r855", "r856", "r869" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Financial Statement Error Correction [Flag]", "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r855", "r856", "r869", "r905" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r890" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Documents Incorporated by Reference", "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r853" ] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticCountryMember", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Domestic Tax Authority", "label": "Domestic Tax Authority [Member]", "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile." } } }, "auth_ref": [] }, "nhic_EarnOutSharesIssuableUponAchievingCertainMilestones": { "xbrltype": "sharesItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "EarnOutSharesIssuableUponAchievingCertainMilestones", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earn-out shares issuable upon achieving certain milestones (in shares)", "label": "Earn Out Shares Issuable Upon Achieving Certain Milestones", "documentation": "Number of earn out shares issuable upon achievement of certain milestones." } } }, "auth_ref": [] }, "nhic_EarnOutSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "EarnOutSharesMember", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesbyAwardTypeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Earn-out shares", "label": "Earn Out Shares", "documentation": "Represents the information pertaining to to earn-out shares." } } }, "auth_ref": [] }, "nhic_EarnOutSharesSubjectToShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "EarnOutSharesSubjectToShareBasedCompensation", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earn-out shares are subject to the share-based compensation (in shares)", "label": "Earn Out Shares Subject To Share Based Compensation", "documentation": "Number of earn out shares subject to share based compensation." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share [Abstract]", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/NetLossperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share - basic (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r219", "r240", "r241", "r243", "r244", "r246", "r252", "r255", "r263", "r264", "r265", "r269", "r538", "r539", "r639", "r658", "r807" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/NetLossperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share - diluted (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r219", "r240", "r241", "r243", "r244", "r246", "r255", "r263", "r264", "r265", "r269", "r538", "r539", "r639", "r658", "r807" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Net Loss per Share Attributable to Common Stockholders", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r48", "r49" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShare" ], "lang": { "en-us": { "role": { "terseLabel": "Net Loss per share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r251", "r266", "r267", "r268" ] }, "nhic_EdgeUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "EdgeUnitsMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Edge Units", "label": "Edge Units [Member]", "documentation": "Edge Units [Member]" } } }, "auth_ref": [] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash and cash equivalents", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r552" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Effective income tax rate", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r498" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate", "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal statutory income tax rate", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r231", "r498", "r519" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in valuation allowance", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r1035", "r1042" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in tax rate", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates." } } }, "auth_ref": [ "r519", "r1035" ] }, "nhic_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfContingentEarnOutLiabilityAndCommonStockLiabilityPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationChangeInFairValueOfContingentEarnOutLiabilityAndCommonStockLiabilityPercent", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value of contingent earn-out liability and contingently issuable common stock liability", "label": "Effective Income Tax Rate Reconciliation, Change in Fair Value of Contingent Earn Out Liability And Common Stock Liability, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Change in fair value of contingent earn-out liability and contingently issuable common stock liability." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Permanent differences", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses." } } }, "auth_ref": [ "r1035", "r1042" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-deductible compensation", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses." } } }, "auth_ref": [ "r1035", "r1042" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent", "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement." } } }, "auth_ref": [ "r1035", "r1042" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r1035", "r1042" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State income taxes, net of federal benefit", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)." } } }, "auth_ref": [ "r1035", "r1042" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in uncertain tax positions", "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies." } } }, "auth_ref": [ "r1035", "r1042" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Federal and state research and development tax credits", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit." } } }, "auth_ref": [ "r1035", "r1042" ] }, "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeNetAbstract", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]", "label": "Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalization of stock compensation", "label": "Share-Based Payment Arrangement, Amount Capitalized", "documentation": "Amount of cost capitalized for award under share-based payment arrangement." } } }, "auth_ref": [ "r479" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesbyAwardTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average period expected of recognition", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r482" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r1034" ] }, "us-gaap_EmployeeStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockMember", "presentation": [ "http://www.evolvtechnology.com/role/CommonStockDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock", "label": "Employee Stock [Member]", "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesbyAwardTypeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options", "verboseLabel": "Options issued and outstanding", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r852" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity [Domain]", "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r852" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r852" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r930" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Public Float", "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r852" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r852" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r852" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r852" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Voluntary Filers", "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Well-known Seasoned Issuer", "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r931" ] }, "nhic_EquipmentHeldForLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "EquipmentHeldForLeaseMember", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equipment held for lease", "label": "Equipment Held For Lease [Member]", "documentation": "Equipment Held For Lease" } } }, "auth_ref": [] }, "us-gaap_EquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquipmentMember", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lab equipment", "label": "Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r14", "r183", "r212", "r213", "r214", "r235", "r236", "r237", "r239", "r247", "r249", "r271", "r337", "r340", "r415", "r484", "r485", "r486", "r512", "r513", "r529", "r530", "r531", "r532", "r533", "r534", "r537", "r553", "r555", "r556", "r557", "r558", "r559", "r580", "r667", "r668", "r669", "r692", "r761" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r898" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r861", "r873", "r883", "r909" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r858", "r870", "r880", "r906" ] }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems", "presentation": [ "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]", "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r240", "r241", "r242", "r246", "r247", "r248", "r249", "r269" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r904" ] }, "nhic_FairValueAdjustmentOfPublicWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "FairValueAdjustmentOfPublicWarrantLiability", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 7.0 }, "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of public warrant liability", "terseLabel": "Change in fair value of public warrant liability", "label": "Fair Value Adjustment Of Public Warrant Liability", "documentation": "The amount of change in fair value of public warrant liability." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r541", "r542", "r547" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r541", "r542", "r547" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r15" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of fair value measurements of common stock warrants granted", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r15" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Domain]", "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r16" ] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Class [Axis]", "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r80", "r81" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r393", "r434", "r435", "r436", "r437", "r438", "r439", "r542", "r593", "r594", "r595", "r815", "r816", "r827", "r828", "r829" ] }, "us-gaap_FairValueByLiabilityClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByLiabilityClassAxis", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsContingentEarnOutandContingentlyIssuableCommonSharesDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsWarrantLiabilityDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability Class [Axis]", "label": "Liability Class [Axis]", "documentation": "Information by class of liability." } } }, "auth_ref": [ "r81", "r149" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Axis]", "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r541", "r542", "r544", "r545", "r548" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r540" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r393", "r434", "r439", "r542", "r593", "r827", "r828", "r829" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r393", "r434", "r439", "r542", "r594", "r815", "r816", "r827", "r828", "r829" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r393", "r434", "r435", "r436", "r437", "r438", "r439", "r542", "r595", "r815", "r816", "r827", "r828", "r829" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsContingentEarnOutandContingentlyIssuableCommonSharesDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsWarrantLiabilityDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value by Liability Class [Domain]", "label": "Fair Value by Liability Class [Domain]", "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "auth_ref": [ "r16" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsContingentEarnOutandContingentlyIssuableCommonSharesDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsWarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsContingentEarnOutandContingentlyIssuableCommonSharesDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsWarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsContingentEarnOutandContingentlyIssuableCommonSharesDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsWarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3." } } }, "auth_ref": [ "r16", "r81" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of common stock warrant liability", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r16", "r81" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Domain]", "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements of Financial Instruments", "label": "Fair Value Measurement, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsContingentEarnOutandContingentlyIssuableCommonSharesDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsWarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Change in fair value", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r546" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsContingentEarnOutandContingentlyIssuableCommonSharesDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsWarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning", "periodEndLabel": "Balance at ending", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r16" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r393", "r434", "r435", "r436", "r437", "r438", "r439", "r593", "r594", "r595", "r815", "r816", "r827", "r828", "r829" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r540", "r548" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails", "http://www.evolvtechnology.com/role/MarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instrument [Axis]", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r342", "r343", "r348", "r349", "r350", "r352", "r353", "r354", "r404", "r412", "r535", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r656", "r812", "r951", "r952", "r953", "r954", "r955", "r956", "r957", "r985", "r986", "r987", "r988" ] }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialLiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities of fair value", "label": "Financial Liabilities Fair Value Disclosure", "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities." } } }, "auth_ref": [] }, "nhic_FinbackCommonStockWarrants2021Member": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "FinbackCommonStockWarrants2021Member", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finback Common Stock Warrants 2021", "label": "Finback Common Stock Warrants 2021 [Member]", "documentation": "Represents information pertaining to Finback Common Stock Warrants." } } }, "auth_ref": [] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Tax Authority", "label": "Foreign Tax Authority [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r865", "r877", "r887", "r913" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r865", "r877", "r887", "r913" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r865", "r877", "r887", "r913" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r865", "r877", "r887", "r913" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r865", "r877", "r887", "r913" ] }, "nhic_FounderSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "FounderSharesMember", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingently issuable common stock", "label": "Unvested Founder Shares", "documentation": "Represents the information pertaining to founder shares ." } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Furniture and fixtures", "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 5.0 }, "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on extinguishment of debt", "negatedLabel": "Loss on extinguishment of debt", "label": "Gain (Loss) on Extinguishment of Debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r8", "r62", "r63" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r116", "r740" ] }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "label": "General and Administrative Expense [Member]", "documentation": "Primary financial statement caption encompassing general and administrative expense." } } }, "auth_ref": [ "r113" ] }, "nhic_GiveEvolvLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "GiveEvolvLlcMember", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Give Evolv LLC", "label": "Give Evolv LLC", "documentation": "Represents information pertaining to Give Evolv LLC." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r114", "r229", "r274", "r288", "r292", "r294", "r335", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r551", "r809", "r998" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "ICFR Auditor Attestation Flag", "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r855", "r856", "r869" ] }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 }, "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss from impairment of property and equipment", "verboseLabel": "Impairment of property and equipment", "label": "Impairment, Long-Lived Asset, Held-for-Use", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)." } } }, "auth_ref": [ "r8", "r58", "r131" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofLossBeforeIncomeTaxExpenseDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofLossBeforeIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations." } } }, "auth_ref": [ "r230", "r518" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 }, "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofLossBeforeIncomeTaxExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofLossBeforeIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r111", "r159", "r274", "r288", "r292", "r294", "r640", "r653", "r809" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofLossBeforeIncomeTaxExpenseDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofLossBeforeIncomeTaxExpenseDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile." } } }, "auth_ref": [ "r230", "r518" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r362", "r363", "r745" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r363", "r745" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority [Axis]", "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r12" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority [Domain]", "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r231", "r493", "r499", "r503", "r509", "r514", "r520", "r521", "r522", "r688" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 1.0 }, "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofIncomeTaxExpenseDetails", "http://www.evolvtechnology.com/role/IncomeTaxesComponentsofLossBeforeIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Provision for income taxes", "terseLabel": "Provision for income taxes", "totalLabel": "Total income tax expense", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r165", "r179", "r248", "r249", "r280", "r497", "r515", "r659" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r211", "r495", "r496", "r503", "r504", "r508", "r510", "r682" ] }, "us-gaap_IncomeTaxUncertaintiesPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxUncertaintiesPolicy", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Uncertainties", "label": "Income Tax Uncertainties, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for tax positions taken in the tax return filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other types of contingencies related to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r7" ] }, "nhic_IncreaseDecreaseInCommissionAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "IncreaseDecreaseInCommissionAssets", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Commission assets", "label": "Increase (Decrease) in Commission Assets", "documentation": "The increase (decrease) during the reporting period of all commission assets associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerAsset", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Contract assets", "label": "Increase (Decrease) in Contract with Customer, Asset", "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r968" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r621", "r968" ] }, "nhic_IncreaseDecreaseInFairValueOfContingentEarnoutLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "IncreaseDecreaseInFairValueOfContingentEarnoutLiability", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 1.0 }, "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Change in fair value of contingent earn-out liability", "verboseLabel": "Change in fair value of earn-out liability", "label": "Increase (Decrease) in Fair Value of Contingent Earnout Liability", "documentation": "The amount of increase (decrease) in fair value of contingent earnout liability" } } }, "auth_ref": [] }, "nhic_IncreaseDecreaseInFairValueOfContingentlyIssuableCommonStockLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "IncreaseDecreaseInFairValueOfContingentlyIssuableCommonStockLiability", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 4.0 }, "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Change in fair value of contingently issuable common stock liability", "verboseLabel": "Change in fair value of contingently issuable common stock", "label": "Increase (Decrease) in Fair Value of Contingently Issuable Common Stock Liability", "documentation": "The amount of increase (decrease) in fair value of contingently issuable common stock liability." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liability", "label": "Increase (Decrease) in Operating Lease Liability", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r945", "r968" ] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other assets", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r868", "r877", "r887", "r904", "r913", "r917", "r925" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r923" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r857", "r929" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r857", "r929" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r857", "r929" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r86", "r161", "r215", "r278", "r560", "r746", "r849", "r1069" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for interest", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r222", "r224", "r225" ] }, "nhic_IntrinsicValueOfWarrantsUnvested": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "IntrinsicValueOfWarrantsUnvested", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intrinsic value of warrants unvested", "label": "Intrinsic Value of Warrants Unvested", "documentation": "Represents the information pertaining to intrinsic value of warrants unvested." } } }, "auth_ref": [] }, "us-gaap_InventoryCurrentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryCurrentTable", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory, Current [Table]", "label": "Inventory, Current [Table]", "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Inventory Disclosure [Abstract]", "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/Inventory" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory", "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r355" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/InventorySummaryofInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/InventorySummaryofInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r128", "r803" ] }, "us-gaap_InventoryLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryLineItems", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory [Line Items]", "label": "Inventory [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 8.0 }, "http://www.evolvtechnology.com/role/InventorySummaryofInventoryDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/InventorySummaryofInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory", "totalLabel": "Total", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r202", "r800", "r838" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r167", "r188", "r201", "r355", "r356", "r358", "r622", "r805" ] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/InventorySummaryofInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/InventorySummaryofInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials", "label": "Inventory, Raw Materials, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r128", "r804" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWriteDown", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Write-off of inventory and change in inventory reserve", "label": "Inventory Write-down", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r357" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r117", "r277" ] }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/MarketableSecurities" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "documentation": "The entire disclosure for investments in certain debt and equity securities." } } }, "auth_ref": [ "r151", "r162", "r163", "r182", "r303", "r304", "r549", "r550" ] }, "nhic_LabEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "LabEquipmentMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lab equipment", "label": "Lab equipment", "documentation": "Represents information pertaining to lab equipment." } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of weighted-average remaining lease term and discount rate", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1048" ] }, "nhic_LeasedEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "LeasedEquipmentMember", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetLeasedEquipmentDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofCompanysRevenuebyRevenueStreamDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leased equipment", "label": "Leased Equipment [Member]", "documentation": "Leased Equipment" } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold improvements", "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r130" ] }, "us-gaap_LeaseholdsAndLeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdsAndLeaseholdImprovementsMember", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold improvements", "label": "Leaseholds and Leasehold Improvements [Member]", "documentation": "Asset held by lessee under finance lease and addition or improvement to asset held under lease arrangement." } } }, "auth_ref": [ "r130" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal Entity [Axis]", "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Leases as a Lessee", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r567" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of future annual lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1049" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total future lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r572" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r572" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r572" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r572" ] }, "nhic_LesseeOperatingLeaseNumberOfStorageSpaces": { "xbrltype": "integerItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "LesseeOperatingLeaseNumberOfStorageSpaces", "presentation": [ "http://www.evolvtechnology.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of storage spaces", "label": "Lessee, Operating Lease, Number Of Storage Spaces", "documentation": "Lessee, Operating Lease, Number Of Storage Spaces" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRenewalTerm", "presentation": [ "http://www.evolvtechnology.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease renewal term", "label": "Lessee, Operating Lease, Renewal Term", "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1047" ] }, "nhic_LesseeOperatingLeaseRenewalTermRequiredNoticePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "LesseeOperatingLeaseRenewalTermRequiredNoticePeriod", "presentation": [ "http://www.evolvtechnology.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Required notice period before renewal", "label": "Lessee, Operating Lease, Renewal Term, Required Notice Period", "documentation": "Lessee, Operating Lease, Renewal Term, Required Notice Period" } } }, "auth_ref": [] }, "nhic_LesseeOperatingLeaseSecurityDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "LesseeOperatingLeaseSecurityDeposit", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Security deposit", "label": "Lessee, Operating Lease, Security Deposit", "documentation": "Lessee, Operating Lease, Security Deposit" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease term", "label": "Lessee, Operating Lease, Term of Contract", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1047" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r563" ] }, "nhic_LessorOperatingLeasePaymentToBeReceivedAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "LessorOperatingLeasePaymentToBeReceivedAfterYearFour", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails": { "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Lessor, Operating Lease, Payment to be Received, after Year Four", "documentation": "Lessor, Operating Lease, Payment to be Received, after Year Four" } } }, "auth_ref": [] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceived", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Lessor, operating lease, payments to be received", "label": "Lessor, Operating Lease, Payment to be Received", "documentation": "Amount of lease payments to be received by lessor for operating lease." } } }, "auth_ref": [ "r575" ] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails": { "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Lessor, Operating Lease, Payment to be Received, Year Four", "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r575" ] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of minimum future payments on noncancelable leases", "label": "Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block]", "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease." } } }, "auth_ref": [ "r1050" ] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails": { "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Lessor, Operating Lease, Payment to be Received, Year One", "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r575" ] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails": { "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Lessor, Operating Lease, Payment to be Received, Year Three", "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r575" ] }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails": { "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofMinimumFuturePaymentsonNoncancelableLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Lessor, Operating Lease, Payment to be Received, Year Two", "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r575" ] }, "us-gaap_LessorOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeaseTermOfContract", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessor, lease term", "label": "Lessor, Operating Lease, Term of Contract", "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1051" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r30", "r229", "r335", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r526", "r527", "r528", "r551", "r715", "r808", "r850", "r998", "r1053", "r1054" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r106", "r158", "r649", "r838", "r972", "r989", "r1046" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities and Stockholders\u2019 Equity", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r32", "r187", "r229", "r335", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r526", "r527", "r528", "r551", "r838", "r998", "r1053", "r1054" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities:", "label": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "nhic_LicenseFeeAndOtherRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "LicenseFeeAndOtherRevenueMember", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentationNarrativeDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "License fee and other revenue", "label": "License Fee And Other Revenue [Member]", "documentation": "License Fee And Other Revenue" } } }, "auth_ref": [] }, "nhic_LicenseFeeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "LicenseFeeMember", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofCompanysRevenuebyRevenueStreamDetails" ], "lang": { "en-us": { "role": { "terseLabel": "License fees", "label": "License Fee [Member]", "documentation": "License Fee" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Long-term debt", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r27", "r157", "r392", "r407", "r815", "r816", "r1063" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails_1": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 }, "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt", "negatedLabel": "Less: Current portion of long-term debt", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r194" ] }, "nhic_LongTermDebtIncludingCurrentPortionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "LongTermDebtIncludingCurrentPortionMember", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt including current portion", "label": "Long-Term Debt Including Current Portion [Member]", "documentation": "Long-Term Debt Including Current Portion" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails_1": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 }, "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, noncurrent", "verboseLabel": "Long-term debt, net of discount", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r195" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails", "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r34" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails", "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r34", "r61" ] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leased equipment", "label": "Machinery and Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]" } } }, "auth_ref": [ "r298", "r822", "r1005", "r1065", "r1066" ] }, "us-gaap_MarketableSecuritiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesCurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities", "label": "Marketable Securities, Current", "documentation": "Amount of investment in marketable security, classified as current." } } }, "auth_ref": [ "r961" ] }, "us-gaap_MarketableSecuritiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesLineItems", "presentation": [ "http://www.evolvtechnology.com/role/MarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities [Line Items]", "label": "Marketable Securities [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_MarketableSecuritiesPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesPolicy", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities", "label": "Marketable Securities, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for investment classified as marketable security." } } }, "auth_ref": [ "r91" ] }, "us-gaap_MarketableSecuritiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesTable", "presentation": [ "http://www.evolvtechnology.com/role/MarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities [Table]", "label": "Marketable Securities [Table]", "documentation": "Disclosure of information about investment in marketable security." } } }, "auth_ref": [] }, "us-gaap_MarketableSecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/MarketableSecuritiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable Securities", "label": "Marketable Securities [Table Text Block]", "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r366", "r367", "r368", "r369", "r442", "r620", "r666", "r707", "r708", "r767", "r769", "r771", "r772", "r774", "r794", "r795", "r811", "r819", "r833", "r840", "r1002", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r896" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r896" ] }, "us-gaap_MeasurementInputControlPremiumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputControlPremiumMember", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Control Premium", "label": "Measurement Input, Control Premium [Member]", "documentation": "Measurement input using amount above fair value that investor seeking to acquire control of entity will pay." } } }, "auth_ref": [ "r1044" ] }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedDividendRateMember", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield", "label": "Measurement Input, Expected Dividend Rate [Member]", "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year." } } }, "auth_ref": [ "r1044" ] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (in years)", "label": "Measurement Input, Expected Term [Member]", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r1044" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Measurement Input, Price Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r1044" ] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r1044" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input Type [Axis]", "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r543" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input Type [Domain]", "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r366", "r367", "r368", "r369", "r442", "r620", "r666", "r707", "r708", "r767", "r769", "r771", "r772", "r774", "r794", "r795", "r811", "r819", "r833", "r840", "r1002", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r916" ] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsMember", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money market funds", "label": "Money Market Funds [Member]", "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities." } } }, "auth_ref": [ "r1007" ] }, "nhic_MotorolaSolutionsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "MotorolaSolutionsIncMember", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Motorola Solutions, Inc.", "label": "Motorola Solutions, Inc. [Member]", "documentation": "Represents information pertaining to Customer." } } }, "auth_ref": [] }, "nhic_MovementInContractWithCustomerLiabilityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "MovementInContractWithCustomerLiabilityRollForward", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofRollforwardofDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Movement in Deferred Revenue [Roll Forward]", "label": "Movement In Contract With Customer, Liability [Roll Forward]", "documentation": "Movement In Contract With Customer, Liability" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r924" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]" } } }, "auth_ref": [ "r298", "r822", "r1005", "r1065", "r1066" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r897" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r223" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r223" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r123", "r124", "r125" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "terseLabel": "Net loss", "verboseLabel": "Net loss", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r112", "r125", "r160", "r185", "r206", "r209", "r214", "r229", "r238", "r240", "r241", "r243", "r244", "r248", "r249", "r261", "r274", "r288", "r292", "r294", "r335", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r539", "r551", "r654", "r737", "r759", "r760", "r809", "r849", "r998" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net income (loss) attributable to common stockholders - basic", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r221", "r240", "r241", "r243", "r244", "r252", "r253", "r262", "r265", "r274", "r288", "r292", "r294", "r809" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net income (loss) attributable to common stockholders - diluted", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r221", "r254", "r257", "r258", "r259", "r260", "r262", "r265" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Numerator:", "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Issued Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "nhic_NhicSubIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "NhicSubIncMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "NHIC Sub Inc", "label": "NHIC Sub Inc", "documentation": "This member stands for NHIC Sub Inc." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r896" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r865", "r877", "r887", "r904", "r913" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r894" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r893" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r904" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r924" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r924" ] }, "us-gaap_NonUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonUsMember", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionRevenuebyGeographicalLocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Non-US [Member]", "documentation": "Countries excluding the United States of America (US)." } } }, "auth_ref": [ "r1072", "r1073", "r1074", "r1075" ] }, "nhic_NoncashInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "NoncashInterestExpense", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash interest expense", "label": "Noncash Interest Expense", "documentation": "Amount of interest expense that result in no cash flow." } } }, "auth_ref": [] }, "nhic_NoncashLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "NoncashLeaseExpense", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash lease expense", "label": "Noncash Lease Expense", "documentation": "Noncash Lease Expense" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expense), net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r118" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense), net:", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segment", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r980" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segment", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r980" ] }, "nhic_NumberOfResellersAndIntegrationPartners": { "xbrltype": "integerItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "NumberOfResellersAndIntegrationPartners", "presentation": [ "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of resellers and integration partners", "label": "Number of Resellers And Integration Partners", "documentation": "Represents number of resellers and integration partners are sold motorola products through company integrated platform." } } }, "auth_ref": [] }, "nhic_NumberOfUnitsDonated": { "xbrltype": "integerItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "NumberOfUnitsDonated", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Evolv Express units donated", "label": "Number of Units Donated", "documentation": "Number of Units Donated" } } }, "auth_ref": [] }, "nhic_NumberOfWarrantsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "NumberOfWarrantsExercised", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of warrants exercised (in shares)", "label": "Number of Warrants Exercised", "documentation": "Number warrants exercised during the period." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses:", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r274", "r288", "r292", "r294", "r809" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease cost", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r568", "r837" ] }, "nhic_OperatingLeaseIncomeComprehensiveIncomeExtensibleListNotDisclosedFlag": { "xbrltype": "stringItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "OperatingLeaseIncomeComprehensiveIncomeExtensibleListNotDisclosedFlag", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofComponentsofLeaseRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease Income Comprehensive Income Extensible List Not Disclosed Flag", "label": "Operating Lease Income Comprehensive Income Extensible List Not Disclosed Flag", "documentation": "Operating Lease Income Comprehensive Income Extensible List Not Disclosed Flag" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLeaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLeaseIncome", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofComponentsofLeaseRevenueDetails": { "parentTag": "us-gaap_RevenueNotFromContractWithCustomer", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofComponentsofLeaseRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease income - operating leases", "label": "Operating Lease, Lease Income", "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable." } } }, "auth_ref": [ "r270", "r574", "r576" ] }, "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLeaseIncomeTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of components of lease revenue", "label": "Operating Lease, Lease Income [Table Text Block]", "documentation": "Tabular disclosure of components of income from operating lease." } } }, "auth_ref": [ "r270", "r576" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/LeasesScheduleofFutureAnnualLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Present value of operating lease liability", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r565" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r565" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities, noncurrent", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r565" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease payments", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r566", "r569" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r564" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.evolvtechnology.com/role/LeasesScheduleofWeightedAverageRemainingLeaseTermandDiscountRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r571", "r837" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.evolvtechnology.com/role/LeasesScheduleofWeightedAverageRemainingLeaseTermandDiscountRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r570", "r837" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net operating losses with expiry", "label": "Operating Loss Carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r75" ] }, "us-gaap_OperatingLossCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsLineItems", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Loss Carryforwards [Line Items]", "label": "Operating Loss Carryforwards [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsTable", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Loss Carryforwards [Table]", "label": "Operating Loss Carryforwards [Table]", "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r74" ] }, "nhic_OperatingLossCarryforwardsWithNoExpiry": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "OperatingLossCarryforwardsWithNoExpiry", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net operating losses with no expiry", "label": "Operating Loss Carryforwards, With No Expiry", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws with no expiration date." } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentation" ], "lang": { "en-us": { "role": { "terseLabel": "Nature of the Business and Basis of Presentation", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r95", "r148", "r678", "r679" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r31" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r204", "r838" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r192" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive loss", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r14", "r26", "r207", "r210", "r217", "r553", "r554", "r559", "r637", "r655", "r965", "r966" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive loss", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Other expense, net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r120" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r896" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r863", "r875", "r885", "r911" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r866", "r878", "r888", "r914" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r866", "r878", "r888", "r914" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r892" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Payables and Accruals [Abstract]", "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtExtinguishmentCosts", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payment of debt issuance costs and prepayment penalty", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireMarketableSecurities", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchases of marketable securities", "label": "Payments to Acquire Marketable Securities", "documentation": "Amount of cash outflow for purchase of marketable security." } } }, "auth_ref": [ "r982" ] }, "nhic_PaymentsToAcquirePropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "PaymentsToAcquirePropertyPlantAndEquipmentNet", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchases of property and equipment", "label": "Payments To Acquire Property, Plant, And Equipment, Net", "documentation": "Payments To Acquire Property, Plant, And Equipment, Net" } } }, "auth_ref": [] }, "us-gaap_PaymentsToDevelopSoftware": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToDevelopSoftware", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Development of internal-use software", "label": "Payments to Develop Software", "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization." } } }, "auth_ref": [ "r122" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r895" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r895" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r894" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r904" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r897" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r893" ] }, "nhic_PercentOfIncreaseOfOutstandingNumberOfCommonStock": { "xbrltype": "percentItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "PercentOfIncreaseOfOutstandingNumberOfCommonStock", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percent of increase of outstanding number of common stock", "label": "Percent Of Increase Of Outstanding Number Of Common Stock", "documentation": "Percent Of Increase Of Outstanding Number Of Common Stock" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Unvested performance stock units", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1008", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1008", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033" ] }, "nhic_PlanOfMergerWithNhicAndMergerSubMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "PlanOfMergerWithNhicAndMergerSubMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan of merger with NHIC and Merger Sub", "label": "Plan of merger with NHIC and Merger Sub", "documentation": "Represents the information pertaining to Plan of merger with NHIC and Merger Sub." } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r100", "r408" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r100", "r717" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r100", "r408" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r100", "r717", "r735", "r1070", "r1071" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, $0.0001 par value; 100,000,000 authorized at December\u00a031, 2023 and December\u00a031, 2022; no shares issued and outstanding at December\u00a031, 2023 and December\u00a031, 2022", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r100", "r645", "r838" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r964" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract", "lang": { "en-us": { "role": { "terseLabel": "Prepaid Expense and Other Assets, Current [Abstract]", "label": "Prepaid Expense and Other Assets, Current [Abstract]" } } }, "auth_ref": [] }, "nhic_PrepaidExpenseAndOtherAssetsCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "PrepaidExpenseAndOtherAssetsCurrentTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/Prepaidexpensesandothercurrentassets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current [Text Block]", "documentation": "The entire disclosure of prepaid expenses and other current assets." } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid subscriptions", "label": "Prepaid Expense, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r203", "r359", "r360", "r801" ] }, "us-gaap_PrepaidInsurance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidInsurance", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Prepaid insurance", "label": "Prepaid Insurance", "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r802", "r813", "r991" ] }, "us-gaap_PrimeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrimeRateMember", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prime Rate", "label": "Prime Rate [Member]", "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers." } } }, "auth_ref": [] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassifications", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r958" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from long-term debt", "label": "Proceeds from Issuance of Long-Term Debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r41", "r683" ] }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from maturities of marketable securities", "label": "Proceeds from Sale and Maturity of Marketable Securities", "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of property and equipment", "label": "Proceeds from Sale of Property, Plant, and Equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r121" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from exercise of stock options", "label": "Proceeds from Stock Options Exercised", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r4", "r23" ] }, "us-gaap_ProductMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductMember", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofCompanysRevenuebyRevenueStreamDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product revenue", "label": "Product [Member]", "documentation": "Article or substance produced by nature, labor or machinery." } } }, "auth_ref": [ "r820" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentationNarrativeDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofCompanysRevenuebyRevenueStreamDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r295", "r623", "r660", "r661", "r662", "r663", "r664", "r665", "r797", "r820", "r839", "r946", "r995", "r996", "r1005", "r1065" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentationNarrativeDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofCompanysRevenuebyRevenueStreamDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r295", "r623", "r660", "r661", "r662", "r663", "r664", "r665", "r797", "r820", "r839", "r946", "r995", "r996", "r1005", "r1065" ] }, "nhic_ProfessionalServicesAndOtherRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ProfessionalServicesAndOtherRevenueMember", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofCompanysRevenuebyRevenueStreamDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Professional services and other revenue", "label": "Professional Services and Other Revenue [Member]", "documentation": "Professional Services and Other Revenue" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Abstract]", "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetLeasedEquipmentDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Axis]", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r9" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNet" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment, Net", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r129", "r171", "r176", "r177" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetLeasedEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leased equipment", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r130", "r190", "r652" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetLeasedEquipmentDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Line Items]", "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 }, "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetLeasedEquipmentDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Property and equipment, net", "totalLabel": "Leased equipment, net", "terseLabel": "Leased equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r9", "r641", "r652", "r838" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r9", "r171", "r176", "r650" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of property and equipment, net", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r9" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetLeasedEquipmentDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Domain]", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r130" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Estimated Useful Life", "terseLabel": "Depreciable lives", "label": "Property, Plant and Equipment, Useful Life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/AccountsReceivableDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Provisions", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r220", "r345" ] }, "us-gaap_PublicUtilitiesInventoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PublicUtilitiesInventoryAxis", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory [Axis]", "label": "Inventory [Axis]", "documentation": "Information by type of inventory held." } } }, "auth_ref": [ "r962" ] }, "us-gaap_PublicUtilitiesInventoryTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PublicUtilitiesInventoryTypeDomain", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory [Domain]", "label": "Inventory [Domain]", "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale." } } }, "auth_ref": [ "r962" ] }, "nhic_PublicWarrantLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "PublicWarrantLiabilityMember", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails", "http://www.evolvtechnology.com/role/FairValueMeasurementsWarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public Warrant liability", "label": "Public Warrant Liability.", "documentation": "Reports to public warrant liability." } } }, "auth_ref": [] }, "nhic_PurchaseOrderCancellationFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "PurchaseOrderCancellationFeesCurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase order cancellation fees", "label": "Purchase Order Cancellation Fees Current", "documentation": "Purchase Order Cancellation Fees Current" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r892" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r892" ] }, "us-gaap_QuarterlyFinancialDataAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "QuarterlyFinancialDataAbstract", "lang": { "en-us": { "role": { "label": "Quarterly Financial Data [Abstract]" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r366", "r367", "r368", "r369", "r433", "r442", "r474", "r475", "r476", "r596", "r620", "r666", "r707", "r708", "r767", "r769", "r771", "r772", "r774", "r794", "r795", "r811", "r819", "r833", "r840", "r843", "r993", "r1002", "r1056", "r1057", "r1058", "r1059", "r1060" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r366", "r367", "r368", "r369", "r433", "r442", "r474", "r475", "r476", "r596", "r620", "r666", "r707", "r708", "r767", "r769", "r771", "r772", "r774", "r794", "r795", "r811", "r819", "r833", "r840", "r843", "r993", "r1002", "r1056", "r1057", "r1058", "r1059", "r1060" ] }, "us-gaap_ReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesAbstract", "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesUncertainTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r858", "r870", "r880", "r906" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical", "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Domain]", "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r440", "r584", "r585", "r710", "r711", "r712", "r713", "r714", "r734", "r736", "r766" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical", "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r232", "r233", "r584", "r585", "r586", "r587", "r710", "r711", "r712", "r713", "r714", "r734", "r736", "r766" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Axis]", "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r584", "r585", "r1052" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Domain]", "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Line Items]", "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r741", "r742", "r745" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Related Party Transactions [Abstract]", "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical", "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Axis]", "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r440", "r584", "r585", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r710", "r711", "r712", "r713", "r714", "r734", "r736", "r766", "r1052" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transactions", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r581", "r582", "r583", "r585", "r588", "r689", "r690", "r691", "r743", "r744", "r745", "r764", "r765" ] }, "nhic_RemainingFounderSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "RemainingFounderSharesOutstanding", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining number of founder shares", "label": "Remaining Founder Shares Outstanding", "documentation": "The remaining number of founder shares outstanding." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of principal on long-term debt", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r42", "r686" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r94", "r492", "r1061" ] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "us-gaap_ResearchMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchMember", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research Tax Credit Carryforward", "label": "Research Tax Credit Carryforward [Member]", "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes." } } }, "auth_ref": [ "r74" ] }, "nhic_ResellerAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ResellerAgreementMember", "presentation": [ "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reseller Agreement", "label": "Reseller Agreement [Member]", "documentation": "Reseller Agreement" } } }, "auth_ref": [] }, "srt_RestatementAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementAdjustmentMember", "presentation": [ "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period, Adjustment", "label": "Revision of Prior Period, Adjustment [Member]" } } }, "auth_ref": [ "r235", "r236", "r237", "r246", "r247", "r269", "r537", "r538", "r937", "r938", "r939", "r940", "r944", "r947", "r948" ] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementAxis", "presentation": [ "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period [Axis]", "label": "Revision of Prior Period [Axis]" } } }, "auth_ref": [ "r184", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r245", "r246", "r247", "r248", "r249", "r250", "r269", "r338", "r339", "r513", "r536", "r537", "r538", "r539", "r562", "r579", "r580", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r680" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r859", "r871", "r881", "r907" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r860", "r872", "r882", "r908" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r867", "r879", "r889", "r915" ] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementDomain", "presentation": [ "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period [Domain]", "label": "Revision of Prior Period [Domain]" } } }, "auth_ref": [ "r184", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r245", "r246", "r247", "r248", "r249", "r250", "r269", "r338", "r339", "r513", "r536", "r537", "r538", "r539", "r562", "r579", "r580", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r680" ] }, "us-gaap_RestrictedCashCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashCurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 }, "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Restricted Cash, Current", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r959", "r969" ] }, "us-gaap_RestrictedCashNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashNoncurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 3.0 }, "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash, noncurrent", "label": "Restricted Cash, Noncurrent", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r166", "r960", "r969" ] }, "nhic_RestrictedStockUnitsAndPhantomShareUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "RestrictedStockUnitsAndPhantomShareUnitsMember", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesbyAwardTypeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "RSUs and PSUs", "label": "Restricted Stock Units And Phantom Share Units [Member]", "documentation": "Restricted Stock Units And Phantom Share Units" } } }, "auth_ref": [] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Unvested restricted stock units", "verboseLabel": "Restricted Stock Units", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r103", "r136", "r648", "r671", "r676", "r687", "r718", "r838" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r183", "r235", "r236", "r237", "r239", "r247", "r249", "r337", "r340", "r484", "r485", "r486", "r512", "r513", "r529", "r531", "r532", "r534", "r537", "r667", "r669", "r692", "r1070" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r275", "r276", "r287", "r290", "r291", "r295", "r296", "r298", "r427", "r428", "r623" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognition" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r180", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r431" ] }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from External Customers by Geographic Areas", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue." } } }, "auth_ref": [ "r24" ] }, "us-gaap_RevenueNotFromContractWithCustomer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueNotFromContractWithCustomer", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofComponentsofLeaseRevenueDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofComponentsofLeaseRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease revenue (less than)", "totalLabel": "Total lease revenue", "label": "Revenue Not from Contract with Customer", "documentation": "Amount of revenue that is not accounted for under Topic 606." } } }, "auth_ref": [ "r950" ] }, "us-gaap_RevenueRecognitionAndDeferredRevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionAndDeferredRevenueAbstract", "lang": { "en-us": { "role": { "label": "Revenue Recognition and Deferred Revenue [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r739", "r796", "r806" ] }, "us-gaap_RevenueRemainingPerformanceObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligation", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total revenue", "label": "Revenue, Remaining Performance Obligation, Amount", "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue." } } }, "auth_ref": [ "r174" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue arrangement period", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r175" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format." } } }, "auth_ref": [ "r175" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of performance obligations", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]", "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation." } } }, "auth_ref": [ "r941" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical", "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentationNarrativeDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionRevenuebyGeographicalLocationDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofCompanysRevenuebyRevenueStreamDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total revenue", "terseLabel": "Revenue", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r216", "r229", "r275", "r276", "r287", "r290", "r291", "r295", "r296", "r298", "r335", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r551", "r640", "r998" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue:", "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "nhic_ReverseRecapitalizationContingentConsiderationEquityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ReverseRecapitalizationContingentConsiderationEquityNoncurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Contingently issuable common stock liability", "label": "Reverse Recapitalization, Contingent Consideration, Equity, Noncurrent", "documentation": "Reverse Recapitalization, Contingent Consideration, Equity, Noncurrent" } } }, "auth_ref": [] }, "nhic_ReverseRecapitalizationContingentConsiderationLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ReverseRecapitalizationContingentConsiderationLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent earn-out liability", "label": "Reverse Recapitalization, Contingent Consideration, Liability, Noncurrent", "documentation": "Reverse Recapitalization, Contingent Consideration, Liability, Noncurrent" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r924" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r924" ] }, "nhic_SaaSMaintenanceAndOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "SaaSMaintenanceAndOtherMember", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionSummaryofCompanysRevenuebyRevenueStreamDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service revenue", "label": "SaaS, Maintenance and Other [Member]", "documentation": "SaaS and Maintenance Services" } } }, "auth_ref": [] }, "nhic_SalesDemoEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "SalesDemoEquipmentMember", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales demo equipment", "label": "Sales demo equipment", "documentation": "Represents the information about Sales Demo Equipment member." } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.evolvtechnology.com/role/SignificantAccountingPoliciesRiskofConcentrationsofCreditSignificantCustomersandSignificantSuppliersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Benchmark", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r298", "r942" ] }, "us-gaap_SalesTypeLeaseInterestIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesTypeLeaseInterestIncome", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofComponentsofLeaseRevenueDetails": { "parentTag": "us-gaap_RevenueNotFromContractWithCustomer", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofComponentsofLeaseRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income on lease receivables", "label": "Sales-type Lease, Interest Income", "documentation": "Amount of interest income from net investment in sales-type lease." } } }, "auth_ref": [ "r270", "r573", "r578" ] }, "us-gaap_SalesTypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesTypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/PrepaidexpensesandothercurrentassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of net investment in sales-type leases", "label": "Sales-Type Lease, Net Investment in Lease, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of net investment in sales-type lease, classified as current." } } }, "auth_ref": [ "r935", "r936" ] }, "us-gaap_SalesTypeLeaseRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesTypeLeaseRevenue", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofComponentsofLeaseRevenueDetails": { "parentTag": "us-gaap_RevenueNotFromContractWithCustomer", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofComponentsofLeaseRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from sales-type leases", "label": "Sales-type Lease, Revenue", "documentation": "Amount of sales-type lease revenue." } } }, "auth_ref": [ "r270", "r577" ] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast", "label": "Forecast [Member]" } } }, "auth_ref": [ "r443", "r977" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Domain]", "label": "Scenario [Domain]" } } }, "auth_ref": [ "r250", "r443", "r933", "r977" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of accrued liabilities", "label": "Schedule of Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r48" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of potential common shares excluded from the computation of diluted net loss per share", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r48" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]", "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]", "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments." } } }, "auth_ref": [ "r147" ] }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of stock-based compensation expense", "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]", "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit." } } }, "auth_ref": [ "r70" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Income Tax Expense", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r145" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of components of long-term debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of net deferred tax assets", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r144" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of basic and diluted net loss per share attributable to common stockholders", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r979" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r143" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesbyAwardTypeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r70" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of allocation of share based compensation expense", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r70" ] }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable", "presentation": [ "http://www.evolvtechnology.com/role/NatureoftheBusinessandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]", "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]", "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments." } } }, "auth_ref": [ "r240", "r241", "r242", "r246", "r247", "r248", "r249", "r269" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of financial assets and liabilities measured at fair value on a recurring basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r541", "r542" ] }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of components of the Company's loss before income tax expense", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions." } } }, "auth_ref": [ "r973" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/InventoryTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of inventory", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r28", "r107", "r108", "r109" ] }, "nhic_ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLifeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLifeTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of estimated useful life of property and equipment", "label": "Schedule of Property, Plant And Equipment, Estimated Useful Life [Table Text Block]", "documentation": "The entire disclosure about schedule of property, plant and equipment, estimated useful life." } } }, "auth_ref": [] }, "nhic_ScheduleOfPropertyPlantAndEquipmentRelatedLeaseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ScheduleOfPropertyPlantAndEquipmentRelatedLeaseTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of leased equipment and the related accumulated depreciation", "label": "Schedule Of Property Plant And Equipment Related Lease [Table Text Block]", "documentation": "Tabular disclosure represents about leased equipment related accumulated depreciation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetLeasedEquipmentDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Table]", "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://www.evolvtechnology.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r88", "r89", "r741", "r742", "r745" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.evolvtechnology.com/role/CommonStockDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r445", "r447", "r449", "r450", "r451", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r473", "r474", "r475", "r476", "r477" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of stock option activity", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r21", "r22", "r69" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of fair value weighted-average assumptions", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r142" ] }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of restricted stock unit activity", "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of warrants to purchase the classes of Preferred Stock and Common Stock outstanding", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r67" ] }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Uncertain Tax Positions", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "documentation": "Tabular disclosure of the change in unrecognized tax benefits." } } }, "auth_ref": [ "r836", "r1036" ] }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of customers that represent 10% or more of the Company's total revenue and accounts receivable", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r50", "r51", "r53", "r54", "r82", "r150" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r851" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r854" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionRevenuebyGeographicalLocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r296", "r297", "r704", "r705", "r706", "r768", "r770", "r773", "r775", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r798", "r821", "r843", "r1005", "r1065" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r281", "r282", "r283", "r284", "r285", "r286", "r296", "r810" ] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and marketing", "label": "Selling and Marketing Expense", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "us-gaap_SellingAndMarketingExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingAndMarketingExpenseMember", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and marketing", "label": "Selling and Marketing Expense [Member]", "documentation": "Primary financial statement caption encompassing selling and marketing expense." } } }, "auth_ref": [ "r113" ] }, "us-gaap_ServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ServiceMember", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service revenue", "label": "Service [Member]", "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service." } } }, "auth_ref": [ "r820" ] }, "nhic_ServiceRevenueArrangementPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ServiceRevenueArrangementPeriod", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue arrangement period", "label": "Service Revenue, Arrangement Period", "documentation": "Service Revenue, Arrangement Period" } } }, "auth_ref": [] }, "nhic_ShareBasedAwardsExcludingEmployeeStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ShareBasedAwardsExcludingEmployeeStockPurchasePlanMember", "presentation": [ "http://www.evolvtechnology.com/role/CommonStockDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Awards Excluding Employee Stock Purchase Plan", "label": "Share-Based Awards Excluding Employee Stock Purchase Plan [Member]", "documentation": "Share-Based Awards Excluding Employee Stock Purchase Plan" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term of stock option", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r834" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r834" ] }, "nhic_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateGrantDateFairValue", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grant date fair value of restricted stock", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Aggregate Grant Date Fair Value", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Aggregate Grant Date Fair Value" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cancelled (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r466" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r464" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding, beginning balance (in dollars per share)", "verboseLabel": "Outstanding, ending balance (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r461", "r462" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grant Date Fair Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r465" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r465" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationGrantDateFairValueofStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r475" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationGrantDateFairValueofStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r474" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationGrantDateFairValueofStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r476" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.evolvtechnology.com/role/CommonStockDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r445", "r447", "r449", "r450", "r451", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r473", "r474", "r475", "r476", "r477" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cancelled (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures", "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event." } } }, "auth_ref": [ "r20" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r19" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding, beginning balance (in shares)", "periodEndLabel": "Outstanding, ending balance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r17", "r18" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of common stock may be issued (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r835" ] }, "nhic_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Abstract", "documentation": "No definition available." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options exercisable (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r455" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options exercisable (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r455" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate intrinsic value of the stock options exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value", "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares." } } }, "auth_ref": [ "r468" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Expired (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements." } } }, "auth_ref": [ "r460" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Forfeited (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r459" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r457" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant date fair value of options granted (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r467" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r68" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at beginning (in shares)", "periodEndLabel": "Outstanding as ending (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r453", "r454" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at beginning (in dollars per share)", "periodEndLabel": "Outstanding at ending (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r453", "r454" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r469" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and expected to vest (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r469" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and expected to vest (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r469" ] }, "nhic_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Remaining Contractual Term (in years)", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term Abstract", "documentation": "No definition available." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.evolvtechnology.com/role/CommonStockDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationPerformanceStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesbyAwardTypeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r449", "r450", "r451", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r473", "r474", "r475", "r476", "r477" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercised (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r458" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expired (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired." } } }, "auth_ref": [ "r460" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r459" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r457" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Tranche One", "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheThreeMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Tranche Three", "label": "Share-Based Payment Arrangement, Tranche Three [Member]", "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheTwoMember", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Tranche Two", "label": "Share-Based Payment Arrangement, Tranche Two [Member]", "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r444", "r452", "r471", "r472", "r473", "r474", "r477", "r487", "r488", "r489", "r490" ] }, "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of performance shares", "label": "Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]", "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares." } } }, "auth_ref": [ "r25" ] }, "nhic_ShareOutstandingExpectedToVestUponCertainMilestone": { "xbrltype": "sharesItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ShareOutstandingExpectedToVestUponCertainMilestone", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding shares expected to vest (in shares)", "label": "Share Outstanding Expected To Vest Upon Certain Milestone", "documentation": "Share Outstanding Expected To Vest Upon Certain Milestone" } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share price (in dollars per share)", "label": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number", "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting percentage", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r1008" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total fair value of shares vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested", "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationGrantDateFairValueofStockOptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r473" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r68" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r68" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r141" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r469" ] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at the beginning (in shares)", "periodEndLabel": "Balance at the end (in shares)", "label": "Shares, Issued", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r14" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares outstanding (in shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of shares", "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares", "documentation": "The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date." } } }, "auth_ref": [ "r64" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r126", "r227" ] }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Software", "label": "Software and Software Development Costs [Member]", "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "us-gaap_SoftwareDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SoftwareDevelopmentMember", "presentation": [ "http://www.evolvtechnology.com/role/PropertyandEquipmentNetDetails", "http://www.evolvtechnology.com/role/PropertyandEquipmentNetNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Internal-use software", "label": "Software Development [Member]", "documentation": "Internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State and Local Jurisdiction", "label": "State and Local Jurisdiction [Member]", "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.evolvtechnology.com/role/Cover", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r181", "r196", "r197", "r198", "r229", "r255", "r256", "r263", "r265", "r272", "r273", "r335", "r370", "r372", "r373", "r374", "r377", "r378", "r408", "r409", "r410", "r411", "r413", "r551", "r683", "r684", "r685", "r686", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r717", "r738", "r761", "r776", "r777", "r778", "r779", "r780", "r932", "r970", "r978" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r14", "r37", "r183", "r212", "r213", "r214", "r235", "r236", "r237", "r239", "r247", "r249", "r271", "r337", "r340", "r415", "r484", "r485", "r486", "r512", "r513", "r529", "r530", "r531", "r532", "r533", "r534", "r537", "r553", "r555", "r556", "r557", "r558", "r559", "r580", "r667", "r668", "r669", "r692", "r761" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionRevenuebyGeographicalLocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r296", "r297", "r704", "r705", "r706", "r768", "r770", "r773", "r775", "r781", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r798", "r821", "r843", "r1005", "r1065" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r235", "r236", "r237", "r271", "r623", "r681", "r703", "r709", "r710", "r711", "r712", "r713", "r714", "r717", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r730", "r731", "r732", "r733", "r734", "r736", "r739", "r740", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r761", "r844" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Liabilities and Stockholders\u2019 Equity", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Axis]", "label": "Scenario [Axis]" } } }, "auth_ref": [ "r250", "r443", "r933", "r934", "r977" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r235", "r236", "r237", "r271", "r623", "r681", "r703", "r709", "r710", "r711", "r712", "r713", "r714", "r717", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r730", "r731", "r732", "r733", "r734", "r736", "r739", "r740", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r761", "r844" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r862", "r874", "r884", "r910" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "nhic_StockIssuedDuringPeriodShareIssuanceOfCommonStockForNetSettlementOfCommonStockUponExerciseOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "StockIssuedDuringPeriodShareIssuanceOfCommonStockForNetSettlementOfCommonStockUponExerciseOfWarrants", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock upon exercise of warrants (in shares)", "label": "Stock Issued During Period, Share, Issuance Of Common Stock For Net Settlement Of Common Stock Upon Exercise Of Warrants" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsAdditionalInformationDetails", "http://www.evolvtechnology.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock in connection with the consummation of the PIPE Investment (in shares)", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r14", "r100", "r101", "r136", "r683", "r761", "r777" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock upon vesting of restricted stock units (in shares)", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited." } } }, "auth_ref": [ "r14", "r100", "r101", "r136" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT", "http://www.evolvtechnology.com/role/StockBasedCompensationStockOptionsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock upon exercise of stock options (in shares)", "negatedLabel": "Exercised (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r14", "r100", "r101", "r136", "r458" ] }, "nhic_StockIssuedDuringPeriodValueIssuanceOfCommonStockForNetSettlementOfCommonStockUponExerciseOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "StockIssuedDuringPeriodValueIssuanceOfCommonStockForNetSettlementOfCommonStockUponExerciseOfWarrants", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock upon exercise of warrants", "verboseLabel": "Finback exercise price", "label": "Stock Issued During Period, Value, Issuance Of Common Stock For Net Settlement Of Common Stock Upon Exercise Of Warrants", "documentation": "Value of stock issued for net settlement of common stock and preferred stock warrants upon settlement of the Merger." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock upon exercise of stock options", "label": "Stock Issued During Period, Value, Stock Options Exercised", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r14", "r37", "r136" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" ], "lang": { "en-us": { "role": { "totalLabel": "Stockholders\u2019 equity", "periodStartLabel": "Balance at the beginning", "periodEndLabel": "Balance at the end", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r101", "r104", "r105", "r127", "r719", "r735", "r762", "r763", "r838", "r850", "r972", "r989", "r1046", "r1070" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "nhic_SubscriptionAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "SubscriptionAgreementsMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subscription Agreements", "label": "Subscription Agreements", "documentation": "Represents the information pertaining to Subscription Agreements." } } }, "auth_ref": [] }, "us-gaap_SubscriptionAndCirculationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubscriptionAndCirculationMember", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/RevenueRecognitionScheduleofPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subscription revenue", "label": "Subscription and Circulation [Member]", "documentation": "Right to receive or access periodic material for specified period of time." } } }, "auth_ref": [ "r1006" ] }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfValuationAllowanceTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of changes in the valuation allowance for deferred tax assets", "label": "Summary of Valuation Allowance [Table Text Block]", "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance." } } }, "auth_ref": [ "r73" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosure of cash flow information", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r903" ] }, "us-gaap_TaxCreditCarryforwardAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAmount", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax credit carryforwards", "label": "Tax Credit Carryforward, Amount", "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r75" ] }, "us-gaap_TaxCreditCarryforwardAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAxis", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward [Axis]", "label": "Tax Credit Carryforward [Axis]", "documentation": "Information by specific tax credit related to an unused tax credit." } } }, "auth_ref": [ "r74" ] }, "us-gaap_TaxCreditCarryforwardNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardNameDomain", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward, Name [Domain]", "label": "Tax Credit Carryforward, Name [Domain]", "documentation": "The name of the tax credit carryforward." } } }, "auth_ref": [ "r74" ] }, "nhic_TermLoansPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "TermLoansPayableMember", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term loans payable", "label": "Term loans payable", "documentation": "Represents information pertaining to term loans payable." } } }, "auth_ref": [] }, "nhic_TermOfPaymentsAfterShipmentOrDeliveryOfProduct": { "xbrltype": "durationItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "TermOfPaymentsAfterShipmentOrDeliveryOfProduct", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term of payments after the shipment or delivery of the product", "label": "Term Of Payments After The Shipment Or Delivery Of The Product", "documentation": "Represents the term of payments after the shipment or delivery of the product." } } }, "auth_ref": [] }, "nhic_ThresholdPercentageOfFairMarketValueOfShareOfCommonStockOnDateOfGrant": { "xbrltype": "percentItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ThresholdPercentageOfFairMarketValueOfShareOfCommonStockOnDateOfGrant", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold percentage", "label": "Threshold Percentage Of Fair Market Value Of A Share Of Common Stock On The Date Of Grant", "documentation": "Threshold percentage of fair market value of a share of common stock on the date of grant in the calculation of exercise price of stock options." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r895" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r902" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r923" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r925" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails", "http://www.evolvtechnology.com/role/MarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Domain]", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r404", "r412", "r535", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r656", "r951", "r952", "r953", "r954", "r955", "r956", "r957", "r985", "r986", "r987", "r988" ] }, "nhic_TransfersOfInventoryToPropertyAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "TransfersOfInventoryToPropertyAndEquipment", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Transfer of property and equipment to inventory", "label": "Transfers Of Inventory To Property And Equipment", "documentation": "Represents the transfers of inventory to property and equipment in noncash investing or financing activities." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r926" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r927" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r925" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r925" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r928" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r926" ] }, "nhic_TriggeringEventOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "TriggeringEventOneMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Triggering Event One", "label": "Triggering Event One", "documentation": "Represents the information pertaining to Triggering Event I." } } }, "auth_ref": [] }, "nhic_TriggeringEventThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "TriggeringEventThreeMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Triggering Event Three", "label": "Triggering Event Three", "documentation": "Represents the information pertaining to Triggering Event III." } } }, "auth_ref": [] }, "nhic_TriggeringEventTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "TriggeringEventTwoMember", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Triggering Event Two", "label": "Triggering Event Two", "documentation": "Represents the information pertaining to Triggering Event II." } } }, "auth_ref": [] }, "nhic_TwentyTwentyOneEmployeeStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "TwentyTwentyOneEmployeeStockPurchasePlanMember", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2021 Employee Stock Purchase Plan", "label": "2021 Employee Stock Purchase Plan", "documentation": "Twenty Twenty One Employee Stock Purchase Plan [Member]" } } }, "auth_ref": [] }, "nhic_TwoThousandAndTwentyOneEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "TwoThousandAndTwentyOneEquityIncentivePlanMember", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2021 Equity Incentive Plan", "label": "2021 Equity Incentive Plan", "documentation": "Represents the information pertaining to two thousand and twenty one equity incentive plan." } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationCompanyUtilizedBlackScholesPricingModelDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentEarnoutDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r524" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.evolvtechnology.com/role/RevenueRecognitionRevenuebyGeographicalLocationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States", "label": "UNITED STATES" } } }, "auth_ref": [] }, "us-gaap_USTreasuryBillSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "USTreasuryBillSecuritiesMember", "presentation": [ "http://www.evolvtechnology.com/role/FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueOnRecurringBasisDetails", "http://www.evolvtechnology.com/role/MarketableSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Treasury bills", "verboseLabel": "Treasury bills", "label": "US Treasury Bill Securities [Member]", "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one year or less, are interest bearing, and are backed by the full faith and credit of the United States government." } } }, "auth_ref": [ "r1062" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r922" ] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesUncertainTaxPositionsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of fiscal year", "periodEndLabel": "Balance at end of fiscal year", "label": "Unrecognized Tax Benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r494", "r500" ] }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesUncertainTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange and others", "label": "Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation", "documentation": "Amount of increase in unrecognized tax benefits resulting from foreign currency translation." } } }, "auth_ref": [ "r1037" ] }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesUncertainTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross increases related to prior year tax positions", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns." } } }, "auth_ref": [ "r501" ] }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability for uncertain tax positions", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate." } } }, "auth_ref": [ "r502" ] }, "nhic_UnvestedStockOptionsAndRestrictedStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "UnvestedStockOptionsAndRestrictedStockUnitsMember", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Unvested Stock Options and Restricted Stock Units", "label": "Unvested Stock Options and Restricted Stock Units", "documentation": "Represents the information pertaining to unvested stock options and unvested restricted stock units." } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r55", "r56", "r57", "r168", "r169", "r172", "r173" ] }, "nhic_ValuationAllowanceDeferredTaxAssetAdditionsToEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ValuationAllowanceDeferredTaxAssetAdditionsToEquity", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesValuationAllowanceforDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additions charged to equity", "label": "Valuation Allowance Deferred Tax Asset Additions To Equity", "documentation": "Valuation Allowance Deferred Tax Asset Additions To Equity" } } }, "auth_ref": [] }, "nhic_ValuationAllowanceDeferredTaxAssetDecreaseForReversalChargedToEquityAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ValuationAllowanceDeferredTaxAssetDecreaseForReversalChargedToEquityAmount", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in equity", "label": "Valuation Allowance, Deferred Tax Asset, Decrease For Reversal Charged To Equity, Amount", "documentation": "Amount of decrease in the valuation allowance for tax benefits related to any reversal of the valuation allowance on net operating losses deferred tax assets for a specified deferred tax asset charged to Equity." } } }, "auth_ref": [] }, "nhic_ValuationAllowanceDeferredTaxAssetDecreaseForReversalChargedToIncomeTaxExpensesBenefitAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ValuationAllowanceDeferredTaxAssetDecreaseForReversalChargedToIncomeTaxExpensesBenefitAmount", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reduction of income tax expense", "label": "Valuation Allowance, Deferred Tax Asset, Decrease For Reversal Charged To Income Tax Expenses (Benefit), Amount", "documentation": "Amount of decrease in the valuation allowance for tax benefits related to any reversal of the valuation allowance on net operating losses deferred tax assets charged income tax expenses." } } }, "auth_ref": [] }, "nhic_ValuationAllowanceDeferredTaxAssetIncreaseChargedToProvisionForIncomeTaxesAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ValuationAllowanceDeferredTaxAssetIncreaseChargedToProvisionForIncomeTaxesAmount", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesValuationAllowanceforDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additions charged to provision for income taxes", "label": "Valuation Allowance, Deferred Tax Asset, Increase Charged To Provision For Income Taxes, Amount", "documentation": "Amount of increase in the valuation allowance by additions charged to provision for income taxes for a specified deferred tax asset." } } }, "auth_ref": [] }, "nhic_ValuationAllowanceDeferredTaxAssetIncreaseCurrencyTranslationAndOtherAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "ValuationAllowanceDeferredTaxAssetIncreaseCurrencyTranslationAndOtherAmount", "crdr": "credit", "presentation": [ "http://www.evolvtechnology.com/role/IncomeTaxesValuationAllowanceforDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation and other", "label": "Valuation Allowance, Deferred Tax Asset, Increase, Currency Translation And Other, Amount", "documentation": "Amount of increase in the valuation allowance by additions charged to Currency translation and other for a specified deferred tax asset." } } }, "auth_ref": [] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Axis]", "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Domain]", "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Axis]", "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1008", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://www.evolvtechnology.com/role/StockBasedCompensationNarrativeDetails", "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesContingentlyIssuableCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Domain]", "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1008", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033" ] }, "nhic_WarrantLiabilityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "WarrantLiabilityPolicyTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Public Warrant Liability", "label": "Warrant Liability [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to warrant liability." } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/StockBasedCompensationStockBasedCompensationExpensesbyAwardTypeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants", "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r841", "r842", "r845", "r846", "r847", "r848" ] }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsNoteDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Warrants and Rights Note Disclosure [Abstract]", "label": "Warrants and Rights Note Disclosure [Abstract]" } } }, "auth_ref": [] }, "nhic_WarrantsAndRightsNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "WarrantsAndRightsNoteDisclosureTextBlock", "presentation": [ "http://www.evolvtechnology.com/role/Warrants" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants", "label": "Warrants and Rights Note Disclosure [Text Block]", "documentation": "The entire disclosure related to warrants and rights." } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstanding", "crdr": "credit", "calculation": { "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Public warrant liability", "label": "Warrants and Rights Outstanding", "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price." } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://www.evolvtechnology.com/role/WarrantsPreferredStockandCommonStockOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contractual Term (in years)", "label": "Warrants and Rights Outstanding, Term", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1045" ] }, "nhic_WarrantsIssuedAtJanuaryTwoThousandTwentyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "WarrantsIssuedAtJanuaryTwoThousandTwentyOneMember", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/WarrantsPreferredStockandCommonStockOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants", "verboseLabel": "January 13, 2021", "label": "Warrants Issued At January Two Thousand Twenty One [Member]", "documentation": "Warrants Issued At January Two Thousand Twenty One" } } }, "auth_ref": [] }, "nhic_WarrantsIssuedAtJulyTwoThousandTwentyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "WarrantsIssuedAtJulyTwoThousandTwentyOneMember", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareAntidilutiveEffectDetails", "http://www.evolvtechnology.com/role/WarrantsPreferredStockandCommonStockOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "July 16, 2021", "label": "July 16, 2021", "documentation": "Represents information pertaining to warrants issued at july two thousand twenty one." } } }, "auth_ref": [] }, "nhic_WarrantsToPurchaseOneShareOfClassCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evolvtechnology.com/20231231", "localname": "WarrantsToPurchaseOneShareOfClassCommonStockMember", "presentation": [ "http://www.evolvtechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants to purchase one share of Class A common stock", "label": "Warrants to purchase one share of Class A common stock", "documentation": "Represents information pertaining to warrants to purchase common stock." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/NetLossperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average common shares outstanding - diluted (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r254", "r265" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.evolvtechnology.com/role/NetLossperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Denominator:", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.evolvtechnology.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.evolvtechnology.com/role/NetLossperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average common shares outstanding - basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r252", "r265" ] }, "us-gaap_WriteOffOfDeferredDebtIssuanceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WriteOffOfDeferredDebtIssuanceCost", "crdr": "debit", "presentation": [ "http://www.evolvtechnology.com/role/LongtermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unamortized debt issuance cost", "label": "Deferred Debt Issuance Cost, Writeoff", "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt." } } }, "auth_ref": [ "r119" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "SubTopic": "20", "Topic": "985", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(1)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(3)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "a", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Subparagraph": "(c)", "Paragraph": "2", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481648/480-10-50-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "05", "Paragraph": "4", "Subparagraph": "(a)-(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "320", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//710/tableOfContent" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "712", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//712/tableOfContent" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "c", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "940", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//940-320/tableOfContent" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//942-320/tableOfContent" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//946-320/tableOfContent" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-2" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "210", "Topic": "954", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1403", "Paragraph": "(b)", "Publisher": "SEC" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-6A" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//310/tableOfContent" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//326/tableOfContent" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-3" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479341/842-30-25-2" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-3" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-12" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r796": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r797": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r798": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r799": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r800": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r801": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r802": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r803": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r806": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r807": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r808": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r809": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r810": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r811": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r812": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r813": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r814": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r815": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r816": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r817": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r818": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r819": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r820": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r821": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r822": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r823": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r824": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r825": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r826": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r827": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r828": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r829": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r830": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r831": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r832": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r833": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r834": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r835": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r836": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "217", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217" }, "r837": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r838": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r839": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r840": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r841": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r842": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r843": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r844": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r845": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r846": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r847": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r848": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r849": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r850": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r860": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r861": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r862": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r863": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r864": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r865": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r869": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r870": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r871": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r872": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r873": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r874": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r875": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r876": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r877": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r878": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r879": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r880": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r881": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r882": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r883": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r884": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r885": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r886": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r887": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r888": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r889": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r890": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r891": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r892": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r893": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r894": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r895": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r896": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r897": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r898": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r899": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r900": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r901": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r902": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r903": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r904": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r905": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r906": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r907": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r908": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r909": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r910": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r911": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r912": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r913": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r914": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r915": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r916": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r917": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r918": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r919": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r920": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r921": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r922": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r923": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r924": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r925": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r926": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r927": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r928": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r929": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r930": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r931": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r932": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r933": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r934": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "30", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-1" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "30", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-2" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-3" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-12" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-3" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 125 0001628280-24-008053-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-24-008053-xbrl.zip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nhic-20231231_htm.xml IDEA: XBRL DOCUMENT 0001805385 2023-01-01 2023-12-31 0001805385 us-gaap:CommonClassAMember 2023-01-01 2023-12-31 0001805385 nhic:WarrantsToPurchaseOneShareOfClassCommonStockMember 2023-01-01 2023-12-31 0001805385 2023-06-30 0001805385 2024-02-28 0001805385 2023-12-31 0001805385 2022-12-31 0001805385 us-gaap:RelatedPartyMember 2023-12-31 0001805385 us-gaap:RelatedPartyMember 2022-12-31 0001805385 us-gaap:ProductMember 2023-01-01 2023-12-31 0001805385 us-gaap:ProductMember 2022-01-01 2022-12-31 0001805385 us-gaap:SubscriptionAndCirculationMember 2023-01-01 2023-12-31 0001805385 us-gaap:SubscriptionAndCirculationMember 2022-01-01 2022-12-31 0001805385 us-gaap:ServiceMember 2023-01-01 2023-12-31 0001805385 us-gaap:ServiceMember 2022-01-01 2022-12-31 0001805385 nhic:LicenseFeeAndOtherRevenueMember 2023-01-01 2023-12-31 0001805385 nhic:LicenseFeeAndOtherRevenueMember 2022-01-01 2022-12-31 0001805385 2022-01-01 2022-12-31 0001805385 us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001805385 us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001805385 us-gaap:CommonStockMember 2021-12-31 0001805385 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001805385 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001805385 us-gaap:RetainedEarningsMember 2021-12-31 0001805385 2021-12-31 0001805385 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001805385 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001805385 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001805385 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001805385 us-gaap:CommonStockMember 2022-12-31 0001805385 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001805385 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001805385 us-gaap:RetainedEarningsMember 2022-12-31 0001805385 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001805385 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001805385 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001805385 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001805385 us-gaap:CommonStockMember 2023-12-31 0001805385 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001805385 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001805385 us-gaap:RetainedEarningsMember 2023-12-31 0001805385 nhic:LicenseFeeAndOtherRevenueMember srt:RestatementAdjustmentMember 2022-01-01 2022-12-31 0001805385 nhic:MotorolaSolutionsIncMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001805385 nhic:MotorolaSolutionsIncMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001805385 nhic:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001805385 nhic:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001805385 nhic:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001805385 nhic:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001805385 nhic:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001805385 nhic:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001805385 nhic:MotorolaSolutionsIncMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001805385 nhic:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001805385 nhic:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001805385 nhic:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001805385 nhic:MotorolaSolutionsIncMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001805385 nhic:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001805385 srt:ScenarioForecastMember us-gaap:CommonClassAMember nhic:PlanOfMergerWithNhicAndMergerSubMember nhic:TriggeringEventOneMember 2026-03-08 2026-03-08 0001805385 srt:MinimumMember srt:ScenarioForecastMember us-gaap:CommonClassAMember nhic:PlanOfMergerWithNhicAndMergerSubMember nhic:TriggeringEventOneMember 2026-03-08 0001805385 srt:ScenarioForecastMember nhic:TriggeringEventOneMember 2026-03-08 2026-03-08 0001805385 srt:ScenarioForecastMember us-gaap:CommonClassAMember nhic:PlanOfMergerWithNhicAndMergerSubMember nhic:TriggeringEventTwoMember 2026-03-08 2026-03-08 0001805385 srt:MinimumMember srt:ScenarioForecastMember us-gaap:CommonClassAMember nhic:PlanOfMergerWithNhicAndMergerSubMember nhic:TriggeringEventTwoMember 2026-03-08 0001805385 srt:ScenarioForecastMember nhic:TriggeringEventTwoMember 2026-03-08 2026-03-08 0001805385 srt:ScenarioForecastMember us-gaap:CommonClassAMember nhic:PlanOfMergerWithNhicAndMergerSubMember nhic:TriggeringEventThreeMember 2026-03-08 2026-03-08 0001805385 srt:MinimumMember srt:ScenarioForecastMember us-gaap:CommonClassAMember nhic:PlanOfMergerWithNhicAndMergerSubMember nhic:TriggeringEventThreeMember 2026-03-08 0001805385 srt:ScenarioForecastMember nhic:TriggeringEventThreeMember 2026-03-08 2026-03-08 0001805385 nhic:PlanOfMergerWithNhicAndMergerSubMember 2023-12-31 0001805385 nhic:NhicSubIncMember 2023-12-31 0001805385 us-gaap:CommonClassBMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-01-01 2023-12-31 0001805385 srt:MaximumMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-01-01 2023-12-31 0001805385 srt:MinimumMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-12-31 0001805385 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-01-01 2023-12-31 0001805385 us-gaap:CommonClassBMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-01-01 2023-12-31 0001805385 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-01-01 2023-12-31 0001805385 srt:MinimumMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-12-31 0001805385 us-gaap:CommonClassBMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-01-01 2023-12-31 0001805385 nhic:GiveEvolvLlcMember 2023-01-01 2023-12-31 0001805385 2021-07-16 0001805385 nhic:EdgeUnitsMember 2023-01-01 2023-12-31 0001805385 nhic:EdgeUnitsMember 2022-01-01 2022-12-31 0001805385 us-gaap:ComputerEquipmentMember 2023-12-31 0001805385 nhic:LabEquipmentMember 2023-12-31 0001805385 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2023-12-31 0001805385 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001805385 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2023-12-31 0001805385 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2023-12-31 0001805385 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2023-12-31 0001805385 us-gaap:SoftwareDevelopmentMember 2023-12-31 0001805385 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001805385 nhic:LeasedEquipmentMember 2023-12-31 0001805385 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001805385 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001805385 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-01-31 0001805385 nhic:BusinessDevelopmentAgreementWithFinbackMember 2021-01-31 0001805385 nhic:SubscriptionAgreementsMember 2023-01-01 2023-12-31 0001805385 us-gaap:USTreasuryBillSecuritiesMember 2023-12-31 0001805385 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2023-12-31 0001805385 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryBillSecuritiesMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryBillSecuritiesMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryBillSecuritiesMember 2023-12-31 0001805385 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryBillSecuritiesMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001805385 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentEarnOutLiabilityMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentEarnOutLiabilityMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentEarnOutLiabilityMember 2023-12-31 0001805385 us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentEarnOutLiabilityMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentlyIssuableCommonStockLiabilityMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentlyIssuableCommonStockLiabilityMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentlyIssuableCommonStockLiabilityMember 2023-12-31 0001805385 us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentlyIssuableCommonStockLiabilityMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember nhic:PublicWarrantLiabilityMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember nhic:PublicWarrantLiabilityMember 2023-12-31 0001805385 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nhic:PublicWarrantLiabilityMember 2023-12-31 0001805385 us-gaap:FairValueMeasurementsRecurringMember nhic:PublicWarrantLiabilityMember 2023-12-31 0001805385 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2022-12-31 0001805385 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001805385 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember nhic:LongTermDebtIncludingCurrentPortionMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember nhic:LongTermDebtIncludingCurrentPortionMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nhic:LongTermDebtIncludingCurrentPortionMember 2022-12-31 0001805385 us-gaap:FairValueMeasurementsRecurringMember nhic:LongTermDebtIncludingCurrentPortionMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentEarnOutLiabilityMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentEarnOutLiabilityMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentEarnOutLiabilityMember 2022-12-31 0001805385 us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentEarnOutLiabilityMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentlyIssuableCommonStockLiabilityMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentlyIssuableCommonStockLiabilityMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentlyIssuableCommonStockLiabilityMember 2022-12-31 0001805385 us-gaap:FairValueMeasurementsRecurringMember nhic:ContingentlyIssuableCommonStockLiabilityMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember nhic:PublicWarrantLiabilityMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember nhic:PublicWarrantLiabilityMember 2022-12-31 0001805385 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nhic:PublicWarrantLiabilityMember 2022-12-31 0001805385 us-gaap:FairValueMeasurementsRecurringMember nhic:PublicWarrantLiabilityMember 2022-12-31 0001805385 nhic:ContingentEarnOutLiabilityMember 2023-01-01 2023-12-31 0001805385 nhic:ContingentEarnOutLiabilityMember us-gaap:MeasurementInputPriceVolatilityMember 2023-01-01 2023-12-31 0001805385 nhic:ContingentEarnOutLiabilityMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-01-01 2023-12-31 0001805385 nhic:ContingentEarnOutLiabilityMember us-gaap:MeasurementInputControlPremiumMember 2023-01-01 2023-12-31 0001805385 nhic:ContingentEarnOutLiabilityMember us-gaap:MeasurementInputExpectedTermMember 2023-01-01 2023-12-31 0001805385 nhic:ContingentEarnOutLiabilityMember 2021-12-31 0001805385 nhic:ContingentEarnOutLiabilityMember 2022-01-01 2022-12-31 0001805385 nhic:ContingentEarnOutLiabilityMember 2022-12-31 0001805385 nhic:ContingentEarnOutLiabilityMember 2023-12-31 0001805385 nhic:ContingentlyIssuableCommonStockLiabilityMember 2021-07-15 2021-07-15 0001805385 nhic:ContingentlyIssuableCommonStockLiabilityMember 2021-07-16 2021-07-16 0001805385 nhic:ContingentlyIssuableCommonStockLiabilityMember 2023-01-01 2023-12-31 0001805385 nhic:ContingentlyIssuableCommonStockLiabilityMember us-gaap:MeasurementInputPriceVolatilityMember 2023-01-01 2023-12-31 0001805385 nhic:ContingentlyIssuableCommonStockLiabilityMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-01-01 2023-12-31 0001805385 nhic:ContingentlyIssuableCommonStockLiabilityMember us-gaap:MeasurementInputControlPremiumMember 2023-01-01 2023-12-31 0001805385 nhic:ContingentlyIssuableCommonStockLiabilityMember us-gaap:MeasurementInputExpectedTermMember 2023-01-01 2023-12-31 0001805385 nhic:ContingentlyIssuableCommonStockLiabilityMember 2021-12-31 0001805385 nhic:ContingentlyIssuableCommonStockLiabilityMember 2022-01-01 2022-12-31 0001805385 nhic:ContingentlyIssuableCommonStockLiabilityMember 2022-12-31 0001805385 nhic:ContingentlyIssuableCommonStockLiabilityMember 2023-12-31 0001805385 nhic:PublicWarrantLiabilityMember 2021-12-31 0001805385 nhic:PublicWarrantLiabilityMember 2022-01-01 2022-12-31 0001805385 nhic:PublicWarrantLiabilityMember 2022-12-31 0001805385 nhic:PublicWarrantLiabilityMember 2023-01-01 2023-12-31 0001805385 nhic:PublicWarrantLiabilityMember 2023-12-31 0001805385 us-gaap:ProductMember 2024-01-01 2023-12-31 0001805385 us-gaap:ProductMember 2025-01-01 2023-12-31 0001805385 us-gaap:ProductMember 2026-01-01 2023-12-31 0001805385 us-gaap:ProductMember 2023-12-31 0001805385 us-gaap:SubscriptionAndCirculationMember 2024-01-01 2023-12-31 0001805385 us-gaap:SubscriptionAndCirculationMember 2025-01-01 2023-12-31 0001805385 us-gaap:SubscriptionAndCirculationMember 2026-01-01 2023-12-31 0001805385 us-gaap:SubscriptionAndCirculationMember 2023-12-31 0001805385 us-gaap:ServiceMember 2024-01-01 2023-12-31 0001805385 us-gaap:ServiceMember 2025-01-01 2023-12-31 0001805385 us-gaap:ServiceMember 2026-01-01 2023-12-31 0001805385 us-gaap:ServiceMember 2023-12-31 0001805385 nhic:LicenseFeeAndOtherRevenueMember 2024-01-01 2023-12-31 0001805385 nhic:LicenseFeeAndOtherRevenueMember 2025-01-01 2023-12-31 0001805385 nhic:LicenseFeeAndOtherRevenueMember 2026-01-01 2023-12-31 0001805385 nhic:LicenseFeeAndOtherRevenueMember 2023-12-31 0001805385 2024-01-01 2023-12-31 0001805385 2025-01-01 2023-12-31 0001805385 2026-01-01 2023-12-31 0001805385 nhic:LeasedEquipmentMember 2023-01-01 2023-12-31 0001805385 nhic:LeasedEquipmentMember 2022-01-01 2022-12-31 0001805385 nhic:SaaSMaintenanceAndOtherMember 2023-01-01 2023-12-31 0001805385 nhic:SaaSMaintenanceAndOtherMember 2022-01-01 2022-12-31 0001805385 nhic:LicenseFeeMember 2023-01-01 2023-12-31 0001805385 nhic:LicenseFeeMember 2022-01-01 2022-12-31 0001805385 nhic:ProfessionalServicesAndOtherRevenueMember 2023-01-01 2023-12-31 0001805385 nhic:ProfessionalServicesAndOtherRevenueMember 2022-01-01 2022-12-31 0001805385 country:US 2023-01-01 2023-12-31 0001805385 country:US 2022-01-01 2022-12-31 0001805385 us-gaap:NonUsMember 2023-01-01 2023-12-31 0001805385 us-gaap:NonUsMember 2022-01-01 2022-12-31 0001805385 nhic:GiveEvolvLlcMember 2023-01-01 2023-12-31 0001805385 nhic:GiveEvolvLlcMember 2022-01-01 2022-12-31 0001805385 2021-05-01 0001805385 2021-05-01 2021-05-01 0001805385 nhic:ComputerAndTelecomEquipmentMember 2023-12-31 0001805385 nhic:ComputerAndTelecomEquipmentMember 2022-12-31 0001805385 us-gaap:EquipmentMember 2023-12-31 0001805385 us-gaap:EquipmentMember 2022-12-31 0001805385 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001805385 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2023-12-31 0001805385 us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2022-12-31 0001805385 nhic:LeasedEquipmentMember 2022-12-31 0001805385 us-gaap:SoftwareDevelopmentMember 2022-12-31 0001805385 nhic:SalesDemoEquipmentMember 2023-12-31 0001805385 nhic:SalesDemoEquipmentMember 2022-12-31 0001805385 nhic:EquipmentHeldForLeaseMember 2023-12-31 0001805385 nhic:EquipmentHeldForLeaseMember 2022-12-31 0001805385 us-gaap:ConstructionInProgressMember 2023-12-31 0001805385 us-gaap:ConstructionInProgressMember 2022-12-31 0001805385 us-gaap:SoftwareDevelopmentMember 2023-01-01 2023-12-31 0001805385 us-gaap:SoftwareDevelopmentMember 2022-01-01 2022-12-31 0001805385 nhic:LeasedEquipmentMember 2023-01-01 2023-12-31 0001805385 nhic:LeasedEquipmentMember 2022-01-01 2022-12-31 0001805385 nhic:TermLoansPayableMember 2023-12-31 0001805385 nhic:TermLoansPayableMember 2022-12-31 0001805385 nhic:A2022SVBTermLoanMember 2023-12-31 0001805385 nhic:A2022SVBTermLoanMember 2023-01-01 2023-12-31 0001805385 nhic:A2022SVBTermLoanTwoMember 2023-12-31 0001805385 nhic:A2022SVBTermLoanTwoMember 2023-01-01 2023-12-31 0001805385 srt:MaximumMember nhic:A2022SVBTermLoanMember us-gaap:PrimeRateMember 2023-12-31 0001805385 srt:MaximumMember nhic:A2022SVBTermLoanMember 2023-12-31 0001805385 nhic:A2022SVBTermLoanMember 2023-12-21 0001805385 nhic:A2022SVBTermLoanMember 2023-03-31 2023-03-31 0001805385 nhic:A2022SVBTermLoanMember 2023-03-31 0001805385 nhic:WarrantsIssuedAtJanuaryTwoThousandTwentyOneMember 2023-12-31 0001805385 nhic:WarrantsIssuedAtJulyTwoThousandTwentyOneMember 2023-12-31 0001805385 nhic:WarrantsIssuedAtJanuaryTwoThousandTwentyOneMember 2022-12-31 0001805385 nhic:WarrantsIssuedAtJulyTwoThousandTwentyOneMember 2022-12-31 0001805385 nhic:ShareBasedAwardsExcludingEmployeeStockPurchasePlanMember 2023-12-31 0001805385 nhic:ShareBasedAwardsExcludingEmployeeStockPurchasePlanMember 2022-12-31 0001805385 us-gaap:EmployeeStockMember 2023-12-31 0001805385 us-gaap:EmployeeStockMember 2022-12-31 0001805385 nhic:TwoThousandAndTwentyOneEquityIncentivePlanMember 2023-12-31 0001805385 nhic:TwoThousandAndTwentyOneEquityIncentivePlanMember 2023-01-01 2023-12-31 0001805385 srt:MaximumMember nhic:TwoThousandAndTwentyOneEquityIncentivePlanMember 2023-01-01 2023-12-31 0001805385 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001805385 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001805385 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001805385 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001805385 us-gaap:PerformanceSharesMember 2021-12-31 0001805385 us-gaap:PerformanceSharesMember 2022-01-01 2022-12-31 0001805385 us-gaap:PerformanceSharesMember 2022-12-31 0001805385 us-gaap:PerformanceSharesMember 2023-01-01 2023-12-31 0001805385 us-gaap:PerformanceSharesMember 2023-12-31 0001805385 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-01-01 2023-12-31 0001805385 us-gaap:PerformanceSharesMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-01-01 2023-12-31 0001805385 nhic:TwentyTwentyOneEmployeeStockPurchasePlanMember 2021-07-16 0001805385 nhic:TwentyTwentyOneEmployeeStockPurchasePlanMember 2021-07-01 2021-07-31 0001805385 nhic:TwentyTwentyOneEmployeeStockPurchasePlanMember 2023-12-31 0001805385 us-gaap:MeasurementInputRiskFreeInterestRateMember nhic:BusinessDevelopmentAgreementWithFinbackMember 2023-12-31 0001805385 us-gaap:MeasurementInputExpectedTermMember nhic:BusinessDevelopmentAgreementWithFinbackMember 2023-12-31 0001805385 us-gaap:MeasurementInputPriceVolatilityMember nhic:BusinessDevelopmentAgreementWithFinbackMember 2023-12-31 0001805385 us-gaap:MeasurementInputExpectedDividendRateMember nhic:BusinessDevelopmentAgreementWithFinbackMember 2023-12-31 0001805385 nhic:BusinessDevelopmentAgreementWithFinbackMember 2023-12-31 0001805385 nhic:FinbackCommonStockWarrants2021Member 2021-01-31 0001805385 nhic:BusinessDevelopmentAgreementWithFinbackMember 2023-01-01 2023-12-31 0001805385 us-gaap:SellingAndMarketingExpenseMember nhic:BusinessDevelopmentAgreementWithFinbackMember 2023-01-01 2023-12-31 0001805385 us-gaap:SellingAndMarketingExpenseMember nhic:BusinessDevelopmentAgreementWithFinbackMember 2022-01-01 2022-12-31 0001805385 us-gaap:CostOfSalesMember 2023-01-01 2023-12-31 0001805385 us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0001805385 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-12-31 0001805385 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-12-31 0001805385 us-gaap:SellingAndMarketingExpenseMember 2023-01-01 2023-12-31 0001805385 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-12-31 0001805385 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-12-31 0001805385 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001805385 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001805385 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001805385 nhic:EarnOutSharesMember 2023-01-01 2023-12-31 0001805385 nhic:EarnOutSharesMember 2022-01-01 2022-12-31 0001805385 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001805385 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001805385 nhic:RestrictedStockUnitsAndPhantomShareUnitsMember 2023-01-01 2023-12-31 0001805385 nhic:RestrictedStockUnitsAndPhantomShareUnitsMember 2022-01-01 2022-12-31 0001805385 nhic:UnvestedStockOptionsAndRestrictedStockUnitsMember 2023-12-31 0001805385 nhic:UnvestedStockOptionsAndRestrictedStockUnitsMember 2023-01-01 2023-12-31 0001805385 us-gaap:DomesticCountryMember 2023-12-31 0001805385 us-gaap:DomesticCountryMember 2022-12-31 0001805385 us-gaap:StateAndLocalJurisdictionMember 2023-12-31 0001805385 us-gaap:StateAndLocalJurisdictionMember 2022-12-31 0001805385 us-gaap:ForeignCountryMember 2023-12-31 0001805385 us-gaap:ForeignCountryMember 2022-12-31 0001805385 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2023-12-31 0001805385 us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember 2023-12-31 0001805385 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2022-12-31 0001805385 us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember 2022-12-31 0001805385 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001805385 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001805385 us-gaap:WarrantMember nhic:WarrantsIssuedAtJulyTwoThousandTwentyOneMember 2023-01-01 2023-12-31 0001805385 us-gaap:WarrantMember nhic:WarrantsIssuedAtJulyTwoThousandTwentyOneMember 2022-01-01 2022-12-31 0001805385 us-gaap:WarrantMember nhic:WarrantsIssuedAtJanuaryTwoThousandTwentyOneMember 2023-01-01 2023-12-31 0001805385 us-gaap:WarrantMember nhic:WarrantsIssuedAtJanuaryTwoThousandTwentyOneMember 2022-01-01 2022-12-31 0001805385 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001805385 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001805385 us-gaap:PerformanceSharesMember 2023-01-01 2023-12-31 0001805385 us-gaap:PerformanceSharesMember 2022-01-01 2022-12-31 0001805385 nhic:EarnOutSharesMember 2023-01-01 2023-12-31 0001805385 nhic:EarnOutSharesMember 2022-01-01 2022-12-31 0001805385 nhic:FounderSharesMember 2023-01-01 2023-12-31 0001805385 nhic:FounderSharesMember 2022-01-01 2022-12-31 0001805385 nhic:DistributionAgreementWithMotorolaMemberMember 2020-12-31 0001805385 nhic:DistributionAgreementWithMotorolaMemberMember us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001805385 nhic:DistributionAgreementWithMotorolaMemberMember us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001805385 nhic:DistributionAgreementWithMotorolaMemberMember us-gaap:RelatedPartyMember 2023-12-31 0001805385 nhic:DistributionAgreementWithMotorolaMemberMember us-gaap:RelatedPartyMember 2022-12-31 0001805385 nhic:ResellerAgreementMember us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001805385 nhic:ResellerAgreementMember us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001805385 nhic:ResellerAgreementMember us-gaap:RelatedPartyMember 2023-12-31 0001805385 nhic:ResellerAgreementMember us-gaap:RelatedPartyMember 2022-12-31 0001805385 2023-10-01 2023-12-31 0001805385 nhic:AnilChitkaraMember 2023-01-01 2023-12-31 0001805385 nhic:AnilChitkaraMember 2023-10-01 2023-12-31 0001805385 nhic:AnilChitkaraMember 2023-12-31 iso4217:USD shares iso4217:USD shares pure utr:D nhic:segment nhic:unit nhic:space nhic:Vote nhic:item 0001805385 2023 FY false P1Y P1Y P1Y P1Y P1Y P1Y P1Y P1Y P1Y P1Y P266D 10-K true 2023-12-31 --12-31 false 001-39417 EVOLV TECHNOLOGIES HOLDINGS, INC. DE 84-4473840 500 Totten Pond Road 4th Floor Waltham MA 02451 (781) 374-8100 Class A common stock, par value $0.0001 per share Warrants to purchase one share of Class A common stock EVLV EVLVW NASDAQ NASDAQ No No Yes Yes Large Accelerated Filer true false true false false 722800000 152182633 Certain portions of the information required to be furnished pursuant to Part III of this Annual Report on Form 10-K will be set forth in, and incorporated by reference from, the registrant’s definitive proxy statement for the annual meeting of stockholders which will be filed with the Securities and Exchange Commission no later than 120 days after the end of the fiscal year ended December 31, 2023. 238 PricewaterhouseCoopers LLP Boston, Massachusetts 67162000 229783000 275000 0 51289000 0 22611000 31920000 9507000 10257000 3707000 2852000 4339000 3384000 16954000 14388000 175844000 292584000 0 275000 451000 1386000 7107000 5655000 112921000 44707000 1195000 1673000 1202000 1835000 298720000 348115000 17400000 18194000 15578000 11545000 47677000 18273000 0 10000000 1391000 1114000 82046000 59126000 23813000 17695000 0 19683000 0 892000 29119000 14218000 6530000 3392000 10889000 6124000 152397000 121130000 0.0001 0.0001 100000000 100000000 0 0 0 0 0 0 0.0001 0.0001 1100000000 1100000000 151310080 151310080 145204974 145204974 15000 15000 444825000 419190000 -53000 -10000 -298464000 -192210000 146323000 226985000 298720000 348115000 1700000 14600000 21977000 31985000 37247000 17569000 16141000 4331000 5053000 1310000 80418000 55195000 26667000 41575000 14991000 7469000 3982000 2200000 949000 2222000 46589000 53466000 33829000 1729000 24455000 18771000 55223000 46639000 42091000 37719000 322000 1161000 122091000 104290000 -88262000 -102561000 654000 712000 6227000 3165000 -84000 -64000 -626000 0 14901000 -6988000 3138000 -1872000 4765000 -4906000 -17941000 16155000 -106203000 -86406000 51000 0 -106254000 -86406000 149168105 149168105 143858668 143858668 -0.71 -0.71 -0.60 -0.60 -106254000 -86406000 -43000 -10000 -43000 -10000 -106297000 -86416000 11300000 13500000 142745021 14000 396064000 0 -105804000 290274000 1894179 1000 827000 828000 565774 22299000 22299000 -10000 -10000 -86406000 -86406000 145204974 15000 419190000 -10000 -192210000 226985000 1735978 0 668000 668000 3265155 1103973 464000 464000 24503000 24503000 -43000 -43000 -106254000 -106254000 151310080 15000 444825000 -53000 -298464000 146323000 -106254000 -86406000 9932000 5465000 1612000 1582000 0 625000 322000 1161000 24151000 22498000 22000 55000 575000 0 478000 811000 382000 150000 -626000 0 14901000 -6988000 3138000 -1872000 4765000 -4906000 -8927000 25593000 644000 8495000 2407000 3675000 -80000 -639000 -633000 419000 2566000 3174000 -5963000 7661000 35522000 26887000 3732000 1462000 -615000 -946000 -9801000 -74728000 3535000 2720000 69134000 21473000 270000 312000 89898000 0 39184000 0 -123113000 -23881000 668000 827000 1876000 29683000 31876000 10000000 332000 0 -29664000 20510000 -43000 -10000 -162621000 -78109000 230058000 308167000 67437000 230058000 710000 581000 218000 0 13322000 7552000 516000 205000 464000 0 67162000 229783000 275000 0 0 275000 67437000 230058000 Nature of the Business and Basis of Presentation<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolv Technologies Holdings, Inc. (the “Company”), a Delaware corporation, is a global leader in AI-based weapons detection for security screening. The Company’s mission is to make the world a safer and more enjoyable place to work, learn, and play. The Company is democratizing security by making it seamless for gathering spaces to address the chronic epidemic of escalating gun violence, mass shootings and terrorist attacks in a cost-effective manner while improving the visitor experience. The Company is headquartered in Waltham, Massachusetts.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this Annual Report on Form 10-K, unless otherwise indicated or the context otherwise requires, references to “we,” “us,” “our,” the “Company” and “Evolv” refer to the consolidated operations of Evolv Technologies Holdings, Inc. and its wholly owned subsidiaries, which include Evolv Technologies, Inc., Evolv Technologies UK Ltd. and Give Evolv LLC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and uncertainties</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is significant uncertainty in the current macroeconomic environment due to inflationary pressures globally, conflicts in Europe and the Middle East, and foreign currency volatility and their impacts on the Company’s business. If economic conditions were to worsen, the Company’s results of operations, financial condition, and cash flows from operations may be materially and adversely impacted.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of presentation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 16, 2021, we consummated the business combination (the “Merger”), contemplated by the Agreement and Plan of Merger, dated March 5, 2021, with NHIC Sub Inc. (“Merger Sub”), a wholly-owned subsidiary of NewHold Investment Corp. (“NHIC”), a special purpose acquisition company, which is our legal predecessor, and Evolv Technologies, Inc. dba Evolv Technology, Inc. (“Legacy Evolv”), as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 by and among NHIC, Merger Sub and Legacy Evolv (the “Amendment” and as amended, the “Merger Agreement”). Pursuant to the Merger Agreement, Merger Sub was merged with and into Legacy Evolv, with Legacy Evolv surviving the Merger as a wholly-owned subsidiary of NHIC. Upon the closing of the Merger, NHIC changed its name to Evolv Technologies Holdings, Inc. Evolv Technologies Holdings, Inc. became the successor entity to NHIC pursuant to Rule 12g-3(a) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2023, the Company began classifying revenue from professional services, which includes installation, training, and event support, as well as other one-time revenue, within license fee and other revenue on the consolidated statements of operations and comprehensive loss, whereas the revenue for these services has previously been included in service revenue. Correspondingly, the Company began classifying costs associated with professional services within cost of license fee and other revenue, whereas these costs were previously included in cost of service revenue. These reclassifications were made to align the presentation of professional services with the Company's internal reporting and analysis. The reclassifications did not impact total revenue or total cost of revenue for any period. Prior year amounts included in this Annual Report on Form 10-K have been reclassified to conform to the current presentation. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2022, the reclassifications resulted in an increase in license fee and other revenue of $1.3 million and a corresponding decrease in service revenue, as well as in increase in cost of license fee and other revenue of $2.2 million and a corresponding decrease in cost of service revenue.</span></div> <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of presentation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”).</span></div> <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 16, 2021, we consummated the business combination (the “Merger”), contemplated by the Agreement and Plan of Merger, dated March 5, 2021, with NHIC Sub Inc. (“Merger Sub”), a wholly-owned subsidiary of NewHold Investment Corp. (“NHIC”), a special purpose acquisition company, which is our legal predecessor, and Evolv Technologies, Inc. dba Evolv Technology, Inc. (“Legacy Evolv”), as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 by and among NHIC, Merger Sub and Legacy Evolv (the “Amendment” and as amended, the “Merger Agreement”). Pursuant to the Merger Agreement, Merger Sub was merged with and into Legacy Evolv, with Legacy Evolv surviving the Merger as a wholly-owned subsidiary of NHIC. Upon the closing of the Merger, NHIC changed its name to Evolv Technologies Holdings, Inc. Evolv Technologies Holdings, Inc. became the successor entity to NHIC pursuant to Rule 12g-3(a) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).</span></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div>During the year ended December 31, 2023, the Company began classifying revenue from professional services, which includes installation, training, and event support, as well as other one-time revenue, within license fee and other revenue on the consolidated statements of operations and comprehensive loss, whereas the revenue for these services has previously been included in service revenue. Correspondingly, the Company began classifying costs associated with professional services within cost of license fee and other revenue, whereas these costs were previously included in cost of service revenue. These reclassifications were made to align the presentation of professional services with the Company's internal reporting and analysis. The reclassifications did not impact total revenue or total cost of revenue for any period. Prior year amounts included in this Annual Report on Form 10-K have been reclassified to conform to the current presentation. 1300000 2200000 Summary of Significant Accounting Policies<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to calculating the standalone selling price for revenue recognition, the valuation of inventory, the expensing and capitalization of costs associated with internal-use software, stock-based awards, the valuation of the contingent earn-out liability, the valuation of the contingently issuable common stock, and the valuation of the public warrant liability. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts, and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk of Concentrations of Credit, Significant Customers and Significant Suppliers</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash equivalents, restricted cash, marketable securities, and accounts receivable, net. We maintain substantially all of our cash and cash equivalents with U.S. and multi-national financial institutions, and our deposits are generally in excess of federally insured limits. The Company maintains its cash, cash equivalents, restricted cash, and marketable securities with financial institutions that management believes to be of high credit quality. The Company has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant customers are those which represent more than 10% of the Company’s total revenue or accounts receivable, net balance at each respective balance sheet date. The following table presents customers that represent 10% or more of the Company’s total revenue for the years ended December 31, 2023 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each customer shown is a reseller partner of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Motorola Solutions, Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Less than 10%</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents customers that represent 10% or more of the Company’s accounts receivable, net. Each customer shown is a reseller partner of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:495.00pt"><tr><td style="width:1.0pt"></td><td style="width:359.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:63.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:63.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Motorola Solutions, Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39.0 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> %</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">55.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Less than 10%</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company relies on one primary third-party contract manufacturer, Columbia Tech, for the production of our touchless security screening systems. Columbia Tech provides a variety of services including sourcing off-the-shelf components, manufacturing custom components/assemblies, final product assembly and integration, end of line testing and quality assurance per our specifications, material and finished goods inventory, and direct shipping to our customers. We also use a different third-party manufacturer as a second source for the production of a key sensor component used in our systems. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers to satisfactorily deliver its products to its customers on time, if at all, which could have a material adverse effect on the Company’s operating results, financial condition and cash flows and damage its customer relationships.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all short-term, highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Restricted cash relates to a letter of credit on the Company’s office lease in Waltham, Massachusetts, all of which is included in restricted cash, current on the consolidated balance sheet as of December 31, 2023. As the letter of credit is reduced, restricted cash is reclassified to cash and cash equivalents. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities are reported at fair value and, at December 31, 2023, are comprised solely of zero coupon U.S. treasury bills with maturities of less than one year that are classified as available-for-sale debt securities. The Company considers an available-for-sale debt security to be impaired if the fair value of the investment is less than its amortized cost basis. The entire difference between the amortized cost basis and the fair value of the Company’s available-for-sale debt securities is recognized on the consolidated statements of operations as an impairment if, (i) the fair value of the security is below its amortized cost and (ii) the Company intends to sell or is more likely than not required to sell the security before recovery of its amortized cost basis. If neither criterion is met, the Company evaluates whether the decline in fair value is due to credit losses or other factors. In making this assessment, the Company considers the changes to the rating of the security by third-party rating agencies, and adverse conditions specific to the security, among other factors. If the Company’s assessment indicates that a credit loss exists, the credit loss is measured based on the Company’s best estimate of the cash flows expected to be collected. When developing its estimate of cash flows expected to be collected, the Company considers all available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable forecasts.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains and losses, net of tax, on marketable securities, if any, are recognized in accumulated other comprehensive income (loss) in the accompanying consolidated balance sheets. Realized net gains and losses on marketable securities, if any, are reflected in interest income in the accompanying consolidated statements of operations and comprehensive loss. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements of Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities of the Company are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 — Quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 — Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s cash equivalents, restricted cash, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">marketable securities,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> derivative liability, contingent earn-out liability, contingently issuable common stock liability and its common stock warrant liability are carried at fair value, determined according to the fair value hierarchy described above (see Note 4). The carrying values of the Company’s accounts receivable, net, accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities. The carrying value of the Company’s long-term debt approximates its fair value (a Level 2 measurement) at each balance sheet date due to its variable interest rate, which approximates a market interest rate.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets that are measured at fair value on a nonrecurring basis primarily relate to property and equipment. We do not periodically adjust carrying value to fair value for property and equipment. Rather, the carrying value of the asset is reduced to its fair value when we determine that impairment has occurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Earn-out</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger and pursuant to the Merger Agreement, certain of the Legacy Evolv’s shareholders and Legacy Evolv Service Providers are entitled to receive additional shares of the Company’s common stock (the “Earn-Out Shares”) upon the Company achieving certain milestones:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Triggering Event I – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $12.50 per share for any 20 trading days within any 30 trading day period.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Triggering Event II – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $15.00 per share for any 20 trading days within any 30 trading day period.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Triggering Event III – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $17.50 per share for any 20 trading days within any 30 trading day period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 815 – Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the earn-out arrangement with the Legacy Evolv shareholders is accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as a change in fair value of contingent earn-out liability in other income (expense), net in the consolidated statements of operations and comprehensive loss. When the Triggering Events have been achieved and the Earn-Out Shares are issued, the Company will reclassify the corresponding amount from a liability to additional paid-in-capital and common stock at par value of $0.0001 per share.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the contingent earn-out shares was determined using a Monte Carlo simulation that simulated the future path of the Company’s stock price over the earn-out period. The significant assumptions utilized in the calculation are based on the achievement of certain stock price milestones including projected stock price, volatility, drift rate, percentage of change in control and expected term.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent earn-out liability is categorized as a Level 3 fair value measurement (see Note 4) because the Company estimates projections during the earn-out period utilizing unobservable inputs, including various potential pay-out scenarios. Contingent earn-out payments involve certain assumptions requiring significant judgment and actual results may differ from assumed and estimated amounts.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Earn-Out Shares issued to employees, officers, directors, and non-employees are based on achievement of certain target share price contingencies and for the employees and officers, subject to continued employment, (the “Earn-Out Service Providers”) represents share-based compensation and is included in additional paid-in capital on the Company’s balance sheet. Corresponding stock-based compensation expense is recorded in the consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. As a condition to being issued Earn-Out Shares, the Earn-Out Service Providers must still be providing services to the Company on the date of the issuance of the shares. If the relationship with the service provider is terminated prior to the issuance of the Earn-Out Shares, the shares will be redistributed to the remaining participants in the Earn-Out Shares.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingently Issuable Common Stock</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Merger, NewHold Industrial Technology Holdings, LLC, the sponsor of the NHIC special purpose acquisition company owned 4,312,500 shares of NHIC Class B common stock (the “Founder Shares). Upon the closing of the Merger, NHIC Class A and Class B common stock became the Company’s common stock. The Founder Shares outstanding were subject to certain share-performance-based vesting provisions as follows:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vesting Provision I – 1,897,500 shares of the Company’s common stock shall vest and no longer be subject to forfeiture as of the Merger;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vesting Provision II – if within five years following the closing of the Merger, the last reported sale price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period, then 948,750 shares of the Company’s common stock shall vest and no longer be subject to forfeiture and</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vesting Provision III – if within five years following the closing of the Merger, the last reported sale price of the Company’s common stock equals or exceeds $15.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period, then 948,750 shares of the Company’s common stock) shall vest and no longer be subject to forfeiture.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining 517,500 Founder Shares were contributed to Give Evolv LLC.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Vesting Provision II and/or Vesting Provision III are not satisfied, the corresponding number of shares specified shall be forfeited and no longer issued and outstanding. If there is a Change of Control event prior to Vesting Provision II and/or Vesting Provision III are satisfied, the Founder shares are no longer subject to forfeiture and shall vest immediately upon the occurrence of a Change of Control event.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 815 – Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the contingently issuable common stock is accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as change in fair value of contingently issuable common stock liability in other income (expense), net in the consolidated statements of operations and comprehensive loss. When the Vesting Provisions have been achieved and the contingently issuable common shares are issued, the Company will reclassify the corresponding amount from a liability to additional paid-in-capital and common stock at par value of $0.0001 per share.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the contingently issuable common shares was determined using a Monte Carlo simulation that simulated the future path of the Company’s stock price over the earn-out period. The assumptions utilized in the calculation are based on the achievement of certain stock price milestones including expected stock price volatility, risk-free rate of return, likelihood of change in control, and remaining term.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingently issuable common shares are categorized as a Level 3 fair value measurement (see Note 4) because the Company estimates projections during the earn-out period utilizing unobservable inputs, including various potential pay-out scenarios. Contingently issuable shares involve certain assumptions requiring significant judgment and actual results may differ from assumed and estimated amounts.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Warrant Liability</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the closing of the Merger, the Company assumed warrants for the purchase of 14,325,000 shares of common stock at an exercise price of $11.50 (the “Public Warrants”). The Public Warrants are classified as a liability pursuant to ASC 815 – </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as the equity derivative scope exception was not met and are measured at fair value, with the changes in fair value reported in earnings as a component of other income (expense), net in the consolidated statements of operations and comprehensive loss with the offset to additional paid in capital.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases as a Lessee</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At contract inception, the Company determines if an arrangement is or contains a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If determined to be or contain a lease, the lease is assessed for classification as either an operating or finance lease at the lease commencement date, defined as the date on which the leased asset is made available for use by the Company (when the Company is the lessee). Where the Company is the lessee, for each lease with a term greater than twelve months, the Company records a right-of-use asset and lease liability.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A right-of-use asset represents the economic benefit conveyed to the Company by the right to use the underlying asset over the lease term. A lease liability represents the obligation to make lease payments arising from the use of the asset over the lease term. Lease liabilities are measured at lease commencement and calculated as the present value of the future lease payments in the contract using the rate implicit in the contract, when available. If an implicit rate is not readily determinable, the Company uses an incremental borrowing rate measured as the rate at which the Company could borrow, on a fully collateralized basis, a commensurate loan in the same currency over a period consistent with the lease term at the commencement date. Right-of-use assets are measured as the amount of the initial lease liability plus initial direct costs and prepaid lease payments, less lease incentives granted by the lessor. The lease term is measured as the noncancelable period in the contract, adjusted for any options to extend or terminate when it is reasonably certain the Company will extend the lease term via such options based on an assessment of economic factors present as of the lease commencement date. The Company elected the practical expedient to not recognize leases with a lease term of twelve months or less.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of a lease are split into three categories: lease components, non-lease components, and non-components. The fixed and in-substance fixed contract consideration (including any consideration related to non-components) are allocated, based on the respective relative fair values, to the lease components and non-lease components. The Company has elected the practical expedient to account for lease and non-lease components together as a single lease component for all underlying assets and allocate all of the contract consideration to the lease component only.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s operating leases are presented in the consolidated balance sheet as operating lease right-of-use assets, classified as noncurrent assets, and operating lease liabilities, classified as current and noncurrent liabilities. Operating lease expense is recognized on a straight-line basis over the lease term. Variable costs associated with a lease, such as maintenance and utilities, are not included in the measurement of the lease liabilities and right-of-use assets but rather are expensed when the events determining the amount of variable consideration to be paid have occurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost or net realizable value with cost being determined using the weighted average method. The Company regularly reviews inventory quantities on-hand for excess and obsolete inventory and, when circumstances indicate, records charges to write down inventories to their estimated net realizable value, after evaluating historical sales, future demand, market conditions and expected product life cycles. Such charges are classified as product cost of revenues in the consolidated statement of operations and comprehensive loss. Any write-down of inventory to net realizable value creates a new cost basis. The Company recorded $1.6 million and $1.6 million in inventory write-offs and change in inventory reserves during the years ended December 31, 2023 and 2022, respectively. Inventory write-offs primarily relate to Edge units and prior generation Express units, as the Company is no longer selling these products, as well as other inventory that was determined to be obsolete or unsellable.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expense are recognized using the straight-line method over the estimated useful life of each asset, as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computers and telecommunications equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lab equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Shorter of useful life of 7 years or remaining lease term</span></div><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leased equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Internal-use software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4 years</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated useful lives are periodically assessed to determine if changes are appropriate. Leasehold improvements are depreciated using the straight-line method over the lesser of the lease term or its estimated economic useful life. Lease terms are used based upon the initial lease agreement and do not consider potential renewals or extensions until such time that the renewals or extensions are contracted. Maintenance and repairs are charged to expense as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation are eliminated from the consolidated balance sheet and any resulting gains or losses are included in the consolidated statements of operations and comprehensive loss in the period of disposal. Costs for capital assets not yet placed into service are capitalized as construction-in-progress and depreciated once placed into service.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s leases for leased equipment generally are 48 months. The Company’s subscription contracts are generally classified as operating leases because title does not transfer and they do not meet any of the other criteria per Accounting Standards Codification 842 – </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASC 842”).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates property and equipment for obsolescence and impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset group for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset group to its carrying value. An impairment loss would be recognized in loss from operations and comprehensive loss when estimated undiscounted future cash flows expected to result from the use of an asset group are less than its carrying amount. The impairment loss is based on the excess of the carrying value of the impaired asset group over its fair value, determined based on discounted cash flows. The Company recorded impairment losses of $0.3 million and $1.2 million during the years ended December 31, 2023 and 2022, respectively. These impairment losses related primarily to Edge and Express prototype units that were taken out of service and retired.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain software development costs, including consulting costs and compensation expenses for employees who devote time to the development projects, beginning upon completion of the preliminary project stage (in relation to internal-use software) or upon establishment of technological feasibility (in relation to software embedded in products to be sold or leased), and through the date the software is ready for its intended use. The Company records software development costs in property and equipment, net. Costs incurred in the preliminary stages of development activities and post implementation are expensed in the period incurred and are recorded in research and development expense in the consolidated statements of operations and comprehensive loss. The Company also capitalizes </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the project is available for general release, capitalization ceases, and the asset can begin amortization. Capitalized software costs are amortized on a straight-line basis over their estimated useful life, which is generally four years, and are recorded in cost of subscription revenue and cost of service revenue in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Issuance Costs</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain legal, accounting, and other third-party fees that are directly associated with the issuance of debt as debt issuance costs. Debt issuance costs are recorded as a direct reduction of the carrying amount of the associated debt on the consolidated balance sheet and amortized as interest expense on the consolidated statement of operations and comprehensive loss using the effective interest method.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that it has one operating segment after considering the Company’s organizational structure and the information regularly reviewed and evaluated by the Company’s chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. The Company has determined that its CODM is its President and Chief Executive Officer. The CODM reviews the financial information on a consolidated basis for purposes of evaluating financial performance and allocating resources. On the basis of these factors, the Company determined that it operates and manages its business as one operating segment, that develops, manufactures, markets and sells security screening products and specific services, and accordingly has one reportable segment for financial reporting purposes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification 606 – </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 606”). Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In order to achieve this core principle, the Company applies the following five steps when recording revenue: (1) identify the contract, or contracts, with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when, or as, performance obligations are satisfied.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive revenue from (1) subscription arrangements generally accounted for as operating leases, including SaaS and maintenance, (2) the sale of products, (3) SaaS and maintenance related to products sold to customers either by Evolv or by Columbia Tech pursuant to the Distribution and License Agreement (as defined below), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) license fees related to the Distribution and License Agreement (as defined below),</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and (5) professional services, including installation, training, and event support. Maintenance consists of preventative maintenance, technical support, bug fixes, and when-and-if available threat updates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our arrangements are generally noncancelable and nonrefundable after ownership passes to the customer. Revenue is recognized net of sales tax.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distribution and License Agreement </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company entered into a distributor licensing agreement (the "Distribution and License Agreement") with Columbia Electrical Contractors, Inc. ("Columbia Tech"). Columbia Tech, a wholly-owned subsidiary of Coghlin Companies, which serves as the Company's primary contract manufacturer. Under this arrangement, the Company has granted a license of its intellectual property to Columbia Tech, which contracts directly with certain of the Company's resellers to fulfill sales demand where the end-user customer prefers to purchase the hardware equipment as opposed to lease the equipment. Columbia Tech pays the Company a hardware license fee for each system it manufactures and sells under the agreement. In these instances, the Company still contracts directly with the reseller to provide a multi-year SaaS and maintenance subscription to the end-users.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has assessed whether it operates as the principal or as an agent in relation to the sale of product made by Columbia Tech to the Company's resellers pursuant to the Distribution and License Agreement. The Company considered various factors, including but not limited to, inventory risk, discretion in establishing pricing, and which entity is primarily responsible for fulfillment. Based on an evaluation of the facts and circumstances, the Company concluded that Columbia Tech is the principal in the arrangement. The Company therefore does not recognize revenue in relation to sales of product pursuant to the Distribution and License Agreement, but does recognize revenue in relation to license fees received from Columbia Tech and the SaaS and maintenance subscription contracts, each as further described below.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company derives revenue from the sale of its Evolv Express equipment and related add-on accessories to customers. Revenue is recognized when control of the product has transferred to the customer. Transfer of control occurs when the Company has transferred title and risk of loss and has a present right to payment for the equipment, which follows the terms of each customer contract. Products are predominantly sold with distinct services, which are described in the services section below.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subscription Revenue - Leases as Lessor</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to selling our products directly to customers, we also derive revenue from leasing our equipment, which we classify as subscription revenue. Lease terms are typically four years, generally do not include unilateral options by either the Company or our customer to extend, terminate or to purchase the underlying asset, and customers generally pay either a quarterly or annual fixed payment for the lease, SaaS, and maintenance elements over the contractual lease term. There are no variable lease payments as a part of these arrangements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting provisions we use to classify transactions as sales-type are: (i) whether the lease transfers ownership of the equipment by the end of the lease term, (ii) whether the lease grants the customer an option to purchase the equipment and the customer is reasonably certain to do so, (iii) whether the lease term is for the major part of the economic life of the underlying equipment, (iv) whether the present value of the lease payments, and any residual value guaranteed by the customer that is not already reflected in the lease payments, is equal to or greater than substantially all of the fair market value of the equipment at the commencement of the lease, and (v) whether the equipment is specific to the customer and of such a specialized nature that it is expected to have no alternative use to the Company at the end of the lease term. Leasing arrangements meeting any of these conditions are accounted for as sales-type leases and revenue attributable to the lease component is recognized in a manner consistent with product revenue and the related equipment is derecognized with the associated expense presented as a cost of revenue. Leasing arrangements that do not meet the criteria for classification as a sales-type lease will be accounted for as a direct-financing lease if the following two conditions are met: (i) the present value of the lease payments, and any residual value guaranteed by the customer that is not already reflected in the lease payments and any other third party unrelated to the Company, is equal to or greater than substantially all of the fair market value of the equipment at the commencement of the lease, and (ii) it is probable that the Company will collect the lease payments and amounts necessary to satisfy a residual value guarantee. Leasing arrangements that do not meet any of the sales-type lease or direct-financing lease classification criteria are accounted for as operating leases and revenue is recognized straight-line over the term of the lease. Historically, nearly all of the Company's equipment leases have been classified as operating leases.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers the economic life of most of our products to be seven years. The Company believes seven years is representative of the period during which the equipment is expected to be economically usable by one or more users, with normal service, for the purpose for which it is intended. The unguaranteed residual value is estimated to be the value at the end of the lease term based on the anticipated fair market value of the units. The Company mitigates residual value risk of our leased equipment by performing regular management and maintenance, as necessary.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, lease arrangements include both lease and non-lease components. The lease component relates to the customer’s right-to-use the equipment over the lease term. The non-lease components relate to (1) distinct services, such as SaaS and maintenance, (2) any add-on accessories, and (3) professional services, including installation, training, and event. Professional services are included in license fees and other revenue, as described below, and add-on accessories are included in product revenue. Because the equipment, SaaS, and maintenance components of a subscription arrangement are recognized as revenue over the same time period and in the same pattern, the Company elected the practical expedient to aggregate non-lease components with the associated lease component and account for the combined component as an </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operating lease for all underlying asset classes. In the evaluation of whether the lease component (equipment) or the non-lease components associated with the lease component (SaaS and maintenance) is the predominant component, the Company determined that the lease component is predominant as we believe the customer would ascribe more value to the use of the security equipment than that of the SaaS and maintenance services. Therefore, the Company accounts for the combined lease component under ASC 842. The equipment lease and SaaS/maintenance performance obligations are classified as a single category of subscription revenue in the consolidated statements of operations and comprehensive loss. The professional services represent distinct services provided to customers. These activities are considered separate performance obligations to the customer and therefore are considered non-lease components. As professional services are generally performed prior to lease commencement, the timing and pattern of transfer for these services differ from that of the lease component and are not eligible to be combined.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude from variable payments all lessor costs that are explicitly required to be paid directly by a lessee on behalf of the lessor to a third party.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional services are generally billed to the lessee as part of the lease contract billing, according to various contractual terms. Professional services costs incurred by the Company are accounted for as a fulfillment cost and are included in the cost of license fees and other revenue in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue consists of subscription-based SaaS and maintenance revenue related to products sold to a customer by either the Company or by Columbia Tech pursuant to the Distribution and License Agreement. Customers generally pay either a quarterly or annual fixed payment for SaaS and maintenance. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SaaS and maintenance revenue is recognized ratably over the period of the arrangement, which is typically 4 years.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License Fee and Other Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">License fee and other revenue includes license fee revenue from the Distribution and License Agreement, revenue from professional services, and other one-time revenue. License fee revenue is recognized upon the shipment of product from our third-party manufacturer to the reseller. Revenue for professional services is recognized upon transfer of control of these services, which are normally rendered over a short duration. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Reseller Partners</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company’s revenue is also generated by sales to its reseller partners. When the Company transacts with a reseller partner, its contractual arrangement is with the reseller partner and not with the end-use customer. In these transactions, the reseller partner is considered the customer; the Company has discretion over the pricing to the reseller partner and maintains overall control of the inventory and sales process to the reseller partner. Right of return does not generally exist. Whether the Company transacts with a reseller partner and receives the order from a reseller partner or directly from an end-use customer, its revenue recognition policy and resulting pattern of revenue recognition is the same.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is the amount of consideration that the Company expects to be entitled for providing goods and services under a contract, which includes fixed amounts, and on rare occasions, variable consideration. The Company may also provide discounts to customers which reduce the transaction price. On infrequent occasions, the Company may offer customers the option to purchase additional goods and services at a fixed price. In these circumstances, the Company assesses whether these offers constitute a material right, and if so, the Company would account for the material right as a separate performance obligation. The Company does not normally provide for rights of returns to customers on product sales and, therefore, does not record a provision for returns. Amounts paid or payable to customers, including those related to sponsorship arrangements, are recognized as a reduction of the transaction price, and therefore, of revenue unless the payment is in exchange for a distinct good or service.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct product or service to a customer that is both capable of being distinct, whereby the customer can benefit from the product or service either on its own or together with other resources that are readily available, and is distinct in the context of the contract, whereby the transfer of the product or service is separately identifiable from other promises in the contract.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment is sold or leased with embedded software, which is considered a single performance obligation. Maintenance, which includes preventative maintenance, future updates, security threat updates, and minor bug fixes on a when-and-if available basis, is considered a single performance obligation. SaaS, which includes data-driven security information and analytics insights, is also considered a performance obligation. Professional services, including installation, training, and event support, are considered separate performance obligations and are included within license fee and other revenue. Any add-on accessories are also considered separate performance obligations and are included in product revenue.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payment terms</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms for customer orders are typically 30 days after the shipment or installation of the product. Generally, the Company’s contracts do not contain a significant financing component.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiple Performance Obligations within an Arrangement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s contracts may include multiple performance obligations when customers purchase a combination of products and services. When the Company’s customer arrangements have multiple performance obligations that contain an equipment lease for the customer’s use as well as distinct services that are delivered simultaneously, the Company allocates the arrangement consideration between the lease deliverables and non-lease deliverables based on the relative estimated SSP of each distinct performance obligation. For multiple performance obligation arrangements that do not contain a lease, the Company allocates the contract’s transaction price to each performance obligation on a relative SSP basis. The Company determines SSP based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, the Company estimates the SSP taking into account available information such as market conditions, internally approved pricing guidelines, and observable pricing data such as standard cost metrics related to the performance obligation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures all stock-based awards granted to employees, officers, directors and non-employees based on their fair value on the date of the grant and recognizes compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. The vesting period for stock options is generally four years and the vesting period for restricted stock units is generally three years. The Company classifies stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. The Company issues stock-based awards with service-based vesting conditions and records the expense for these awards using the straight-line method. Forfeitures are accounted for as they occur.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In January 2021, the Company granted warrants (the "Finback Common Stock Warrants") exercisable for 2,552,913 shares of common stock at an exercise price of $0.42 per share to Finback Evolv OBH, LLC ("Finback"), a consulting group affiliated with one of the Company's shareholders. The Finback Common Stock Warrants vest upon meeting certain sales criteria as defined in a business development agreement (the "Finback BDA") which has a term of three years. The Finback Common Stock Warrants expire in January 2031. The Finback Common Stock Warrants are accounted for under ASC 718 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as the warrants vest upon certain performance conditions being met.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the closing of the Merger, there was not a public market for the shares of the Company’s common stock. The Company’s determination of the fair value of stock options on the date of grant utilized the Black-Scholes option-pricing model and was impacted by its common stock price, as determined by the Board of Directors with input from the Company’s management, as well as changes in assumptions regarding a number of subjective variables. These variables </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included, but were not limited to, the expected term that options remained outstanding, the expected common stock price volatility over the term of the option awards, risk-free interest rates, and expected dividends. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company valued its common stock taking into consideration its most recently available valuation of common stock performed by third parties as well as additional factors since the date of the most recent contemporaneous valuation through the date of grant. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the closing of the Merger, the Company determines the fair value of each share of common stock underlying stock-based awards based on the closing price of the Company’s common stock as reported by Nasdaq on the date of grant.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Merger Agreement, the Company will issue 15,000,000 earn-out shares of the Company’s common stock to Legacy Evolv shareholders and Legacy Evolv Service Providers including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employees, officers, directors, and non-employees based on the achievement of certain target share price contingencies and subject to continued employment. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company classifies the share-based compensation arrangement with Legacy Evolv Service Providers as equity on its balance sheet and corresponding </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. As of December 31, 2023, of the total 15,000,000 earn-out shares of the Company’s common stock, 2,115,304 earn-out shares can be earned by the Legacy </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolv Service Providers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are subject to the stock-based compensation guidance. As a condition for Earn-Out Shares being issued to Earn-Out Service Providers, the service provider must be providing services to the Company on the date of the issuance of the shares. If the relationship with the service provider is terminated prior to the issuance of the Earn-Out Shares, the shares will be redistributed to the remaining participants in the Earn-Out Shares.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company’s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the likelihood that its deferred tax assets will be recovered from future sources of income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. The potential for recovery of deferred tax assets is evaluated by analyzing past operating results, estimating the future taxable profits expected and considering prudent and feasible tax planning strategies.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates at the end of each reporting period whether some or all the undistributed earnings of its foreign subsidiaries are permanently reinvested. The Company would recognize deferred income tax liabilities to the extent that management asserts that undistributed earnings of its foreign subsidiaries are not permanently reinvested and will not be permanently reinvested in the future. For the year ended December 31, 2023, the Company had less than $0.1 million in foreign earnings. For the year ended December 31, 2022, the Company had no foreign earnings in any foreign jurisdictions. The Company will continue to evaluate its position in the future based on its future strategy and cash needs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss per Share Attributable to Common Stockholders</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net loss attributable to common stockholders is computed by adjusting net loss attributable to common stockholders for the impact </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the extent a denominator adjustment is required. Diluted net loss per share attributable to common stockholders is computed by dividing the diluted net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period, including the dilutive effect of potential dilutive common shares as determined under the treasury stock method. For purposes of this calculation, outstanding stock options, convertible preferred stock, convertible notes, warrants to purchase common stock, and warrants to purchase preferred stock are considered potential dilutive common shares.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In periods in which the Company reported a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December 31, 2023 and 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Becoming a Large Accelerated Filer</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to December 31, 2023, the Company qualified as an "emerging growth company", as defined in the Jumpstart our Business Startups Act of 2012, and elected not to “opt out” of the extended transition related to complying with new or revised accounting standards.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company became a large accelerated filer and ceased to qualify as an emerging growth company as of December 31, 2023. The adoption dates discussed below for recently adopted accounting pronouncements reflect the updated transition periods required as a result of becoming a "large accelerated filer" (as defined under Rule 12b-2 of the Exchange Act) as of December 31, 2023. The Company will be required to adopt all future new or revised accounting pronouncements in accordance with applicable public company timelines specified in those accounting pronouncements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326) (“ASU 2016-13”). The new standard adjusts the accounting for assets held at amortized cost basis, including marketable securities accounted for as available for sale, and trade receivables. The standard eliminates the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For public entities except smaller reporting companies, the guidance is effective for annual reporting periods beginning after December 15, 2019 and for interim periods within those fiscal years. In November 2019, the FASB issued ASU No. 2019-10, which deferred the effective date for non-public entities and smaller reporting companies to annual reporting periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is allowed. The Company adopted this guidance effective January 1, 2023, and the adoption of this guidance did not have a material impact on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The amendments in ASU 2021-08 are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption of the amendments is permitted, including adoption in an interim period. The Company adopted this guidance effective January 1, 2023, and the adoption of this guidance did not have an impact on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, the FASB issued Accounting Standards Update ASU 2023-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“Presentation of Financial Statement (Topic 205), Income Statement - Reporting Comprehensive Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation - Stock Compensation (Topic 718),”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to amend various U.S. Securities Exchange Commission ("SEC") paragraphs in the Accounting Standards Codification to reflect the issuance of SEC Staff Accounting Bulletin No. 120, among other things. The ASU does not provide any new guidance so there is no transition or </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effective date associated with it. The Company is currently assessing the impact of adopting ASU 2023-03 on the consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2023, the FASB issued ASU 2023-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“Disclosure Improvements – Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative,”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to disclosure or presentation requirements for various subtopics in the FASB’s Accounting Standards Codification (“Codification”). The amendments in the update are intended to align the requirements in the Codification with the SEC regulations and facilitate the application of GAAP for all entities. The effective date for each amendment is the date on which the SEC removal of the related disclosure requirement from Regulation S-X or Regulation S-K becomes effective, or if the SEC has not removed the requirements by June 30, 2027, this amendment will be removed from the Codification and will not become effective for any entity. Early adoption is prohibited. The Company does not expect this update to have a material impact on the consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The updated accounting guidance requires enhanced reportable segment disclosures, primarily related to significant segment expenses which are regularly provided to the chief operating decision maker. The guidance is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required and early adoption is permitted. The Company is currently evaluating the impact of this standard on the disclosures within the consolidated financial statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Income Taxes (Topic 740): Improvements to Income Tax Disclosures."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU 2023-09 is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. A public entity should apply the amendments in ASU 2023-09 prospectively to all annual periods beginning after December 15, 2024. The Company is currently evaluating the impact of this standard on the disclosures within the consolidated financial statements.</span></div> <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to calculating the standalone selling price for revenue recognition, the valuation of inventory, the expensing and capitalization of costs associated with internal-use software, stock-based awards, the valuation of the contingent earn-out liability, the valuation of the contingently issuable common stock, and the valuation of the public warrant liability. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts, and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.</span></div> <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk of Concentrations of Credit, Significant Customers and Significant Suppliers</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash equivalents, restricted cash, marketable securities, and accounts receivable, net. We maintain substantially all of our cash and cash equivalents with U.S. and multi-national financial institutions, and our deposits are generally in excess of federally insured limits. The Company maintains its cash, cash equivalents, restricted cash, and marketable securities with financial institutions that management believes to be of high credit quality. The Company has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant customers are those which represent more than 10% of the Company’s total revenue or accounts receivable, net balance at each respective balance sheet date. The following table presents customers that represent 10% or more of the Company’s total revenue for the years ended December 31, 2023 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each customer shown is a reseller partner of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Motorola Solutions, Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Less than 10%</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents customers that represent 10% or more of the Company’s accounts receivable, net. Each customer shown is a reseller partner of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:495.00pt"><tr><td style="width:1.0pt"></td><td style="width:359.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:63.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:63.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Motorola Solutions, Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39.0 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> %</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">55.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Less than 10%</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company relies on one primary third-party contract manufacturer, Columbia Tech, for the production of our touchless security screening systems. Columbia Tech provides a variety of services including sourcing off-the-shelf components, manufacturing custom components/assemblies, final product assembly and integration, end of line testing and quality assurance per our specifications, material and finished goods inventory, and direct shipping to our customers. We also use a different third-party manufacturer as a second source for the production of a key sensor component used in our systems. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers to satisfactorily deliver its products to its customers on time, if at all, which could have a material adverse effect on the Company’s operating results, financial condition and cash flows and damage its customer relationships.</span></div> <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash equivalents, restricted cash, marketable securities, and accounts receivable, net. We maintain substantially all of our cash and cash equivalents with U.S. and multi-national financial institutions, and our deposits are generally in excess of federally insured limits. The Company maintains its cash, cash equivalents, restricted cash, and marketable securities with financial institutions that management believes to be of high credit quality. The Company has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant customers are those which represent more than 10% of the Company’s total revenue or accounts receivable, net balance at each respective balance sheet date. The following table presents customers that represent 10% or more of the Company’s total revenue for the years ended December 31, 2023 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each customer shown is a reseller partner of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Motorola Solutions, Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Less than 10%</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents customers that represent 10% or more of the Company’s accounts receivable, net. Each customer shown is a reseller partner of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:495.00pt"><tr><td style="width:1.0pt"></td><td style="width:359.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:63.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:63.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Motorola Solutions, Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39.0 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> %</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">55.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> %</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Less than 10%</span></div> 0.120 0.209 0.101 0.104 0.224 0.310 0.10 0.10 0.390 0.160 0.550 0.10 0.10 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div>The Company considers all short-term, highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Restricted cash relates to a letter of credit on the Company’s office lease in Waltham, Massachusetts, all of which is included in restricted cash, current on the consolidated balance sheet as of December 31, 2023. As the letter of credit is reduced, restricted cash is reclassified to cash and cash equivalents. <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities are reported at fair value and, at December 31, 2023, are comprised solely of zero coupon U.S. treasury bills with maturities of less than one year that are classified as available-for-sale debt securities. The Company considers an available-for-sale debt security to be impaired if the fair value of the investment is less than its amortized cost basis. The entire difference between the amortized cost basis and the fair value of the Company’s available-for-sale debt securities is recognized on the consolidated statements of operations as an impairment if, (i) the fair value of the security is below its amortized cost and (ii) the Company intends to sell or is more likely than not required to sell the security before recovery of its amortized cost basis. If neither criterion is met, the Company evaluates whether the decline in fair value is due to credit losses or other factors. In making this assessment, the Company considers the changes to the rating of the security by third-party rating agencies, and adverse conditions specific to the security, among other factors. If the Company’s assessment indicates that a credit loss exists, the credit loss is measured based on the Company’s best estimate of the cash flows expected to be collected. When developing its estimate of cash flows expected to be collected, the Company considers all available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable forecasts.</span></div>Unrealized gains and losses, net of tax, on marketable securities, if any, are recognized in accumulated other comprehensive income (loss) in the accompanying consolidated balance sheets. Realized net gains and losses on marketable securities, if any, are reflected in interest income in the accompanying consolidated statements of operations and comprehensive loss. <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements of Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities of the Company are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 — Quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 — Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s cash equivalents, restricted cash, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">marketable securities,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> derivative liability, contingent earn-out liability, contingently issuable common stock liability and its common stock warrant liability are carried at fair value, determined according to the fair value hierarchy described above (see Note 4). The carrying values of the Company’s accounts receivable, net, accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities. The carrying value of the Company’s long-term debt approximates its fair value (a Level 2 measurement) at each balance sheet date due to its variable interest rate, which approximates a market interest rate.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets that are measured at fair value on a nonrecurring basis primarily relate to property and equipment. We do not periodically adjust carrying value to fair value for property and equipment. Rather, the carrying value of the asset is reduced to its fair value when we determine that impairment has occurred.</span></div> <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Earn-out</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger and pursuant to the Merger Agreement, certain of the Legacy Evolv’s shareholders and Legacy Evolv Service Providers are entitled to receive additional shares of the Company’s common stock (the “Earn-Out Shares”) upon the Company achieving certain milestones:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Triggering Event I – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $12.50 per share for any 20 trading days within any 30 trading day period.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Triggering Event II – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $15.00 per share for any 20 trading days within any 30 trading day period.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Triggering Event III – a one-time issuance of a number of Earn-Out Shares equal to 5,000,000 shall occur if, by March 8, 2026, the price of the Company’s common stock is greater than $17.50 per share for any 20 trading days within any 30 trading day period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 815 – Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the earn-out arrangement with the Legacy Evolv shareholders is accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as a change in fair value of contingent earn-out liability in other income (expense), net in the consolidated statements of operations and comprehensive loss. When the Triggering Events have been achieved and the Earn-Out Shares are issued, the Company will reclassify the corresponding amount from a liability to additional paid-in-capital and common stock at par value of $0.0001 per share.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the contingent earn-out shares was determined using a Monte Carlo simulation that simulated the future path of the Company’s stock price over the earn-out period. The significant assumptions utilized in the calculation are based on the achievement of certain stock price milestones including projected stock price, volatility, drift rate, percentage of change in control and expected term.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent earn-out liability is categorized as a Level 3 fair value measurement (see Note 4) because the Company estimates projections during the earn-out period utilizing unobservable inputs, including various potential pay-out scenarios. Contingent earn-out payments involve certain assumptions requiring significant judgment and actual results may differ from assumed and estimated amounts.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Earn-Out Shares issued to employees, officers, directors, and non-employees are based on achievement of certain target share price contingencies and for the employees and officers, subject to continued employment, (the “Earn-Out Service Providers”) represents share-based compensation and is included in additional paid-in capital on the Company’s balance sheet. Corresponding stock-based compensation expense is recorded in the consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. As a condition to being issued Earn-Out Shares, the Earn-Out Service Providers must still be providing services to the Company on the date of the issuance of the shares. If the relationship with the service provider is terminated prior to the issuance of the Earn-Out Shares, the shares will be redistributed to the remaining participants in the Earn-Out Shares.</span></div> 5000000 12.50 20 30 5000000 15.00 20 30 5000000 17.50 20 30 0.0001 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingently Issuable Common Stock</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Merger, NewHold Industrial Technology Holdings, LLC, the sponsor of the NHIC special purpose acquisition company owned 4,312,500 shares of NHIC Class B common stock (the “Founder Shares). Upon the closing of the Merger, NHIC Class A and Class B common stock became the Company’s common stock. The Founder Shares outstanding were subject to certain share-performance-based vesting provisions as follows:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vesting Provision I – 1,897,500 shares of the Company’s common stock shall vest and no longer be subject to forfeiture as of the Merger;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vesting Provision II – if within five years following the closing of the Merger, the last reported sale price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 trading day period, then 948,750 shares of the Company’s common stock shall vest and no longer be subject to forfeiture and</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vesting Provision III – if within five years following the closing of the Merger, the last reported sale price of the Company’s common stock equals or exceeds $15.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period, then 948,750 shares of the Company’s common stock) shall vest and no longer be subject to forfeiture.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining 517,500 Founder Shares were contributed to Give Evolv LLC.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Vesting Provision II and/or Vesting Provision III are not satisfied, the corresponding number of shares specified shall be forfeited and no longer issued and outstanding. If there is a Change of Control event prior to Vesting Provision II and/or Vesting Provision III are satisfied, the Founder shares are no longer subject to forfeiture and shall vest immediately upon the occurrence of a Change of Control event.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 815 – Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the contingently issuable common stock is accounted for as a liability and subsequently remeasured at each reporting date with changes in fair value recorded as change in fair value of contingently issuable common stock liability in other income (expense), net in the consolidated statements of operations and comprehensive loss. When the Vesting Provisions have been achieved and the contingently issuable common shares are issued, the Company will reclassify the corresponding amount from a liability to additional paid-in-capital and common stock at par value of $0.0001 per share.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the contingently issuable common shares was determined using a Monte Carlo simulation that simulated the future path of the Company’s stock price over the earn-out period. The assumptions utilized in the calculation are based on the achievement of certain stock price milestones including expected stock price volatility, risk-free rate of return, likelihood of change in control, and remaining term.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingently issuable common shares are categorized as a Level 3 fair value measurement (see Note 4) because the Company estimates projections during the earn-out period utilizing unobservable inputs, including various potential pay-out scenarios. Contingently issuable shares involve certain assumptions requiring significant judgment and actual results may differ from assumed and estimated amounts.</span></div> 4312500 1897500 P5Y 12.50 20 30 948750 P5Y 15.00 20 30 948750 517500 0.0001 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Warrant Liability</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the closing of the Merger, the Company assumed warrants for the purchase of 14,325,000 shares of common stock at an exercise price of $11.50 (the “Public Warrants”). The Public Warrants are classified as a liability pursuant to ASC 815 – </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as the equity derivative scope exception was not met and are measured at fair value, with the changes in fair value reported in earnings as a component of other income (expense), net in the consolidated statements of operations and comprehensive loss with the offset to additional paid in capital.</span></div> 14325000 11.50 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases as a Lessee</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At contract inception, the Company determines if an arrangement is or contains a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If determined to be or contain a lease, the lease is assessed for classification as either an operating or finance lease at the lease commencement date, defined as the date on which the leased asset is made available for use by the Company (when the Company is the lessee). Where the Company is the lessee, for each lease with a term greater than twelve months, the Company records a right-of-use asset and lease liability.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A right-of-use asset represents the economic benefit conveyed to the Company by the right to use the underlying asset over the lease term. A lease liability represents the obligation to make lease payments arising from the use of the asset over the lease term. Lease liabilities are measured at lease commencement and calculated as the present value of the future lease payments in the contract using the rate implicit in the contract, when available. If an implicit rate is not readily determinable, the Company uses an incremental borrowing rate measured as the rate at which the Company could borrow, on a fully collateralized basis, a commensurate loan in the same currency over a period consistent with the lease term at the commencement date. Right-of-use assets are measured as the amount of the initial lease liability plus initial direct costs and prepaid lease payments, less lease incentives granted by the lessor. The lease term is measured as the noncancelable period in the contract, adjusted for any options to extend or terminate when it is reasonably certain the Company will extend the lease term via such options based on an assessment of economic factors present as of the lease commencement date. The Company elected the practical expedient to not recognize leases with a lease term of twelve months or less.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of a lease are split into three categories: lease components, non-lease components, and non-components. The fixed and in-substance fixed contract consideration (including any consideration related to non-components) are allocated, based on the respective relative fair values, to the lease components and non-lease components. The Company has elected the practical expedient to account for lease and non-lease components together as a single lease component for all underlying assets and allocate all of the contract consideration to the lease component only.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s operating leases are presented in the consolidated balance sheet as operating lease right-of-use assets, classified as noncurrent assets, and operating lease liabilities, classified as current and noncurrent liabilities. Operating lease expense is recognized on a straight-line basis over the lease term. Variable costs associated with a lease, such as maintenance and utilities, are not included in the measurement of the lease liabilities and right-of-use assets but rather are expensed when the events determining the amount of variable consideration to be paid have occurred.</span></div> <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost or net realizable value with cost being determined using the weighted average method. The Company regularly reviews inventory quantities on-hand for excess and obsolete inventory and, when circumstances indicate, records charges to write down inventories to their estimated net realizable value, after evaluating historical sales, future demand, market conditions and expected product life cycles. Such charges are classified as product cost of revenues in the consolidated statement of operations and comprehensive loss. Any write-down of inventory to net realizable value creates a new cost basis. The Company recorded $1.6 million and $1.6 million in inventory write-offs and change in inventory reserves during the years ended December 31, 2023 and 2022, respectively. Inventory write-offs primarily relate to Edge units and prior generation Express units, as the Company is no longer selling these products, as well as other inventory that was determined to be obsolete or unsellable.</span></div> 1600000 1600000 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expense are recognized using the straight-line method over the estimated useful life of each asset, as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computers and telecommunications equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lab equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Shorter of useful life of 7 years or remaining lease term</span></div><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leased equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Internal-use software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4 years</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated useful lives are periodically assessed to determine if changes are appropriate. Leasehold improvements are depreciated using the straight-line method over the lesser of the lease term or its estimated economic useful life. Lease terms are used based upon the initial lease agreement and do not consider potential renewals or extensions until such time that the renewals or extensions are contracted. Maintenance and repairs are charged to expense as incurred. When assets are retired or otherwise disposed of, the cost of these assets and related accumulated depreciation are eliminated from the consolidated balance sheet and any resulting gains or losses are included in the consolidated statements of operations and comprehensive loss in the period of disposal. Costs for capital assets not yet placed into service are capitalized as construction-in-progress and depreciated once placed into service.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s leases for leased equipment generally are 48 months. The Company’s subscription contracts are generally classified as operating leases because title does not transfer and they do not meet any of the other criteria per Accounting Standards Codification 842 – </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASC 842”).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates property and equipment for obsolescence and impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset group for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset group to its carrying value. An impairment loss would be recognized in loss from operations and comprehensive loss when estimated undiscounted future cash flows expected to result from the use of an asset group are less than its carrying amount. The impairment loss is based on the excess of the carrying value of the impaired asset group over its fair value, determined based on discounted cash flows. The Company recorded impairment losses of $0.3 million and $1.2 million during the years ended December 31, 2023 and 2022, respectively. These impairment losses related primarily to Edge and Express prototype units that were taken out of service and retired.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain software development costs, including consulting costs and compensation expenses for employees who devote time to the development projects, beginning upon completion of the preliminary project stage (in relation to internal-use software) or upon establishment of technological feasibility (in relation to software embedded in products to be sold or leased), and through the date the software is ready for its intended use. The Company records software development costs in property and equipment, net. Costs incurred in the preliminary stages of development activities and post implementation are expensed in the period incurred and are recorded in research and development expense in the consolidated statements of operations and comprehensive loss. The Company also capitalizes </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the project is available for general release, capitalization ceases, and the asset can begin amortization. Capitalized software costs are amortized on a straight-line basis over their estimated useful life, which is generally four years, and are recorded in cost of subscription revenue and cost of service revenue in the consolidated statements of operations and comprehensive loss.</span></div> Depreciation and amortization expense are recognized using the straight-line method over the estimated useful life of each asset, as follows:<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computers and telecommunications equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lab equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Shorter of useful life of 7 years or remaining lease term</span></div><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leased equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Internal-use software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4 years</span></td></tr></table></div> P3Y P5Y P4Y P5Y P7Y P4Y P7Y P4Y P48M 300000 1200000 P4Y <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Issuance Costs</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain legal, accounting, and other third-party fees that are directly associated with the issuance of debt as debt issuance costs. Debt issuance costs are recorded as a direct reduction of the carrying amount of the associated debt on the consolidated balance sheet and amortized as interest expense on the consolidated statement of operations and comprehensive loss using the effective interest method.</span></div> <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that it has one operating segment after considering the Company’s organizational structure and the information regularly reviewed and evaluated by the Company’s chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. The Company has determined that its CODM is its President and Chief Executive Officer. The CODM reviews the financial information on a consolidated basis for purposes of evaluating financial performance and allocating resources. On the basis of these factors, the Company determined that it operates and manages its business as one operating segment, that develops, manufactures, markets and sells security screening products and specific services, and accordingly has one reportable segment for financial reporting purposes.</span></div> 1 1 1 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification 606 – </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 606”). Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In order to achieve this core principle, the Company applies the following five steps when recording revenue: (1) identify the contract, or contracts, with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when, or as, performance obligations are satisfied.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive revenue from (1) subscription arrangements generally accounted for as operating leases, including SaaS and maintenance, (2) the sale of products, (3) SaaS and maintenance related to products sold to customers either by Evolv or by Columbia Tech pursuant to the Distribution and License Agreement (as defined below), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) license fees related to the Distribution and License Agreement (as defined below),</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and (5) professional services, including installation, training, and event support. Maintenance consists of preventative maintenance, technical support, bug fixes, and when-and-if available threat updates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our arrangements are generally noncancelable and nonrefundable after ownership passes to the customer. Revenue is recognized net of sales tax.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distribution and License Agreement </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company entered into a distributor licensing agreement (the "Distribution and License Agreement") with Columbia Electrical Contractors, Inc. ("Columbia Tech"). Columbia Tech, a wholly-owned subsidiary of Coghlin Companies, which serves as the Company's primary contract manufacturer. Under this arrangement, the Company has granted a license of its intellectual property to Columbia Tech, which contracts directly with certain of the Company's resellers to fulfill sales demand where the end-user customer prefers to purchase the hardware equipment as opposed to lease the equipment. Columbia Tech pays the Company a hardware license fee for each system it manufactures and sells under the agreement. In these instances, the Company still contracts directly with the reseller to provide a multi-year SaaS and maintenance subscription to the end-users.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has assessed whether it operates as the principal or as an agent in relation to the sale of product made by Columbia Tech to the Company's resellers pursuant to the Distribution and License Agreement. The Company considered various factors, including but not limited to, inventory risk, discretion in establishing pricing, and which entity is primarily responsible for fulfillment. Based on an evaluation of the facts and circumstances, the Company concluded that Columbia Tech is the principal in the arrangement. The Company therefore does not recognize revenue in relation to sales of product pursuant to the Distribution and License Agreement, but does recognize revenue in relation to license fees received from Columbia Tech and the SaaS and maintenance subscription contracts, each as further described below.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company derives revenue from the sale of its Evolv Express equipment and related add-on accessories to customers. Revenue is recognized when control of the product has transferred to the customer. Transfer of control occurs when the Company has transferred title and risk of loss and has a present right to payment for the equipment, which follows the terms of each customer contract. Products are predominantly sold with distinct services, which are described in the services section below.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subscription Revenue - Leases as Lessor</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to selling our products directly to customers, we also derive revenue from leasing our equipment, which we classify as subscription revenue. Lease terms are typically four years, generally do not include unilateral options by either the Company or our customer to extend, terminate or to purchase the underlying asset, and customers generally pay either a quarterly or annual fixed payment for the lease, SaaS, and maintenance elements over the contractual lease term. There are no variable lease payments as a part of these arrangements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting provisions we use to classify transactions as sales-type are: (i) whether the lease transfers ownership of the equipment by the end of the lease term, (ii) whether the lease grants the customer an option to purchase the equipment and the customer is reasonably certain to do so, (iii) whether the lease term is for the major part of the economic life of the underlying equipment, (iv) whether the present value of the lease payments, and any residual value guaranteed by the customer that is not already reflected in the lease payments, is equal to or greater than substantially all of the fair market value of the equipment at the commencement of the lease, and (v) whether the equipment is specific to the customer and of such a specialized nature that it is expected to have no alternative use to the Company at the end of the lease term. Leasing arrangements meeting any of these conditions are accounted for as sales-type leases and revenue attributable to the lease component is recognized in a manner consistent with product revenue and the related equipment is derecognized with the associated expense presented as a cost of revenue. Leasing arrangements that do not meet the criteria for classification as a sales-type lease will be accounted for as a direct-financing lease if the following two conditions are met: (i) the present value of the lease payments, and any residual value guaranteed by the customer that is not already reflected in the lease payments and any other third party unrelated to the Company, is equal to or greater than substantially all of the fair market value of the equipment at the commencement of the lease, and (ii) it is probable that the Company will collect the lease payments and amounts necessary to satisfy a residual value guarantee. Leasing arrangements that do not meet any of the sales-type lease or direct-financing lease classification criteria are accounted for as operating leases and revenue is recognized straight-line over the term of the lease. Historically, nearly all of the Company's equipment leases have been classified as operating leases.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers the economic life of most of our products to be seven years. The Company believes seven years is representative of the period during which the equipment is expected to be economically usable by one or more users, with normal service, for the purpose for which it is intended. The unguaranteed residual value is estimated to be the value at the end of the lease term based on the anticipated fair market value of the units. The Company mitigates residual value risk of our leased equipment by performing regular management and maintenance, as necessary.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, lease arrangements include both lease and non-lease components. The lease component relates to the customer’s right-to-use the equipment over the lease term. The non-lease components relate to (1) distinct services, such as SaaS and maintenance, (2) any add-on accessories, and (3) professional services, including installation, training, and event. Professional services are included in license fees and other revenue, as described below, and add-on accessories are included in product revenue. Because the equipment, SaaS, and maintenance components of a subscription arrangement are recognized as revenue over the same time period and in the same pattern, the Company elected the practical expedient to aggregate non-lease components with the associated lease component and account for the combined component as an </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operating lease for all underlying asset classes. In the evaluation of whether the lease component (equipment) or the non-lease components associated with the lease component (SaaS and maintenance) is the predominant component, the Company determined that the lease component is predominant as we believe the customer would ascribe more value to the use of the security equipment than that of the SaaS and maintenance services. Therefore, the Company accounts for the combined lease component under ASC 842. The equipment lease and SaaS/maintenance performance obligations are classified as a single category of subscription revenue in the consolidated statements of operations and comprehensive loss. The professional services represent distinct services provided to customers. These activities are considered separate performance obligations to the customer and therefore are considered non-lease components. As professional services are generally performed prior to lease commencement, the timing and pattern of transfer for these services differ from that of the lease component and are not eligible to be combined.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude from variable payments all lessor costs that are explicitly required to be paid directly by a lessee on behalf of the lessor to a third party.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional services are generally billed to the lessee as part of the lease contract billing, according to various contractual terms. Professional services costs incurred by the Company are accounted for as a fulfillment cost and are included in the cost of license fees and other revenue in the consolidated statements of operations and comprehensive loss.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue consists of subscription-based SaaS and maintenance revenue related to products sold to a customer by either the Company or by Columbia Tech pursuant to the Distribution and License Agreement. Customers generally pay either a quarterly or annual fixed payment for SaaS and maintenance. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SaaS and maintenance revenue is recognized ratably over the period of the arrangement, which is typically 4 years.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License Fee and Other Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">License fee and other revenue includes license fee revenue from the Distribution and License Agreement, revenue from professional services, and other one-time revenue. License fee revenue is recognized upon the shipment of product from our third-party manufacturer to the reseller. Revenue for professional services is recognized upon transfer of control of these services, which are normally rendered over a short duration. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Reseller Partners</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company’s revenue is also generated by sales to its reseller partners. When the Company transacts with a reseller partner, its contractual arrangement is with the reseller partner and not with the end-use customer. In these transactions, the reseller partner is considered the customer; the Company has discretion over the pricing to the reseller partner and maintains overall control of the inventory and sales process to the reseller partner. Right of return does not generally exist. Whether the Company transacts with a reseller partner and receives the order from a reseller partner or directly from an end-use customer, its revenue recognition policy and resulting pattern of revenue recognition is the same.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is the amount of consideration that the Company expects to be entitled for providing goods and services under a contract, which includes fixed amounts, and on rare occasions, variable consideration. The Company may also provide discounts to customers which reduce the transaction price. On infrequent occasions, the Company may offer customers the option to purchase additional goods and services at a fixed price. In these circumstances, the Company assesses whether these offers constitute a material right, and if so, the Company would account for the material right as a separate performance obligation. The Company does not normally provide for rights of returns to customers on product sales and, therefore, does not record a provision for returns. Amounts paid or payable to customers, including those related to sponsorship arrangements, are recognized as a reduction of the transaction price, and therefore, of revenue unless the payment is in exchange for a distinct good or service.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct product or service to a customer that is both capable of being distinct, whereby the customer can benefit from the product or service either on its own or together with other resources that are readily available, and is distinct in the context of the contract, whereby the transfer of the product or service is separately identifiable from other promises in the contract.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment is sold or leased with embedded software, which is considered a single performance obligation. Maintenance, which includes preventative maintenance, future updates, security threat updates, and minor bug fixes on a when-and-if available basis, is considered a single performance obligation. SaaS, which includes data-driven security information and analytics insights, is also considered a performance obligation. Professional services, including installation, training, and event support, are considered separate performance obligations and are included within license fee and other revenue. Any add-on accessories are also considered separate performance obligations and are included in product revenue.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payment terms</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms for customer orders are typically 30 days after the shipment or installation of the product. Generally, the Company’s contracts do not contain a significant financing component.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiple Performance Obligations within an Arrangement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s contracts may include multiple performance obligations when customers purchase a combination of products and services. When the Company’s customer arrangements have multiple performance obligations that contain an equipment lease for the customer’s use as well as distinct services that are delivered simultaneously, the Company allocates the arrangement consideration between the lease deliverables and non-lease deliverables based on the relative estimated SSP of each distinct performance obligation. For multiple performance obligation arrangements that do not contain a lease, the Company allocates the contract’s transaction price to each performance obligation on a relative SSP basis. The Company determines SSP based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, the Company estimates the SSP taking into account available information such as market conditions, internally approved pricing guidelines, and observable pricing data such as standard cost metrics related to the performance obligation.</span></div> P4Y P7Y P7Y P4Y P30D <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures all stock-based awards granted to employees, officers, directors and non-employees based on their fair value on the date of the grant and recognizes compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. The vesting period for stock options is generally four years and the vesting period for restricted stock units is generally three years. The Company classifies stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. The Company issues stock-based awards with service-based vesting conditions and records the expense for these awards using the straight-line method. Forfeitures are accounted for as they occur.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In January 2021, the Company granted warrants (the "Finback Common Stock Warrants") exercisable for 2,552,913 shares of common stock at an exercise price of $0.42 per share to Finback Evolv OBH, LLC ("Finback"), a consulting group affiliated with one of the Company's shareholders. The Finback Common Stock Warrants vest upon meeting certain sales criteria as defined in a business development agreement (the "Finback BDA") which has a term of three years. The Finback Common Stock Warrants expire in January 2031. The Finback Common Stock Warrants are accounted for under ASC 718 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as the warrants vest upon certain performance conditions being met.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the closing of the Merger, there was not a public market for the shares of the Company’s common stock. The Company’s determination of the fair value of stock options on the date of grant utilized the Black-Scholes option-pricing model and was impacted by its common stock price, as determined by the Board of Directors with input from the Company’s management, as well as changes in assumptions regarding a number of subjective variables. These variables </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included, but were not limited to, the expected term that options remained outstanding, the expected common stock price volatility over the term of the option awards, risk-free interest rates, and expected dividends. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company valued its common stock taking into consideration its most recently available valuation of common stock performed by third parties as well as additional factors since the date of the most recent contemporaneous valuation through the date of grant. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the closing of the Merger, the Company determines the fair value of each share of common stock underlying stock-based awards based on the closing price of the Company’s common stock as reported by Nasdaq on the date of grant.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Merger Agreement, the Company will issue 15,000,000 earn-out shares of the Company’s common stock to Legacy Evolv shareholders and Legacy Evolv Service Providers including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employees, officers, directors, and non-employees based on the achievement of certain target share price contingencies and subject to continued employment. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company classifies the share-based compensation arrangement with Legacy Evolv Service Providers as equity on its balance sheet and corresponding </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient’s payroll costs are classified or by the nature of the services provided by consultants are classified. As of December 31, 2023, of the total 15,000,000 earn-out shares of the Company’s common stock, 2,115,304 earn-out shares can be earned by the Legacy </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evolv Service Providers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are subject to the stock-based compensation guidance. As a condition for Earn-Out Shares being issued to Earn-Out Service Providers, the service provider must be providing services to the Company on the date of the issuance of the shares. If the relationship with the service provider is terminated prior to the issuance of the Earn-Out Shares, the shares will be redistributed to the remaining participants in the Earn-Out Shares.</span></div> P4Y P3Y 2552913 0.42 P3Y 15000000 15000000 2115304 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company’s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the likelihood that its deferred tax assets will be recovered from future sources of income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. The potential for recovery of deferred tax assets is evaluated by analyzing past operating results, estimating the future taxable profits expected and considering prudent and feasible tax planning strategies.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates at the end of each reporting period whether some or all the undistributed earnings of its foreign subsidiaries are permanently reinvested. The Company would recognize deferred income tax liabilities to the extent that management asserts that undistributed earnings of its foreign subsidiaries are not permanently reinvested and will not be permanently reinvested in the future. For the year ended December 31, 2023, the Company had less than $0.1 million in foreign earnings. For the year ended December 31, 2022, the Company had no foreign earnings in any foreign jurisdictions. The Company will continue to evaluate its position in the future based on its future strategy and cash needs.</span></div> 100000 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss per Share Attributable to Common Stockholders</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net loss attributable to common stockholders is computed by adjusting net loss attributable to common stockholders for the impact </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the extent a denominator adjustment is required. Diluted net loss per share attributable to common stockholders is computed by dividing the diluted net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period, including the dilutive effect of potential dilutive common shares as determined under the treasury stock method. For purposes of this calculation, outstanding stock options, convertible preferred stock, convertible notes, warrants to purchase common stock, and warrants to purchase preferred stock are considered potential dilutive common shares.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In periods in which the Company reported a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December 31, 2023 and 2022.</span></div> <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Becoming a Large Accelerated Filer</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to December 31, 2023, the Company qualified as an "emerging growth company", as defined in the Jumpstart our Business Startups Act of 2012, and elected not to “opt out” of the extended transition related to complying with new or revised accounting standards.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company became a large accelerated filer and ceased to qualify as an emerging growth company as of December 31, 2023. The adoption dates discussed below for recently adopted accounting pronouncements reflect the updated transition periods required as a result of becoming a "large accelerated filer" (as defined under Rule 12b-2 of the Exchange Act) as of December 31, 2023. The Company will be required to adopt all future new or revised accounting pronouncements in accordance with applicable public company timelines specified in those accounting pronouncements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326) (“ASU 2016-13”). The new standard adjusts the accounting for assets held at amortized cost basis, including marketable securities accounted for as available for sale, and trade receivables. The standard eliminates the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For public entities except smaller reporting companies, the guidance is effective for annual reporting periods beginning after December 15, 2019 and for interim periods within those fiscal years. In November 2019, the FASB issued ASU No. 2019-10, which deferred the effective date for non-public entities and smaller reporting companies to annual reporting periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is allowed. The Company adopted this guidance effective January 1, 2023, and the adoption of this guidance did not have a material impact on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The amendments in ASU 2021-08 are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption of the amendments is permitted, including adoption in an interim period. The Company adopted this guidance effective January 1, 2023, and the adoption of this guidance did not have an impact on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, the FASB issued Accounting Standards Update ASU 2023-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“Presentation of Financial Statement (Topic 205), Income Statement - Reporting Comprehensive Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation - Stock Compensation (Topic 718),”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to amend various U.S. Securities Exchange Commission ("SEC") paragraphs in the Accounting Standards Codification to reflect the issuance of SEC Staff Accounting Bulletin No. 120, among other things. The ASU does not provide any new guidance so there is no transition or </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effective date associated with it. The Company is currently assessing the impact of adopting ASU 2023-03 on the consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2023, the FASB issued ASU 2023-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“Disclosure Improvements – Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative,”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to disclosure or presentation requirements for various subtopics in the FASB’s Accounting Standards Codification (“Codification”). The amendments in the update are intended to align the requirements in the Codification with the SEC regulations and facilitate the application of GAAP for all entities. The effective date for each amendment is the date on which the SEC removal of the related disclosure requirement from Regulation S-X or Regulation S-K becomes effective, or if the SEC has not removed the requirements by June 30, 2027, this amendment will be removed from the Codification and will not become effective for any entity. Early adoption is prohibited. The Company does not expect this update to have a material impact on the consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.”</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The updated accounting guidance requires enhanced reportable segment disclosures, primarily related to significant segment expenses which are regularly provided to the chief operating decision maker. The guidance is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required and early adoption is permitted. The Company is currently evaluating the impact of this standard on the disclosures within the consolidated financial statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Income Taxes (Topic 740): Improvements to Income Tax Disclosures."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU 2023-09 is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. A public entity should apply the amendments in ASU 2023-09 prospectively to all annual periods beginning after December 15, 2024. The Company is currently evaluating the impact of this standard on the disclosures within the consolidated financial statements.</span></div> Marketable Securities<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities as of December 31, 2023 consisted of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gain/(Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities at December 31, 2023 are comprised solely of zero coupon U.S. treasury bills with maturities of less than one year that are classified as available-for-sale debt securities. The Company did not record any unrealized gains or losses on available-for-sale securities for the year ended December 31, 2023. The accretion of discounts on marketable securities is included in interest income on the consolidated statements of operations and comprehensive income. The Company did not have any marketable securities as of December 31, 2022.</span></div> <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities as of December 31, 2023 consisted of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gain/(Loss)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury bills</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 51289000 0 51289000 51289000 0 51289000 Fair Value Measurements<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements at December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,829 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,829 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,829 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,118 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable common stock liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,530 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,530 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,889 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,889 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,889 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,649 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,538 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,971 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,971 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,971 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,971 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt including current portion</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,218 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,218 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable common stock liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,683 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,610 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,417 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds are included in cash and cash equivalents on the consolidated balance sheets. As of December 31, 2023, all outstanding treasury bills, which totaled $51.3 million, had maturities greater than 3 months and are reflected as marketable securities. The fair value of the treasury bills, which are classified as Level 2 securities, is calculated by a third-party pricing service and is based on estimates obtained from various sources.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also value its non-financial assets and liabilities, including items such as inventories and property and equipment, at fair value on a non-recurring basis if it is determined that impairment has occurred. Such fair value measurements use significant unobservable inputs and are classified as Level 3.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and cash equivalents, accounts receivable, restricted cash, accounts payable, accrued liabilities, and other accrued expenses approximate fair value because of their short maturity.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During each of the years ended December 31, 2023 and 2022, there were no transfers between Level 1, Level 2, and Level 3.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of Contingent Earn-out</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, the Legacy Evolv stockholders, immediately prior to the Merger, were entitled to receive additional shares of the Company’s common stock upon the Company achieving certain milestones as described in Note 2. The Company’s contingent earn-out shares were recorded at fair value as contingent earn-out liability upon the </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">closing of the Merger and are remeasured at each reporting period. As of December 31, 2023, no milestones have been achieved.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent earn-out is calculated using a Monte Carlo analysis in order to simulate the future path of the Company’s stock price over the earn-out period. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value. The significant assumptions used in the Monte Carlo model as of December 31, 2023 were as follows: 90% expected stock price volatility, a risk-free rate of return of 4.2%, a 25% likelihood of change in control, and a remaining term of 2.2 years.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a rollforward of the contingent earn-out liability (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,206 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,901 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,119 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of Contingently Issuable Common Stock</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Merger, certain NHIC shareholders owned 4,312,500 Founder Shares. Of these shares, 1,897,500 shares vested at the closing of the Merger, 517,500 shares were transferred back to NHIC and then contributed to Give Evolv LLC and the remaining 1,897,500 outstanding shares will vest upon the Company achieving certain milestones (see Note 2). The Company’s contingently issuable common stock was recorded at fair value as contingent shares on the closing of the Merger and will be remeasured at each reporting period. As of December 31, 2023, no milestones have been achieved.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingently issued common shares is determined using a Monte Carlo analysis in order to simulate the future path of the Company’s stock price over the vesting period. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value. The significant assumptions used in the Monte Carlo model as of December 31, 2023 were as follows: 90% expected stock price volatility, a risk-free rate of return of 4.1%, a 25% likelihood of change in control, and a remaining term of 2.5 years.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a rollforward of the contingently issuable common shares (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,872)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,392 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,530 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of Public Warrant Liability</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the Merger, the Company assumed the Public Warrants to purchase shares of the Company’s common stock. The Public Warrants are publicly traded and the initial fair value of the public warrants were based on the closing price as reported by Nasdaq on the date of the Merger and remeasured at each reporting period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a rollforward of the public warrant liability (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,030 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,906)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,765 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,889 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements at December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,829 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,829 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,829 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,118 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable common stock liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,530 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,530 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,889 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,889 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,889 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,649 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,538 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurements at December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,971 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,971 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,971 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,971 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt including current portion</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,218 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,218 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable common stock liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,683 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,610 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,417 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 57829000 0 0 57829000 0 51289000 0 51289000 57829000 51289000 0 109118000 0 0 29119000 29119000 0 0 6530000 6530000 10889000 0 0 10889000 10889000 0 35649000 46538000 149971000 0 0 149971000 149971000 0 0 149971000 0 29683000 0 29683000 0 0 14218000 14218000 0 0 3392000 3392000 6124000 0 0 6124000 6124000 29683000 17610000 53417000 51300000 0 0.90 0.042 0.25 P2Y2M12D <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a rollforward of the contingent earn-out liability (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,206 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,218 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,901 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,119 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a rollforward of the contingently issuable common shares (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,264 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,872)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,392 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,530 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a rollforward of the public warrant liability (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,030 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,906)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,765 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,889 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 21206000 -6988000 14218000 14901000 29119000 4312500 1897500 517500 1897500 0 0.90 0.041 0.25 P2Y6M 5264000 -1872000 3392000 3138000 6530000 11030000 -4906000 6124000 4765000 10889000 Revenue Recognition<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially satisfied) as of December 31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Less than 1 year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">1 - 2 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">More than 2 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">997 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">997 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Subscription revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">56,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">52,188 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">63,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">172,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21,255 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,898 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">67,101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">License fee and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">79,214 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">73,136 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">88,163 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">240,513 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of minimum future leases is based on expected income recognition. As of December 31, 2023, future minimum payments on noncancelable leases are as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ending December 31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">56,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">52,188 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21,118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">172,272 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances from Contracts with Customers</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets arise from unbilled amounts in customer arrangements when revenue recognized exceeds the amount billed to the customer and the Company’s right to payment is conditional and not only subject to the passage of time. As of December 31, 2023 and December 31, 2022, the Company had $3.7 million and $2.9 million in current portion of contract assets and $0.5 million and $1.4 million in contract assets, noncurrent on the consolidated balance sheets, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities represent the Company’s obligation to transfer goods or services to a customer for which it has received consideration (or the amount is due) from the customer. The Company has a contract liability related to service revenue, which consists of amounts that have been invoiced but that have not been recognized as revenue. Amounts expected to be recognized as revenue within 12 months of the balance sheet date are classified as current deferred revenue and amounts expected to be recognized as revenue beyond 12 months of the balance sheet date are classified as deferred revenue, noncurrent. The Company recognized revenue of $19.1 million during the year ended December 31, 2023 that was included in the 2022 deferred revenue balance. The Company recognized revenue of $6.6 million during the year ended December 31, 2022 that was included in the 2021 deferred revenue balance.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a rollforward of deferred revenue (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,074 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue recognized in relation to the beginning of the year contract liability balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">33,526 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,968 </span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue recognized in relation to the beginning of the year contract liability balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(19,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue deferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">54,626 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">71,490 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s components of lease revenue (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue from sales-type leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,123 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest income on lease receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lease income - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37,247 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37,444 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,916 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue from sales-type leases is related to the Evolv Express units where the lease term is for the major part of the economic life of the underlying equipment and is classified as product revenue in the consolidated statements of operations and comprehensive loss. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest income on lease receivables is classified under interest income in the consolidated statements of operations and comprehensive loss. The lease income from operating leases is related to the leased equipment under subscription arrangements and is classified as subscription revenue in the consolidated statements of operations and comprehensive loss. Revenue related to leases entered into with related parties were $0.9 million and $0.6 million during the years ended December 31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregated Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s revenue by revenue stream (in thousands). Certain prior period amounts have been reclassified to conform to current period presentation:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21,977 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31,985 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Leased equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,141 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,331 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">License fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Professional services and other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,310 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">80,418 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">55,195 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's revenue by geographical region based on customer location (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">78,556 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53,815 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,380 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">80,418 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">55,195 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurs and pays commissions on product sales. The Company applies the practical expedient for contracts less than one year in duration to expense the commission costs in the period in which they were incurred. Commissions on product sales and services are expensed in the period in which the related revenue is recognized. Commissions on subscription arrangements and maintenance are expensed ratably over the life of the contract. The Company had a deferred asset related to commissions of $11.4 million and $9.0 million as of December 31, 2023 and December 31, 2022, respectively. During the years ended December 31, 2023 and 2022, the Company recognized commission expense of $5.6 million and $4.1 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Give Evolv LLC</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the Merger, the NHIC Founders transferred 517,500 shares of its common stock to Evolv NewHold Benefit LLC (“ENHB”), which represented the initial contribution to be used to pay for the donation of Evolv’s Express units to public venues and institutions, primarily schools in locations that might not otherwise be able to afford weapon detection security screening systems and related products and services. In September 2021, ENHB was renamed to Give Evolv LLC (“Give Evolv”). Give Evolv is deemed an entity under common control and a consolidating entity as it is under the same management as the Company. As such, the shares held by Give Evolv are not considered outstanding or issued.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For such arrangements, Give Evolv generally purchases the related products and services from Evolv through an intercompany transaction using the available donated proceeds from the transfer of common stock upon the closing of the Merger. Evolv will be responsible for the delivery of the units, in addition to providing related services, such as installation, training, and maintenance. Consideration transferred to Evolv for the related products and services may be in the form of common stock or cash. Shares of common stock may be sold to generate funds for the purposes of paying for the donated goods and services. The sales transactions between Evolv and Give Evolv eliminate in consolidation.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2023, the Company donated five Evolv Express units to schools resulting in $0.2 million in general and administrative expenses in the Company's consolidated statements of operations and comprehensive loss. During the year ended December 31, 2022, the Company donated six Evolv Express units to schools, resulting in $0.2 million in general and administrative expenses in the Company's consolidated statements of operations and comprehensive loss.</span></div> <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially satisfied) as of December 31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Less than 1 year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">1 - 2 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">More than 2 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">997 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">997 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Subscription revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">56,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">52,188 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">63,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">172,272 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21,255 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,898 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">67,101 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">License fee and other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">79,214 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">73,136 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">88,163 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">240,513 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 997000 0 0 997000 56819000 52188000 63265000 172272000 21255000 20948000 24898000 67101000 143000 0 0 143000 79214000 73136000 88163000 240513000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of minimum future leases is based on expected income recognition. As of December 31, 2023, future minimum payments on noncancelable leases are as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ending December 31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">56,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">52,188 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21,118 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">172,272 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 56819000 52188000 41088000 21118000 1059000 172272000 3700000 2900000 500000 1400000 19100000 6600000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a rollforward of deferred revenue (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,074 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue recognized in relation to the beginning of the year contract liability balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue deferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">33,526 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,968 </span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue recognized in relation to the beginning of the year contract liability balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(19,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue deferred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">54,626 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">71,490 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 9074000 6632000 33526000 35968000 19104000 54626000 71490000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s components of lease revenue (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue from sales-type leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,123 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest income on lease receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lease income - operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37,247 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37,444 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,916 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 1123000 197000 224000 Lease income - operating leases 37247000 17569000 37444000 18916000 900000 600000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s revenue by revenue stream (in thousands). Certain prior period amounts have been reclassified to conform to current period presentation:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21,977 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31,985 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Leased equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37,247 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,141 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,331 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">License fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Professional services and other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,310 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">80,418 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">55,195 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 21977000 31985000 37247000 17569000 16141000 4331000 2963000 0 2090000 1310000 80418000 55195000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's revenue by geographical region based on customer location (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">78,556 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53,815 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,380 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">80,418 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">55,195 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 78556000 53815000 1862000 1380000 80418000 55195000 11400000 9000000 5600000 4100000 517500 5 200000 6 200000 Leases<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company Headquarters (Waltham, MA)</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company entered into a sublease agreement for office and storage space for its corporate headquarters located at 500 Totten Pond Road in Waltham, MA. The Company entered into an amendment to the sublease agreement in August 2023 in order to lease additional space within the building. The sublease expires on October 31, 2024. The Company is required to maintain a minimum cash balance of $0.3 million as a security deposit on the space which is classified as restricted cash, current on the consolidated balance sheets. The Company pays for its proportionate share of building operating expenses and taxes that are treated as variable costs and excluded from the measurement of the lease. The sublease grants the Company an option to extend the term for an additional three years at the fair market rent by giving </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the landlord nine months written notice. The Company was not reasonably certain to exercise the option to extend the lease and therefore the extension term was excluded from the measurement of the lease.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Storage Facilities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company additionally leases three storage spaces on a month-to-month basis that are classified as short-term leases.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost recognized during the years ended December 31, 2023 and December 31, 2022 was $1.2 million and $1.0 million, respectively. Cash paid for amounts included in the measurement of lease liabilities for the years ended December 31, 2023 and December 31, 2022 was $1.4 million and $1.1 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average remaining lease term and discount rate were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future annual lease payments under non-cancelable operating leases as of December 31, 2023 were as follows (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of operating lease liability </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,391 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 300000 P3Y P9M 3 1200000 1000000 1400000 1100000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average remaining lease term and discount rate were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> P0Y9M18D P1Y9M18D 0.0775 0.0695 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future annual lease payments under non-cancelable operating leases as of December 31, 2023 were as follows (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of operating lease liability </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,391 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1432000 0 1432000 41000 1391000 Accounts Receivable<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Expected Credit Losses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the allowance for expected credit losses were as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Allowance for Expected Credit Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2021</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(50)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Write-offs, net of recoveries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(200)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Write-offs, net of recoveries</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">28</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(582)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the allowance for expected credit losses were as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Allowance for Expected Credit Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2021</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(50)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Write-offs, net of recoveries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(200)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Write-offs, net of recoveries</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">28</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(582)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 50000 150000 0 200000 410000 28000 582000 Inventory<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,869 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,638 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,923 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,507 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,257 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,869 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,638 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,923 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,507 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,257 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1869000 2334000 7638000 7923000 9507000 10257000 Prepaid expenses and other current assets<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,177 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,666 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid subscriptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of net investment in sales-type leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,954 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,388 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,177 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,666 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid subscriptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of net investment in sales-type leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,954 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,388 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 12177000 9666000 1868000 897000 367000 337000 1208000 2374000 1334000 1114000 16954000 14388000 Property and Equipment, Net<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computers and telecom equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lab equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leased equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,206 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,983 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales demo equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment held for lease</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,910 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,826 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,493 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,175 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,493 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,921 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,707 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Represents equipment that has not yet been deployed to a customer and, accordingly, is not being depreciated.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023 and 2022, the net book value of capitalized software was $7.0 million and $3.5 million, respectively. These amounts include $0.7 million and approximately $0.2 million of capitalized stock compensation costs, respectively. Depreciation expense and amortization expense related to property and equipment was $9.9 million and $5.5 </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million for the years ended December 31, 2023 and 2022, respectively, which included amortization expense of capitalized software of $1.0 million and $0.6 million for the years ended December 31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leased equipment and the related accumulated depreciation were as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leased equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,983 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,802)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leased equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,923 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,181 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense related to leased units was $8.0 million and $4.3 million during the years ended December 31, 2023 and 2022, respectively. Depreciable lives are generally 7 years, consistent with the Company’s planned and historical usage of the equipment subject to operating leases.</span></div>Loss from impairment of property and equipment was $0.3 million and $1.2 million during the years ended December 31, 2023 and 2022, respectively. This primarily related to the removal of Evolv Edge units and Evolv Express prototypes from service, resulting in an impairment of the remaining economic value of such units. <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computers and telecom equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lab equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leased equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,206 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,983 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales demo equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment held for lease</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,910 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,826 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,493 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,175 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,493 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,921 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,707 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Represents equipment that has not yet been deployed to a customer and, accordingly, is not being depreciated.</span></div> 1331000 599000 1171000 871000 111000 111000 566000 542000 80206000 35983000 8629000 4150000 2758000 2340000 32910000 7826000 2493000 71000 130175000 52493000 17254000 7786000 112921000 44707000 7000000 3500000 700000 200000 9900000 5500000 1000000 600000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leased equipment and the related accumulated depreciation were as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leased equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,206 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,983 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,283)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,802)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leased equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,923 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,181 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 80206000 35983000 13283000 5802000 66923000 30181000 8000000 4300000 P7Y 300000 1200000 Accrued Expenses and Other Current Liabilities<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee compensation and benefits expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,780 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,225 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services and consulting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase order cancellation fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,578 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,545 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee compensation and benefits expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,780 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,225 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services and consulting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,579 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase order cancellation fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,388 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,918 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,578 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,545 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 7780000 7225000 1579000 722000 1643000 1680000 1188000 0 3388000 1918000 15578000 11545000 Long-term Debt<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s long-term debt consisted of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Term loans payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,683 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Long-term debt, net of discount</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,683 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Silicon Valley Bank Term Loan Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Company entered into a loan and security agreement (the "2022 SVB Credit Agreement") with Silicon Valley Bank ("SVB") in order to finance purchases of hardware to be leased to customers. The 2022 SVB Credit Agreement provided for an initial term loan advance of $30.0 million, which was approximately equivalent to the value of all hardware purchases made to support leasing transactions with the Company's customers through December 21, </span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 (the "SVB Closing Date"), with the opportunity to obtain, within 18 months after the SVB Closing Date, additional term loan advances, subject to the satisfaction of certain conditions, in an aggregate principal amount equal to $20.0 million (subject to an increase of an additional $25.0 million upon the satisfaction of certain conditions and approval from SVB). The interest rate applicable to the SVB term loans was the greater of (a) the Wall Street Journal Prime Rate plus 1.0% or (b) 7.25% per annum. Interest and principal under the 2022 SVB Credit Agreement was payable monthly. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2023, SVB was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Corporation ("FDIC") as receiver. The FDIC created a successor bridge bank, Silicon Valley Bridge Bank, N.A. ("SVBB"), and all deposits of SVB were transferred to SVBB under a systemic risk exception approved by the Federal Reserve Board, the U.S. Treasury Department, and the FDIC. On March 12, 2023, the Federal Reserve Board, the U.S. Treasury Department, and the FDIC announced in a joint statement that all SVB deposits, including both insured and uninsured amounts, would be available in full to account holders. SVB was acquired by First Citizens Bank on March 27, 2023.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the foregoing, on March 28, 2023, upon the recommendation of the Company’s newly-formed Investment Committee of the Board of Directors, the Company (i) gave notice of its desire and intent to terminate the commitments under the 2022 SVB Credit Agreement and (ii) transferred its excess cash out of First Citizens Bank (the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“Transfer”). The Transfer resulted in an event of default under the 2022 SVB Credit Agreement. Upon the occurrence of such event of default, First Citizens Bank could have, but was not required to, declare all obligations under the 2022 SVB Credit Agreement immediately due and payable. First Citizens Bank did not make such declaration following such event of default. </span></div>On March 31, 2023, the Company fully repaid all borrowings and accrued interest under the 2022 SVB Credit Agreement and terminated the 2022 SVB Credit Agreement. In accordance with the terms of the 2022 SVB Credit Agreement, the Company was required to pay a prepayment premium equal to 1.0% of the principal balance on the date of repayment. The Company incurred a loss on debt extinguishment of $0.6 million, consisting of the prepayment penalty of $0.3 million and the write-off of $0.3 million of unamortized debt issuance costs. <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s long-term debt consisted of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Term loans payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,683 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Long-term debt, net of discount</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,683 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 30000000 0 317000 0 29683000 0 10000000 0 19683000 30000000 P18M 20000000 25000000 0.010 0.0725 0.010 -600000 300000 300000 Warrants<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023 and 2022, warrants to purchase the following classes of common stock outstanding consisted of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Warrant Description</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underlying Equity<br/>Instrument</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares Issuable<br/>Upon Exercise<br/>of Warrant</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finback Common Stock Warrants (see Note 15)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 13, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,317,327 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public Warrants (see Note 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 16, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,324,893 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,642,220 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Warrant Description</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underlying Equity<br/>Instrument</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares Issuable<br/>Upon Exercise<br/>of Warrant</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finback Common Stock Warrants (see Note 15)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 13, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,421,200 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public Warrants (see Note 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 16, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,324,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,746,194 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div> <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023 and 2022, warrants to purchase the following classes of common stock outstanding consisted of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Warrant Description</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underlying Equity<br/>Instrument</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares Issuable<br/>Upon Exercise<br/>of Warrant</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finback Common Stock Warrants (see Note 15)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 13, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,317,327 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public Warrants (see Note 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 16, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,324,893 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,642,220 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.661%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Warrant Description</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Issuance Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Underlying Equity<br/>Instrument</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares Issuable<br/>Upon Exercise<br/>of Warrant</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finback Common Stock Warrants (see Note 15)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 13, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,421,200 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Public Warrants (see Note 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 16, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,324,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,746,194 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div> P10Y 1317327 0.42 P5Y 14324893 11.50 15642220 P10Y 2421200 0.42 P5Y 14324994 11.50 16746194 Common Stock<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the board of directors, subject to the preferential dividend rights of Preferred Stock. As of December 31, 2023 and 2022, no cash dividends had been declared or paid.</span></div>As of December 31, 2023 and 2022, the Company had reserved 80,298,297 and 79,795,376 shares, respectively, of common stock for the exercise of outstanding stock options, vesting of outstanding restricted stock units and performance stock units, vesting of contingent earn-out shares, vesting of contingently issuable common stock, granting of awards under the Company’s 2021 Equity Incentive Plan (see Note 15), and the exercise of outstanding warrants (see Note 13). In addition, as of December 31, 2023 and 2022, the Company had 6,315,248 and 4,863,198 shares, respectively, of common stock available to be issued under the 2021 Employee Stock Purchase Plan (see Note 15). 1 0 0 80298297 79795376 6315248 4863198 Stock-Based Compensation<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Equity Incentive Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) provides for the Company to grant incentive stock options or nonqualified stock options, restricted stock awards, restricted stock units, performance stock units, and other stock-based awards to employees, officers, directors, and non-employees of the Company. A total of 21,177,295 shares of common stock were initially authorized under the 2021 Plan, subject to annual evergreen increases of up to 5% of total common shares outstanding as of the end of the prior year. As of December 31, 2023, 14,007,370 shares were available for future grant under the 2021 Plan. Shares, units, and options that are expired, forfeited, canceled, or otherwise terminated without having been fully exercised will be available for future grant under the 2021 Plan. In addition, shares of common stock that are tendered to the Company by a participant to exercise an award are added to the number of shares of common stock available for future grants.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Plan is administered by the Board of Directors or, at the discretion of the Board of Directors, by a committee of the Board of Directors. The exercise prices, vesting, and other restrictions are determined at the discretion of the Board of Directors, or its committee if so delegated, except that the exercise price per share of stock options may not be less than 100% of the fair market value of a share of common stock on the date of grant and the term of the stock option may not be greater than ten years. Stock options granted to employees, officers, members of the Board of Directors and non-employees vesting terms are determined on an individual basis on the date of grant. Prior to the closing of the Merger, the Company’s Board of Directors valued the Company’s common stock, taking into consideration its most recently available valuation of common stock performed by third parties as well as additional factors which may have changed since the date of the most recent contemporaneous valuation through the date of grant. After the closing of the Merger, the fair value of each share of common stock underlying stock-based awards is based on the closing price of our common stock as reported by Nasdaq on the date of grant.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted during the years ended December 31, 2023 and 2022:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.2 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.6 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">87.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">75.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company’s stock option activity under the 2021 Equity Incentive Plan (in thousands, except for share and per share data):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Remaining<br/>Contractual Term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,769,130</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.39 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,262,925</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,896,975)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(710,707)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(27,549)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,396,824</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,840,421</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,735,978)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,164,932)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(11,807)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,324,528</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.04 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74,768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and expected to vest as of December 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,324,528</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.04 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74,768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options exercisable as of December 31, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,114,401</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">65,339 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for those options that had exercise prices lower than the fair value of the Company’s common stock.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of stock options granted was $2.35 and $2.32 during the years ended December 31, 2023 and 2022, respectively. The aggregate intrinsic value of the stock options exercised was $8.7 million and $4.4 million during the years ended December 31, 2023 and 2022, respectively. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s restricted stock units activity under its existing restricted stock unit plan:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,951,924</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.76 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,613,472</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(565,774)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,497,677)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,501,945</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.54 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,477,014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,833,155)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,099,125)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,046,679</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.49 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2023 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the aggregate grant-date fair value of restricted stock units issued under the 2021 Plan was $33.0 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $24.9 million, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. RSUs generally vest ratably over a three year period subject to the grantee's continued service through the applicable vesting date. During the year ended December 31, 2023 and 2022, the total fair value of shares vested was $10.1 million and $3.8 million, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Stock Units</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's performance stock units activity under its existing performance stock units plan:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">947,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(83,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">864,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.65 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(432,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(52,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">380,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.64 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon the terms of the award agreements and achievement of the performance goal, 50% of the applicable performance stock units vested on January 1, 2023 and 50% on January 1, 2024, subject to the grantee’s continued service through the applicable vesting date.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Employee Stock Purchase Plan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company’s Board of Directors adopted the 2021 Employee Stock Purchase Plan (“2021 ESPP”), which was subsequently approved by the Company’s stockholders and became effective on July 16, 2021. The 2021 ESPP authorizes the initial issuance of up to 3,435,748 shares of the Company’s common stock to eligible employees of the Company or, as designated by the Company’s Board of Directors, employees of a related company. The 2021 ESPP provides that the number of shares reserved and available for issuance under the 2021 ESPP will automatically increase each January 1, beginning on January 1, 2022 and ending on (and including) January 1, 2032, by an amount equal to the lesser of (i) 1% of the outstanding number of shares of common stock on the immediately preceding December 31 and (ii) such smaller number of shares as determined by the Company’s Board of Directors. As of December 31, 2023, 6,315,248 shares of the Company’s common stock were available for future issuance. The Company’s Board of Directors may from time to time grant or provide for the grant to eligible employees of options to purchase common stock under the 2021 ESPP during a specific offering period. As of December 31, 2023, no offerings have been approved.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finback Common Stock Warrants</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilized a Black-Scholes pricing model to determine the grant-date fair value of the Finback Common Stock Warrants. The assumptions used are presented in the following table:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Warrants - Black Scholes</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company granted warrants (the "Finback Common Stock Warrants") to purchase 2,552,913 shares of the Company's Class A common stock at an exercise price of $0.42 per share to Finback Evolv OBH, LLC ("Finback"), a consulting group affiliated with one of the Company's stockholders. The Finback Common Stock Warrants vest upon meeting certain sales criteria as defined in a business development agreement (the "Finback BDA"), which has a term of 3 years. The Finback BDA expired on January 1, 2023, subject to a 1-year "tail period" expiring on January 1, 2024. During the tail period, the Finback Common Stock Warrants will continue to vest related to any sale consummated by the Company for which it is determined Finback provided services prior to January 1, 2023 in furtherance of the sale. The Finback Common Stock Warrants expire in January 2031. The Finback Common Stock Warrants are accounted for under ASC 718 Compensation – Stock Compensation as the warrants vest upon certain performance conditions being met. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the date of issuance, the Finback Common Stock Warrants were valued at $19.5 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the Merger, vested Finback Common Stock Warrants automatically converted into 131,713 shares of the Company’s common stock. As of December 31, 2023, 117,423 Finback Common Stock Warrants were exercisable at a total aggregate intrinsic value of $0.5 million. The remaining 1,199,904 Finback Common Stock Warrants are unvested and have a total unrecognized grant date fair value of $9.1 million. As of December 31, 2023, 1,103,873 of the Finback common stock warrants were exercised. The Company recognizes compensation expense for the Finback Common Stock Warrants when the warrants become vested based on meeting the specified sales criteria. During the years ended December 31, 2023 and 2022, the Company recorded $3.1 million and $4.5 million, respectively, of stock-based compensation expense within sales and marketing expense related to the Finback Common Stock Warrants.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was classified in the consolidated statements of operations and comprehensive loss as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">583</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">829</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,284</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Sales and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,387</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,038</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,897</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,622</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,151</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,498</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense by award type recognized in the consolidated statements of operations and comprehensive loss was as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stock options </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,925</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,594</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Earn-out shares</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,073</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,499</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,147</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,523</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">RSUs and PSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,006</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,882</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total stock-based compensation expense </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,151</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,498</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unrecognized compensation expense related to stock options and restricted stock units as of December 31, 2023, was $40.8 million, which is expected to be recognized over a weighted average period of 2.1 years. Total unrecognized compensation expense related to earn-out shares associated with the share-based compensation arrangement as of December 31, 2023, was $0.2 million, which is expected to be recognized over a weighted average period of 0.5 years.</span></div> 21177295 0.05 14007370 1 P10Y <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted during the years ended December 31, 2023 and 2022:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.2 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.6 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">87.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">75.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div> 0.042 0.016 P6Y1M6D P6Y1M6D 0.875 0.750 0.000 0.000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company’s stock option activity under the 2021 Equity Incentive Plan (in thousands, except for share and per share data):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Remaining<br/>Contractual Term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,769,130</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.39 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,262,925</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,896,975)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(710,707)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(27,549)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,396,824</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.73 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,840,421</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,735,978)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,164,932)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(11,807)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,324,528</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.04 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74,768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and expected to vest as of December 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,324,528</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.04 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74,768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options exercisable as of December 31, 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,114,401</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">65,339 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 20769130 0.39 2262925 3.49 1896975 0.43 710707 0.42 27549 0.42 20396824 0.73 2840421 3.12 1735978 0.38 1164932 1.72 11807 0.42 20324528 1.04 P6Y 74768000 20324528 1.04 P6Y 74768000 16114401 0.67 P5Y4M24D 65339000 2.35 2.32 8700000 4400000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s restricted stock units activity under its existing restricted stock unit plan:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,951,924</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.76 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,613,472</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(565,774)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,497,677)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,501,945</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.54 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,477,014</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.48 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,833,155)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,099,125)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,046,679</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.49 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1951924 6.76 7613472 3.26 565774 6.72 1497677 5.15 7501945 3.54 9477014 3.48 2833155 3.55 1099125 3.54 13046679 3.49 33000000 24900000 P3Y 10100000 3800000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's performance stock units activity under its existing performance stock units plan:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">947,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(83,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">864,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.65 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(432,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(52,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">380,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.64 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 0 947000 2.65 0 0 83000 2.65 864000 2.65 0 0 432000 2.65 52000 2.67 380000 2.64 0.50 0.50 3435748 0.01 6315248 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilized a Black-Scholes pricing model to determine the grant-date fair value of the Finback Common Stock Warrants. The assumptions used are presented in the following table:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Warrants - Black Scholes</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div> 0.4 3.0 23.9 0 2552913 0.42 3 19500000 131713 117423 500000 1199904 9100000 1103873 3100000 4500000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was classified in the consolidated statements of operations and comprehensive loss as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">583</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">829</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,284</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Sales and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,387</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,038</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,897</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,622</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,151</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,498</span></td></tr></table></div> 583000 829000 4284000 4009000 9387000 10038000 9897000 7622000 24151000 22498000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense by award type recognized in the consolidated statements of operations and comprehensive loss was as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stock options </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,925</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,594</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Earn-out shares</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,073</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,499</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,147</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,523</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">RSUs and PSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,006</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,882</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total stock-based compensation expense </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,151</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,498</span></td></tr></table></div> 2925000 1594000 2073000 6499000 3147000 4523000 16006000 9882000 24151000 22498000 40800000 P2Y1M6D 200000 P0Y6M Income Taxes<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s loss before income tax expense are as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">United States</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(106,261)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(85,760)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(646)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss before income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(106,203)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(86,406)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense is comprised of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">27</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total current income tax expense</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">51</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total deferred income tax expense</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">51</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate differs from the U.S. federal statutory rate primarily due to the full valuation allowance maintained on the Company’s net deferred tax assets and non-deductible fair value adjustments for the years ended December 31, 2023 and 2022. A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal statutory income tax rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21.0 %</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21.0 %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal and state research and development tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value of contingent earn-out liability and contingently issuable common stock liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(23.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-deductible compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax assets consisted of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41,541</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">36,518</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development tax credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,802</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,836</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Capitalized research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,043</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,965</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,230</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,660</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,206</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,884</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lease liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">351</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">490</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,305</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">106</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">85,478</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">66,459</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(82,558)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(64,570)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total deferred tax assets, net of valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,920</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,889</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Right of use lease asset</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(302)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(409)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(17)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,920)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,889)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023 and December 31, 2022, the Company had gross federal net operating losses of $20.1 million and $20.1 million that are subject to expire at various dates beginning in 2033, and federal net operating losses of $142.4 million and $124.3 million, which have no expiration date and can be used to offset up to 80% of future taxable income in any one tax period, respectively. The Company also had gross state net operating loss carryforwards of $142.4 </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million and $103.8 million for the years ended December 31, 2023 and 2022, respectively, which may be available to offset future state taxable income and which begin to expire in 2033. Additionally, the Company had no UK net operating loss carryforwards as of December 31, 2023 and gross UK net operating loss carryforwards of approximately $2.3 million that will not expire as of December 31, 2022. As of December 31, 2023, the Company had gross U.S. federal and state research and development and other tax credit carryforwards of $2.5 million and $1.6 million, respectively, which may be available to offset future tax liabilities and the majority of which begin to expire in 2033 and 2030, respectively. As of December 31, 2022, the Company had gross U.S. federal and state research and development and other tax credit carryforwards of $2.5 million and $1.6 million, respectively, which may be available to offset future tax liabilities and the majority of which begin to expire in 2033 and 2029, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of the U.S. federal and state net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Sections 382 and 383 of the Internal Revenue Code of 1986, and corresponding provisions of state law, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income or tax liabilities. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards would be subject to an annual limitation under Section 382, which is determined by first multiplying the value of the Company’s stock at the time of the ownership change by the applicable long-term tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the significant negative evidence of its history of cumulative net operating losses incurred since inception, as well as other positive and negative evidence bearing upon its ability to realize the deferred tax assets, and has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets as of December 31, 2023 and 2022. If or when recognized, the tax benefits related to any reversal of the valuation allowance on deferred tax assets as of December 31, 2023, will be accounted for as follows: approximately $80.0 million will be recognized as a reduction of income tax expense and $2.5 million will be recorded as an increase in equity. The Company reevaluates the positive and negative evidence at each reporting period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the valuation allowance for deferred tax assets related primarily to the increase in net operating loss carryforwards and capitalized R&amp;D costs and were as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Valuation allowance as of beginning of year</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">64,570</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">43,966</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions charged to provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,988</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,320</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions charged to equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">332</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Currency translation and other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(48)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Valuation allowance as of end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">82,558</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">64,570</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income tax uncertainties in accordance with ASC 740 Income Taxes, which prescribes a recognition threshold and measurement criteria for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Benefits from tax positions should be recognized in the financial statements only when it is more likely than not that the tax position will be sustained upon examination by the appropriate taxing authority that would have full knowledge of all relevant information. A tax position that meets the more likely than not recognition threshold is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Tax positions that previously failed to meet the more likely than not recognition threshold should be recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more likely than not recognition threshold should be derecognized in the first subsequent </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial reporting period in which that threshold is no longer met. ASC 740 also provides guidance on the accounting for and disclosure of liabilities for uncertain tax positions, interest and penalties. The Company’s policy is to record interest and penalties related to income taxes as part of its income tax provision.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company’s uncertain tax positions (excluding interest and penalties and related tax attributes) (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of fiscal year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross increases related to prior year tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">407</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Foreign exchange and others</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of fiscal year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">428</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s liability for uncertain tax positions as of December 31, 2023, includes $0.4 million related to amounts that, if recognized, would affect the effective tax rate (excluding related interest and penalties).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal, state, and non-US jurisdictions, where applicable. The Company is open to future tax examinations in the US under statute from 2020 to the present; however, carryforward attributes that were generated prior to 2020 may still be adjusted upon examination by federal, state, or local tax authorities if they either have been or will be used in a future period. The Company is also open for future tax examinations under statute from 2021 to the present in the UK. The Company has not received notice of examination in any jurisdictions for any tax year open under statute.</span></div> <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s loss before income tax expense are as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">United States</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(106,261)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(85,760)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">58 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(646)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss before income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(106,203)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(86,406)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -106261000 -85760000 58000 -646000 -106203000 -86406000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense is comprised of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">27</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total current income tax expense</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">51</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total deferred income tax expense</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">51</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr></table></div> 0 0 27000 0 24000 0 51000 0 0 0 0 0 0 0 0 0 51000 0 A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal statutory income tax rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21.0 %</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21.0 %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal and state research and development tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value of contingent earn-out liability and contingently issuable common stock liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(23.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-deductible compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div> 0.210 0.210 0.034 0.035 0 0.012 -0.045 0.034 -0.169 -0.236 -0.004 0 0.008 -0.001 -0.006 -0.002 -0.024 -0.026 -0.001 -0.002 -0.003 0 0.000 0.000 <div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax assets consisted of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41,541</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">36,518</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development tax credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,802</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,836</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Capitalized research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,043</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,965</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,230</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,660</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,206</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,884</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lease liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">351</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">490</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,305</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">106</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">85,478</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">66,459</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(82,558)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(64,570)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total deferred tax assets, net of valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,920</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,889</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Right of use lease asset</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(302)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(409)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(17)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,920)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,889)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr></table></div> 41541000 36518000 3802000 3836000 13043000 9965000 7230000 6660000 18206000 8884000 351000 490000 1305000 106000 85478000 66459000 82558000 64570000 2920000 1889000 2601000 1464000 302000 409000 17000 16000 2920000 1889000 0 0 20100000 20100000 142400000 124300000 142400000 103800000 0 2300000 2500000 1600000 2500000 1600000 80000000 2500000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the valuation allowance for deferred tax assets related primarily to the increase in net operating loss carryforwards and capitalized R&amp;D costs and were as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Valuation allowance as of beginning of year</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">64,570</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">43,966</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions charged to provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,988</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,320</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additions charged to equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">332</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Currency translation and other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(48)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Valuation allowance as of end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">82,558</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">64,570</span></td></tr></table></div> 64570000 43966000 17988000 20320000 0 332000 0 -48000 82558000 64570000 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income tax uncertainties in accordance with ASC 740 Income Taxes, which prescribes a recognition threshold and measurement criteria for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Benefits from tax positions should be recognized in the financial statements only when it is more likely than not that the tax position will be sustained upon examination by the appropriate taxing authority that would have full knowledge of all relevant information. A tax position that meets the more likely than not recognition threshold is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Tax positions that previously failed to meet the more likely than not recognition threshold should be recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more likely than not recognition threshold should be derecognized in the first subsequent </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial reporting period in which that threshold is no longer met. ASC 740 also provides guidance on the accounting for and disclosure of liabilities for uncertain tax positions, interest and penalties. The Company’s policy is to record interest and penalties related to income taxes as part of its income tax provision.</span></div> <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company’s uncertain tax positions (excluding interest and penalties and related tax attributes) (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of fiscal year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross increases related to prior year tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">407</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Foreign exchange and others</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of fiscal year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">428</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td></tr></table></div> 0 0 407000 0 21000 0 428000 0 400000 Net Loss per Share<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income (loss) attributable to common stockholders – basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(106,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(86,406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average common shares outstanding - basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,168,105</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,858,668</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss per share attributable to common stockholders – basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.71)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.60)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,324,528 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,396,824 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Public Warrants to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,324,893 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,324,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase common stock (Finback)**</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,317,327 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,421,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,046,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,501,945 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unvested performance stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">380,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">864,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Earn-out shares*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,000,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,000,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contingently issuable common stock*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,897,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,897,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">66,290,927 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">62,406,463 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.242%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Issuance of Earn-out shares and Contingently issuable common stock is contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Includes 117,423 vested warrants and 1,199,904 unvested warrants as of December 31, 2023.</span></div> <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income (loss) attributable to common stockholders – basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(106,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(86,406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average common shares outstanding - basic and diluted</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,168,105</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,858,668</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss per share attributable to common stockholders – basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.71)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.60)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -106254000 -106254000 -86406000 -86406000 149168105 149168105 143858668 143858668 -0.71 -0.71 -0.60 -0.60 <div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Year Ended December 31, </span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,324,528 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,396,824 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Public Warrants to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,324,893 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,324,994 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase common stock (Finback)**</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,317,327 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,421,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,046,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,501,945 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unvested performance stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">380,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">864,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Earn-out shares*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,000,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,000,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contingently issuable common stock*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,897,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,897,500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">66,290,927 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">62,406,463 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.242%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Issuance of Earn-out shares and Contingently issuable common stock is contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Includes 117,423 vested warrants and 1,199,904 unvested warrants as of December 31, 2023.</span></div> 20324528 20396824 14324893 14324994 1317327 2421200 13046679 7501945 380000 864000 15000000 15000000 1897500 1897500 66290927 62406463 117423 1199904 Related Party Transactions<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Development Agreement with Finback</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company granted the Finback Common Stock Warrants subject to the terms of the Finback BDA, as discussed in Note 15.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger and pursuant to the Merger Agreement, in addition to earn-out shares allocated to Finback based on its common stock ownership percentage as of the Merger date, Finback is entitled to receive a proportional share of earn-out shares based upon its remaining unvested warrants as of the Merger Date.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Original Equipment Manufacturer Partnership Agreement with Motorola Solutions, Inc.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company entered into an original equipment manufacturer partnership agreement with Motorola Solutions, Inc. ("Motorola"), an investor in the Company. The partnership agreement has since been amended and restated.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Motorola sells Motorola-branded premium products based on the Evolv Express platform through their worldwide network of over 2,000 resellers and integration partners, and has integrated the Evolv Express platform with Motorola products. During the years ended December 31, 2023 and 2022, revenue from Motorola’s distributor services was $9.6 million and $11.6 million, respectively. As of December 31, 2023 and 2022, accounts receivable related to Motorola’s distributor services were $1.2 million and $12.5 million, respectively.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reseller Agreement with Stanley Black &amp; Decker</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company entered into a reseller agreement with Stanley Black &amp; Decker, an investor in the Company. Stanley Black &amp; Decker's electronic security business was acquired by Securitas AB ("Securitas") in 2023. Securitas, directly or through its affiliates, resells the Company's products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the years ended December 31, 2023 and 2022, revenue from Stanley Black &amp; Decker’s reseller services was $1.7 million and $1.9 million, respectively. As of December 31, 2023 and 2022, accounts receivable related to Stanley Black &amp; Decker’s reseller services were $0.6 million and $2.2 million, respectively.</span></div> 2000 9600000 11600000 1200000 12500000 1700000 1900000 600000 2200000 Commitments and Contingencies<div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnification Agreements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its Board of Directors and certain of its executive officers and employees that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their role, status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not currently aware of any indemnification claims and has not accrued any liabilities related to such obligations in its consolidated financial statements as of December 31, 2023 or 2022.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not a party to any litigation of a material nature and does not have contingency reserves established for any litigation liabilities. At each reporting date, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company expenses the costs related to such legal proceedings as incurred.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company is subject to regulatory and governmental examinations, information gathering requests, inquiries, and investigations. The FTC has previously requested information about certain aspects of the Company's marketing practices. The Company is cooperating with the investigation and has provided documentation and information responsive to the FTC inquiry. We currently do not expect this investigation to have a material effect on our results of operations, financial condition or liquidity, either individually or in the aggregate.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, in February 2024, we received a subpoena from the SEC, Division of Enforcement, requesting that we produce certain documents and informatio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n, much </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of which is similar to the documents and information previously requested by the FTC. We are cooperating and intend to continue to cooperate with the SEC's investigation. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We can offer no assurances as to the outcome of these investigations or their potential effect, if any, on us or our results of operations. There can be no assurance whether there will be further information requests or potential enforcement action or litigation, which is necessarily uncertain.</span></div> Benefit Plans<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established a defined contribution savings plan under Section 401(k) of the Code. This plan covers all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pre-tax basis. The Company made $0.3 million matching contributions to the plan during the year ended December 31, 2023. The Company did not make any matching contributions to the plan during the year ended December 31, 2022.</span></div> 300000 0 false false false <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On December 15, 2023, Anil Chitkara, Chief Growth Officer and Founder, adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 200,000 shares of the Company’s common stock until September 6, 2024.</span> December 15, 2023 Anil Chitkara Chief Growth Officer and Founder true 200000 Includes related party accounts receivable, net of $1.7 million and $14.6 million as of December 31, 2023 and December 31, 2022, respectively. Includes related party revenue of $11.3 million and $13.5 million for the years ended December 31, 2023 and 2022, respectively.

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